Go to
JCI Insight
Citations to this article
Guang Chen, … , Jianping Zhao, Qin Ning
Published March 27, 2020
Citation Information: J Clin Invest. 2020;130(5):2620-2629. https://doi.org/10.1172/JCI137244.
Citation Information: J Clin Invest. 2020;130(5):2620-2629. https://doi.org/10.1172/JCI137244.
Abstract
BACKGROUND Since December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, and is now becoming a global threat. We aimed to delineate and compare the immunological features of severe and moderate COVID-19.METHODS In this retrospective study, the clinical and immunological characteristics of 21 patients (17 male and 4 female) with COVID-19 were analyzed. These patients were classified as severe (11 cases) and moderate (10 cases) according to the guidelines released by the National Health Commission of China.RESULTS The median age of severe and moderate cases was 61.0 and 52.0 years, respectively. Common clinical manifestations included fever, cough, and fatigue. Compared with moderate cases, severe cases more frequently had dyspnea, lymphopenia, and hypoalbuminemia, with higher levels of alanine aminotransferase, lactate dehydrogenase, C-reactive protein, ferritin, and D-dimer as well as markedly higher levels of IL-2R, IL-6, IL-10, and TNF-α. Absolute numbers of T lymphocytes, CD4+ T cells, and CD8+ T cells decreased in nearly all the patients, and were markedly lower in severe cases (294.0, 177.5, and 89.0 × 106/L, respectively) than moderate cases (640.5, 381.5, and 254.0 × 106/L, respectively). The expression of IFN-γ by CD4+ T cells tended to be lower in severe cases (14.1%) than in moderate cases (22.8%).CONCLUSION The SARS-CoV-2 infection may affect primarily T lymphocytes, particularly CD4+ and CD8+ T cells, resulting in a decrease in numbers as well as IFN-γ production by CD4+ T cells. These potential immunological markers may be of importance because of their correlation with disease severity in COVID-19.TRIAL REGISTRATION This is a retrospective observational study without a trial registration number.FUNDING This work is funded by grants from Tongji Hospital for the Pilot Scheme Project, and partly supported by the Chinese National Thirteenth Five Years Project in Science and Technology for Infectious Disease (2017ZX10202201).
Authors
Guang Chen, Di Wu, Wei Guo, Yong Cao, Da Huang, Hongwu Wang, Tao Wang, Xiaoyun Zhang, Huilong Chen, Haijing Yu, Xiaoping Zhang, Minxia Zhang, Shiji Wu, Jianxin Song, Tao Chen, Meifang Han, Shusheng Li, Xiaoping Luo, Jianping Zhao, Qin Ning
Total citations by year
Citation information
Citations to this article (3049)
| Title and authors | Publication | Year |
|---|---|---|
|
Long-term mitochondrial and metabolic impairment in lymphocytes of subjects who recovered after severe COVID-19
Gómez-Delgado I, López-Pastor AR, González-Jiménez A, Ramos-Acosta C, Hernández-Garate Y, Martínez-Micaelo N, Amigó N, Espino-Paisán L, Anguita E, Urcelay E |
Cell Biology and Toxicology | 2025 |
|
The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells
Tu TH, Bennani FE, Masroori N, Liu C, Nemati A, Rozza N, Grunbaum AM, Kremer R, Milhalcioiu C, Roy DC, Rudd CE |
Communications Biology | 2025 |
|
An animal model of severe acute respiratory distress syndrome for translational research
Chu KA, Lai CY, Chen YH, Kuo FH, Chen IY, Jiang YC, Liu YL, Ko TL, Fu YS |
Laboratory Animal Research | 2025 |
|
Polymorphisms Influence the Expression of the Fas and FasL Genes in COVID-19
dos Santos Brito WR, de Brito WB, dos Santos Ferreira F, Santana EG, da Costa Lopes J, da Silva Graça Amoras E, Lima SS, dos Santos EF, da Costa FP, de Sarges KM, Cantanhede MH, de Brito MT, da Silva AL, de Meira Leite M, de Nazaré do Socorro de Almeida Viana M, Rodrigues FB, da Silva R, Viana GM, do Socorro Souza Chaves T, de Oliveira Lameira Veríssimo A, da Silva Carvalho M, Henriques DF, da Silva CP, Nunes JA, Costa IB, Brasil-Costa I, Quaresma JA, Cayres-Vallinoto IM, Reis LO, Falcão LF, dos Santos EJ, Vallinoto AC, Queiroz MA |
International Journal of Molecular Sciences | 2025 |
|
Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials
Moharram FA, Ibrahim RR, Mahgoub S, Abdel-Aziz MS, Said AM, Huang HC, Chen LY, Lai KH, Hashad N, Mady MS |
PLOS ONE | 2025 |
|
COVID-19 and HIV: Clinical Outcomes and Inflammatory Markers in a Cohort from a Reference Hospital in Rio de Janeiro, Brazil
de Sá NB, Macieira KV, Coelho MR, Goulart MN, Ribeiro-Alves M, Rosadas LA, Geraldo KM, Ribeiro MP, Cardoso SW, Grinsztejn B, Veloso VG, Cazote AD, de Almeida DV, Giacoia-Gripp CB, Côrtes FH, Morgado MG |
Viruses | 2025 |
|
Utility of Protein Markers in COVID-19 Patients
Alicia LB, María Ángeles OG, Desirée MG, Maximino R, Marilina GA |
International Journal of Molecular Sciences | 2025 |
|
Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19
Guironnet-Paquet A, Hamzeh-Cognasse H, Berard F, Cognasse F, Richard JC, Yonis H, Mezidi M, Desebbe O, Delannoy B, Demeret S, Marois C, Saheb S, Le QV, Schoeffler M, Pugliesi PS, Debord S, Bastard P, Cobat A, Casanova JL, Pescarmona R, Viel S, Nicolas JF, Nosbaum A, Vocanson M, Hequet O |
Frontiers in Immunology | 2025 |
|
Immature Platelets and Platelet Reactivity in Patients with COVID-19
Balmakov Y, Mark T, Barnett I, Cipok M, Lev EI, Cohen A, Aviram E, Mayo A |
Clinical and Applied Thrombosis/Hemostasis | 2025 |
|
A Review of the Hematological Picture of Severe COVID-19 Infection
Amoroso D, Bongo S, Copponi A, Rossi V, Di Giorgio R, Bernardini S, Ippoliti L, Morello M |
Cureus | 2025 |
|
Challenging the notion of endothelial infection by SARS-CoV-2: insights from the current scientific evidence
Subramaniam S, Jose A, Kenney D, O\u2019Connell AK, Bosmann M, Douam F, Crossland N |
Frontiers in Immunology | 2025 |
|
RNA Viruses, Toll-Like Receptors, and Cytokines: The Perfect Storm?
Stegeman SK, Kourko O, Amsden H, Pellizzari Delano IE, Mamatis JE, Roth M, Colpitts CC, Gee K |
Journal of Innate Immunity | 2025 |
|
Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review
Zhao Y, Tang Y, Wang QY, Li J |
Frontiers in Immunology | 2025 |
|
Lymphocyte Inhibition Mechanisms and Immune Checkpoints in COVID-19: Insights into Prognostic Markers and Disease Severity
Schniederova M, Bobcakova A, Grendar M, Markocsy A, Ceres A, Cibulka M, Dobrota D, Jesenak M |
Medicina | 2025 |
|
Deep learning enhances the prediction of HLA class I-presented CD8+ T cell epitopes in foreign pathogens
Wohlwend J, Nathan A, Shalon N, Crain CR, Tano-Menka R, Goldberg B, Richards E, Gaiha GD, Barzilay R |
Nature Machine Intelligence | 2025 |
|
The predictive value of the LDH-albumin ratio on poor clinical course and mortality in COVID-19 patients: A single-center study
Kaya H, Argun Baris S, Gultepe B, Basyigit I, Boyaci H |
Medicine | 2025 |
|
The Impact of SARS-CoV-2 Infection on Glucose Homeostasis in Hospitalized Patients with Pulmonary Impairment
Parlițeanu OA, Bălteanu MA, Zaharia DC, Constantinescu T, Cristea AM, Dumitrache-Rujinscki Ș, Nica AE, Voineag C, Alexe OS, Tabacu E, Croitoru A, Strâmbu I, Nemeș RM, Mahler B |
Diagnostics | 2025 |
|
The short-term follow-up of patients with diabetes mellitus presenting with COVID-19
Lespezeanu DA, Kraft A, Moldovan C, Ungureanu D, Bacalbasa N |
Journal of Medicine and Life | 2025 |
|
Epidemiological and clinical characteristics of COVID-19 mortality: a retrospective study
Hu Y, Lu Y, Dong J, Xia D, Li J, Wang H, Rao M, Wang C, Tong W |
Frontiers in Medicine | 2025 |
|
Impact of Early Administration of Albumin on Mortality Among Severe COVID-19 Patients, China
Sha J, Kong G, Fu L, Wang P, Zhang L, Wang T, Song F, Chu Y, Meng M |
Infection and Drug Resistance | 2025 |
|
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach
Fratta Pasini AM, Stranieri C, Di Leo EG, Bertolone L, Aparo A, Busti F, Castagna A, Vianello A, Chesini F, Friso S, Girelli D, Cominacini L |
Viruses | 2025 |
|
Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development
Alrasheed AR, Awadalla M, Alnajran H, Alammash MH, Almaqati AM, Qadri I, Alosaimi B |
Frontiers in Immunology | 2025 |
|
Single-cell immune aging clocks reveal inter-individual heterogeneity during infection and vaccination
Li W, Zhang Z, Kumar S, Botey-Bataller J, Zoodsma M, Ehsani A, Zhan Q, Alaswad A, Zhou L, Grondman I, Koeken V, Yang J, Wang G, Volland S, Crişan TO, Joosten LA, Illig T, Xu CJ, Netea MG, Li Y |
Nature Aging | 2025 |
|
Differential immunoregulation by human surfactant protein A variants determines severity of SARS-CoV-2-induced lung disease
Jacob IB, Lawal AO, Mahmoud SS, Kopsack EM, Reynolds ES, Meng Q, Fan H, Massa PT, Thangamani S, Jia H, Wang G |
Frontiers in Immunology | 2025 |
|
Decoding Inflammation: The Role of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Predicting Critical Outcomes in COVID-19 Patients
Adamescu AI, Tilișcan C, Stratan LM, Mihai N, Ganea OA, Ciobanu S, Marinescu AG, Aramă V, Aramă ȘS |
Medicina | 2025 |
|
The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis
Yuan L, Stoddard M, Sarkar S, van Egeren D, Mangalaganesh S, Nolan RP, Rogers MS, Hather G, White LF, Chakravarty A |
Vaccines | 2025 |
|
Weathering the Storm: How Age and Biologics Influence the COVID-19 Cytokine Surge
Astroth C, Shah KS, Agrawal S, Agrawal A |
Pathogens | 2025 |
|
Environmental exposures and familial background alter the induction of neuropathology and inflammation after SARS-CoV-2 infection
Chatterjee D, Kurup D, Smeyne RJ |
NPJ Parkinson's Disease | 2025 |
|
Cytokine, chemokine, and acute-phase protein profiles in plasma as correlative biomarkers of clinical outcomes for patients with COVID-19.
Vanderkamp SG, Niazy M, Stegelmeier AA, Stinson KJ, Ricker N, Bridle BW |
Scientific reports | 2025 |
|
Efficacy of tocilizumab for hospitalized patients with COVID-19 pneumonia and high IL-6 levels: A randomized controlled trial.
Sellarès-Nadal J, Espinosa-Pereiro J, Burgos J, Falcó V, Guillén-Del-Castillo A, Augustin S, Bañares-Sánchez J, Prio-Ruatg A, Martínez-Valle F, Kirkegaard-Biosca C, Sánchez-Montalvá A |
Infection | 2025 |
|
Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice.
Beltrami VA, Martins FRB, Martins DG, Queiroz-Junior CM, Félix FB, Resende LC, Santos FRDS, Lacerda LSB, Costa VRM, da Silva WN, Guimaraes PPG, Guimaraes G, Soriani FM, Teixeira MM, Costa VV, Pinho V |
Inflammation research : official journal of the European Histamine Research Society ... [et al.] | 2025 |
|
Serum lactate dehydrogenase as a prognostic marker for 90-day mortality in connective tissue disease patients receiving glucocorticoids and hospitalized with pneumonia: a cohort study.
Cheng X, Liu L, Tian Y, Lin Y |
Scientific reports | 2025 |
|
A comparative analysis of estrogen receptors, ACE2 and cytokines in pre-and postmenopausal women and men with COVID-19.
Lizarazo-Taborda MDR, Vega-Magaña N, Díaz-Palomera CD, Villegas-Pineda JC, Godínez-Rubí M, Bayardo-González RA, Ramírez-de-Arellano A, Pereira-Suárez AL |
Frontiers in public health | 2025 |
|
Post-COVID-19 lung disease: utility of biochemical and imaging markers in uncovering residual lung inflammation and monitoring anti-inflammatory therapy, a prospective study.
Khandelwal Y, Ora M, Jain B, Dixit M, Singh P, Khan A, Nath A, Agarwal V, Gambhir S |
European journal of nuclear medicine and molecular imaging | 2025 |
|
Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapy
Davis-Porada J, Tozlu C, Aiello C, Apostolidis SA, Bar-Or A, Bove R, Espinoza DA, Ferreira Brito S, Jacobs D, Kakara M, Onomichi K, Ricci A, Sabatino JJ Jr, Walker E, Wherry EJ, Zhang L, Zhu W, Xia Z, De Jager P, Wesley SF, Straus Farber R, Farber DL |
NPJ Vaccines | 2025 |
|
Tuberculosis Trends in the Post-COVID-19 Era: Is It Going to be a Global Concern?
Khojasteh-Kaffash S, Habibzadeh A, Moghaddam S, Afra F, Samieefar N, Fateh A |
Health science reports | 2025 |
|
Association between Prognostic Nutritional Index and Mortality Risk in Critically Ill Patients with Chronic Obstructive Pulmonary Disease: A Retrospective Study.
Liu QD, Wang DX |
International journal of chronic obstructive pulmonary disease | 2025 |
|
Serum cytokine levels in children with community-acquired pneumonia caused by different respiratory pathogens.
Duan Y, Ou Y, Li J, Gan X, Cao J |
Italian journal of pediatrics | 2025 |
|
Exploratory analyses of leukocyte responses in hospitalized patients treated with ozanimod following a severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection
Courtemanche O, Blais\u2010Lecours P, Lesage S, Chabot\u2010Roy G, Coderre L, Blanchet M, Châteauvert N, Lellouche F, Marsolais D |
Immunology and Cell Biology | 2025 |
|
Association between serum ferritin and mortality in patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study
Xiao W, Zhang L, Zhang Y, Hu J, Zhang J, Hua T, Yang M |
PLOS Neglected Tropical Diseases | 2025 |
|
Integrated transcriptomic analysis of COVID-19 stages and recovery: insights into key gene signatures, immune features, and diagnostic biomarkers through machine learning
Gong Z, An H |
Frontiers in Genetics | 2025 |
|
TREM-1-Linked Inflammatory Cargo in SARS-CoV-2-Stimulated Macrophage Extracellular Vesicles Drives Cellular Senescence and Impairs Antibacterial Defense
da Silva-Neto PV, de Carvalho JC, Toro DM, Oliveira BT, Cominal JG, Castro RC, Almeida MA, Prado CM, Arruda E, Frantz FG, Ramos AP, Ciancaglini P, Martins RB, da Silveira JC, Almeida F, Malmegrim KC, Sorgi CA |
Viruses | 2025 |
|
Assessment of the Abnormalities in Chest Computed Tomography and Pulmonary Function Test in Convalescents Six Months After COVID-19
Guziejko K, Moniuszko-Malinowska A, Flisiak R, Czupryna P, Sołomacha S, Sowa P, Dubatówka M, Łapińska M, Kiszkiel Ł, Szczerbiński Ł, Laskowski PP, Alimowski M, Trojan G, Kamiński KA |
Medicina | 2025 |
|
Early Immunological and Inflammation Proteomic Changes in Elderly COVID-19 Patients Predict Severe Disease Progression
Liu S, Xu W, Tu B, Xiao Z, Li X, Huang L, Yuan X, Zhou J, Yang X, Yang J, Chang D, Chen W, Wang FS |
Biomedicines | 2025 |
|
High‐Dimensional Immunophenotyping of Post‐COVID‐19 and Post‐Influenza Patients Reveals Persistent and Specific Immune Signatures After Acute Respiratory Infection
Pérez\u2010Cózar F, Cal\u2010Sabater P, Rybakowska P, Arribas\u2010Rodríguez E, Fiz\u2010López A, García\u2010Blesa A, Hernández J, Gutiérrez S, Tellería P, Novoa C, Rello SR, De Prado Á, Pérez C, Sedano R, Domínguez\u2010Gil M, Peñarrubia MJ, Pieren DK, Garrote JA, Arranz E, Eiros JM, Tamayo E, Orduña A, van Els CA, Dueñas C, Marañón C, Bernardo D, Cuesta\u2010Sancho S |
Journal of Medical Virology | 2025 |
|
Respuesta inmune innata de interferón gamma en pacientes graves positivos a COVID-19
Villalobos-Gómez FD, Palacios-Marmolejo A, Salinas-Gutiérrez R, Lagunes-Servín HE |
Revista Médica del Instituto Mexicano del Seguro Social | 2025 |
|
COVID‐19 and Liver Injury, Beyond the First Pandemic Waves: Clinical and Immune‐Virological Features
Foroghi Biland L, Di Lorenzo A, De Maria F, Muratore G, Compagno M, Campogiani L, Coppola L, Teti E, Malagnino V, Iannetta M, Sarmati L |
Journal of Viral Hepatitis | 2025 |
|
NMDA receptor antagonists mitigate COVID-19-induced neuroinflammation and improve survival in a mouse model
Prantzalos ER, Chesser JP, Logan JS, McLaurin KA, Anderson CD, Gabbard JD, Severson WE, Palmer KE, Mullins BJ, Dwoskin L, Turner JR |
Scientific Reports | 2025 |
|
COVID-19 induces persistent transcriptional changes in adipose tissue that are not associated with Long COVID
DeLine-Caballero S, Ratnasiri K, Chen H, Sahagun SJ, Mangalanathan UM, Barnard TR, Turk N, Yang J, Saini N, Ayhan EM, Memetimin H, Finlin BS, Leicht Z, Kern PA, Emery I, Leeman BM, Edelstein GE, Costa S, Choi A, Li JZ, Rosen C, McLaughlin T, Blish CA |
bioRxiv | 2025 |
|
Patients Hospitalized with COVID-19 Demonstrate Distinct Plasma Cytokine and Chemokine Concentrations in vivo and TLR-Mediated Cytokine and Chemokine Production in Whole Blood in vitro
Nguyen AN, Kouyate TS, Ryff K, Plotkin AL, Doss-Gollin S, Thomas S, McEnaney K, Ozonoff A, Diray-Arce J, Levy O, Odumade OA, Baden LR, van Haren SD, Smolen KK |
Journal of Innate Immunity | 2025 |
|
Airway Basal Stem Cells Inflammatory Alterations in COVID‐19 and Mitigation by Mesenchymal Stem Cells
Du S, Jin J, Tang C, Su Z, Wang L, Chen X, Zhang M, Zhu Y, Wang J, Ju C, Song X, Li S |
Cell Proliferation | 2025 |
|
The cyclophilin A-integrin β2 complex as a therapeutic target of viral pneumonia
Xiaoyuan Bai, Wenxian Yang, Yuna Zhao, Tongtong Cao, Runshan Lin, Pengtao Jiao, Heqiao Li, Huizi Li, Jie Min, Xiaoxiao Jia, He Zhang, Wenhui Fan, Xiaojuan Jia, Yuhai Bi, Wenjun Liu, Lei Sun |
Molecular Therapy | 2024 |
|
Modeling “two-hit” severe pneumonia in mice: pathological characteristics and mechanistic studies
Mengjia Zhao, Bixu Wang, Fangmei Zhou, Bingqi Zhu, Mingyuan Zhou, Xiaoqing Ye, Yuchi Chen, Zhishan Ding |
Inflammation | 2024 |
|
Serum soluble toll-like receptor 4 and risk for clinical severity in COVID-19 patients.
Houssen ME, Elmaria MO, Badr D, El-Mahdy R, Ghannam MA, El-Ashwah S, Denewer M, Mortada MI |
2024 | |
|
Kinetics of IL-6, C-reactive Protein and Fibrinogen Levels in COVID-19 Outpatients Who Evolved to Hypoxemia
Mendes-Filho SP, de Souza Pinheiro R, Martins FS, Giroldi PJ, e Melo RH, de Oliveira EL, dos Santos AB, Medeiros DC, Lopes JA, Chaves YO, Zuliani JP, Nogueira PA |
2024 | |
|
MBOAT7 expression is associated with disease progression in COVID-19 patients
Radwan E, Abdelaziz A, Mandour MA, Meki AR, El-kholy MM, Mohamed MN |
Molecular Biology Reports | 2024 |
|
Adaptive immune cells are necessary for SARS-CoV-2–induced pathology
Imbiakha B, Sahler JM, Buchholz DW, Ezzatpour S, Jager M, Choi A, Monreal IA, Byun H, Adeleke RA, Leach J, Whittaker G, Dewhurst S, Rudd BD, Aguilar HC, August A |
Science Advances | 2024 |
|
Accelarated immune ageing is associated with COVID-19 disease severity
Lord JM, Veenith T, Sullivan J, Sharma-Oates A, Richter AG, Greening NJ, McAuley HJ, Evans RA, Moss P, Moore SC, Turtle L, Gautam N, Gilani A, Bajaj M, Wain LV, Brightling C, Raman B, Marks M, Singapuri A, Elneima O, Openshaw PJ, Duggal NA |
Immunity & ageing : I & A | 2024 |
|
Pyroptosis: a double-edged sword in lung cancer and other respiratory diseases
Liang X, Qin Y, Wu D, Wang Q, Wu H |
Cell communication and signaling : CCS | 2024 |
|
COVID-19 and Bone Loss: A Review of Risk Factors, Mechanisms, and Future Directions.
Creecy A, Awosanya OD, Harris A, Qiao X, Ozanne M, Toepp AJ, Kacena MA, McCune T |
Current Osteoporosis Reports | 2024 |
|
Causal relationship between COVID-19 and chronic pain: A mendelian randomization study.
Fan Y, Liang X |
PloS one | 2024 |
|
Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study.
Wolszczak-Biedrzycka B, Dorf J, Wojewódzka-Żelezniakowicz M, Żendzian-Piotrowska M, Dymicka-Piekarska V, Matowicka-Karna J, Maciejczyk M |
Frontiers in immunology | 2024 |
|
SARS-CoV-2 and its Multifaceted Impact on Bone Health: Mechanisms and Clinical Evidence.
Harris A, Creecy A, Awosanya OD, McCune T, Ozanne MV, Toepp AJ, Kacena MA, Qiao X |
Current Osteoporosis Reports | 2024 |
|
Classical monocytes-low expressing HLA-DR is associated with higher mortality rate in SARS-CoV-2+ young patients with severe pneumonia.
Henao-Agudelo JS, Ayala S, Badiel M, Zea-Vera AF, Matta Cortes L |
Heliyon | 2024 |
|
Obesity and diabetes mellitus are associated with SARS-CoV-2 outcomes without influencing signature genes of extrapulmonary immune compartments at the RNA level
Lücke J, Böttcher M, Nawrocki M, Meins N, Schnell J, Heinrich F, Bertram F, Sabihi M, Seeger P, Pfaff M, Notz S, Blankenburg T, Zhang T, Kempski J, Reeh M, Wolter S, Mann O, Lütgehetmann M, Hackert T, Izbicki JR, Duprée A, Huber S, Ondruschka B, Giannou AD |
Heliyon | 2024 |
|
Mechanistic insights into bone remodelling dysregulation by human viral pathogens.
Caetano CCS, Azamor T, Meyer NM, Onwubueke C, Calabrese CM, Calabrese LH, Visperas A, Piuzzi NS, Husni ME, Foo SS, Chen W |
Nature Microbiology | 2024 |
|
A basally active cGAS-STING pathway limits SARS-CoV-2 replication in a subset of ACE2 positive airway cell models.
Puray-Chavez M, LaPak KM, Jasuja R, Pan J, Xu J, Eschbach JE, Mohammed S, Lawson DQ, Wang Q, Brody SL, Major MB, Goldfarb D, Kutluay SB |
bioRxiv : the preprint server for biology | 2024 |
|
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome.
Hammond TC, Purbhoo MA, Kadel S, Ritz J, Nikiforow S, Daley H, Shaw K, van Besien K, Gomez-Arteaga A, Stevens D, Ortuzar W, Michelet X, Smith R, Moskowitz D, Masakayan R, Yigit B, Boi S, Soh KT, Chamberland J, Song X, Qin Y, Mishchenko I, Kirby M, Nasonenko V, Buffa A, Buell JS, Chand D, van Dijk M, Stebbing J, Exley MA |
Nature Communications | 2024 |
|
Morphological abnormalities of peripheral blood cells among patients with COVID-19 disease
Karapetyan A, Niazyan L, Shushanyan R, Abgaryan T, Iritsyan S, Galechyan T, Sargsyan K, Grigoryan A |
Heliyon | 2024 |
|
Features of Cytokine and VEGFA Gene Expression Modified with SARS-CoV-2 Virus in an In Vitro Experiment (Using the Example of the SARS-CoV-2 Vaccine Antigen).
Starkova KG, Dolgikh OV, Alikina IN, Kazakova OA, Nikonoshina NA, Alekseev VB |
Bulletin of Experimental Biology and Medicine | 2024 |
|
The mechanisms of milder clinical symptoms of COVID-19 in children compared to adults
Luo C, Chen W, Cai J, He Y |
Italian Journal of Pediatrics | 2024 |
|
GrimAge is elevated in older adults with mild COVID-19 an exploratory analysis.
García-delaTorre P, Rivero-Segura NA, Sánchez-García S, Becerril-Rojas K, Sandoval-Rodriguez FE, Castro-Morales D, Cruz-Lopez M, Vazquez-Moreno M, Rincón-Heredia R, Ramirez-Garcia P, Gomez-Verjan JC |
GeroScience | 2024 |
|
Nasopharyngeal and Peripheral Blood Type II Interferon Signature Evaluation in Infants during Respiratory Syncytial Virus Infection.
Savino F, Dini M, Clemente A, Calvi C, Pau A, Galliano I, Gambarino S, Bergallo M |
2024 | |
|
Blood urea nitrogen and clinical prognosis in patients with COVID-19: A retrospective study.
Yin J, Wang Y, Jiang H, Wu C, Sang Z, Sun W, Wei J, Wang W, Liu D, Huang H |
Medicine | 2024 |
|
Role of epinephrine in attenuating cytokine storm, decreasing ferritin, and inhibiting ferroptosis in SARS-CoV-2.
El-Molla A, Fetouh FA, Bawazir S, Ali Y, Alwahby Y, Bahadeg M, Gotah Y, Badahdah FA, Alsaeed AH, Basseet A |
2024 | |
|
Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2.
Pérez-Jurado LA, Cáceres A, Balagué-Dobón L, Esko T, López de Heredia M, Quintela I, Cruz R, Lapunzina P, Carracedo Á, González JR |
Communications biology | 2024 |
|
Advances in understanding of dendritic cell in the pathogenesis of acute kidney injury.
Lv D, Jiang H, Yang X, Li Y, Niu W, Zhang D |
Frontiers in immunology | 2024 |
|
Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populations
Titova E, Kan VW, Lozy T, Ip A, Shier K, Prakash VP, Starolis M, Ansari S, Goldgirsh K, Kim S, Pelliccia MC, Mccutchen A, Megalla M, Gunning TS, Kaufman HW, Meyer WA III, Perlin DS |
Microbiology spectrum | 2024 |
|
Epidemiology of fungal infection in COVID 19 in Spain during 2020 and 2021: a nationwide study
López-Herrero R, Sánchez-de Prada L, Tamayo-Velasco A, Heredia-Rodríguez M, Bardají Carrillo M, Jorge Monjas P, de la Varga-Martínez O, Resino S, Sarmentero-López de Quintana G, Gómez-Sánchez E, Tamayo E |
Scientific Reports | 2024 |
|
Impact of Corticosteroid Therapy on ICU Patient Outcomes in Severe COVID-19 Cases: A Retrospective Cohort Study in Saudi Arabia
Alkhunaizi L, Almutairi JA, Almanea SH, Alzahuf SM, Fehaid M, Alharthi A, Alhebs T, Alshuqayfi SM, Alotaibi R, Alharbi M, Abdalwahab ZE, Aloqaybi A, Talebi SH, Kharaba AM |
Cureus | 2024 |
|
Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections
Lee SG, Furth PA, Hennighausen L, Lee HK |
iScience | 2024 |
|
Evaluation of the Levels of Selected Cytokines and Their Possible Influence on the Development of Cardiovascular and Pulmonary Complications in Patients after COVID-19
Stanjek-Cichoracka A, Niedziela JT, Łaszewska A, Mędrala Z, Nowowiejska-Wiewióra A, Kaczmarski J, Grzanka A, Gąsior M |
Medicina | 2024 |
|
Post-COVID-19 condition: systemic inflammation and low functional exercise capacity.
de Castro GS, Gama LR, Ramos AF, Gatti da Silva G, Teixeira AAS, Cunha-Neto E, de Souza HP, Marie SK, Talib LL, Coelho V, Kalil J, de Araujo AL, Ritto AP, Belon AR, Santos AS, Barrére APN, Sawamura MVY, Lamas CA, Baldi BG, Carvalho CRR, Kulikowski LD, Damiano RF, Imamura M, Rosa Neto JC, Lira FS, Otoch JP, Miguel EC, Battistella L, Forlenza OV, Busatto G, Seelaender M |
Frontiers in Nutrition | 2024 |
|
Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation.
Sivaraman K, Liu B, Martinez-Delgado B, Held J, Büttner M, Illig T, Volland S, Gomez-Mariano G, Jedicke N, Yevsa T, Welte T, DeLuca DS, Wrenger S, Olejnicka B, Janciauskiene S |
Lung | 2024 |
|
Infection kinetics, syncytia formation, and inflammatory biomarkers as predictive indicators for the pathogenicity of SARS-CoV-2 Variants of Concern in Calu-3 cells
Purwono PB, Vacharathit V, Manopwisedjaroen S, Ludowyke N, Suksatu A, Thitithanyanont A |
PloS one | 2024 |
|
Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit.
Iacovelli A, Oliva A, Mirabelli FM, Giannone S, Laguardia M, Morviducci M, Nicolardi ML, Repaci E, Sanzari MT, Leanza C, Raponi G, Mastroianni C, Palange P |
BMC Infectious Diseases | 2024 |
|
Association of Coagulopathy and Inflammatory Biomarkers with Severity in SARS-CoV-2-Infected Individuals of the Al-Qunfudhah Region of Saudi Arabia.
Izhari MA, Hadadi MAA, Alharbi RA, Gosady ARA, Sindi AAA, Dardari DMM, Alotaibi FE, Klufah F, Albanghali MA, Alharbi TH |
2024 | |
|
Liver injury and prolonged hospitalization as indicators of severity in patients with adenovirus infections
Tang S, Qin R, Zhang D, He X, Yu C, Chen D, Li X, Liu S |
BMC Infectious Diseases | 2024 |
|
Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2
Opsteen S, Fram T, Files JK, Levitan EB, Goepfert P, Erdmann N |
Journal of acquired immune deficiency syndromes (1999) | 2024 |
|
SARS-Cov-2 spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9
Luo Y, Zhang Z, Ren J, Dou C, Wen J, Yang Y, Li X, Yan Z, Han Y |
Frontiers in immunology | 2024 |
|
Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity.
Tu TH, Grunbaum A, Santinon F, Kazanova A, Rozza N, Kremer R, Mihalcioiu C, Rudd CE |
Communications biology | 2024 |
|
Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19.
Hou XY, Danzeng LM, Wu YL, Ma QH, Yu Z, Li MY, Li LS |
World journal of stem cells | 2024 |
|
FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case-control study in Egyptian patients.
Elgedawy GA, Elabd NS, Salem RH, Awad SM, Amer AA, Torayah MM, El-Koa AA, Abozeid M, Montaser BA, Aboshabaan HS, Abdelkreem M, Helal ML |
Infection | 2024 |
|
Critical COVID-19, Victivallaceae abundance, and celiac disease: A mediation Mendelian randomization study.
Zou Y, Pan M, Zhou T, Yan L, Chen Y, Yun J, Wang Z, Guo H, Zhang K, Xiong W |
PloS one | 2024 |
|
The critical impacts of cytokine storms in respiratory disorders.
Riyaz Tramboo S, Elkhalifa AME, Quibtiya S, Ali SI, Nazir Shah N, Taifa S, Rakhshan R, Hussain Shah I, Ahmad Mir M, Malik M, Ramzan Z, Bashir N, Ahad S, Khursheed I, Bazie EA, Mohamed Ahmed E, Elderdery AY, Alenazy FO, Alanazi A, Alzahrani B, Alruwaili M, Manni E, E Hussein S, Abdalhabib EK, Nabi SU |
Heliyon | 2024 |
|
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease
Nambulli S, Escriou N, Rennick LJ, Demers MJ, Tilston\u2011Lunel NL, McElroy AK, Barbeau DJ, Crossland NA, Hoehl RM, Schrauf S, White AG, Borish HJ, Tomko JA, Frye LJ, Scanga CA, Flynn JL, Martin A, Gerke C, Hartman AL, Duprex WP |
Journal of virology | 2024 |
|
The Dysregulation of the Monocyte–Dendritic Cell Interplay Is Associated with In-Hospital Mortality in COVID-19 Pneumonia
Galati D, Mallardo D, Nicastro C, Zanotta S, Capitelli L, Lombardi C, Baino B, Cavalcanti E, Sale S, Labonia F, Boenzi R, Atripaldi L, Ascierto PA, Bocchino M |
Journal of Clinical Medicine | 2024 |
|
COVID-19 was associated with the complications after allogeneic hematopoietic stem cell transplantation
Wen Q, Guo Z, Zhang XH, Xu LP, Wang Y, Yan CH, Chen H, Chen YH, Han W, Wang FR, Sun YQ, Huang XJ, Mo XD |
Scientific Reports | 2024 |
|
Paracrinal regulation of neutrophil functions by coronaviral infection in iPSC-derived alveolar type II epithelial cells
Chien Y, Huang XY, Yarmishyn AA, Chien CS, Liu YH, Hsiao YJ, Lin YY, Lai WY, Huang SC, Lee MS, Chiou SH, Yang YP, Chiou GY |
Virus Research | 2024 |
|
Evaluation of Biochemical Characteristics in a Retrospective Cohort of COVID-19 Patients
Jerah AA, Farasani A, Abu-Tawil HI, Kuriri H, Kuriri A, Alkhayrat M, Kariri K, Kariri SA, Abdelwahab SI |
Cureus | 2024 |
|
Diabetes and Infectious Diseases with a Focus on Melioidosis.
Uthaya Kumar A, Ahmad Zan M, Ng CL, Chieng S, Nathan S |
Current Microbiology | 2024 |
|
G protein subunit Gγ13-mediated signaling pathway is critical to the inflammation resolution and functional recovery of severely injured lungs
Li YH, Yang YS, Xue YB, Lei H, Zhang SS, Qian J, Yao Y, Zhou R, Huang L |
eLife | 2024 |
|
Development and validation of a prognostic model for assessing long COVID risk following Omicron wave—a large population-based cohort study
Fang LC, Ming XP, Cai WY, Hu YF, Hao B, Wu JH, Tuohuti A, Chen X |
Virology Journal | 2024 |
|
Intravenous high-dose anakinra drops venous thrombosis and acute coronary syndrome in severe and critical COVID-19 patients: a propensity score matched study
Çakmak R, Yüce S, Ay M, Uyar MH, Kılıç Mİ, Bektaş M |
Scientific Reports | 2024 |
|
T‐cell responses in COVID‐19 survivors 6−8 months after infection: A longitudinal cohort study in Pune
Suryawanshi P, Patil\u2010Takbhate B, Athavale P, Mirza S, Tripathy A, Kanitkar S, Shivnitwar S, Barthwal MS, Dole S, Chavan H, Jali P, Pawale S, Kakad D, Kakrani AL, Bhawalkar J, Gandhi M, Chaturvedi S, Karandikar M, Tripathy S |
Immunity, Inflammation and Disease | 2024 |
|
Dietary patterns and micronutrients in respiratory infections including COVID-19: a narrative review
Salehi Z, Askari M, Jafari A, Ghosn B, Surkan PJ, Hosseinzadeh-Attar MJ, Pouraram H, Azadbakht L |
BMC Public Health | 2024 |
|
Comparative Analysis of Lymphocyte Populations in Post-COVID-19 Condition and COVID-19 Convalescent Individuals
Berger L, Wolf J, Kalbitz S, Kellner N, Lübbert C, Borte S |
Diagnostics | 2024 |
|
TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication
Gonzalez-Orozco M, Tseng HC, Hage A, Xia H, Behera P, Afreen K, Peñaflor-Tellez Y, Giraldo MI, Huante M, Puebla-Clark L, van Tol S, Odle A, Crown M, Teruel N, Shelite TR, Menachery V, Endsley M, Endsley JJ, Najmanovich RJ, Bashton M, Stephens R, Shi PY, Xie X, Freiberg AN, Rajsbaum R |
2024 | |
|
SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147
Shouman S, El-Kholy N, Hussien AE, El-Derby AM, Magdy S, Abou-Shanab AM, Elmehrath AO, Abdelwaly A, Helal M, El-Badri N |
Cell communication and signaling : CCS | 2024 |
|
Progress in SARS-CoV-2, diagnostic and clinical treatment of COVID-19
Li Y, Lu SM, Wang JL, Yao HP, Liang LG |
Heliyon | 2024 |
|
Network-based pharmacology and UHPLC-Q-Exactive-Orbitrap-MS reveal Jinhua Qinggan granule's mechanism in reducing cellular inflammation in COVID-19
Qian L, Zeng Z |
Frontiers in immunology | 2024 |
|
Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review
Kozłowski P, Leszczyńska A, Ciepiela O |
2024 | |
|
Persistent Vascular Complications in Long COVID: The Role of ACE2 Deactivation, Microclots, and Uniform Fibrosis
Sideratou CM, Papaneophytou C |
Infectious disease reports | 2024 |
|
Smoking and vaping alter genes related to mechanisms of SARS-CoV-2 susceptibility and severity: a systematic review and meta-analysis.
Bowsher R, Marczylo TH, Gooch K, Bailey A, Wright MD, Marczylo EL |
European Respiratory Journal | 2024 |
|
Inflammation in the COVID-19 airway is due to inhibition of CFTR signaling by the SARS-CoV-2 spike protein.
Caohuy H, Eidelman O, Chen T, Mungunsukh O, Yang Q, Walton NI, Pollard BS, Khanal S, Hentschel S, Florez C, Herbert AS, Pollard HB |
Scientific Reports | 2024 |
|
Post-COVID-19 Changes in Appetite—An Exploratory Study
Inceu G, Nechifor RE, Rusu A, Ciobanu DM, Draghici NC, Pop RM, Craciun AE, Porojan M, Negrut M, Roman G, Fodor A, Bala C |
Nutrients | 2024 |
|
Immune Stimulation with Imiquimod to Best Face SARS-CoV-2 Infection and Prevent Long COVID
Pacheco-García U, Varela-López E, Serafín-López J |
International journal of molecular sciences | 2024 |
|
Altered spike IgG Fc N-linked glycans are associated with hyperinflammatory state in adult COVID and Multisystem Inflammatory Syndrome in Children
Sherman JD, Karmali V, Kumar B, Simon TW, Bechnak S, Panjwani A, Ciric CR, Wang D, Huerta C, Johnson B, Anderson EJ, Rouphael N, Collins MH, Rostad CA, Azadi P, Scherer EM |
2024 | |
|
The Link between Inflammation, Lipid Derivatives, and Microbiota Metabolites in COVID-19 Patients: Implications on Eating Behaviors and Nutritional Status
Hawryłkowicz V, Stasiewicz B, Maciejewska D, Sołek-Pastuszka J, Komorniak N, Skonieczna-Żydecka K, Martynova-Van Kley A, Stachowska E |
International journal of molecular sciences | 2024 |
|
Nutritional and Inflammatory Markers Associated with SARS-CoV-2 Infection in the Elderly
Budelon Gonçalves JI, Lermen FM, Gonçalves JB, Zanirati G, Machado DC, Marques HM, Erwig HS, Becker BM, Wagner F, Boff MO, Rocha MG, Da Costa JC, Marinowic ED |
International journal of molecular sciences | 2024 |
|
Rujin Jiedu decoction protects against influenza virus infection by modulating gut microbiota
Huang Q, Yang G, Tang C, Dou B, Hu Y, Liu H, Wu X, Zhang H, Wang H, Xu L, Yang XD, Xu Y, Zheng Y |
Heliyon | 2024 |
|
Comparative Analysis of Viral Load and Cytokines during SARS-CoV-2 Infection between Pregnant and Non-Pregnant Women
Liu D, Li H, Li X, Rodriguez GD, Pietz H, Fiel RH, Konadu E, Singh V, Loo F, Rodgers WH |
International journal of molecular sciences | 2024 |
|
Factors Associated with Prolonged SARS-CoV-2 Viral Positivity in an Italian Cohort of Hospitalized Patients
De Grazia S, Pollicino F, Giannettino C, Errera CM, Veronese N, Giammanco GM, Cacioppo F, Sanfilippo GL, Barbagallo M |
Diseases | 2024 |
|
A prediction model for secondary invasive fungal infection among severe SARS-CoV-2 positive patients in ICU
Su L, Yu T, Zhang C, Huo P, Zhao Z |
Frontiers in Cellular and Infection Microbiology | 2024 |
|
Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation
Sherratt SC, Libby P, Dawoud H, Bhatt DL, Mason RP |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2024 |
|
Taming the storm: potential anti-inflammatory compounds targeting SARS-CoV-2 MPro.
Anton DB, de Lima JC, Dahmer BR, Camini AM, Goettert MI, Timmers LFSM |
InflammoPharmacology | 2024 |
|
The impact of hypertension on clinical manifestations of Omicron variant BA.1 infection in adult patients.
Wang J, Dong H, Zhao J, Zhou C, Wang M, Cui Y, Gao G, Ji X, Mu H, Peng L |
Microbiology spectrum | 2024 |
|
COVID-19: from immune response to clinical intervention.
Guo ZY, Tang YQ, Zhang ZB, Liu J, Zhuang YX, Li T |
2024 | |
|
The therapeutic potential of gelsolin in attenuating cytokine storm, ARDS, and ALI in severe COVID-19.
Zhi J, Zhao KX, Liu JH, Yang D, Deng XM, Xu J, Zhang H |
Frontiers in pharmacology | 2024 |
|
The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients’ survival and long COVID
Noviello M, De Lorenzo R, Chimienti R, Maugeri N, De Lalla C, Siracusano G, Lorè NI, Rancoita PM, Cugnata F, Tassi E, Dispinseri S, Abbati D, Beretta V, Ruggiero E, Manfredi F, Merolla A, Cantarelli E, Tresoldi C, Pastori C, Caccia R, Sironi F, Marzinotto I, Saliu F, Ghezzi S, Lampasona V, Vicenzi E, Cinque P, Manfredi AA, Scarlatti G, Dellabona P, Lopalco L, Di Serio C, Malnati M, Ciceri F, Rovere-Querini P, Bonini C |
Frontiers in immunology | 2024 |
|
The top 50 most-cited articles about COVID-19 and the complications of COVID-19: A bibliometric analysis
Singh T, Rao Padubidri J, Shetty PH, Antony Manoj M, Mary T, Thejaswi Pallempati B |
F1000Research | 2024 |
|
COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals
de Souza Goncalves B, Sangani D, Nayyar A, Puri R, Irtiza M, Nayyar A, Khalyfa A, Sodhi K, Pillai SS |
International Journal of Molecular Sciences | 2024 |
|
Comparative Study of Blood Neopterin and Biopterins in Patients with COVID-19 and Secondary Bacterial Infection
Eguchi T, Niiyama S, Kamikokuryo C, Madokoro Y, Shimono K, Hara S, Ichinose H, Kakihana Y |
Journal of Clinical Medicine | 2024 |
|
The top 50 most-cited articles about COVID-19 and the complications of COVID-19: A bibliometric analysis.
Singh T, Rao Padubidri J, Shetty PH, Antony Manoj M, Mary T, Thejaswi Pallempati B |
F1000Research | 2024 |
|
A crucial role of neutrophil extracellular traps in pulmonary infectious diseases
Pan T, Lee JW |
Chinese Medical Journal Pulmonary and Critical Care Medicine | 2024 |
|
NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage.
Balachandran H, Kroll K, Terry K, Manickam C, Jones R, Woolley G, Hayes T, Martinot AJ, Sharma A, Lewis M, Jost S, Reeves RK |
PLoS pathogens | 2024 |
|
Immunological insights: assessing immune parameters in medical professionals exposed to SARS-CoV-2
Wojas-Krawczyk K, Krawczyk P, Błach J, Kucharczyk T, Grenda A, Krzyżanowska N, Szklener K, Horaczyńska-Wojtaś A, Wójcik-Superczyńska M, Chmielewska I, Milanowski J |
BMC Infectious Diseases | 2024 |
|
Can human IgG subclasses distinguish between confirmed and unconfirmed SARS-CoV-2 infections?
Mohamed Bahgat M, Hassan Nasraa M, Nadeem R, Amer K, Hassan WA, Abd EL-Raouf A, Nadeem Abd-Elshafy D |
Journal of Genetic Engineering & Biotechnology | 2024 |
|
Identification of biomarkers for COVID-19 associated secondary hemophagocytic lymphohistiocytosis
Canny SP, Stanaway IB, Holton SE, Mitchem M, O\u2019Rourke AR, Pribitzer S, Baxter SK, Wurfel MM, Malhotra U, Buckner JH, Bhatraju PK, Morrell ED, Speake C, Mikacenic C, Hamerman JA |
bioRxiv | 2024 |
|
In silico modelling of neuron signal impact of cytokine storm-induced demyelination
Adonias GL, Siljak H, Balasubramaniam S, Barros MT |
Open Biology | 2024 |
|
Correlates of disease severity in bluetongue as a model of acute arbovirus infection
Herder V, Caporale M, MacLean OA, Pintus D, Huang X, Nomikou K, Palmalux N, Nichols J, Scivoli R, Boutell C, Taggart A, Allan J, Malik H, Ilia G, Gu Q, Ronchi GF, Furnon W, Zientara S, Bréard E, Antonucci D, Capista S, Giansante D, Cocco A, Mercante MT, Di Ventura M, Da Silva Filipe A, Puggioni G, Sevilla N, Stewart ME, Ligios C, Palmarini M |
PLOS Pathogens | 2024 |
|
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19
Subbarao Malireddi RK, Sharma BR, Kanneganti TD |
Annual review of immunology | 2024 |
|
Investigating the relationship between lymphocyte cells apoptosis and DNA damage and oxidative stress and therapeutic and clinical outcomes of COVID-19 elderly patients.
Abiri E, Mirzaii M, Moghbeli M, Atashi A, Harati AA |
BMC infectious diseases | 2024 |
|
Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19: A Multicenter, Randomized Clinical Trial
Llanos Jiménez L, Alvarez-Alvarez B, Fonseca Aizpuru E, Peces-Barba G, Pindao Quesada G, Rodríguez Nieto MJ, Ruiz-Hornillos FJ, Seijo Maceiras L, Robles Barrena I, Mena-de-Cea A, Meijide-Míguez H, Sánchez-Pernaute O |
Journal of Clinical Medicine | 2024 |
|
Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria
Tapela K, Prah DA, Tetteh B, Nuokpem F, Dosoo D, Coker A, Kumi-Ansah F, Amoako E, Assah KO, Kilba C, Nyakoe N, Quansah D, Languon S, Anyigba CA, Ansah F, Agyeman S, Owusu IA, Schneider K, Ampofo WK, Mutungi JK, Amegatcher G, Aniweh Y, Awandare GA, Quashie PK, Bediako Y |
Cell Reports | 2024 |
|
Macrophage Activation Syndrome in Coinciding Pandemics of Obesity and COVID-19: Worse than Bad.
Engin AB, Engin ED, Engin A |
Advances in experimental medicine and biology | 2024 |
|
Effect of subcutaneous vs. intravenous tocilizumab in patients with severe COVID-19: a systematic review.
Li Y, Li X, Zheng X |
European journal of clinical pharmacology | 2024 |
|
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19
Wang B, Golubov J, Oswald EM, Poon P, Wei Q, Lett C, Shehadeh F, Kaczynski M, Felix LO, Mishra B, Mylona EK, Wipperman MF, Chio E, Hamon SC, Hooper AT, Somersan-Karakaya S, Musser BJ, Petro CD, Hamilton JD, Sleeman MA, Kalliolias GD, Mylonakis E, Skokos D |
eBioMedicine | 2024 |
|
SARS-CoV2 pneumonia patients admitted to the ICU: Analysis according to clinical and biological parameters and the extent of lung parenchymal lesions on chest CT scan, a monocentric observational study
Krisht AA, Grapin K, de Beauchene RC, Bonnet B, Cassagnes L, Evrard B, Adda M, Souweine B, Dupuis C |
PLOS ONE | 2024 |
|
A Review on Role of Inflammation in Coronavirus Disease.
Lotfi A, Hajian P, Abbasi L, Gargari MK, Fard NNG, Naderi D |
Endocrine, metabolic & immune disorders drug targets | 2024 |
|
The first century of JCI and beyond
McNally EM |
The Journal of Clinical Investigation | 2024 |
|
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Kazemi-Sufi S, Alipour S, Rabieepour M, Roshan-Milani S, Naderi R |
BMC Infectious Diseases | 2024 |
|
Survival of hospitalised COVID-19 patients in Hawassa, Ethiopia: a cohort study
Anteneh AB, LeBlanc M, Natnael AA, Asfaw ZG |
BMC Infectious Diseases | 2024 |
|
Non-Conventional Prognostic Markers in Life-Threatening COVID-19 Cases—When Less Is More
Rozanovic M, Várady-Szabó K, Domokos K, Kiss T, Loibl C, Márovics G, Rendeki S, Csontos C |
Journal of Clinical Medicine | 2024 |
|
A Histological Analysis and Detection of Complement Regulatory Protein CD55 in SARS-CoV-2 Infected Lungs
Silawal S, Gögele C, Pelikan P, Werner C, Levidou G, Mahato R, Schulze-Tanzil G |
Life | 2024 |
|
Complex Interplay of COVID-19 ARDS with Guillain-Barré Syndrome and Cerebral Infarction: A Case Study
Morikawa D, Fujitani S, Shirahige T, Hagiwara Y, Morisawa K, Yoshida T |
The American Journal of Case Reports | 2024 |
|
Pharmacological targets and validation of remdesivir for the treatment of COVID-19-associated pulmonary fibrosis: A network-based pharmacology and bioinformatics study
Zhao X, Yang L |
Medicine | 2024 |
|
Using random forest and biomarkers for differentiating COVID-19 and Mycoplasma pneumoniae infections
Zhou X, Zhang J, Deng XM, Fu FM, Wang JM, Zhang ZY, Zhang XQ, Luo YX, Zhang SY |
Scientific Reports | 2024 |
|
Serum tumor necrosis factor-alpha status in hospitalized patients with coronavirus disease-2019 (COVID-19)
Babaei M, Heidari B, Sadeghi Haddad Zavareh M, Ahmadnia Z, Ghorbani H, Rouhi S |
Caspian Journal of Internal Medicine | 2024 |
|
Comprehensive insights into mechanism of nanotoxicity, assessment methods and regulatory challenges of nanomedicines.
Havelikar U, Ghorpade KB, Kumar A, Patel A, Singh M, Banjare N, Gupta PN |
Discover nano | 2024 |
|
Prospective Variation of Cytokine Trends during COVID-19: A Progressive Approach from Disease Onset until Outcome.
Deus MC, Gadotti AC, Dias ES, Monte Alegre JB, Van Spitzenbergen BAK, Andrade GB, Tozoni SS, Stocco RB, Olandoski M, Tuon FFB, Pinho RA, de Noronha L, Baena CP, Moreno-Amaral AN |
International journal of molecular sciences | 2024 |
|
Dynamic Characteristics of Lymphocyte Subsets and Their Predictive Value for Disease Progression and Prognosis in Primary Infection and Unvaccinated COVID-19 Patients.
Zhang X, Chen Z, Zheng J, Feng C, Zhao B, Lan L, Liu D |
International journal of general medicine | 2024 |
|
SARS-CoV-2 infection perturbs the gastrointestinal tract and induces modest microbial translocation across the intestinal barrier
Brooks K, Nelson CE, Aguilar C, Hoang TN, Ortiz AM, Langner CA, Yee DS, Flynn JK, Vrba S, Laidlaw E, Vannella KM, Grazioli A, Saharia KK, Purcell M, Singireddy S, Wu J, Stankiewicz J, Chertow DS, Sereti I, Paiardini M, Hickman HD, Via LE, Barber DL, Brenchley JM |
Journal of Virology | 2024 |
|
Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2
Hsieh LL, Looney M, Figueroa A, Massaccesi G, Stavrakis G, Anaya EU, D'Alessio FR, Ordonez AA, Pekosz AS, DeFilippis VR, Karakousis PC, Karaba AH, Cox AL |
mBio | 2024 |
|
Neutrophil-platelet ratio as a predictor of acute kidney injury in severe COVID-19
Sayan M, Altinisik HB, Sayan O |
Medicine | 2024 |
|
Pro-Resolving Inflammatory Effects of a Marine Oil Enriched in Specialized Pro-Resolving Mediators (SPMs) Supplement and Its Implication in Patients with Post-COVID Syndrome (PCS).
Gracia Aznar A, Moreno Egea F, Gracia Banzo R, Gutierrez R, Rizo JM, Rodriguez-Ledo P, Nerin I, Regidor PA |
Biomedicines | 2024 |
|
Targeting Lactate: An Emerging Strategy for Macrophage Regulation in Chronic Inflammation and Cancer.
Jiang R, Ren WJ, Wang LY, Zhang W, Jiang ZH, Zhu GY |
Biomolecules | 2024 |
|
T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination.
Notarbartolo S |
Vaccines | 2024 |
|
Old disease-New reflections: Gaucher, immunity, and inflammation.
Şoroğlu CV, Berkay EG |
Journal of cellular and molecular medicine | 2024 |
|
Humoral and cellular immune response to AZD1222 /Covishield and BV152/Covaxin COVID-19 vaccines among adults in India.
Tripathy AS, Singh D, Trimbake D, Salwe S, Tripathy S, Kakrani A, Jali P, Chavan H, Yadav P, Sahay R, Sarje P, Babar P, Shete A, Nandapurkar A, Kulkarni M |
Human vaccines & immunotherapeutics | 2024 |
|
Endogenous Endophthalmitis Associated With COVID-19: A Systematic Review on Its Incidence, Risk Factors, Causative Organisms, and Prognosis
Alshehri AM |
Cureus | 2024 |
|
Delineating sex-specific circulating host response signatures associated with COVID-19 severity and mortality.
Keur N, Flikweert AW, Ricaño-Ponce I, Muller Kobold AC, van der Sar-van der Brugge S, Rodenhuis-Zybert IA, Le KTT, van Meurs M, Grootenboers MJ, van der Voort PHJ, Heeringa P, Kumar V, Moser J |
iScience | 2024 |
|
Altered Spike Immunoglobulin G Fc N-Linked Glycans Are Associated With Hyperinflammatory State in Adult Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome in Children.
Sherman JD, Karmali V, Kumar B, Simon TW, Bechnak S, Panjwani A, Ciric CR, Wang D, Huerta C, Johnson B, Anderson EJ, Rouphael N, Collins MH, Rostad CA, Azadi P, Scherer EM |
Open forum infectious diseases | 2024 |
|
Evaluation of the Relationship between Early Clinical Manifestations and Changes in Biochemical, Inflammatory, and Coagulation Parameters and the Prognosis of Pregnant Women with COVID-19 Admitted to the ICU
Ebrahim Babai M, Kabiri A, Movahedi M, Ghahiri A, Hajhashemi M, Dehghan M |
Advanced Biomedical Research | 2024 |
|
Cytokine Storm in COVID-19: Exploring IL-6 Signaling and Cytokine-Microbiome Interactions as Emerging Therapeutic Approaches
Paranga TG, Mitu I, Pavel-Tanasa M, Rosu MF, Miftode IL, Constantinescu D, Obreja M, Plesca CE, Miftode E |
International Journal of Molecular Sciences | 2024 |
|
T Lymphocyte Mitochondrial Markers as Independent Risk Factors for Poor Prognosis of COVID-19.
Yang M, Li Q, Huang M, Liu X, Wang B |
Infection and drug resistance | 2024 |
|
Emerging signs of Alzheimer‐like tau hyperphosphorylation and neuroinflammation in the brain post recovery from COVID‐19
Qi X, Yuan S, Ding J, Sun W, Shi Y, Xing Y, Liu Z, Yao Y, Fu S, Sun B, Qi X, Xia B, Liu F, Yi M, Mao J, Wan Y, Zheng J |
Aging Cell | 2024 |
|
COVID-19 among Physically Active and Physically Inactive Individuals
KALPANA M, KATTA R, MADHUSUDHAN U, GAUR A, GANJI V, TARANIKANTI M, NITIN J, KASTURI VK |
Mædica | 2024 |
|
COVID-19 in Children and Vitamin D
Durá-Travé T, Gallinas-Victoriano F |
International Journal of Molecular Sciences | 2024 |
|
Proteomic Profiling of COVID-19 Patients Sera: Differential Expression with Varying Disease Stage and Potential Biomarkers
Dandachi I, Alaiya A, Shinwari Z, Abbas B, Karkashan A, Al-Amari A, Aljabr W |
Diagnostics | 2024 |
|
Bone Mineral Density, Bone Biomarkers, and Joints in Acute, Post, and Long COVID-19: A Systematic Review
Alghamdi F, Mokbel K, Meertens R, Obotiba AD, Alharbi M, Knapp KM, Strain WD |
Viruses | 2024 |
|
TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication
Gonzalez-Orozco M, Tseng HC, Hage A, Xia H, Behera P, Afreen K, Peñaflor-Tellez Y, Giraldo MI, Huante M, Puebla-Clark L, van Tol S, Odle A, Crown M, Teruel N, Shelite TR, Moreno-Contreras J, Terasaki K, Makino S, Menachery V, Endsley M, Endsley JJ, Najmanovich RJ, Bashton M, Stephens R, Shi PY, Xie X, Freiberg AN, Rajsbaum R |
Nature Communications | 2024 |
|
Dysregulated nicotinamide adenine dinucleotide metabolome in patients hospitalized with COVID‐19
Valderrábano RJ, Wipper B, Pencina KM, Migaud M, Shang YV, Latham NK, Montano M, Cunningham JM, Wilson L, Peng L, Memish\u2010Beleva Y, Bhargava A, Swain PM, Lehman P, Lavu S, Livingston DJ, Bhasin S |
Aging Cell | 2024 |
|
Predicting severe COVID-19 using readily available admission indicators: SpO2/FiO2 ratio, comorbidity index, and gender
Vu LD, Christofferson RC, O\u2019Neal HR Jr, Hamer D, Phan AT, Vance KM, Turner EA, Kumar A, Yola IM, Lim N, Ogden B, Cormier SA |
Experimental Biology and Medicine | 2024 |
|
Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approaches
Abba Moussa D, Vazquez M, Chable-Bessia C, Roux-Portalez V, Tamagnini E, Pedotti M, Simonelli L, Ngo G, Souchard M, Lyonnais S, Chentouf M, Gros N, Marsile-Medun S, Dinter H, Pugnière M, Martineau P, Varani L, Juan M, Calderon H, Naranjo-Gomez M, Pelegrin M |
Emerging Microbes & Infections | 2024 |
|
Predictive validity of interleukin 6 (IL-6) for the mortality in critically ill COVID-19 patients with the B.1.617.2 (Delta) variant in Vietnam: a single-centre, cross-sectional study
Nguyen CV, Luong CQ, Dao CX, Nguyen MH, Pham DT, Khuat NH, Pham QT, Hoang DT, Nguyen AD, Nguyen PM, Cao DD, Pham DT, Nguyen TQ, Nong VM, Dang DT, Nguyen DT, Nguyen VD, Le TQ, Nguyen VK, Ngo HD, Nguyen DV, Pham TT, Nguyen DT, Nguyen NT, Do TD, Huynh NT, Phan NT, Nguyen CD, Vo KH, Vu TT, Do CD, Dang TQ, Vu GV, Nguyen TC, Do SN |
BMJ Open | 2024 |
|
Persistent CD19+ B cell lymphopenia in critically ill COVID-19 patients 50 days after symptom onset
An H, Li T, Zhang X, Hu H, Zhang C, Wang Y, Jin S, Li M |
Frontiers in Cellular and Infection Microbiology | 2024 |
|
Dynamics of cytokine and antibody responses in community versus hospital SARS-CoV-2 infections
Singh T, Macintyre AN, Burke TW, Anderson J, Petzold E, Stover EL, French MJ, Oguin TH III, Demarco T, McClain MT, Ko ER, Park LP, Denny T, Sempowski GD, Woods CW |
Frontiers in Immunology | 2024 |
|
Exploring the shared pathogenic mechanisms of tuberculosis and COVID-19: emphasizing the role of VNN1 in severe COVID-19
Sun P, Wang Y, Zhou S, Liang J, Zhang B, Li P, Han R, Fei G, Cao C, Wang R |
Frontiers in Cellular and Infection Microbiology | 2024 |
|
Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors
Subbarayan K, Al-Samadi A, Schäfer H, Massa C, Salo T, Biehl K, Vaxevanis CK, Ulagappan K, Wahbi W, Reimers M, Drexler F, Moreira-Soto A, Bachmann M, Seliger B |
Cellular and Molecular Life Sciences: CMLS | 2024 |
|
Identification of immune-related hub genes and potential molecular mechanisms involved in COVID-19 via integrated bioinformatics analysis
Zhu R, Zhao Y, Yin H, Shu L, Ma Y, Tao Y |
Scientific Reports | 2024 |
|
Diagnostic Usefulness of Serum Hyaluronic Acid in Patients with SARS-CoV-2 Infection
Cylwik B, Gan K, Kazberuk M, Gruszewska E, Panasiuk A, Chrostek L |
Journal of Clinical Medicine | 2024 |
|
Herpesvirus Antibodies Are Correlated With Greater Expression of p16 in the T Cells of Humans
Noppert G, Wragg K, Li C, Duchowny K, Mody L, Aiello AE, Nyquist L, O\u2019Brien M, Yung R, Goldstein D |
Open Forum Infectious Diseases | 2024 |
|
Calceolarioside B inhibits SARS-CoV-2 Omicron BA.2 variant cell entry and modulates immune response
Lin XB, Yao YZ, Wen QR, Liu FB, Cai YX, Chen RH, Han J |
Virology Journal | 2024 |
|
Efficacy of Ulinastatin in the Treatment of COVID-19: A Retrospective Study
Liu P, Wu Q, Li M |
International Journal of General Medicine | 2024 |
|
Long-Term Pulmonary Sequelae and Immunological Markers in Patients Recovering from Severe and Critical COVID-19 Pneumonia: A Comprehensive Follow-Up Study
Strumiliene E, Urbonienė J, Jurgauskiene L, Zeleckiene I, Bliudzius R, Malinauskiene L, Zablockiene B, Samuilis A, Jancoriene L |
Medicina | 2024 |
|
Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study
Vazquez-Alejo E, De La Sierra Espinar-Buitrago M, Magro-Lopez E, Tarancon-Diez L, Díez C, Bernardino JI, Rull A, De Los Santos I, Alonso R, Zamora A, Jiménez JL, Muñoz-Fernández MÁ |
Medical Microbiology and Immunology | 2024 |
|
Detrimental Effects of Anti-Nucleocapsid Antibodies in SARS-CoV-2 Infection, Reinfection, and the Post-Acute Sequelae of COVID-19
Nakayama EE, Shioda T |
Pathogens | 2024 |
|
The Association of Blood Eosinophils and Neutrophils Expressing Eosinophilic Surface Markers with the Severity and Outcome of COVID-19
Wang J, Li X, Ren J, Rao Y, Qiao Y, Sun L, Liang Y, Chang C, Zhou Q, Sun Y |
Microorganisms | 2024 |
|
Dynamics of Biomarkers in COVID-19 Patients Treated with Anakinra
Yordanova R, Strashimirov D, Grozdeva R, Ivanov D, Trifonova I, Yancheva N, Tcherveniakova T |
Biomedicines | 2024 |
|
Gut microbiota in post-acute COVID-19 syndrome: not the end of the story
An Y, He L, Xu X, Piao M, Wang B, Liu T, Cao H |
Frontiers in Microbiology | 2024 |
|
IL-1β-driven NF-κB transcription of ACE2 as a Mechanism of Macrophage Infection by SARS-CoV-2
Lee C, Khan R, Mantsounga CS, Sharma S, Pierce J, Amelotte E, Butler CA, Farinha A, Parry C, Caballero O, Morrison JA, Uppuluri S, Whyte JJ, Kennedy JL, Zhang X, Choudhary G, Olson RM, Morrison AR |
bioRxiv | 2024 |
|
Can there be calm during a cytokine storm? Immune checkpoint pathways affecting the severity of COVID-19 disease
Meggyes M, Nagy DU, Toth I, Feik T, Peterfalvi A, Polgar B, Sipos D, Kemeny A, Szereday L |
Frontiers in Microbiology | 2024 |
|
Similar kinetics of pulmonary SARS-CoV-2 load in intensive care unit patients with COVID-19 pneumonia with or without autoantibodies neutralizing type I interferons
Le Stang V, Bastard P, Langouet E, de Chambrun MP, Chommeloux J, Gervais A, Bizien L, Puel A, Cobat A, Mayaux J, Demoule A, Casanova JL, Boutolleau D, Combes A, Burrel S, Luyt CE |
Journal of clinical immunology | 2024 |
|
Covid-19 y diabetes mellitus tipo 2: implicaciones en las células beta pancreáticas
Sánchez-Cervantes IG, González-Sánchez I, López-Martínez IE, Aguirre-Benítez EL, Coronel-Cruz C |
Revista Médica del Instituto Mexicano del Seguro Social | 2024 |
|
Mitochondrial dysfunction in acute and post-acute phases of COVID-19 and risk of non-communicable diseases
Madsen HB, Durhuus JA, Andersen O, Straten PT, Rahbech A, Desler C |
npj Metabolic Health and Disease | 2024 |
|
A sex-biased imbalance of circulating Tfr cells, Tph cells and extrafollicular B-cells determines antibody responses in COVID-19 patients
Jonas Søndergaard, Janyerkye Tulyeu, Ryuya Edahiro, Yuya Shirai, Yuta Yamaguchi, Teruaki Murakami, Takayoshi Morita, Yasuhiro Kato, Haruhiko Hirata, Yoshito Takeda, Daisuke Okuzaki, Shimon Sakaguchi, Atsushi Kumanogoh, Yukinori Okada, James Wing |
Proceedings of the National Academy of Sciences | 2023 |
|
Mitigation of influenza-mediated inflammation by immunomodulatory matrix-bound nanovesicles.
Raphael J Crum, Brydie Huckestien, Gaelen K. Dwyer, Lisa Mathews, David Nascari, George Hussey, Heth Turnquist, John Alcorn, Stephen Badylak |
Science Advances | 2023 |
|
Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation
Yunis J, Short KR, Yu D |
Trends in Microbiology | 2023 |
|
SARS-CoV-2 Spike protein activates TMEM16F-mediated platelet procoagulant activity
Cappelletto A, Allan HE, Crescente M, Schneider E, Bussani R, Ali H, Secco I, Vodret S, Simeone R, Mascaretti L, Zacchigna S, Warner TD, Giacca M |
Frontiers in Cardiovascular Medicine | 2023 |
|
Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial.
Taher A, Lashkari M, Keramat F, Hashemi SH, Sedighi L, Poorolajal J, Mehrpooya M |
Wiener Medizinische Wochenschrift | 2023 |
|
T-cell cellular stress and reticulocyte signatures, but not loss of naïve T lymphocytes, characterize severe COVID-19 in older adults.
Jergović M, Watanabe M, Bhat R, Coplen CP, Sonar SA, Wong R, Castaneda Y, Davidson L, Kala M, Wilson RC, Twigg HL 3rd, Knox K, Erickson HE, Weinkauf CC, Bime C, Bixby BA, Parthasarathy S, Mosier JM, LaFleur BJ, Bhattacharya D, Nikolich JZ |
GeroScience | 2023 |
|
COVID-19 and kidney disease: Progress in health inequity from low income settings
Tannor EK, Bajpal D, Nlandu YM, Wijewickrama E |
Seminars in Nephrology | 2023 |
|
Immunogenic Potential of the Mediterranean Fever Gene in Patients with Coronavirus Disease: A Cross-Sectional Study
Salehzadeh F, Pourfarzi F, Molatefi R, Davarnia B, Shahbazfar E, Ahmadabadi F |
Iranian journal of medical sciences | 2023 |
|
COVID-19’s immuno-pathology and cardiovascular diseases
Nasab EM, Aghajani H, Makoei RH, Athari SS |
Journal of Investigative Medicine | 2023 |
|
Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
Montero C, Torres R, Benavidez C, Garcia P, Jimenez S, Yomayusa N, Gayon D, Perez J, Rosselli D, Restrepo H, Alvarez-Moreno C |
2023 | |
|
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Dhawan M, Rabaan AA, Fawarah MM, Almuthree SA, Alsubki RA, Alfaraj AH, Mashraqi MM, Alshamrani SA, Abduljabbar WA, Alwashmi AS, Ibrahim FA, Alsaleh AA, Khamis F, Alsalman J, Sharma M, Emran TB |
Human vaccines | 2023 |
|
T Cells Immunophenotyping and CD38 Overexpression as Hallmarks of the Severity of COVID-19 and Predictors of Patients’ Outcomes
Tarbiah NI, Alkhattabi NA, Alsahafi AJ, Aljahdali HS, Joharjy HM, Al-Zahrani MH, Sabban AM, Alghamdi RA, Balgoon MJ, Khalifa RA |
Journal of Clinical Medicine | 2023 |
|
COVID-19: A Comprehensive Review on Cardiovascular Alterations, Immunity, and Therapeutics in Older Adults
Rivera-Torres J, Girón N, San José E |
Journal of Clinical Medicine | 2023 |
|
COVID-19 Heart Lesions in Children: Clinical, Diagnostic and Immunological Changes
Vasichkina E, Alekseeva D, Kudryavtsev I, Glushkova A, Starshinova AY, Malkova A, Kudlay D, Starshinova A |
International journal of molecular sciences | 2023 |
|
Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators
Yasmeen N, Harikrishnan S, Lakhawat SS, Datta M, Sharma PK, Jain A, Khanna R, Jayalakshmi S, Kumar V |
Biochemical Pharmacology | 2023 |
|
Liver injury on admission linked to worse outcomes in COVID-19: an analysis of 14,138 patients
Chela HK, Tallon EM, Baskett W, Gangu K, Tahan V, Shyu CR, Daglilar E |
Translational Gastroenterology and Hepatology | 2023 |
|
Secondary subcutaneous abscess due to mixed infections by Peptoniphilus olsenii and Gleimia europaea after COVID‐19
Yamamoto Y, Shiroyama T, Hirata H, Matsumoto K, Kuge T, Yoneda M, Yamamoto M, Uchiyama A, Takeda Y, Kumanogoh A |
Clinical Case Reports | 2023 |
|
Predictors of Mortality in COVID-19 patients: An observational study
Qureshi MA, Toori KU, Ahmed RM |
Pakistan Journal of Medical Sciences | 2023 |
|
Therapeutic potential of curcumin in ARDS and COVID‐19
Suresh MV, Francis S, Aktay S, Kralovich G, Raghavendran K |
Clinical and experimental pharmacology & physiology | 2023 |
|
Innate immune recognition against SARS-CoV-2
Yamada T, Takaoka A |
Ensho Saisei | 2023 |
|
Pulmonary embolism in COVID-19 infection: a high case-fatality related to pulmonary embolism characteristics
Couturaud F, Tromeur C, Le Mao R |
European Respiratory Journal | 2023 |
|
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
Chavda VP, Bezbaruah R, Dolia S, Shah N, Verma S, Savale S, Ray S |
2023 | |
|
Coagulopathy and the humoral response against viral proteins in patients at different stages of COVID-19
Monteiro FP, Tavares VD, Souza RD, Venâncio LP, Fabres-Klein MH, do Carmo RF, Klein RC, Lima JB, Araújo-Santos T |
Memórias do Instituto Oswaldo Cruz | 2023 |
|
Blood transcriptome responses in patients correlate with severity of COVID-19 disease
Wang Y, Schughart K, Pelaia TM, Chew T, Kim K, Karvunidis T, Knippenberg B, Teoh S, Phu AL, Short KR, Iredell J, Thevarajan I, Audsley J, Macdonald S, Burcham J, McLean A, Tang B, Shojaei M |
Frontiers in immunology | 2023 |
|
Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants
Won Kwak H, Park HJ, Jung SY, Young Oh E, Park SI, Kim Y, Park HJ, Park S, Kim YJ, Li Ko H, Lee JA, Won H, Hwang YH, Yeon Kim S, Eun Kim S, Eun Bae S, Yoon M, Kim JO, Song M, Jeen Lee S, Seo KW, Lee K, Kim D, Kim H, Lee SM, Hong SH, Nam JH |
Vaccine | 2023 |
|
[Artículo traducido] Impacto de los corticoides sistémicos en el tiempo de hospitalización en pacientes con COVID-19
Ester Z, Carlos C, Elena V, Rodolfo ÁS, Borobia Alberto M, Gómez-Carrera L, Antonio B, Concepción PM |
Farmacia Hospitalaria | 2023 |
|
Role of T cells in severe COVID-19 disease, protection, and long term immunity
Hermens JM, Kesmir C |
Immunogenetics | 2023 |
|
Venous thromboembolism in viral diseases: A comprehensive literature review
Zerangian N, Erabi G, Poudineh M, Monajjem K, Diyanati M, Khanlari M, Khalaji A, Allafi D, Faridzadeh A, Amali A, Alizadeh N, Salimi Y, Ghane Ezabadi S, Abdi A, Hasanabadi Z, ShojaeiBaghini M, Deravi N |
2023 | |
|
Repositioning linifanib as a potent anti-necroptosis agent for sepsis
Yu L, Yang K, He X, Li M, Gao L, Zha Y |
Cell Death Discovery | 2023 |
|
Defending against SARS-CoV-2: The T cell perspective
Almendro-Vázquez P, Laguna-Goya R, Paz-Artal E |
Frontiers in immunology | 2023 |
|
Immune responses in mildly versus critically ill COVID-19 patients
Nasrollahi H, Talepoor AG, Saleh Z, Eshkevar Vakili M, Heydarinezhad P, Karami N, Noroozi M, Meri S, Kalantar K |
Frontiers in immunology | 2023 |
|
Evaluation of Convalescent Plasma in the Management of Critically Ill COVID-19 Patients (with No Detectable Neutralizing Antibodies Nab) in Kashmir, India
Elkhalifa AM, Nabi SU, Shah NN, Dar KA, Quibtiya S, Bashir SM, Ali SI, Taifa S, Hussain I |
Healthcare | 2023 |
|
The Role of IL-6 in Inner Ear Impairment: Evidence from 146 Recovered Patients with Omicron Infected in Tianjin, China
Chen Y, Mao X, Kuang M, Zhang Z, Bo M, Yang Y, Lin P, Wang W, Shen Z |
Journal of Clinical Medicine | 2023 |
|
Expert-opinion-based guidance for the care of children with lysosomal storage diseases during the COVID-19 pandemic: An experience-based Turkey perspective
Akgun A, Gokcay G, Mungan NO, Sivri HS, Tezer H, Zeybek CA, Ezgu F |
Frontiers in public health | 2023 |
|
Lung abscess as a secondary infection of COVID-19: A case report and literature review
Umamoto K, Horiba M |
Journal of Infection and Chemotherapy | 2023 |
|
Anti-inflammatory or anti-SARS-CoV-2 ingredients in Huashi Baidu Decoction and their corresponding targets: target screening and molecular docking study
Wang Z, Gao H |
Arabian Journal of Chemistry | 2023 |
|
Endotoxin tolerance and low activation of TLR-4/NF-κB axis in monocytes of COVID-19 patients
Dorneles GP, Teixeira PC, Peres A, Rodrigues Júnior LC, da Fonseca SG, Monteiro MC, Eller S, Oliveira TF, Wendland EM, Romão PR |
Journal of Molecular Medicine | 2023 |
|
Liver injury associated with the severity of COVID-19: A meta-analysis
Yang R, Feng J, Wan H, Zeng X, Ji P, Zhang J |
Frontiers in public health | 2023 |
|
Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosis
Chan KR, Koh CW, Ng DH, Qin S, Ooi JS, Ong EZ, Zhang SL, Sam H, Kalimuddin S, Low JG, Ooi EE |
EBioMedicine | 2023 |
|
SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity
Rosichini M, Bordoni V, Silvestris DA, Mariotti D, Matusali G, Cardinale A, Zambruno G, Condorelli AG, Flamini S, Genah S, Catanoso M, Del Nonno F, Trezzi M, Galletti L, De Stefanis C, Cicolani N, Petrini S, Quintarelli C, Agrati C, Locatelli F, Velardi E |
Journal of Allergy and Clinical Immunology | 2023 |
|
Evaluation of anakinra in the management of patients with COVID-19 infection: A randomized clinical trial
Elmekaty EZ, Maklad A, Abouelhassan R, Munir W, Ibrahim MI, Nair A, Alibrahim R, Iqbal F, Al Bishawi A, Abdelmajid A, Aboukamar M, Hadi HA, Khattab MA, Al Soub H, Al Maslamani M |
Frontiers in microbiology | 2023 |
|
Neurologıcal Complıcatıons and Potentıal Effects of Covıd-19: Symptoms and Conceıvable Mechanısms
Sarıoğlu E, Yılmaz Sarıaltın S, Çoban T |
2023 | |
|
Atherosclerosis, Cardiovascular Disorders and COVID-19: Comorbid Pathogenesis
Makarova YA, Ryabkova VA, Salukhov VV, Sagun BV, Korovin AE, Churilov LP |
Diagnostics | 2023 |
|
Clinical Value of Platelets and Coagulation Parameters in Predicting the Severity of Delta Variant SARS-CoV-2
Chen YE, Ren FL, Gu X, Zhang HJ, Li WJ, Yang H, Shang FQ |
Pathobiology | 2023 |
|
The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury
Xiang M, Wu X, Jing H, Novakovic VA, Shi J |
Frontiers in Cardiovascular Medicine | 2023 |
|
COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells
Jankauskas SS, Kansakar U, Sardu C, Varzideh F, Avvisato R, Wang X, Matarese A, Marfella R, Ziosi M, Gambardella J, Santulli G |
Antioxidants | 2023 |
|
The paradigm of prophylactic viral outbreaks measures by microbial biosurfactants
Kumari K, Nandi A, Sinha A, Ghosh A, Sengupta S, Saha U, Singh PK, Panda PK, Raina V, Verma SK |
Journal of Infection and Public Health | 2023 |
|
Regulating the microenvironment with nanomaterials: Potential strategies to ameliorate COVID-19
Liu Z, Han Z, Jin X, An J, Kim J, Chen W, Kim JS, Zheng J, Deng J |
Acta pharmaceutica Sinica. B | 2023 |
|
Reactive arthritis following COVID-19: cause for concern
Migliorini F, Karlsson J, Maffulli N |
Knee Surgery, Sports Traumatology, Arthroscopy | 2023 |
|
Early immune system alterations in patients with septic shock
Tang H, Qin S, Li Z, Gao W, Tang M, Dong X |
Frontiers in immunology | 2023 |
|
Animal Models for the Study of SARS-CoV-2–induced Respiratory Disease and Pathology
Dillard JA, Martinez SA, Dearing JJ, Montgomery SA, Baxter VK |
Comparative medicine | 2023 |
|
Persistence of inflammatory and vascular mediators 5 months after hospitalization with COVID-19 infection
Melhorn J, Alamoudi A, Mentzer AJ, Fraser E, Fries A, Cassar MP, Kwok A, Knight JC, Raman B, Talbot NP, Petousi N |
Frontiers in Medicine | 2023 |
|
Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review
Tirelli C, De Amici M, Albrici C, Mira S, Nalesso G, Re B, Corsico AG, Mondoni M, Centanni S |
Biology | 2023 |
|
The Interplay among Glucocorticoid Therapy, Platelet-Activating Factor and Endocannabinoid Release Influences the Inflammatory Response to COVID-19
de Carvalho JC, da Silva-Neto PV, Toro DM, Fuzo CA, Nardini V, Pimentel VE, Pérez MM, Fraga-Silva TF, Oliveira CN, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, da Rocha JJ, Feres O, Vilar FC, Gaspar GG, Santos IK, Fernandes AP, Maruyama SR, Russo EM, Bonato VL, Cardoso CR, Dias-Baruffi M, Faccioli LH, Sorgi CA |
Viruses | 2023 |
|
Patients with SARS-CoV-2-Induced Viral Sepsis Simultaneously Show Immune Activation, Impaired Immune Function and a Procoagulatory Disease State
Limmer A, Engler A, Kattner S, Gregorius J, Pattberg KT, Schulz R, Schwab J, Roth J, Vogl T, Krawczyk A, Witzke O, Zelinskyy G, Dittmer U, Brenner T, Berger MM |
Human vaccines | 2023 |
|
Harnessing the Power of Venomous Animal-Derived Toxins against COVID-19
Oliveira I, Ferreira I, Jacob B, Cardenas K, Cerni F, Baia-da-Silva D, Arantes E, Monteiro W, Pucca M |
Toxins | 2023 |
|
Post-COVID-19 Pneumocystis pneumonia cases from Pakistan: an observational study
Niamatullah H, Nasir N, Jabeen K, Rattani S, Farooqi J, Ghanchi N, Irfan M |
2023 | |
|
Case Report: Acquired Brown Syndrome after COVID-19 Vaccination
Fayed AE, Rakha NK |
Optometry and Vision Science | 2023 |
|
Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19
Goudswaard LJ, Williams CM, Khalil J, Burley KL, Hamilton F, Arnold D, Milne A, Lewis PA, Heesom KJ, Mundell SJ, Davidson AD, Poole AW, Hers I |
Journal of Thrombosis and Haemostasis | 2023 |
|
Alterations in Gut Microbiota Composition in Patients with COVID-19: A Pilot Study of Whole Hypervariable 16S rRNA Gene Sequencing
Mańkowska-Wierzbicka D, Zuraszek J, Wierzbicka A, Gabryel M, Mahadea D, Baturo A, Zakerska-Banaszak O, Slomski R, Skrzypczak-Zielinska M, Dobrowolska A |
Biomedicines | 2023 |
|
Autopsies Revealed Pathological Features of COVID-19 in Unvaccinated vs. Vaccinated Patients
Colombo D, Del Nonno F, Marchioni L, Lalle E, Gallì P, Vaia F, Falasca L |
Biomedicines | 2023 |
|
Serial Changes in Blood-Cell-Count-Derived and CRP-Derived Inflammatory Indices of COVID-19 Patients
Khadzhieva MB, Gracheva AS, Belopolskaya OB, Chursinova YV, Redkin IV, Pisarev MV, Kuzovlev AN |
Diagnostics | 2023 |
|
Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?
Fialho MF, Brum ES, Oliveira SM |
InflammoPharmacology | 2023 |
|
Insight into the mechanisms of coronaviruses evading host innate immunity.
Yao T, Foo C, Zheng G, Huang R, Li Q, Shen J, Wang Z |
2023 | |
|
Alterations in the immune system persist after one year of convalescence in severe COVID-19 patients.
Abarca-Zabalía J, González-Jiménez A, Calle-Rubio M, López-Pastor AR, Fariña T, Ramos-Acosta C, Anguita E, Urcelay E, Espino-Paisán L |
Frontiers in immunology | 2023 |
|
Bioactive omega-3 fatty acids are associated with reduced risk and severity of SARS-CoV-2 infection.
Calder PC |
The American journal of clinical nutrition | 2023 |
|
Inflammasome genes polymorphisms are associated with progression to mechanical ventilation and death in a cohort of hospitalized COVID-19 patients in a reference hospital in Rio de Janeiro, Brazil
Neira-Goulart M, de Sá NB, Ribeiro-Alves M, Perazzo H, Geraldo KM, Ribeiro MP, Cardoso SW, Grinsztejn B, Veloso VG, Rodrigues Gomes L, Cazote AD, de Almeida DV, Giacoia-Gripp CB, Côrtes FH, Morgado MG |
Gene | 2023 |
|
Effect of ferritin, INR, and D-dimer immunological parameters levels as predictors of COVID-19 mortality: A strong prediction with the decision trees
Huyut MT, Huyut Z |
Heliyon | 2023 |
|
Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
Zheng Z, Peng F, Zhou Y |
2023 | |
|
Pulmonary Cryptococcosis in Patient with COVID-19: A Case Report
Ahmad S, Alsaeed M |
2023 | |
|
The role of immune activation and antigen persistence in acute and long COVID.
Opsteen S, Files JK, Fram T, Erdmann N |
Journal of investigative medicine : the official publication of the American Federation for Clinical Research | 2023 |
|
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Theoharides TC, Kempuraj D |
Cells | 2023 |
|
Impacts of COVID-19 in Breast Cancer: From Molecular Mechanism to the Treatment Approach.
Stipp MC, Corso CR, Acco A |
Current pharmaceutical biotechnology | 2023 |
|
How Does COVID-19 Affect the Heart?
Sewanan LR, Clerkin KJ, Tucker NR, Tsai EJ |
Current Cardiology Reports | 2023 |
|
Reactive arthritis following COVID-19 current evidence, diagnosis, and management strategies.
Migliorini F, Bell A, Vaishya R, Eschweiler J, Hildebrand F, Maffulli N |
Journal of orthopaedic surgery and research | 2023 |
|
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2
Purbey PK, Roy K, Gupta S, Paul MK |
Molecular Immunology | 2023 |
|
Sarcopenia and COVID-19 Outcomes
Wang Y, Tan S, Yan Q, Gao Y |
Clinical Interventions in Aging | 2023 |
|
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance.
Scaramuzzo G, Nucera F, Asmundo A, Messina R, Mari M, Montanaro F, Johansen MD, Monaco F, Fadda G, Tuccari G, Hansbro NG, Hansbro PM, Hansel TT, Adcock IM, David A, Kirkham P, Caramori G, Volta CA, Spadaro S |
Journal of inflammation (London, England) | 2023 |
|
Bone fragility during the COVID-19 pandemic: the role of macro- and micronutrients.
Moretti A, Liguori S, Paoletta M, Migliaccio S, Toro G, Gimigliano F, Iolascon G |
Therapeutic Advances in Musculoskeletal Diseases | 2023 |
|
On the Methodological Aspects of the Clinical Trials for COVID-19 Conducted in the First Year of the Pandemic: A Descriptive Analysis
Georgiadi E, Sachlas A |
Statistics in Biosciences | 2023 |
|
A single-cell atlas reveals shared and distinct immune responses and metabolic profiles in SARS-CoV-2 and HIV-1 infections
Pan T, Cao G, Tang E, Zhao Y, Penaloza-MacMaster P, Fang Y, Huang J |
Frontiers in Genetics | 2023 |
|
SARS-CoV-2 Mpro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals
Chen SA, Arutyunova E, Lu J, Khan MB, Rut W, Zmudzinski M, Shahbaz S, Iyyathurai J, Moussa EW, Turner Z, Bai B, Lamer T, Nieman JA, Vederas JC, Julien O, Drag M, Elahi S, Young HS, Lemieux MJ |
ACS Central Science | 2023 |
|
Molecular Determinants of the Early Life Immune Response to COVID-19 Infection and Immunization
Beijnen EM, Odumade OA, van Haren SD |
Human vaccines | 2023 |
|
Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections
Urazov S, Chernov A, Popov O, Klenkova N, Sushentseva N, Polkovnikova I, Apalko S, Kislyuk K, Pavlovich D, Ivanov A, Shcherbak S |
International journal of molecular sciences | 2023 |
|
Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID
Dhawan M, Rabaan AA, Alwarthan S, Alhajri M, Halwani MA, Alshengeti A, Najim MA, Alwashmi AS, Alshehri AA, Alshamrani SA, AlShehail BM, Garout M, Al-Abdulhadi S, Al-Ahmed SH, Thakur N, Verma G |
Human vaccines | 2023 |
|
COVID-19 and Frailty
Ciarambino T, Crispino P, Minervini G, Giordano M |
Human vaccines | 2023 |
|
Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity
Pacheco-García U, Serafín-López J |
Human vaccines | 2023 |
|
Correlation of Lymphocyte Subpopulations, Clinical Features and Inflammatory Markers during Severe COVID-19 Onset
Liontos A, Asimakopoulos AG, Markopoulos GS, Biros D, Athanasiou L, Tsourlos S, Dova L, Rapti IC, Tsiakas I, Ntzani E, Evangelou E, Tzoulaki I, Tsilidis K, Vartholomatos G, Dounousi E, Milionis H, Christaki E |
Pathogens | 2023 |
|
A Scoping Review of the Impact of COVID-19 on Kidney Transplant Patients in the United States
Karas M, Bernal I, Diaz O, Alshammari O, Baggett D, Bronk T, Chawdhury S, Eylon A, Garcia E, Haughton K, Kothe B, Joseph AM, Jacobs RJ |
Cureus | 2023 |
|
Epigenetic immune monitoring for COVID-19 disease course prognosis.
Samans B, Rosselló Chornet M, Rosselló Chornet A, Jung J, Schildknecht K, Lozza L, Alos Zaragoza L, Hernández Laforet J, Babel N, Olek S |
Frontiers in immunology | 2023 |
|
Gender Differences Associated with Hyper-Inflammatory Conditions in COVID-19 Patients
Shoeb F, Mahdi F, Hussain I |
Aging and disease | 2023 |
|
Comparison of Real-time RT-PCR cycle threshold (Ct) values with clinical features and severity of COVID-19 disease among hospitalized patients in the first and second waves of COVID-19 pandemic in Chennai, India
Natarajan S, Ranganathan M, Natarajan PL, Nesakumar M, Anbalagan S, Lucia Precilla K, Hemalatha H, Kannan M, Narendran G, Mahalakshmi S, Karmegam G, Prakash L, Narayanasamy K, Hanna LE |
2023 | |
|
Neutrophilic inflammation promotes SARS-CoV-2 infectivity and augments the inflammatory responses in airway epithelial cells
Calvert BA, Quiroz EJ, Lorenzana Z, Doan N, Kim S, Senger CN, Anders JJ, Wallace WD, Salomon MP, Henley J, Ryan AL |
Frontiers in immunology | 2023 |
|
The Outcome of COVID-19 Infection in Patients With Gastrointestinal Diseases: An Experience at a Tertiary Center
Tafaj I, Cuko L, Çili Q, Hysenj A, Sadiku E |
Cureus | 2023 |
|
Dynamic changes in radiological parameters, immune cells, selected miRNAs, and cytokine levels in peripheral blood of patients with severe COVID‑19
Bukreieva T, Kyryk V, Nikulina V, Svitina H, Vega A, Chybisov O, Shablii I, Mankovska O, Lobyntseva G, Nemtinov P, Skrypkina I, Shablii V |
Biomedical Reports | 2023 |
|
High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR, Brito ACS, Manfro WFP, Ribeiro-Alves M, Ribeiro RSA, da Cal MS, Lisboa VDC, Abreu DPB, Castilho LDR, Porto LCMS, Mafort TT, Lopes AJ, da Silva SAG, Dutra PML, Rodrigues LS |
PloS one | 2023 |
|
Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.
Zhang W, Liu L, Xiao X, Zhou H, Peng Z, Wang W, Huang L, Xie Y, Xu H, Tao L, Nie W, Yuan X, Liu F, Yuan Q |
Frontiers in immunology | 2023 |
|
Clinical and Cytokine Profile of Children With COVID-19: A Report From Turkey.
Dalkıran T, Kara EM, Ünsal V, Yurttutan S, İpek S, Dağoğlu B, Kandur Y |
Cureus | 2023 |
|
Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study.
Montrucchio G, Sales G, Balzani E, Lombardo D, Giaccone A, Cantù G, D'Antonio G, Rumbolo F, Corcione S, Simonetti U, Bonetto C, Zanierato M, Fanelli V, Filippini C, Mengozzi G, Brazzi L |
Frontiers in Medicine | 2023 |
|
SARS-CoV-2 infection aggravates cigarette smoke-exposed cell damage in primary human airway epithelia.
Chen R, Hui KP, Liang Y, Ng KC, Nicholls JM, Ip MS, Peiris M, Chan MC, Mak JC |
Virology Journal | 2023 |
|
The potential of Panax notoginseng against COVID-19 infection
Hu Y, He Z, Zhang W, Niu Z, Wang Y, Zhang J, Shen T, Cheng H, Hu W |
Journal of Ginseng Research | 2023 |
|
Skull Base Involvement in Covid Associated Rhino-Orbital-Cerebral Mucormycosis: A Comprehensive Analysis
Chakravarty S, Nagarkar NM, Mehta R, Arora R, Ghosh A, Sharma AK, Satpute S, Aggarwal A |
Indian Journal of Otolaryngology and Head & Neck Surgery | 2023 |
|
Purinergic signaling pathway in severe COVID-19
Arruvito L, Sananez I, Seery V, Russo C, Geffner J |
Current Opinion in Pharmacology | 2023 |
|
Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study
Wang J, Dong H, Zhao J, Li T, Wang M, Zhou C, Mu H |
Frontiers in microbiology | 2023 |
|
Mapping CircRNA–miRNA–mRNA regulatory axis identifies hsa_circ_0080942 and hsa_circ_0080135 as a potential theranostic agents for SARS-CoV-2 infection
Ayaz H, Aslam N, Awan FM, Basri R, Rauff B, Alzahrani B, Arif M, Ikram A, Obaid A, Naz A, Khan SN, Yang BB, Nazir A |
PloS one | 2023 |
|
A quantitative systems pharmacology model of the pathophysiology and treatment of COVID-19 predicts optimal timing of pharmacological interventions
Rao R, Musante CJ, Allen R |
npj Systems Biology and Applications | 2023 |
|
Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals
Cavic M, Nesic A, Mirjacic Martinovic K, Vuletic A, Besu Zizak I, Tisma Miletic N, Krivokuca A, Jankovic R, Gavrovic-Jankulovic M |
Scientific Reports | 2023 |
|
Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm.
Mahmoud IS, Jarrar YB, Febrimarsa |
Clinical and Experimental Medicine | 2023 |
|
Post-COVID-19 Afferent Baroreflex Failure.
Elkholey K, Wahba A, Paranjape SY, Saleem M, Kirabo A, Joos KM, Diedrich A, Shibao CA, Biaggioni I |
2023 | |
|
Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients.
Leyfman Y, Emmanuel N, Menon GP, Joshi M, Wilkerson WB, Cappelli J, Erick TK, Park CH, Sharma P |
Journal of Hematology & Oncology | 2023 |
|
Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement
Sayyadi M, Hassani S, Shams M, Dorgalaleh A |
Annals of Hematology | 2023 |
|
Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients' susceptibility to COVID-19 to the possible caution of future global diabetes tsunami.
Sharbatdar Y, Mousavian R, Noorbakhsh Varnosfaderani SM, Aziziyan F, Liaghat M, Baziyar P, Yousefi Rad A, Tavakol C, Moeini AM, Nabi-Afjadi M, Zalpoor H, Kazemi-Lomedasht F |
InflammoPharmacology | 2023 |
|
Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity.
Edahiro R, Shirai Y, Takeshima Y, Sakakibara S, Yamaguchi Y, Murakami T, Morita T, Kato Y, Liu YC, Motooka D, Naito Y, Takuwa A, Sugihara F, Tanaka K, Wing JB, Sonehara K, Tomofuji Y, Namkoong H, Tanaka H, Lee H, Fukunaga K, Hirata H, Takeda Y, Okuzaki D, Kumanogoh A, Okada Y |
Nature Genetics | 2023 |
|
Relationship between Vitamin D and Immunity in Older People with COVID-19.
Lauretani F, Salvi M, Zucchini I, Testa C, Cattabiani C, Arisi A, Maggio M |
International journal of environmental research and public health | 2023 |
|
Intestinal Damage, Inflammation and Microbiota Alteration during COVID-19 Infection
Saviano A, Brigida M, Petruzziello C, Zanza C, Candelli M, Morabito Loprete MR, Saleem F, Ojetti V |
Biomedicines | 2023 |
|
Reduced IL-8 Secretion by NOD-like and Toll-like Receptors in Blood Cells from COVID-19 Patients
Carreto-Binaghi LE, Herrera MT, Guzmán-Beltrán S, Juárez E, Sarabia C, Salgado-Cantú MG, Juarez-Carmona D, Guadarrama-Pérez C, González Y |
Biomedicines | 2023 |
|
Ruxolitinib as an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report
Wang L, Zhang X, Huang B, Hou Y, Liu X, Jiao H |
Infection and drug resistance | 2023 |
|
IL-6 and cfDNA monitoring throughout COVID-19 hospitalization are accurate markers of its outcomes
Bello S, Lasierra AB, López-Vergara L, de Diego C, Torralba L, de Gopegui PR, Lahoz R, Abadía C, Godino J, Cebollada A, Jimeno B, Bello C, Tejada A, Torres A |
Respiratory Research | 2023 |
|
Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extracellular trap formation
Li Y, Hook JS, Ding Q, Xiao X, Chung SS, Mettlen M, Xu L, Moreland JG, Agathocleous M |
Nature Communications | 2023 |
|
Acute coronavirus infection triggers a TNF-dependent osteoporotic phenotype in mice
Queiroz-Junior CM, Santos AC, Gonçalves MR, Brito CB, Barrioni B, Almeida PJ, Gonçalves-Pereira MH, Silva T, Oliveira SR, Pereira MM, Santiago HC, Teixeira MM, Costa VV |
Life Sciences | 2023 |
|
Identifying cerebral microstructural changes in patients with COVID-19 using MRI: A systematic review
Alhazmi FH, Alsharif WM, Alshoabi SA, Gameraddin M, Aloufi KM, Abdulaal OM, Qurashi AA |
Brain Circulation | 2023 |
|
Persistent Luminescence Zn(2)GeO(4):Mn(2+) Nanoparticles Functionalized with Polyacrylic Acid: One-Pot Synthesis and Biosensing Applications.
Calderón-Olvera RM, Arroyo E, Jankelow AM, Bashir R, Valera E, Ocaña M, Becerro AI |
ACS Applied Materials & Interfaces | 2023 |
|
COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants
Padasas BT, Españo E, Kim SH, Song Y, Lee CK, Kim JK |
Immune Network | 2023 |
|
SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups
Liatsos GD |
World Journal of Gastroenterology | 2023 |
|
Response to Intravenous N-Acetylcysteine Supplementation in Critically Ill Patients with COVID-19
Gamarra-Morales Y, Herrera-Quintana L, Molina-López J, Vázquez-Lorente H, Machado-Casas JF, Castaño-Pérez J, Pérez-Villares JM, Planells E |
Nutrients | 2023 |
|
Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics
Sayahinouri M, Mashayekhi Firouz S, Ebrahimi Sadrabadi A, Masoudnia M, Abdolahi M, Jafarzadeh F, Nouripour M, Mirzazadeh S, Zangeneh N, Jalili A, Aghdami N |
BioImpacts : BI | 2023 |
|
Immunology of SARS-CoV-2 infection and vaccination
Lin B, Cheng L, Zhang J, Yang M, Zhang Y, Liu J, Qin X |
Clinica chimica acta; international journal of clinical chemistry | 2023 |
|
Evaluation of circulating insulin-like growth factor-1, heart-type fatty acid-binding protein, and endotrophin levels as prognostic markers of COVID-19 infection severity
Mohamed AA, Nour AA, Mosbah NM, Wahba AS, Esmail OE, Eysa B, Heiba A, Samir HH, El-Kassas AA, Adroase AS, Elamir AY, Mahmoud GM, Rafaat RS, Hassan HA, El Abd YS |
Virology Journal | 2023 |
|
Evaluation of Vitamin D Serum Levels in Pregnant Women with COVID-19 Compared with the Control Group in Pregnant Women: A Case–Control Study
Sedaghat M, Talebi-Ghane E, Goodarzi A, Kamkari S, Anvari R, Beheshti rouy R, Radnia N |
2023 | |
|
Vessel-on-a-Chip: A Powerful Tool for Investigating Endothelial COVID-19 Fingerprints
Shevchuk O, Palii S, Pak A, Chantada N, Seoane N, Korda M, Campos-Toimil M, Álvarez E |
Cells | 2023 |
|
The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis.
Soheili M, Khateri S, Moradpour F, Mohammadzedeh P, Zareie M, Mortazavi SMM, Manifar S, Kohan HG, Moradi Y |
Annals of clinical microbiology and antimicrobials | 2023 |
|
STAT-1-Controlled Lipin-2 Is a Master Regulator of the Antiviral and Anti-Inflammatory Responses to Interferon
Nagore de Pablo, Clara Meana, Javier Martínez-García, Pablo Martínez-Vicente, Manuel Albert, Susana Guerra, Ana Angulo, Jesús Balsinde, María Balboa |
EMBO reports | 2023 |
|
Early Outcomes of Adult Heart Transplantation From COVID-19 Infected Donors
Madan S, Chan MA, Saeed O, Hemmige V, Sims DB, Forest SJ, Goldstein DJ, Patel SR, Jorde UP |
Journal of the American College of Cardiology | 2023 |
|
Prognostic Value of C-Reactive Protein in SARS-CoV-2 Infection: A Simplified Biomarker of COVID-19 Severity in Northern Ethiopia
Gebrecherkos T, Challa F, Tasew G, Gessesse Z, Kiros Y, Gebreegziabxier A, Abdulkader M, Desta AA, Atsbaha AH, Tollera G, Abrahim S, Urban BC, Schallig H, Rinke de Wit T, Wolday D |
Infection and drug resistance | 2023 |
|
T Lymphocyte Subset Counts and Interferon-Gamma Production in Adults and Children with COVID-19: A Narrative Review
De Rose DU, Pace PG, Ceccherini-Silberstein F, Dotta A, Andreoni M, Sarmati L, Iannetta M |
Journal of Personalized Medicine | 2023 |
|
Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies.
Lucane Z, Slisere B, Gersone G, Papirte S, Gailite L, Tretjakovs P, Kurjane N |
Viruses | 2023 |
|
Superimposed Pulmonary Tuberculosis (PTB) in a 26-Year-Old Female with No Underlying Co-Morbidities Recovering from COVID-19-Case Report.
Njekwa K, Muyoyeta M, Mulenga B, Chisenga CC, Simuyandi M, Chilengi R |
Tropical Medicine and Infectious Disease | 2023 |
|
Inflammatory Response in COVID-19 Depending on the Severity of the Disease and the Vaccination Status.
Trofin F, Nastase EV, Roșu MF, Bădescu AC, Buzilă ER, Miftode EG, Manciuc DC, Dorneanu OS |
International journal of molecular sciences | 2023 |
|
The controversial effect of smoking and nicotine in SARS-CoV-2 infection.
Salehi Z, Motlagh Ghoochani BFN, Hasani Nourian Y, Jamalkandi SA, Ghanei M |
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology | 2023 |
|
Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation
García-Nicolás O, Godel A, Zimmer G, Summerfield A |
Cellular and Molecular Immunology | 2023 |
|
Downregulation of MALAT1 is a hallmark of tissue and peripheral proliferative T cells in COVID-19
Dey S, Ashwin H, Milross L, Hunter B, Majo J, Filby AJ, Fisher AJ, Kaye PM, Lagos D |
Clinical & Experimental Immunology | 2023 |
|
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.
Chen P, Wu M, He Y, Jiang B, He ML |
Signal Transduction and Targeted Therapy | 2023 |
|
Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients
Smail SW, Babaei E, Amin K, Abdulahad WH |
Frontiers in immunology | 2023 |
|
Basement membrane product, endostatin, as a link between inflammation, coagulation and vascular permeability in COVID-19 and non-COVID-19 acute respiratory distress syndrome
Jandl K, Berg JL, Birnhuber A, Fliesser E, Borek I, Seeliger B, David S, Schmidt JJ, Gorkiewicz G, Zacharias M, Welte T, Olschewski H, Heinemann A, Wygrecka M, Kwapiszewska G |
Frontiers in immunology | 2023 |
|
Recombinant SARS-CoV-2 Spike Protein Stimulates Secretion of Chymase, Tryptase, and IL-1β from Human Mast Cells, Augmented by IL-33
Tsilioni I, Theoharides TC |
International journal of molecular sciences | 2023 |
|
COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications
Imam MT, Almalki ZS, Alzahrani AR, Al-Ghamdi SS, Falemban AH, Alanazi IM, Shahzad N, Muhammad Alrooqi M, Jabeen Q, Shahid I |
International Immunopharmacology | 2023 |
|
Tocilizumab versus anakinra in COVID-19: results from propensity score matching
Arcani R, Correard F, Suchon P, Kaplanski G, Jean R, Cauchois R, Leprince M, Arcani V, Seguier J, De Sainte Marie B, Andre B, Koubi M, Rossi P, Gayet S, Gobin N, Garrido V, Weiland J, Jouve E, Couderc AL, Villani P, Daumas A |
Frontiers in immunology | 2023 |
|
Systems genetics identifies miRNA-mediated regulation of host response in COVID-19
Gjorgjieva T, Chaloemtoem A, Shahin T, Bayaraa O, Dieng MM, Alshaikh M, Abdalbaqi M, Del Monte J, Begum G, Leonor C, Manikandan V, Drou N, Arshad M, Arnoux M, Kumar N, Jabari A, Abdulle A, ElGhazali G, Ali R, Shaheen SY, Abdalla J, Piano F, Gunsalus KC, Daggag H, Al Nahdi H, Abuzeid H, Idaghdour Y |
Human genomics | 2023 |
|
The role of trained immunity in COVID-19: Lessons for the next pandemic
Netea MG, Ziogas A, Benn CS, Giamarellos-Bourboulis EJ, Joosten LA, Arditi M, Chumakov K, van Crevel R, Gallo R, Aaby P, van der Meer JW |
Cell Host & Microbe | 2023 |
|
Antiviral response and immunopathogenesis of interleukin 27 in COVID-19.
Valdés-López JF, Urcuqui-Inchima S |
Archives of Virology | 2023 |
|
COVID-19 and interstitial lung diseases: a multifaceted look at the relationship between the two diseases
Fukihara J, Kondoh Y |
Respiratory Investigation | 2023 |
|
Post-COVID-19 Syndrome Mechanisms, Prevention and Management
Najafi MB, Javanmard SH |
International journal of preventive medicine | 2023 |
|
Documenting the immune response in patients with COVID-19-induced acute respiratory distress syndrome
Lu J, Zeng X, Lu W, Feng J, Yang Y, Wei Y, Chen Y, Zhang J, Pinhu L |
Frontiers in Cell and Developmental Biology | 2023 |
|
IL1β, IL-6, and TNF-α cytokines cooperate to modulate a complicated medical condition among COVID-19 patients: case-control study
Faraj SS, Jalal PJ |
Annals of Medicine and Surgery | 2023 |
|
Secondary fungal infections in SARS-CoV-2 patients: pathological whereabouts, cautionary measures, and steadfast treatments.
Singh R, Malik P, Kumar M, Kumar R, Alam MS, Mukherjee TK |
Pharmacological reports : PR | 2023 |
|
Emerging aspects of cytokine storm in COVID-19: the role of proinflammatory cytokines and therapeutic prospects
Dharra R, Kumar Sharma A, Datta S |
Cytokine | 2023 |
|
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine
Grandi A, Tomasi M, Ullah I, Bertelli C, Vanzo T, Accordini S, Gagliardi A, Zanella I, Benedet M, Corbellari R, Lascio GD, Tamburini S, Caproni E, Croia L, Ravà M, Fumagalli V, Lucia PD, Marotta D, Sala E, Iannacone M, Kumar P, Mothes W, Uchil PD, Cherepanov P, Bolognesi M, Pizzato M, Grandi G |
Research square | 2023 |
|
Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes
Keur N, Saridaki M, Ricaño-Ponce I, Netea MG, Giamarellos-Bourboulis EJ, Kumar V |
Respiratory Medicine | 2023 |
|
Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months.
Santopaolo M, Gregorova M, Hamilton F, Arnold D, Long A, Lacey A, Oliver E, Halliday A, Baum H, Hamilton K, Milligan R, Pearce O, Knezevic L, Morales Aza B, Milne A, Milodowski E, Jones E, Lazarus R, Goenka A, Finn A, Maskell N, Davidson AD, Gillespie K, Wooldridge L, Rivino L |
eLife | 2023 |
|
Oxidative stress, DNA damage, and inflammation in COVID-19 patients
Bektemur G, Bozali K, Colak S, Aktas S, Guler EM |
Northern Clinics of Istanbul | 2023 |
|
Progressive multifocal leukoencephalopathy in multiple myeloma: a case report of a patient with SARS-CoV-2 infection and an updated systematic literature review.
Paolucci M, Gentile L, Gentile M, Borghi A, Merli E, Marchionni E, Guerra L, Galluzzo S, Cilloni N, Simonetti L, Zini A |
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2023 |
|
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Tsilingiris D, Vallianou NG, Karampela I, Christodoulatos GS, Papavasileiou G, Petropoulou D, Magkos F, Dalamaga M |
International journal of molecular sciences | 2023 |
|
Sequential Shifting in T-helper and T-cytotoxic Subset Cell Population in Mild and Severe COVID-19 Patients Infected With Variant B.1.61
Agarwal J, Awasthi NP, Singh S, Tiwari V |
Cureus | 2023 |
|
SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial.
Papadopoulou A, Karavalakis G, Papadopoulou E, Xochelli A, Bousiou Z, Vogiatzoglou A, Papayanni PG, Georgakopoulou A, Giannaki M, Stavridou F, Vallianou I, Kammenou M, Varsamoudi E, Papadimitriou V, Giannaki C, Sileli M, Stergiouda Z, Stefanou G, Kourlaba G, Gounelas G, Triantafyllidou M, Siotou E, Karaglani A, Zotou E, Chatzika G, Boukla A, Papalexandri A, Koutra MG, Apostolou D, Pitsiou G, Morfesis P, Doumas M, Karampatakis T, Kapravelos N, Bitzani M, Theodorakopoulou M, Serasli E, Georgolopoulos G, Sakellari I, Fylaktou A, Tryfon S, Anagnostopoulos A, Yannaki E |
Nature Medicine | 2023 |
|
Editorial: Chronic Inflammation and Related Diseases: From Mechanisms to Therapies
Kang SY, Ryu Y |
International journal of molecular sciences | 2023 |
|
Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19
Tavakoli R, Rahimi P, Hamidi-Fard M, Eybpoosh S, Doroud D, Ahmadi I, Anvari E, Aghasadeghi M, Fateh A |
Future Virology | 2023 |
|
NK cells from COVID-19 positive patients exhibit enhanced cytotoxic activity upon NKG2A and KIR2DL1 blockade.
Lee G, Schauner R, Burke J, Borocz J, Vasana S, Sobieraj L, Giraudo M, Jackson Z, Ansari Q, Navas M, Sakr H, Wald D |
Frontiers in immunology | 2023 |
|
Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19.
Chen S, Zhang C, Chen D, Dong L, Chang T, Tang ZH |
Frontiers in immunology | 2023 |
|
Respiratory Infections in the Aging Lung: Implications for Diagnosis, Therapy, and Prevention
Häder A, Köse-Vogel N, Schulz L, Mlynska L, Hornung F, Hagel S, Teichgräber U, Lang SM, Pletz MW, Saux CJ, Löffler B, Deinhardt-Emmer S |
Aging and disease | 2023 |
|
Host genetic polymorphisms involved in long-term symptoms of COVID-19
Udomsinprasert W, Nontawong N, Saengsiwaritt W, Panthan B, Jiaranai P, Thongchompoo N, Santon S, Runcharoen C, Sensorn I, Jittikoon J, Chaikledkaew U, Chantratita W |
Emerging Microbes & Infections | 2023 |
|
Hydrogen Sulfide Ameliorates SARS-CoV-2-Associated Lung Endothelial Barrier Disruption
Escaffre O, Szaniszlo P, Törő G, Vilas CL, Servantes BJ, Lopez E, Juelich TL, Levine CB, McLellan SL, Cardenas JC, Freiberg AN, Módis K |
Biomedicines | 2023 |
|
Association of Serum Ferritin With Severity of Disease in Real-Time Reverse Transcription-Polymerase Chain Reaction Negative COVID-19 Patients.
Sai Bharath BV, Tudu PK, Dash SC, Sahoo N |
Cureus | 2023 |
|
Auto-immunoproteomics analysis of COVID-19 ICU patients revealed increased levels of autoantibodies related to the male reproductive system.
Schmidt F, Abdesselem HB, Suhre K, Vaikath NN, Sohail MU, Al-Nesf M, Bensmail I, Mashod F, Sarwath H, Bernhardt J, Schaefer-Ramadan S, Tan TM, Morris PE, Schenck EJ, Price D, Mohamed-Ali V, Al-Maadheed M, Arredouani A, Decock J, Blackburn JM, Choi AMK, El-Agnaf OM |
Frontiers in physiology | 2023 |
|
Effectiveness and safety of normoxic allogenic umbilical cord mesenchymal stem cells administered as adjunctive treatment in patients with severe COVID-19.
Soetjahjo B, Malueka RG, Nurudhin A, Purwoko, Sumardi, Wisaksana R, Adhiputri A, Sudadi, Soeroto AY, Sidharta BRA, Thobari JA, Murni TW, Soewondo W, Herningtyas EH, Sudjud RW, Trisnawati I, Ananda NR, Faried A |
Scientific Reports | 2023 |
|
Identification of Gene Markers Associated with COVID-19 Severity and Recovery in Different Immune Cell Subtypes
Ren JX, Gao Q, Zhou XC, Chen L, Guo W, Feng KY, Lu L, Huang T, Cai YD |
Biology | 2023 |
|
Total network controllability analysis discovers explainable drugs for Covid-19 treatment
Wei X, Pan C, Zhang X, Zhang W |
Research square | 2023 |
|
Research landscape on COVID-19 and liver dysfunction: A bibliometric analysis
Zyoud SH |
World Journal of Gastroenterology | 2023 |
|
Acute Respiratory Distress Syndrome in Patients with Cardiovascular Disease
Zainab A, Gooch M, Tuazon DM |
Methodist DeBakey Cardiovascular Journal | 2023 |
|
Evaluation of Specific IgG Antibody in Subjects Who Had Been Previously Infected with SARS-CoV-2
Rostami S, Ahangarzadeh S, Zamani Moghaddam A, Nokhodian Z, Modaresifar H, Roustaei A, Shoaei P, Rowzati M, Tahvilian Z, Nazari A, Kassaian N, Haghjooy Javanmard S, Ataei B |
Advanced Biomedical Research | 2023 |
|
Cytokine Kinetics during Progression of COVID-19 in Rwanda Patients: Could IL-9/IFNγ Ratio Predict Disease Severity?
Ndoricyimpaye EL, Van Snick J, Robert R, Bikorimana E, Majyambere O, Mukantwari E, Nshimiyimana T, Mbonigaba V, Coutelier JP, Rujeni N |
International journal of molecular sciences | 2023 |
|
COVID-19 and Acute Cardiac Injury: Clinical Manifestations, Biomarkers, Mechanisms, Diagnosis, and Treatment.
Qiu H, Li J, Li J, Li H, Xin Y |
Current Cardiology Reports | 2023 |
|
The In Vitro, In Vivo, and PBPK Evaluation of a Novel Lung-Targeted Cardiac-Safe Hydroxychloroquine Inhalation Aerogel.
Alsmadi MM, Jaradat MM, Obaidat RM, Alnaief M, Tayyem R, Idkaidek N |
AAPS PharmSciTech | 2023 |
|
Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies
Rabin J, Zhao Y, Mostafa E, Al-Suqi M, Fleischmann E, Conaway MR, Mann BJ, Chhabra P, Brayman KL, Krupnick A, Linden J, Lau CL |
PloS one | 2023 |
|
Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
Yu F, He H, Huang T, Zhou Y |
Open Life Sciences | 2023 |
|
A Case Report of Invasive Mucormycosis in a COVID-19 Positive and Newly-Diagnosed Diabetic Patient
Davis K, Almog R, Peleg Y, Spiegelman L |
2023 | |
|
m(6)A methylation: a potential key player in understanding and treating COVID-2019 infection.
Qian W, Zhou J, Duan L, Wang H, Xu S, Cao Y |
Cell Death Discovery | 2023 |
|
The TIGIT(+) T regulatory cells subset associates with nosocomial infection and fatal outcome in COVID-19 patients under mechanical ventilation.
de Lima MHF, Machado CC, Nascimento DC, Silva CMS, Toller-Kawahisa JE, Rodrigues TS, Veras FP, Pontelli MC, Castro IA, Zamboni DS, Filho JA, Cunha TM, Arruda E, da Cunha LD, Oliveira RDR, Cunha FQ, Louzada-Junior P |
Scientific Reports | 2023 |
|
The central role of neutrophil extracellular traps (NETs) and by‐products in COVID‐19 related pulmonary thrombosis
Li S, Wang H, Shao Q |
Immunity, Inflammation and Disease | 2023 |
|
Being Eaten Alive: How Energy-Deprived Cells Are Disposed of, Mediated by C-Reactive Protein-Including a Treatment Option.
Sheriff A, Kunze R, Brunner P, Vogt B |
Biomedicines | 2023 |
|
Macrophage Polarization Status Impacts Nanoceria Cellular Distribution but Not Its Biotransformation or Ferritin Effects.
Graham UM, Dozier AK, Feola DJ, Tseng MT, Yokel RA |
2023 | |
|
Protective Role of Vitamin K3 on SARS-CoV-2 Structural Protein-Induced Inflammation and Cell Death.
Zhan Y, Zha D, Lin H, Mao X, Yang L, Huang H, He Z, Zhou S, Xu F, Qian Y, Liu Y |
Pharmaceuticals (Basel, Switzerland) | 2023 |
|
Accelerated T-Cell Immunosenescence in Cytomegalovirus-Seropositive Individuals After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Álvarez-Heredia P, Reina-Alfonso I, Domínguez-Del-Castillo JJ, Gutiérrez-González C, Hassouneh F, Batista-Duharte A, Pérez AB, Tarazona R, Solana R, Pera A |
The Journal of Infectious Diseases | 2023 |
|
PROTAC targeting cyclophilin A controls virus-induced cytokine storm
Li H, Yang W, Li H, Bai X, Zhang H, Fan W, Liu W, Sun L |
iScience | 2023 |
|
Engineered clinical-grade mesenchymal stromal cells combating SARS-CoV-2 omicron variants by secreting effective neutralizing antibodies
Wang Y, Gao T, Li W, Tai C, Xie Y, Chen D, Liu S, Huang F, Wang W, Chen Y, Wang B |
Cell & Bioscience | 2023 |
|
Exploring heterogeneity in reported venous thromboembolism risk in COVID-19 and comparison to other viral pneumonias: a systematic review and meta-regression
Bhoelan S, Codreanu C, Tichelaar V, Borjas Howard J, Meijer K |
Research and Practice in Thrombosis and Haemostasis | 2023 |
|
SARS-CoV-2 prevalence in domestic and wildlife animals: A genomic and docking based structural comprehensive review
Das T, Sikdar S, Chowdhury MH, Nyma KJ, Adnan M |
Heliyon | 2023 |
|
Total network controllability analysis discovers explainable drugs for Covid-19 treatment
Wei X, Pan C, Zhang X, Zhang W |
Biology direct | 2023 |
|
Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19
Zhang Z, Dai W, Zhu W, Rodriguez M, Lund H, Xia Y, Chen Y, Rau M, Schneider EA, Graham MB, Jobe S, Wang D, Cui W, Wen R, Whiteheart SW, Wood JP, Silverstein R, Berger JS, Kreuziger LB, Barrett TJ, Zheng Z |
Research and Practice in Thrombosis and Haemostasis | 2023 |
|
Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA.
Li B, Jiang AY, Raji I, Atyeo C, Raimondo TM, Gordon AGR, Rhym LH, Samad T, MacIsaac C, Witten J, Mughal H, Chicz TM, Xu Y, McNamara RP, Bhatia S, Alter G, Langer R, Anderson DG |
Nature Biomedical Engineering | 2023 |
|
The relationship between CMV reactivation, anti-cytokine treatment and mortality in critical COVID-19 patients.
Gozukucuk R, Kilic HH |
Pakistan Journal of Medical Sciences | 2023 |
|
Methylprednisolone or dexamethasone? How should we choose to respond to COVID-19?: A systematic review and meta-analysis of randomized controlled trials.
Li Z, Xue Y, Li L, Li C |
Medicine | 2023 |
|
Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines
Yue C, Wang P, Tian J, Gao GF, Liu K, Liu WJ |
International journal of biological sciences | 2023 |
|
Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19
Geyer CE, Chen HJ, Bye AP, Manz XD, Guerra D, Caniels TG, Bijl TP, Griffith GR, Hoepel W, de Taeye SW, Veth J, Vlaar AP, Vidarsson G, Bogaard HJ, Aman J, Gibbins JM, van Gils MJ, de Winther MP, den Dunnen J |
Life science alliance | 2023 |
|
Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity
Rahni Z, Hosseini SM, Shahrokh S, Saeedi Niasar M, Shoraka S, Mirjalali H, Nazemalhosseini-Mojarad E, Rostami-Nejad M, Malekpour H, Zali MR, Mohebbi SR |
Virus Research | 2023 |
|
Immune and cytokine alterations and RNA-sequencing analysis in gestational tissues from pregnant women after recovery from COVID-19.
Xin X, Yao W, Zhang Z, Yang X, Li S, Zhu Y, Zhang C, Zhang L, Huang H, Dong T, Dong H, Feng L, Wang S |
BMC Infectious Diseases | 2023 |
|
Defining the role of natural killer cells in COVID-19.
Lee MJ, Blish CA |
Nature Immunology | 2023 |
|
Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword
Verma G, Dhawan M, Saied AA, Kaur G, Kumar R, Emran TB |
Immunity, Inflammation and Disease | 2023 |
|
Recombinant SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Stimulate Release of Different Pro-Inflammatory Mediators via Activation of Distinct Receptors on Human Microglia Cells.
Tsilioni I, Theoharides TC |
Molecular Neurobiology | 2023 |
|
Leukopenia and leukocytosis as strong predictors of COVID‐19 severity: A cross‐sectional study of the hematologic abnormalities and COVID‐19 severity in hospitalized patients
Sharafi F, Jafarzadeh Esfehani R, Moodi Ghalibaf A, Jarahi L, Shamshirian A, Mozdourian M |
2023 | |
|
Non-Anticoagulant Activities of Low Molecular Weight Heparins—A Review
Feng K, Wang K, Zhou Y, Xue H, Wang F, Jin H, Zhao W |
Pharmaceuticals | 2023 |
|
Is there an association between peri-diagnostic vaccination and clinical outcomes in COVID-19 patients?
Casazza JA, Thakur B, Perl TM, Hanna JJ, Diaz MI, Ho M, Lanier H, Pickering M, Saleh SN, Shah P, Shah D, Navar AM, Lehmann CU, Medford RJ, Turer RW |
2023 | |
|
Conversion and Obsessive–Phobic Symptoms Predict IL-33 and IL-28A Levels in Individuals Diagnosed with COVID-19
Stoyanova K, Stoyanov D, Petrov S, Baldzhieva A, Bozhkova M, Murdzheva M, Kalfova T, Andreeva H, Taskov H, Vassilev P, Todev A |
Brain Sciences | 2023 |
|
Assessment of the Negative Impact of Urban Air Pollution on Population Health Using Machine Learning Method
Temirbekov N, Temirbekova M, Tamabay D, Kasenov S, Askarov S, Tukenova Z |
International journal of environmental research and public health | 2023 |
|
Prevalence of Cardiovascular Complications in Coronavirus Disease 2019 adult Patients: A Systematic Review and Meta-Analysis
Torabizadeh C, Iloonkashkooli R, Haghshenas H, Fararouei M |
Iranian journal of medical sciences | 2023 |
|
The predictive role of biochemical markers on outcomes of severe COVID-19 patients admitted to intensive care unit
Mirjanić-Azarić B, Pejić I, Mijić S, Pejčić A, Đurđević-Svraka A, Svraka D, Knežević D, Milivojac T, Bogavac-Stanojević N |
Journal of Medical Biochemistry | 2023 |
|
Immunophenotyping characteristics and outcome of COVID‐19 patients: peripheral blood CD8+T cell as a prognostic biomarker for patients with Nirmatrelvir
Sun Y, Dian Y, Gao Q, Deng G |
Frontiers in immunology | 2023 |
|
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
Hackney JA, Shivram H, Vander Heiden J, Overall C, Orozco L, Gao X, Kim E, West N, Qamra A, Chang D, Chakrabarti A, Choy DF, Combes AJ, Courau T, Fragiadakis GK, Rao AA, Ray A, Tsui J, Hu K, Kuhn NF, Krummel MF, Erle DJ, Kangelaris K, Sarma A, Lyon Z, Calfee CS, Woodruff PG, Ghale R, Mick E, Byrne A, Zha BS, Langelier C, Hendrickson CM, van der Wijst MG, Hartoularos GC, Grant T, Bueno R, Lee DS, Greenland JR, Sun Y, Perez R, Ogorodnikov A, Ward A, Ye CJ, Ramalingam T, McBride JM, Cai F, Teterina A, Bao M, Tsai L, Rosas IO, Regev A, Kapadia SB, Bauer RN, Rosenberger CM |
iScience | 2023 |
|
Incompetent memory immune response in severe COVID-19 patients under treatment
Das S, Rai G, Sood V, Singh PK, Tyagi A, Salhotra R, Gupta C, Jaggi VK, Dar SA, Ansari MA |
Heliyon | 2023 |
|
COVID-19 patients display changes in lymphocyte subsets with a higher frequency of dysfunctional CD8lo T cells associated with disease severity
Onofrio LI, Marin C, Dutto J, Brugo MB, Baigorri RE, Bossio SN, Quiróz JN, Almada L, Ruiz Moreno F, Olivera C, Silvera-Ruiz SM, Ponce NE, Icely PA, Amezcua Vesely MC, Fozzatti L, Rodríguez-Galán MC, Stempin CC, Cervi L, Maletto BA, Acosta Rodríguez EV, Bertone M, Abiega CD, Escudero D, Kahn A, Caeiro JP, Maccioni M, Motrán CC, Gruppi A, Sotomayor CE, Chiapello LS, Montes CL |
Frontiers in immunology | 2023 |
|
SARS-CoV-2 spike-specific TFH cells exhibit unique responses in infected and vaccinated individuals
He R, Zheng X, Zhang J, Liu B, Wang Q, Wu Q, Liu Z, Chang F, Hu Y, Xie T, Liu Y, Chen J, Yang J, Teng S, Lu R, Pan D, Wang Y, Peng L, Huang W, Terzieva V, Liu W, Wang Y, Li YP, Qu X |
Signal Transduction and Targeted Therapy | 2023 |
|
Prediction of tsunami of resistance to some antibiotics is not far‐fetched which used during COVID‐19 pandemic
Hosseini M, Ahmed Hamad M, Mohseni G, Salamy S, Dehghan Tarzjani S, Taati Moghadam M |
Journal of Clinical Laboratory Analysis | 2023 |
|
Role of SARS‑CoV‑2 nucleocapsid protein in affecting immune cells and insights on its molecular mechanisms
Lu Y, Ye Z, Liu X, Zhou L, Ding X, Hou Y |
Experimental and therapeutic medicine | 2023 |
|
Clinical utilization of artificial intelligence-based COVID-19 pneumonia quantification using chest computed tomography – a multicenter retrospective cohort study in Japan
Tanaka H, Maetani T, Chubachi S, Tanabe N, Shiraishi Y, Asakura T, Namkoong H, Shimada T, Azekawa S, Otake S, Nakagawara K, Fukushima T, Watase M, Terai H, Sasaki M, Ueda S, Kato Y, Harada N, Suzuki S, Yoshida S, Tateno H, Yamada Y, Jinzaki M, Hirai T, Okada Y, Koike R, Ishii M, Hasegawa N, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K |
Respiratory Research | 2023 |
|
Temporal evolution of laboratory characteristics in patients critically ill with COVID‑19 admitted to the intensive care unit (Review)
Kokkoris S, Kanavou A, Kremmydas P, Katsaros D, Karageorgiou S, Gkoufa A, Georgakopoulou VE, Spandidos DA, Giannopoulos C, Kardamitsi M, Routsi C |
2023 | |
|
Assessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 cases
Dündar NB, Sarphie D, Yüce K, Gaygısız Ü, Kaskatı OT, Türkoğlu M, Bıkmaz GA, Karabıyık L, Çağlar K, Bozdayı G, Mian R, Moss P, İlhan MN |
Intensive Care Medicine Experimental | 2023 |
|
Nasopharynx Battlefield: Cellular Immune Responses Mediated by Midkine in Nasopharyngeal Carcinoma and COVID-19
Kam NW, Lau CY, Che CM, Lee VH |
Cancers | 2023 |
|
Mesenchymal Stem Cells in the Treatment of COVID-19
Guo BC, Wu KH, Chen CY, Lin WY, Chang YJ, Lee TA, Lin MJ, Wu HP |
International journal of molecular sciences | 2023 |
|
Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV
Shahbaz S, Sligl W, Osman M, Elahi S |
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology | 2023 |
|
Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial
Walborn AT, Heath A, Neal MD, Zarychanski R, Kornblith LZ, Hunt BJ, Castellucci LA, Hochman JS, Lawler PR, Paul JD |
Research and Practice in Thrombosis and Haemostasis | 2023 |
|
Molecular diagnostic approaches for SARS-CoV-2 detection and pathophysiological consequences.
Salazar-Ardiles C, Asserella-Rebollo L, Cornejo C, Arias D, Vasquez-Muñoz M, Toledo C, Andrade DC |
Molecular Biology Reports | 2023 |
|
Enhancement of IL-6 Production Induced by SARS-CoV-2 Nucleocapsid Protein and Bangladeshi COVID-19 Patients' Sera.
Hasan A, Rahim R, Nakayama EE, Uno K, Hasan N, Rahman M, Shioda T |
Viruses | 2023 |
|
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.
Grandi A, Tomasi M, Ullah I, Bertelli C, Vanzo T, Accordini S, Gagliardi A, Zanella I, Benedet M, Corbellari R, Di Lascio G, Tamburini S, Caproni E, Croia L, Ravà M, Fumagalli V, Di Lucia P, Marotta D, Sala E, Iannacone M, Kumar P, Mothes W, Uchil PD, Cherepanov P, Bolognesi M, Pizzato M, Grandi G |
Human vaccines | 2023 |
|
Multi-omic Profiling Reveals Early Immunological Indicators for Identifying COVID-19 Progressors.
Drake KA, Talantov D, Tong GJ, Lin JT, Verheijden S, Katz S, Leung JM, Yuen B, Krishna V, Wu MJ, Sutherland A, Short SA, Kheradpour P, Mumbach M, Franz K, Trifonov V, Lucas MV, Merson J, Kim CC, Chen C, Parthasarathy S, Tapson VF, Moy JN, deFilippi CR, Rosas IO, Basit M, Salvatore M, Krishnan JA |
bioRxiv : the preprint server for biology | 2023 |
|
SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
Bouhaddou M, Reuschl AK, Polacco BJ, Thorne LG, Ummadi MR, Ye C, Rosales R, Pelin A, Batra J, Jang GM, Xu J, Moen JM, Richards AL, Zhou Y, Harjai B, Stevenson E, Rojc A, Ragazzini R, Whelan MVX, Furnon W, De Lorenzo G, Cowton V, Syed AM, Ciling A, Deutsch N, Pirak D, Dowgier G, Mesner D, Turner JL, McGovern BL, Rodriguez ML, Leiva-Rebollo R, Dunham AS, Zhong X, Eckhardt M, Fossati A, Liotta NF, Kehrer T, Cupic A, Rutkowska M, Mena I, Aslam S, Hoffert A, Foussard H, Olwal CO, Huang W, Zwaka T, Pham J, Lyons M, Donohue L, Griffin A, Nugent R, Holden K, Deans R, Aviles P, Lopez-Martin JA, Jimeno JM, Obernier K, Fabius JM, Soucheray M, Hüttenhain R, Jungreis I, Kellis M, Echeverria I, Verba K, Bonfanti P, Beltrao P, Sharan R, Doudna JA, Martinez-Sobrido L, Patel AH, Palmarini M, Miorin L, White K, Swaney DL, Garcia-Sastre A, Jolly C, Zuliani-Alvarez L, Towers GJ, Krogan NJ |
Cell | 2023 |
|
Interleukin-6 and Its Soluble Receptor Complex in Intensive Care Unit COVID-19 Patients: An Analysis of Second Wave Patients.
Di Spigna G, Spalletti Cernia D, Covelli B, Vargas M, Rubino V, Iacovazzo C, Napolitano F, Postiglione L |
2023 | |
|
Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses.
Awad AM, Hansen K, Del Rio D, Flores D, Barghash RF, Kakkola L, Julkunen I, Awad K |
Biomolecules | 2023 |
|
Cytokine-Induced iNOS in A549 Alveolar Epithelial Cells: A Potential Role in COVID-19 Lung Pathology.
Barilli A, Recchia Luciani G, Visigalli R, Sala R, Soli M, Dall'Asta V, Rotoli BM |
Biomedicines | 2023 |
|
In-stent Thrombosis and COVID-19 Infection: Current Insights on the Mechanistic Relationship
El-Medany A, Kandoole V, Lonsdale N, Doolub G, Felekos I |
Current cardiology reviews | 2023 |
|
Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial
Gysan MR, Milacek C, Bal C, Zech A, Brugger J, Milos RI, Antoniewicz L, Idzko M, Gompelmann D |
PloS one | 2023 |
|
Two-stage multi-objective optimization for ICU bed allocation under multiple sources of uncertainty
Wan F, Fondrevelle J, Wang T, Duclos A |
Scientific Reports | 2023 |
|
Suppressed transcript diversity and immune response in COVID-19 ICU patients: a longitudinal study
Mehta P, Chattopadhyay P, Mohite R, D\u2019Rozario R, Bandopadhyay P, Sarif J, Ray Y, Ganguly D, Pandey R |
Life science alliance | 2023 |
|
Incidence and Risk Factors Associated with Thromboembolic Events among Patients with COVID-19 Inpatients: A Retrospective Study
Tashkandi WA |
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine | 2023 |
|
Association between History of Vaccination and Symptoms at Diagnosis of Coronavirus Disease 2019
Shiraiwa T, Takahara M, Maeno Y, Yamamoto K, Shiraiwa Y, Yoshida Y, Nishioka N, Kurihara K, Yamada Y |
2023 | |
|
Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future
Abramson HN |
International journal of molecular sciences | 2023 |
|
Gastrointestinal Manifestations and Outcomes of COVID-19: A Comprehensive Systematic Review and Meta-analysis
Mehta D, Kelkar R, Patel N, Trivedi PD, Dawoodi S, Patel D, Solanki D, Hussain A, Nagaraj S, Khayat A, Samala Venkata V, Mansuri U, Patel UK, Sacks H, Atreja A |
Cureus | 2023 |
|
Implications of LDH in patients with coronavirus disease 2019 pneumonia
Mu T, Wang X, Lu Z, Tong J |
Frontiers in Cellular and Infection Microbiology | 2023 |
|
T cell immune memory after covid-19 and vaccination
Wang L, Nicols A, Turtle L, Richter A, Duncan CJ, Dunachie SJ, Klenerman P, Payne RP |
2023 | |
|
Tracking severe acute respiratory syndrome coronavirus 2 transmission and co‐infection with other acute respiratory pathogens using a sentinel surveillance system in Rift Valley, Kenya
Ruttoh VK, Symekher SL, Majanja JM, Opanda SM, Chitechi EW, Wadegu M, Tonui R, Rotich PK, Nyandwaro TT, Mwangi AW, Mwangi IN, Oira RM, Musimbi AG, Nzou SM |
Influenza and Other Respiratory Viruses | 2023 |
|
The COVID-19 pandemic: new challenges for the mental health protection system
Mishyiev V, Mykhaylov B, Grinevich E, Omelyanovich V, Kaafarani A |
2023 | |
|
Predictive Model for Mortality in Severe COVID-19 Patients across the Six Pandemic Waves
Casillas N, Ramón A, Torres AM, Blasco P, Mateo J |
Viruses | 2023 |
|
Transcriptional Profiling of SARS-CoV-2-Infected Calu-3 Cells Reveals Immune-Related Signaling Pathways
Pereira EP, da Silva Felipe SM, de Freitas RM, da Cruz Freire JE, Oliveira AE, Canabrava N, Soares PM, van Tilburg MF, Guedes MI, Grueter CE, Ceccatto VM |
Pathogens | 2023 |
|
SARS-CoV-2 Papain-like Protease Negatively Regulates the NLRP3 Inflammasome Pathway and Pyroptosis by Reducing the Oligomerization and Ubiquitination of ASC
Meng H, Zhou J, Wang M, Zheng M, Xing Y, Wang Y |
Microorganisms | 2023 |
|
Longitudinal Follow-Up of Serum and Urine Biomarkers Indicative of COVID-19-Associated Acute Kidney Injury: Diagnostic and Prognostic Impacts
Lablad Y, Vanhomwegen C, De Prez E, Antoine MH, Hasan S, Baudoux T, Nortier J |
International journal of molecular sciences | 2023 |
|
Heterotypic responses against nsp12/nsp13 from prior SARS-CoV-2 infection associates with lower subsequent endemic coronavirus incidence
Bean DJ, Monroe J, Liang YM, Borberg E, Senussi Y, Swank Z, Chalise S, Walt D, Weinberg J, Sagar M |
2023 | |
|
Progressive shingles in a toddler due to reactivation of Varicella Zoster vaccine virus four days after infection with SARS-CoV-2; a case report.
Miller C, Taylor-Salmon E, Emuren L, Landry M, Gershon A, Miller G |
BMC Infectious Diseases | 2023 |
|
Amplification of poly(I:C)-induced interleukin-6 production in human bronchial epithelial cells by priming with interferon-γ.
Okuma N, Ito MA, Shimizu T, Hasegawa A, Ohmori S, Yoshida K, Matsuoka I |
Scientific Reports | 2023 |
|
T Lymphocyte Characteristic Changes Under Serum Cytokine Deviations and Prognostic Factors of COVID-19 in Pregnant Women.
Aminsobahni E, Hosseini M, Gholizadeh N, Soltani-Zangbar MS, Savari G, Motlagh Asghari K, Pourlak T, Zolfaghari M, Chakari-Khiavi F, Motavalli R, Chakari-Khiavi A, Shekarchi AA, Mahmoodpoor A, Ahmadian Heris J, Pouya K, Mehdizadeh A, Babalou Z, Yousefi M |
Applied Biochemistry and Biotechnology | 2023 |
|
A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection.
Narayanan SA, Jamison DA Jr, Guarnieri JW, Zaksas V, Topper M, Koutnik AP, Park J, Clark KB, Enguita FJ, Leitão AL, Das S, Moraes-Vieira PM, Galeano D, Mason CE, Trovão NS, Schwartz RE, Schisler JC, Coelho-Dos-Reis JGA, Wurtele ES, Beheshti A |
European journal of human genetics : EJHG | 2023 |
|
Clinical features that predict the mortality risk in older patients with Omicron pneumonia: the MLWAP score.
Pei Y, Li T, Chen C, Huang Y, Yang Y, Zhou T, Shi M |
Internal and Emergency Medicine | 2023 |
|
Correlation of serum interleukin-6 levels and neutrophil-lymphocyte ratio in the severity of COVID-19.
Esa T, Budu B, Mulyono B, Soraya GV, Usman AN, Intansari US |
F1000Research | 2023 |
|
Epidemiological and laboratory characteristics of Omicron infection in a general hospital in Guangzhou: a retrospective study.
Chen J, Wang Y, Yu H, Wang R, Yu X, Huang H, Ai L, Zhang T, Huang B, Liu M, Ding T, Luo Y, Chen P |
Frontiers in public health | 2023 |
|
More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patients.
Joly C, Desjardins D, Porcher R, Péré H, Bruneau T, Zhang Q, Bastard P, Cobat A, Resmini L, Lenoir O, Savale L, Lécuroux C, Verstuyft C, Roque-Afonso AM, Veyer D, Baron G, Resche-Rigon M, Ravaud P, Casanova JL, Le Grand R, Hermine O, Tharaux PL, Mariette X |
Frontiers in immunology | 2023 |
|
Clinico-epidemiological profile of non-survivors of COVID-19 during the last two waves in a tertiary care hospital of North India: A retrospective descriptive study.
Husaini SHM, Waseem SMA, Siddiqui Z, Ali WM, Nasreen F, Athar M, Ahmad M, Khan HM |
Journal of Family Medicine and Primary Care | 2023 |
|
The DNA glycosylase NEIL2 is protective during SARS-CoV-2 infection.
Tapryal N, Chakraborty A, Saha K, Islam A, Pan L, Hosoki K, Sayed IM, Duran JM, Alcantara J, Castillo V, Tindle C, Sarker AH, Wakamiya M, Cardenas VJ, Sharma G, Crotty Alexander LE, Sur S, Sahoo D, Ghosh G, Das S, Ghosh P, Boldogh I, Hazra TK |
Nature Communications | 2023 |
|
Integrating SARS-CoV-2-specific interferon-γ release assay testing in the evaluation of patients hospitalized with COVID-19.
Masiá M, de la Rica A, Fernández-González M, García JA, Padilla S, García-Abellán J, Botella Á, Mascarell P, Gutiérrez F |
Microbiology spectrum | 2023 |
|
Identification of toll‐like receptor 5 and acyl‐CoA synthetase long chain family member 1 as hub genes are correlated with the severe forms of COVID‐19 by Weighted gene co‐expression network analysis
Wang L, Mao Z, Shao F |
IET Systems Biology | 2023 |
|
Actinomycotic Sinomaxillary Infection in a COVID-19 Patient: A Case Report and Review of the Literature
Moaddabi A, Cernera M, Armogida NG, Soltani P, Spagnuolo G |
Journal of Investigative Medicine High Impact Case Reports | 2023 |
|
Unveiling COVID-19 Secrets: Harnessing Cytokines as Powerful Biomarkers for Diagnosis and Predicting Severity
Wolszczak-Biedrzycka B, Dorf J, Wojewódzka-Żelezniakowicz M, Żendzian-Piotrowska M, Dymicka-Piekarska VJ, Matowicka-Karna J, Maciejczyk M |
Journal of inflammation research | 2023 |
|
The value of age IgG and IL6 in estimating time of viral clearance in asymptomatic or mild patients with COVID-19.
Cao X, Xie YL, Zhou CL, Mu H |
Frontiers in microbiology | 2023 |
|
Variant- and Vaccination-Specific Alternative Splicing Profiles in SARS-CoV-2 Infections
Lee SG, Furth PA, Hennighausen L, Lee HK |
2023 | |
|
Clinical course and management of COVID-19 in the era of widespread population immunity.
Meyerowitz EA, Scott J, Richterman A, Male V, Cevik M |
Nature reviews. Microbiology | 2023 |
|
Alterations in B and NK cells highly correlate with disease severity in children with COVID-19
TOPYILDIZ E, EDEER KARACA N, TAŞKIN B, AYGÜN A, ŞAHBUDAK BAL Z, SAZ EU, KURUGÖL NZ, KÜTÜKÇÜLER N, AKSU G |
2023 | |
|
Pathogen evolution, prevention/control strategy and clinical features of COVID-19: experiences from China.
Wei D, Xie Y, Liu X, Chen R, Zhou M, Zhang X, Qu J |
Frontiers of Medicine | 2023 |
|
Sarcoidosis-related autoimmune inflammation in COVID-19 convalescent patients
Rubinstein A, Kudryavtsev I, Malkova A, Mammedova J, Isakov D, Isakova-Sivak I, Kudlay D, Starshinova A |
Frontiers in Medicine | 2023 |
|
SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis
Valdes Angues R, Perea Bustos Y |
Cureus | 2023 |
|
Transcriptomic analysis of sorted lung cells revealed a proviral activity of the NF-κB pathway toward SARS-CoV-2
Bhargava A, Szachnowski U, Chazal M, Foretek D, Caval V, Aicher SM, Pipoli da Fonseca J, Jeannin P, Beauclair G, Monot M, Morillon A, Jouvenet N |
iScience | 2023 |
|
The Functional Roles of MDSCs in Severe COVID-19 Pathogenesis.
Len JS, Koh CWT, Chan KR |
Viruses | 2023 |
|
COVID-19 and cardiovascular complications: updates of emergency medicine
Zhao J, Xie Y, Meng Z, Liu C, Wu Y, Zhao F, Ma X, Christopher TA, Lopez BJ, Wang Y |
2023 | |
|
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis.
Potere N, Garrad E, Kanthi Y, Di Nisio M, Kaplanski G, Bonaventura A, Connors JM, De Caterina R, Abbate A |
Cardiovascular Research | 2023 |
|
COVID-19 and the impact on Alzheimer’s disease pathology
Furman S, Green K, Lane TE |
Journal of Neurochemistry | 2023 |
|
COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and Pharmacokinetics
McColl ER, Croyle MA, Zamboni WC, Honer WG, Heise M, Piquette-Miller M, Goralski KB |
Drug Metabolism and Disposition | 2023 |
|
Probable Neuropsychological and Cognitive Complications Due to Cytokine Storm in Patients With COVID-19
Keshtgar Z, Chalabianloo G, Esmaeili N |
Basic and clinical neuroscience | 2023 |
|
Pathological Interplay and Clinical Complications between COVID-19 and Cardiovascular Diseases: An Overview in 2023
Zhou S, Zhang A, Liao H, Liu Z, Yang F |
Cardiology | 2023 |
|
Risk of extended viral shedding of Omicron BA.2 in Shanghai: Implications for vaccination strategy optimization
Huang J, Huang L, Xi J, Li Y, Zhou J, Bao Z, Cheng Q, Li Q, Zhou M, Zhao R, Li Y |
Chinese Medical Journal Pulmonary and Critical Care Medicine | 2023 |
|
Liver dysfunction on admission worsens clinical manifestations and outcomes of coronavirus disease 2019.
Lu F, Chen R, Xu K, Huang J, Yang D, Bai T, Xie Y, Ling Y, Liu K, Du W, Yan J, Lin H, Li J, Feng Y, Zhou M, Guo Y |
Chinese medical journal pulmonary and critical care medicine | 2023 |
|
Chronic alcohol use primes bronchial cells for altered inflammatory response and barrier dysfunction during SARS-CoV-2 infection
Easley KF, Edenfield RC, Lott ME, Reed RC, Das Sarma J, Mehta AJ, Staitieh BS, Lipp EK, Cho IK, Johnson SK, Jones CA, Bebin-Blackwell AG, Levy JM, Tompkins SM, Easley CA 4th, Koval M |
American Journal of Physiology - Lung Cellular and Molecular Physiology | 2023 |
|
Knowledge and Attitudes towards COVID-19 Infection and Anxiety Levels of Nigerian Youths Regarding the COVID-19 Pandemic
James BC, Mary AC, Emeka AF, Ede SS, Chullapant K, Chidimma N, Michael UI |
Acta Medica Philippina | 2023 |
|
Utility of Hematological and Biochemical Parameters as a Screening Tool for Assessing Coronavirus Disease 2019 Infection and its Severity
Alam S, Khan S, Jain V, Kashyap V, Kapur P |
Journal of Microscopy and Ultrastructure | 2023 |
|
Role of innate immunity in SARS-CoV-2 infection
Wang Z, Cheng F, Xu Y, Li X, Meng S |
Biosafety and Health | 2023 |
|
Temporal transcriptomic analysis using TrendCatcher identifies early and persistent neutrophil activation in severe COVID-19
Xinge Wang, Mark A Sanborn, Yang Dai, Jalees Rehman |
JCI Insight | 2022 |
|
RAGE has potential pathogenetic and prognostic value in non-intubated hospitalized patients with COVID-19
Katherine D. Wick, Lianne Siegel, James Neaton, Cathryn Oldmixon, Jens Lundgren, Robin L Dewar, H. Lane, B. Taylor Thompson, Michael Matthay |
JCI Insight | 2022 |
|
Bacillus Calmette–Guérin-Induced Trained Immunity Protects Against SARS-CoV-2 Challenge in K18-hACE2 Mice
Bao-Zhong Zhang, Huiping Shuai, Hua-rui Gong, Jing-Chu Hu, Bingpeng Yan, Terrence Tsz-Tai Yuen, Ye-Fan Hu, Chaemin Yoon, Xiaolei Wang, Yuxin Hou, Xuansheng Lin, Xiner Huang, Renhao Li, Yee-Man Au-Yeung, Wenjun Li, Bingjie Hu, Yue Chai, Ming Yue, Jian-Piao Cai, Guang Ling, Ivan Hung, K.Y. Yuen, Jasper F.W. Chan, Jian-Dong Huang, Hin Chu |
JCI Insight | 2022 |
|
Lethal Synergy between SARS-CoV-2 and Streptococcus pneumoniae in hACE2 Mice and Protective Efficacy of Vaccination
Tarani Kanta Barman, Amit Singh, Jesse L. Bonin, Tanvir N Nafiz, Sharon Salmon, Dennis W. Metzger |
JCI Insight | 2022 |
|
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
Jasimuddin Ahamed, Jeffrey Laurence |
Journal of Clinical Investigation | 2022 |
|
Novel prognostic determinants of COVID-19-related mortality: a pilot study on severely-ill patients in Russia
Kseniya Rubina, Anna Shmakova, Aslan Shabanov, Yulii Andreev, Natalia Borovkova, Vladimir Kulabukhov, Anatoliy Evseev, Konstantin Popugaev, Sergey Petrikov, Ekaterina Semina |
PloS one | 2022 |
|
Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes
G Lasso, S Khan, S Allen, M Mariano, C Florez, E Orner, J Quiroz, G Quevedo, A Massimi, A Hegde, A Wirchnianski, R Bortz, R Malonis, G Georgiev, K Tong, N Herrera, N Morano, S Garforth, A Malaviya, A Khokhar, E Laudermilch, M Dieterle, J Fels, D Haslwanter, R Jangra, J Barnhill, S Almo, K Chandran, J Lai, L Kelly, J Daily, O Vergnolle, A Smith |
PLoS computational biology | 2022 |
|
Short and long-term immune changes in different severity groups of COVID-19 disease
Khuloud Al Maamari, Ibrahim Busaidi, Mahmood Al Kindi, Fahad Zadjali, Fatma BaAlawi, Wijesinghe Anesta, Kawthar Amri, Wafa Albalushi, Hamed Balushi, Ayman Amri, Mahmood Aljufaili, Mujahid Al-Busaidi, Zakariya Muharrmi, Abdullah Balkhair, Nafila Al Riyami, Zahraa Ghanim, Jalila AlShekaili |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022 |
|
Long Lasting Cellular Immune Response Induced by mRNA Vaccination: Implication for Prevention Strategies
L Vitiello, L Gatta, S Ilari, S Bonassi, M Cristina, F Ciatti, M Fini, S Proietti, P Russo, C Tomino, D Limongi |
Frontiers in immunology | 2022 |
|
Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization
Giulia Lamacchia, Alessio Mazzoni, Michele Spinicci, Anna Vanni, Lorenzo Salvati, Benedetta Peruzzi, Sara Bencini, Manuela Capone, Alberto Carnasciali, Parham Farahvachi, Arianna Rocca, Seble Kiros, Lucia Graziani, Lorenzo Zammarchi, Jessica Mencarini, Maria Colao, Roberto Caporale, Francesco Liotta, Lorenzo Cosmi, Gian Rossolini, Alessandro Bartoloni, Laura Maggi, Francesco Annunziato |
2022 | |
|
Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis
W Ji, L Chen, W Yang, K Li, J Zhao, C Yan, C You, M Jiang, M Zhou, X Shen |
Cell & Bioscience | 2022 |
|
Low T Cell Responsiveness in the Early Phase of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant Recipients
M Cremoni, S Cuozzo, E Martinuzzi, S Barbosa, N Hassen, F Massa, E Demonchy, M Durand, O Thaunat, V Esnault, M Quintrec, S Caillard, N Glaichenhaus, A Sicard |
Viruses | 2022 |
|
Calcium dobesilate reduces SARS-CoV-2 entry into endothelial cells by inhibiting virus binding to heparan sulfate
Yulia Kiyan, Anna Schultalbers, Ekaterina Chernobrivaia, Sergey Tkachuk, Rong Song, Nelli Shushakova, Hermann Haller |
Scientific Reports | 2022 |
|
Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19
G Kassianidis, A Siampanos, G Poulakou, G Adamis, A Rapti, H Milionis, G Dalekos, V Petrakis, S Sympardi, S Metallidis, Z Alexiou, T Gkavogianni, E Giamarellos-Bourboulis, T Theoharides |
International journal of molecular sciences | 2022 |
|
Coinfection of SARS-CoV-2 and Influenza A virus increased disease severity, impaired neutralizing antibody, and CD4+ T cell responses
E Kim, T Nguyen, M Casel, R Rollon, S Kim, Y Kim, K Yu, S Jang, J Yang, H Poo, J Jung, Y Choi |
Journal of virology | 2022 |
|
Opposing roles for sMAdCAM and IL‐15 in COVID‐19 associated cellular immune pathology
A Singh, N Kasarpalkar, S Bhowmick, G Paradkar, M Talreja, K Shah, A Tiwari, H Palav, S Kaginkar, R Kulkarni, A Patil, V Kalsurkar, S Agrawal, J Shastri, R Dere, R Bharmal, S Mahale, V Bhor, V Patel |
Journal of leukocyte biology | 2022 |
|
Severe COVID-19 patients are hallmarked by hyper-inflammatory cytokine-producing NK cells and NK cell-platelet aggregates
Bert Malengier-Devlies, Jessica Filtjens, Kourosh Ahmadzadeh, Bram Boeckx, Jessica Vandenhaute, Amber Visscher, Eline Bernaerts, Tania Mitera, Cato Jacobs, Lore Vanderbeke, Pierre Mol, Yannick Herck, Greet Hermans, Philippe Meersseman, Alexander Wilmer, the consortium, Mieke Gouwy, Abhishek Garg, Stephanie Humblet, Frederik De Smet, Kimberly Martinod, Els Wauters, Paul Proost, Carine Wouters, Georges Leclercq, Diether Lambrechts, Joost Wauters, Patrick Matthys |
Frontiers in immunology | 2022 |
|
Dominant CD8+ T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination
E Taus, C Hofmann, F Ibarrondo, M Hausner, J Fulcher, P Krogstad, K Ferbas, N Tobin, A Rimoin, G Aldrovandi, O Yang |
Frontiers in immunology | 2022 |
|
Dysfunctional purinergic signaling contributes to immunopathogenesis in COVID-19 patients
Anna Pietrobon, Roberta Andrejew, Ricardo Custódio, Luana Oliveira, Juliete Scholl, Franciane Teixeira, Cyro Brito, Talita Glaser, Julia Kazmierski, Christine Goffinet, Anna Turdo, Tatiana Yendo, Valeria Aoki, Fabricio Figueiró, Ana Battastini, Henning Ulrich, Gill Benard, Alberto Duarte, Maria Sato |
Frontiers in immunology | 2022 |
|
Cardiovascular Dysfunction in COVID-19: Association Between Endothelial Cell Injury and Lactate
K Yang, M Holt, M Fan, V Lam, Y Yang, T Ha, D Williams, C Li, X Wang |
Frontiers in immunology | 2022 |
|
Metabolic and nutritional triggers associated with increased risk of liver complications in SARS-CoV-2
R de Jesus, J de Carvalho, L de Oliveira, C de Magalhães Cunha, T Alves, S Vieira, V Figueiredo, A Bueno |
World journal of hepatology | 2022 |
|
SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets
P Shivshankar, H Karmouty-Quintana, T Mills, M Doursout, Y Wang, A Czopik, S Evans, H Eltzschig, X Yuan |
Inflammation | 2022 |
|
Fungal Infections in Critically Ill COVID-19 Patients: Inevitabile Malum
N Rovina, E Koukaki, V Romanou, S Ampelioti, K Loverdos, V Chantziara, A Koutsoukou, G Dimopoulos |
Journal of Clinical Medicine | 2022 |
|
Tissue Resident Foxp3+ Regulatory T Cells: Sentinels and Saboteurs in Health and Disease
J Lee, D Kim, B Min |
Frontiers in immunology | 2022 |
|
Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora
K Alharbi, Y Singh, W almalki, S Rawat, O Afzal, A Altamimi, I Kazmi, F Al-Abbasi, S Alzarea, S Singh, S Bhatt, D Chellappan, K Dua, G Gupta |
Chemico-Biological Interactions | 2022 |
|
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Q Ning, D Wu, X Wang, , T Chen, G Chen, H Wang, H Lu, M Wang, L Zhu, J Hu, T Liu, K Ma, M Han, X Luo |
Signal Transduction and Targeted Therapy | 2022 |
|
CD8+ T Cell Senescence: Lights and Shadows in Viral Infections, Autoimmune Disorders and Cancer
V Tedeschi, G Paldino, M Kunkl, M Paroli, R Sorrentino, L Tuosto, M Fiorillo |
International journal of molecular sciences | 2022 |
|
Mesenchymal stem cell treatment for COVID-19
R Xu, Z Feng, F Wang |
EBioMedicine | 2022 |
|
Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthood
G Muscogiuri, S Bettini, M Boschetti, L Barrea, S Savastano, A Colao |
International Journal of Obesity | 2022 |
|
A critical evaluation of risk to reward ratio of quercetin supplementation for COVID ‐19 and associated comorbid conditions
A Pawar, M Russo, I Rani, K Goswami, G Russo, A Pal |
Phytotherapy research : PTR | 2022 |
|
A Review on Measures to Rejuvenate Immune System: Natural Mode of Protection Against Coronavirus Infection
A Islam, A Haque, A Rahman, F Hossen, M Reza, A Barua, A Marzan, T Das, S Baral, C He, F Ahmed, P Bhattacharya, Jakariya |
Frontiers in immunology | 2022 |
|
Peramivir, an Anti-Influenza Virus Drug, Exhibits Potential Anti-Cytokine Storm Effects
C Zhang, Y Tu, X Sun, D Chen, W Zhang, C Zhuang, Z Wang, L Su |
Frontiers in immunology | 2022 |
|
SARS-CoV-2 Morbidity in the CNS and the Aged Brain Specific Vulnerability
T Casoli |
International journal of molecular sciences | 2022 |
|
Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients
F Bidar, S Hamada, M Gossez, R Coudereau, J Lopez, M Cazalis, C Tardiveau, K Brengel-Pesce, M Mommert, M Buisson, F Conti, T Rimmelé, A Lukaszewicz, L Argaud, M Cour, G Monneret, F Venet, R Pescarmona, L Garnier, C Lombard, M Perret, M Villard, S Viel, V Cheynet, E Cerrato, E Peronnet, J Llitjos, L Itah, I Boussaha, F Poitevin-Later, C Malcus, M Godignon, F Wallet, M Delignette, F Dailler, M Simon, A Dargent, P Bertrand, N Stevic, M Provent, L Bignet, V Cerro, J Richard, L Bitker, M Mezidi, L Baboi |
Annals of Intensive Care | 2022 |
|
COVID-19 and the role of cytokines in this disease
A Hasanvand |
Inflammopharmacology | 2022 |
|
Innate Immune Response in SARS-CoV-2 Infection
G Schiuma, S Beltrami, D Bortolotti, S Rizzo, R Rizzo |
Microorganisms | 2022 |
|
COVID-19 and cancer: start the resolution!
C Barksdale, F Kipper, S Tripathy, S Subbian, C Serhan, D Panigrahy |
Cancer and Metastasis Reviews | 2022 |
|
The role of antigen-presenting cells in the pathogenesis of COVID-19
R Farzi, P Aghbash, N Eslami, A Azadi, A Shamekh, N Hemmat, T Entezari-Maleki, H Baghi |
Pathology, research and practice | 2022 |
|
Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction
R Ahmad, M Haque |
Human vaccines | 2022 |
|
SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases
R Larionova, K Byvaltsev, О Kravtsova, E Takha, S Petrov, G Kazarian, A Valeeva, E Shuralev, M Mukminov, Y Renaudineau, M Arleevskaya |
2022 | |
|
Regulatory T Cells: Angels or Demons in the Pathophysiology of Sepsis?
Y Gao, Y Yao, X Zhang, F Chen, X Meng, X Chen, C Wang, Y Liu, X Tian, S Shou, Y Chai |
Frontiers in immunology | 2022 |
|
Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein
E Nakayama, R Kubota-Koketsu, T Sasaki, K Suzuki, K Uno, J Shimizu, T Okamoto, H Matsumoto, H Matsuura, S Hashimoto, T Tanaka, H Harada, M Tomita, M Kaneko, K Yoshizaki, T Shioda |
Scientific Reports | 2022 |
|
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
YC Hwang, RM Lu, SC Su, PY Chiang, SH Ko, FY Ke, KH Liang, TY Hsieh, HC Wu |
Journal of Biomedical Science | 2022 |
|
Adrenal tropism of SARS-CoV-2 and adrenal findings in a post-mortem case series of patients with severe fatal COVID-19
T Paul, S Ledderose, H Bartsch, N Sun, S Soliman, B Märkl, V Ruf, J Herms, M Stern, O Keppler, C Delbridge, S Müller, G Piontek, Y Kimoto, F Schreiber, T Williams, J Neumann, T Knösel, H Schulz, R Spallek, M Graw, T Kirchner, A Walch, M Rudelius |
Nature Communications | 2022 |
|
Diabetes and COVID-19; A Bidirectional Interplay
P Kazakou, V Lambadiari, I Ikonomidis, A Kountouri, G Panagopoulos, S Athanasopoulos, E Korompoki, I Kalomenidis, M Dimopoulos, A Mitrakou |
Frontiers in Endocrinology | 2022 |
|
Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications
Z Ma, KY Yang, Y Huang, KO Lui |
Journal of Molecular and Cellular Cardiology | 2022 |
|
Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis
R Qin, L He, Z Yang, N Jia, R Chen, J Xie, W Fu, H Chen, X Lin, R Huang, T Luo, Y Liu, S Yao, M Jiang, J Li |
Clinical Reviews in Allergy & Immunology | 2022 |
|
Increased Circulating Cytokines Have a Role in COVID-19 Severity and Death With a More Pronounced Effect in Males: A Systematic Review and Meta-Analysis
H Hu, H Pan, R Li, K He, H Zhang, L Liu |
Frontiers in pharmacology | 2022 |
|
Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age
J Fabião, B Sassi, E Pedrollo, F Gerchman, C Kramer, C Leitão, L Pinto |
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.] | 2022 |
|
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab
J Sims, J Poorbaugh, C Chang, T Holzer, L Zhang, S Engle, S Beasley, T Doman, L Naughton, R Higgs, N Kallewaard, R Benschop |
Journal of Translational Medicine | 2022 |
|
Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
T Theoharides |
Molecular Neurobiology | 2022 |
|
Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection
A Kumar, A Sharma, N Tirpude, S Sharma, Y Padwad, S Kumar |
Inflammopharmacology | 2022 |
|
Immunoediting in SARS-CoV-2: Mutual relationship between the virus and the host
N Kheshtchin, P Bakhshi, S Arab, M Nourizadeh |
International Immunopharmacology | 2022 |
|
New Discovery of Myeloid-Derived Suppressor Cell’s Tale on Viral Infection and COVID-19
S Park, D Nam, H Seong, Y Hahn |
Frontiers in immunology | 2022 |
|
SARS-CoV-2 Immunization Orchestrates the Amplification of IFNγ-Producing T Cell and NK Cell Persistence
L Sala, S Gandini, A Bruno, R Allevi, M Gallazzi, P Senesi, M Palano, P Meregalli, E Longhi, C Sommese, L Luzi, E Trabucchi |
Frontiers in immunology | 2022 |
|
Hematopoietic responses to SARS-CoV-2 infection
S Elahi |
Cellular and Molecular Life Sciences | 2022 |
|
Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
I Laurén, S Havervall, H Ng, Martin, A Pettke, N GreilertNorin, L Gabrielsson, A Chourlia, C AmoêdoLeite, V Josyula, M Eltahir, I Kerzeli, A Falk, J Hober, W Christ, A Wiberg, M Hedhammar, H Tegel, J Burman, F Xu, E Pin, A Månberg, J Klingström, G Christoffersson, S Hober, P Nilsson, M Philipson, P Dönnes, R Lindsay, C Thålin, S Mangsbo |
Immunity, Inflammation and Disease | 2022 |
|
Differences in Characteristics of T-Cell Immunity to SARS-CoV-2 in Clinically Healthy Subjects
N Sushentseva, O Popov, I Polkovnikova, S Alpako, S Shcherbak |
Bulletin of Experimental Biology and Medicine | 2022 |
|
MicroRNAs based regulation of cytokine regulating immune expressed genes and their transcription factors in COVID-19
M Khokhar, S Tomo, P Purohit |
Meta Gene | 2022 |
|
Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
X He, X Zeng |
Drug design, development and therapy | 2022 |
|
Hypothesis: Emerging Roles for Aryl Hydrocarbon Receptor in Orchestrating CoV-2-Related Inflammation
T Guarnieri |
Cells | 2022 |
|
Tryptophan Metabolism and COVID-19-Induced Skeletal Muscle Damage: Is ACE2 a Key Regulator?
H Takeshita, K Yamamoto |
Frontiers in Nutrition | 2022 |
|
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses
A Anantharaj, S Gujjar, N Verma, NA Khan, H Shaman, P Sharanabasava, A Das, R Pandey, AK Pandey, GR Medigeshi |
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2022 |
|
Dysregulation of the leukocyte signaling landscape during acute COVID-19
I Turnbull, A Fuchs, K Remy, M Kelly, E Frazier, S Ghosh, S Chang, M Mazer, A Hess, J Leonard, M Hoofnagle, M Colonna, R Hotchkiss, S Hira |
PloS one | 2022 |
|
Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?
A Costanza, A Amerio, A Aguglia, G Serafini, M Amore, R Hasler, J Ambrosetti, G Bondolfi, G Sampogna, I Berardelli, A Fiorillo, M Pompili, K Nguyen |
Neuroscience and biobehavioral reviews | 2022 |
|
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
A Shafqat, S Shafqat, S Salameh, J Kashir, K Alkattan, A Yaqinuddin |
Frontiers in immunology | 2022 |
|
Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
S Das, S Kar, S Samanta, J Banerjee, B Giri, S Dash |
Immunologic Research | 2022 |
|
Factors associated with dexamethasone efficacy in COVID‐19. A retrospective investigative cohort study
R Arcani, R Cauchois, P Suchon, R Jean, P Jarrot, Q Pinho, J Dalmas, E Jean, B Andre, V Veit, M Koubi, G Kaplanski |
Journal of Medical Virology | 2022 |
|
Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults
M Girona-Alarcon, G Argüello, A Esteve-Sole, S Bobillo-Perez, XP Burgos-Artizzu, E Bonet-Carne, A Mensa-Vilaró, A Codina, M Hernández-Garcia, C Jou, L Alsina, I Jordan |
iScience | 2022 |
|
ACE2 overexpressing mesenchymal stem cells alleviates COVID-19 lung injury by inhibiting pyroptosis
J Wei, R Shang, J Wang, S Zhu, J Yin, Y Chen, Y Zhao, G Chen |
iScience | 2022 |
|
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3
L Henderson, S Canna, K Friedman, M Gorelik, S Lapidus, H Bassiri, E Behrens, K Kernan, G Schulert, P Seo, M Son, A Tremoulet, C VanderPluym, R Yeung, A Mudano, A Turner, D Karp, J Mehta |
Arthritis & Rheumatology | 2022 |
|
Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals
S Gil-Manso, I Blanco, R López-Esteban, D Carbonell, L López-Fernández, L West, R Correa-Rocha, M Pion |
Frontiers in immunology | 2022 |
|
TREC/KREC Levels and T and B Lymphocyte Subpopulations in COVID-19 Patients at Different Stages of the Disease
A Savchenko, E Tikhonova, I Kudryavtsev, D Kudlay, I Korsunsky, V Beleniuk, A Borisov |
Viruses | 2022 |
|
A guide to immunotherapy for COVID-19
F van de Veerdonk, E Giamarellos-Bourboulis, P Pickkers, L Derde, H Leavis, R van Crevel, J Engel, W Wiersinga, A Vlaar, M Shankar-Hari, T van der Poll, M Bonten, D Angus, J van der Meer, M Netea |
Nature Medicine | 2022 |
|
Associations between the von Willebrand Factor—ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality
G Sinkovits, M Réti, V Müller, Z Iványi, J Gál, L Gopcsa, P Reményi, B Szathmáry, B Lakatos, J Szlávik, I Bobek, Z Prohászka, Z Förhécz, B Mező, D Csuka, L Hurler, E Kajdácsi, L Cervenak, P Kiszel, T Masszi, I Vályi-Nagy, Z Prohászka |
Thrombosis and Haemostasis | 2022 |
|
VIP plasma levels associate with survival in severe COVID‐19 patients, correlating with protective effects in SARS‐CoV‐2‐infected cells
J Temerozo, C Sacramento, N FintelmanRodrigues, C Pão, C Freitas, S Dias, A Ferreira, M Mattos, V Soares, L Teixeira, I AzevedoQuintanilha, E Hottz, P Kurtz, F Bozza, P Bozza, T Souza, D BouHabib |
Journal of leukocyte biology | 2022 |
|
Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update
W Zhang, C Qin, Y Fei, M Shen, Y Zhou, Y Zhang, X Zeng, S Zhang |
Clinical Immunology | 2022 |
|
Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm
P Niedźwiedzka-Rystwej, A Majchrzak, S Kurkowska, P Małkowska, O Sierawska, R Hrynkiewicz, M Parczewski |
International journal of molecular sciences | 2022 |
|
Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients
H Wang, D Yan, Y Li, Y Gong, Y Mai, B Li, X Zhu, X Wan, L Xie, H Jiang, M Zhang, M Sun, Y Yao, Y Zhu |
Infectious Diseases of Poverty | 2022 |
|
T cell responses to SARS-CoV-2 in humans and animals
S Mattoo, J Myoung |
The Journal of Microbiology | 2022 |
|
The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies
S Zhang, L Wang, G Cheng |
Molecular Therapy | 2022 |
|
The T cell immune response against SARS-CoV-2
P Moss |
Nature Immunology | 2022 |
|
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response
F Alberici, S Affatato, D Moratto, F Mescia, E Delbarba, A Guerini, M Tedesco, P Burbelo, R Zani, I Castagna, A Gallico, M Tonoli, M Venturini, A Roccaro, M Giacomelli, J Cohen, V Giustini, K Dobbs, H Su, C Fiorini, V Quaresima, F Viola, V Vizzardi, M Gaggiotti, N Bossini, P Gaggia, R Badolato, L Notarangelo, M Chiarini, F Scolari |
Journal of Nephrology | 2022 |
|
The Association between TNF-α, IL-6, and Vitamin D Levels and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis
C Halim, A Mirza, M Sari |
Pathogens | 2022 |
|
Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients
N Gatselis, V Lygoura, A Lyberopoulou, G Giannoulis, A Samakidou, A Vaiou, G Vatidis, K Antoniou, A Stefos, S Georgiadou, D Sagris, D Sveroni, D Stergioula, S Gabeta, G Ntaios, G Dalekos |
Viruses | 2022 |
|
Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm
A Abubakar, R Ahmad, A Rowaiye, S Rahman, K Iskandar, S Dutta, A Oli, S Dhingra, M Tor, A Etando, S Kumar, M Irfan, M Gowere, K Chowdhury, F Akter, D Jahan, N Schellack, M Haque |
Life Sciences | 2022 |
|
Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19
A Alsalman, M Al-Mterin, E Elkord, M Dwivedi |
Journal of Immunology Research | 2022 |
|
Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review
Y Huang, Q Ling, A Manyande, D Wu, B Xiang |
Frontiers in neuroscience | 2022 |
|
Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
M Al-Mterin, A Alsalman, E Elkord |
Frontiers in immunology | 2022 |
|
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
E Gusev, A Sarapultsev, L Solomatina, V Chereshnev |
International journal of molecular sciences | 2022 |
|
Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2
M Salleh, M Norazmi, Z Deris |
PeerJ | 2022 |
|
Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
S Kar, P Devnath, T Emran, T Tallei, S Mitra, K Dhama |
Immunity, Inflammation and Disease | 2022 |
|
Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection
N Silverstein, Y Wang, Z Manickas-Hill, C Carbone, A Dauphin, B Boribong, M Loiselle, J Davis, M Leonard, L Kuri-Cervantes, N Meyer, M Betts, J Li, B Walker, X Yu, L Yonker, J Luban |
eLife | 2022 |
|
COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches
M Zavvar, A Yahyapoor, H Baghdadi, S Zargaran, S Assadiasl, K Abdolmohammadi, A Abooei, M Sattarian, M JalaliFarahani, N Zarei, A Farahvash, Y Fatahi, G Deniz, M Zarebavani, M Nicknam |
International Immunopharmacology | 2022 |
|
Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19
A Sen, A Nigam, M Vachher |
International Journal of Peptide Research and Therapeutics | 2022 |
|
Neutrophil Extracellular Traps, Sepsis and COVID-19 – A Tripod Stand
Ventura-Santana E, Ninan JR, Snyder CM, Okeke EB |
Frontiers in immunology | 2022 |
|
The Impact of Iron Dyshomeostasis and Anaemia on Long-Term Pulmonary Recovery and Persisting Symptom Burden after COVID-19: A Prospective Observational Cohort Study
Sonnweber T, Grubwieser P, Sahanic S, Böhm AK, Pizzini A, Luger A, Schwabl C, Koppelstätter S, Kurz K, Puchner B, Sperner-Unterweger B, Hüfner K, Wöll E, Nairz M, Widmann G, Tancevski I, Löffler-Ragg J, Weiss G |
Metabolites | 2022 |
|
Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features.
Rommasi F, Nasiri MJ, Mirsaeidi M |
Molecular and Cellular Biochemistry | 2022 |
|
Effect of Expanded Hemodialysis with Theranova® in Patients with COVID-19.
Serrano Salazar ML, Portolés J, de Valdenebro Recio M, Rosado Garcia S, Llópez Carratalá MDR, Bernabeu-Andreu FA, Sánchez-López AJ, López-Sánchez P |
Blood Purification | 2022 |
|
ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology.
Gawish R, Starkl P, Pimenov L, Hladik A, Lakovits K, Oberndorfer F, Cronin SJ, Ohradanova-Repic A, Wirnsberger G, Agerer B, Endler L, Capraz T, Perthold JW, Cikes D, Koglgruber R, Hagelkruys A, Montserrat N, Mirazimi A, Boon L, Stockinger H, Bergthaler A, Oostenbrink C, Penninger JM, Knapp S |
eLife | 2022 |
|
Role of genetic variants and host polymorphisms on COVID-19: From viral entrance mechanisms to immunological reactions.
Adli A, Rahimi M, Khodaie R, Hashemzaei N, Hosseini SM |
Journal of Medical Virology | 2022 |
|
Update of the recommendations of the Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group for the approach to COVID-19 in Intensive Care Medicine.
Mendes JJ, Paiva JA, Gonzalez F, Mergulhão P, Froes F, Roncon R, Gouveia J |
Revista Brasileira de Terapia Intensiva | 2022 |
|
Vitamin D can reduce severity in COVID-19 through regulation of PD-L1.
Aygun H |
Naunyn-Schmiedeberg's Archives of Pharmacology | 2022 |
|
Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.
Kohli A, Sauerhering L, Fehling SK, Klann K, Geiger H, Becker S, Koch B, Baer PC, Strecker T, Münch C |
Life science alliance | 2022 |
|
Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides.
Hikichi T, Sakamoto M, Harada M, Saito M, Yamane Y, Tokumura K, Nakamura Y |
Journal of Human Genetics | 2022 |
|
COVID-19-associated Pulmonary Cryptococcosis: A Rare Case Presentation.
Sharma S, Agrawal G, Das S |
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine | 2022 |
|
Persistent Endothelial Dysfunction in Coronavirus Disease-2019 Survivors Late After Recovery.
Gao YP, Zhou W, Huang PN, Liu HY, Bi XJ, Zhu Y, Sun J, Tang QY, Li L, Zhang J, Zhu WH, Cheng XQ, Liu YN, Deng YB |
Frontiers in Medicine | 2022 |
|
Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates.
He Q, Mao Q, Peng X, He Z, Lu S, Zhang J, Gao F, Bian L, An C, Yu W, Yang F, Zhou Y, Yang Y, Li Y, Yuan Y, Yan X, Yang J, Wu X, Huang W, Li C, Wang J, Liang Z, Xu M |
Signal Transduction and Targeted Therapy | 2022 |
|
Programmed cell death: the pathways to severe COVID-19?
Bader SM, Cooney JP, Pellegrini M, Doerflinger M |
Biochemical Journal | 2022 |
|
Covid-19 and leptospirosis, pulmonary involvement and response to steroids: A comparative observational study from a rural Tertiary care center in Kerala.
Xavier V, Baby B, George JM, Ittyachen AM |
Journal of Family Medicine and Primary Care | 2022 |
|
Elucidating the Correlation of D-Dimer Levels with COVID-19 Severity: A Scoping Review.
Nasif WA, El-Moursy Ali AS, Hasan Mukhtar M, Alhuzali AMH, Yahya Alnashri YA, Ahmed Gadah ZI, Edrees EAA, Albarakati HAM, Muhji Aloufi HS |
Anemia | 2022 |
|
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial.
Rebelatto CLK, Senegaglia AC, Franck CL, Daga DR, Shigunov P, Stimamiglio MA, Marsaro DB, Schaidt B, Micosky A, de Azambuja AP, Leitão CA, Petterle RR, Jamur VR, Vaz IM, Mallmann AP, Carraro Junior H, Ditzel E, Brofman PRS, Correa A |
Stem Cell Research & Therapy | 2022 |
|
Inflammation and oxidative stress, the links between obesity and COVID-19: a narrative review.
Moreno-Fernandez J, Ochoa J, Ojeda ML, Nogales F, Carreras O, Díaz-Castro J |
Journal of Physiology and Biochemistry | 2022 |
|
The Prevalence and Impact of Coinfection and Superinfection on the Severity and Outcome of COVID-19 Infection: An Updated Literature Review.
Omoush SA, Alzyoud JAM |
2022 | |
|
Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients.
Oliveira LB, Mwangi VI, Sartim MA, Delafiori J, Sales GM, de Oliveira AN, Busanello ENB, Val FFAE, Xavier MS, Costa FT, Baía-da-Silva DC, Sampaio VS, de Lacerda MVG, Monteiro WM, Catharino RR, de Melo GC |
Frontiers in microbiology | 2022 |
|
Vitamin D: The Missing Nutrient Behind the Two Deadly Pandemics, COVID-19 and Cardiovascular Diseases.
Singh A, Chidharla A, Agarwal K, Singh P, Jain N, Hassen G, Abdelwahed S, Bhandari R, Patel K, Gupta S, Koritala T, Rabbani R |
Cureus | 2022 |
|
Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19.
Zhang Y, Shi F, Wang Y, Meng Y, Zhang Q, Wang K, Zeng P, Diao H |
Frontiers in Molecular Biosciences | 2022 |
|
A network-biology led computational drug repurposing strategy to prioritize therapeutic options for COVID-19.
Khurana P, Varshney R, Gupta A |
Heliyon | 2022 |
|
High dose melatonin as an adjuvant therapy in intubated patients with COVID-19: A randomized clinical trial.
Alizadeh N, Dianatkhah M, Alimohamadi Y, Moradi H, Akbarpour S, Akrami M, Mansouri F, Faraji N, Rezaie Z, Alizadeh M, Hosamirudsari H |
Journal of Taibah University Medical Sciences | 2022 |
|
The Relationship Between Convergent IGH Signatures and Severity of COVID-19 Patients by Next-Generation Sequencing of B-Cell Repertoire.
Cai H, Hu J, Huang L, Gao C, Xu M, Gao Y, Sun T, Fang X |
Frontiers in microbiology | 2022 |
|
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations.
Chakraborty C, Sharma AR, Bhattacharya M, Lee SS |
Frontiers in immunology | 2022 |
|
The Role of Nutrients in Prevention, Treatment and Post-Coronavirus Disease-2019 (COVID-19).
Motti ML, Tafuri D, Donini L, Masucci MT, De Falco V, Mazzeo F |
Nutrients | 2022 |
|
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues.
Nelson CE, Namasivayam S, Foreman TW, Kauffman KD, Sakai S, Dorosky DE, Lora NE, Brooks K, Potter EL, Garza NL, Lafont BAP, Johnson RF, Roederer M, Sher A, Weiskopf D, Sette A, de Wit E, Hickman HD, Brenchley JM, Via LE, Barber DL, Abdi A, Dayao EK, Fleegle JD, Gomez F, Piazza MK, Repoli KM, Sloan BY, Butler AL, Walker AM, Weiner DM, Woodcock MJ, Vatthauer A |
Science Immunology | 2022 |
|
Cardiac Arrest and Hypoxic-Ischemic Encephalopathy Following an Emergency Caesarean Section in a COVID-19 Patient.
Palati S, Sanchez A, Campbell M, Castaneda M |
Cureus | 2022 |
|
Vitamin D: A Role Also in Long COVID-19?
Barrea L, Verde L, Grant WB, Frias-Toral E, Sarno G, Vetrani C, Ceriani F, Garcia-Velasquez E, Contreras-Briceño J, Savastano S, Colao A, Muscogiuri G |
Nutrients | 2022 |
|
Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19.
Ben Jemaa A, Salhi N, Ben Othmen M, Ben Ali H, Guissouma J, Ghadhoune H, Oueslati R, Dhaouadi H |
International Immunopharmacology | 2022 |
|
SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies.
Wang Z, Yang X, Mei X, Zhou Y, Tang Z, Li G, Zhong J, Yu M, Huang M, Su X, Lin B, Cao P, Yang J, Ran P |
Signal Transduction and Targeted Therapy | 2022 |
|
Elevated Serum Lactate Dehydrogenase Predicts Unfavorable Outcomes After rt-PA Thrombolysis in Ischemic Stroke Patients.
Jin H, Bi R, Hu J, Xu D, Su Y, Huang M, Peng Q, Li Z, Chen S, Hu B |
Frontiers in neurology | 2022 |
|
From COVID-19 to Sarcoidosis: How Similar Are These Two Diseases?
Zhao M, Tian C, Cong S, Di X, Wang K |
Frontiers in immunology | 2022 |
|
Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
Bonaventura A, Vecchié A, Dagna L, Tangianu F, Abbate A, Dentali F |
Inflammation research : official journal of the European Histamine Research Society ... [et al.] | 2022 |
|
Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination.
Grimaldi V, Benincasa G, Moccia G, Sansone A, Signoriello G, Napoli C |
Journal of Immunological Methods | 2022 |
|
Comparison of pure tone audiometry thresholds and transient evoked otoacoustic emissions (TEOAE) of patients with and without Covid-19 pneumonia.
Yıldız E |
American Journal of Otolaryngology | 2022 |
|
SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network.
Li W, Yang S, Xu P, Zhang D, Tong Y, Chen L, Jia B, Li A, Lian C, Ru D, Zhang B, Liu M, Chen C, Fu W, Yuan S, Gu C, Wang L, Li W, Liang Y, Yang Z, Ren X, Wang S, Zhang X, Song Y, Xie Y, Lu H, Xu J, Wang H, Yu W |
EBioMedicine | 2022 |
|
Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?
Quan Y, Li L, Yin Z, Chen S, Yi J, Lang J, Zhang L, Yue Q, Zhao J |
Frontiers in pharmacology | 2022 |
|
Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities.
Fouladseresht H, Ghamar Talepoor A, Eskandari N, Norouzian M, Ghezelbash B, Beyranvand MR, Nejadghaderi SA, Carson-Chahhoud K, Kolahi AA, Safiri S |
Frontiers in immunology | 2022 |
|
Exophiala dermatitidis, 'the real black fungus' fungemia in a patient with COVID-19.
Tzar MN, Meor Jamaludin WHB, Abdul Wahab A, Ding CH |
IDCases | 2022 |
|
Discovery and characterization of a monoclonal antibody targeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/ IL-6Rα/gp130 hexameric signaling complex formation.
Chou CC, Hua KT, Chen MW, Wu CJ, Hsu CH, Wang JT, Hsiao M, Wei LH |
mAbs | 2022 |
|
Triglyceride/High-Density Lipoprotein Cholesterol Ratio is Associated with the Mortality of COVID-19: A Retrospective Study in China.
Peng F, Lei S, Zhang Q, Zhong Y, Wu S |
International journal of general medicine | 2022 |
|
Evaluation of ferritin level in COVID-19 patients and its inflammatory response.
Chen J, He ZX, Wang FK |
Applied Nanoscience | 2022 |
|
Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches.
Mahboubi Mehrabani M, Karvandi MS, Maafi P, Doroudian M |
Reviews in Medical Virology | 2022 |
|
Bioactive hybrid metal-organic framework (MOF)-based nanosensors for optical detection of recombinant SARS-CoV-2 spike antigen.
Rabiee N, Fatahi Y, Ahmadi S, Abbariki N, Ojaghi A, Rabiee M, Radmanesh F, Dinarvand R, Bagherzadeh M, Mostafavi E, Ashrafizadeh M, Makvandi P, Lima EC, Saeb MR |
The Science of The Total Environment | 2022 |
|
Two Uncommon Presentations of COVID-19-Associated Mucormycosis.
Rathna R, D'Souza C, D'Silva C, Joseph JM, Varghese AK |
Cureus | 2022 |
|
Within-host models of SARS-CoV-2: What can it teach us on the biological factors driving virus pathogenesis and transmission?
Prague M, Alexandre M, Thiébaut R, Guedj J |
Anaesthesia Critical Care & Pain Medicine | 2022 |
|
Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol.
Chopra A, Chavan-Gautam P, Tillu G, Saluja M, Borse S, Sarmukaddam S, Chaudhuri S, Rao B, Yadav B, Srikanth N, Patwardhan B |
Frontiers in Medicine | 2022 |
|
Mucormycosis infection in patients with COVID-19: A systematic review.
SeyedAlinaghi S, Karimi A, Barzegary A, Pashaei Z, Afsahi AM, Alilou S, Janfaza N, Shojaei A, Afroughi F, Mohammadi P, Soleimani Y, Nazarian N, Amiri A, Tantuoyir MM, Oliaei S, Mehraeen E, Dadras O |
2022 | |
|
Epidemiology, Clinical Features, and Outcomes of Multisystem Inflammatory Syndrome in Children (MIS-C) and Adolescents-a Live Systematic Review and Meta-analysis.
Jiang L, Tang K, Irfan O, Li X, Zhang E, Bhutta Z |
Current Pediatrics Reports | 2022 |
|
Associations between Serum Interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis.
Chang Y, Bai M, You Q |
BioMed Research International | 2022 |
|
Prevalence of Micronutrient Deficiencies in Patients Hospitalized with COVID-19: An Observational Cohort Study.
Voelkle M, Gregoriano C, Neyer P, Koch D, Kutz A, Bernasconi L, Conen A, Mueller B, Schuetz P |
Nutrients | 2022 |
|
Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer's and Parkinson's Disease.
Silva J, Patricio F, Patricio-Martínez A, Santos-López G, Cedillo L, Tizabi Y, Limón ID |
Frontiers in neuroscience | 2022 |
|
Organ-specific immune response in lethal SARS-CoV-2 infection by deep spatial phenotyping.
Balachander A, Lee B, Biswas SK, Lye DC, Lin RT, Leo YS, Chui P, Ng LF, Renia L |
IBMS BoneKEy | 2022 |
|
Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern.
Vikkurthi R, Ansari A, Pai AR, Jha SN, Sachan S, Pandit S, Nikam B, Kalia A, Jit BP, Parray HA, Singh S, Kshetrapal P, Wadhwa N, Shrivastava T, Coshic P, Kumar S, Sharma P, Sharma N, Taneja J, Pandey AK, Sharma A, Thiruvengadam R, Grifoni A, Weiskopf D, Sette A, Bhatnagar S, Gupta N |
Nature Microbiology | 2022 |
|
Isolated Abducens Nerve Palsy in a Patient With COVID-19: A Case Report and Literature Review.
Manolopoulos A, Katsoulas G, Kintos V, Koutsokera M, Lykou C, Lapaki KM, Acquaviva PT |
The Neurologist | 2022 |
|
Vascular findings in CTA body and extremity of critically ill COVID-19 patients: commonly encountered vascular complications with review of literature.
Lee EE, Gong AJ, Gawande RS, Fishman EK, Vadvala HV |
Emergency Radiology | 2022 |
|
The occurrence and risk factors associated with post-traumatic stress disorder among discharged COVID-19 patients in Tianjin, China.
Mei Z, Wu X, Zhang X, Zheng X, Li W, Fan R, Yu H, Zhang S, Gu Y, Wang X, Xia Y, Meng G, Shen J, Niu K |
Brain and Behavior | 2022 |
|
Musculoskeletal and Neurological Pain Symptoms Among Hospitalized COVID-19 Patients.
Jena D, Sahoo J, Barman A, Gupta A, Patel V |
American Journal of Physical Medicine & Rehabilitation | 2022 |
|
Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study.
Chen Y, Xie J, Wu W, Li S, Hu Y, Hu M, Li J, Yang Y, Huang T, Zheng K, Wang Y, Kang H, Huang Y, Jiang L, Zhang W, Zhong M, Sang L, Zheng X, Pan C, Zheng R, Li X, Tong Z, Qiu H, Weng L, Du B |
Frontiers in immunology | 2022 |
|
SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients.
Quarleri J, Delpino MV |
GeroScience | 2022 |
|
COVID-19 and Intracranial Hemorrhage: A Multicenter Case Series, Systematic Review and Pooled Analysis.
Schmidbauer ML, Ferse C, Salih F, Klingner C, Musleh R, Kunst S, Wittstock M, Neumann B, Schebesch KM, Bösel J, Godau J, Lochner P, Adam EH, Jahnke K, Knier B, Schirotzek I, Müllges W, Notz Q, Dengl M, Güldner A, Onur OA, Garcia Borrega J, Dimitriadis K, Günther A, On Behalf Of The Ignite Study Group |
Journal of Clinical Medicine | 2022 |
|
The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It.
Ahmad Malik J, Ahmed S, Shinde M, Almermesh MHS, Alghamdi S, Hussain A, Anwar S |
Saudi Journal of Biological Sciences | 2022 |
|
Cell specific peripheral immune responses predict survival in critical COVID-19 patients.
Amrute JM, Perry AM, Anand G, Cruchaga C, Hock KG, Farnsworth CW, Randolph GJ, Lavine KJ, Steed AL |
Nature Communications | 2022 |
|
Chronic diseases, chest computed tomography, and laboratory tests as predictors of severe respiratory failure and death in elderly Brazilian patients hospitalized with COVID-19: a prospective cohort study.
Junior AF, Azevedo E, Paes AT, Lima E, Campos Guerra JC, Ingham SJMN |
BMC geriatrics | 2022 |
|
Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.
Ma Y, Qiu F, Deng C, Li J, Huang Y, Wu Z, Zhou Y, Zhang Y, Xiong Y, Yao Y, Zhong Y, Qu J, Su J |
Genome Medicine | 2022 |
|
COVID-19-Associated Pulmonary Aspergillosis in a Tertiary Hospital.
Marta GC, Lorena FE, Laura MV, Angela LM, Blanca LG, Rodrigo AA, Marta SG, Santiago MG, Liliana PM, Maria Luisa SN, de la Rasilla Teresa PG |
2022 | |
|
SARS-CoV-2 (COVID-19)-specific T cell and B cell responses in convalescent rheumatoid arthritis: Monozygotic twins pair case observation.
Arruda LCM, Gaballa A, Da Silva Rodrigues R, Makower B, Uhlin M |
Scandinavian Journal of Immunology | 2022 |
|
Distinguishing Incubation and Acute Disease Stages of Mild-to-Moderate COVID-19.
Müller M, Volzke J, Subin B, Schmidt CJ, Geerdes-Fenge H, Reisinger EC, Müller-Hilke B |
Viruses | 2022 |
|
Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm.
Abusalah MAH, Khalifa M, Al-Hatamleh MAI, Jarrar M, Mohamud R, Chan YY |
Journal of Personalized Medicine | 2022 |
|
Therapeutic Vitamin D Supplementation Following COVID-19 Diagnosis: Where Do We Stand?-A Systematic Review.
Bania A, Pitsikakis K, Mavrovounis G, Mermiri M, Beltsios ET, Adamou A, Konstantaki V, Makris D, Tsolaki V, Gourgoulianis K, Pantazopoulos I |
Journal of Personalized Medicine | 2022 |
|
Intravenous N-Acetylcysteine in Management of COVID-19: A Case Series.
Chen B, Raja K, Pierre-Louis F, Patel M, Patel R, Kang S, Daniel N, Attalla M, Philips M |
Journal of Pharmacy Practice | 2022 |
|
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group.
Hermine O, Mariette X, Porcher R, Djossou F, Nguyen Y, Arlet JB, Savale L, Diehl JL, Georgin-Lavialle S, Cadranel J, Pialoux G, Lacombe K, Mekinian A, Gros H, Lescure X, Ghosn J, Coupez E, Grapin K, Rapp C, Michel M, Lecapitaine AL, Michot JM, Costedoat-Chalumeau N, Nguyen LBL, Semerano L, Raffi F, Aguillar C, Rouzaud C, Gottenberg JE, Hansmann Y, Bienvenu B, London J, Fantchou FS, Ackermann F, Gros A, Morel A, Gambier N, Sène D, Mégarbane B, Azoulay E, Bureau S, Dougados M, Emmerich J, Fartoukh M, Guidet B, Humbert M, Mahevas M, Pène F, Schlemmer F, Pourcher-Martinez V, Tibi A, Baron G, Perrodeau E, Baron S, Steg G, Yazdapanah Y, Simon T, Resche-Rigon M, Tharaux PL, Ravaud P |
2022 | |
|
Copeptin: a neuroendocrine biomarker of COVID-19 severity.
Hammad R, Elshafei A, Khidr EG, El-Husseiny AA, Gomaa MH, Kotb HG, Eltrawy HH, Farhoud H |
Biomarkers in Medicine | 2022 |
|
Viral load is associated with mitochondrial dysfunction and altered monocyte phenotype in acute severe SARS-CoV-2 infection.
Romão PR, Teixeira PC, Schipper L, da Silva I, Santana Filho P, Júnior LCR, Peres A, Gonçalves da Fonseca S, Chagas Monteiro M, Lira FS, Andrey Cipriani Frade M, Comerlato J, Comerlato C, Sant'Anna FH, Bessel M, Abreu CM, Wendland EM, Dorneles GP |
International Immunopharmacology | 2022 |
|
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
Rovito R, Augello M, Ben-Haim A, Bono V, d\u2019Arminio Monforte A, Marchetti G |
Frontiers in immunology | 2022 |
|
Vitamin D regulation of immune function during covid-19.
Bikle DD |
Reviews in endocrine & metabolic disorders | 2022 |
|
Endothelial Dysfunction in Covid-19 Infection.
Otifi HM, Adiga BK |
The American Journal of the Medical Sciences | 2022 |
|
Statistical Analysis and Machine Learning Prediction of Disease Outcomes for COVID-19 and Pneumonia Patients.
Zhao Y, Zhang R, Zhong Y, Wang J, Weng Z, Luo H, Chen C |
Frontiers in Cellular and Infection Microbiology | 2022 |
|
Th1/Th2/Th17 Cytokine Profile among Different Stages of COVID-19 Infection.
Gupta G, Shareef I, Tomar S, Kumar MSN, Pandey S, Sarda R, Singh R, Das BK, Sinha S |
2022 | |
|
Successful outcome using Tocilizumab in COVID-19 pneumonia with respiratory failure on a ward level.
Morărașu BC, Basirat A, Kooblall M, Lane S |
2022 | |
|
SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters.
Qiao W, Lau HE, Xie H, Poon VK, Chan CC, Chu H, Yuan S, Yuen TT, Chik KK, Tsang JO, Chan CC, Cai JP, Luo C, Yuen KY, Cheung KM, Chan JF, Yeung KW |
Nature Communications | 2022 |
|
Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
Kim SH, Hong JY, Bae S, Lee H, Wi YM, Ko JH, Kim B, Joo EJ, Seok H, Shi HJ, Yoo JR, Hyun M, Kim HA, Jang S, Mun SJ, Kim J, Kim MC, Jung DS, Kim SH, Peck KR |
Journal of Korean Medical Science | 2022 |
|
COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases.
Bourguiba R, Kyheng M, Koné-Paut I, Rouzaud D, Avouac J, Devaux M, Abdallah NA, Fautrel B, Ferreira-Maldent N, Langlois V, Ledoult E, Nielly H, Queyrel V, Sellam J, Tieulie N, Chazerain P, Evon P, Labreuche J, Savey L, Hentgen V, Grateau G, Georgin-Lavialle S |
RMD Open | 2022 |
|
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis.
Trougakos IP, Terpos E, Alexopoulos H, Politou M, Paraskevis D, Scorilas A, Kastritis E, Andreakos E, Dimopoulos MA |
Trends in Molecular Medicine | 2022 |
|
The humoral response and antibodies against SARS-CoV-2 infection.
Qi H, Liu B, Wang X, Zhang L |
Nature Immunology | 2022 |
|
Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation
Wu H, He P, Ren Y, Xiao S, Wang W, Liu Z, Li H, Wang Z, Zhang D, Cai J, Zhou X, Jiang D, Fei X, Zhao L, Zhang H, Liu Z, Chen R, Li W, Wang C, Zhang S, Qin J, Nashan B, Sun C |
Nature Communications | 2022 |
|
Investigating underlying human immunity genes, implicated diseases and their relationship to COVID-19
Ahmed Z, Renart EG, Zeeshan S |
Personalized Medicine | 2022 |
|
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Hsu RJ, Yu WC, Peng GR, Ye CH, Hu S, Chong PC, Yap KY, Lee JY, Lin WC, Yu SH |
Frontiers in immunology | 2022 |
|
DNA damage in peripheral blood lymphocytes of severely ill COVID-19 patients in relation to inflammatory markers and parameters of hemostasis
Mihaljevic O, Zivancevic-Simonovic S, Cupurdija V, Marinkovic M, Tubic Vukajlovic J, Markovic A, Stanojevic-Pirkovic M, Milosevic-Djordjevic O |
Mutagenesis | 2022 |
|
Body composition, physical capacity, and immuno-metabolic profile in community-acquired pneumonia caused by COVID-19, influenza, and bacteria: a prospective cohort study.
Ryrsø CK, Dungu AM, Hegelund MH, Jensen AV, Sejdic A, Faurholt-Jepsen D, Krogh-Madsen R, Lindegaard B |
International Journal of Obesity | 2022 |
|
Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness.
Yates AG, Weglinski CM, Ying Y, Dunstan IK, Strekalova T, Anthony DC |
Journal of Neuroinflammation | 2022 |
|
Co-infecting pathogens can contribute to inflammatory responses and severe symptoms in COVID-19.
Chen L, Shen L, Wu W, Guan W, Zhou J, Luo G, Chen Q, Zhou H, Deng Z, Chen Y, Zhao W, Jin W, Qiu M, Zheng Q, Wang Y, Liu C, Bai X, Guo D, Holmes EC, Zhong N, Shi M, Yang Z |
Journal of Thoracic Disease | 2022 |
|
Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection.
Li W, Syed F, Yu R, Yang J, Xia Y, Relich RF, Russell PM, Zhang S, Khalili M, Huang L, Kacena MA, Zheng X, Yu Q |
Frontiers in immunology | 2022 |
|
Vascular Dysfunction and Its Cardiovascular Consequences During and After COVID-19 Infection: A Narrative Review.
Kar M |
Vascular Health and Risk Management | 2022 |
|
A urinary proteomic landscape of COVID-19 progression identifies signaling pathways and therapeutic options.
Liu Y, Song L, Zheng N, Shi J, Wu H, Yang X, Xue N, Chen X, Li Y, Sun C, Chen C, Tang L, Ni X, Wang Y, Shi Y, Guo J, Wang G, Zhang Z, Qin J |
Science China Life Sciences | 2022 |
|
The Effect of COVID-19 Pandemic on Patients with Primary Immunodeficiency: A Cohort Study.
Babaei M, Kanannejad Z, Sepahi N, Alyasin S |
Iranian journal of medical sciences | 2022 |
|
Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19.
Leone VF, Imeraj A, Gastoldi S, Mele C, Liguori L, Condemi C, Ruggenenti P, Remuzzi G, Carrara C |
Frontiers in pharmacology | 2022 |
|
[CRP apheresis in acute myocardial infarction and COVID-19].
Buerke M, Sheriff A, Garlichs CD |
2022 | |
|
Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP).
Sweet AN, André NM, Stout AE, Licitra BN, Whittaker GR |
Viruses | 2022 |
|
The impact of 2020 French municipal elections on the spread of COVID-19.
Cassan G, Sangnier M |
Journal of Population Economics | 2022 |
|
Analysis of Clinical Course and Vaccination Influence on Serological Response in COVID-19 Convalescents.
Adamczuk J, Czupryna P, Dunaj-Małyszko J, Kruszewska E, Pancewicz S, Kamiński K, Borawski K, Grygorczuk S, Moniuszko-Malinowska A |
Microbiology spectrum | 2022 |
|
Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients.
Yang X, Rutkovsky AC, Zhou J, Zhong Y, Reese J, Schnell T, Albrecht H, Owens WB, Nagarkatti PS, Nagarkatti M |
Journal of immunology (Baltimore, Md. : 1950) | 2022 |
|
Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences.
Gasparello J, Papi C, Zurlo M, Cosenza LC, Breveglieri G, Zuccato C, Gambari R, Finotti A |
PloS one | 2022 |
|
D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes.
Park YJ, Acosta D, Vassell R, Tang J, Khurana S, Weiss CD, Golding H, Zaitseva M |
PLoS pathogens | 2022 |
|
Clinical Characterization and Possible Pathological Mechanism of Acute Myocardial Injury in COVID-19.
Li S, Wang J, Yan Y, Zhang Z, Gong W, Nie S |
Frontiers in Cardiovascular Medicine | 2022 |
|
Massive pulmonary embolism treated with low-dose thrombolysis on the geriatric ward during the COVID-19 pandemic.
Shepherd TD, Niaz TS, Yadav R |
BMJ case reports | 2022 |
|
The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3.
Schroeder JT, Bieneman AP |
Frontiers in immunology | 2022 |
|
Experiences and actions related to living with type 1 diabetes during the COVID-19 pandemic in Norway: a qualitative study conducted during July to December 2020.
Pleym K, Iversen MM, Broström A |
BMJ Open | 2022 |
|
Cytokine response over the course of COVID-19 infection in pregnant women
Rosen DB, Murphy EA, Gejman RS, Capili A, Friedlander RL, Rand S, Cagino KA, Glynn SM, Matthews KC, Kubiak JM, Yee J, Prabhu M, Riley LE, Yang YJ |
Cytokine | 2022 |
|
The relationship between peripheral immune response and disease severity in SARS‐CoV‐2‐infected subjects: A cross‐sectional study
Walter LO, Cardoso CC, Santos\u2010Pirath ÍM, Costa HZ, Gartner R, Werle I, Mohr ET, da Rosa JS, Felisberto M, Kretzer IF, Masukawa II, Vanny PD, Luiz MC, de Moraes AC, Dalmarco EM, Santos\u2010Silva MC |
Immunology | 2022 |
|
Exploring the Utility of NK Cells in COVID-19
Deng X, Terunuma H, Nieda M |
Biomedicines | 2022 |
|
Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19
Schroeder P, Brenner L, Kaur V, Cromer S, Armstrong K, LaRocque R, Ryan E, Meigs J, Florez J, Charles R, Mercader J, Leong A |
Research square | 2022 |
|
COVID-19 Infection in Patients with Comorbidities: Clinical and Immunological Insight
El-Badawy O, Elsherbiny NM, Abdeltawab D, Magdy DM, Bakkar LM, Hassan SA, Hassan EA, Thabet AM, Ashmawy AM, Moustafa EF, Abbas WA, Ahmad AB, Rayan A, Saad K, Elhoufey A, Hussein HA, Thabet AA, Zahran AM |
Clinical and Applied Thrombosis/Hemostasis | 2022 |
|
Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19
Bline K, Andrews A, Moore-Clingenpeel M, Mertz S, Ye F, Best V, Sayegh R, Tomatis-Souverbielle C, Quintero AM, Maynard Z, Glowinski R, Mejias A, Ramilo O |
Frontiers in Pediatrics | 2022 |
|
Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes
Karwaciak I, Karaś K, Sałkowska A, Pastwińska J, Ratajewski M |
Molecules (Basel, Switzerland) | 2022 |
|
Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects.
Abdolahi S, Hosseini M, Rezaei R, Mohebbi SR, Rostami-Nejad M, Mojarad EN, Mirjalali H, Yadegar A, Asadzadeh Aghdaei H, Zali MR, Baghaei K |
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases | 2022 |
|
Inflammation and Mortality in COVID-19 Hospitalized Patients With and Without Type 2 Diabetes.
Guo J, Lin WW, Zucker JE, Nandakumar R, Uhlemann AC, Wang S, Shivakoti R |
The Journal of clinical endocrinology and metabolism | 2022 |
|
Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury.
Vaka R, Khan S, Ye B, Risha Y, Parent S, Courtman D, Stewart DJ, Davis DR |
Stem Cell Research & Therapy | 2022 |
|
Severe versus common COVID-19: an early warning nomogram model.
Chang Y, Wan X, Fu X, Yang Z, Lu Z, Wang Z, Fu L, Yin L, Zhang Y, Zhang Q |
Aging | 2022 |
|
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19.
Vasbinder A, Anderson E, Shadid H, Berlin H, Pan M, Azam TU, Khaleel I, Padalia K, Meloche C, O'Hayer P, Michaud E, Catalan T, Feroze R, Blakely P, Launius C, Huang Y, Zhao L, Ang L, Mikhael M, Mizokami-Stout K, Pennathur S, Kretzler M, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Feldman EL, Pop-Busui R, Hayek SS, Hayek SS, Blakely P, Berlin H, Azam TU, Shadid H, Pan M, O'Hayer P, Meloche C, Feroze R, Padalia KJ, Anderson E, Perry D, Bitar A, Kaakati R, Huang Y, Zhao L, Reiser J, Samelko B, Hlepas A, Patel PP, Wang X, Eugen-Olsen J, Altintas I, Stauning M, Baltzer Houlind M, Lindstrøm MB, Gamst-Jensen H, Hartmann LJ, Nehlin JO, Kallemose T, Parvaiz I, Rasmussen C, Andersen O, Tingleff J, Giamarellos-Bourboulis EJ, Adami ME, Solomonidi N, Tsilika M, Saridaki M, Lekakis V, Loosen SH, Luedde T, Keitel V, Chalkias A, Arnaoutoglou E, Pantazopoulos I, Laou E, Kolonia K, Skoulakis A, Tacke F, Tober-Lau P, Mohr R, Kurth F, Sander LE, Jochum C |
Diabetes care | 2022 |
|
Computed tomography scan in COVID-19: a systematic review and meta-analysis.
Sharif PM, Nematizadeh M, Saghazadeh M, Saghazadeh A, Rezaei N |
Polish Journal of Radiology | 2022 |
|
Wie sich COVID-19 in der 3D-Zellkultur simulieren lässt.
Wilflingseder D, Posch W |
2022 | |
|
Evaluation of the Levels of Peripheral CD3+, CD4+, and CD8+ T Cells and IgG and IgM Antibodies in COVID-19 Patients at Different Stages of Infection.
Aljabr W, Al-Amari A, Abbas B, Karkashan A, Alamri S, Alnamnakani M, Al-Qahtani A |
Microbiology spectrum | 2022 |
|
Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection.
Pekayvaz K, Leunig A, Kaiser R, Joppich M, Brambs S, Janjic A, Popp O, Nixdorf D, Fumagalli V, Schmidt N, Polewka V, Anjum A, Knottenberg V, Eivers L, Wange LE, Gold C, Kirchner M, Muenchhoff M, Hellmuth JC, Scherer C, Rubio-Acero R, Eser T, Deák F, Puchinger K, Kuhl N, Linder A, Saar K, Tomas L, Schulz C, Wieser A, Enard W, Kroidl I, Geldmacher C, von Bergwelt-Baildon M, Keppler OT, Munschauer M, Iannacone M, Zimmer R, Mertins P, Hubner N, Hoelscher M, Massberg S, Stark K, Nicolai L |
Nature Communications | 2022 |
|
Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study.
Hafez W, Ziade MA, Arya A, Saleh H, Abdelshakor M, Fadl Alla O, Agrawal P, Ali S, Rao SR, Gupta S, Abdelli I, Sebastian H, Ali M, Gador M, Al Baha Z, Abdelrahman A |
2022 | |
|
A Peek into Pandora's Box: COVID-19 and Neurodegeneration.
Chandra A, Johri A |
Brain Sciences | 2022 |
|
Looking at COVID-19 from a Systems Biology Perspective.
Turilli ES, Lualdi M, Fasano M |
Biomolecules | 2022 |
|
Flipped inflammatory time and the role of antibodies against SARS-CoV-2: optimising tocilizumab against COVID-19.
Guisado-Vasco P, Aguareles J, Carralón González MM, Sotres Fernandez G, Carnevali Ruiz D |
The Journal of Infectious Diseases | 2022 |
|
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity.
Gu W, Gan H, Ma Y, Xu L, Cheng ZJ, Li B, Zhang X, Jiang W, Sun J, Sun B, Hao C |
Virology Journal | 2022 |
|
When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA.
Noll J, Reichert M, Dietrich M, Riedel JG, Hecker M, Padberg W, Weigand MA, Hecker A |
Langenbeck's Archives of Surgery | 2022 |
|
Impact of diabetes on COVID-19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta-analysis.
Kastora S, Patel M, Carter B, Delibegovic M, Myint PK |
2022 | |
|
A Case of Cytomegalovirus Colitis in an Immunocompetent COVID-19 Patient.
Bakir M, Rebh F, Mahdi E, AlFiaar A, Mansoor GS |
Cureus | 2022 |
|
The Relationship Between Vitamin D Levels and Severity in Illness in COVID-19 Patients: A Cross-Sectional Study.
Nimavat N, Singh S, Patel D, Singh P, Hasan MM, Mandala G, Bhangu R, Priya A |
Cureus | 2022 |
|
COVID-19 Autopsies Reveal Underreporting of SARS-CoV-2 Infection and Scarcity of Co-infections.
Schwab N, Nienhold R, Henkel M, Baschong A, Graber A, Frank A, Mensah N, Koike J, Hernach C, Sachs M, Daun T, Zsikla V, Willi N, Junt T, Mertz KD |
Frontiers in Medicine | 2022 |
|
A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients.
Mazaheri T, Ranasinghe R, Al-Hasani W, Luxton J, Kearney J, Manning A, Dimitriadis GK, Mare T, Vincent RP |
PloS one | 2022 |
|
Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines.
Mouro V, Fischer A |
Mucosal Immunology | 2022 |
|
Acute pericarditis after COVID 19 in a peritoneal dialysis patient.
Marques da Silva B, Oliveira J, Pereira M, Lopes JA, Pinto Abreu C |
CEN Case Reports | 2022 |
|
Vitamin D Regulation of Immune Function.
Bikle DD |
Current Osteoporosis Reports | 2022 |
|
Increased proinflammatory cytokines in tears correspond with conjunctival SARS-CoV-2 positivity in symptomatic COVID-19 patients.
Niedźwiedź A, Kawa M, Pius-Sadowska E, Kuligowska A, Ziontkowska A, Wrzałek D, Wiącek MP, Parczewski M, Ossowski A, Zielińska G, Safranow K, Kozłowski K, Machaliński B, Machalińska A |
Scientific Reports | 2022 |
|
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.
Zhu DY, Gorman MJ, Yuan D, Yu J, Mercado NB, McMahan K, Borducchi EN, Lifton M, Liu J, Nampanya F, Patel S, Peter L, Tostanoski LH, Pessaint L, Van Ry A, Finneyfrock B, Velasco J, Teow E, Brown R, Cook A, Andersen H, Lewis MG, Lauffenburger DA, Barouch DH, Alter G |
PLoS Biology | 2022 |
|
Comparison of Clinical Characteristics of COVID-19-Related and Unrelated Acute Stroke Patients During the COVID-19 Pandemic in Turkey.
Demirelli DS, Genc G, Basarir CI, Bulut S |
2022 | |
|
Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency.
Hamali HA, Saboor M, Dobie G, Madkhali AM, Akhter MS, Hakamy A, Al-Mekhlafi HM, Jackson DE, Matari YH, Mobarki AA |
Infection and drug resistance | 2022 |
|
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection
Romani L, Del Chierico F, Macari G, Pane S, Ristori MV, Guarrasi V, Gardini S, Pascucci GR, Cotugno N, Perno CF, Rossi P, Villani A, Bernardi S, Campana A, Palma P, Putignani L |
Frontiers in Cellular and Infection Microbiology | 2022 |
|
SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation
MacDougall M, El-Hajj Sleiman J, Beauchemin P, Rangachari M |
Frontiers in immunology | 2022 |
|
Adaptive Immune Responses and Immunity to SARS-CoV-2
Primorac D, Vrdoljak K, Brlek P, Pavelić E, Molnar V, Matišić V, Erceg Ivkošić I, Parčina M |
Frontiers in immunology | 2022 |
|
The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses
Kuijpers Y, Chu X, Jaeger M, Moorlag SJ, Koeken VA, Zhang B, de Nooijer A, Grondman I, Gupta MK, Janssen N, Mourits VP, de Bree LC, de Mast Q, van de Veerdonk FL, Joosten LA, Li Y, Netea MG, Xu CJ |
Frontiers in immunology | 2022 |
|
BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus
Soto JA, Díaz FE, Retamal-Díaz A, Gálvez NM, Melo-González F, Piña-Iturbe A, Ramírez MA, Bohmwald K, González PA, Bueno SM, Kalergis AM |
Human vaccines | 2022 |
|
Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview
Kudryavtsev I, Rubinstein A, Golovkin A, Kalinina O, Vasilyev K, Rudenko L, Isakova-Sivak I |
Viruses | 2022 |
|
Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses
Lyudovyk O, Kim JY, Qualls D, Hwee MA, Lin YH, Boutemine SR, Elhanati Y, Solovyov A, Douglas M, Chen E, Babady NE, Ramanathan L, Vedantam P, Bandlamudi C, Gouma S, Wong P, Hensley SE, Greenbaum B, Huang AC, Vardhana SA |
Cancer Cell | 2022 |
|
Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19
Legebeke J, Lord J, Penrice-Randal R, Vallejo AF, Poole S, Brendish NJ, Dong X, Hartley C, Holloway JW, Lucas JS, Williams AP, Wheway G, Strazzeri F, Gardner A, Schofield JP, Skipp PJ, Hiscox JA, Polak ME, Clark TW, Baralle D |
Frontiers in immunology | 2022 |
|
A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection
Vahdat S |
2022 | |
|
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness
Morrell ED, Bhatraju PK, Sathe NA, Lawson J, Mabrey L, Holton SE, Presnell SR, Wiedeman A, Acosta-Vega C, Mitchem MA, Liu T, Chai XY, Sahi S, Brager C, Orlov M, Sakr SS, Sader A, Lum DM, Koetje N, Garay A, Barnes E, Cromer G, Bray MK, Pipavath S, Fink SL, Evans L, Long SA, West TE, Wurfel MM, Mikacenic C |
AJP Lung Cellular and Molecular Physiology | 2022 |
|
Nervous system manifestations related to COVID-19 and their possible mechanisms
Xie Z, Hui H, Zhao Z, Yu W, Wu R, Zhu Y, Song Y, Cao B, Shi W, Zhao D, Zhao Y, Lv J, Yao Q, Duan Y, Li J, Zhang H, Zhou L, Wang X, Tian Y, Zhao G |
Brain Research Bulletin | 2022 |
|
Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies
Latifi-Pupovci H |
Biomedicine & Pharmacotherapy | 2022 |
|
Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals
Beliakova-Bethell N, Maruthai K, Xu R, Salvador LC, Garg A |
Frontiers in immunology | 2022 |
|
Cyanidin-3-O-glucoside and Peonidin-3-O-glucoside-Rich Fraction of Black Rice Germ and Bran Suppresses Inflammatory Responses from SARS-CoV-2 Spike Glycoprotein S1-Induction In Vitro in A549 Lung Cells and THP-1 Macrophages via Inhibition of the NLRP3 Inflammasome Pathway
Semmarath W, Mapoung S, Umsumarng S, Arjsri P, Srisawad K, Thippraphan P, Yodkeeree S, Dejkriengkraikul P |
Nutrients | 2022 |
|
The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
Moga E, Lynton-Pons E, Domingo P |
Frontiers in immunology | 2022 |
|
The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection
Xu Z, Jiang X, Dai X, Li B |
Frontiers in immunology | 2022 |
|
Can iron, zinc, copper and selenium status be a prognostic determinant in COVID-19 patients?
Engin AB, Engin ED, Engin A |
Environmental Toxicology and Pharmacology | 2022 |
|
Proteomic and Metabolomic Characterization of SARS-CoV-2-Infected Cynomolgus Macaque at Early Stage
Wang T, Miao F, Lv S, Li L, Wei F, Hou L, Sun R, Li W, Zhang J, Zhang C, Yang G, Xiang H, Meng K, Wan Z, Wang B, Feng G, Zhao Z, Luo D, Li N, Tu C, Wang H, Xue X, Liu Y, Gao Y |
Frontiers in immunology | 2022 |
|
Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond
Faist A, Janowski J, Kumar S, Hinse S, Çalışkan DM, Lange J, Ludwig S, Brunotte L |
Cells | 2022 |
|
Practical Applicability of the ISARIC-4C Score on Severity and Mortality due to SARS-CoV-2 Infection in Patients with Type 2 Diabetes
Albai O, Frandes M, Sima A, Timar B, Vlad A, Timar R |
Medicina | 2022 |
|
Is the epithelial barrier hypothesis the key to understanding the higher incidence and excess mortality during COVID-19 pandemic? The case of Northern Italy.
Fiorito S, Soligo M, Gao Y, Ogulur I, Akdis CA, Bonini S |
Allergy | 2022 |
|
COVID-19 and plasma cells: Is there long-lived protection?
Nguyen DC, Lamothe PA, Woodruff MC, Saini AS, Faliti CE, Sanz I, Lee FE |
Immunological Reviews | 2022 |
|
Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2.
Gallo V, Arienzo A, Iacobelli S, Iacobelli V, Antonini G |
International journal of molecular sciences | 2022 |
|
Neutrophilic inflammation promotes SARS-CoV-2 infectivity and augments the inflammatory responses in airway epithelial cells
Calvert B, Quiroz E, Lorenzana Z, Doan N, Kim S, Senger C, Wallace W, Salomon M, Henley J, Ryan A |
2022 | |
|
Emerging complications of COVID-19 in a subset of Indian population: a pathological review with clinico-radiological case scenarios
Agarwal A, Prachi, Haider A, Lalit E, Agarwal AK, Agarwal S |
The Egyptian Journal of Radiology and Nuclear Medicine | 2022 |
|
Cellular therapies for the treatment and prevention of SARS-CoV-2 infection
Conway SR, Keller MD, Bollard CM |
Blood | 2022 |
|
Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies
Premeaux TA, Yeung ST, Bukhari Z, Bowler S, Alpan O, Gupta R, Ndhlovu LC |
Frontiers in immunology | 2022 |
|
COVID-19-associated Isolated Cortical Vein Thrombosis: Detection of SARS‐CoV‐2 in CSF
Oktar AÇ, Göçgün N, Yaşgüçlükal MA, Bayar MD, Alaçam S, Karabulut N, Duman EB, Şişman B, Baştan B, Balcı BP, Çokar Ö |
The Neurohospitalist | 2022 |
|
A retrospective cohort study of 238,000 COVID-19 hospitalizations and deaths in Brazil
Sobral MF, Roazzi A, da Penha Sobral AI, de Oliveira BR, Duarte GB, da Silva JF, Nogueira RM |
Scientific Reports | 2022 |
|
KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19
Li J, Zaslavsky M, Su Y, Guo J, Sikora MJ, van Unen V, Christophersen A, Chiou SH, Chen L, Li J, Ji X, Wilhelmy J, McSween AM, Palanski BA, Mallajosyula VV, Bracey NA, Dhondalay GK, Bhamidipati K, Pai J, Kipp LB, Dunn JE, Hauser SL, Oksenberg JR, Satpathy AT, Robinson WH, Dekker CL, Steinmetz LM, Khosla C, Utz PJ, Sollid LM, Chien YH, Heath JR, Fernandez-Becker NQ, Nadeau KC, Saligrama N, Davis MM |
Science (New York, N.Y.) | 2022 |
|
Lymphopenia in patients affected by SARS-CoV-2 infection is caused by margination of lymphocytes in large bowel: an [18F]FDG PET/CT study
Signore A, Lauri C, Colandrea M, Di Girolamo M, Chiodo E, Grana CM, Campagna G, Aceti A |
European Journal of Nuclear Medicine and Molecular Imaging | 2022 |
|
Acute neuromuscular syndromes with respiratory failure during COVID-19 pandemic: Where we stand and challenges ahead
Galassi G, Marchioni A |
Journal of Clinical Neuroscience | 2022 |
|
2D MXenes for combatting COVID-19 Pandemic: A perspective on latest developments and innovations
Panda S, Deshmukh K, Mustansar Hussain C, Khadheer Pasha SK |
2022 | |
|
Effectiveness of corticosteroids to treat coronavirus disease 2019 symptoms: A meta-analysis
Zeng Y, Zeng W, Yang B, Liu Z |
2022 | |
|
HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
Ripamonti C, Spadotto V, Pozzi P, Stevenazzi A, Vergani B, Marchini M, Sandrone G, Bonetti E, Mazzarella L, Minucci S, Steinkühler C, Fossati G |
Frontiers in immunology | 2022 |
|
Single-cell RNA sequencing reveals immunological rewiring at the maternal-fetal interface following asymptomatic/mild SARS-CoV-2 infection
Sureshchandra S, Zulu MZ, Doratt BM, Jankeel A, Tifrea D, Edwards R, Rincon M, Marshall NE, Messaoudi I |
Cell Reports | 2022 |
|
Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection
Rasmi Y, Hatamkhani S, Naderi R, Shokati A, Nayeb Zadeh V, Hosseinzadeh F, Farnamian Y, Jalali L |
Acta Histochemica | 2022 |
|
SARS-CoV-2 infects human cardiomyocytes promoted by inflammation and oxidative stress
Tangos M, Budde H, Kolijn D, Sieme M, Zhazykbayeva S, Lódi M, Herwig M, Gömöri K, Hassoun R, Robinson EL, Meister TL, Jaquet K, Kovács Á, Mustroph J, Evert K, Babel N, Fagyas M, Lindner D, Püschel K, Westermann D, Mannherz HG, Paneni F, Pfaender S, Tóth A, Mügge A, Sossalla S, Hamdani N |
International Journal of Cardiology | 2022 |
|
Review on acute pancreatitis attributed to COVID-19 infection
Onoyama T, Koda H, Hamamoto W, Kawahara S, Sakamoto Y, Yamashita T, Kurumi H, Kawata S, Takeda Y, Matsumoto K, Isomoto H |
World Journal of Gastroenterology | 2022 |
|
Resistance Training before, during, and after COVID-19 Infection: What Have We Learned So Far?
Gentil P, de Lira CA, Vieira CA, Ramirez-Campillo R, Haghighi AH, Clemente FM, Souza D |
International journal of environmental research and public health | 2022 |
|
Do the Successive Waves of SARS-CoV-2, Vaccination Status and Place of Infection Influence the Clinical Picture and COVID-19 Severity among Patients with Persistent Clinical Symptoms? The Retrospective Study of Patients from the STOP-COVID Registry of the PoLoCOV-Study
Chudzik M, Babicki M, Kapusta J, Kołat D, Kałuzińska Ż, Mastalerz-Migas A, Jankowski P |
Journal of Personalized Medicine | 2022 |
|
Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels
Caufriez A, Tabernilla A, Van Campenhout R, Cooreman A, Leroy K, Sanz Serrano J, Kadam P, dos Santos Rodrigues B, Lamouroux A, Ballet S, Vinken M |
International journal of molecular sciences | 2022 |
|
Ischemic Stroke and SARS-CoV-2 Infection: The Bidirectional Pathology and Risk Morbidities
Chavda V, Chaurasia B, Fiorindi A, Umana GE, Lu B, Montemurro N |
Neurology international | 2022 |
|
Disengaging the COVID-19 Clutch as a Discerning Eye Over the Inflammatory Circuit During SARS-CoV-2 Infection
Anwar MM, Sah R, Shrestha S, Ozaki A, Roy N, Fathah Z, Rodriguez-Morales AJ |
Inflammation | 2022 |
|
The DNA glycosylase NEIL2 plays a vital role in combating SARS-CoV-2 infection
Hazra T, Tapryal N, Chakraborty A, Rayavara K, Wakamiya M, Islam A, Pan L, Hsu J, Tat V, Maruyama J, Hosoki K, Sayed I, Alcantara J, Castillo V, Tindle C, Sarker A, Cardenas V, Sharma G, Alexander LC, Sur S, Ghosh G, Paessler S, Sahoo D, Ghosh P, Das S, Boldogh I, Tseng CT |
Research square | 2022 |
|
A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine
Adam A, Shi Q, Wang B, Zou J, Mai J, Osman SR, Wu W, Xie X, Aguilar PV, Bao X, Shi PY, Shen H, Wang T |
Translational Research | 2022 |
|
Deciphering the balance of IL-6/IL-10 cytokines in severe to critical COVID-19 patients
Azaiz MB, Jemaa AB, Sellami W, Romdhani C, Ouslati R, Gharsallah H, Ghazouani E, Ferjani M |
Immunobiology | 2022 |
|
Evaluation and Comparison of Mucormycosis Patients' Features Undergoing Functional Endoscopic Sinus Surgery Prior to and during the COVID-19 Pandemic: A Case-Control Study
Dehghanpisheh L, Eghbal M, Salari M, Shahriarirad R, Borzou N, Vatankhah P |
International Journal of Clinical Practice | 2022 |
|
Can natural products modulate cytokine storm in SARS-CoV2 patients?
Abou Baker DH |
Biotechnology Reports | 2022 |
|
Comparison of COVID-19 Induced Respiratory Failure and Typical ARDS: Similarities and Differences
Lu S, Huang X, Liu R, Lan Y, Lei Y, Zeng F, Tang X, He H |
Frontiers in Medicine | 2022 |
|
Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients
Ali ET, Sajid Jabbar A, Al Ali HS, Shaheen Hamadi S, Jabir MS, Albukhaty S |
International Journal of Inflammation | 2022 |
|
Nitrogen dioxide pollution increases vulnerability to COVID-19 through altered immune function
Di Ciaula A, Bonfrate L, Portincasa P, Appice C, Belfiore A, Binetti M, Cafagna G, Campanale G, Carrieri A, Cascella G, Cataldi S, Cezza A, Ciannarella M, Cicala L, D\u2019Alitto F, Dell\u2019Acqua A, Dell\u2019Anna L, Diaferia M, Erroi G, Fiermonte F, Galerati I, Giove M, Grimaldi L, Mallardi C, Mastrandrea E, Mazelli GD, Mersini G, Messina G, Messina M, Montesano A, Noto A, Novielli ME, Noviello M, Palma MV, Palmieri VO, Passerini F, Perez F, Piro C, Prigigallo F, Pugliese S, Rossi O, Stasi C, Stranieri R, Vitariello G |
Environmental Science and Pollution Research | 2022 |
|
Healing Field: Using Alternating Electric Fields to Prevent Cytokine Storm by Suppressing Clonal Expansion of the Activated Lymphocytes in the Blood Sample of the COVID-19 Patients
Abadijoo H, Khayamian MA, Faramarzpour M, Ghaderinia M, Simaee H, Shalileh S, Yazdanparast SM, Ghabraie B, Makarem J, Sarrami-Forooshani R, Abdolahad M |
Frontiers in Bioengineering and Biotechnology | 2022 |
|
Cognitive after-effects and associated correlates among post-illness COVID-19 survivors: a cross-sectional study, Egypt
Abdelghani M, Atwa SA, Said A, Zayed NE, Abdelmoaty AA, Hassan MS |
2022 | |
|
Elevated Levels of Pleiotropic Interleukin-6 (IL-6) and Interleukin-10 (IL-10) are Critically Involved With the Severity and Mortality of COVID-19: An Updated Longitudinal Meta-Analysis and Systematic Review on 147 Studies
Jafrin S, Aziz MA, Islam MS |
Biomarker insights | 2022 |
|
Increased respiratory dead space could associate with coagulation activation and poor outcomes in COVID-19 ARDS
Graf J, Pérez R, López R |
Journal of Critical Care | 2022 |
|
Dexamethasone: a corticosteroid drug for the treatment of coronavirus disease 2019
Riaz M, Akram M, Egbuna C, Olatunde A, Tijjani H, Adetunji CO, Ifemeje JC, Patrick-Iwuanyanwu KC, Shivamallu C, Olisah MC, Uche CZ, Chikwendu JC |
2022 | |
|
C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19
Giner-Galvañ V, Pomares-Gómez FJ, Quesada JA, Rubio-Rivas M, Tejada-Montes J, Baltasar-Corral J, Taboada-Martínez ML, Sánchez-Mesa B, Arnalich-Fernández F, Del Corral-Beamonte E, López-Sampalo A, Pesqueira-Fontán PM, Fernández-Garcés M, Gómez-Huelgas R, Ramos-Rincón JM |
Biomedicines | 2022 |
|
Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets
Russo A, Morrone HL, Rotundo S, Trecarichi EM, Torti C |
Diagnostics | 2022 |
|
Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection
Wiech M, Chroscicki P, Swatler J, Stepnik D, De Biasi S, Hampel M, Brewinska-Olchowik M, Maliszewska A, Sklinda K, Durlik M, Wierzba W, Cossarizza A, Piwocka K |
Frontiers in immunology | 2022 |
|
Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients
Cugno M, Meroni PL, Consonni D, Griffini S, Grovetti E, Novembrino C, Torri A, Griffante G, Gariglio M, Varani L, Peyvandi F |
Microorganisms | 2022 |
|
Potential Role of Certain Biomarkers Such as Vitamin B12, ROS, Albumin, as Early Predictors for Prognosis of COVID-19 Outcomes
Lymperaki E, Kazeli K, Variti G, Gerothanasi M, Gkinoudis A, Tsamesidis I, Vagdatli E |
Medicines | 2022 |
|
Evaluation of the Effect of Biochemistry Parameters on the Clinical Course in COVID-19 Patients Who Received Tocilizumab Treatment
Duksal F, Burnik C, Mermer M, Yavuz S |
Southern Medical Journal | 2022 |
|
Cytokines and microRNAs in SARS-CoV-2: What do we know?
Rarani FZ, Rashidi B, Jafari Najaf Abadi MH, Hamblin MR, Reza Hashemian SM, Mirzaei H |
2022 | |
|
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
Feyaerts D, Hédou J, Gillard J, Chen H, Tsai ES, Peterson LS, Ando K, Manohar M, Do E, Dhondalay GK, Fitzpatrick J, Artandi M, Chang I, Snow TT, Chinthrajah RS, Warren CM, Wittman R, Meyerowitz JG, Ganio EA, Stelzer IA, Han X, Verdonk F, Gaudillière DK, Mukherjee N, Tsai AS, Rumer KK, Jacobsen DR, Bjornson-Hooper ZB, Jiang S, Saavedra SF, Valdés Ferrer SI, Kelly JD, Furman D, Aghaeepour N, Angst MS, Boyd SD, Pinsky BA, Nolan GP, Nadeau KC, Gaudillière B, McIlwain DR |
Cell reports. Medicine | 2022 |
|
Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19
Zhao W, Chen W, Li J, Chen M, Li Q, Lv M, Zhou S, Bai S, Wang Y, Zhang L, Zhang P, Wang J, Zheng Q, Wu J |
mBio | 2022 |
|
Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
Shah T, Shah Z, Yasmeen N, Baloch Z, Xia X |
Frontiers in immunology | 2022 |
|
Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With Coronavirus Disease-19
Rabbani A, Rafique A, Wang X, Campbell D, Wang D, Brownell N, Capdevilla K, Garabedian V, Chaparro S, Herrera R, Parikh RV, Ardehali R |
Frontiers in Cardiovascular Medicine | 2022 |
|
Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19
Hong L, He M, Li S, Zhao J |
Chinese medicine | 2022 |
|
NKG2A Expression among CD8 Cells Is Associated with COVID-19 Progression in Hypertensive Patients: Insights from the BRACE CORONA Randomized Trial
Moll-Bernardes R, Fortier SC, Sousa AS, Lopes RD, Vera N, Conde L, Feldman A, Arruda G, Cabral-Castro M, Albuquerque DC, Paula TC, Furquim T, Loures VA, Giusti K, Oliveira N, Macedo A, Barros e Silva P, De Luca F, Kotsugai M, Domiciano R, Silva FA, Santos MF, Souza OF, Bozza FA, Luiz RR, Medei E |
Journal of Clinical Medicine | 2022 |
|
Diagnosis and Prognosis of COVID-19 Disease Using Routine Blood Values and LogNNet Neural Network
Huyut MT, Velichko A |
Sensors (Basel, Switzerland) | 2022 |
|
Epigenetic activation of antiviral sensors and effectors of interferon response pathways during SARS-CoV-2 infection
Bińkowski J, Taryma-Leśniak O, Łuczkowska K, Niedzwiedź A, Lechowicz K, Strapagiel D, Jarczak J, Davalos V, Pujol A, Esteller M, Kotfis K, Machaliński B, Parczewski M, Wojdacz TK |
Biomedicine & Pharmacotherapy | 2022 |
|
Potential role of biochemical markers in the prognosis of COVID-19 patients
Niraula A, Baral N, Lamsal M, Bataju M, Thapa S |
SAGE Open Medicine | 2022 |
|
Mediators of Obesity Do Not Influence SARS-CoV-2 Infection or Activation of Primary Human Lung Microvascular Endothelial Cells In Vitro
ter Ellen BM, Niewold J, Flikweert A, Muller Kobold AC, Heeringa P, van Meurs M, Smit JM, van der Voort PH, Rodenhuis-Zybert IA, Moser J |
Frontiers in immunology | 2022 |
|
Comparison between clinical characteristics and laboratory findings among patients with complicated and noncomplicated SARS‐CoV‐2 infection: A single‐center experience from Shebin Al‐Kom, Egypt
Fadda WA, Al\u2010Batanony MA, Aboukhalil RE, Khader HF, Al Rugaie O |
Immunity, Inflammation and Disease | 2022 |
|
Antiphospholipid antibodies and vitamin D deficiency in COVID-19 infection with and without venous or arterial thrombosis: A pilot case-control study
Shah R, Mohammed YN, Koehler TJ, Kaur J, Toufeili M, Pulipati P, Alqaysi A, Khan A, Khalid M, Lee Y, Dhillon P, Dan AT, Kumar N, Bowen M, Sule AA, Krishnamoorthy G |
PloS one | 2022 |
|
COVID-19: Clinical laboratory diagnosis and monitoring of novel coronavirus infected patients using molecular, serological and biochemical markers: A review
Rasool G, Riaz M, Abbas M, Fatima H, Qamar MM, Zafar F, Mahmood Z |
International journal of immunopathology and pharmacology | 2022 |
|
In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19
Viurcos-Sanabria R, Manjarrez-Reyna AN, Solleiro-Villavicencio H, Rizo-Téllez SA, Méndez-García LA, Viurcos-Sanabria V, González-Sanabria J, Arroyo-Valerio A, Carrillo-Ruíz JD, González-Chávez A, León-Pedroza JI, Flores-Mejía R, Rodríguez-Cortés O, Escobedo G |
Frontiers in immunology | 2022 |
|
Management of Severe and Critical COVID-19 Infection with Immunotherapies
Athale J, Gallagher J, Busch LM |
Infectious Disease Clinics of North America | 2022 |
|
Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report
Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M, Farjad R |
European journal of ophthalmology | 2022 |
|
Association of vitamin D and severity of COVID-19 in children
Karimian P, Tahami MS, Sayyahfar S, Delavar MA |
European Journal of Translational Myology | 2022 |
|
CoVITEST: A Fast and Reliable Method to Monitor Anti-SARS-CoV-2 Specific T Cells From Whole Blood
Egri N, Olivé V, Hernández-Rodríguez J, Castro P, De Guzman C, Heredia L, Segura AC, Fernandez MD, de Moner N, Torradeflot M, Ballús J, Martinez R, Vazquez M, Costa MV, Dobaño C, Mazza M, Mazzotti L, Pascal M, Juan M, González-Navarro EA, Calderón H |
Frontiers in immunology | 2022 |
|
Inflammatory and thrombotic parameters associated with the COVID-19 course in Poland (SARSTer study)
Czupryna P, Moniuszko-Malinowska A, Rogalska M, Zarębska-Michaluk D, Lorenc B, Rorat M, Kozielewicz D, Tudrujek-Zdunek M, Sikorska K, Berkan-Kawińska A, Bolewska B, Mazur W, Kowalska J, Oczko-Grzesik B, Podlasin R, Piekarska A, Kłos K, Szymczak A, Leszczyński P, Maciejewska K, Pancewicz S, Jaroszewicz J, Milewski R, Groth M, Flisiak R |
Advances in Medical Sciences | 2022 |
|
Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19
Yong YK, Wong WF, Vignesh R, Chattopadhyay I, Velu V, Tan HY, Zhang Y, Larsson M, Shankar EM |
Frontiers in immunology | 2022 |
|
Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
Qu W, Wang Z, Engelberg-Cook E, Yan D, Siddik AB, Bu G, Allickson JG, Kubrova E, Caplan AI, Hare JM, Ricordi C, Pepine CJ, Kurtzberg J, Pascual JM, Mallea JM, Rodriguez RL, Nayfeh T, Saadi S, Durvasula RV, Richards EM, March K, Sanfilippo FP |
Stem Cells Translational Medicine | 2022 |
|
Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19
Schroeder PH, Brenner LN, Kaur V, Cromer SJ, Armstrong K, LaRocque RC, Ryan ET, Meigs JB, Florez JC, Charles RC, Mercader JM, Leong A |
Cardiovascular Diabetology | 2022 |
|
COVID-19 and liver diseases
Elghannam MT, Hassanien MH, Ameen YA, ELattar GM, ELRay AA, Turky EA, ELTalkawy MD |
Egyptian Liver Journal | 2022 |
|
Prediabetes Induces More Severe Acute COVID-19 Associated With IL-6 Production Without Worsening Long-Term Symptoms
Bonyek-Silva I, Cerqueira-Silva T, Nunes S, Machado AF, Cruz MR, Pereira B, Estrela L, Silva J, Isis A, Barral A, Oliveira PR, Khouri R, Serezani CH, Brodskyn C, Caldas JR, Barral-Netto M, Boaventura V, Tavares NM |
Frontiers in Endocrinology | 2022 |
|
The Association Between Vitamin D Serum Level and COVID-19 Patients’ Outcomes in a Tertiary Center in Saudi Arabia: A Retrospective Cohort Study
Alzahrani MA, Almalki F, Aljohani A, Alharbi B, Alsulami B, Alhaddad A, Althubaiti A, Khawaji B, Farahat F |
Cureus | 2022 |
|
The Associations between Cytokine Levels, Kidney and Heart Function Biomarkers, and Expression Levels of Angiotensin-Converting Enzyme-2 and Neuropilin-1 in COVID-19 Patients
Sultan RH, Abdallah M, Ali TM, Ahmed AE, Assal HH, Elesawy BH, Ahmed OM |
Human vaccines | 2022 |
|
Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models
Khalil MA, El-Ansary MR, Bassyouni RH, Mahmoud EE, Ali IA, Ahmed TI, Hassan EA, Samir TM |
Diagnostics | 2022 |
|
Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies
Huang X, Liang X, Zhang J, Su H, Chen Y |
Journal of Clinical Medicine | 2022 |
|
Correlations between Kidney and Heart Function Bioindicators and the Expressions of Toll-Like, ACE2, and NRP-1 Receptors in COVID-19
Sultan RH, Elesawy BH, Ali TM, Abdallah M, Assal HH, Ahmed AE, Ahmed OM |
Human vaccines | 2022 |
|
Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19
Chaudhary JK, Saini D, Chaudhary PK, Maurya A, Verma GK, Gupta AK, Roshan R, Vats TK, Garg N, Yadav D, Kant N, Meena AK, Mirza-Shariff AA |
Cells | 2022 |
|
Prognosing the risk of COVID-19 death through a machine learning-based routine blood panel: A retrospective study in Brazil
Araújo DC, Veloso AA, Borges KB, Carvalho MD |
International journal of medical informatics | 2022 |
|
Study on Hydroxychloroquinine Sulfate Being Given to the Admitted COVID -19 Positive Patients at Institute of JLNMCH, Bhagalpur, Bihar, India
Choudhary R, Ali O, Singh BK |
Cureus | 2022 |
|
Vitamin D and the Ability to Produce 1,25(OH)2D Are Critical for Protection from Viral Infection of the Lungs
Arora J, Patel DR, Nicol MJ, Field CJ, Restori KH, Wang J, Froelich NE, Katkere B, Terwilliger JA, Weaver V, Luley E, Kelly K, Kirimanjeswara GS, Sutton TC, Cantorna MT |
Nutrients | 2022 |
|
Plasticity of natural killer cells in pregnant patients infected with SARS-CoV-2 and their neonates during childbirth
Carbonnel M, Daclin C, Tarantino N, Groiseau O, Morin V, Rousseau A, Vasse M, Hertig A, Kennel T, Ayoubi JM, Vieillard V |
Frontiers in immunology | 2022 |
|
COVID-19 imparted immune manifestation can be combated by NLGP: Lessons from cancer research
Bose A, Baral R |
Cytokine | 2022 |
|
Pyroptotic Patterns in Blood Leukocytes Predict Disease Severity and Outcome in COVID-19 Patients
Tang Y, Zhang P, Liu Q, Cao L, Xu J |
Frontiers in immunology | 2022 |
|
Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis
Maleknia S, Tavassolifar MJ, Mottaghitalab F, Zali MR, Meyfour A |
Molecular Medicine | 2022 |
|
The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1
Whyte CS, Simpson M, Morrow GB, Wallace CA, Mentzer AJ, Knight JC, Shapiro S, Curry N, Bagot CN, Watson H, Cooper JG, Mutch NJ |
Journal of Thrombosis and Haemostasis | 2022 |
|
Alterations in CD39/CD73 axis of T cells associated with COVID‐19 severity
Dorneles GP, Teixeira PC, da Silva IM, Schipper LL, Santana Filho PC, Rodrigues Junior LC, Bonorino C, Peres A, Fonseca SG, Monteiro MC, Boeck CR, Eller S, Oliveira TF, Wendland EM, Romão PR |
Journal of Cellular Physiology | 2022 |
|
A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond
Shapira S, Ben Shimon M, Hay\u2010Levi M, Shenberg G, Choshen G, Bannon L, Tepper M, Kazanov D, Seni J, Lev\u2010Ari S, Peer M, Boubas D, Stebbing J, Tsiodras S, Arber N |
EMBO Molecular Medicine | 2022 |
|
Single‐cell transcriptomic atlas reveals distinct immunological responses between COVID‐19 vaccine and natural SARS‐CoV‐2 infection
Wang Y, Wang X, Luu LD, Li J, Cui X, Yao H, Chen S, Fu J, Wang L, Wang C, Yuan R, Cai Q, Huang X, Huang J, Li Z, Li S, Zhu X, Tai J |
Journal of Medical Virology | 2022 |
|
The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update
Jasim SA, Mahdi RS, Bokov DO, Najm MA, Sobirova GN, Bafoyeva ZO, Taifi A, Alkadir OK, Mustafa YF, Mirzaei R, Karampoor S |
Journal of Medical Virology | 2022 |
|
Immunological evaluation of patients with 2019 novel coronavirus pneumonia: CD4+ and CD16+ cells may predict severity and prognosis
Alahyari S, Rajaeinejad M, Jalaeikhoo H, Chegini L, Almasi Aghdam M, Asgari A, Nasiri M, Khoshdel A, Faridfar A |
PloS one | 2022 |
|
Immunomodulatory mechanisms of abatacept: A therapeutic strategy for COVID-19
Yang D, Li H, Chen Y, Ren W, Dong M, Li C, Jiao Q |
Frontiers in Medicine | 2022 |
|
Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19
Philippe A, Puel M, Narjoz C, Gendron N, Durey-Dragon MA, Vedie B, Balduyck M, Chocron R, Hauw-Berlemont C, Sanchez O, Mirault T, Diehl JL, Smadja DM, Loriot MA |
Biochimie | 2022 |
|
Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use
Foletto VS, da Rosa TF, Serafin MB, Hörner R |
European Journal of Clinical Pharmacology | 2022 |
|
Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies
Wu S, Xu Y, Zhang J, Ran X, Jia X, Wang J, Sun L, Yang H, Li Y, Fu B, Huang C, Liao P, Sun W |
Frontiers in immunology | 2022 |
|
Roles of RNA Sensors in Host Innate Response to Influenza Virus and Coronavirus Infections
Li W, Wang H, Zheng SJ |
International journal of molecular sciences | 2022 |
|
Clinical, virological, imaging and pathological findings in a SARS CoV-2 antibody positive cat
Ozer K, Yilmaz A, Carossino M, Yuzbasioglu Ozturk G, Erdogan Bamac O, Tali HE, Mahzunlar E, Cizmecigil UY, Aydin O, Tali HB, Yilmaz SG, Mutlu Z, Kekec AI, Turan N, Gurel A, Balasuriya U, Iqbal M, Richt JA, Yilmaz H |
Journal of Veterinary Science | 2022 |
|
Innate immunity to SARS-CoV-2 infection: a review
Silva MJ, Rodrigues YC, Lima KV, Lima LN |
Epidemiology and Infection | 2022 |
|
Mortality-Related Risk Factors for Coronavirus Disease (COVID-19)-Associated Mucormycosis: a systematic review and meta-analysis
Ostovan VR, Tabrizi R, Bazrafshan H, Bahrami Z, Khazraei H, Khazraei S, Borhani-Haghighi A, Moghadami M, Grant M |
Current Fungal Infection Reports | 2022 |
|
Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation
Beirag N, Kumar C, Madan T, Shamji MH, Bulla R, Mitchell D, Murugaiah V, Neto MM, Temperton N, Idicula-Thomas S, Varghese PM, Kishore U |
Frontiers in immunology | 2022 |
|
Pulmonary cryptococcosis after recovery from COVID-19 in an immunocompetent patient: A rare case report
Choi HS |
Medicine | 2022 |
|
Hyponatremia and SARS-CoV-2 infection: A narrative review
Habas E, Ali E, Habas A, Rayani A, Ghazouani H, Khan F, Farfar K, Elzouki AN |
Medicine | 2022 |
|
Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohort
Vigón L, Galán M, Torres M, Martín-Galiano AJ, Rodríguez-Mora S, Mateos E, Corona M, Malo R, Navarro C, Murciano-Antón MA, García-Gutiérrez V, Planelles V, Martínez-Laso J, López-Huertas MR, Coiras M |
PloS one | 2022 |
|
Redox stress in COVID-19: Implications for hematologic disorders
Yang M |
Best practice & research. Clinical haematology | 2022 |
|
Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning.
Zucco AG, Agius R, Svanberg R, Moestrup KS, Marandi RZ, MacPherson CR, Lundgren J, Ostrowski SR, Niemann CU |
Scientific Reports | 2022 |
|
Advances in cell death mechanisms involved in viral myocarditis
Yang Y, Li W, You B, Zhou C |
Frontiers in Cardiovascular Medicine | 2022 |
|
Inflammatory-Metal Profile as a Hallmark for COVID-19 Severity During Pregnancy
Vásquez-Procopio J, Espejel-Nuñez A, Torres-Torres J, Martinez-Portilla RJ, Espino Y. Sosa S, Mateu-Rogell P, Ortega-Castillo V, Tolentino-Dolores M, Perichart-Perera O, Franco-Gallardo JO, Carranco-Martínez JA, Prieto-Rodríguez S, Guzmán-Huerta M, Missirlis F, Estrada-Gutierrez G |
Frontiers in Cell and Developmental Biology | 2022 |
|
The dark side of Tregs during aging
Palatella M, Guillaume SM, Linterman MA, Huehn J |
Frontiers in immunology | 2022 |
|
Where do T cell subsets stand in SARS-CoV-2 infection: an update
Tarique M, Suhail M, Naz H, Muhammad N, Tabrez S, Zughaibi TA, Abuzenadah AM, Hashem AM, Shankar H, Saini C, Sharma A |
Frontiers in Cellular and Infection Microbiology | 2022 |
|
Impact of vitamin D level and supplementation on systemic lupus erythematosus patients during COVID-19 pandemic
Adel Y, Elgamal M, Adel Abdelsalam S |
Archives of rheumatology | 2022 |
|
Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics
Khalid Z, Huan M, Sohail Raza M, Abbas M, Naz Z, Kombe Kombe AJ, Zeng W, He H, Jin T |
Frontiers in microbiology | 2022 |
|
High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19
Tveita A, Murphy SL, Holter JC, Kildal AB, Michelsen AE, Lerum TV, Kaarbø M, Heggelund L, Holten AR, Finbråten AK, Müller KE, Mathiessen A, Bøe S, Fevang B, Granerud BK, Tonby K, Lind A, Dudman SG, Henriksen KN, Müller F, Skjønsberg OH, Trøseid M, Barratt-Due A, Dyrhol-Riise AM, Aukrust P, Halvorsen B, Dahl TB, Ueland T |
The Journal of Infectious Diseases | 2022 |
|
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model
Nobori H, Fukao K, Kuroda T, Anan N, Tashima R, Nakashima M, Noda S, Tajiri M, Torii M, Toba S, Uemura K, Sanaki T, Shishido T, Tachibana Y, Kato T |
Journal of Antimicrobial Chemotherapy | 2022 |
|
Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19
Adesse D, Gladulich L, Alvarez-Rosa L, Siqueira M, Marcos AC, Heider M, Motta CS, Torices S, Toborek M, Stipursky J |
Fluids and barriers of the CNS | 2022 |
|
Excessive neutrophil recruitment promotes typical T-helper 17 responses in Coronavirus disease 2019 patients
Choto TA, Makupe I, Cakana AZ, Sibanda EN, Mduluza T |
PloS one | 2022 |
|
Pulmonary cavitation in follow-up COVID 2019 cases: An etiological perspective
Singh P, Tiwari S, Yadav A, Singh S, Thareja S, Mohimen A, Dhull P, Ahuja NB, Mitra D |
Medical Journal Armed Forces India | 2022 |
|
Natural killer cell exhaustion in SARS-CoV-2 infection
Gallardo-Zapata J, Maldonado-Bernal C |
Innate immunity | 2022 |
|
Molecular Mimicry, Hyperactive Immune System, And SARS-COV-2 Are Three Prerequisites of the Autoimmune Disease Triangle Following COVID-19 Infection
Vahabi M, Ghazanfari T, Sepehrnia S |
International Immunopharmacology | 2022 |
|
T cell perturbations persist for at least 6 months following hospitalization for COVID-19
Govender M, Hopkins FR, Göransson R, Svanberg C, Shankar EM, Hjorth M, Nilsdotter-Augustinsson Å, Sjöwall J, Nyström S, Larsson M |
Frontiers in immunology | 2022 |
|
Publication trends of research on COVID-19 and host immune response: A bibliometric analysis
Xia Y, Yao RQ, Zhao PY, Tao ZB, Zheng LY, Zhou HT, Yao YM, Song XM |
Frontiers in public health | 2022 |
|
SARS-CoV-2-reactive IFN-γ-producing CD4+ and CD8+ T cells in blood do not correlate with clinical severity in unvaccinated critically ill COVID-19 patients
Olea B, Albert E, Giménez E, Torres I, Amat P, Remigia MJ, Alberola J, Carbonell N, Ferreres J, Blasco ML, Navarro D |
Scientific Reports | 2022 |
|
Utility of NO and H2S donating platforms in managing COVID-19: Rationale and promise
Oza PP, Kashfi K |
Nitric Oxide | 2022 |
|
Cytokine Storm Signature in Patients with Moderate and Severe COVID-19
Kalinina O, Golovkin A, Zaikova E, Aquino A, Bezrukikh V, Melnik O, Vasilieva E, Karonova T, Kudryavtsev I, Shlyakhto E |
International journal of molecular sciences | 2022 |
|
Vascular Implications of COVID-19: Role of Radiological Imaging, Artificial Intelligence, and Tissue Characterization: A Special Report
Khanna NN, Maindarkar M, Puvvula A, Paul S, Bhagawati M, Ahluwalia P, Ruzsa Z, Sharma A, Munjral S, Kolluri R, Krishnan PR, Singh IM, Laird JR, Fatemi M, Alizad A, Dhanjil SK, Saba L, Balestrieri A, Faa G, Paraskevas KI, Misra DP, Agarwal V, Sharma A, Teji J, Al-Maini M, Nicolaides A, Rathore V, Naidu S, Liblik K, Johri AM, Turk M, Sobel DW, Pareek G, Miner M, Viskovic K, Tsoulfas G, Protogerou AD, Mavrogeni S, Kitas GD, Fouda MM, Kalra MK, Suri JS |
Journal of Cardiovascular Development and Disease | 2022 |
|
Assessment of drugs administered in the Middle East as part of the COVID-19 management protocols
Elekhnawy E, Negm WA, El-Sherbeni SA, Zayed A |
InflammoPharmacology | 2022 |
|
Epicardial adipose tissue volume and CT-attenuation as prognostic factors for pulmonary embolism and mortality in critically ill patients affected by COVID-19
Rossi AP, Donadello K, Schweiger V, Zamboni GA, Valle ZD, Zamboni M, Polati E, Gottin L |
European Journal of Clinical Nutrition | 2022 |
|
Current Vaccine Platforms in Enhancing T-Cell Response
Ura T, Takeuchi M, Kawagoe T, Mizuki N, Okuda K, Shimada M |
Human vaccines | 2022 |
|
The radiographic assessment of lung edema score of lung edema severity correlates with inflammatory parameters in patients with coronavirus disease 2019—Potential new admission biomarkers to predict coronavirus disease 2019 worsening
Marques P, Fernandez-Presa L, Carretero A, Gómez-Cabrera MC, Viña J, Signes-Costa J, Sanz MJ |
Frontiers in Medicine | 2022 |
|
Defying convention in the time of COVID-19: Insights into the role of γδ T cells
Sanz M, Mann BT, Chitrakar A, Soriano-Sarabia N |
Frontiers in immunology | 2022 |
|
Comparison of SARS-CoV-2 spike RNA sequences in feces and nasopharynx indicates intestinal replication.
Beck-Friis T, Kärmander A, Nyström K, Wang H, Gisslén M, Andersson LM, Norder H |
Gut pathogens | 2022 |
|
The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms
Musazadeh V, Karimi A, bagheri N, Jafarzadeh J, Sanaie S, Vajdi M, Karimi M, Niazkar HR |
Biomedicine & Pharmacotherapy | 2022 |
|
Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza.
Pacheco-Hernández LM, Ramírez-Noyola JA, Gómez-García IA, Ignacio-Cortés S, Zúñiga J, Choreño-Parra JA |
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research | 2022 |
|
Mucormycosis co-infection in COVID-19 patients: An update
Alkhamiss AS, Ahmed AA, Rasheed Z, Alghsham R, Shariq A, Alsaeed T, Althwab SA, Alsagaby S, Aljohani AS, Alhumaydhi FA, Alduraibi SK, Alduraibi AK, Alhomaidan HT, Allemailem KS, Alharbi RA, Alamro SA, Alqusayer AM, Alharbi SA, Alharby TA, Almujaydil MS, Mousa AM, Alghaniam SA, Alghunaim AA, Alghamdi R, Fernández N, Al Abdulmonem W |
Open Life Sciences | 2022 |
|
Nutraceutical prospects of Houttuynia cordata against the infectious viruses
Ghosh A, Ghosh B, Parihar N, Ilaweibaphyrnai M, Panda SR, Alexander A, Chella N, Murty U, Naidu V, Kumar G J, Pemmaraju DB |
Food Bioscience | 2022 |
|
Bioinformatics analysis of potential pathogenesis and risk genes of immunoinflammation-promoted renal injury in severe COVID-19
Chen Z, Chen C, Chen F, Lan R, Lin G, Xu Y |
Frontiers in immunology | 2022 |
|
Novel skewed usage of B-cell receptors in COVID-19 patients with various clinical presentations
Ma J, Bai H, Gong T, Mao W, Nie Y, Zhang X, Da Y, Wang X, Qin H, Zeng Q, Hu F, Qi X, Shi B, Zhang C |
Immunology Letters | 2022 |
|
The landscape of potential health benefits of carotenoids as natural supportive therapeutics in protecting against Coronavirus infection
Lu LW, Gao Y, Quek SY, Foster M, Eason CT, Liu M, Wang M, Chen JH, Chen F |
Biomedicine & Pharmacotherapy | 2022 |
|
Human coronaviruses disassemble processing bodies
Kleer M, Mulloy RP, Robinson CA, Evseev D, Bui-Marinos MP, Castle EL, Banerjee A, Mubareka S, Mossman K, Corcoran JA |
PLoS pathogens | 2022 |
|
Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key
Khare K, Pandey R |
Frontiers in immunology | 2022 |
|
COVID-19 and Long-Term Outcomes: Lessons from Other Critical Care Illnesses and Potential Mechanisms
Arbov E, Tayara A, Wu S, Rich TC, Wagener BM |
American journal of respiratory cell and molecular biology | 2022 |
|
Intensive Care of Patients with COVID-19
Petrikov SS, Popugaev KA, Zhuravel\u2019 SV |
Herald of the Russian Academy of Sciences | 2022 |
|
Serum-derived extracellular vesicles: Novel biomarkers reflecting the disease severity of COVID-19 patients.
Tertel T, Tomić S, Đokić J, Radojević D, Stevanović D, Ilić N, Giebel B, Kosanović M |
Journal of Extracellular Vesicles | 2022 |
|
Study of Albumin Oxidation in COVID-19 Pneumonia Patients: Possible Mechanisms and Consequences.
Wybranowski T, Napiórkowska M, Bosek M, Pyskir J, Ziomkowska B, Cyrankiewicz M, Pyskir M, Pilaczyńska-Cemel M, Rogańska M, Kruszewski S, Przybylski G |
International journal of molecular sciences | 2022 |
|
Measuring T-Cell Responses against SARS-CoV-2 Is of Utility for Disease and Vaccination Management.
Safont G, Latorre I, Villar-Hernández R, Stojanovic Z, Marín A, Pérez-Cano C, Lacoma A, Molina-Moya B, Solis AJ, Arméstar F, Matllo J, Díaz-Fernández S, Cendón A, Sokalchuk L, Tolosa G, Casas I, Rosell A, Domínguez J |
Journal of Clinical Medicine | 2022 |
|
COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses.
Yi J, Miao J, Zuo Q, Owusu F, Dong Q, Lin P, Wang Q, Gao R, Kong X, Yang L |
Frontiers in immunology | 2022 |
|
Potential of ATR-FTIR-Chemometrics in Covid-19: Disease Recognition.
Calvo-Gomez O, Calvo H, Cedillo-Barrón L, Vivanco-Cid H, Alvarado-Orozco JM, Fernandez-Benavides DA, Arriaga-Pizano L, Ferat-Osorio E, Anda-Garay JC, López-Macias C, López MG |
ACS Omega | 2022 |
|
SARS-CoV-2 pneumonia and bacterial pneumonia patients differ in a second hit immune response model.
Moser D, Feuerecker M, Biere K, Han B, Hoerl M, Schelling G, Kaufmann I, Choukér A, Woehrle T |
Scientific Reports | 2022 |
|
In vitro Screening of Herbal Medicinal Products for Their Supportive Curing Potential in the Context of SARS-CoV-2
Tran HT, Peterburs P, Seibel J, Abramov-Sommariva D, Lamy E |
Evidence-based complementary and alternative medicine : eCAM | 2022 |
|
Role of serum IL-6 and TNF-α in coronavirus disease 2019 (COVID-19) associated renal impairment
Chen LD, Hu L, Song Y, Huang YP, Yang SJ, Yang J, Zhang XB |
2022 | |
|
Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
Svanberg R, MacPherson C, Zucco A, Agius R, Faitova T, Andersen MA, da Cunha-Bang C, Gjærde LK, Møller ME, Brooks PT, Lindegaard B, Sejdic A, Gang AO, Hersby DS, Brieghel C, Nielsen SD, Podlekareva D, Hald A, Bay JT, Marquart H, Lundgren J, Lebech AM, Helleberg M, Niemann CU, Ostrowski SR |
2022 | |
|
Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil
de Sá NB, Neira-Goulart M, Ribeiro-Alves M, Perazzo H, Geraldo KM, Ribeiro MP, Cardoso SW, Grinsztejn B, Veloso VG, Capão A, Siqueira MM, de Lima Bezerra OC, Garcia CC, Gomes LR, da Silva Cazote A, de Almeida DV, Giacoia-Gripp CB, Côrtes FH, Morgado MG |
BioMed Research International | 2022 |
|
Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients
Saleki K, Shirzad M, Javanian M, Mohammadkhani S, Alijani MH, Miri N, Oladnabi M, Azadmehr A |
Frontiers in immunology | 2022 |
|
Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
Montero C, Torres R, Benavidez C, Garcia P, Jimenez S, Yomayusa N, Gayon D, Perez J, Rosselli D, Restrepo H, Alvarez C |
2022 | |
|
Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients
Kudryavtsev IV, Arsentieva NA, Korobova ZR, Isakov DV, Rubinstein AA, Batsunov OK, Khamitova IV, Kuznetsova RN, Savin TV, Akisheva TV, Stanevich OV, Lebedeva AA, Vorobyov EA, Vorobyova SV, Kulikov AN, Sharapova MA, Pevtsov DE, Totolian AA |
Viruses | 2022 |
|
A Pilot Study to Examine If Dietary Habits Can Affect Symptomology in Mild Pre-Vaccination COVID-19 Cases.
McDaid KM, Chopra M |
Biology | 2022 |
|
Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review
Gianni P, Goldin M, Ngu S, Zafeiropoulos S, Geropoulos G, Giannis D |
World Journal of Experimental Medicine | 2022 |
|
Circulating multimeric immune complexes contribute to immunopathology in COVID-19
Ankerhold J, Giese S, Kolb P, Maul-Pavicic A, Voll RE, Göppert N, Ciminski K, Kreutz C, Lother A, Salzer U, Bildl W, Welsink T, Morgenthaler NG, Grawitz AB, Emmerich F, Steinmann D, Huzly D, Schwemmle M, Hengel H, Falcone V |
Nature Communications | 2022 |
|
Hemostatic system and COVID-19 crosstalk: A review of the available evidence
Wifi MN, Morad MA, El Sheemy R, Abdeen N, Afify S, Abdalgaber M, Abdellatef A, Zaghloul M, Alboraie M, El-Kassas M |
World Journal of Methodology | 2022 |
|
Immune responses to SARS-CoV-2 in dialysis and kidney transplantation
Cantarelli C, Angeletti A, Perin L, Russo LS, Sabiu G, Podestà MA, Cravedi P |
Clinical Kidney Journal | 2022 |
|
Correlation between thymic output and disease severity in critically ill COVID-19 patients: extended abstract
Marouf A, Cuvelier P, Roux H, Couëdel-Courteille A, Dutrieux J, Naudin C, Charmeteau de Muylder B, Cheynier R, Squara P, Marullo S |
2022 | |
|
Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection
de Almeida L, da Silva AL, Rodrigues TS, Oliveira S, Ishimoto AY, Seribelli AA, Becerra A, Andrade WA, Ataide MA, Caetano CC, de Sá KS, Pelisson N, Martins RB, de Paula Souza J, Arruda E, Batah SS, Castro R, Frantz FG, Cunha FQ, Cunha TM, Fabro AT, Cunha LD, Louzada-Junior P, de Oliveira RD, Zamboni DS |
Science Advances | 2022 |
|
A post-lockdown online cross-sectional survey on knowledge, attitude and anxiety levels of Nigerian youths towards COVID-19 disease
James BC, Aroh CM, Ede SS, Anyiam FE, Uhuo MI, Chullapant K, Osirim E, Nwojiji M |
The Pan African medical journal | 2022 |
|
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
Rey-Reñones C, Martinez-Torres S, Martín-Luján FM, Pericas C, Redondo A, Vilaplana-Carnerero C, Dominguez A, Grau M |
Biomedicines | 2022 |
|
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Lao US, Law CF, Baptista-Hon DT, Tomlinson B |
Journal of Clinical Medicine | 2022 |
|
Characteristics of COVID-19 Infection in a Hospitalized Autoimmune Hepatitis Patient
da Costa VD, Wiggers WJ, Ivantes CA, da Fonseca RJ, Dávila AM, Moreira OC, Ferreira BI, de Paula VS, da Silva LL, Santos AC, Villar LM |
Pathogens | 2022 |
|
Ivermectin-Induced Clinical Improvement and Alleviation of Significant Symptoms of COVID-19 Outpatients: A Cross-Sectional Study
Niaee MS, Zolghadr L, Hosseinkhani Z, Namdar P, Allami A, Amini F, Varnaseri M, Pourdast A, Gheibi N |
2022 | |
|
SARS-CoV-2-specicific humoral immunity in convalescent patients with mild COVID-19 is supported by CD4+ T-cell help and negatively correlated with Alphacoronavirus-specific antibody titer
Odendahl M, Endler I, Haubold B, Rodionov RN, Bornstein SR, Tonn T |
Immunology Letters | 2022 |
|
Atypical Hemolytic Uremic Syndrome after SARS-CoV-2 Infection: Report of Two Cases
Smarz-Widelska I, Syroka-Główka M, Janowska-Jaremek J, Kozioł MM, Załuska W |
International journal of environmental research and public health | 2022 |
|
COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity
Daamen AR, Bachali P, Bonham CA, Somerville L, Sturek JM, Grammer AC, Kadl A, Lipsky PE |
Frontiers in immunology | 2022 |
|
Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
Wei X, Rong N, Liu J |
Frontiers in immunology | 2022 |
|
Rhino-orbital-cerebral mucormycosis as a complication of coronavirus disease 2019
Al-Ani RM |
World Journal of Virology | 2022 |
|
Acute kidney injury and electrolyte disorders in COVID-19
Nogueira GM, Silva NL, Moura AF, Duarte Silveira MA, Moura-Neto JA |
World Journal of Virology | 2022 |
|
Tissue factor in COVID-19-associated coagulopathy
Subramaniam S, Kothari H, Bosmann M |
Thrombosis Research | 2022 |
|
Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa
Tapela K, Oyawoye FO, Olwal CO, Opurum PC, Amponsah JA, Segbedzi KA, Tetteh B, Kumi-Ansah F, Mutungi JK, Obodai E, Amoako E, Agyemang S, Ndam NT, Ampofo WK, Rayner JC, Awandare GA, Paemka L, Bediako Y, Quashie PK |
BMC Medicine | 2022 |
|
COVID-19 Vaccination Outcomes and Antibiotic Crisis and Overuse During the COVID-19 Pandemic in Bosnia and Herzegovina
Dedic V, Sljivo A, Arnautovic A, Mulac A |
Materia socio-medica | 2022 |
|
A case of cytokine release syndrome accompanied with COVID‐19 infection during treatment with immune checkpoint inhibitors for non‐small cell lung cancer
Murata D, Azuma K, Tokisawa S, Tokito T, Hoshino T |
Thoracic Cancer | 2022 |
|
Low baseline IFN-γ response could predict hospitalization in COVID-19 patients
Cremoni M, Allouche J, Graça D, Zorzi K, Fernandez C, Teisseyre M, Benzaken S, Ruetsch-Chelli C, Esnault VL, Dellamonica J, Carles M, Barrière J, Ticchioni M, Brglez V, Seitz-Polski B |
Frontiers in immunology | 2022 |
|
Therapeutic Effect of Tocilizumab on Inhibiting Cytokine Release Syndrome in Severe Coronavirus Disease 2019 Patients
Xu L, Liu X, Zhou Y, Liu A, Xu X, Wang X, Zhong X, Qiao Y, Wen L, Xi H, Mao Y |
2022 | |
|
Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis
Fialek B, Pruc M, Smereka J, Jas R, Rahnama-Hezavah M, Denegri A, Szarpak A, Jaguszewski MJ, Peacock FW, Szarpak L |
Cardiology journal | 2022 |
|
Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients
Sánchez-de Prada L, Gorgojo-Galindo Ó, Fierro I, Martínez-García AM, de Quintana GS, Gutiérrez-Bustillo R, Pelaez-Jareño MT, Álvarez-Fuente E, Gómez-Sánchez E, Tamayo E, Tamayo-Velasco Á, Martín-Fernández M |
Frontiers in immunology | 2022 |
|
COVID-19: imbalanced cell-mediated immune response drives to immunopathology
Wang J, Li Q, Qiu Y, Lu H |
Emerging Microbes & Infections | 2022 |
|
The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors
Xiang M, Wu X, Jing H, Liu L, Wang C, Wang Y, Novakovic VA, Shi J |
Frontiers in immunology | 2022 |
|
Relation of Pulmonary Diffusing Capacity Decline to HRCT and VQ SPECT/CT Findings at Early Follow-Up after COVID-19: A Prospective Cohort Study (The SECURe Study)
Katzenstein TL, Christensen J, Lund TK, Kalhauge A, Rönsholt F, Podlekareva D, Arndal E, Berg RM, Helt TW, Lebech AM, Mortensen J |
Journal of Clinical Medicine | 2022 |
|
A soluble DR5‐Fc chimeric protein attenuates inflammatory responses induced by coronavirus MHV‐A59 and SARS‐CoV‐2
Peng H, Zheng B, Yang S, Du J, Cao L, Liu L, Ma Z, Wu J, Li C, Zhang H, Guo D |
Journal of Medical Virology | 2022 |
|
ARDS in the time of corona: context and perspective
Voelkel NF, Bogaard HJ, Kuebler WM |
AJP Lung Cellular and Molecular Physiology | 2022 |
|
Post–Coronavirus Disease 2019 Pulmonary Fibrosis: Wait or Needs Intervention
Yoon HY, Uh ST |
Tuberculosis and Respiratory Diseases | 2022 |
|
Premenopausal and postmenopausal women during the COVID-19 pandemic
Pertyńska-Marczewska M, Pertyński T |
2022 | |
|
COVID-19 disease and immune dysregulation
Davitt E, Davitt C, Mazer MB, Areti SS, Hotchkiss RS, Remy KE |
Best practice & research. Clinical haematology | 2022 |
|
Wave of Invasive Fungal Disease on the Shores of COVID-19: A Case Series of COVID-19 Associated Rhino-Orbital Fungal Rhinosinusitis and Literature Review
Trehan S, Chaudhary N, Bhasarkar A |
Indian Journal of Otolaryngology and Head & Neck Surgery | 2022 |
|
COVID-19 Related Myocarditis in Adults: A Systematic Review of Case Reports
Urban S, Fułek M, Błaziak M, Iwanek G, Jura M, Fułek K, Guzik M, Garus M, Gajewski P, Lewandowski Ł, Biegus J, Ponikowski P, Trzeciak P, Tycińska A, Zymliński R |
Journal of Clinical Medicine | 2022 |
|
Online single-cell data integration through projecting heterogeneous datasets into a common cell-embedding space
Xiong L, Tian K, Li Y, Ning W, Gao X, Zhang QC |
Nature Communications | 2022 |
|
A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID-19 Disease
Keykavousi K, Nourbakhsh F, Abdollahpour N, Fazeli F, Sedaghat A, Soheili V, Sahebkar A |
International Journal of Analytical Chemistry | 2022 |
|
A systemic study on the vulnerability and fatality of prostate cancer patients towards COVID-19 through analysis of the TMPRSS2, CXCL10 and their co-expressed genes.
Raza MT, Mizan S |
Genomics & Informatics | 2022 |
|
Role of biological markers and CT severity score in predicting mortality in patients with COVID‑19: An observational retrospective study
Todor SB, Bîrluțiu V, Topîrcean D, Mihăilă RG |
Experimental and therapeutic medicine | 2022 |
|
D-dimer levels and characteristics of lymphocyte subsets, cytokine profiles in peripheral blood of patients with severe COVID-19: A systematic review and meta-analysis
Zhang H, Wu H, Pan D, Shen W |
Frontiers in Medicine | 2022 |
|
Determining laboratory parameters in pregnant women with severe COVID-19
Djusad S, Irwinda R, Harzif AK, Surya R, Wibowo N, Saroyo YB, Adjie JS |
SAGE Open Medicine | 2022 |
|
SARS-CoV-2 Infection: A Possible Risk Factor for Incidence and Recurrence of Cancers.
Jafarzadeh A, Gosain R, Mortazavi SMJ, Nemati M, Jafarzadeh S, Ghaderi A |
International journal of hematology-oncology and stem cell research | 2022 |
|
Post COVID-19 rhinocerebral mucormycosis: a case report and literature review.
El Korbi A, Bhar S, Bergaoui E, Harrathi K, Koubaa J |
The Pan African medical journal | 2022 |
|
Influence of Coronavirus Disease 2019 on some Physiological Blood Parameters in Patients with Kidney Failure in Iraq.
Rahman Mohamed Al-Saedi M, Yahia Hassan Almurshidi S, Fadel Mohammed H |
Archives of Razi Institute | 2022 |
|
Genetic Sequence of Coronavirus Strains Isolated from Iraqi Patients and their Relationship with some Liver Enzymes and Interleukins.
Salih RA, Mohamed NS, Taha AA |
Archives of Razi Institute | 2022 |
|
Cytokine Patterns in COVID-19 Patients: Which Cytokines Predict Mortality and Which Protect Against?
Basheer M, Saad E, Kananeh M, Asad L, Khayat O, Badarne A, Abdo Z, Arraf N, Milhem F, Bassal T, Boulos M, Assy N |
Current issues in molecular biology | 2022 |
|
Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical Manifestation.
Tana C, Cinetto F, Mantini C, Bernardinello N, Tana M, Ricci F, Ticinesi A, Meschi T, Scarpa R, Cipollone F, Giamberardino MA, Spagnolo P |
Biomedicines | 2022 |
|
Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19.
Vitali L, Merlini A, Galvagno F, Proment A, Sangiolo D |
Biomedicines | 2022 |
|
Eccentric Training in Pulmonary Rehabilitation of Post-COVID-19 Patients: An Alternative for Improving the Functional Capacity, Inflammation, and Oxidative Stress.
Contreras-Briceño F, Espinosa-Ramírez M, Rozenberg D, Reid WD |
Biology | 2022 |
|
The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19.
Prasad AS, Malysa A, Bepler G, Fribley A, Bao B |
2022 | |
|
Obesity as a Risk Factor for Severe COVID-19 in Hospitalized Patients: Epidemiology and Potential Mechanisms.
Aburto S, Cisterna M, Acuña J, Ruíz C, Viscardi S, Márquez JL, Villano I, Letelier P, Guzmán N |
2022 | |
|
Application of a Decision Tree Model to Predict the Outcome of Non-Intensive Inpatients Hospitalized for COVID-19.
Giotta M, Trerotoli P, Palmieri VO, Passerini F, Portincasa P, Dargenio I, Mokhtari J, Montagna MT, De Vito D |
International journal of environmental research and public health | 2022 |
|
Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review.
Yaghoobpoor S, Fathi M, Vakili K, Tutunchian Z, Dehghani M, Bahrami A, Hajibeygi R, Eslami S, Yaghoobpour T, Hajiesmaeili M |
Journal of Clinical Medicine | 2022 |
|
COVID-19 Associated with Cryptococcosis: A New Challenge during the Pandemic.
Chan KS, Lai CC, Yu WL, Chao CM |
2022 | |
|
Insights into CD24 and Exosome Physiology and Potential Role in View of Recent Advances in COVID-19 Therapeutics: A Narrative Review.
Tsioulos G, Grigoropoulos I, Moschopoulos CD, Shapira S, Poulakou G, Antoniadou A, Boumpas D, Arber N, Tsiodras S |
2022 | |
|
The Association between Admission Procalcitonin Level and The Severity of COVID-19 Pneumonia: A Retrospective Cohort Study.
Aon M, Alsaeedi A, Alzafiri A, Ibrahim MM, Al-Shammari A, Al-Shammari O, Tawakul M, Taha S, Alherz N, Alshammari J, Albazee E, Alharbi T, Alshammari D, Alenezi Z, Alenezi M, Aldouseri S, Eyadah M, Aldhafeeri M, Aoun AH |
2022 | |
|
COVID-19 and Gut Injury.
Shen S, Gong M, Wang G, Dua K, Xu J, Xu X, Liu G |
Nutrients | 2022 |
|
Correlations between Cytokine Levels, Liver Function Markers, and Neuropilin-1 Expression in Patients with COVID-19.
El Kazafy SA, Fouad YM, Said AF, Assal HH, Ali TM, Ahmed AE, Elesawy BH, Ahmed OM |
Human vaccines | 2022 |
|
Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network.
Papanikolaou C, Rapti V, Stellas D, Stefanou DT, Syrigos K, Pavlakis GN, Souliotis VL |
Human vaccines | 2022 |
|
Blood types (ABO/Rhesus) and SARS-CoV-2 infection: a retrospective, cross-sectional study in 2828 healthcare workers.
Copur B, Surme S, Sayili U, Tuncer G, Ozcelik MN, Yilmaz-Ak H, Topal M, Ustun-Al S, Pehlivanoglu F, Sengoz G |
Future Virology | 2022 |
|
Shared mechanisms and crosstalk of COVID-19 and osteoporosis via vitamin D.
Liu F, Song C, Cai W, Chen J, Cheng K, Guo D, Duan DD, Liu Z |
Scientific Reports | 2022 |
|
CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses.
Jalloh S, Olejnik J, Berrigan J, Nisa A, Suder EL, Akiyama H, Lei M, Ramaswamy S, Tyagi S, Bushkin Y, Mühlberger E, Gummuluru S |
PLoS pathogens | 2022 |
|
A potent inflammatory response is triggered in asymptomatic blood donors with recent SARS-CoV-2 infection.
Martins ML, Silva-Malta MCFD, Araújo AL, Gonçalves FA, Botelho ML, Oliveira IR, Boy LSMF, Moreira HM, Barbosa-Stancioli EF, Ribeiro MA, Chaves DG |
Revista da Sociedade Brasileira de Medicina Tropical | 2022 |
|
Genetics of COVID‐19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review
Tziastoudi M, Cholevas C, Stefanidis I, Theoharides TC |
Annals of Clinical and Translational Neurology | 2022 |
|
Exploring NFκB pathway as a potent strategy to mitigate COVID-19 severe morbidity and mortality.
Muhammad M, Hassan TM, Baba SS, Radda MI, Mutawakkil MM, Musa MA, AbuBakar S, Loong SK, Yusuf I |
Journal of Public Health in Africa | 2022 |
|
An opinion on Wastewater-Based Epidemiological Monitoring (WBEM) with Clinical Diagnostic Test (CDT) for detecting high-prevalence areas of community COVID-19 Infections.
Islam A, Hossen F, Rahman A, Sultana KF, Hasan MN, Haque A, Sosa-Hernández JE, Oyervides-Muñoz MA, Parra-Saldívar R, Ahmed T, Islam T, Dhama K, Sangkham S, Bahadur NM, Reza HM, Jakariya, Al Marzan A, Bhattacharya P, Sonne C, Ahmed F |
2022 | |
|
Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
Patel UK, Mehta N, Patel A, Patel N, Ortiz JF, Khurana M, Urhoghide E, Parulekar A, Bhriguvanshi A, Patel N, Mistry AM, Patel R, Arumaithurai K, Shah S |
Cureus | 2022 |
|
Unique cellular immune signatures of multisystem inflammatory syndrome in children.
Rajamanickam A, Nathella PK, Venkataraman A, Varadarjan P, Kannan S, Pandiarajan AN, Renji RM, Elavarasan E, Thimmaiah A, Sasidaran K, Krishnamoorthy N, Natarajan S, Ramaswamy G, Sundaram B, Putlibai S, Hissar S, Selladurai E, Uma Devi KR, Nutman TB, Babu S |
PLoS pathogens | 2022 |
|
Clinical and immunological features of convalescent pediatric patients infected with the SARS-CoV-2 Omicron variant in Tianjin, China.
Wang JY, Li TN, Zhou CL, Zhao J, Wang M, Wang Y, Jiang Y, Dong HN, Qi QR, Mu H |
Virologica Sinica | 2022 |
|
Outcome predictors in COVID-19: An analysis of emergent systemic inflammation indices in Mexican population.
Gutiérrez-Pérez IA, Buendía-Roldán I, Pérez-Rubio G, Chávez-Galán L, Hernández-Zenteno RJ, Aguilar-Duran H, Fricke-Galindo I, Zaragoza-García O, Falfán-Valencia R, Guzmán-Guzmán IP |
Frontiers in Medicine | 2022 |
|
Evaluation of the diagnosis and treatment options for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Kouhpayeh H |
Journal of Family Medicine and Primary Care | 2022 |
|
Respiratory muscle strength and pulmonary function in unvaccinated athletes before and after COVID-19 infection: A prospective cohort study
Bostancı Ö, Karaduman E, Çolak Y, Yılmaz AK, Kabadayı M, Bilgiç S |
Respiratory Physiology & Neurobiology | 2022 |
|
SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions
Vinjamuri S, Li L, Bouvier M |
Frontiers in immunology | 2022 |
|
Effect of Antioxidants on the Production of MCP-1 Chemokine by EA.hy926 Cells in Response to IL-6
Chelombitko MA, Galkin II, Pletjushkina OY, Zinovkin RA, Popova EN |
Moscow University Biological Sciences Bulletin | 2022 |
|
Xuanfei Baidu Formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-κB and MAPK pathways in LPS-induced ALI and inflammation models
Li Z, Pan H, Yang J, Chen D, Wang Y, Zhang H, Cheng Y |
Phytomedicine | 2022 |
|
CD8+ T-cell immune escape by SARS-CoV-2 variants of concern
Kombe Kombe AJ, Biteghe FA, Ndoutoume ZN, Jin T |
Frontiers in immunology | 2022 |
|
Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages
Aw ZQ, Mok CK, Wong YH, Chen H, Mak TM, Lin RT, Lye DC, Tan KS, Chu JJ |
Frontiers in immunology | 2022 |
|
Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins
Di Simone M, Corsale AM, Lo Presti E, Scichilone N, Picone C, Giannitrapani L, Dieli F, Meraviglia S |
Cells | 2022 |
|
An electrochemical paper-based hydrogel immunosensor to monitor serum cytokine for predicting the severity of COVID-19 patients
Shi D, Zhang C, Li X, Yuan J |
Biosensors & bioelectronics | 2022 |
|
Therapeutic role of N-acetyl cysteine (NAC) for the treatment and/or management of SARS-CoV-2-induced lung damage in hamster model
Suresh V, Behera P, Parida D, Mohapatra AP, Das SK, Kumari S, Avula K, Mohapatra A, Syed GH, Senapati S |
European Journal of Pharmacology | 2022 |
|
Leukocyte metabolism in obese type 2 diabetic individuals associated with COVID-19 severity
Lobato TB, Gennari-Felipe M, Pauferro JR, Correa IS, Santos BF, Dias BB, de Oliveira Borges JC, dos Santos CS, de Sousa Santos ES, de Araújo MJ, Ferreira LA, Pereira SA, Serdan TD, Levada-Pires AC, Hatanaka E, Borges L, Cury-Boaventura MF, Vinolo MA, Pithon-Curi TC, Masi LN, Curi R, Hirabara SM, Gorjão R |
Frontiers in microbiology | 2022 |
|
COVID-19 Acute Respiratory Distress Syndrome: One Pathogen, Multiple Phenotypes
Empson S, Rogers AJ, Wilson JG |
Critical Care Clinics | 2022 |
|
Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise.
Razi O, Teixeira AM, Tartibian B, Zamani N, Knechtle B |
Molecular and Cellular Biochemistry | 2022 |
|
Differential effects of age, sex and dexamethasone therapy on ACE2/TMPRSS2 expression and susceptibility to SARS-CoV-2 infection
Shahbaz S, Oyegbami O, Saito S, Osman M, Sligl W, Elahi S |
Frontiers in immunology | 2022 |
|
Exploration of blood−derived coding and non-coding RNA diagnostic immunological panels for COVID-19 through a co-expressed-based machine learning procedure
Zarei Ghobadi M, Emamzadeh R, Teymoori-Rad M, Afsaneh E |
Frontiers in immunology | 2022 |
|
Evaluation of Hepcidin Level in COVID-19 Patients Admitted to the Intensive Care Unit.
Ciotti M, Nuccetelli M, Pieri M, Petrangeli CM, Giovannelli A, Cosio T, Rosa L, Valenti P, Leonardis F, Legramante JM, Bernardini S, Campione E, Minieri M |
2022 | |
|
Influence of SARS-COV-2 Infection on Cytokine Production by Mitogen-Stimulated Peripheral Blood Mononuclear Cells and Neutrophils in COVID-19 Intensive Care Unit Patients.
Essa S, Shamsah M, Alsarraf AH, Esmaeil A, Al-Shammasi A, Raghupathy R |
Microorganisms | 2022 |
|
Neuro-Immune Interactions in Severe COVID-19 Infection.
Rossi E, Mutti L, Morrione A, Giordano A |
2022 | |
|
A Review of Potential Therapeutic Strategies for COVID-19.
Meng J, Li R, Zhang Z, Wang J, Huang Q, Nie D, Fan K, Guo W, Zhao Z, Han Z |
Viruses | 2022 |
|
Combined Use of ECMO, Prone Positioning, and APRV in the Management of Severe COVID-19 Patients.
Ong SL, Tantawy H, Assi R, Chichra A, Treggiari MM |
Clinical medicine insights. Circulatory, respiratory and pulmonary medicine | 2022 |
|
Bioinformatics and systems biology approaches to identify molecular targeting mechanism influenced by COVID-19 on heart failure.
Yang K, Liu J, Gong Y, Li Y, Liu Q |
Frontiers in immunology | 2022 |
|
Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants.
Noor R |
Viruses | 2022 |
|
Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity
Dai W, Zhong A, Qiao Q, Wu J, Li W, Wu Q, Zhou H, Qin S, Jiang W, Zhang J, Xia X |
Virology Journal | 2022 |
|
Association of miR-144 levels in the peripheral blood with COVID-19 severity and mortality
Madè A, Greco S, Vausort M, Miliotis M, Schordan E, Baksi S, Zhang L, Baryshnikova E, Ranucci M, Cardani R, Fagherazzi G, Ollert M, Tastsoglou S, Vatsellas G, Hatzigeorgiou A, Firat H, Devaux Y, Martelli F |
Scientific Reports | 2022 |
|
An adaptable in vitro cytokine release assay (CRA): Susceptibility to cytokine storm in COVID-19 as a model
Alam M, Choudhury R, Lamers RJ |
2022 | |
|
Identification of COVID-19 severity biomarkers based on feature selection on single-cell RNA-Seq data of CD8+ T cells
Lu J, Meng M, Zhou X, Ding S, Feng K, Zeng Z, Huang T, Cai YD |
Frontiers in Genetics | 2022 |
|
Human Vδ2 T Cells and Their Versatility for Immunotherapeutic Approaches
Sanz M, Mann BT, Chitrakar A, Soriano-Sarabia N |
Cells | 2022 |
|
Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes
Messing M, Sekhon MS, Hughes MR, Stukas S, Hoiland RL, Cooper J, Ahmed N, Hamer MS, Li Y, Shin SB, Tung LW, Wellington CL, Sin DD, Leslie KB, McNagny KM |
Frontiers in immunology | 2022 |
|
Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises
Satapathy P, Ratho RK, Sethi S |
Frontiers in pharmacology | 2022 |
|
Effect of Obesity among Hospitalized Cancer Patients with or without COVID-19 on a National Level
Cottenet J, Tapia S, Arveux P, Bernard A, Dabakuyo-Yonli TS, Quantin C |
Cancers | 2022 |
|
Comparative analysis of clinical and biological characteristics of COVID-19 patients: A retrospective cohort study
Yahyaoui A, Amrani A, Idrissi A, Belmahi S, Nassiri O, Mouhoub B, Sebbar E, Hamaz S, Choukri M |
Clinical Epidemiology and Global Health | 2022 |
|
CT-based pathological lung opacities volume as a predictor of critical illness and inflammatory response severity in patients with COVID-19
Torres-Ramirez CA, Timaran-Montenegro D, Mateo-Camacho YS, Morales-Jaramillo LM, Tapia-Rangel EA, Fuentes-Badillo KD, Morales-Dominguez V, Punzo-Alcaraz R, Feria-Arroyo GA, Parra-Guerrero LM, Saenz-Castillo PF, Hernandez-Rojas AM, Falla-Trujillo MG, Obando-Bravo DE, Contla-Trejo GS, Jacome-Portilla KI, Chavez-Sastre J, Govea-Palma J, Carrillo-Alvarez S, Bonifacio D, Orozco-Vazquez JD |
Heliyon | 2022 |
|
Essential Oils and COVID-19
Elsebai MF, Albalawi MA |
Molecules (Basel, Switzerland) | 2022 |
|
Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial.
Lukhna K, do Carmo HRP, Castillo AR, Davidson SM, Geffen H, Giesz S, Golforoush P, Bovi TG, Gorag D, Salama A, Imamdin A, Kalkhoran S, Lecour S, Perroud MW Jr, Ntsekhe M, Sposito AC, Yellon DM |
Cardiovascular Drugs and Therapy | 2022 |
|
Elevated ubiquitination contributes to protective immunity against severe SARS-CoV-2 infection.
Che Y, Jiang D, Zhang Y, Zhang J, Xu T, Sun Y, Fan J, Wang J, Chang N, Wu Y, Yang S, Xu L, Ding J, Hu C, Huang Y, Zhang J, Yang K |
Clinical and Translational Medicine | 2022 |
|
Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Homma T, Nagata N, Hashimoto M, Iwata-Yoshikawa N, Seki NM, Shiwa-Sudo N, Ainai A, Dohi K, Nikaido E, Mukai A, Ukai Y, Nakagawa T, Shimo Y, Maeda H, Shirai S, Aoki M, Sonoyama T, Sato M, Fumoto M, Nagira M, Nakata F, Hashiguchi T, Suzuki T, Omoto S, Hasegawa H |
Scientific Reports | 2022 |
|
Repurposing of drugs for combined treatment of COVID-19 cytokine storm using machine learning
Gantla MR, Tsigelny IF, Kouznetsova VL |
2022 | |
|
Increased IL-26 associates with markers of hyperinflammation and tissue damage in patients with acute COVID-19
Cardenas EI, Ekstedt S, Piersiala K, Petro M, Karlsson A, Kågedal Å, Kumlien Georén S, Cardell LO, Lindén A |
Frontiers in immunology | 2022 |
|
Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19
Abbas AA, Alghamdi A, Mezghani S, Ben Ayed M, Alamori AM, Alghamdi GA, Bajhmom W, Wajeeh H, Almutairi SS, Radwan WM |
Journal of Immunology Research | 2022 |
|
Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities
Nova Z, Zemanek T, Botek N |
International journal of molecular sciences | 2022 |
|
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
Liang H, Nian X, Wu J, Liu D, Feng L, Lu J, Peng Y, Zhou Z, Deng T, Liu J, Ji D, Qiu R, Lin L, Zeng Y, Xia F, Hu Y, Li T, Duan K, Li X, Wang Z, Zhang Y, Zhang H, Zhu C, Wang S, Wu X, Wang X, Li Y, Huang S, Mao M, Guo H, Yang Y, Jia R, Xufang J, Wang X, Liang S, Qiu Z, Zhang J, Ding Y, Li C, Zhang J, Fu D, He Y, Zhou D, Li C, Zhang J, Yu D, Yang XM |
Cell Discovery | 2022 |
|
Epidemiology, risk factors and prognosis of ventilator-associated pneumonia during severe COVID-19: multicenter observational study across 149 European intensive care units
Garnier M, Constantin JM, Heming N, Camous L, Ferré A, Razazi K, Lapidus N |
Anaesthesia Critical Care & Pain Medicine | 2022 |
|
Characterization of regulatory T cells in SARS-CoV-2 infected hemodialysis patients: relation to clinical and radiological severity.
Samaan E, Elmaria MO, Khedr D, Gaber T, Elsayed AG, Shenouda RN, Gamal H, Shahin D, Abousamra NK, Shemies R |
BMC Nephrology | 2022 |
|
Impact of gender-affirming hormone therapy on the development of COVID-19 infections and associated complications: A systematic review.
Ferraro JJ, Reynolds A, Edoigiawerie S, Seu MY, Horen SR, Aminzada A, Hamidian Jahromi A |
World Journal of Methodology | 2022 |
|
Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response.
Ash MK, Bhimalli PP, Cho BK, Mattamana BB, Gambut S, Tarhoni I, Fhied CL, Reyes AF, Welninski SJ, Arivalagan J, Negrão F, Goel R, Beck TL, Hope TJ, Sha BE, Goo YA, Al-Harthi L, Mamede JI, Borgia JA, Kelleher NL, Schneider JR |
Cell Reports | 2022 |
|
Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates.
Yazdanpanah S, Ahmadi M, Zare Z, Nikoupour H, Arabsheybani S, Jabrodini A, Eghtedarnejad E, Chamanpara P, Geramizadeh B, Anbardar MH, Malekizadeh Z, Gashtasebi M, Mohsenzadeh M, Shafiekhani M, Zomorodian K |
Mycopathologia | 2022 |
|
Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients.
Bussolati E, Cultrera R, Quaranta A, Cricca V, Marangoni E, La Rosa R, Bertacchini S, Bellonzi A, Ragazzi R, Volta CA, Spadaro S, Scaramuzzo G |
Journal of Clinical Medicine | 2022 |
|
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
Plocque A, Mitri C, Lefèvre C, Tabary O, Touqui L, Philippart F |
Drugs | 2022 |
|
Association Between Guillain-Barré Syndrome and COVID-19 Infection: Experience of a Turkish Neurophysiology Laboratory
Durmaz ŞE, Kaya BU, Gümüşyayla Ş |
2022 | |
|
Dexmedetomidine attenuates subarachnoid hemorrhage-induced acute lung injury through regulating autophagy and TLR/NFκB signaling pathway
Han DW, Oh JE, Lim BJ, Han Y, Song Y |
Korean Journal of Anesthesiology | 2022 |
|
Humulus lupus extract rich in xanthohumol improves the clinical course in critically ill COVID-19 patients
Dabrowski W, Gagos M, Siwicka-Gieroba D, Piechota M, Siwiec J, Bielacz M, Kotfis K, Stepulak A, Grzycka-Kowalczyk L, Jaroszynski A, Malbrain ML |
Biomedicine & Pharmacotherapy | 2022 |
|
Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib
Claude L, Martino F, Hermand P, Chahim B, Roger P, de Bourayne M, Garnier Y, Tressieres B, Colin Y, Le Van Kim C, Romana M, Baccini V |
Research and Practice in Thrombosis and Haemostasis | 2022 |
|
Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019
Gao Q, Yin X, Tan B, Wang J, Chen J, Zhao B, Yang Q, Li Z |
BMC Infectious Diseases | 2022 |
|
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity
Tangye SG |
Journal of Allergy and Clinical Immunology | 2022 |
|
Impact of systemic corticosteroids on hospital length of stay among patients with COVID-19
Ester Z, Carlos C, Elena V, Rodolfo ÁS, Borobia Alberto M, Gómez-Carrera L, Antonio B, Concepción PM |
Farmacia Hospitalaria | 2022 |
|
The Infected Lungs and Brain Interface in COVID-19: The Impact on Cognitive Function
Joaquim L, Della Giustina A, Machado RS, Metzker KL, Bonfante S, Danielski LG, Goldim MP, Petronilho F |
Neuroimmunomodulation | 2022 |
|
Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy
Wang WX, Jia R, Song JW, Zhang X, Zhou SN, Wang FS, Fu J |
Frontiers in microbiology | 2022 |
|
Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in COVID-19.
Zhang B, Zhang Z, Koeken VACM, Kumar S, Aillaud M, Tsay HC, Liu Z, Kraft ARM, Soon CF, Odak I, Bošnjak B, Vlot A, Swertz MA, Ohler U, Geffers R, Illig T, Huehn J, Saliba AE, Sander LE, Förster R, Xu CJ, Cornberg M, Schulte LN, Li Y |
2022 | |
|
The dynamics of γδ T cell responses in nonhuman primates during SARS-CoV-2 infection.
Fears AC, Walker EM, Chirichella N, Slisarenko N, Merino KM, Golden N, Picou B, Spencer S, Russell-Lodrigue KE, Doyle-Meyers LA, Blair RV, Beddingfield BJ, Maness NJ, Roy CJ, Rout N |
Communications biology | 2022 |
|
SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
Zheng Q, Lin R, Chen Y, Lv Q, Zhang J, Zhai J, Xu W, Wang W |
Frontiers in immunology | 2022 |
|
Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals.
Chattopadhyay P, Khare K, Kumar M, Mishra P, Anand A, Maurya R, Gupta R, Sahni S, Gupta A, Wadhwa S, Yadav A, Devi P, Tardalkar K, Joshi M, Sethi T, Pandey R |
Frontiers in immunology | 2022 |
|
Effectiveness of corticosteroids to treat coronavirus disease 2019 symptoms: A meta-analysis.
Zeng Y, Zeng W, Yang B, Liu Z |
2022 | |
|
SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D
Lee MJ, Leong MW, Rustagi A, Beck A, Zeng L, Holmes S, Qi LS, Blish CA |
Cell Reports | 2022 |
|
Resultados en la práctica asistencial y coste marginal del tratamiento con tocilizumab en pacientes COVID-19.
Garcia-Molina A, Alos-Almiñana M |
Farmacia Hospitalaria | 2022 |
|
A case of pericarditis in a middle‐aged woman with COVID‐19
Kushima H, Shimizu S, Koide Y, Kawamura A, Ishii H |
Clinical Case Reports | 2022 |
|
Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus
Mackman N, Grover SP, Antoniak S |
Journal of Thrombosis and Haemostasis | 2022 |
|
Drug Repurposing Using Gene Co-Expression and Module Preservation Analysis in Acute Respiratory Distress Syndrome (ARDS), Systemic Inflammatory Response Syndrome (SIRS), Sepsis, and COVID-19
Mailem RC, Tayo LL |
Biology | 2022 |
|
Correlation between COVID-19 and hepatitis B: A systematic review
He YF, Jiang ZG, Wu N, Bian N, Ren JL |
World Journal of Gastroenterology | 2022 |
|
Development of Multiplexed Bead-Based Immunoassays for Profiling Soluble Cytokines and CD163 Using Mass Cytometry
Liu J, Allo B, Winnik MA |
2022 | |
|
Eosinopenia as Predictor of Poor Outcome in Hospitalized COVID-19 Adult Patients from Waves 1 and 2 of 2020 Pandemic
Cauchois R, Pietri L, Dalmas JB, Koubi M, Capron T, Cassir N, Potere N, Polidoro I, Jean R, Jarrot PA, Andre B, Veit V, Carvelli J, Pauly V, Chanez P, Papazian L, Kaplanski G |
Microorganisms | 2022 |
|
Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment
Pérez R, Glaser T, Villegas C, Burgos V, Ulrich H, Paz C |
Life Sciences | 2022 |
|
A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients – indications for their potential involvement in the development of Long COVID?
Haunhorst S, Bloch W, Javelle F, Krüger K, Baumgart S, Drube S, Lemhöfer C, Reuken P, Stallmach A, Müller M, Zielinski CE, Pletz MW, Gabriel HH, Puta C |
Frontiers in immunology | 2022 |
|
T cell repertoire profiling in allografts and native tissues in recipients with COVID–19 after solid organ transplantation: Insight into T cell–mediated allograft protection from viral infection
Fu J, Rust D, Fang Z, Jiao W, Lagana S, Batal I, Chen B, Merl S, Jones R, Sykes M, Weiner J |
Frontiers in immunology | 2022 |
|
[Should we interfere with the interleukin-6 receptor during COVID-19: What do we know?].
Lefèvre C, Plocque A, Tran M, Creux M, Philippart F |
Revue des Maladies Respiratoires | 2022 |
|
Bioinformatics and systems biology approaches to identify the effects of COVID-19 on neurodegenerative diseases: A review
Bu F, Guan R, Wang W, Liu Z, Yin S, Zhao Y, Chai J |
Medicine | 2022 |
|
[TRANSLATED ARTICLE] Efficacy and marginal cost of treatment with tocilizumab in COVID-19 patients
Garcia-Molina A, Alos-Almiñana M |
Farmacia Hospitalaria | 2022 |
|
Assessment of some Physiological Biomarkers in COVID-19 Patients in Thi-Qar, Iraq.
Jouda J, Abdul Kareem Jabbar E, Salih Abdulhadi F, Atiyah Kamil Y |
Archives of Razi Institute | 2022 |
|
The Effects of Laboratory Parameters on the Prognosis of COVID-19.
Kesmez Can F, Alay H, Albayrak A, Özden K, Yilmaz S, Öztürk N, Özkurt Z, Parlak E, Tekin E, Koçak AO |
The Eurasian Journal of Medicine | 2022 |
|
Purple toes following critical COVID-19 infection.
Ng AT, Miller A, Bodemer AA, Drolet BA, Arkin L |
Pediatric Dermatology | 2022 |
|
Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device
Kim WJ, Roberts CC, Song JY, Yoon JG, Seong H, Hyun HJ, Lee H, Gil A, Oh Y, Park JE, Jeon B, Lee JE, Choi SK, Yoon SK, Lee S, Kim B, Kane D, Spruill S, Kudchodkar SB, Muthumani K, Park YK, Kwon I, Jeong M, Maslow JN |
International Journal of Infectious Diseases | 2022 |
|
Baicalein self‐microemulsion based on drug–phospholipid complex for the alleviation of cytokine storm
Liao H, Ye J, Gao Y, Lian C, Liu L, Xu X, Feng Y, Yang Y, Yang Y, Shen Q, Gao L, Liu Z, Liu Y |
Bioengineering & Translational Medicine | 2022 |
|
Severe COVID-19 May Impact Hepatic Fibrosis /Hepatic Stellate Cells Activation as Indicated by a Pathway and Population Genetic Study
Moya L, Farashi S, Suravajhala P, Janaththani P, Batra J |
Genes & development | 2022 |
|
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression
De Vito A, Colpani A, Saderi L, Puci M, Zauli B, Fiore V, Fois M, Meloni MC, Bitti A, Di Castri C, Maida I, Babudieri S, Sotgiu G, Madeddu G |
Viruses | 2022 |
|
A Cross-Sectional Comparative Characterization of Hematological Changes in Patients with COVID-19 Infection, Non-COVID Influenza-like Illnesses and Healthy Controls
Kala M, Ahmad S, Dhebane M, Das K, Raturi M, Tyagi M, Kusum A |
Viruses | 2022 |
|
Relation between Cytokine Levels and Pulmonary Dysfunction in COVID-19 Patients: A Case-Control Study
El Kazafy SA, Fouad YM, Said AF, Assal HH, Ahmed AE, El Askary A, Ali TM, Ahmed OM |
Journal of Personalized Medicine | 2022 |
|
Immunophenotyping characteristics of COVID‐19 patients: Peripheral blood CD8+ HLA‐DR+ T cells as a biomarker for mortality outcome
Mirsharif ES, Chenary MR, Bozorgmehr M, Mohammadi S, Hashemi SM, Ardestani SK, Beigmohammadi M, Abdollahi A, Sadeghipour A, Kariminia A, Tuserkani F, Ghazanfari T |
Journal of Medical Virology | 2022 |
|
Neutrophils during SARS‐CoV‐2 infection: Friend or foe?
Castanheira FV, Kubes P |
Immunological Reviews | 2022 |
|
Red blood cells from COVID-19 patients suffer from increased oxidative stress and may have increased lactate influx
Mullen E, Bergin S, Healy G, Quinn J, Glavey S, Murphy PT |
Blood Research | 2022 |
|
SARS-CoV-2 vaccines: What we know, what we can do to improve them and what we could learn from other well-known viruses
Fiorino S, Carusi A, Hong W, Cernuschi P, Gallo CG, Ferrara E, Maloberti T, Visani M, Lari F, de Biase D, Zippi M |
AIMS Microbiology | 2022 |
|
Efficacy of therapeutic plasma exchange in severe COVID‐19 disease: A meta‐analysis
Prakash S, Sahu A, Routray SS, Maiti R, Mitra JK, Mukherjee S |
Vox Sanguinis | 2022 |
|
Comparison of outcomes and costs of extracorporeal blood purification therapies in critically ill COVID‐19 patients
Dianaty S, Khodadadi S, Alimoghaddam R, Mirzaei A |
Therapeutic Apheresis and Dialysis | 2022 |
|
A novel plant‐made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS‐CoV‐2 Omicron variant
Jugler C, Sun H, Nguyen K, Palt R, Felder M, Steinkellner H, Chen Q |
Plant Biotechnology Journal | 2022 |
|
Autoinflammatory manifestations in adult patients.
Rodolfi S, Nasone I, Folci M, Selmi C, Brunetta E |
Clinical & Experimental Immunology | 2022 |
|
Characteristics and Predictive Value of T-lymphocyte Subset Absolute Counts in Patients with COVID-19-associated Acute Respiratory Failure: A Retrospective Study
Vadi S, Pednekar A, Suthar D, Sanwalka N, Ghodke K, Rabade N |
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine | 2022 |
|
Factors associated with death among hospitalized COVID-19 patients in Lagos State, Nigeria: a retrospective cross-sectional study
Adejumo OA, Ogunniyan T, Adetola AV, Mba SC, Ogunbayo O, Oladokun OD, Oluwadun OB, Erinoso O, Adesola S, Bowale A |
African health sciences | 2022 |
|
Factors Affecting the Risk of Interstitial Lung Disease Development in Hospitalized Patients With COVID-19 Pneumonia
Polat G, Özdemir Ö, Ermin S, Unat DS, Şahin GV, Türk MA, Güldaval F, Susam S, Kıraklı C |
Respiratory Care | 2022 |
|
Study of Microbial Infections and Some Immunological Parameters among Covid-19 in ICU Patients in Najaf Governorate, Iraq
SH R |
Archives of Razi Institute | 2022 |
|
The role of CD8+ regulatory T cells and B cell subsets in patients with COVID-19
UÇARYILMAZ H, ERGÜN D, VATANSEV H, KÖKSAL H, URAL O, ARSLAN U, ARTAÇ H |
2022 | |
|
Correlation of Vitamin D deficiency with chest X-rays severity scores and different inflammatory markers in severe and critical COVID-19 patients
Ali S, Ashraf, Rahman N, Nasir J, Akbar N |
Ghana Medical Journal | 2022 |
|
COVID-19: A Cause of HELLP Syndrome? A Case Report
Arslan E |
International journal of women's health | 2022 |
|
CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses.
Jalloh S, Olejnik J, Berrigan J, Nisa A, Suder EL, Akiyama H, Lei M, Tyagi S, Bushkin Y, Mühlberger E, Gummuluru S |
bioRxiv : the preprint server for biology | 2022 |
|
T-cell cellular stress and reticulocyte signatures, but not loss of naïve T lymphocytes, characterize severe COVID-19 in older adults.
Jergović M, Watanabe M, Bhat R, Coplen CP, Sonar SA, Wong R, Castaneda Y, Davidson L, Kala M, Wilson RC, Twigg HL 3rd, Knox K, Erickson HE, Weinkauf CC, Bime C, Bixby BA, Parthasarathy S, Mosier JM, LaFleur BJ, Bhattacharya D, Nikolich JŽ |
bioRxiv : the preprint server for biology | 2022 |
|
Effect of tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospective cohort study.
Küçük MP, Küçük AO, Pehlivanlar A, Mürtezaoğlu SA, Çoban K, Kılıç G, Ayçiçek O, Öztuna F, Bülbül Y, Özlü T |
2022 | |
|
Stroke-induced changes to immune function and their relevance to increased risk of severe COVID-19 disease.
McCulloch L, Mouat IC, South K, McColl BW, Allan SM, Smith CJ |
2022 | |
|
SARS-CoV-2-Mediated Neuropathogenesis, Deterioration of Hippocampal Neurogenesis and Dementia.
Radhakrishnan RK, Kandasamy M |
American journal of Alzheimer's disease and other dementias | 2022 |
|
Use of chronic medications and risk of death due to COVID-19 in hospitalised patients
Larrosa-García M, Garcia-Garcia S, Louro J, Sánchez-Montalvá A, Sampol Sirvent J, Augustín Recio S, Guillén del Castillo A, Riera-Arnau J, Gorgas MQ, Miarons M |
2022 | |
|
Effect of Hypertension Comorbidity on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type, the Delta or Omicron Variant SARS-CoV-2
Zhang J, Zhang J, Tao Z |
2022 | |
|
The pathological maelstrom of COVID-19 and cardiovascular disease.
Giacca M, Shah AM |
Nature cardiovascular research | 2022 |
|
Cytokine Storm and Neuropathological Alterations in Patients with Neurological Manifestations of COVID-19.
Tsagkaris C, Bilal M, Aktar I, Aboufandi Y, Tas A, Aborode AT, Suvvari TK, Ahmad S, Shkodina A, Phadke R, Emhamed MS, Baig AA, Alexiou A, Ashraf GM, Kamal MA |
Current Alzheimer research | 2022 |
|
Effectiveness and safety profile of mesenchymal stem cell secretome as a treatment for severe cases of COVID-19: a randomized controlled trial
Abdullah M, Pawitan JA, Irawan C, - R, Aditianingsih D, Liem IK, Sinto R, Susilo A, Yulianti M, Handayani RR, Pratomo IP, Burhan E, Damayanti T, Wibowo H, Dilogo IH, Muliawan HS, Elhidsi M |
F1000Research | 2022 |
|
Effectiveness and safety profile of mesenchymal stem cell secretome as a treatment for severe cases of COVID-19: a randomized controlled trial.
Abdullah M, Pawitan JA, Irawan C, - R, Aditianingsih D, Liem IK, Sinto R, Susilo A, Yulianti M, Handayani RRD, Pratomo IP, Burhan E, Damayanti T, Wibowo H, Dilogo IH, Muliawan HS, Elhidsi M |
F1000Research | 2022 |
|
Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection
Jacob K. Files, Sushma Boppana, Mildred D. Perez, Sanghita Sarkar, Kelsey E. Lowman, Kai Qin, Sarah Sterrett, Eric Carlin, Anju Bansal, Steffanie Sabbaj, Dustin M. Long, Olaf Kutsch, James Kobie, Paul Goepfert, Nathaniel Erdmann |
Journal of Clinical Investigation | 2021 |
|
Recent endemic coronavirus infection is associated with less severe COVID-19
Manish Sagar, Katherine Reifler, Michael Rossi, Nancy S. Miller, Pranay Sinha, Laura White, Joseph P. Mizgerd |
Journal of Clinical Investigation | 2021 |
|
The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity
Hamid Bolouri, Cate Speake, David Skibinski, S. Alice Long, Anne M. Hocking, Daniel J. Campbell, Jessica A. Hamerman, Uma Malhotra, Jane H. Buckner |
Journal of Clinical Investigation | 2021 |
|
Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity
Sara Falck-Jones, Sindhu Vangeti, Meng Yu, Ryan Falck-Jones, Alberto Cagigi, Isabella Badolati, Björn Österberg, Maximilian Julius Lautenbach, Eric Ahlberg, Ang Lin, Rico Lepzien, Inga Szurgot, Klara Lenart, Fredrika Hellgren, Holden T Maecker, Jörgen Sälde, Jan Albert, Niclas Johansson, Max Bell, Karin Lore, Anna Färnert, Anna Smed-Sörensen |
Journal of Clinical Investigation | 2021 |
|
Attenuated activation of pulmonary immune cells in mRNA-1273 vaccinated hamsters after SARS-CoV-2 infection
Michelle Meyer, Yuan Wang, Darin Edwards, Gregory R. Smith, Aliza B. Rubenstein, Palaniappan Ramanathan, Chad E Mire, Colette Pietzsch, Xi Chen, Yongchao Ge, Wan Sze Cheng, Carole Henry, Angela Woods, LingZhi Ma, Guillaume B. E. Stewart-Jones, Kevin W. Bock, Mahnaz Minai, Bianca M. Nagata, Sivakumar Periasamy, Pei-Yong Shi, Barney S Graham, Ian Moore, Irene Ramos, Olga G Troyanskaya, Elena Zaslavsky, Andrea Carfi, Stuart Sealfon, Alexander Bukreyev |
Journal of Clinical Investigation | 2021 |
|
An immune-based biomarker signature is associated with mortality in COVID-19 patients
Michael S. Abers, Ottavia M. Delmonte, Emily E. Ricotta, Jonathan Fintzi, Danielle Fink, Adriana A. de Jesus, Kol A. Zarember, Sara Alehashemi, Vasileios Oikonomou, Jigar V. Desai, Scott W. Canna, Bita Shakoory, Kerry Dobbs, Luisa Imberti, Alessandra Sottini, Eugenia Quiros-Roldan, Francesco Castelli, Camillo Rossi, Duilio Brugnoni, Andrea Biondi, Laura R. Bettini, Mariella D’Angio’, Paolo Bonfanti, Riccardo Castagnoli, Daniela Montagna, Amelia Licari, Gian Luigi Marseglia, Emily Gliniewicz, Elana R. Shaw, Dana Kahle, Andre T. Rastegar, Michael A Stack, Katherine Myint-Hpu, Susan L. Levinson, Mark J. DiNubile, Daniel W. Chertow, Peter Burbelo, Jeffrey I. Cohen, Katherine R. Calvo, John S. Tsang, Helen C. Su, John I. Gallin, Douglas B. Kuhns, Raphaela Goldbach-Mansky, Michail S Lionakis, Luigi D Notarangelo |
JCI Insight | 2021 |
|
Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2
Krystle K.Q. Yu, Stephanie Fischinger, Malisa T. Smith, Caroline Atyeo, Deniz Cizmeci, Caitlin R. Wolf, Erik D. Layton, Jennifer K. Logue, Melissa S. Aguilar, Kiel Shuey, Carolin Loos, Jingyou Yu, Nicholas M Franko, Robert Y. Choi, Anna Wald, Dan H. Barouch, David M. Koelle, Douglas Lauffenburger, Helen Y. Chu, Galit Alter, Chetan Seshadri |
JCI Insight | 2021 |
|
A Specific Low-density Neutrophil Population Correlates with Hypercoagulation and Disease Severity in Hospitalized COVID-19 Patients
Samantha Morrissey, Anne E Geller, Xiaoling Hu, David Tieri, Chuanlin Ding, Christopher Klaes, Elizabeth Cooke, Matthew R. Woeste, Zachary Martin, Oscar Chen, Sarah E Bush, Huang-ge Zhang, Rodrigo Cavallazzi, Sean Clifford, James Chen, Smita Ghare, Shirish Barve, Lu Cai, Maiying Kong, Eric C. Rouchka, Kenneth R McLeish, Silvia M. Uriarte, Corey T. Watson, Jiapeng Huang, Jun Yan |
JCI Insight | 2021 |
|
Nucleocapsid-specific and PD-L1+CXCR3+ CD8 polyfunctional T-cell abundances are associated with survival of critical SARS-CoV2-infected patients
Lucille Adam, Pierre Rosenbaum, Paul Quentric, Christophe Parizot, Olivia Bonduelle, Noëlline Guillou, Aurelien Corneau, Karim Dorgham, Makoto Miyara, Charles-Edouard Luyt, Amélie Guihot, Guy Gorochov, Christophe Combadière, Behazine Combadière |
JCI Insight | 2021 |
|
Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19
Alec A Schmaier, Gabriel M. Pajares Hurtado, Zachary Manickas-Hill, Kelsey D Sack, Siyu M Chen, Victoria Bhambhani, Juweria Quadir, Anjali K Nath, Ai-ris Y Collier, Debby Ngo, Dan Barouch, Nathan I Shapiro, Robert E Gerszten, Xu Yu, Kevin G Peters, Robert Flaumenhaft, Samir M Parikh |
JCI Insight | 2021 |
|
TNFRSF13B genotypes control immune-mediated pathology by regulating the functions of innate B cells
Mayara Garcia de Mattos Barbosa, Adam R. Lefferts, Daniel Huynh, Hui Liu, Yu Zhang, Beverly Fu, Jenna Barnes, Milagros Samaniego, Richard J. Bram, Raif Geha, Ariella Shikanov, Eline T. Luning Prak, Evan A Farkash, Jeffrey L. Platt, Marilia Cascalho |
JCI Insight | 2021 |
|
Exhausting T Cells During HIV Infection May Improve the Prognosis of Patients with COVID-19
HS Lin, XH Lin, JW Wang, DN Wen, J Xiang, YQ Fan, HD Li, J Wu, Y Lin, YL Lin, XR Sun, YF Chen, CJ Chen, NF Lian, HS Xie, SH Lin, QF Xie, CW Li, FZ Peng, N Wang, JQ Lin, WJ Chen, CL Huang, Y Fu |
Frontiers in Cellular and Infection Microbiology | 2021 |
|
Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19
G Zhao, Y Xu, J Li, X Cui, X Tan, H Zhang, L Dang |
Bioscience Reports | 2021 |
|
Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19
B Liao, Z Liu, L Tang, L Li, Q Gan, H Shi, Q Jiao, Y Guan, M Xie, , H Zhao, W Chen, Y Liu, L Li, Y Wang, Y Cao, Y Shi, Y Li, C Lei |
International journal of medical sciences | 2021 |
|
SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients
H Chen, W Liu, Y Wang, D Liu, L Zhao, J Yu |
EBioMedicine | 2021 |
|
SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage
F Reizine, M Lesouhaitier, M Gregoire, K Pinceaux, A Gacouin, A Maamar, B Painvin, C Camus, YL Tulzo, P Tattevin, M Revest, AL Bot, A Ballerie, B Cador-Rousseau, M Lederlin, T Lebouvier, Y Launey, M Latour, C Verdy, D Rossille, SL Gallou, J Dulong, C Moreau, C Bendavid, M Roussel, M Cogne, K Tarte, JM Tadié |
Journal of Clinical Immunology | 2021 |
|
Age cohorts stratified according to age-distributions of COVID-19 morbidity statistics identify uniquely age-dependent CD3+CD8+ T-cell lymphocytopenia in COVID-19 patients without comorbidities on admission
S Jin, H An, T Zhou, T Li, C Chen, B Ying, Z Xu, X Li, M Li |
Aging | 2021 |
|
Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity
JL Yates, DJ Ehrbar, DT Hunt, RC Girardin, AP Dupuis, AF Payne, M Sowizral, S Varney, KE Kulas, VL Demarest, KM Howard, K Carson, M Hales, M Ejemel, Q Li, Y Wang, R Peredo-Wende, A Ramani, G Singh, K Strle, NJ Mantis, KA McDonough, WT Lee |
Reproduction | 2021 |
|
Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
M Vogel-González, M Talló-Parra, V Herrera-Fernández, G Pérez-Vilaró, M Chillón, X Nogués, S Gómez-Zorrilla, I López-Montesinos, I Arnau-Barrés, ML Sorli-Redó, JP Horcajada, N García-Giralt, J Pascual, J Díez, R Vicente, R Güerri-Fernández |
Nutrients | 2021 |
|
The gut microbiota of critically ill patients with COVID-19
Paolo Gaibani, Federica D’Amico, Michele Bartoletti, Donatella Lombardo, Simone Rampelli, Giacomo Fornaro, Simona Coladonato, Antonio Siniscalchi, Maria C. Re, Pierluigi Viale, Patrizia Brigidi, Silvia Turroni, Maddalena Giannella |
Frontiers in Cellular and Infection Microbiology | 2021 |
|
Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients
XN Zhao, Y You, XM Cui, HX Gao, GL Wang, SB Zhang, L Yao, LJ Duan, KL Zhu, YL Wang, L Li, JH Lu, HB Wang, JF Fan, HW Zheng, EH Dai, LY Tian, MJ Ma |
Signal Transduction and Targeted Therapy | 2021 |
|
The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes
G Tang, M Huang, Y Luo, W Liu, Q Lin, L Mao, S Wu, Z Xiong, H Hou, Z Sun, F Wang |
Frontiers in immunology | 2021 |
|
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients
G Riva, S Castellano, V Nasillo, AM Ottomano, G Bergonzini, A Paolini, B Lusenti, J Milić, SD Biasi, L Gibellini, A Cossarizza, S Busani, M Girardis, G Guaraldi, C Mussini, R Manfredini, M Luppi, E Tagliafico, T Trenti |
Scientific Reports | 2021 |
|
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
Y Lévy, A Wiedemann, BP Hejblum, M Durand, C Lefebvre, M Surénaud, C Lacabaratz, M Perreau, E Foucat, M Déchenaud, P Tisserand, F Blengio, B Hivert, M Gauthier, M Cervantes-Gonzalez, D Bachelet, C Laouénan, L Bouadma, JF Timsit, Y Yazdanpanah, G Pantaleo, H Hocini, R Thiébaut |
iScience | 2021 |
|
Prolonged symptom onset to admission time is associated with severe Coronavirus disease: A meta combined propensity‐adjusted analysis
Y Guan, C Chen, A Guo, J Wei, J Cai, H Han, Z Hei, H Tan, X Li |
Journal of Medical Virology | 2021 |
|
Dysregulation of the Leukocyte Signaling Landscape during Acute COVID-19
Isaiah Turnbull, Anja Fuchs, Kenneth Remy, Michael Kelly, Elfaridah Frazier, Sarbani Ghosh, Shin-Wen Chang, Monty Mazer, Annie Hess, Jennifer Leonard, Mark Hoofnagle, Marco Colonna, Richard Hotchkiss |
Research square | 2021 |
|
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1)
JA Choreño-Parra, LA Jiménez-Álvarez, A Cruz-Lagunas, TS Rodríguez-Reyna, G Ramírez-Martínez, M Sandoval-Vega, DL Hernández-García, EM Choreño-Parra, YI Balderas-Martínez, ME Martinez-Sánchez, E Márquez-García, E Sciutto, J Moreno-Rodríguez, JO Barreto-Rodríguez, H Vázquez-Rojas, GI Centeno-Sáenz, N Alvarado-Peña, C Salinas-Lara, C Sánchez-Garibay, D Galeana-Cadena, G Hernández, C Mendoza-Milla, A Domínguez, J Granados, L Mena-Hernández, LÁ Pérez-Buenfil, G Domínguez-Cheritt, C Cabello-Gutiérrez, C Luna-Rivero, J Salas-Hernández, P Santillán-Doherty, J Regalado, A Hernández-Martínez, L Orozco, F Ávila-Moreno, EA García-Latorre, CM Hernández-Cárdenas, SA Khader, A Zlotnik, J Zúñiga |
Frontiers in immunology | 2021 |
|
Cytokine signatures of end organ injury in COVID-19
LG Gómez-Escobar, KL Hoffman, JJ Choi, A Borczuk, S Salvatore, SL Alvarez-Mulett, MD Galvan, Z Zhao, SE Racine-Brzostek, HS Yang, HW Stout-Delgado, ME Choi, AM Choi, SJ Cho, EJ Schenck |
Scientific Reports | 2021 |
|
COVID-19 Impairs Immune Response to Candida albicans
D Moser, K Biere, B Han, M Hoerl, G Schelling, A Choukér, T Woehrle |
Frontiers in immunology | 2021 |
|
A distinct association of inflammatory molecules with outcomes of COVID-19 in younger versus older adults
JJ Shin, S Jeon, S Unlu, J Par-Young, MS Shin, JK Kuster, Y Afinogenova, Y Kang, M Simonov, G Buller, R Bucala, I Kang |
Clinical Immunology | 2021 |
|
Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1
TJ Cory, RS Emmons, JR Yarbro, KL Davis, BD Pence |
Frontiers in immunology | 2021 |
|
Persistent High Percentage of HLA-DR+CD38high CD8+ T Cells Associated With Immune Disorder and Disease Severity of COVID-19
J Du, L Wei, G Li, M Hua, Y Sun, D Wang, K Han, Y Yan, C Song, R Song, H Zhang, J Han, J Liu, Y Kong |
Frontiers in immunology | 2021 |
|
Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
C Ruetsch, V Brglez, M Crémoni, K Zorzi, C Fernandez, S Boyer-Suavet, S Benzaken, E Demonchy, K Risso, J Courjon, E Cua, C Ichai, J Dellamonica, T Passeron, B Seitz-Polski |
Frontiers in Medicine | 2021 |
|
COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity
M Kroemer, L Spehner, L Vettoretti, A Bouard, G Eberst, SP Floury, G Capellier, Q Lepiller, E Orillard, L Mansi, AL Clairet, V Westeel, S Limat, M Dubois, L Malinowski, L Bohard, C Borg, C Chirouze, K Bouiller |
Journal of Infection | 2021 |
|
Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19
J Yang, M Zhong, E Zhang, K Hong, Q Yang, D Zhou, J Xia, YQ Chen, M Sun, B Zhao, J Xiang, Y Liu, Y Han, M Xu, , C Huang, Y Shang, H Yan, J Wu |
Journal of Molecular Cell Biology | 2021 |
|
High levels of soluble CD25 in COVID‐19 severity suggest a divergence between anti‐viral and pro‐inflammatory T‐cell responses
M Xie, J Yunis, Y Yao, J Shi, Y Yang, P Zhou, K Liang, Y Wan, A Mehdi, Z Chen, N Wang, S Xu, M Zhou, M Yu, K Wang, Y Tao, Y Zhou, X Li, X Liu, X Yu, Y Wei, Z Liu, J Sprent, D Yu |
IBMS BoneKEy | 2021 |
|
SARS‐CoV‐2 innate effector associations and viral load in early nasopharyngeal infection
TG Liou, FR Adler, BC Cahill, DR Cox, JE Cox, GJ Grant, KE Hanson, SC Hartsell, ND Hatton, MN Helms, JL Jensen, C Kartsonaki, Y Li, DT Leung, JE Marvin, EA Middleton, SM OsburnStaker, KA Packer, SM Shakir, AB Sturrock, KD Tardif, KJ Warren, LJ Waddoups, LJ Weaver, E Zimmerman, R Paine |
Physiological Reports | 2021 |
|
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients
S Bibert, N Guex, J Lourenco, T Brahier, M Papadimitriou-Olivgeris, L Damonti, O Manuel, R Liechti, L Götz, J Tschopp, M Quinodoz, P Vollenweider, JL Pagani, M Oddo, O Hügli, F Lamoth, V Erard, C Voide, M Delorenzi, N Rufer, F Candotti, C Rivolta, N Boillat-Blanco, PY Bochud |
Frontiers in immunology | 2021 |
|
Mechanisms of TLR4-Mediated Autophagy and Nitroxidative Stress
K Zhang, Q Huang, S Deng, Y Yang, J Li, S Wang |
Frontiers in Cellular and Infection Microbiology | 2021 |
|
Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection
K Singh, YC Chen, S Hassanzadeh, K Han, JT Judy, F Seifuddin, I Tunc, MN Sack, M Pirooznia |
Frontiers in Genetics | 2021 |
|
Improving the Efficacy of Regulatory T Cell Therapy
P Baeten, LV Zeebroeck, M Kleinewietfeld, N Hellings, B Broux |
Clinical Reviews in Allergy & Immunology | 2021 |
|
Interplay between inflammation and thrombosis in cardiovascular pathology
K Stark, S Massberg |
Nature Reviews Cardiology | 2021 |
|
Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome
XQ Chen, Z Xing, QD Chen, RJ Salvi, X Zhang, B Tycko, WC Mobley, YE Yu |
Frontiers in aging neuroscience | 2021 |
|
Complement Activation in Kidneys of Patients With COVID-19
F Pfister, E Vonbrunn, T Ries, HM Jäck, K Überla, G Lochnit, A Sheriff, M Herrmann, M Büttner-Herold, K Amann, C Daniel |
Frontiers in immunology | 2021 |
|
Microbial Pathogenesis: Infection and Immunity
U Kishore |
2021 | |
|
Lung Inflammation in Health and Disease, Volume II
YX Wang |
2021 | |
|
Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study
V Maldonado, C Hernandez-Ramírez, EA Oliva-Pérez, CO Sánchez-Martínez, JF Pimentel-González, JR Molina-Sánchez, YZ Jiménez-Villalba, J Chávez-Alderete, MA Loza-Mejía |
International Immunopharmacology | 2021 |
|
A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS: A computational and mechanistic study
ZZ Wang, K Li, AR Maskey, W Huang, AA Toutov, N Yang, K Srivastava, J Geliebter, R Tiwari, M Miao, XM Li |
The FASEB Journal | 2021 |
|
The Immunopathobiology of SARS-CoV-2 Infection
M Patel, F Shahjin, JD Cohen, M Hasan, J Machhi, H Chugh, S Singh, S Das, TA Kulkarni, J Herskovitz, DD Meigs, R Chandra, KS Hettie, RL Mosley, BD Kevadiya, HE Gendelman |
FEMS Microbiology Reviews | 2021 |
|
Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients
MT Liao, CC Wu, SF Wu, MC Lee, WC Hu, KW Tsai, CH Yang, CL Lu, SK Chiu, KC Lu |
Antioxidants | 2021 |
|
Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation
RD Castle, MA Williams, WC Bushell, JA Rindfleisch, CT Peterson, J Marzolf, K Brouwer, PJ Mills |
Journal of inflammation research | 2021 |
|
Differences in Immune Responses between Children and Adults with COVID-19
Y Yuan, Q Wang, D Sun, Z Wu, H Peng, X Liu, Y Liu |
2021 | |
|
Chemokines and chemokine receptors during COVID-19 infection
BA Khalil, NM Elemam, AA Maghazachi |
Computational and Structural Biotechnology Journal | 2021 |
|
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm
S Narain, DG Stefanov, AS Chau, AG Weber, G Marder, B Kaplan, P Malhotra, O Bloom, A Liu, ML Lesser, N Hajizadeh, SL Cohen, J Cookingham, DA Hirschwerk, NI Maria, SK Satapathy, C Sison, M Taylor, M Qiu |
Chest | 2021 |
|
Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
M Kiener, N Roldan, C Machahua, A Sengupta, T Geiser, OT Guenat, M Funke-Chambour, N Hobi, MK Julio |
Frontiers in Medicine | 2021 |
|
Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study
O Krysko, E Kondakova, O Vershinina, E Galova, A Blagonravova, E Gorshkova, C Bachert, M Ivanchenko, DV Krysko, M Vedunova |
Frontiers in immunology | 2021 |
|
Characteristics of T‐cell responses in COVID‐19 patients with prolonged SARS‐CoV‐2 positivity – a cohort study
J Yang, M Zhong, K Hong, Q Yang, E Zhang, D Zhou, J Xia, YQ Chen, M Sun, B Zhao, J Xiang, Y Liu, Y Han, M Xu, , C Huang, Y Shang, H Yan |
IBMS BoneKEy | 2021 |
|
Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes
A Kountouri, E Korakas, I Ikonomidis, A Raptis, N Tentolouris, G Dimitriadis, V Lambadiari |
Antioxidants | 2021 |
|
Coagulation abnormalities & thromboprophylaxis in COVID-19
A Jandial, A Gupta, A Malviya, S Agastam, D Kumar |
The Indian journal of medical research | 2021 |
|
On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers
A Vázquez-Jiménez, UE León, M Matadamas-Guzman, EA Muciño-Olmos, YE Martínez-López, T Escobedo-Tapia, O Resendis-Antonio |
Frontiers in immunology | 2021 |
|
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities
M Hayn, M Hirschenberger, L Koepke, R Nchioua, JH Straub, S Klute, V Hunszinger, F Zech, CP Bozzo, W Aftab, MH Christensen, C Conzelmann, JA Müller, SS Badarinarayan, CM Stürzel, I Forne, S Stenger, KK Conzelmann, J Münch, FI Schmidt, D Sauter, A Imhof, F Kirchhoff, KM Sparrer |
Cell Reports | 2021 |
|
Kidney involvement in multisystem inflammatory syndrome in children: a pediatric nephrologist’s perspective
SK Sethi, A Rana, H Adnani, M McCulloch, K Alhasan, A Sultana, R Safadi, N Agrawal, R Raina |
Clinical Kidney Journal | 2021 |
|
COVID-19 convalescent plasma composition and immunological effects in severe patients
Y Acosta-Ampudia, DM Monsalve, M Rojas, Y Rodríguez, JE Gallo, JC Salazar-Uribe, MJ Santander, MP Cala, W Zapata, MI Zapata, R Manrique, JM Pardo-Oviedo, B Camacho, C Ramírez-Santana, JM Anaya |
Journal of Autoimmunity | 2021 |
|
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
DM Smadja, SJ Mentzer, M Fontenay, MA Laffan, M Ackermann, J Helms, D Jonigk, R Chocron, GB Pier, N Gendron, S Pons, JL Diehl, C Margadant, C Guerin, EJ Huijbers, A Philippe, N Chapuis, P Nowak-Sliwinska, C Karagiannidis, O Sanchez, P Kümpers, D Skurnik, AM Randi, AW Griffioen |
Angiogenesis | 2021 |
|
sFlt-1 and CA 15.3 are indicators of endothelial damage and pulmonary fibrosis in SARS-CoV-2 infection
M Greco, S Suppressa, RA Lazzari, F Sicuro, C Catanese, G Lobreglio |
Scientific Reports | 2021 |
|
Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes)
E Gusev, A Sarapultsev, D Hu, V Chereshnev |
International journal of molecular sciences | 2021 |
|
Hepcidin Increases Cytokines in Alzheimer’s Disease and Down’s Syndrome Dementia: Implication of Impaired Iron Homeostasis in Neuroinflammation
AA Raha, SD Ghaffari, J Henderson, S Chakraborty, K Allinson, RP Friedland, A Holland, SH Zaman, EB Mukaetova-Ladinska, R Raha-Chowdhury |
Frontiers in aging neuroscience | 2021 |
|
Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19
RK Thimmulappa, KK Mudnakudu-Nagaraju, C Shivamallu, KJ Subramaniam, A Radhakrishnan, S Bhojraj, G Kuppusamy |
Heliyon | 2021 |
|
Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome
P Cuvelier, H Roux, A Couëdel-Courteille, J Dutrieux, C Naudin, BC de Muylder, R Cheynier, P Squara, S Marullo |
Critical Care | 2021 |
|
Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19
Z Sun, G He, N Huang, K Thilakavathy, JC Lim, SS Kumar, C Xiong |
Frontiers in pharmacology | 2021 |
|
SARS-CoV-2 may affect the immune response via direct inhibition of T cell receptor: Mechanistic hypothesis and rationale
AB Sigalov |
Biochimie | 2021 |
|
SARS-CoV-2: is there neuroinvasion?
C McQuaid, M Brady, R Deane |
Fluids and barriers of the CNS | 2021 |
|
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals
H Lingel, S Meltendorf, U Billing, C Thurm, K Vogel, C Majer, F Prätsch, D Roggenbuck, HG Heuft, T Hachenberg, E Feist, D Reinhold, MC Brunner-Weinzierl |
Journal of Autoimmunity | 2021 |
|
Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19
R Bhandari, G Khanna, D Kaushik, A Kuhad |
Molecular Neurobiology | 2021 |
|
Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson’s Disease
IO Awogbindin, B Ben-Azu, BA Olusola, ET Akinluyi, PA Adeniyi, TD Paolo, MÈ Tremblay |
Frontiers in cellular neuroscience | 2021 |
|
Xanthine Oxidase-Induced Inflammatory Responses in Respiratory Epithelial Cells: A Review in Immunopathology of COVID-19
IP Pratomo, DR Noor, K Kusmardi, A Rukmana, RI Paramita, L Erlina, F Fadilah, A Gayatri, M Fitriani, TT Purnomo, A Ariane, R Heryanto, A Tedjo, HJ Moshage |
International Journal of Inflammation | 2021 |
|
Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype
AC Trombetta, GB Farias, AM Gomes, A Godinho-Santos, P Rosmaninho, CM Conceição, J Laia, DF Santos, AR Almeida, C Mota, A Gomes, M Serrano, M Veldhoen, AE Sousa, SM Fernandes |
Frontiers in immunology | 2021 |
|
Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity
AD Lorenzo, V Estato, HC Castro-Faria-Neto, E Tibirica |
Journal of inflammation research | 2021 |
|
Neutrophils at the crossroads of acute viral infections and severity
S Rawat, S Vrati, A Banerjee |
Molecular Aspects of Medicine | 2021 |
|
Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity
M Delshad, A Safaroghli-Azar, A Pourbagheri-Sigaroodi, B Poopak, S Shokouhi, D Bashash |
International Immunopharmacology | 2021 |
|
Immunosuppression in kidney transplant recipients with COVID-19 infection – where do we stand and where are we heading?
A Daoud, A Alqassieh, D Alkhader, MA Salas, V Rao, T Fülöp, KM Soliman |
Renal Failure | 2021 |
|
COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury
A Lasbleiz, B Gaborit, A Soghomonian, A Bartoli, P Ancel, A Jacquier, A Dutour |
Frontiers in Endocrinology | 2021 |
|
Digestive system involvement of infections with SARS-CoV-2 and other coronaviruses: Clinical manifestations and potential mechanisms
GF Zhan, Y Wang, N Yang, AL Luo, SY Li |
World journal of gastroenterology : WJG | 2021 |
|
Cytokines: From Clinical Significance to Quantification
C Liu, D Chu, K KalantarZadeh, J George, HA Young, G Liu |
Advanced Science | 2021 |
|
Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2
SY Cheon, BN Koo |
International journal of molecular sciences | 2021 |
|
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
VP Sukhatme, AM Reiersen, SJ Vayttaden, VV Sukhatme |
Frontiers in pharmacology | 2021 |
|
Neutrophils in COVID-19
N Reusch, ED Domenico, L Bonaguro, J Schulte-Schrepping, K Baßler, JL Schultze, AC Aschenbrenner |
Frontiers in immunology | 2021 |
|
Regulatory T cells in COVID-19
H Wang, Z Wang, W Cao, Q Wu, Y Yuan, X Zhang |
Aging and disease | 2021 |
|
The role of CD4 + FoxP3 + regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment
Y Wang, J Zheng, S Islam, Y Yang, Y Hu, X Chen |
International journal of biological sciences | 2021 |
|
Maternal natural killer cells at the intersection between reproduction and mucosal immunity
EV Shmeleva, F Colucci |
Mucosal Immunology | 2021 |
|
Uremia-Associated Immunological Aging and Severity of COVID-19 Infection
MG Betjes |
Frontiers in Medicine | 2021 |
|
Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections
AE Kennedy, L Cook, JA Breznik, B Cowbrough, JG Wallace, A Huynh, JW Smith, K Son, H Stacey, J Ang, A McGeer, BL Coleman, M Larché, M Larché, N Hambly, P Nair, K Ask, MS Miller, J Bramson, MK Levings, I Nazy, S Svenningsen, M Mukherjee, DM Bowdish |
Viruses | 2021 |
|
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
OJ McElvaney, GF Curley, S Rose-John, NG McElvaney |
The lancet. Respiratory medicine | 2021 |
|
A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder
AR Sarohan, M Kızıl, AÇ İnkaya, S Mahmud, M Akram, O Cen |
Cellular Signalling | 2021 |
|
Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic
G Baresi, M Giacomelli, D Moratto, M Chiarini, IC Conforti, R Padoan, P Poli, S Timpano, F Caldarale, R Badolato |
Frontiers in Pediatrics | 2021 |
|
Immunological analysis of the murine anti‐CD3‐induced cytokine release syndrome model and therapeutic efficacy of anti‐cytokine antibodies
L Nouveau, V Buatois, L Cons, L Chatel, G Pontini, N Pleche, WG Ferlin |
European Journal of Immunology | 2021 |
|
Targeting mesenchymal stem cell therapy for severe pneumonia patients
G Lam, Y Zhou, JX Wang, YP Tsui |
World journal of stem cells | 2021 |
|
A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS
L Reyes, MA Sanchez-Garcia, T Morrison, AJ Howden, ER Watts, S Arienti, P Sadiku, P Coelho, AS Mirchandani, A Zhang, D Hope, SK Clark, J Singleton, S Johnston, R Grecian, A Poon, S McNamara, I Harper, MH Fourman, AJ Brenes, S Pathak, A Lloyd, GR Blanco, A von Kriegsheim, B Ghesquiere, W Vermaelen, CT Cologna, K Dhaliwal, N Hirani, DH Dockrell, MK Whyte, D Griffith, DA Cantrell, SR Walmsley |
Wellcome Open Research | 2021 |
|
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
R Duerr, KM Crosse, AM Valero-Jimenez, M Dittmann |
Microorganisms | 2021 |
|
Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice
M Ghasemzadeh, A Ghasemzadeh, E Hosseini |
Human Immunology | 2021 |
|
Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
VJ Venditto, D Haydar, A Abdel-Latif, JC Gensel, MI Anstead, MG Pitts, J Creameans, TJ Kopper, C Peng, DJ Feola |
Frontiers in immunology | 2021 |
|
PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking
C Lugnier, HM Al-Kuraishy, E Rousseau |
Biochemical Pharmacology | 2021 |
|
Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6
P Li, Z Lu, Q Li, Z Wang, Y Guo, C Cai, S Wang, P Liu, X Su, Y Huang, Y Dong, W Qiu, Y Ling, L Yarmus, F Luo, L Zeng, C Bai, W Zhang |
Frontiers in Molecular Biosciences | 2021 |
|
Human Coronaviruses: Counteracting the Damage by Storm
D Schoeman, BC Fielding |
Viruses | 2021 |
|
Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers
V Seery, SC Raiden, SC Algieri, NA Grisolía, D Filippo, ND Carli, SD Lalla, H Cairoli, MJ Chiolo, CN Meregalli, LI Gimenez, G Gregorio, M Sarli, AL Alcalde, C Davenport, MJ Bruera, N Simaz, MF Pérez, V Nivela, C Bayle, P Tuccillo, MT Agosta, H Pérez, SV Nova, P Suárez, EM Takata, M García, J Lattner, MJ Rolón, P Coll, I Sananez, MP Holgado, F Ferrero, J Geffner, L Arruvito |
EBioMedicine | 2021 |
|
Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications
AM Pasini, C Stranieri, L Cominacini, C Mozzini |
Antioxidants | 2021 |
|
Single-cell analysis reveals cell communication triggered by macrophages associated with the reduction and exhaustion of CD8+ T cells in COVID-19
L He, Q Zhang, Y Zhang, Y Fan, F Yuan, S Li |
Cell Communication and Signaling | 2021 |
|
Immune response to COVID-19 in older adults
M Jergovic, CP Coplen, JL Uhrlaub, J Nikolich-Zugich |
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation | 2021 |
|
COVID-19: Immunology, Immunopathogenesis and Potential Therapies
A Bhardwaj, L Sapra, C Saini, Z Azam, PK Mishra, B Verma, GC Mishra, RK Srivastava |
International Reviews of Immunology | 2021 |
|
Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer
AM Zahran, O El-Badawy, WA Ali, ZG Mahran, EE Mahran, A Rayan, HA Messiha |
PloS one | 2021 |
|
The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
G Morris, CC Bortolasci, BK Puri, W Marx, A O'Neil, E Athan, K Walder, M Berk, L Olive, AF Carvalho, M Maes |
Cytokine | 2021 |
|
NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
C Gillot, J Favresse, F Mullier, T Lecompte, JM Dogné, J Douxfils |
Frontiers in pharmacology | 2021 |
|
SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis
PS Aghbash, N Eslami, A Shamekh, T Entezari-Maleki, HB Baghi |
Life Sciences | 2021 |
|
Metabolic programs define dysfunctional immune responses in severe COVID-19 patients
EA Thompson, K Cascino, AA Ordonez, W Zhou, A Vaghasia, A Hamacher-Brady, NR Brady, IH Sun, R Wang, AZ Rosenberg, M Delannoy, R Rothman, K Fenstermacher, L Sauer, K Shaw-Saliba, EM Bloch, AD Redd, AA Tobian, M Horton, K Smith, A Pekosz, FR DAlessio, S Yegnasubramanian, H Ji, AL Cox, JD Powell |
Cell Reports | 2021 |
|
COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy
L Xie, Z Zhang, Q Wang, Y Chen, D Lu, W Wu |
Frontiers in Endocrinology | 2021 |
|
Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
E Mortaz, P Tabarsi, H Jamaati, ND Roofchayee, NK Dezfuli, SM Hashemian, A Moniri, M Marjani, M Malekmohammad, D Mansouri, M Varahram, G Folkerts, IM Adcock |
Frontiers in immunology | 2021 |
|
Upregulation of CCR4 in activated CD8 + T cells indicates enhanced lung homing in patients with severe acute SARS‐CoV‐2 infection
S Spoerl, AN Kremer, M Aigner, N Eisenhauer, P Koch, L Meretuk, P Löffler, M Tenbusch, C Maier, K Überla, L Heinzerling, B Frey, G LutznyGeier, TH Winkler, G Krönke, M Vetter, H Bruns, MF Neurath, A Mackensen, AE Kremer, S Völkl |
European Journal of Immunology | 2021 |
|
Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients
AH Janneh, MF Kassir, CJ Dwyer, P Chakraborty, JS Pierce, PA Flume, H Li, SN Nadig, S Mehrotra, B Ogretmen |
Scientific Reports | 2021 |
|
COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
CP Landstra, EJ de Koning |
Frontiers in Endocrinology | 2021 |
|
Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2
CM Su, L Wang, D Yoo |
Scientific Reports | 2021 |
|
2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2
MA Unal, F Bayrakdar, L Fusco, O Besbinar, CE Shuck, S Yalcin, MT Erken, A Ozkul, C Gurcan, O Panatli, GY Summak, C Gokce, M Orecchioni, A Gazzi, F Vitale, J Somers, E Demir, SS Yildiz, H Nazir, JC Grivel, D Bedognetti, A Crisanti, KC Akcali, Y Gogotsi, LG Delogu, A Yilmazer |
Nano Today | 2021 |
|
Interplay between hypoxia and inflammation contributes to the progression and severity of respiratory viral diseases
S Bhattacharya, S Agarwal, NM Shrimali, P Guchhait |
Molecular Aspects of Medicine | 2021 |
|
Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
A Hasan, E Al-Ozairi, Z Al-Baqsumi, R Ahmad, F Al-Mulla |
ImmunoTargets and Therapy | 2021 |
|
Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases
AM Johnson, R Barigye, H Saminathan |
Human Vaccines & Immunotherapeutics | 2021 |
|
Alterations in T and B cell function persist in convalescent COVID-19 patients
HA Shuwa, TN Shaw, SB Knight, K Wemyss, FA McClure, L Pearmain, I Prise, C Jagger, DJ Morgan, S Khan, O Brand, ER Mann, A Ustianowski, ND Bakerly, P Dark, CE Brightling, S Brij, T Felton, A Simpson, JR Grainger, T Hussell, JE Konkel, M Menon, R Ahmed, M Avery, K Birchall, E Charsley, A Chenery, C Chew, R Clark, E Connolly, K Connolly, S Dawson, L Durrans, H Durrington, J Egan, K Filbey, C Fox, H Francis, M Franklin, S Glasgow, N Godfrey, KJ Gray, S Grundy, J Guerin, P Hackney, C Hayes, E Hardy, J Harris, A John, B Jolly, V Kästele, G Kerry, S Lui, L Lin, AG Mathioudakis, J Mitchell, C Moizer, K Moore, S Moss, SM Baker, R Oliver, G Padden, C Parkinson, M Phuycharoen, A Saha, B Salcman, NA Scott, S Sharma, J Shaw, J Shaw, E Shepley, L Smith, S Stephan, R Stephens, G Tavernier, R Tudge, L Wareing, R Warren, T Williams, L Willmore, M Younas |
The American Journal of Medicine | 2021 |
|
Zinc deficiency as a possible risk factor for increased susceptibility and severe progression of Corona Virus Disease 19
I Wessels, B Rolles, AJ Slusarenko, L Rink |
British Journal of Nutrition | 2021 |
|
Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality
B Alosaimi, A Mubarak, ME Hamed, AZ Almutairi, AA Alrashed, A AlJuryyan, M Enani, FQ Alenzi, W Alturaiki |
Frontiers in immunology | 2021 |
|
An overview of basic molecular biology of SARS-CoV-2 and current COVID-19 prevention strategies
A Das, R Ahmed, S Akhtar, K Begum, S Banu |
Gene Reports | 2021 |
|
Immunometabolic bases of type 2 diabetes in the severity of COVID-19
R Viurcos-Sanabria, G Escobedo |
World journal of diabetes | 2021 |
|
A bird's eye view on the role of dendritic cells in SARS‐CoV‐2 infection: Perspectives for immune‐based vaccines
D Galati, S Zanotta, L Capitelli, M Bocchino |
Allergy | 2021 |
|
Peripheral and lung resident memory T cell responses against SARS-CoV-2
J Grau-Expósito, N Sánchez-Gaona, N Massana, M Suppi, A Astorga-Gamaza, D Perea, J Rosado, A Falcó, C Kirkegaard, A Torrella, B Planas, J Navarro, P Suanzes, D Álvarez-Sierra, A Ayora, I Sansano, J Esperalba, C Andrés, A Antón, SR y Cajal, B Almirante, R Pujol-Borrell, V Falcó, J Burgos, MJ Buzón, M Genescà |
Nature Communications | 2021 |
|
Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection
JL Simões, JB de Araújo, MD Bagatini |
Molecular Neurobiology | 2021 |
|
Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection
NS Sharif-Askari, FS Sharif-Askari, B Mdkhana, SA Heialy, HS Alsafar, R Hamoudi, Q Hamid, R Halwani |
Molecular Therapy — Methods & Clinical Development | 2021 |
|
Immunotherapy of Multiple Myeloma: Promise and Challenges
HN Abramson |
ImmunoTargets and Therapy | 2021 |
|
How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era
J Caron, LA Ridgley, M Bodman-Smith |
Frontiers in immunology | 2021 |
|
Endothelial dysfunction in COVID-19 calls for immediate attention: the emerging roles of the endothelium in inflammation caused by SARS-CoV-2
W Hang, C Chen, XA Zhang, DW Wang |
Frontiers of Medicine | 2021 |
|
Therapeutic potential of induced iron depletion using iron chelators in Covid-19
PP Naseef, M Elayadeth-Meethal, KT Salim, A Anjana, C Muhas, KA Vajid, MS Kuruniyan |
Saudi Journal of Biological Sciences | 2021 |
|
Triple Jeopardy in Ageing: COVID-19, Co-morbidities and Inflamm-ageing
IM Rea, HD Alexander |
Ageing Research Reviews | 2021 |
|
Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes
N Liu, C Jiang, P Cai, Z Shen, W Sun, H Xu, M Fang, X Yao, L Zhu, X Gao, J Fang, J Lin, C Guo, K Qu |
Cell Reports | 2021 |
|
Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects
DM Mizurini, ED Hottz, PT Bozza, RQ Monteiro |
Frontiers in Cardiovascular Medicine | 2021 |
|
Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients
F Palmas, J Clarke, RA Colas, EA Gomez, A Keogh, M Boylan, N McEvoy, OJ McElvaney, O McElvaney, R Alalqam, NG McElvaney, GF Curley, J Dalli, F DAcquisto |
PloS one | 2021 |
|
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
EC Morris, SS Neelapu, T Giavridis, M Sadelain |
Nature Reviews Immunology | 2021 |
|
A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling
D Hasan, A Shono, CK van Kalken, PJ van der Spek, EP Krenning, T Kotani |
Purinergic Signalling | 2021 |
|
Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy
X Li, M Shao, X Zeng, P Qian, H Huang |
Signal Transduction and Targeted Therapy | 2021 |
|
Potential Effects of Melatonin and Micronutrients on Mitochondrial Dysfunction during a Cytokine Storm Typical of Oxidative/Inflammatory Diseases
VM Giménez, N de las Heras, L Ferder, V Lahera, RJ Reiter, W Manucha |
Diseases | 2021 |
|
Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19
V Chilunda, P Martinez-Aguado, LC Xia, L Cheney, A Murphy, V Veksler, V Ruiz, TM Calderon, JW Berman |
Frontiers in immunology | 2021 |
|
Immune dysregulation and system pathology in COVID-19
M Jamal, HI Bangash, M Habiba, Y Lei, T Xie, J Sun, Z Wei, Z Hong, L Shao, Q Zhang |
Virulence | 2021 |
|
CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients
M Hernandez-Cedeño, R Venegas-Rodriguez, R Peña-Ruiz, M Bequet-Romero, R Santana-Sanchez, E Penton-Arias, G Martinez-Donato, G Guillén-Nieto, M del Carmen Dominguez-Horta |
Cell Stress and Chaperones | 2021 |
|
Immunological Approaches to the Treatment of Novel Coronavirus Infection (Review)
NA Lyubavina, SG Saltsev, NV Menkov, LV Tyurikova, SS Plastinina, ML Shonia, AA Tulichev, MY Milyutina, EV Makarova |
2021 | |
|
Monocytes and Macrophages in COVID-19
R Knoll, JL Schultze, J Schulte-Schrepping |
Frontiers in immunology | 2021 |
|
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
LM Khosroshahi, M Rokni, T Mokhtari, F Noorbakhsh |
International Immunopharmacology | 2021 |
|
Personalized therapy: can it tame the COVID-19 monster?
M Arish, F Naz |
Personalized Medicine | 2021 |
|
Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19
J Neidleman, X Luo, AF George, M McGregor, J Yang, C Yun, V Murray, G Gill, WC Greene, J Vasquez, SA Lee, E Ghosn, KL Lynch, NR Roan |
Cell Reports | 2021 |
|
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
NA Valdez-Cruz, E García-Hernández, C Espitia, L Cobos-Marín, C Altamirano, CG Bando-Campos, LF Cofas-Vargas, EW Coronado-Aceves, RA González-Hernández, P Hernández-Peralta, D Juárez-López, PA Ortega-Portilla, S Restrepo-Pineda, P Zelada-Cordero, MA Trujillo-Roldán |
Microbial cell factories | 2021 |
|
COVID-19 in Immunosuppressed Children
E Nicastro, L Verdoni, LR Bettini, G Zuin, A Balduzzi, G Montini, A Biondi, L D'Antiga |
Frontiers in Pediatrics | 2021 |
|
Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis
YW Kang, S Park, KJ Lee, D Moon, YM Kim, SW Lee |
Immune Network | 2021 |
|
Molecular Insights into the Crosstalk Between Immune Inflammation Nexus and SARS-CoV-2 Virus
P Bose, P Sunita, SP Pattanayak |
Current Microbiology | 2021 |
|
When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak
Y Taoufik, MG de Goër de Herve, S Corgnac, A Durrbach, F Mami-Chouaib |
Frontiers in immunology | 2021 |
|
Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential
K Suvarna, D Biswas, MG Pai, A Acharjee, R Bankar, V Palanivel, A Salkar, A Verma, A Mukherjee, M Choudhury, S Ghantasala, S Ghosh, A Singh, A Banerjee, A Badaya, S Bihani, G Loya, K Mantri, A Burli, J Roy, A Srivastava, S Agrawal, O Shrivastav, J Shastri, S Srivastava |
Frontiers in physiology | 2021 |
|
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19
LA Vella, JR Giles, AE Baxter, DA Oldridge, C Diorio, L Kuri-Cervantes, C Alanio, MB Pampena, JE Wu, Z Chen, YJ Huang, EM Anderson, S Gouma, KO McNerney, J Chase, C Burudpakdee, JH Lee, SA Apostolidis, AC Huang, D Mathew, O Kuthuru, EC Goodwin, ME Weirick, MJ Bolton, CP Arevalo, A Ramos, CJ Jasen, PE Conrey, S Sayed, HM Giannini, K DAndrea, NJ Meyer, EM Behrens, H Bassiri, SE Hensley, SE Henrickson, DT Teachey, MR Betts, EJ Wherry |
Science Immunology | 2021 |
|
The Effects of COVID-19 on the Placenta During Pregnancy
HS Rad, J Röhl, N Stylianou, MC Allenby, SR Bazaz, ME Warkiani, FS Guimaraes, VL Clifton, A Kulasinghe |
Frontiers in immunology | 2021 |
|
The Immunopathology of COVID-19 and the Cannabis Paradigm
N Paland, A Pechkovsky, M Aswad, H Hamza, T Popov, E Shahar, I Louria-Hayon |
Frontiers in immunology | 2021 |
|
Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease
HF Peñaloza, JS Lee, P Ray, TE Morrison |
PLoS pathogens | 2021 |
|
Findings from Studies Are Congruent with Obesity Having a Viral Origin, but What about Obesity-Related NAFLD?
G Tarantino, V Citro, M Cataldi |
Viruses | 2021 |
|
A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19
JG Yeo, JY Leong, SH Tay, KD Nadua, DE Anderson, AJ Lim, XW Ng, SL Poh, D Guo, KN Yaung, P Kumar, M Wasser, SN Hazirah, N Sutamam, CJ Chua, M Qui, R Foo, AM Gamage, KT Yeo, L Ramakrishna, T Arkachaisri, BE Young, DC Lye, LF Wang, CY Chong, NW Tan, J Li, KQ Kam, F Ginhoux, KC Thoon, JK Chan, CF Yung, S Albani |
Frontiers in immunology | 2021 |
|
The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
D Darif, I Hammi, A Kihel, IE Saik, F Guessous, K Akarid |
Microbial Pathogenesis | 2021 |
|
Senescence-associated hyper-activation to inflammatory stimuli in vitro
V Budamagunta, S Manohar-Sindhu, Y Yang, Y He, DO Traktuev, TC Foster, D Zhou |
Aging | 2021 |
|
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19
B Krämer, R Knoll, L Bonaguro, M ToVinh, J Raabe, R Astaburuaga-García, J Schulte-Schrepping, KM Kaiser, GJ Rieke, J Bischoff, MB Monin, C Hoffmeister, S Schlabe, ED Domenico, N Reusch, K Händler, G Reynolds, N Blüthgen, G Hack, C Finnemann, HD Nischalke, CP Strassburg, E Stephenson, Y Su, L Gardner, D Yuan, D Chen, J Goldman, P Rosenstiel, SV Schmidt, E Latz, K Hrusovsky, AJ Ball, JM Johnson, PA Koenig, FI Schmidt, M Haniffa, JR Heath, BM Kümmerer, V Keitel, B Jensen, P Stubbemann, F Kurth, LE Sander, B Sawitzki, AC Aschenbrenner, JL Schultze, J Nattermann, J Altmüller, A Angelov, AC Aschenbrenner, R Bals, A Bartholomäus, A Becker, M Becker, D Bezdan, M Bitzer, C Blumert, E Bonifacio, P Bork, B Boyke, H Blum, N Casadei, T Clavel, M Colome-Tatche, M Cornberg, IA Velázquez, A Diefenbach, A Dilthey, N Fischer, K Förstner, S Franzenburg, JS Frick, G Gabernet, J Gagneur, T Ganzenmueller, M Gauder, J Geißert, A Goesmann, S Göpel, A Grundhoff, H Grundmann, T Hain, F Hanses, U Hehr, A Heimbach, M Hoeper, F Horn, D Hübschmann, M Hummel, T Iftner, A Iftner, T Illig, S Janssen, J Kalinowski, R Kallies, B Kehr, A Keller, OT Keppler, S Kim-Hellmuth, C Klein, M Knop, O Kohlbacher, K Köhrer, J Korbel, PG Kremsner, D Kühnert, I Kurth, M Landthaler, Y Li, KU Ludwig, O Makarewicz, F Marini, M Marz, AC McHardy, C Mertes, M Münchhoff, S Nahnsen, M Nöthen, F Ntoumi, P Nürnberg, S Ossowski, J Overmann, S Peter, K Pfeffer, I Pink, AR Poetsch, U Protzer, A Pühler, N Rajewsky, M Ralser, K Reiche, O Rieß, S Ripke, UN da Rocha, P Rosenstiel, AE Saliba, LE Sander, B Sawitzki, S Scheithauer, P Schiffer, J Schmid-Burgk, W Schneider, EC Schulte, JL Schultze, A Sczyrba, ML Sharaf, Y Singh, M Sonnabend, O Stegle, J Stoye, F Theis, T Ulas, J Vehreschild, TP Velavan, J Vogel, S Volland, M von Kleist, A Walker, J Walter, D Wieczorek, S Winkler, J Ziebuhr |
Immunity | 2021 |
|
The signal pathways and treatment of cytokine storm in COVID-19
L Yang, X Xie, Z Tu, J Fu, D Xu, Y Zhou |
Signal Transduction and Targeted Therapy | 2021 |
|
Animal Models of COVID-19 II. Comparative Immunology
RT Veenhuis, CJ Zeiss |
ILAR journal / National Research Council, Institute of Laboratory Animal Resources | 2021 |
|
The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients
D Dęborska-Materkowska, D Kamińska |
Viruses | 2021 |
|
Hypotheses and facts for genetic factors related to severe COVID-19
SV Kotsev, D Miteva, S Krayselska, M Shopova, M Pishmisheva-Peleva, SA Stanilova, T Velikova |
World Journal of Virology | 2021 |
|
Type I Interferons in COVID-19 Pathogenesis
E Palermo, DD Carlo, M Sgarbanti, J Hiscott |
Biology : open access journal | 2021 |
|
Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19
H Fouladseresht, M Doroudchi, N Rokhtabnak, H Abdolrahimzadehfard, A Roudgari, G Sabetian, S Paydar |
Cytokine & Growth Factor Reviews | 2021 |
|
Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19
S Patel, B Saxena, P Mehta |
Heliyon | 2021 |
|
Immune response variables and viral mutations impact on COVID-19 reinfection and relapse
S Sanaie, E Golipour, A Shamekh, MR Sadaie, A Mahmoodpoor, M Yousefi |
International Immunopharmacology | 2021 |
|
Age-Related Expression of IFN-λ1 Versus IFN-I and Beta-Defensins in the Nasopharynx of SARS-CoV-2-Infected Individuals
C Gilbert, C Lefeuvre, L Preisser, A Pivert, R Soleti, S Blanchard, Y Delneste, A Ducancelle, D Couez, P Jeannin |
Frontiers in immunology | 2021 |
|
ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling via Elevating Suppressor of Cytokine Signaling 1
R Wang, X Yang, M Chang, Z Xue, W Wang, L Bai, S Zhao, E Liu |
Frontiers in microbiology | 2021 |
|
Overview of the pathogenesis of COVID‑19 (Review)
C Li, Q He, H Qian, J Liu |
Experimental and therapeutic medicine | 2021 |
|
The severity of SARS-CoV-2 infection is dictated by host factors? Epigenetic perspectives
DV Sethumadhavan, CA Jabeena, G Govindaraju, A Soman, A Rajavelu |
2021 | |
|
Understanding the role of milk in regulating human homeostasis in the context of the COVID-19 global pandemic
G Ren, G Cheng, J Wang |
Trends in Food Science & Technology | 2021 |
|
Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody
S Gebremeskel, J Schanin, KM Coyle, M Butuci, T Luu, EC Brock, A Xu, A Wong, J Leung, W Korver, RD Morin, RP Schleimer, BS Bochner, BA Youngblood |
Frontiers in immunology | 2021 |
|
Neurological pathophysiology of SARS‐CoV‐2 and pandemic potential RNA viruses: a comparative analysis
N Chakravarty, T Senthilnathan, S Paiola, P Gyani, SC Cario, E Urena, A Jeysankar, P Jeysankar, JI Irudayam, SN Subramanian, H Lavretsky, S Joshi, G Garcia, A Ramaiah, V Arumugaswami |
FEBS Letters | 2021 |
|
The Binary Model of Chronic Diseases Applied to COVID-19
Z Elkoshi |
Frontiers in immunology | 2021 |
|
T cell immunity to SARS-CoV-2 following natural infection and vaccination
AT DiPiazza, BS Graham, TJ Ruckwardt |
Biochemical and Biophysical Research Communications | 2021 |
|
Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes
S Shao, Q Yang, R Pan, X Yu, Y Chen |
Frontiers in Endocrinology | 2021 |
|
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
J Roberts, AL Pritchard, AT Treweeke, AG Rossi, N Brace, P Cahill, SM MacRury, J Wei, IL Megson |
Frontiers in Cardiovascular Medicine | 2021 |
|
MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19
V Bumiller-Bini, C de Freitas Oliveira-Toré, TM Carvalho, GC Kretzschmar, LB Gonçalves, N de Moura Alencar, MA Filho, MH Beltrame, AB Boldt |
Genetics and molecular biology | 2021 |
|
Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients
Y Guo, T Li, X Xia, B Su, H Li, Y Feng, J Han, X Wang, L Jia, Z Bao, J Li, Y Liu, L Li |
Frontiers in immunology | 2021 |
|
LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications
B Combadière, L Adam, N Guillou, P Quentric, P Rosenbaum, K Dorgham, O Bonduelle, C Parizot, D Sauce, J Mayaux, CE Luyt, A Boissonnas, Z Amoura, V Pourcher, M Miyara, G Gorochov, A Guihot, C Combadière |
Frontiers in immunology | 2021 |
|
A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene
N Magusali, AC Graham, TM Piers, P Panichnantakul, U Yaman, M Shoai, RH Reynolds, JA Botia, KJ Brookes, T Guetta-Baranes, E Bellou, S Bayram, D Sokolova, M Ryten, CS Frigerio, V Escott-Price, K Morgan, JM Pocock, J Hardy, DA Salih |
Brain | 2021 |
|
Viral coinfections in COVID‐19
PS Aghbash, N Eslami, M Shirvaliloo, HB Baghi |
Journal of Medical Virology | 2021 |
|
COVID-19 illness and autoimmune diseases: recent insights
J Li, HH Liu, XD Yin, CC Li, J Wang |
Inflammation Research | 2021 |
|
The Immunological Factors Predisposing to Severe Covid-19 Are Already Present in Healthy Elderly and Men
G Kilic, O Bulut, M Jaeger, R ter Horst, VA Koeken, SJ Moorlag, VP Mourits, C de Bree, J Domínguez-Andrés, LA Joosten, MG Netea |
Frontiers in immunology | 2021 |
|
COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond
BM Mussa, A Srivastava, AJ Verberne |
Viruses | 2021 |
|
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
P Tebas, SP Yang, JD Boyer, EL Reuschel, A Patel, A Christensen-Quick, VM Andrade, MP Morrow, K Kraynyak, J Agnes, M Purwar, A Sylvester, J Pawlicki, E Gillespie, I Maricic, FI Zaidi, KY Kim, Y Dia, D Frase, P Pezzoli, K Schultheis, TR Smith, SJ Ramos, T McMullan, K Buttigieg, MW Carroll, J Ervin, MC Diehl, E Blackwood, MP Mammen, J Lee, MJ Dallas, AS Brown, JE Shea, JJ Kim, DB Weiner, KE Broderick, LM Humeau |
2021 | |
|
Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies
BG Pijls, S Jolani, A Atherley, RT Derckx, JI Dijkstra, GH Franssen, S Hendriks, A Richters, A Venemans-Jellema, S Zalpuri, MP Zeegers |
BMJ Open | 2021 |
|
Interaction of the inflammatory response and megakaryocytes in COVID-19 infection
HL Battina, VJ Alentado, EF Srour, AR Moliterno, MA Kacena |
Experimental Hematology | 2021 |
|
The Journal of Clinical Investigation in the time of COVID-19
A Casadevall, S Jackson, GL Semenza, GF Tomaselli, RS Ahima |
Journal of Clinical Investigation | 2021 |
|
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
A Mazzoni, L Salvati, L Maggi, F Annunziato, L Cosmi |
Seminars in Immunology | 2021 |
|
The role of unconventional T cells in COVID-19
K Orumaa, MR Dunne |
Irish Journal of Medical Science | 2021 |
|
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis
BJ Langford, M So, S Raybardhan, V Leung, JP Soucy, D Westwood, N Daneman, DR MacFadden |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021 |
|
Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences
J Meng, Y Ma, J Jia, M Wang, J Teng, H Shi, H Liu, Y Su, J Ye, Y Sun, X Cheng, H Chi, T Liu, D Zhu, Z Zhou, L Wan, Z Wang, F Wang, X Qiao, X Chen, H Zhang, Z Tang, C Yang, Q Hu |
Frontiers in immunology | 2021 |
|
Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China
M Wang, Y Fan, Y Chai, W Cheng, K Wang, J Cao, X Hu |
Frontiers in Cellular and Infection Microbiology | 2021 |
|
T Cells: Warriors of SARS-CoV-2 Infection
P de Candia, F Prattichizzo, S Garavelli, G Matarese |
Trends in Immunology | 2021 |
|
COVID-19, cytokines, inflammation, and spices: How are they related?
AB Kunnumakkara, V Rana, D Parama, K Banik, S Girisa, S Henamayee, KK Thakur, U Dutta, P Garodia, SC Gupta, BB Aggarwal |
Life Sciences | 2021 |
|
The laboratory findings and different COVID-19 severities: a systematic review and meta-analysis
E Kazemi, RS Nejat, F Ashkan, H Sheibani |
Annals of clinical microbiology and antimicrobials | 2021 |
|
High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19
A Ma, L Zhang, X Ye, J Chen, J Yu, L Zhuang, C Weng, F Petersen, Z Wang, X Yu |
Frontiers in immunology | 2021 |
|
Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis
Z Zhang, G Ai, L Chen, S Liu, C Gong, X Zhu, C Zhang, H Qin, J Hu, J Huang |
BMC Infectious Diseases | 2021 |
|
Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19
W Hamouche, M Bisserier, A Brojakowska, A Eskandari, K Fish, DA Goukassian, L Hadri |
Journal of Molecular and Cellular Cardiology | 2021 |
|
The Convalescent Plasma Craze! Where Does India Stand?
AJ Priyadarsini, K Karan, S Arulselvi |
Journal of laboratory physicians | 2021 |
|
Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries
MS Rejeki, N Sarnadi, R Wihastuti, V Fazharyasti, WY Samin, FA Yudhaputri, E Johar, N Nurainy, NS Bachtiar, DH Muljono |
2021 | |
|
Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment Available with Emphasis on ACE2
H Rathi, V Burman, SK Datta, SV Rana, AA Mirza, S Saha, R Kumar, M Naithani |
Indian Journal of Clinical Biochemistry | 2021 |
|
Implications of Laboratory Tests in Disease Grading and Death Risk Stratification of COVID-19: A Retrospective Study in Wuhan, China
Y Bai, E Wang, S Zhao, J Li, Y Zhu, Y Zhang, L Cao, H Liu, Y Dong, F Wang, G Liang, L Liu |
Frontiers in Medicine | 2021 |
|
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
MF Osuchowski, MS Winkler, T Skirecki, S Cajander, M Shankar-Hari, G Lachmann, G Monneret, F Venet, M Bauer, FM Brunkhorst, S Weis, A Garcia-Salido, M Kox, JM Cavaillon, F Uhle, MA Weigand, SB Flohé, WJ Wiersinga, R Almansa, A de la Fuente, I Martin-Loeches, C Meisel, T Spinetti, JC Schefold, C Cilloniz, A Torres, EJ Giamarellos-Bourboulis, R Ferrer, M Girardis, A Cossarizza, MG Netea, T van der Poll, JF Bermejo-Martín, I Rubio |
The lancet. Respiratory medicine | 2021 |
|
T cell counts and IL‐6 concentration in blood of North African COVID‐19 patients are two independent prognostic factors for severe disease and death
B Belaid, LL Mahammad, B Mihi, SY Rahali, A Djidjeli, Z Larab, L Berkani, I Berkane, W Sayah, F Merah, NZ Lazli, L Kheddouci, A Kadi, M Ouali, R Khellafi, D Mekideche, A Kheliouen, S Ayoub, RM Hamidi, F Derrar, M Gharnaout, I Allam, R Djidjik |
Journal of leukocyte biology | 2021 |
|
SARS-CoV-2-specific T cells in infection and vaccination
A Bertoletti, NL Bert, M Qui, AT Tan |
Cellular and Molecular Immunology | 2021 |
|
SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals
MS Rha, AR Kim, EC Shin |
Immune Network | 2021 |
|
SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells
Y Singh, C Trautwein, R Fendel, N Krickeberg, G Berezhnoy, R Bissinger, S Ossowski, MS Salker, N Casadei, O Riess |
Heliyon | 2021 |
|
Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
TC Theoharides, C Cholevas, K Polyzoidis, A Politis |
BioFactors (Oxford, England) | 2021 |
|
Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, Including Response to SARS-CoV-2, in Autism Spectrum Disorder
TC Theoharides |
Journal of Personalized Medicine | 2021 |
|
Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients
S Tomić, J Đokić, D Stevanović, N Ilić, A Gruden-Movsesijan, M Dinić, D Radojević, M Bekić, N Mitrović, R Tomašević, D Mikić, D Stojanović, M Čolić |
Frontiers in immunology | 2021 |
|
Immunological Characteristics of Non-Intensive Care Hospitalized COVID-19 Patients: A Preliminary Report
S Corrao, F Gervasi, FD Bernardo, G Natoli, M Raspanti, N Catalano, C Argano |
Journal of Clinical Medicine | 2021 |
|
SARS-CoV-2-Associated T-Cell Responses in the Presence of Humoral Immunodeficiency
S Gupta, H Su, T Narsai, S Agrawal |
International Archives of Allergy and Immunology | 2021 |
|
Adaptive immune responses to SARS-CoV-2
D Forthal |
Advanced Drug Delivery Reviews | 2021 |
|
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
A Synowiec, A Szczepański, E Barreto-Duran, LK Lie, K Pyrc |
Clinical microbiology reviews | 2021 |
|
Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions
I Siemińska, K Węglarczyk, M Surmiak, D Kurowska-Baran, M Sanak, M Siedlar, J Baran |
Frontiers in immunology | 2021 |
|
Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
D Ricci, MP Etna, F Rizzo, S Sandini, M Severa, EM Coccia |
International journal of molecular sciences | 2021 |
|
Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients
E Martín-Sánchez, JJ Garcés, C Maia, S Inogés, AL de Cerio, F Carmona-Torre, M Marin-Oto, F Alegre, E Molano, M Fernandez-Alonso, C Perez, C Botta, A Zabaleta, AB Alcaide, MF Landecho, M Rua, T Pérez-Warnisher, L Blanco, S Sarvide, A Vilas-Zornoza, D Alignani, C Moreno, I Pineda, M Sogbe, J Argemi, B Paiva, JR Yuste |
Frontiers in immunology | 2021 |
|
Clinical Relevance of Elevated Soluble ST2, HSP27 and 20S Proteasome at Hospital Admission in Patients with COVID-19
R Wendt, MT Lingitz, M Laggner, M Mildner, D Traxler, A Graf, P Krotka, B Moser, K Hoetzenecker, S Kalbitz, C Lübbert, J Beige, HJ Ankersmit |
Biology : open access journal | 2021 |
|
Severe Acute Respiratory Syndrome Coronavirus 2: Manifestations of Disease and Approaches to Treatment and Prevention in Humans
ME Watson, K Inagaki, JB Weinberg |
Comparative medicine | 2021 |
|
Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities
CF Chu, F Sabath, S Fibi-Smetana, S Sun, R Öllinger, E Noeßner, YY Chao, L Rinke, E Winheim, R Rad, AB Krug, L Taher, CE Zielinski |
Frontiers in immunology | 2021 |
|
NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19
L Bergantini, M d'Alessandro, P Cameli, D Cavallaro, S Gangi, B Cekorja, P Sestini, E Bargagli |
Cells | 2021 |
|
Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study
E Kalicińska, D Szymczak, A Zińczuk, B Adamik, J Smiechowicz, T Skalec, D Nowicka-Suszko, M Biernat, A Bogucka-Fedorczuk, J Rybka, A Martuszewski, W Gozdzik, K Simon, T Wróbel |
Cells | 2021 |
|
Single-cell immunology of SARS-CoV-2 infection
Y Tian, LN Carpp, HE Miller, M Zager, EW Newell, R Gottardo |
Nature Biotechnology | 2021 |
|
Early Response of CD8+ T Cells in COVID-19 Patients
D Ramljak, M Vukoja, M Curlin, K Vukojevic, M Barbaric, U Glamoclija, B Purisevic, O Peric, V Soljic |
Journal of Personalized Medicine | 2021 |
|
Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment
K Shi, Y Liu, Q Zhang, C Ran, J Hou, Y Zhang, X Wang |
Chinese Journal of Integrative Medicine | 2021 |
|
High‑dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS‑CoV‑2 infection: A case‑based review of the literature (Review)
A Stoian, Z Bajko, S Maier, R Cioflinc, B Grigorescu, A Moțățăianu, L Bărcuțean, R Balașa, M Stoian |
Experimental and therapeutic medicine | 2021 |
|
Delivery Routes for COVID-19 Vaccines
JH Park, HK Lee |
Human vaccines | 2021 |
|
Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes
K Renner, T Schwittay, S Chaabane, J Gottschling, C Müller, C Tiefenböck, JN Salewski, F Winter, S Buchtler, S Balam, MV Malfertheiner, M Lubnow, D Lunz, B Graf, F Hitzenbichler, F Hanses, H Poeck, M Kreutz, E Orsó, R Burkhardt, T Niedermair, C Brochhausen, A Gessner, B Salzberger, M Mack |
Nature Communications | 2021 |
|
Role of the Immune Microenvironment in SARS-CoV-2 Infection
CH Ye, WL Hsu, GR Peng, WC Yu, WC Lin, SY Hu, SH Yu |
Cell Transplantation | 2021 |
|
Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19
Y Yang, W Huang, Y Fan, GQ Chen |
Frontiers in Molecular Biosciences | 2021 |
|
Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19
W Sayah, I Berkane, I Guermache, M Sabri, FZ Lakhal, SY Rahali, A Djidjeli, LL mahammed, F Merah, B Belaid, L Berkani, NZ Lazli, L Kheddouci, A Kadi, M Ouali, R Khellafi, D Mekideche, A Kheliouen, RM Hamidi, S Ayoub, NB Raaf, F Derrar, M Gharnaout, I Allam, R Djidjik |
Cytokine | 2021 |
|
PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19
MS Rha, HW Jeong, JH Ko, SJ Choi, IH Seo, JS Lee, M Sa, AR Kim, EJ Joo, JY Ahn, JH Kim, KH Song, ES Kim, DH Oh, MY Ahn, HK Choi, JH Jeon, JP Choi, HB Kim, YK Kim, SH Park, WS Choi, JY Choi, KR Peck, EC Shin |
Immunity | 2021 |
|
An update on host immunity correlates and prospects of re-infection in COVID-19
N Negi, S Maurya, R Singh, B Das |
International Reviews of Immunology | 2021 |
|
Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology
A Codd, S Hanna, E Compeer, F Richter, E Pring, E Gea-Mallorquí, M Borsa, O Moon, D Scourfield, D Ahern, H Almuttaqi, D Alonzi, A Alrubayyi, G Alsaleh, V Bart, V Batchelor, R Bayliss, D Berthold, J Bezbradica, T Bharuchq, H Borrmann, M Borsa, R Borst, J Brun, S Burnell, L Capitani, A Cavounidis, L Chapman, A Chauveau, L Cifuentes, A Codd, E Compeer, C Coveney, A Cross, S Danielli, L Davies, C Dendrou, S Dimonte, R Durairaj, L Dustin, A Dyer, C Fielding, F Fischer, A Gallimore, S Galloway, A Gammage, E Gea-Mallorquí, A Godkin, S Hanna, C Heuberger, S Hulin-Curtis, F Issa, E Jones, R Jones, K Ladell, S Lauder, K Liddiard, P Ligoxygakis, F Lu, B MacLachlan, S Maleki-Toyserkani, E Mann, A Marzeda, R Matthews, J Mazet, A Milicic, E Mitchell, O Moon, V Nguyen, M O'Hanlon, C Pavillet, D Peppa, A Pires, E Pring, M Quastel, S Reed, J Rehwinkel, N Richmond, F Richter, A Robinson, P Rodrigues, P Sabberwal, A Sami, R Peres, Q Sattentau, B Schonfeldova, D Scourfield, T Selvakumar, F Shepherd, C Shorten, A Simon, A Smith, A Crespo, M Tellier, E Thornton, L Uhl, E van Grinsven, A Wann, R Williams, J Wilson, D Zhou, Z Zhu, A Gallimore, A Milicic |
2021 | |
|
Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID‐19 patients
Y Mitamura, D Schulz, S Oro, N Li, I Kolm, C Lang, R Ziadlou, G Tan, B Bodenmiller, P Steiger, A Marzano, N Prost, O Caudin, M Levesque, C Stoffel, P SchmidGrendelmeier, E Maverakis, CA Akdis, MC Brüggen |
Allergy | 2021 |
|
High-value laboratory testing for hospitalized COVID-19 patients: a review
D Cihakova, MB Streiff, SP Menez, TK Chen, NA Gilotra, ED Michos, KA Marr, AH Karaba, ML Robinson, PW Blair, MV Dioverti, WS Post, AL Cox, AA Antar |
Future Virology | 2021 |
|
Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis
A Zawawi, AY Naser, H Alwafi, F Minshawi |
Frontiers in immunology | 2021 |
|
Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19
R Saji, M Nishii, K Sakai, K Miyakawa, Y Yamaoka, T Ban, T Abe, Y Ohyama, K Nakajima, T Hiromi, R Matsumura, N Suzuki, H Taniguchi, T Otsuka, Y Oi, F Ogawa, M Uchiyama, K Takahashi, M Iwashita, Y Kimura, S Fujii, R Furuya, T Tamura, A Ryo, I Takeuchi, C Lazzeri |
PloS one | 2021 |
|
Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis
AK Melo, KM Milby, AL Caparroz, AC Pinto, RR Santos, AP Rocha, GA Ferreira, VA Souza, LD Valadares, RM Vieira, GS Pileggi, VF Trevisani, J Chalmers |
PloS one | 2021 |
|
Immunomodulation of COVID‐19 severity by helminth co‐infection: Implications for COVID‐19 vaccine efficacy
Y Akelew, H Andualem, E Ebrahim, A Atnaf, W Hailemichael |
Immunity, Inflammation and Disease | 2021 |
|
SARS-CoV-2 Infection in Pregnant Women: Neuroimmune-Endocrine Changes at the Maternal-Fetal Interface
MG Granja, AC da Rocha Oliveira, CS de Figueiredo, AP Gomes, EC Ferreira, E Giestal-de-Araujo, HC de Castro-Faria-Neto |
Neuroimmunomodulation | 2021 |
|
Electrochemical sensing: A prognostic tool in the fight against COVID-19
S Kotru, M Klimuntowski, H Ridha, Z Uddin, AA Askhar, G Singh, MM Howlader |
Trends in analytical chemistry : TRAC | 2021 |
|
Biomarkers of Post-COVID Depression
P Lorkiewicz, N Waszkiewicz |
Journal of Clinical Medicine | 2021 |
|
Immune interventions in COVID-19: a matter of time?
L Plaçais, Q Richier, N Noël, K Lacombe, X Mariette, O Hermine |
Mucosal Immunology | 2021 |
|
Tissue-Specific Immunopathology in Fatal COVID-19
DA Dorward, CD Russell, IH Um, M Elshani, SD Armstrong, R Penrice-Randal, T Millar, CE Lerpiniere, G Tagliavini, CS Hartley, NP Randle, NN Gachanja, PM Potey, X Dong, AM Anderson, VL Campbell, AJ Duguid, WA Qsous, R BouHaidar, JK Baillie, K Dhaliwal, WA Wallace, CO Bellamy, S Prost, C Smith, JA Hiscox, DJ Harrison, CD Lucas |
American journal of respiratory and critical care medicine | 2021 |
|
IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression
SK Dhar, V K, S Damodar, S Gujar, M Das |
Heliyon | 2021 |
|
Corticosteroid treatment in COVID‐19 modulates host inflammatory responses and transcriptional signatures of immune dysregulation
AN Pinski, TL Steffen, MZ Zulu, SL George, A Dickson, D Tifrea, KJ Maroney, N Tedeschi, Y Zhang, RH Scheuermann, AK Pinto, JD Brien, I Messaoudi |
Journal of leukocyte biology | 2021 |
|
Viral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19
AA Rabaan, R Tirupathi, AA Sule, J Aldali, AA Mutair, S Alhumaid, Muzaheed, N Gupta, T Koritala, R Adhikari, M Bilal, M Dhawan, R Tiwari, S Mitra, TB Emran, K Dhama |
Diagnostics | 2021 |
|
Rationale for azithromycin in COVID-19: an overview of existing evidence
I Gyselinck, W Janssens, P Verhamme, R Vos |
BMJ Open Respiratory Research | 2021 |
|
Evaluation of Cytokines as Robust Diagnostic Biomarkers for COVID-19 Detection
Á Tamayo-Velasco, MJ Peñarrubia-Ponce, FJ Álvarez, H Gonzalo-Benito, I de la Fuente, M Martín-Fernández, JM Eiros, P Martínez-Paz, JP Miramontes-González, A Fiz-López, E Arribas-Rodríguez, P Cal-Sabater, R Aller, C Dueñas, M Heredia-Rodríguez, E Tamayo, D Bernardo, E Gómez-Sánchez |
Journal of Personalized Medicine | 2021 |
|
Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19
JC Wilson, D Kealy, SR James, T Plowman, K Newling, C Jagger, K Filbey, ER Mann, JE Konkel, M Menon, SB Knight, A Simpson, A Prihartadi, G Forshaw, N Todd, DR Yates, JR Grainger, T Hussell, PM Kaye, N Signoret, D Lagos |
iScience | 2021 |
|
Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19
L Ling, Z Chen, G Lui, CK Wong, WT Wong, RW Ng, EY Tso, KS Fung, V Chan, AC Yeung, DS Hui, PK Chan |
Frontiers in immunology | 2021 |
|
Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
AR Daamen, P Bachali, KA Owen, KM Kingsmore, EL Hubbard, AC Labonte, R Robl, S Shrotri, AC Grammer, PE Lipsky |
Scientific Reports | 2021 |
|
SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients
L Gutiérrez-Chamorro, E Riveira-Muñoz, C Barrios, V Palau, M Nevot, S Pedreño-López, J Senserrich, M Massanella, B Clotet, C Cabrera, O Mitjà, M Crespo, J Pascual, M Riera, E Ballana |
Viruses | 2021 |
|
Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages—Potential Implications for Cytokine Storm Syndrome
I Karwaciak, A Sałkowska, K Karaś, J Dastych, M Ratajewski |
Human vaccines | 2021 |
|
Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology
A Karaba, W Zhou, L Hsieh, A Figueroa, G Massaccesi, R Rothman, K Fenstermacher, L Sauer, K Shaw-Saliba, P Blair, M Robinson, S Leung, R Wesson, N Alachkar, R El-Diwany, H Ji, A Cox |
Clinical Infectious Diseases | 2021 |
|
SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics
N Hartog, W Faber, A Frisch, J Bauss, CP Bupp, S Rajasekaran, JW Prokop |
Expert Review of Proteomics | 2021 |
|
Aging in COVID-19: Vulnerability, immunity and intervention
Y Chen, SL Klein, BT Garibaldi, H Li, C Wu, NM Osevala, T Li, JB Margolick, G Pawelec, SX Leng |
Ageing Research Reviews | 2021 |
|
SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
A Salimi-Jeda, S Abbassi, A Mousavizadeh, M Esghaie, F Bokharaei-Salim, F Jeddi, M Shafaati, A Abdoli |
International Immunopharmacology | 2021 |
|
Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics
M Puccetti, C Costantini, M Ricci, S Giovagnoli |
Pharmaceutics | 2021 |
|
Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis
MG Ferrarini, A Lal, R Rebollo, AJ Gruber, A Guarracino, IM Gonzalez, T Floyd, DS de Oliveira, J Shanklin, E Beausoleil, T Pusa, BE Pickett, V Aguiar-Pulido |
2021 | |
|
Prior immunosuppressive therapy is associated with mortality in COVID‐19 patients: A retrospective study of 835 patients
EH AkamaGarren, JX Li |
Journal of Medical Virology | 2021 |
|
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
JD Chalmers, ML Crichton, PC Goeminne, B Cao, M Humbert, M Shteinberg, KM Antoniou, CS Ulrik, H Parks, C Wang, T Vandendriessche, J Qu, D Stolz, C Brightling, T Welte, S Aliberti, AK Simonds, T Tonia, N Roche |
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology | 2021 |
|
Association of Early Inflammation with Age and Asymptomatic Disease in COVID-19
C Xie, Q Li, L Li, X Peng, Z Ling, B Xiao, J Feng, Z Chen, D Chang, L Xie, CS Cruz, L Sharma |
Journal of inflammation research | 2021 |
|
Coronavirus infection: An immunologists' perspective
JB Sanctis, AH García, D Moreno, M Hajduch |
Scandinavian Journal of Immunology | 2021 |
|
Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection
M Roussel, J Ferrant, F Reizine, SL Gallou, J Dulong, S Carl, M Lesouhaitier, M Gregoire, N Bescher, C Verdy, M Latour, I Bézier, M Cornic, A Vinit, C Monvoisin, B Sawitzki, S Leonard, S Paul, J Feuillard, R Jeannet, T Daix, VK Tiwari, JM Tadié, M Cogné, K Tarte |
Cell reports. Medicine | 2021 |
|
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
A Pérez-Gómez, J Vitallé, C Gasca-Capote, A Gutierrez-Valencia, M Trujillo-Rodriguez, A Serna-Gallego, E Muñoz-Muela, M de los Reyes Jiménez-Leon, MR Benhnia, I Rivas-Jeremias, C Sotomayor, C Roca-Oporto, N Espinosa, C Infante-Domínguez, JC Crespo-Rivas, A Fernández-Villar, A Pérez-González, LF López-Cortés, E Poveda, E Ruiz-Mateos, JM Cisneros, S Salto-Alejandre, J Berastegui-Cabrera, P Camacho-Martínez, C Infante-Domínguez, M Carretero-Ledesma, JC Crespo-Rivas, E Márquez, JM Lomas, C Bueno, R Amaya, JA Lepe, J Pachón, E Cordero, J Sánchez-Céspedes, M Aguilar-Guisado, A Aguilera, C Aguilera, T Aldabo-Pallas, V Alfaro-Lara, C Amodeo, J Ampuero, MD Avilés, M Asensio, B Barón-Franco, L Barrera-Pulido, R Bellido-Alba, M Bernabeu-Wittel, C Caballero-Eraso, M Cabrera, E Calderón, J Carbajal-Guerrero, M Cid-Cumplido, Y Corcia-Palomo, J Delgado, A Domínguez-Petit, A Deniz, R Dusseck-Brutus, A Escoresca-Ortega, F Espinosa, N Espinosa, M Espinoza, C Ferrándiz-Millón, M Ferrer, T Ferrer, I Gallego-Texeira, R Gámez-Mancera, E García, H García-Delgado, M García-Gutiérrez, ML Gascón-Castillo, A González-Estrada, D González, C Gómez-González, R González-León, C Grande-Cabrerizo, S Gutiérrez, C Hernández-Quiles, IC Herrera-Melero, M Herrero-Romero, L Jara, C Jiménez-Juan, S Jiménez-Jorge, M Jiménez-Sánchez, J Lanseros-Tenllado, C López, I López, Á López-Barrios, LF López-Cortés, R Luque-Márquez, D Macías-García, G Martín-Gutiérrez, L Martín-Villén, J Molina, A Morillo, MD Navarro-Amuedo, D Nieto-Martín, F Ortega, M Paniagua-García, A Peña-Rodríguez, E Pérez, M Poyato, J Praena-Segovia, R Ríos, C Roca-Oporto, JF Rodríguez, MJ Rodríguez-Hernández, S Rodríguez-Suárez, Á Rodríguez-Villodres, N Romero-Rodríguez, R Ruiz, ZR de Azua, C Salamanca, S Sánchez, VM Sánchez-Montagut, C Sotomayor, AS Benjumea, J Toral |
Cellular and Molecular Immunology | 2021 |
|
A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections
SC Vick, M Frutoso, F Mair, AJ Konecny, E Greene, CR Wolf, JK Logue, NM Franko, J Boonyaratanakornkit, R Gottardo, JT Schiffer, HY Chu, M Prlic, JM Lund |
Science Advances | 2021 |
|
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients
PR Tembhare, H Sriram, G Chatterjee, T Khanka, A Gokarn, S Mirgh, A Rajendra, A Chaturvedi, SG Ghogale, N Deshpande, K Girase, K Dalvi, S Rajpal, N Patkar, B Trivedi, A Joshi, V Murthy, N Shetty, S Nair, A More, S Kamtalwar, P Chavan, V Bhat, P Bhat, PG Subramanian, S Gupta, N Khattry |
Immunology and Cell Biology | 2021 |
|
Immune response to SARS‐CoV‐2 in children: A review of the current knowledge
F Filippatos, EB Tatsi, A Michos |
2021 | |
|
Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19
D Brain, A Plant-Hately, B Heaton, U Arshad, C David, C Hedrich, A Owen, NJ Liptrott |
Advanced Drug Delivery Reviews | 2021 |
|
The role of immunomodulatory medications in the treatment of COVID-19
SE Sattui, MK Crow, I Navarro-Millán |
Current Opinion in Rheumatology | 2021 |
|
Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients
A Polimeni, I Leo, C Spaccarotella, A Mongiardo, S Sorrentino, J Sabatino, SD Rosa, C Indolfi |
Scientific Reports | 2021 |
|
A new p65 isoform that bind the glucocorticoid hormone and is expressed in inflammation liver diseases and COVID-19
G Spinelli, G Biddeci, A Artale, F Valentino, G Tarantino, G Gallo, F Gianguzza, PG Conaldi, S Corrao, F Gervasi, TS Aronica, AD Leonardo, G Duro, FD Blasi |
Scientific Reports | 2021 |
|
Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019
V Lesan, M Bewarder, C Metz, A Becker, S Mang, E Regitz, L Thurner, F Neumann, I Kos, K Christofyllakis, G Danziger, S Stilgenbauer, R Bals, PM Lepper, D Kaddu-Mulindwa, T Rixecker |
Intensive Care Medicine Experimental | 2021 |
|
Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study
A Lombardi, S Duiella, LL Piani, A Comelli, F Ceriotti, M Oggioni, A Muscatello, A Bandera, A Gori, E Ferrazzi |
Scientific Reports | 2021 |
|
Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults
MR Petrara, F Bonfante, P Costenaro, A Cantarutti, F Carmona, E Ruffoni, CD Chiara, M Zanchetta, L Barzon, D Donà, LD Dalt, A Bortolami, M Pagliari, M Plebani, P Rossi, N Cotugno, P Palma, C Giaquinto, AD Rossi |
Frontiers in immunology | 2021 |
|
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
ME Ligotti, F Pojero, G Accardi, A Aiello, C Caruso, G Duro, G Candore |
Frontiers in Cell and Developmental Biology | 2021 |
|
Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease
H Bukulmez |
Current Rheumatology Reports | 2021 |
|
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
TP Vogel, KA Top, C Karatzios, DC Hilmers, LI Tapia, P Moceri, L Giovannini-Chami, N Wood, RE Chandler, NP Klein, EP Schlaudecker, MC Poli, E Muscal, FM Munoz |
Vaccine | 2021 |
|
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2
LA Henderson, SW Canna, KG Friedman, M Gorelik, SK Lapidus, H Bassiri, EM Behrens, A Ferris, KF Kernan, GS Schulert, P Seo, MB Son, AH Tremoulet, RS Yeung, AS Mudano, AS Turner, DR Karp, JJ Mehta |
Arthritis & Rheumatology | 2021 |
|
Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19
A Golovkin, O Kalinina, V Bezrukikh, A Aquino, E Zaikova, T Karonova, O Melnik, E Vasilieva, I Kudryavtsev |
Viruses | 2021 |
|
Immunopathology of Hyperinflammation in COVID-19
JN Gustine, D Jones |
The American Journal of Pathology | 2021 |
|
Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome
F Caldarale, M Giacomelli, E Garrafa, N Tamassia, A Morreale, P Poli, S Timpano, G Baresi, F Zunica, M Cattalini, D Moratto, M Chiarini, ES Cannizzo, G Marchetti, MA Cassatella, A Taddio, A Tommasini, R Badolato |
Frontiers in immunology | 2021 |
|
Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents
G Costagliola, E Spada, R Consolini |
Pediatric Rheumatology | 2021 |
|
Local and systemic responses to SARS-CoV-2 infection in children and adults
M Yoshida, K Worlock, N Huang, R Lindeboom, C Butler, N Kumasaka, C Conde, L Mamanova, L Bolt, L Richardson, K Polanski, E Madissoon, J Barnes, J Allen-Hyttinen, E Kilich, B Jones, A de Wilton, A Wilbrey-Clark, W Sungnak, J Pett, J Weller, E Prigmore, H Yung, P Mehta, A Saleh, A Saigal, V Chu, J Cohen, C Cane, A Iordanidou, S Shibuya, A Reuschl, I Herczeg, A Argento, R Wunderink, S Smith, T Poor, C Gao, J Dematte, G Budinger, H Donnelly, N Markov, Z Lu, G Reynolds, M Haniffa, G Bowyer, M Coates, M Clatworthy, F Calero-Nieto, B Göttgens, C OCallaghan, N Sebire, C Jolly, P Coppi, C Smith, A Misharin, S Janes, S Teichmann, M Nikolić, K Meyer |
Nature | 2021 |
|
Contribution of STAT3 to the pathogenesis of COVID-19
A Jafarzadeh, M Nemati, S Jafarzadeh |
Microbial Pathogenesis | 2021 |
|
SARS-CoV-2 infection induces greater T-cell responses compared to vaccination in solid organ transplant recipients
VH Ferreira, T Marinelli, M Ierullo, T Ku, VG Hall, B Majchrzak-Kita, V Kulasingam, A Humar, D Kumar |
The Journal of Infectious Diseases | 2021 |
|
A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic
CR Triggle, D Bansal, H Ding, M Islam, EA Farag, HA Hadi, AA Sultan |
Frontiers in immunology | 2021 |
|
Add-on effect of Chinese herbal medicine in the treatment of mild to moderate COVID-19: A systematic review and meta-analysis
X Du, L Shi, W Cao, B Zuo, A Zhou, A Negida |
PloS one | 2021 |
|
Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients
S Caldrer, C Mazzi, M Bernardi, M Prato, N Ronzoni, P Rodari, A Angheben, C Piubelli, N Tiberti |
Frontiers in immunology | 2021 |
|
COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
R Singh, A Kang, X Luo, M Jeyanathan, A Gillgrass, S Afkhami, Z Xing |
The FASEB Journal | 2021 |
|
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS: COVID and Thrombosis
N Semeraro, M Colucci |
Mediterranean journal of hematology and infectious diseases | 2021 |
|
Post-acute COVID-19 syndrome
A Nalbandian, K Sehgal, A Gupta, MV Madhavan, C McGroder, JS Stevens, JR Cook, AS Nordvig, D Shalev, TS Sehrawat, N Ahluwalia, B Bikdeli, D Dietz, C Der-Nigoghossian, N Liyanage-Don, GF Rosner, EJ Bernstein, S Mohan, AA Beckley, DS Seres, TK Choueiri, N Uriel, JC Ausiello, D Accili, DE Freedberg, M Baldwin, A Schwartz, D Brodie, CK Garcia, MS Elkind, JM Connors, JP Bilezikian, DW Landry, EY Wan |
Nature Medicine | 2021 |
|
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity
L Vanderbeke, PV Mol, YV Herck, FD Smet, S Humblet-Baron, K Martinod, A Antoranz, I Arijs, B Boeckx, FM Bosisio, M Casaer, D Dauwe, WD Wever, C Dooms, E Dreesen, A Emmaneel, J Filtjens, M Gouwy, J Gunst, G Hermans, S Jansen, K Lagrou, A Liston, N Lorent, P Meersseman, T Mercier, J Neyts, J Odent, D Panovska, PA Penttila, E Pollet, P Proost, J Qian, K Quintelier, J Raes, S Rex, Y Saeys, J Sprooten, S Tejpar, D Testelmans, K Thevissen, TV Buyten, J Vandenhaute, SV Gassen, LC Pereira, R Vos, B Weynand, A Wilmer, J Yserbyt, AD Garg, P Matthys, C Wouters, D Lambrechts, E Wauters, J Wauters |
Nature Communications | 2021 |
|
MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model
H Kaspi, J Semo, N Abramov, C Dekel, S Lindborg, R Kern, C Lebovits, R Aricha |
Stem Cell Research & Therapy | 2021 |
|
Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications
Y Higashikuni, W Liu, T Obana, M Sata |
International journal of molecular sciences | 2021 |
|
Inflammation, a common mechanism in frailty and COVID‐19 , and stem cells as a therapeutic approach
J Becerra, I Duran |
Stem Cells Translational Medicine | 2021 |
|
COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?
MJ Ombrello, GS Schulert |
Translational research : the journal of laboratory and clinical medicine | 2021 |
|
Efficacy and Safety of Immunomodulators in Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
T Ngamprasertchai, R Kajeekul, C Sivakorn, N Ruenroegnboon, V Luvira, T Siripoon, N Luangasanatip |
Infectious Diseases and Therapy | 2021 |
|
Deciphering the state of immune silence in fatal COVID-19 patients
P Bost, FD Sanctis, S Canè, S Ugel, K Donadello, M Castellucci, D Eyal, A Fiore, C Anselmi, RM Barouni, R Trovato, S Caligola, A Lamolinara, M Iezzi, F Facciotti, A Mazzariol, D Gibellini, PD Nardo, E Tacconelli, L Gottin, E Polati, B Schwikowski, I Amit, V Bronte |
Nature Communications | 2021 |
|
Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin
J Bosch-Barrera, A Roqué, E Teixidor, M Carmona-Garcia, A Arbusà, J Brunet, B Martin-Castillo, E Cuyàs, S Verdura, J Menendez |
Pharmaceuticals (Basel, Switzerland) | 2021 |
|
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
P Ljungman, R de la Camara, M Mikulska, G Tridello, B Aguado, MA Zahrani, J Apperley, A Berceanu, RM Bofarull, M Calbacho, F Ciceri, L Lopez-Corral, C Crippa, ML Fox, A Grassi, MJ Jimenez, SK Demir, M Kwon, CV Llamas, JL Lorenzo, S Mielke, K Orchard, RP Porras, D Vallisa, A Xhaard, NS Knelange, A Cedillo, N Kröger, JL Piñana, J Styczynski |
Leukemia | 2021 |
|
Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
L Li, Y Honda-Okubo, Y Huang, H Jang, MA Carlock, J Baldwin, S Piplani, AG Bebin-Blackwell, D Forgacs, K Sakamoto, A Stella, S Turville, T Chataway, A Colella, J Triccas, TM Ross, N Petrovsky |
Vaccine | 2021 |
|
The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients
H Luo, T Jia, J Chen, S Zeng, Z Qiu, S Wu, X Li, Y Lei, X Wang, W Wu, R Zhang, X Zou, T Feng, R Ding, Y Zhang, YQ Chen, C Sun, T Wang, S Fang, Y Shu |
Frontiers in immunology | 2021 |
|
Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease
SM Lynch, G Guo, DS Gibson, AJ Bjourson, TS Rai |
Cells | 2021 |
|
Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19
AM Cantwell, H Singh, M Platt, Y Yu, YH Lin, Y Ikeno, G Hubbard, Y Xiang, N Gonzalez-Juarbe, PH Dube, T Gallagher |
Journal of virology | 2021 |
|
K18-hACE2 mice develop respiratory disease resembling severe COVID-19
CK Yinda, JR Port, T Bushmaker, IO Owusu, JN Purushotham, VA Avanzato, RJ Fischer, JE Schulz, MG Holbrook, MJ Hebner, R Rosenke, T Thomas, A Marzi, SM Best, E de Wit, C Shaia, N van Doremalen, VJ Munster, K Subbarao |
PLoS pathogens | 2021 |
|
Clinical characteristics and predictive value of lower CD4+T cell level in patients with moderate and severe COVID-19: a multicenter retrospective study
X Wen, D Jiang, L Gao, J Zhou, J Xiao, X Cheng, B He, Y Chen, P Lei, X Tan, S Qin, D Zhang |
BMC Infectious Diseases | 2021 |
|
Recombinant interleukin-2 stimulates lymphocyte recovery in patients with severe COVID-19
ME Zhu, Q Wang, S Zhou, B Wang, L Ke, P He |
Experimental and therapeutic medicine | 2021 |
|
Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2
D Fernández-Lázaro, CI Fernandez-Lazaro, J Mielgo-Ayuso, DP Adams, JL Hernández, J González-Bernal, M González-Gross |
Frontiers in immunology | 2021 |
|
β-Glucans Could Be Adjuvants for SARS-CoV-2 Virus Vaccines (COVID-19)
A Córdova-Martínez, A Caballero-García, E Roche, D Noriega |
International journal of environmental research and public health | 2021 |
|
Antifungal Drug Susceptibility and Genetic Characterization of Fungi Recovered from COVID-19 Patients
M Kordalewska, KD Guerrero, R Garcia-Rubio, C Jiménez-Ortigosa, JR Mediavilla, MH Cunningham, F Hollis, T Hong, KF Chow, BN Kreiswirth, DS Perlin |
Journal of Fungi | 2021 |
|
Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa
B Morton, KG Barnes, C Anscombe, K Jere, P Matambo, J Mandolo, R Kamngona, C Brown, J Nyirenda, T Phiri, NP Banda, CV Veer, KS Mndolo, K Mponda, J Rylance, C Phiri, J Mallewa, M Nyirenda, G Katha, P Kambiya, J Jafali, HC Mwandumba, SB Gordon, J Phulusa, M Mkandawire, S Kaimba, H Thole, S Nthala, E Nsomba, L Keyala, P Mandala, B Chinoko, M Gmeiner, V Kaudzu, S Lissauer, B Freyne, P MacPherson, TD Swarthout, PY Tam, S Sichone, A Ahmadu, O Kanjewa, V Nyasulu, E Chinyama, A Zuza, B Denis, E Storey, N Bondera, D Matchado, A Chande, A Chingota, C Ntwea, L Mkandawire, C Mhango, A Lakudzala, M Chaponda, P Mwenechanya, L Mvaya, D Tembo, MY Henrion, J Chirombo, C Masesa, J Gondwe, J Cornick, KC Jambo |
Nature Communications | 2021 |
|
Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine
J Russick, PE Foy, N Josseaume, M Meylan, NB Hamouda, A Kirilovsky, CE Sissy, E Tartour, DM Smadja, A Karras, JS Hulot, M Livrozet, A Fayol, JB Arlet, JL Diehl, MA Dragon-Durey, F Pagès, I Cremer |
Frontiers in immunology | 2021 |
|
Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
P Ahluwalia, K Vaibhav, M Ahluwalia, AK Mondal, N Sahajpal, AM Rojiani, R Kolhe |
Frontiers in immunology | 2021 |
|
The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
M Delshad, N Tavakolinia, A Pourbagheri-Sigaroodi, A Safaroghli-Azar, N Bagheri, D Bashash |
International Immunopharmacology | 2021 |
|
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
EM Bange, NA Han, P Wileyto, JY Kim, S Gouma, J Robinson, AR Greenplate, MA Hwee, F Porterfield, O Owoyemi, K Naik, C Zheng, M Galantino, AR Weisman, CA Ittner, EM Kugler, AE Baxter, O Oniyide, RS Agyekum, TG Dunn, TK Jones, HM Giannini, ME Weirick, CM McAllister, NE Babady, A Kumar, AJ Widman, S DeWolf, SR Boutemine, C Roberts, KR Budzik, S Tollett, C Wright, T Perloff, L Sun, D Mathew, JR Giles, DA Oldridge, JE Wu, C Alanio, S Adamski, AL Garfall, LA Vella, SJ Kerr, JV Cohen, RA Oyer, R Massa, IP Maillard, KN Maxwell, JP Reilly, PG Maslak, RH Vonderheide, JD Wolchok, SE Hensley, EJ Wherry, NJ Meyer, AM DeMichele, SA Vardhana, R Mamtani, AC Huang |
Nature Medicine | 2021 |
|
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer
Alexander Huang, Erin Bange, Nicholas Han, E Paul Wileyto, Justin Kim, Sigrid Gouma, James Robinson, Allison Greenplate, Florence Porterfield, Olutosin Owoyemi, Karan Naik, Cathy Zheng, Michael Galantino, Ariel Weisman, Carolin Ittner, Emily Kugler, Amy Baxter, Madison Weirick, Christopher McAllister, Ngolela Esther Babady, Anita Kumar, Adam Widman, Susan Dewolf, Sawsan Boutemine, Charlotte Roberts, Krista Budzik, Susan Tollett, Carla Wright, Tara Perloff, Lova Sun, Divij Mathew, Josephine Giles, Derek Oldridge, Jennifer Wu, Cecile Alanio, Sharon Adamski, Laura Vella, Samuel Kerr, Justine Cohen, Randall Oyer, Ryan Massa, Ivan Maillard, Kara Maxwell, Peter Maslak, Robert Vonderheide, Jedd D Wolchok, Scott Hensley, E Wherry, Nuala Meyer, Angela DeMichele, Santosha Vardhana, Ronac Mamtani, Oluwatosin Oniyide, Roseline Agyekum, Thomas Dunn, Tiffanie Jones, Heather Giannini, Alfred Garfall, John Reilly |
Research square | 2021 |
|
A call for discovery: Re‐envisioning The Cancer Genome Atlas as a blueprint for a TCGA2.0—The COVID‐19 Genome Atlas
KM Hargadon |
2021 | |
|
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status
J Neidleman, X Luo, M McGregor, G Xie, V Murray, WC Greene, SA Lee, NR Roan |
eLife | 2021 |
|
Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges
CH Masterson, A Ceccato, A Artigas, C dos Santos, PR Rocco, SR Enes, DJ Weiss, D McAuley, MA Matthay, K English, GF Curley, JG Laffey |
Intensive Care Medicine Experimental | 2021 |
|
The value of lymphocyte count in determining the severity of COVID-19 and estimating the time for nucleic acid test results to turn negative.
Li Y, Yang T, Wang S, Zheng J, Zhou J, Jiang M, Zhou T, Cao Y, Wang H |
2021 | |
|
Potential benefits of dietary seaweeds as protection against COVID-19.
Tamama K |
Nutrition Reviews | 2021 |
|
Clinical characteristics and outcomes in women and men hospitalized for coronavirus disease 2019 in New Orleans.
Yoshida Y, Gillet SA, Brown MI, Zu Y, Wilson SM, Ahmed SJ, Tirumalasetty S, Lovre D, Krousel-Wood M, Denson JL, Mauvais-Jarvis F |
Biology of sex differences | 2021 |
|
Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data.
Beyrouti R, Best JG, Chandratheva A, Perry RJ, Werring DJ |
Journal of Neurology | 2021 |
|
The three frontlines against COVID-19: Brain, Behavior, and Immunity.
Wang SC, Su KP, Pariante CM |
Brain, Behavior, and Immunity | 2021 |
|
Correlation of refractory hypoxemia with biochemical markers and clinical outcomes of COVID-19 patients in a developing country: A retrospective observational study: Running head: Predictors of hypoxemia in COVID-19.
Asghar MS, Ahmed I, Alvi H, Iqbal S, Khan I, Alvi RS, Saeed Z, Irfan S, Akhtar M, Fatima I |
Journal of Community Hospital Internal Medicine Perspectives | 2021 |
|
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department.
Solimando AG, Susca N, Borrelli P, Prete M, Lauletta G, Pappagallo F, Buono R, Inglese G, Forina BM, Bochicchio D, Capobianco M, Carrieri V, Cicco S, Leone P, Silvestris N, Saracino A, Ria R, Procacci V, Migliore G, Vacca A, Racanelli V |
Frontiers in Medicine | 2021 |
|
Interleukin-6 Trajectory and Secondary Infections in Mechanically Ventilated Patients With Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Treated With Interleukin-6 Receptor Blocker.
Vazquez Guillamet MC, Kulkarni HS, Montes K, Samant M, Shaikh PA, Betthauser K, Mudd PA, Reynolds D, O'Halloran J, Lyons P, McEvoy C, Vazquez Guillamet R |
2021 | |
|
Neuropathology of COVID-19 (neuro-COVID): clinicopathological update.
Lou JJ, Movassaghi M, Gordy D, Olson MG, Zhang T, Khurana MS, Chen Z, Perez-Rosendahl M, Thammachantha S, Singer EJ, Magaki SD, Vinters HV, Yong WH |
Free neuropathology | 2021 |
|
A Matter of Caution: Coagulation Parameters in COVID-19 Do Not Differ from Patients with Ruled-Out SARS-CoV-2 Infection in the Emergency Department.
Bauer W, Galtung N, Neuwinger N, Kaufner L, Langer E, Somasundaram R, Tauber R, Kappert K |
TH Open | 2021 |
|
Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19.
Xie X, Cheng X, Wang G, Zhang B, Liu M, Chen L, Cheng H, Hao S, Zhou J, Zhu P, Cheng T |
Science China Life Sciences | 2021 |
|
Association of α1-Blocker Receipt With 30-Day Mortality and Risk of Intensive Care Unit Admission Among Adults Hospitalized With Influenza or Pneumonia in Denmark.
Thomsen RW, Christiansen CF, Heide-Jørgensen U, Vogelstein JT, Vogelstein B, Bettegowda C, Tamang S, Athey S, Sørensen HT |
2021 | |
|
Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19.
Costagliola G, Spada E, Consolini R |
Immunity, Inflammation and Disease | 2021 |
|
Association between peripheral lymphocyte count and the mortality risk of COVID-19 inpatients.
Wang S, Sheng Y, Tu J, Zhang L |
BMC Pulmonary Medicine | 2021 |
|
Montelukast in hospitalized patients diagnosed with COVID-19.
Khan AR, Misdary C, Yegya-Raman N, Kim S, Narayanan N, Siddiqui S, Salgame P, Radbel J, Groote F, Michel C, Mehnert J, Hernandez C, Braciale T, Malhotra J, Gentile MA, Jabbour SK |
Journal of Asthma | 2021 |
|
Influence of aging on T cell response and renin-angiotensin system imbalance during SARS-CoV-2 infection.
Quarleri J, Cevallos C, Delpino MV |
Immunology Letters | 2021 |
|
Extracorporeal Membrane Oxygenation Therapy for Critically Ill Coronavirus Disease 2019 Patients in Wuhan, China: A Retrospective Multicenter Cohort Study.
Fang J, Li R, Chen Y, Qin JJ, Hu M, Huang CL, Cheng L, He Y, Li Y, Zhou Q, Zhou DX, Huang F, Lei F, Yang B, Chen J, Deng HP, Yuan YF, Xia JH, Wan S, Li HL, Wei X |
2021 | |
|
COVID-19 and Dentistry in 72 Questions: An Overview of the Literature.
Derruau S, Bouchet J, Nassif A, Baudet A, Yasukawa K, Lorimier S, Prêcheur I, Bloch-Zupan A, Pellat B, Chardin H, Jung S, On Behalf Of Task Force Covid-Collège National des EnseignantS En Biologie Orale Cnesbo-France |
Journal of Clinical Medicine | 2021 |
|
The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis.
Dziedzic A, Saluk-Bijak J, Miller E, Niemcewicz M, Bijak M |
International journal of molecular sciences | 2021 |
|
Nutraceuticals in the Prevention of Viral Infections, including COVID-19, among the Pediatric Population: A Review of the Literature.
Parisi GF, Carota G, Castruccio Castracani C, Spampinato M, Manti S, Papale M, Di Rosa M, Barbagallo I, Leonardi S |
International journal of molecular sciences | 2021 |
|
Hematological and Inflammatory Parameters to Predict the Prognosis in COVID-19.
Keski H |
Indian Journal of Hematology and Blood Transfusion | 2021 |
|
The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic.
Samad N, Sodunke TE, Abubakar AR, Jahan I, Sharma P, Islam S, Dutta S, Haque M |
Journal of inflammation research | 2021 |
|
C-Reactive Protein Triggers Cell Death in Ischemic Cells.
Sheriff A, Kayser S, Brunner P, Vogt B |
Frontiers in immunology | 2021 |
|
Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
Borah P, Deb PK, Chandrasekaran B, Goyal M, Bansal M, Hussain S, Shinu P, Venugopala KN, Al-Shar'i NA, Deka S, Singh V |
Frontiers in Molecular Biosciences | 2021 |
|
Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies.
Garritsen A, Scholzen A, van den Nieuwenhof DWA, Smits APF, Datema ES, van Galen LS, Kouwijzer MLCE |
Infectious diseases (London, England) | 2021 |
|
Placenta-derived mesenchymal stem cells (P-MSCs) for COVID-19 pneumonia-a regenerative dogma.
Siddesh SE, Gowda DM, Jain R, Gulati A, Patil GS, Anudeep TC, Jeyaraman N, Muthu S, Jeyaraman M |
Stem Cell Investigation | 2021 |
|
Chest computed tomography scan findings of coronavirus disease 2019 (COVID-19) patients: a comprehensive systematic review and meta-analysis.
Karimian M, Azami M |
Polish Journal of Radiology | 2021 |
|
Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis - a systematic review and meta-analysis.
Syahrul S, Maliga HA, Ilmawan M, Fahriani M, Mamada SS, Fajar JK, Frediansyah A, Syahrul FN, Imran I, Haris S, Rambe AS, Emran TB, Rabaan AA, Tiwari R, Dhama K, Nainu F, Mutiawati E, Harapan H |
F1000Research | 2021 |
|
Targeting Cytokine Storm in COVID-19: A Role of Online Hemodiafiltration with Asymmetric Cellulose Triacetate in Maintenance Hemodialysis Patients-A Report of 10 Cases.
De La Flor JC, Valga F, Marschall A, Monzon T, Albarracín C, Ruiz E, Rodeles M |
Case Reports in Nephrology | 2021 |
|
The next-generation coronavirus diagnostic techniques with particular emphasis on the SARS-CoV-2.
Hemida MG |
Journal of Medical Virology | 2021 |
|
Moderate vs. mild cases of overseas-imported COVID-19 in Beijing: a retrospective cohort study.
Zhai W, Luo Z, Zheng Y, Dong D, Wu E, Wang Z, Zhai J, Han Y, Liu H, Wang Y, Feng Y, Wang J, Ma Y |
Scientific Reports | 2021 |
|
Risk profiles of severe illness in children with COVID-19: a meta-analysis of individual patients.
Zhou B, Yuan Y, Wang S, Zhang Z, Yang M, Deng X, Niu W |
Pediatric Research | 2021 |
|
Risk stratification by long non-coding RNAs profiling in COVID-19 patients.
Cheng J, Zhou X, Feng W, Jia M, Zhang X, An T, Luan M, Pan Y, Zhang S, Zhou Z, Wen L, Sun Y, Zhou C |
Journal of Cellular and Molecular Medicine | 2021 |
|
Implications of preexisting asthma on COVID-19 pathogenesis.
Ramakrishnan RK, Al Heialy S, Hamid Q |
American journal of physiology. Lung cellular and molecular physiology | 2021 |
|
COVID-19, Virchow's triad and thromboembolic risk in obese pregnant women.
Carbillon L, Fermaut M, Benbara A, Boujenah J |
Clinical Cardiology | 2021 |
|
Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis.
Crespo-Facorro B, Ruiz-Veguilla M, Vázquez-Bourgon J, Sánchez-Hidalgo AC, Garrido-Torres N, Cisneros JM, Prieto C, Sainz J |
Frontiers in pharmacology | 2021 |
|
Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.
Gao F, Zheng KI, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, Targher G, Byrne CD, George J, Zheng MH |
Frontiers in Endocrinology | 2021 |
|
Mutant glucocorticoid receptor binding elements on the interleukin-6 promoter regulate dexamethasone effects.
Chang WT, Hong MY, Chen CL, Hwang CY, Tsai CC, Chuang CC |
BMC Immunology | 2021 |
|
COVID-19 and the liver: an adverse outcome pathway perspective.
Vinken M |
Toxicology | 2021 |
|
The diagnostic value of platelet distribution width in patients with mild COVID-19.
Wang Y, Fan Z, Wang S, Zhuang C |
Journal of Clinical Laboratory Analysis | 2021 |
|
The Good Treatment, the Bad Virus, and the Ugly Inflammation: Pathophysiology of Kidney Involvement During COVID-19.
Le Stang MB, Desenclos J, Flamant M, Chousterman BG, Tabibzadeh N |
Frontiers in physiology | 2021 |
|
Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
Han M, Ma K, Wang X, Yan W, Wang H, You J, Wang Q, Chen H, Guo W, Chen T, Ning Q, Luo X |
Frontiers in Endocrinology | 2021 |
|
The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis.
Mahat RK, Panda S, Rathore V, Swain S, Yadav L, Sah SP |
Clinical Epidemiology and Global Health | 2021 |
|
Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.
Crooke PS 3rd, Tossberg JT, Porter KP, Aune TM |
Journal of immunology (Baltimore, Md. : 1950) | 2021 |
|
Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.
Yassin A, Nawaiseh M, Shaban A, Alsherbini K, El-Salem K, Soudah O, Abu-Rub M |
BMC neurology | 2021 |
|
COVID-19 and Thromboinflammation: Is There a Role for Statins?
Ferrari F, Martins VM, Teixeira M, Santos RD, Stein R |
2021 | |
|
Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2.
Tahmasebi S, Saeed BQ, Temirgalieva E, Yumashev AV, El-Esawi MA, Navashenaq JG, Valizadeh H, Sadeghi A, Aslani S, Yousefi M, Jadidi-Niaragh F, Adigozalou J, Ahmadi M, Roshangar L |
Life Sciences | 2021 |
|
The Age-AST-D Dimer (AAD) Regression Model Predicts Severe COVID-19 Disease.
Higuera-de-la-Tijera F, Servín-Caamaño A, Reyes-Herrera D, Flores-López A, Robiou-Vivero EJA, Martínez-Rivera F, Galindo-Hernández V, Rosales-Salyano VH, Casillas-Suárez C, Chapa-Azuela O, Chávez-Morales A, Jiménez-Bobadilla B, Hernández-Medel ML, Orozco-Zúñiga B, Zacarías-Ezzat JR, Camacho S, Pérez-Hernández JL |
Disease Markers | 2021 |
|
Comparison of Cancer Patients to Non-Cancer Patients among COVID-19 Inpatients at a National Level.
Bernard A, Cottenet J, Bonniaud P, Piroth L, Arveux P, Tubert-Bitter P, Quantin C |
Cancers | 2021 |
|
Severe COVID-19 Infection Associated with Endothelial Dysfunction Induces Multiple Organ Dysfunction: A Review of Therapeutic Interventions.
Matsuishi Y, Mathis BJ, Shimojo N, Subrina J, Okubo N, Inoue Y |
Biomedicines | 2021 |
|
SARS-CoV-2 Infection: Modulator of Pulmonary Embolism Paradigm.
Akhter MS, Hamali HA, Mobarki AA, Rashid H, Oldenburg J, Biswas A |
Journal of Clinical Medicine | 2021 |
|
SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention.
Inchingolo AD, Inchingolo AM, Bordea IR, Malcangi G, Xhajanka E, Scarano A, Lorusso F, Farronato M, Tartaglia GM, Isacco CG, Marinelli G, D'Oria MT, Hazballa D, Santacroce L, Ballini A, Contaldo M, Inchingolo F, Dipalma G |
Microorganisms | 2021 |
|
Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective.
Funk CD, Laferrière C, Ardakani A |
Viruses | 2021 |
|
Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19.
Qeadan F, Tingey B, Gu LY, Packard AH, Erdei E, Saeed AI |
Viruses | 2021 |
|
Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019.
Wang GL, Gao HX, Wang YL, Wei X, Liu YZ, Lu JH, Li L, Wang HB, Zhao L, Rong YX, Yao L, Duan LJ, Anderson BD, Ma MJ, Dai EH, Zhao XN |
Cytokine | 2021 |
|
Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.
Galassi G, Marchioni A |
Acta Neurologica Belgica | 2021 |
|
Peripheral Plasma Cells Associated with Mortality Benefit in Severe COVID-19: A Marker of Disease Resolution.
Boulanger M, Molina E, Wang K, Kickler T, Xu Y, Garibaldi BT |
The American Journal of Medicine | 2021 |
|
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support.
Birati EY, Najjar SS, Tedford RJ, Houston BA, Shore S, Vorovich E, Atluri P, Urgo K, Molina M, Chambers S, Escobar N, Hsich E, Estep JD, Alexander KM, Teuteberg JJ, Chaudhry SP, Ravichandran A, DeVore AD, Margulies KB, Hanff TC, Zimmer R, Kilic A, Wald JW, Vidula H, Martens J, Blumberg EA, Mazurek JA, Owens AT, Goldberg LR, Alvarez-Garcia J, Mancini DM, Moss N, Genuardi MV |
Circulation. Heart failure | 2021 |
|
A High Percentage of Patients Recovered From COVID-19 but Discharged With Abnormal Liver Function Tests.
Gan Q, Gong B, Sun M, Cao Z, Zheng Y, Zhang Y, Wen P, Shen Y, Hong L, Hou T, Jia Y, Li W, Li H, Xie Q |
Frontiers in physiology | 2021 |
|
Proteinuria in COVID-19.
Mohamed MMB, Velez JCQ |
Clinical Kidney Journal | 2021 |
|
SARS-CoV-2 Emergency and Long-Term Cognitive Impairment in Older People.
Rizzo MR, Paolisso G |
Aging and disease | 2021 |
|
Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
Yonal-Hindilerden I, Hindilerden F, Mastanzade M, Tiryaki TO, Tasan-Yenigun S, Bilen Y, Aksoz S, Cagatay AA, Nalcaci M |
Frontiers in Oncology | 2021 |
|
Exploration of severe Covid-19 associated risk factor in China: Meta-analysis of current evidence.
Zhang YJ, Sun XF, Xie B, Feng WJ, Han SL |
International Journal of Clinical Practice | 2021 |
|
[Research progress in coagulation dysfunction and its relationship with cytokine storm syndrome in patients with severe/critical COVID-19].
Zhang J, Gao XL, Yang LH |
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi | 2021 |
|
Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury.
Swenson KE, Swenson ER |
Critical Care Clinics | 2021 |
|
The Associations of Lymphocyte Ratio and Neutrophil Ratio on Liver Dysfunction in COVID-19 Patients.
Liu F, Liu H, Yu WY, Liu Z, Zhang X, Wang Y, Miao LB, Li ZY, Huang JS, Bao JF |
Frontiers in immunology | 2021 |
|
From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling.
Castiglione F, Deb D, Srivastava AP, Liò P, Liso A |
Frontiers in immunology | 2021 |
|
Venous thromboembolism in patients with COVID-19. A prevalent and a preventable complication of the pandemic.
Razi M, Gu J, He X, Kong J, Ahmed MJ |
2021 | |
|
Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19.
Santos AF, Póvoa P, Paixão P, Mendonça A, Taborda-Barata L |
Frontiers in Chemistry | 2021 |
|
Soluble IL-2R Levels Predict in-Hospital Mortality in COVID-19 Patients with Respiratory Failure.
Jang HJ, Leem AY, Chung KS, Ahn JY, Jung JY, Kang YA, Park MS, Kim YS, Lee SH |
Journal of Clinical Medicine | 2021 |
|
Vitamin D and Platelets: A Menacing Duo in COVID-19 and Potential Relation to Bone Remodeling.
Salamanna F, Maglio M, Sartori M, Landini MP, Fini M |
International journal of molecular sciences | 2021 |
|
Mutational Landscape and Interaction of SARS-CoV-2 with Host Cellular Components.
Srivastava M, Hall D, Omoru OB, Gill HM, Smith S, Janga SC |
Microorganisms | 2021 |
|
The Vitamin D, IL-6 and the eGFR Markers a Possible Way to Elucidate the Lung-Heart-Kidney Cross-Talk in COVID-19 Disease: A Foregone Conclusion.
Balzanelli MG, Distratis P, Lazzaro R, Cefalo A, Catucci O, Aityan SK, Dipalma G, Vimercati L, Inchingolo AD, Maggiore ME, Mancini A, Santacroce L, Gesualdo L, Pham VH, Iacobone D, Contaldo M, Serpico R, Scarano A, Lorusso F, Toai TC, Tafuri S, Migliore G, Inchingolo AM, Nguyen KCD, Inchingolo F, Tomassone D, Gargiulo Isacco C |
Microorganisms | 2021 |
|
Neuropsychiatric Disorders and COVID-19: What We Know So Far.
Majolo F, Silva GLD, Vieira L, Anli C, Timmers LFSM, Laufer S, Goettert MI |
Pharmaceuticals (Basel, Switzerland) | 2021 |
|
Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19.
Sharma HN, Latimore COD, Matthews QL |
2021 | |
|
Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages.
Maemura T, Kuroda M, Armbrust T, Yamayoshi S, Halfmann PJ, Kawaoka Y |
mBio | 2021 |
|
Iron Related Biomarkers Predict Disease Severity in a Cohort of Portuguese Adult Patients during COVID-19 Acute Infection.
Moreira AC, Teles MJ, Silva T, Bento CM, Alves IS, Pereira L, Guimarães JT, Porto G, Oliveira P, Gomes MS |
Viruses | 2021 |
|
High-Fat High-Sugar Diet-Induced Changes in the Lipid Metabolism Are Associated with Mildly Increased COVID-19 Severity and Delayed Recovery in the Syrian Hamster.
Port JR, Adney DR, Schwarz B, Schulz JE, Sturdevant DE, Smith BJ, Avanzato VA, Holbrook MG, Purushotham JN, Stromberg KA, Leighton I, Bosio CM, Shaia C, Munster VJ |
Viruses | 2021 |
|
SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted.
Verma HK, Bhaskar L |
World Journal of Gastroenterology | 2021 |
|
Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population.
Cyprian FS, Suleman M, Abdelhafez I, Doudin A, Masud Danjuma M, Mir FA, Parray A, Yousaf Z, Siddiqui MYA, Abdelmajid A, Mulhim M, Al-Shokri S, Abukhattab M, Shaheen R, Elkord E, Al-Khal AL, Elzouki AN, Girardi G |
Frontiers in immunology | 2021 |
|
Treatment of patients with Covid-19 with a high dose of ulinastatin.
Huang H, Hu PF, Sun LL, Guo YB, Wang Q, Liu ZM, Yin JZ, Shi PM, Yuan ZL, Xie WF |
Experimental and therapeutic medicine | 2021 |
|
Interplay of Nutrition and Psychoneuroendocrineimmune Modulation: Relevance for COVID-19 in BRICS Nations.
Mehta A, Kumar Ratre Y, Sharma K, Soni VK, Tiwari AK, Singh RP, Dwivedi MK, Chandra V, Prajapati SK, Shukla D, Vishvakarma NK |
Frontiers in microbiology | 2021 |
|
Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
Tsang HW, Chua GT, To KKW, Wong JSC, Tu W, Kwok JSY, Wong WHS, Wang X, Zhang Y, Rosa Duque JS, Chan GCF, Chu WK, Pang CP, Tam PKH, Lau YL, Wong ICK, Leung WH, Yuen KY, Kwan MYW, Ip P |
Frontiers in immunology | 2021 |
|
Crystal Structures of Bat and Human Coronavirus ORF8 Protein Ig-Like Domain Provide Insights Into the Diversity of Immune Responses.
Chen X, Zhou Z, Huang C, Zhou Z, Kang S, Huang Z, Jiang G, Hong Z, Chen Q, Yang M, He S, Liu S, Chen J, Li K, Li X, Liao J, Chen J, Chen S |
Frontiers in immunology | 2021 |
|
Foods to deliver immune-supporting nutrients.
Calder PC |
Current Opinion in Food Science | 2021 |
|
Relationship between lung injury extent and phenotype manifested in non-contrast CT and cardiac injury during acute stage of COVID-19.
So A, Yang Z, Li L, Li W, Pan C, Vivekanantha P, Yun HW, Xie XY, Yun CH, Huang WM, Hung CL, Gao M, Zhang X, Zha Y, Shen J |
2021 | |
|
A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS
Reyes L, A. Sanchez-Garcia M, Morrison T, Howden AJ, Watts ER, Arienti S, Sadiku P, Coelho P, Mirchandani AS, Zhang A, Hope D, Clark SK, Singleton J, Johnston S, Grecian R, Poon A, McNamara S, Harper I, Fourman MH, Brenes AJ, Pathak S, Lloyd A, Blanco GR, von Kriegsheim A, Ghesquiere B, Vermaelen W, Cologna CT, Dhaliwal K, Hirani N, Dockrell DH, Whyte MK, Griffith D, Cantrell DA, Walmsley SR |
Wellcome Open Research | 2021 |
|
Persons With Human Immunodeficiency Virus and the Coronavirus Disease 2019 Pandemic: A Viral Synergy of Biology and Sociology.
Collins LF |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021 |
|
Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.
Olajide OA, Iwuanyanwu VU, Lepiarz-Raba I, Al-Hindawi AA |
Inflammation | 2021 |
|
Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
Doghish AS, Elkhatib WF, Hassan EA, Elkhateeb AF, Mahmoud EE, Ahmed MI, Khalil MAF |
PloS one | 2021 |
|
Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity.
Cornelissen A, Kutyna M, Cheng Q, Sato Y, Kawakami R, Sakamoto A, Kawai K, Mori M, Fernandez R, Guo L, Pellegrini D, Guagliumi G, Barakat M, Virmani R, Finn A |
Cardiovascular revascularization medicine : including molecular interventions | 2021 |
|
Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection-Implications for Therapeutic Monitoring and Therapeutic Targets.
Drewett GP, Copaescu A, Mouhtouris E, Hannan N, James F, Smibert O, Holmes NE, Trubiano JA |
Journal of Clinical Immunology | 2021 |
|
Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2.
Ghaebi M, Tahmasebi S, Jozghorbani M, Sadeghi A, Thangavelu L, Zekiy AO, Esmaeilzadeh A |
Life Sciences | 2021 |
|
Prolonged humoral and cellular immunity in COVID-19-recovered patients.
Alsayb MA, Alsamiri ADD, Makhdoom HQ, Alwasaidi T, Osman HM, Mahallawi WH |
Saudi Journal of Biological Sciences | 2021 |
|
Perspectives on RNA Vaccine Candidates for COVID-19.
Borah P, Deb PK, Al-Shar'i NA, Dahabiyeh LA, Venugopala KN, Singh V, Shinu P, Hussain S, Deka S, Chandrasekaran B, Jaradat DMM |
Frontiers in Molecular Biosciences | 2021 |
|
Treatment of a Critically Ill COVID-19 Patient with the Seraph 100 Microbind Affinity Filter.
Pape A, Kielstein JT, Krüger T, Fühner T, Brunkhorst R |
2021 | |
|
Mucosal-associated invariant T cell responses differ by sex in COVID-19.
Yu C, Littleton S, Giroux NS, Mathew R, Ding S, Kalnitsky J, Yang Y, Petzold E, Chung HA, Rivera GO, Rotstein T, Xi R, Ko ER, Tsalik EL, Sempowski GD, Denny TN, Burke TW, McClain MT, Woods CW, Shen X, Saban DR |
2021 | |
|
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
Adeniji OS, Giron LB, Purwar M, Zilberstein NF, Kulkarni AJ, Shaikh MW, Balk RA, Moy JN, Forsyth CB, Liu Q, Dweep H, Kossenkov A, Weiner DB, Keshavarzian A, Landay A, Abdel-Mohsen M |
mBio | 2021 |
|
Single-cell multi-omics analysis of the immune response in COVID-19.
Stephenson E, Reynolds G, Botting RA, Calero-Nieto FJ, Morgan MD, Tuong ZK, Bach K, Sungnak W, Worlock KB, Yoshida M, Kumasaka N, Kania K, Engelbert J, Olabi B, Spegarova JS, Wilson NK, Mende N, Jardine L, Gardner LCS, Goh I, Horsfall D, McGrath J, Webb S, Mather MW, Lindeboom RGH, Dann E, Huang N, Polanski K, Prigmore E, Gothe F, Scott J, Payne RP, Baker KF, Hanrath AT, Schim van der Loeff ICD, Barr AS, Sanchez-Gonzalez A, Bergamaschi L, Mescia F, Barnes JL, Kilich E, de Wilton A, Saigal A, Saleh A, Janes SM, Smith CM, Gopee N, Wilson C, Coupland P, Coxhead JM, Kiselev VY, van Dongen S, Bacardit J, King HW, Rostron AJ, Simpson AJ, Hambleton S, Laurenti E, Lyons PA, Meyer KB, Nikolić MZ, Duncan CJA, Smith KGC, Teichmann SA, Clatworthy MR, Marioni JC, Göttgens B, Haniffa M |
Nature Medicine | 2021 |
|
Paradoxical Embolism Causing Myocardial Infarction in a COVID-19 Patient Presenting With Pulmonary Embolism.
Yu MD, Desai N, Sanagala T, Darki A |
Cureus | 2021 |
|
Development of a severity of disease score and classification model by machine learning for hospitalized COVID-19 patients.
Marcos M, Belhassen-García M, Sánchez-Puente A, Sampedro-Gomez J, Azibeiro R, Dorado-Díaz PI, Marcano-Millán E, García-Vidal C, Moreiro-Barroso MT, Cubino-Bóveda N, Pérez-García ML, Rodríguez-Alonso B, Encinas-Sánchez D, Peña-Balbuena S, Sobejano-Fuertes E, Inés S, Carbonell C, López-Parra M, Andrade-Meira F, López-Bernús A, Lorenzo C, Carpio A, Polo-San-Ricardo D, Sánchez-Hernández MV, Borrás R, Sagredo-Meneses V, Sanchez PL, Soriano A, Martín-Oterino JÁ |
PloS one | 2021 |
|
Potential Predictors of Poor Prognosis among Severe COVID-19 Patients: A Single-Center Study.
Ghaith MM, Albanghali MA, Aldairi AF, Iqbal MS, Almaimani RA, AlQuthami K, Alqasmi MH, Almaimani W, El-Readi MZ, Alghamdi A, Almasmoum HA |
2021 | |
|
Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19.
Syed F, Li W, Relich RF, Russell PM, Zhang S, Zimmerman MK, Yu Q |
The Journal of Infectious Diseases | 2021 |
|
Kidney disease and COVID-19 disease severity-systematic review and meta-analysis.
Singh J, Malik P, Patel N, Pothuru S, Israni A, Chakinala RC, Hussain MR, Chidharla A, Patel H, Patel SK, Rabbani R, Patel U, Chugh S, Kichloo A |
Clinical and Experimental Medicine | 2021 |
|
Outcomes of COVID-19 Complications and their Possibilities as Potential Triggers of Stroke.
Patel U, Malik P, Mehta D, Rajput P, Shrivastava M, Naveed M, Urhoghide E, Martin M, Somi S, Jaiswal R, Patel A, Israni A, Singh J, Kichloo A, Shah S, Lunagariya A |
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2021 |
|
COVID-19 and severe ENT infections in pediatric patients. IS there a relationship?
Enrique GL, Margarita BB, Ángel MJ, Saturnino SS, María Jesús DR |
International Journal of Pediatric Otorhinolaryngology | 2021 |
|
Thymosin a1 use is not associated with reduced COVID-19 mortality.
Liu T, Liu S, Li T, Zhang J |
The American Journal of Emergency Medicine | 2021 |
|
Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut.
Triana S, Metz-Zumaran C, Ramirez C, Kee C, Doldan P, Shahraz M, Schraivogel D, Gschwind AR, Sharma AK, Steinmetz LM, Herrmann C, Alexandrov T, Boulant S, Stanifer ML |
Molecular Systems Biology | 2021 |
|
Comprehensive evaluation of bronchoalveolar lavage from patients with severe COVID-19 and correlation with clinical outcomes.
Gelarden I, Nguyen J, Gao J, Chen Q, Morales-Nebreda L, Wunderink R, Li L, Chmiel JS, Hrisinko M, Marszalek L, Momnani S, Patel P, Sumugod R, Chao Q, Jennings LJ, Zembower TR, Ji P, Chen YH |
Human Pathology | 2021 |
|
ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.
Posch W, Vosper J, Zaderer V, Noureen A, Constant S, Bellmann-Weiler R, Lass-Flörl C, Wilflingseder D |
mBio | 2021 |
|
Interleukin‑6 signalling as a valuable cornerstone for molecular medicine (Review).
Trovato M, Sciacchitano S, Facciolà A, Valenti A, Visalli G, Di Pietro A |
International journal of molecular medicine | 2021 |
|
COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management.
Kohansal Vajari M, Shirin M, Pourbagheri-Sigaroodi A, Akbari ME, Abolghasemi H, Bashash D |
Cell biology international | 2021 |
|
Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections.
Abdel-Hamed EF, Ibrahim MN, Mostafa NE, Moawad HSF, Elgammal NE, Darwiesh EM, El-Rafey DS, ElBadawy NE, Al-Khoufi EA, Hindawi SI |
Gut pathogens | 2021 |
|
Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients.
Manganotti P, Bellavita G, Tommasini V, D Acunto L, Fabris M, Cecotti L, Furlanis G, Sartori A, Bonzi L, Buoite Stella A, Pesavento V |
Journal of Medical Virology | 2021 |
|
Cautions on the laboratory indicators of COVID-19 patients on and during admission.
Liu H, Shang X, Chen S, Li T, Zhang J |
Journal of Clinical Laboratory Analysis | 2021 |
|
Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol.
Tang H, Bohannon L, Lew M, Jensen D, Jung SH, Zhao A, Sung AD, Wischmeyer PE |
BMJ Open | 2021 |
|
Efficient management strategy of COVID-19 patients based on cluster analysis and clinical decision tree classification.
Li Z, Wang L, Huang LS, Zhang M, Cai X, Xu F, Wu F, Li H, Huang W, Zhou Q, Yao J, Liang Y, Liu G |
Scientific Reports | 2021 |
|
Delayed production of neutralizing antibodies correlates with fatal COVID-19.
Lucas C, Klein J, Sundaram ME, Liu F, Wong P, Silva J, Mao T, Oh JE, Mohanty S, Huang J, Tokuyama M, Lu P, Venkataraman A, Park A, Israelow B, Vogels CBF, Muenker MC, Chang CH, Casanovas-Massana A, Moore AJ, Zell J, Fournier JB, Wyllie AL, Campbell M, Lee AI, Chun HJ, Grubaugh ND, Schulz WL, Farhadian S, Dela Cruz C, Ring AM, Shaw AC, Wisnewski AV, Yildirim I, Ko AI, Omer SB, Iwasaki A |
Nature Medicine | 2021 |
|
A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome.
Pascreau T, Tcherakian C, Zuber B, Farfour E, Vasse M, Lassalle P |
Critical Care | 2021 |
|
Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.
Crooke PS 3rd, Tossberg JT, Porter KP, Aune TM |
2021 | |
|
Clinical Manifestations of COVID-19.
Eskian M, Rezaei N |
Advances in experimental medicine and biology | 2021 |
|
Pediatrics and COVID-19.
Toptan T, Ciesek S, Hoehl S |
Advances in experimental medicine and biology | 2021 |
|
Dietary Supplements for COVID-19.
Mullin GE, Limektkai B, Wang L, Hanaway P, Marks L, Giovannucci E |
Advances in experimental medicine and biology | 2021 |
|
Leptin Deficiency, Caused by Malnutrition, Makes You Susceptible to SARS-CoV-2 Infection but Could Offer Protection from Severe COVID-19.
Schoeman D, Fielding BC |
mSphere | 2021 |
|
Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives.
Dejani NN, Elshabrawy HA, Bezerra Filho CDSM, de Sousa DP |
Biomolecules | 2021 |
|
Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection.
Manosso LM, Arent CO, Borba LA, Ceretta LB, Quevedo J, Réus GZ |
Cells | 2021 |
|
Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus.
Coloretti I, Berlot G, Busani S, De Rosa FG, Donati A, Forfori F, Grasselli G, Mirabella L, Tascini C, Viale P, Girardis M |
Journal of Clinical Medicine | 2021 |
|
COVID and Animal Trials: A Systematic Review.
Moothedath M, Muhamood M, Bhosale YS, Bhatia A, Gupta P, Reddy MRH, Tiwari RVC |
Journal of Pharmacy & Bioallied Sciences | 2021 |
|
A Glimpse into the Diverse Cellular Immunity against SARS-CoV-2.
Chang CW, Liu Y, Jiao C, Liu H, Gong J, Chen X, Chang LJ |
Human vaccines | 2021 |
|
Animal Coronavirus Diseases: Parallels with COVID-19 in Humans.
Lin CN, Chan KR, Ooi EE, Chiou MT, Hoang M, Hsueh PR, Ooi PT |
Viruses | 2021 |
|
Clinical and Histopathologic Features of a Feline SARS-CoV-2 Infection Model Are Analogous to Acute COVID-19 in Humans.
Rudd JM, Tamil Selvan M, Cowan S, Kao YF, Midkiff CC, Narayanan S, Ramachandran A, Ritchey JW, Miller CA |
Viruses | 2021 |
|
Postacute COVID-19 Laryngeal Injury and Dysfunction.
Neevel AJ, Smith JD, Morrison RJ, Hogikyan ND, Kupfer RA, Stein AP |
2021 | |
|
In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR.
Gasparello J, d'Aversa E, Breveglieri G, Borgatti M, Finotti A, Gambari R |
International Immunopharmacology | 2021 |
|
Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines.
Picchianti Diamanti A, Rosado MM, Nicastri E, Sesti G, Pioli C, Laganà B |
Frontiers in immunology | 2021 |
|
Central Retinal Vein Occlusion in patients with COVID-19 infection: A systematic review.
Ullah I, Sohail A, Shah MUFA, Khurshid M, Diwan MN, Qadir A, Irfan M |
2021 | |
|
Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection.
Munnur D, Teo Q, Eggermont D, Lee HHY, Thery F, Ho J, van Leur SW, Ng WWS, Siu LYL, Beling A, Ploegh H, Pinto-Fernandez A, Damianou A, Kessler B, Impens F, Mok CKP, Sanyal S |
Nature Immunology | 2021 |
|
COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.
Ostaszewski M, Niarakis A, Mazein A, Kuperstein I, Phair R, Orta-Resendiz A, Singh V, Aghamiri SS, Acencio ML, Glaab E, Ruepp A, Fobo G, Montrone C, Brauner B, Frishman G, Monraz Gómez LC, Somers J, Hoch M, Kumar Gupta S, Scheel J, Borlinghaus H, Czauderna T, Schreiber F, Montagud A, Ponce de Leon M, Funahashi A, Hiki Y, Hiroi N, Yamada TG, Dräger A, Renz A, Naveez M, Bocskei Z, Messina F, Börnigen D, Fergusson L, Conti M, Rameil M, Nakonecnij V, Vanhoefer J, Schmiester L, Wang M, Ackerman EE, Shoemaker JE, Zucker J, Oxford K, Teuton J, Kocakaya E, Summak GY, Hanspers K, Kutmon M, Coort S, Eijssen L, Ehrhart F, Rex DAB, Slenter D, Martens M, Pham N, Haw R, Jassal B, Matthews L, Orlic-Milacic M, Senff Ribeiro A, Rothfels K, Shamovsky V, Stephan R, Sevilla C, Varusai T, Ravel JM, Fraser R, Ortseifen V, Marchesi S, Gawron P, Smula E, Heirendt L, Satagopam V, Wu G, Riutta A, Golebiewski M, Owen S, Goble C, Hu X, Overall RW, Maier D, Bauch A, Gyori BM, Bachman JA, Vega C, Grouès V, Vazquez M, Porras P, Licata L, Iannuccelli M, Sacco F, Nesterova A, Yuryev A, de Waard A, Turei D, Luna A, Babur O, Soliman S, Valdeolivas A, Esteban-Medina M, Peña-Chilet M, Rian K, Helikar T, Puniya BL, Modos D, Treveil A, Olbei M, De Meulder B, Ballereau S, Dugourd A, Naldi A, Noël V, Calzone L, Sander C, Demir E, Korcsmaros T, Freeman TC, Augé F, Beckmann JS, Hasenauer J, Wolkenhauer O, Wilighagen EL, Pico AR, Evelo CT, Gillespie ME, Stein LD, Hermjakob H, D'Eustachio P, Saez-Rodriguez J, Dopazo J, Valencia A, Kitano H, Barillot E, Auffray C, Balling R, Schneider R |
Molecular Systems Biology | 2021 |
|
Role of Dexamethasone on Oxygen Requirement, Mortality, and Survival Incidence among COVID-19 Patients: Quasi-Experimental Study.
Mahajan L, Singh AP, Singla A, Singh G |
Anesthesia Essays and Researches | 2021 |
|
Impact of immunosuppression on the immune response to SARS-CoV-2 infection: A mechanistic study.
Hall VG, Ferreira V, Kumar D, Humar A |
Transplant Infectious Disease | 2021 |
|
SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best.
Salinas AF, Mortari EP, Terreri S, Quintarelli C, Pulvirenti F, Di Cecca S, Guercio M, Milito C, Bonanni L, Auria S, Romaggioli L, Cusano G, Albano C, Zaffina S, Perno CF, Spadaro G, Locatelli F, Carsetti R, Quinti I |
Journal of Clinical Immunology | 2021 |
|
Metagenomic Next-Generation Sequencing in the Diagnosis of HHV-1 Reactivation in a Critically Ill COVID-19 Patient: A Case Report.
Shi L, Xia H, Moore MD, Deng C, Li N, Ren H, Chen Y, Liu J, Du F, Zheng G, Li J, Han Q, Fan W, Ye F, Lin S, Liu Z, Liu H, Wang Y, Yang J, Liu Q, Zhao Y, Chen T |
Frontiers in Medicine | 2021 |
|
COVID and Lung Cancer.
Calabrò L, Rossi G, Covre A, Morra A, Maio M |
Current Oncology Reports | 2021 |
|
The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies.
Durdagi S, Avsar T, Orhan MD, Serhatli M, Balcioglu BK, Ozturk HU, Kayabolen A, Cetin Y, Aydinlik S, Bagci-Onder T, Tekin S, Demirci H, Guzel M, Akdemir A, Calis S, Oktay L, Tolu I, Butun YE, Erdemoglu E, Olkan A, Tokay N, Işık Ş, Ozcan A, Acar E, Buyukkilic S, Yumak Y |
Molecular Therapy | 2021 |
|
The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19.
Tseng HT, Wu XC, Huang CY, Shih CM, Lin YW, Lin FY |
Pharmaceuticals (Basel, Switzerland) | 2021 |
|
The Complex Interplay between Immunonutrition, Mast Cells, and Histamine Signaling in COVID-19.
Kakavas S, Karayiannis D, Mastora Z |
Nutrients | 2021 |
|
Standardized Extract of Asparagus officinalis Stem Attenuates SARS-CoV-2 Spike Protein-Induced IL-6 and IL-1β Production by Suppressing p44/42 MAPK and Akt Phosphorylation in Murine Primary Macrophages.
Shirato K, Takanari J, Kizaki T |
Molecules (Basel, Switzerland) | 2021 |
|
Establishment of the reference intervals of lymphocyte subsets for healthy Chinese Han adults and its influencing factors.
Xu K, Miao L, Chen W, Wu H, Gong Y, Tu X, Guo W, Pan B, Qu C, Wu X, Wang B |
Annals of translational medicine | 2021 |
|
COVID-19 Associated Thyroid Storm: A Case Report.
Sullivan K, Helgeson J, McGowan A |
2021 | |
|
ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.
Wu B, Ramaiah A, Garcia G Jr, Hasiakos S, Arumugaswami V, Srikanth S |
Journal of immunology (Baltimore, Md. : 1950) | 2021 |
|
Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis.
Zahoor I, Li Y, Rattan R, Giri S |
Advances in experimental medicine and biology | 2021 |
|
A case report describing the immune response of an infant with congenital heart disease and severe COVID-19.
Wurzel D, Neeland MR, Anderson J, Abo YN, Do LAH, Donato CM, Bines JE, Toh ZQ, Higgins RA, Jalali S, Cole T, Subbarao K, McMinn A, Dohle K, Haeusler GM, McNab S, Alafaci A, Overmars I, Clifford V, Lee LY, Daley AJ, Buttery J, Bryant PA, Burgner D, Steer A, Tosif S, Konstantinov IE, Duke T, Licciardi PV, Pellicci DG, Crawford NW |
2021 | |
|
Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients
Ni L, Cheng ML, Feng Y, Zhao H, Liu J, Ye F, Ye Q, Zhu G, Li X, Wang P, Shao J, Deng YQ, Wei P, Chen F, Qin CF, Wang G, Li F, Zeng H, Dong C |
Frontiers in immunology | 2021 |
|
Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19
Denson JL, Gillet AS, Zu Y, Brown M, Pham T, Yoshida Y, Mauvais-Jarvis F, Douglas IS, Moore M, Tea K, Wetherbie A, Stevens R, Lefante J, Shaffer JG, Armaignac DL, Belden KA, Kaufman M, Heavner SF, Danesh VC, Cheruku SR, St. Hill CA, Boman K, Deo N, Bansal V, Kumar VK, Walkey AJ, Kashyap R |
2021 | |
|
Elevated serum ferritin level effectively discriminates severity illness and liver injury of coronavirus disease 2019 pneumonia.
Cao P, Wu Y, Wu S, Wu T, Zhang Q, Zhang R, Wang Z, Zhang Y |
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals | 2021 |
|
Early Warning Factors of Death in COVID-19 Patients.
Shang M, Wei J, Zou HD, Zhou QS, Zhang YT, Wang CY |
2021 | |
|
ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19.
Pascreau T, Zia-Chahabi S, Zuber B, Tcherakian C, Farfour E, Vasse M |
Thrombosis Research | 2021 |
|
COVID-19: Imbalanced Immune Responses and Potential Immunotherapies.
Xie B, Zhang J, Li Y, Yuan S, Shang Y |
Frontiers in immunology | 2021 |
|
Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study.
Cremoni M, Ruetsch C, Zorzi K, Fernandez C, Boyer-Suavet S, Benzaken S, Demonchy E, Dellamonica J, Ichai C, Esnault V, Brglez V, Seitz-Polski B |
Frontiers in Medicine | 2021 |
|
Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients.
Chaudhary R, Garg J, Houghton DE, Murad MH, Kondur A, Chaudhary R, Wysokinski WE, McBane RD 2nd |
2021 | |
|
COVID-19 induces a hyperactive phenotype in circulating platelets.
Comer SP, Cullivan S, Szklanna PB, Weiss L, Cullen S, Kelliher S, Smolenski A, Murphy C, Altaie H, Curran J, O'Reilly K, Cotter AG, Marsh B, Gaine S, Mallon P, McCullagh B, Moran N, Ní Áinle F, Kevane B, Maguire PB |
PLoS Biology | 2021 |
|
COVID-19 Related Cardiovascular Comorbidities and Complications in Critically Ill Patients: A Systematic Review and Meta-analysis.
Koeppen M, Rosenberger P, Magunia H |
Clinical medicine insights. Circulatory, respiratory and pulmonary medicine | 2021 |
|
Development and validation of an online model to predict critical COVID-19 with immune-inflammatory parameters.
Gao Y, Chen L, Chi J, Zeng S, Feng X, Li H, Liu D, Feng X, Wang S, Wang Y, Yu R, Yuan Y, Xu S, Li C, Zhang W, Li S, Gao Q |
Journal of Intensive Care | 2021 |
|
Pain in Covid Era.
Alonso-Matielo H, da Silva Oliveira VR, de Oliveira VT, Dale CS |
Frontiers in physiology | 2021 |
|
Clinical features and prognosis of patients with COVID-19 after lung surgery: A retrospective clinical study.
Bai J, Chu H, Ma S, Ge Q |
Asia-Pacific Journal of Clinical Oncology | 2021 |
|
Coronavirus-induced autoimmunity.
Salle V |
Clinical Immunology | 2021 |
|
SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
Cyprian F, Sohail MU, Abdelhafez I, Salman S, Attique Z, Kamareddine L, Al-Asmakh M |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
|
The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences.
Filgueira TO, Castoldi A, Santos LER, de Amorim GJ, de Sousa Fernandes MS, Anastácio WLDN, Campos EZ, Santos TM, Souto FO |
Frontiers in immunology | 2021 |
|
Evaluation of serum ferritin for prediction of severity and mortality in COVID-19- A cross sectional study.
Ahmed S, Ansar Ahmed Z, Siddiqui I, Haroon Rashid N, Mansoor M, Jafri L |
2021 | |
|
Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes.
Zhou Z, Huang C, Zhou Z, Huang Z, Su L, Kang S, Chen X, Chen Q, He S, Rong X, Xiao F, Chen J, Chen S |
iScience | 2021 |
|
Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients.
Luis BM, Miguel MB, Pedro DL, David IP, Itziar A, Ana GH, Enrique IJ, María LV, Noelia TF, Julio César BB, Marta UI, Rodrigo SL, María CB, Andrés LM, Javier MI, Juan Pablo GM, Gerardo HF, Carolina NF, Jorge BL, María FR, Fernando CT, Sergio OE, Lourdes FC, María GE, Gregoria ML, Adolfo SR, José Antonio FR |
2021 | |
|
Splenic infarction and spontaneous rectus sheath hematomas in COVID-19 patient.
Dennison JJ, Carlson S, Faehling S, Phelan H, Tariq M, Mubarik A |
Radiology Case Reports | 2021 |
|
The Pathophysiology and Dangers of Silent Hypoxemia in COVID-19 Lung Injury.
Swenson KE, Ruoss SJ, Swenson ER |
Annals of the American Thoracic Society | 2021 |
|
Progesterone in Addition to Standard of Care vs Standard of Care Alone in the Treatment of Men Hospitalized With Moderate to Severe COVID-19: A Randomized, Controlled Pilot Trial.
Ghandehari S, Matusov Y, Pepkowitz S, Stein D, Kaderi T, Narayanan D, Hwang J, Chang S, Goodman R, Ghandehari H, Mirocha J, Bresee C, Tapson V, Lewis M |
Chest | 2021 |
|
Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19.
Zhang J, Zhao C, Zhao W |
Frontiers in immunology | 2021 |
|
A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem.
Lalueza A, Lora-Tamayo J, Maestro-de la Calle G, Folgueira D, Arrieta E, de Miguel-Campo B, Díaz-Simón R, Lora D, de la Calle C, Mancheño-Losa M, Marchán-López Á, García-Reyne A, Fernández-Ruiz M, Sayas-Catalán J, Serrano A, Cueto-Felgueroso C, San Juan R, García-García R, Catalán M, Villena V, Aguado JM, Lumbreras C |
Internal and Emergency Medicine | 2021 |
|
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.
Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe Å, Abbondanza D, Fleming SJ, Subramanian A, Montoro DT, Jagadeesh KA, Dey KK, Sen P, Slyper M, Pita-Juárez YH, Phillips D, Biermann J, Bloom-Ackermann Z, Barkas N, Ganna A, Gomez J, Melms JC, Katsyv I, Normandin E, Naderi P, Popov YV, Raju SS, Niezen S, Tsai LT, Siddle KJ, Sud M, Tran VM, Vellarikkal SK, Wang Y, Amir-Zilberstein L, Atri DS, Beechem J, Brook OR, Chen J, Divakar P, Dorceus P, Engreitz JM, Essene A, Fitzgerald DM, Fropf R, Gazal S, Gould J, Grzyb J, Harvey T, Hecht J, Hether T, Jané-Valbuena J, Leney-Greene M, Ma H, McCabe C, McLoughlin DE, Miller EM, Muus C, Niemi M, Padera R, Pan L, Pant D, Pe'er C, Pfiffner-Borges J, Pinto CJ, Plaisted J, Reeves J, Ross M, Rudy M, Rueckert EH, Siciliano M, Sturm A, Todres E, Waghray A, Warren S, Zhang S, Zollinger DR, Cosimi L, Gupta RM, Hacohen N, Hibshoosh H, Hide W, Price AL, Rajagopal J, Tata PR, Riedel S, Szabo G, Tickle TL, Ellinor PT, Hung D, Sabeti PC, Novak R, Rogers R, Ingber DE, Jiang ZG, Juric D, Babadi M, Farhi SL, Izar B, Stone JR, Vlachos IS, Solomon IH, Ashenberg O, Porter CBM, Li B, Shalek AK, Villani AC, Rozenblatt-Rosen O, Regev A |
Nature | 2021 |
|
Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19.
Bodro M, Cofan F, Ríos J, Herrera S, Linares L, Marcos MA, Soriano A, Moreno A, Diekmann F |
Journal of Clinical Medicine | 2021 |
|
Cardiovascular Outcomes in the Acute Phase of COVID-19.
Nakano H, Shiina K, Tomiyama H |
International journal of molecular sciences | 2021 |
|
COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns.
Joma M, Fovet CM, Seddiki N, Gressens P, Laforge M |
Human vaccines | 2021 |
|
A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).
Lotfi R, Kalmarzi RN, Roghani SA |
Immunologic research | 2021 |
|
New perspectives on natural flavonoids on COVID-19-induced lung injuries.
Santana FPR, Thevenard F, Gomes KS, Taguchi L, Câmara NOS, Stilhano RS, Ureshino RP, Prado CM, Lago JHG |
Phytotherapy research : PTR | 2021 |
|
Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants.
Shoily SS, Ahsan T, Fatema K, Sajib AA |
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases | 2021 |
|
Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab.
Sinagra JL, Vedovelli C, Binazzi R, Salemme A, Moro F, Mazzanti C, Didona B, Di Zenzo G |
Frontiers in immunology | 2021 |
|
Risk of Covid-19 infection after resection of high grade transitional cell carcinoma with renal impairment.
Murshidi MM, Ihmeidan MK, Murshidi MM, Murshidi RMSM, Murshidi RM |
International Journal of Surgery Case Reports | 2021 |
|
Clinical laboratory evaluation of COVID-19.
Chen Z, Xu W, Ma W, Shi X, Li S, Hao M, Fang Y, Zhang L |
Clinica chimica acta; international journal of clinical chemistry | 2021 |
|
Combination therapy of tocilizumab and steroid for COVID-19 patients: A meta-analysis.
Moosazadeh M, Mousavi T |
Journal of Medical Virology | 2021 |
|
COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review.
Jaiswal V, Sarfraz Z, Sarfraz A, Mukherjee D, Batra N, Hitawala G, Yaqoob S, Patel A, Agarwala P, Ruchika, Sarfraz M, Bano S, Azeem N, Naz S, Jaiswal A, Sharma P, Chaudhary G |
Journal of Primary Care & Community Health | 2021 |
|
Abnormal Transcript Levels of Cytokines Among Iranian COVID-19 Patients.
Samsami M, Fatemi A, Jalili Khoshnoud R, Kohansal K, Hussen BM, Soghala S, Taheri M, Ghafouri-Fard S |
Journal of molecular neuroscience : MN | 2021 |
|
Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
Shcherbak SG, Anisenkova AY, Mosenko SV, Glotov OS, Chernov AN, Apalko SV, Urazov SP, Garbuzov EY, Khobotnikov DN, Klitsenko OA, Minina EM, Asaulenko ZP |
Frontiers in immunology | 2021 |
|
Severe acute respiratory syndrome coronavirus 2 causes lung inflammation and injury.
Wang LL, Yang JW, Xu JF |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021 |
|
Total antioxidant capacity as a marker of severity of COVID-19 infection: Possible prognostic and therapeutic clinical application.
Yaghoubi N, Youssefi M, Jabbari Azad F, Farzad F, Yavari Z, Zahedi Avval F |
Journal of Medical Virology | 2021 |
|
SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells.
Barreda D, Santiago C, Rodríguez JR, Rodríguez JF, Casasnovas JM, Mérida I, Ávila-Flores A |
Cells | 2021 |
|
Nutritional risk of vitamin D, vitamin C, zinc, and selenium deficiency on risk and clinical outcomes of COVID-19: A narrative review.
Pedrosa LFC, Barros ANAB, Leite-Lais L |
Clinical Nutrition ESPEN | 2021 |
|
Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases.
Law MF, Ho R, Law KWT, Cheung CKM |
World journal of hepatology | 2021 |
|
Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice
Zhu A, Chen Z, Wang Y, Zeng Q, Sun J, Zhuang Z, Li F, Zhao J, Zhao J, Zhong N |
2021 | |
|
Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges
Hakim A, Hasan MM, Hasan M, Lokman SM, Azim KF, Raihan T, Chowdhury PA, Azad AK |
Frontiers in microbiology | 2021 |
|
Altered pre-existing SARS-CoV-2-specific T cell responses in elderly individuals
Taira N, Toguchi S, Miyagi M, Mori T, Tomori H, Oshiro K, Tamai O, Kina M, Miyagi M, Tamaki K, Collins MK, Ishikawa H |
2021 | |
|
Early prediction of mortality risk among patients with severe COVID-19, using machine learning.
Hu C, Liu Z, Jiang Y, Shi O, Zhang X, Xu K, Suo C, Wang Q, Song Y, Yu K, Mao X, Wu X, Wu M, Shi T, Jiang W, Mu L, Tully DC, Xu L, Jin L, Li S, Tao X, Zhang T, Chen X |
International Journal of Epidemiology | 2021 |
|
Severe Acute Respiratory Syndrome Coronavirus 2-Induced Immune Activation and Death of Monocyte-Derived Human Macrophages and Dendritic Cells.
Zheng J, Wang Y, Li K, Meyerholz DK, Allamargot C, Perlman S |
The Journal of Infectious Diseases | 2021 |
|
COVID-19: Risk Factors Associated with Infectivity and Severity.
Fadl N, Ali E, Salem TZ |
Scandinavian Journal of Immunology | 2021 |
|
Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths.
Xiong L, Zang X, Feng G, Zhao F, Wang S, Zeng W, Yu K, Zhai Y |
Aging | 2021 |
|
Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?
Söderberg-Nauclér C |
Immunity & ageing : I & A | 2021 |
|
The first 12 months of COVID-19: a timeline of immunological insights.
Carvalho T, Krammer F, Iwasaki A |
Nature reviews. Immunology | 2021 |
|
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries.
Tan EH, Sena AG, Prats-Uribe A, You SC, Ahmed WU, Kostka K, Reich C, Duvall SL, Lynch KE, Matheny ME, Duarte-Salles T, Bertolin SF, Hripcsak G, Natarajan K, Falconer T, Spotnitz M, Ostropolets A, Blacketer C, Alshammari TM, Alghoul H, Alser O, Lane JCE, Dawoud DM, Shah K, Yang Y, Zhang L, Areia C, Golozar A, Recalde M, Casajust P, Jonnagaddala J, Subbian V, Vizcaya D, Lai LYH, Nyberg F, Morales DR, Posada JD, Shah NH, Gong M, Vivekanantham A, Abend A, Minty EP, Suchard M, Rijnbeek P, Ryan PB, Prieto-Alhambra D |
Rheumatology (Oxford, England) | 2021 |
|
SARS-CoV-2 Infection of Airway Epithelial Cells.
Ryu G, Shin HW |
Immune Network | 2021 |
|
Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
Ravindra NG, Alfajaro MM, Gasque V, Huston NC, Wan H, Szigeti-Buck K, Yasumoto Y, Greaney AM, Habet V, Chow RD, Chen JS, Wei J, Filler RB, Wang B, Wang G, Niklason LE, Montgomery RR, Eisenbarth SC, Chen S, Williams A, Iwasaki A, Horvath TL, Foxman EF, Pierce RW, Pyle AM, van Dijk D, Wilen CB |
PLoS Biology | 2021 |
|
What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease?
Barbalho SM, Matias JN, Flato UAP, Pilon JPG, Bitelli P, Pagani Junior MA, de Carvalho ACA, Haber JFDS, Reis CHB, Goulart RA |
Gastroenterology Research | 2021 |
|
Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019.
Meng L, Xu J, Zhang J, Zhang K, Shang P, Li Q, Li Y, Wang L, Cai B |
Aging | 2021 |
|
Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection.
Wang Z, Yang X, Zhong J, Zhou Y, Tang Z, Zhou H, He J, Mei X, Tang Y, Lin B, Chen Z, McCluskey J, Yang J, Corbett AJ, Ran P |
Nature Communications | 2021 |
|
Nexus between COVID-19 and periodontal disease.
Sukumar K, Tadepalli A |
2021 | |
|
Practical Recommendations Relevant to the Use of Resistance Training for COVID-19 Survivors.
Gentil P, de Lira CAB, Coswig V, Barroso WKS, Vitorino PVO, Ramirez-Campillo R, Martins W, Souza D |
Frontiers in physiology | 2021 |
|
Meta-analysis of laboratory results in patients with severe coronavirus disease 2019.
Huang Y, Zhang Y, Ma L |
Experimental and therapeutic medicine | 2021 |
|
C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
Pink I, Raupach D, Fuge J, Vonberg RP, Hoeper MM, Welte T, Rademacher J |
Infection | 2021 |
|
The impact of COVID-19 outbreak on the incidence of acute invasive fungal rhinosinusitis.
Ismaiel WF, Abdelazim MH, Eldsoky I, Ibrahim AA, Alsobky ME, Zafan E, Hasan A |
American Journal of Otolaryngology | 2021 |
|
Immunological map in COVID-19.
Li CH, Chiou HC, Lin MH, Kuo CH, Lin YC, Lin YC, Hung CH, Kuo CH |
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2021 |
|
Associations of D-Dimer on Admission and Clinical Features of COVID-19 Patients: A Systematic Review, Meta-Analysis, and Meta-Regression.
Zhao R, Su Z, Komissarov AA, Liu SL, Yi G, Idell S, Matthay MA, Ji HL |
Frontiers in immunology | 2021 |
|
Comparison of the coagulopathies associated with COVID-19 and sepsis.
Campbell RA, Hisada Y, Denorme F, Grover SP, Bouck EG, Middleton EA, Wolberg AS, Rondina MT, Mackman N |
Research and Practice in Thrombosis and Haemostasis | 2021 |
|
Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations.
Greco R, Alexander T, Burman J, Del Papa N, de Vries-Bouwstra J, Farge D, Henes J, Kazmi M, Kirgizov K, Muraro PA, Ricart E, Rovira M, Saccardi R, Sharrack B, Snarski E, Withers B, Jessop H, Boglione C, Kramer E, Badoglio M, Labopin M, Orchard K, Corbacioglu S, Ljungman P, Mikulska M, De la Camara R, Snowden JA |
Bone Marrow Transplantation | 2021 |
|
Coronavirus disease 2019 (COVID-19): Biophysical and biochemical aspects of SARS-CoV-2 and general characteristics.
Güler G, Özdemir H, Omar D, Akdoğan G |
Progress in Biophysics and Molecular Biology | 2021 |
|
Aspergillus fumigatus and aspergillosis: From basics to clinics.
Arastehfar A, Carvalho A, Houbraken J, Lombardi L, Garcia-Rubio R, Jenks JD, Rivero-Menendez O, Aljohani R, Jacobsen ID, Berman J, Osherov N, Hedayati MT, Ilkit M, Armstrong-James D, Gabaldón T, Meletiadis J, Kostrzewa M, Pan W, Lass-Flörl C, Perlin DS, Hoenigl M |
Studies in Mycology | 2021 |
|
Mucormycosis associated with COVID-19 in two kidney transplant patients.
Arana C, Cuevas Ramírez RE, Xipell M, Casals J, Moreno A, Herrera S, Bodro M, Cofan F, Diekmann F, Esforzado N |
Transplant Infectious Disease | 2021 |
|
Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity.
Dragon-Durey MA, Chen X, Kirilovsky A, Ben Hamouda N, El Sissy C, Russick J, Charpentier E, Binois Y, Marliot F, Meylan M, Granier C, Pere H, Saldmann A, Rance B, Jannot AS, Baron S, Chebbi M, Fayol A, Josseaume N, Rives-Lange C, Tharaux PL, Cholley B, Diehl JL, Arlet JB, Azizi M, Karras A, Czernichow S, Smadja DM, Hulot JS, Cremer I, Tartour E, Mousseaux E, Pagès F |
PloS one | 2021 |
|
Knowledge, attitudes, practices, and the effects of COVID-19 among the youth in Kenya.
Karijo E, Wamugi S, Lemanyishoe S, Njuki J, Boit F, Kibui V, Karanja S, Abuya T |
BMC Public Health | 2021 |
|
Immune status determined as per guidelines of Ayurveda found associated with clinical outcomes of COVID-19 disease - Results of a cross-sectional pilot study.
Sharma M, Sharma C, Mandal SK, Nesari TM, Kumar A |
Journal of Ayurveda and integrative medicine | 2021 |
|
Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.
Nossent EJ, Schuurman AR, Reijnders TDY, Saris A, Jongerius I, Blok SG, de Vries H, Duitman J, Vonk Noordegraaf A, Meijboom LJ, Lutter R, Heunks L, Bogaard HJ, van der Poll T |
Frontiers in immunology | 2021 |
|
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19.
Bellan M, Azzolina D, Hayden E, Gaidano G, Pirisi M, Acquaviva A, Aimaretti G, Aluffi Valletti P, Angilletta R, Arioli R, Avanzi GC, Avino G, Balbo PE, Baldon G, Baorda F, Barbero E, Baricich A, Barini M, Barone-Adesi F, Battistini S, Beltrame M, Bertoli M, Bertolin S, Bertolotti M, Betti M, Bobbio F, Boffano P, Boglione L, Borrè S, Brucoli M, Calzaducca E, Cammarata E, Cantaluppi V, Cantello R, Capponi A, Carriero A, Casciaro GF, Castello LM, Ceruti F, Chichino G, Chirico E, Cisari C, Cittone MG, Colombo C, Comi C, Croce E, Daffara T, Danna P, Della Corte F, De Vecchi S, Dianzani U, Di Benedetto D, Esposto E, Faggiano F, Falaschi Z, Ferrante D, Ferrero A, Gagliardi I, Galbiati A, Gallo S, Garavelli PL, Gardino CA, Garzaro M, Gastaldello ML, Gavelli F, Gennari A, Giacomini GM, Giacone I, Giai Via V, Giolitti F, Gironi LC, Gramaglia C, Grisafi L, Inserra I, Invernizzi M, Krengli M, Labella E, Landi IC, Landi R, Leone I, Lio V, Lorenzini L, Maconi A, Malerba M, Manfredi GF, Martelli M, Marzari L, Marzullo P, Mennuni M, Montabone C, Morosini U, Mussa M, Nerici I, Nuzzo A, Olivieri C, Padelli SA, Panella M, Parisini A, Paschè A, Patrucco F, Patti G, Pau A, Pedrinelli AR, Percivale I, Ragazzoni L, Re R, Rigamonti C, Rizzi E, Rognoni A, Roveta A, Salamina L, Santagostino M, Saraceno M, Savoia P, Sciarra M, Schimmenti A, Scotti L, Spinoni E, Smirne C, Tarantino V, Tillio PA, Tonello S, Vaschetto R, Vassia V, Zagaria D, Zavattaro E, Zeppegno P, Zottarelli F, Sainaghi PP |
Disease Markers | 2021 |
|
Existing Drugs Considered as Promising in COVID-19 Therapy.
Janik E, Niemcewicz M, Podogrocki M, Saluk-Bijak J, Bijak M |
International journal of molecular sciences | 2021 |
|
Hepatic Failure in COVID-19: Is Iron Overload the Dangerous Trigger?
Del Nonno F, Nardacci R, Colombo D, Visco-Comandini U, Cicalini S, Antinori A, Marchioni L, D'Offizi G, Piacentini M, Falasca L |
Cells | 2021 |
|
Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies.
Deng H, Tang TX, Chen D, Tang LS, Yang XP, Tang ZH |
2021 | |
|
Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity.
Rutkowska E, Kwiecień I, Żabicka M, Maliborski A, Raniszewska A, Kłos K, Urbańska W, Klajnowicz I, Rzepecki P, Chciałowski A |
Viruses | 2021 |
|
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.
Zhao N, Di B, Xu LL |
Cytokine & Growth Factor Reviews | 2021 |
|
Single-cell RNA-seq landscape midbrain cell responses to red spotted grouper nervous necrosis virus infection.
Wang Q, Peng C, Yang M, Huang F, Duan X, Wang S, Cheng H, Yang H, Zhao H, Qin Q |
PLoS pathogens | 2021 |
|
Cryptococcus neoformans Meningoencephalitis in an Immunocompetent Patient after COVID-19 Infection.
Ghanem H, Sivasubramanian G |
Case Reports in Infectious Diseases | 2021 |
|
The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.
Ansari S, Hays JP, Kemp A, Okechukwu R, Murugaiyan J, Ekwanzala MD, Ruiz Alvarez MJ, Paul-Satyaseela M, Iwu CD, Balleste-Delpierre C, Septimus E, Mugisha L, Fadare J, Chaudhuri S, Chibabhai V, Wadanamby JMRWW, Daoud Z, Xiao Y, Parkunan T, Khalaf Y, M'Ikanatha NM, van Dongen MBM |
2021 | |
|
Outcome of early short-course corticosteroids in hospitalized patients with coronavirus disease-2019 (COVID-19): A report from a Saudi Arabian hospital.
Al-Bahrani SY, Al-Shammari AS, Al-Otaibi MJ, Ahmed ZR |
Journal of family & community medicine | 2021 |
|
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
Lafon E, Diem G, Witting C, Zaderer V, Bellmann-Weiler RM, Reindl M, Bauer A, Griesmacher A, Fux V, Hoermann G, Miller C, Zabernigg A, Wöll E, Wilflingseder D, Lass-Flörl C, Posch W |
Frontiers in immunology | 2021 |
|
A brief molecular insight of COVID-19: epidemiology, clinical manifestation, molecular mechanism, cellular tropism and immuno-pathogenesis.
Singh S, Pandey R, Tomar S, Varshney R, Sharma D, Gangenahalli G |
Molecular and Cellular Biochemistry | 2021 |
|
Relative COVID-19 Viral Persistence and Antibody Kinetics.
Huang CG, Dutta A, Huang CT, Chang PY, Hsiao MJ, Hsieh YC, Lin SM, Shih SR, Tsao KC, Yang CT |
2021 | |
|
The Many Faces of Innate Immunity in SARS-CoV-2 Infection.
Hanan N, Doud RL Jr, Park IW, Jones HP, Mathew SO |
Human vaccines | 2021 |
|
Comparative Anti-Inflammatory Effects of Salix Cortex Extracts and Acetylsalicylic Acid in SARS-CoV-2 Peptide and LPS-Activated Human In Vitro Systems.
Le NPK, Herz C, Gomes JVD, Förster N, Antoniadou K, Mittermeier-Kleßinger VK, Mewis I, Dawid C, Ulrichs C, Lamy E |
International journal of molecular sciences | 2021 |
|
A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner.
Choi YM, Jeong H, Park U, Cho NH, Kim BJ |
Viruses | 2021 |
|
Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review.
Cong W, Poudel AN, Alhusein N, Wang H, Yao G, Lambert H |
2021 | |
|
Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives.
Sagris M, Theofilis P, Antonopoulos AS, Tsioufis C, Oikonomou E, Antoniades C, Crea F, Kaski JC, Tousoulis D |
International journal of molecular sciences | 2021 |
|
Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses.
Siri M, Dastghaib S, Zamani M, Rahmani-Kukia N, Geraylow KR, Fakher S, Keshvarzi F, Mehrbod P, Ahmadi M, Mokarram P, Coombs KM, Ghavami S |
International journal of molecular sciences | 2021 |
|
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme.
Lisco G, De Tullio A, Stragapede A, Solimando AG, Albanese F, Capobianco M, Giagulli VA, Guastamacchia E, De Pergola G, Vacca A, Racanelli V, Triggiani V |
Journal of Clinical Medicine | 2021 |
|
Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients.
Wu D, Wu X, Huang J, Rao Q, Zhang Q, Zhang W |
BMC Infectious Diseases | 2021 |
|
CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients.
Mallajosyula V, Ganjavi C, Chakraborty S, McSween AM, Pavlovitch-Bedzyk AJ, Wilhelmy J, Nau A, Manohar M, Nadeau KC, Davis MM |
Science Immunology | 2021 |
|
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans.
Sadarangani M, Marchant A, Kollmann TR |
Nature reviews. Immunology | 2021 |
|
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.
Puray-Chavez M, LaPak KM, Schrank TP, Elliott JL, Bhatt DP, Agajanian MJ, Jasuja R, Lawson DQ, Davis K, Rothlauf PW, Liu Z, Jo H, Lee N, Tenneti K, Eschbach JE, Shema Mugisha C, Cousins EM, Cloer EW, Vuong HR, VanBlargan LA, Bailey AL, Gilchuk P, Crowe JE Jr, Diamond MS, Hayes DN, Whelan SPJ, Horani A, Brody SL, Goldfarb D, Major MB, Kutluay SB |
Cell Reports | 2021 |
|
Case reports of cerebral sinus venous thrombosis in COVID-19 patients.
Sitanggang PA, Tini K, Susilawathi NM, Wijayanti IAS, Dewi PU, Samatra DPGP |
2021 | |
|
Lower mortality rate in health workers and their families infected with COVID-19 associated pneumonia in Quetta, Baluchistan.
Aslam M, Zehri MT, Mandoklel H, Kamal R, Din M |
Pakistan Journal of Medical Sciences | 2021 |
|
Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
Ma Q, Wang Z, Chen R, Lei B, Liu B, Jiang H, Chen Z, Cai X, Guo X, Zhou M, Huang J, Li X, Dai J, Yang Z |
Phytomedicine : international journal of phytotherapy and phytopharmacology | 2021 |
|
Evidence of SARS-CoV-2 infection in gallbladder and aggravating cholecystitis to septic shock: a case report.
Hong X, He J, Li P, Chen J, Zou B, Li Z, Jia Y, Liu Y, Yang L, Li J |
Annals of translational medicine | 2021 |
|
Salivary Ferritin Changes in Patients with COVID-19.
Franco-Martínez L, Cerón JJ, Vicente-Romero MR, Bernal E, Torres Cantero A, Tecles F, Sánchez Resalt C, Martínez M, Tvarijonaviciute A, Martínez-Subiela S |
International journal of environmental research and public health | 2021 |
|
Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines
dos Santos WG |
Biomedicine & Pharmacotherapy | 2021 |
|
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
Moustaqil M, Ollivier E, Chiu HP, Van Tol S, Rudolffi-Soto P, Stevens C, Bhumkar A, Hunter DJB, Freiberg AN, Jacques D, Lee B, Sierecki E, Gambin Y |
Emerging Microbes & Infections | 2021 |
|
An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.
Fleming N, Sacks LJ, Pham CT, Neoh SL, Ekinci EI |
Diabetic medicine : a journal of the British Diabetic Association | 2021 |
|
Clinical and laboratory characteristics of severe and non-severe patients with COVID-19: A retrospective cohort study in China.
Shi S, Nie B, Chen X, Cai Q, Lin C, Zhao G, Zhang X |
Journal of Clinical Laboratory Analysis | 2021 |
|
Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy.
Ho P, Zheng JQ, Wu CC, Hou YC, Liu WC, Lu CL, Zheng CM, Lu KC, Chao YC |
International journal of medical sciences | 2021 |
|
Characteristic of Parkinson's disease with severe COVID-19: a study of 10 cases from Wuhan.
Zhai H, Lv Y, Xu Y, Wu Y, Zeng W, Wang T, Cao X, Xu Y |
Journal of neural transmission (Vienna, Austria : 1996) | 2021 |
|
Epidemiology, clinical characteristics and treatment of critically ill patients with COVID-19): a protocol for a living systematic review.
Milovanovic L, Hessey E, Sebastianski M, Keto-Lambert D, Vandermeer B, Bagshaw SM, Rewa O |
BMJ Open | 2021 |
|
Clinical characteristics and predictors of mortality in young adults with severe COVID-19: a retrospective observational study.
Lu Y, Huang Z, Wang M, Tang K, Wang S, Gao P, Xie J, Wang T, Zhao J |
Annals of clinical microbiology and antimicrobials | 2021 |
|
COVID-19, leprosy, and neutrophils.
Schmitz V, Dos Santos JB |
PLoS neglected tropical diseases | 2021 |
|
Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients.
Silverio A, Di Maio M, Citro R, Esposito L, Iuliano G, Bellino M, Baldi C, De Luca G, Ciccarelli M, Vecchione C, Galasso G |
BMC Cardiovascular Disorders | 2021 |
|
Usefulness of the New Hematological Parameter: Reactive Lymphocytes RE-LYMP with Flow Cytometry Markers of Inflammation in COVID-19.
Rutkowska E, Kwiecień I, Kulik K, Chełstowska B, Kłos K, Rzepecki P, Chciałowski A |
Cells | 2021 |
|
Pre-diagnostic circulating concentrations of insulin-like growth factor-1 and risk of COVID-19 mortality: results from UK Biobank.
Fan X, Yin C, Wang J, Yang M, Ma H, Jin G, Song M, Hu Z, Shen H, Hang D |
European Journal of Epidemiology | 2021 |
|
Pilot trial of high-dose vitamin C in critically ill COVID-19 patients.
Zhang J, Rao X, Li Y, Zhu Y, Liu F, Guo G, Luo G, Meng Z, De Backer D, Xiang H, Peng Z |
Annals of Intensive Care | 2021 |
|
Excess body weight is an independent risk factor for severe forms of COVID-19.
Pietri L, Giorgi R, Bégu A, Lojou M, Koubi M, Cauchois R, Grangeot R, Dubois N, Kaplanski G, Valéro R, Béliard S |
Metabolism: clinical and experimental | 2021 |
|
Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient.
Fakharian A, Barati S, Mohamadi M, Dastan F |
Journal of Cardiothoracic and Vascular Anesthesia | 2021 |
|
Polysaccharides obtained from natural edible sources and their role in modulating the immune system: Biologically active potential that can be exploited against COVID-19.
Barbosa JR, de Carvalho Junior RN |
Trends in Food Science & Technology | 2021 |
|
The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases.
Xiao F, Han M, Zhu X, Tang Y, Huang E, Zou H, Jiang Q, Lu L |
Modern Rheumatology | 2021 |
|
Residence, Clinical Features, and Genetic Risk Factors Associated with Symptoms of COVID-19 in a Cohort of Older People in Madrid.
Del Ser T, Fernández-Blázquez MA, Valentí M, Zea-Sevilla MA, Frades B, Alfayate E, Saiz L, Calero O, García-López FJ, Rábano A, Medina M, Calero M |
Gerontology | 2021 |
|
Excess Cerebrovascular Mortality in the United States During the COVID-19 Pandemic.
Sharma R, Kuohn LR, Weinberger DM, Warren JL, Sansing LH, Jasne A, Falcone G, Dhand A, Sheth KN |
Stroke; a journal of cerebral circulation | 2021 |
|
ABO / Rh-D Blood types and susceptibility to Corona Virus Disease-19 in Peshawar, Pakistan.
Rahim F, Amin S, Bahadur S, Noor M, Mahmood A, Gul H |
Pakistan Journal of Medical Sciences | 2021 |
|
Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients.
Lavillegrand JR, Garnier M, Spaeth A, Mario N, Hariri G, Pilon A, Berti E, Fieux F, Thietart S, Urbina T, Turpin M, Darrivere L, Fartoukh M, Verdonk F, Dumas G, Tedgui A, Guidet B, Maury E, Chantran Y, Voiriot G, Ait-Oufella H |
Annals of Intensive Care | 2021 |
|
The Fatty Acid Lipid Metabolism Nexus in COVID-19.
Tanner JE, Alfieri C |
Viruses | 2021 |
|
Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.
Aschenbrenner AC, Mouktaroudi M, Krämer B, Oestreich M, Antonakos N, Nuesch-Germano M, Gkizeli K, Bonaguro L, Reusch N, Baßler K, Saridaki M, Knoll R, Pecht T, Kapellos TS, Doulou S, Kröger C, Herbert M, Holsten L, Horne A, Gemünd ID, Rovina N, Agrawal S, Dahm K, van Uelft M, Drews A, Lenkeit L, Bruse N, Gerretsen J, Gierlich J, Becker M, Händler K, Kraut M, Theis H, Mengiste S, De Domenico E, Schulte-Schrepping J, Seep L, Raabe J, Hoffmeister C, ToVinh M, Keitel V, Rieke G, Talevi V, Skowasch D, Aziz NA, Pickkers P, van de Veerdonk FL, Netea MG, Schultze JL, Kox M, Breteler MMB, Nattermann J, Koutsoukou A, Giamarellos-Bourboulis EJ, Ulas T |
Genome Medicine | 2021 |
|
Observations on the use of Bruton's tyrosine kinase inhibitors in SAR-CoV-2 and cancer.
Benner B, Carson WE |
Journal of Hematology & Oncology | 2021 |
|
Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
Lee E, Sandgren K, Duette G, Stylianou VV, Khanna R, Eden JS, Blyth E, Gottlieb D, Cunningham AL, Palmer S |
Journal of virology | 2021 |
|
Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis.
Martha JW, Wibowo A, Pranata R |
Postgraduate medical journal | 2021 |
|
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research.
Daga S, Fallerini C, Baldassarri M, Fava F, Valentino F, Doddato G, Benetti E, Furini S, Giliberti A, Tita R, Amitrano S, Bruttini M, Meloni I, Pinto AM, Raimondi F, Stella A, Biscarini F, Picchiotti N, Gori M, Pinoli P, Ceri S, Sanarico M, Crawley FP, Birolo G, Renieri A, Mari F, Frullanti E |
European journal of human genetics : EJHG | 2021 |
|
Risk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study.
Zhang N, Zhang H, Tang Y, Zhang H, Ma A, Xu F, Sun Y, Jiang L, Shan F |
International journal of medical sciences | 2021 |
|
Perfusion Patterns of Peripheral Pulmonary Lesions in COVID-19 Patients Using Contrast-Enhanced Ultrasound (CEUS): A Case Series.
Safai Zadeh E, Beutel B, Dietrich CF, Keber CU, Huber KP, Görg C, Trenker C |
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine | 2021 |
|
Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
Liu Y, Tan W, Chen H, Zhu Y, Wan L, Jiang K, Guo Y, Tang K, Xie C, Yi H, Kuang Y, Luo Y |
BMC Infectious Diseases | 2021 |
|
Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies.
Cristiano A, Fortunati V, Cherubini F, Bernardini S, Nuccetelli M |
Clinical Rheumatology | 2021 |
|
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK, Ojha S, Jha SK, Dureja H, Singh SK, Shukla SD, Chellappan DK, Gupta G, Bhardwaj S, Kumar N, Jeyaraman M, Jain R, Muthu S, Kar R, Kumar D, Goswami VK, Ruokolainen J, Kesari KK, Singh SK, Dua K |
Journal of molecular neuroscience : MN | 2021 |
|
When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It.
Cappanera S, Palumbo M, Kwan SH, Priante G, Martella LA, Saraca LM, Sicari F, Vernelli C, Di Giuli C, Andreani P, Mariottini A, Francucci M, Sensi E, Costantini M, Bruzzone P, D'Andrea V, Gioia S, Cirocchi R, Tiri B |
Journal of Clinical Medicine | 2021 |
|
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR |
Frontiers in physiology | 2021 |
|
Comparative profile for COVID-19 cases from China and North America: Clinical symptoms, comorbidities and disease biomarkers.
Badawi A, Vasileva D |
World journal of clinical cases | 2021 |
|
Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment.
Basiri A, Mansouri F, Azari A, Ranjbarvan P, Zarein F, Heidari A, Golchin A |
Stem Cell Reviews and Reports | 2021 |
|
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.
Tan AT, Linster M, Tan CW, Le Bert N, Chia WN, Kunasegaran K, Zhuang Y, Tham CYL, Chia A, Smith GJD, Young B, Kalimuddin S, Low JGH, Lye D, Wang LF, Bertoletti A |
Cell Reports | 2021 |
|
The relationship between obesity, hemoglobin A1c and the severity of COVID-19 at an urban tertiary care center in New York City: a retrospective cohort study.
Randhawa G, Syed KA, Singh K, Kundal SV, Oli S, Silver M, Syed SA, Suban Na Ayutthaya T, Williams S, Lodato ZL, Rozvadovskiy V, Kamholz S, Wolf L |
BMJ Open | 2021 |
|
Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19.
Hyder Pottoo F, Abu-Izneid T, Mohammad Ibrahim A, Noushad Javed M, AlHajri N, Hamrouni AM |
2021 | |
|
Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19.
Morenikeji OB, Bernard K, Strutton E, Wallace M, Thomas BN |
Frontiers in Bioengineering and Biotechnology | 2021 |
|
Tuberculosis mimicking Crohn's disease and respiratory infection by COVID-19.
Estébanez Ferrero B, Ruiz Pardo J, Velasco Albendea FJ, Vidaña Márquez E, Moreno Moraleda I |
2021 | |
|
The protective effect of rheumatic disease agents in COVID-19.
Valenzuela-Almada MO, Putman MS, Duarte-García A |
Best practice & research. Clinical rheumatology | 2021 |
|
Risk factors for mortality of critically ill patients with COVID-19 receiving invasive ventilation.
Tu Y, Yang P, Zhou Y, Wen X, Li Q, Zhou J, Wang J, Hu J, He N, Wang K, Wang C, Tian X, Luo A, Gao F |
International journal of medical sciences | 2021 |
|
COVID-19-associated liver injury: from bedside to bench.
Li D, Ding X, Xie M, Tian D, Xia L |
Journal of Gastroenterology | 2021 |
|
Predictive value of the preliminary findings in the severity of COVID-19 disease and the effect on therapeutic approaches.
Khayat Kashani HR, Hajijafari M, Khayat Kashani F, Salimi S |
Dermatologic Therapy | 2021 |
|
Discharge Clinical Characteristics and Post-Discharge Events in Patients with Severe COVID-19: A Descriptive Case Series.
Saab FG, Chiang JN, Brook R, Adamson PC, Fulcher JA, Halperin E, Manuel V, Goodman-Meza D |
Journal of General Internal Medicine | 2021 |
|
COVID-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects.
Polverino F, Kheradmand F |
Frontiers in Medicine | 2021 |
|
Chemosensory Dysfunction in Patients with COVID-19: What Do We Learn from the Global Outbreak?
Zeng M, Wang DY, Mullol J, Liu Z |
Current Allergy and Asthma Reports | 2021 |
|
COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.
Calabretta E, Moraleda JM, Iacobelli M, Jara R, Vlodavsky I, O'Gorman P, Pagliuca A, Mo C, Baron RM, Aghemo A, Soiffer R, Fareed J, Carlo-Stella C, Richardson P |
British Journal of Haematology | 2021 |
|
Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients.
Deb S, Arrighi S |
European Journal of Drug Metabolism and Pharmacokinetics | 2021 |
|
The characteristics of 527 discharged COVID-19 patients undergoing long-term follow-up in China.
Zhang J, Xu J, Zhou S, Wang C, Wang X, Zhang W, Ning K, Pan Y, Liu T, Zhao J, Dong L |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
|
Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients.
Jiang N, Li Z, Yang B, Jin M, Sun Y, He Y, Liu Y, Wang Y, Si D, Ma P, Zhang J, Liu T, Yu Q |
BioMed Research International | 2021 |
|
Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients.
Deschler S, Kager J, Erber J, Fricke L, Koyumdzhieva P, Georgieva A, Lahmer T, Wiessner JR, Voit F, Schneider J, Horstmann J, Iakoubov R, Treiber M, Winter C, Ruland J, Busch DH, Knolle PA, Protzer U, Spinner CD, Schmid RM, Quante M, Böttcher K |
Viruses | 2021 |
|
An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital.
Acar HC, Can G, Karaali R, Börekçi Ş, Balkan İİ, Gemicioğlu B, Konukoğlu D, Erginöz E, Erdoğan MS, Tabak F |
BMC Infectious Diseases | 2021 |
|
HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients.
Tamayo-Velasco Á, Martínez-Paz P, Peñarrubia-Ponce MJ, de la Fuente I, Pérez-González S, Fernández I, Dueñas C, Gómez-Sánchez E, Lorenzo-López M, Gómez-Pesquera E, Heredia-Rodríguez M, Carnicero-Frutos I, Muñoz-Moreno MF, Bernardo D, Álvarez FJ, Tamayo E, Gonzalo-Benito H |
Journal of Clinical Medicine | 2021 |
|
Thromboembolic Complications of SARS-CoV-2 and Metabolic Derangements: Suggestions from Clinical Practice Evidence to Causative Agents.
Nappi F, Iervolino A, Avtaar Singh SS |
Metabolites | 2021 |
|
Cytokine levels and pathological characteristics of a patient with severe coronavirus disease 2019: a case report.
Kang K, Gao Y, Zhao M, Fei D, Ye M, Gao Y, Yang W, Wang C, Liu H, Chang G, Kang X, Luo Y, Du X, Qi J, Tian L, Zhou M, Hao C, Yu K |
Chinese Medical Journal | 2021 |
|
Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings.
Guerrero JI, Barragán LA, Martínez JD, Montoya JP, Peña A, Sobrino FE, Tovar-Spinoza Z, Ghotme KA |
BMC Infectious Diseases | 2021 |
|
Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation.
Anand G, Perry AM, Cummings CL, St Raymond E, Clemens RA, Steed AL |
Journal of immunology (Baltimore, Md. : 1950) | 2021 |
|
Pericardial Diseases in COVID19: a Contemporary Review.
Furqan MM, Verma BR, Cremer PC, Imazio M, Klein AL |
Current Cardiology Reports | 2021 |
|
Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries.
Karcioglu Batur L, Hekim N |
Journal of Medical Virology | 2021 |
|
Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
Wang J, Yang X, Li Y, Huang JA, Jiang J, Su N |
Virology Journal | 2021 |
|
Origin, Pathogenesis, Diagnosis and Treatment Options for SARS-CoV-2: A Review.
Sajjad H, Majeed M, Imtiaz S, Siddiqah M, Sajjad A, Din M, Ali M |
Biologia | 2021 |
|
Alteration of Autonomic Nervous System Is Associated With Severity and Outcomes in Patients With COVID-19.
Pan Y, Yu Z, Yuan Y, Han J, Wang Z, Chen H, Wang S, Wang Z, Hu H, Zhou L, Lai Y, Zhou Z, Wang Y, Meng G, Yu L, Jiang H |
Frontiers in physiology | 2021 |
|
Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19.
Mendoza R, Saha N, Momeni A, Gabutan E, Alawad M, Dehghani A, Diks J, Lin B, Wang D, Alshal M, Fyke W, Wang B, Himanen JP, Premsrirut P, Nikolov DB |
Heliyon | 2021 |
|
Chronic Cardio-Metabolic Disease Increases the Risk of Worse Outcomes Among Hospitalized Patients With COVID-19: A Multicenter, Retrospective, and Real-World Study.
Chen Q, Wang L, Li C, Hu W, Fan Y, Chen Z, Wu L, Lu Z, Ye J, Chen S, Tong J, Ruan L, Mei J, Lu H |
Journal of the American Heart Association | 2021 |
|
A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come?
Shakaib B, Zohra T, Ikram A, Shakaib MB, Ali A, Bashir A, Salman M, Khan MA, Ansari J |
Virology Journal | 2021 |
|
Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.
Tan Y, Zhang W, Zhu Z, Qiao N, Ling Y, Guo M, Yin T, Fang H, Xu X, Lu G, Zhang P, Yang S, Fu Z, Liang D, Xie Y, Zhang R, Jiang L, Yu S, Lu J, Jiang F, Chen J, Xiao C, Wang S, Chen S, Bian XW, Lu H, Liu F, Chen S |
Cell Discovery | 2021 |
|
SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons in vitro and in vivo.
Luo W, Huang L, Wang X, Ma Y, Xiao J, Song X, Liu P, Wang Y, Wang Y, Ren Z |
International journal of medical sciences | 2021 |
|
The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19.
Ekholm M, Kahan T |
Frontiers in pharmacology | 2021 |
|
HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave.
Karim F, Gazy I, Cele S, Zungu Y, Krause R, Bernstein M, Khan K, Ganga Y, Rodel H, Mthabela N, Mazibuko M, Muema D, Ramjit D, Ndung'u T, Hanekom W, Gosnell B, Lessells RJ, Wong EB, de Oliveira T, Moosa MS, Lustig G, Leslie A, Kløverpris H, Sigal A |
eLife | 2021 |
|
Ruxolitinib and the Mitigation of Severe COVID-19: A Systematic Review and Meta-analysis.
Quiros JR, Ross-Comptis J, Hathaway D 3rd, Sarfraz A, Sarfraz Z, Grigoryan Z, Romero KA, Gapizov A, Príncipe-Meneses FS, Somagutta MR, Riva-Moscoso A, Kapasi A |
Infection & Chemotherapy | 2021 |
|
Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report.
Sherwood KR, Nicholl DDM, Fenninger F, Wu V, Wong P, Benedicto V, Cina DP, Wang M, Pobran TD, De Marco ML, Márquez AC, Jassem AN, Sekirov I, Morshed MG, Bardi M, Sekhon M, Keown P, Kadatz M, Lan JH |
Frontiers in immunology | 2021 |
|
Mesenchymal stem cells and COVID-19: What they do and what they can do.
Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S |
World journal of stem cells | 2021 |
|
Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity.
Gangadharan C, Ahluwalia R, Sigamani A |
World journal of diabetes | 2021 |
|
Microsecond molecular dynamics suggest that a non-synonymous mutation, frequently observed in patients with mild symptoms in Tokyo, alters dynamics of the SARS-CoV-2 main protease.
Kuroda D, Tsumoto K |
2021 | |
|
Women's Lives Matter-The Critical Need for Women to Prioritize Optimal Physical Activity to Reduce COVID-19 Illness Risk and Severity.
Garcia-Pelagio KP, Hew-Butler T, Fahlman MM, Roche JA |
International journal of environmental research and public health | 2021 |
|
Early Prediction of Severe COVID-19 in Patients by a Novel Immune-Related Predictive Model.
Sun C, Xue M, Yang M, Zhu L, Zhao Y, Lv X, Lin Y, Ma D, Shen X, Cheng Y, Xuan H, Jia X, Li T, Han L |
mSphere | 2021 |
|
Assessment of thyroid function of newly diagnosed SARS-CoV-2 infected patients in Nigeria.
Okwor CJ, Meka IA, Akinwande KS, Edem VF, Okwor VC |
The Pan African medical journal | 2021 |
|
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19.
Kaplonek P, Wang C, Bartsch Y, Fischinger S, Gorman MJ, Bowman K, Kang J, Dayal D, Martin P, Nowak RP, Villani AC, Hsieh CL, Charland NC, Gonye ALK, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilley BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Sade-Feldman M, Feldman J, Julg B, Nilles EJ, Musk ER, Menon AS, Fischer ES, McLellan JS, Schmidt A, Goldberg MB, Filbin MR, Hacohen N, Lauffenburger DA, Alter G |
Science Immunology | 2021 |
|
The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients.
Hasan ZT, Atrakji DMQYMAA, Mehuaiden DAK |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
|
First Manic Attack During COVID-19 Treatment: A Case Report.
Varsak N, Topaloğlu M, Özdemir E |
2021 | |
|
Immunosuppressant Management in Renal Transplant Patients with COVID-19.
Ahmadian E, Zununi Vahed S, Mammadova S, Abediazar S |
BioMed Research International | 2021 |
|
SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity.
Parray A, Mir FA, Doudin A, Iskandarani A, Danjuma MM, Kuni RAT, Abdelmajid A, Abdelhafez I, Arif R, Mulhim M, Abukhattab M, Dar SR, Moustafa AA, Elkord E, Al Khal AL, Elzouki AN, Cyprian F |
Human vaccines | 2021 |
|
Combination of the CD8+:B-cell and Neutrophil-to-Lymphocyte Ratio as a Novel Prediction Model for Intubation Need and Disease Severity in COVID-19 Patients.
Detsika MG, Grigoriou E, Psarra K, Jahaj E, Tsipilis S, Athanassiou N, Zacharis A, Dimopoulou I, Orfanos SE, Tsirogianni A, Kotanidou A |
In vivo (Athens, Greece) | 2021 |
|
Intubated COVID-19 predictive (ICOP) score for early mortality after intubation in patients with COVID-19.
Nishikimi M, Rasul R, Sison CP, Jafari D, Shoaib M, Shinozaki K, Li T, Hayashida K, Rolston DM, Hirsch JS, Becker LB |
Scientific Reports | 2021 |
|
Neutrophil Extracellular Trap Formation Potential Correlates with Lung Disease Severity in COVID-19 Patients.
Kinnare N, Hook JS, Patel PA, Monson NL, Moreland JG |
Inflammation | 2021 |
|
An overview on the current available treatment for COVID-19 and the impact of antibiotic administration during the pandemic.
Paula HSC, Santiago SB, Araújo LA, Pedroso CF, Marinho TA, Gonçalves IAJ, Santos TAP, Pinheiro RS, Oliveira GA, Batista KA |
2021 | |
|
The Immunomodulatory Function of Vitamin D, with Particular Reference to SARS-CoV-2.
Caballero-García A, Noriega DC, Bello HJ, Roche E, Córdova-Martínez A |
2021 | |
|
MicroRNA-Mediated Regulation of the Virus Cycle and Pathogenesis in the SARS-CoV-2 Disease.
Battaglia R, Alonzo R, Pennisi C, Caponnetto A, Ferrara C, Stella M, Barbagallo C, Barbagallo D, Ragusa M, Purrello M, Di Pietro C |
International journal of molecular sciences | 2021 |
|
Modulatory Effects of Physical Activity Levels on Immune Responses and General Clinical Functions in Adult Patients with Mild to Moderate SARS-CoV-2 Infections-A Protocol for an Observational Prospective Follow-Up Investigation: Fit-COVID-19 Study.
Lira FS, Pereira T, Guerra Minuzzi L, Figueiredo C, Olean-Oliveira T, Figueira Freire APC, Coelho-E-Silva MJ, Caseiro A, Thomatieli-Santos RV, Dos Santos VR, Gobbo LA, Seelaender M, Krüger K, Pinho RA, Rosa-Neto JC, de Alencar Silva BS |
International journal of environmental research and public health | 2021 |
|
Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice.
Bi Z, Hong W, Que H, He C, Ren W, Yang J, Lu T, Chen L, Lu S, Peng X, Wei X |
Signal Transduction and Targeted Therapy | 2021 |
|
Risk of ischemic stroke in patients with COVID-19 infection: A systematic review and meta-analysis.
Cui Y, Zhao B, Li T, Yang Z, Li S, Le W |
Brain Research Bulletin | 2021 |
|
Favourable outcome of severe COVID-19 patients in hyperinflammatory phase with high dose dexamethasone pulse therapy: A series of 10 cases.
Pradhan S, Sharma S, Kumar A, Singh PK |
Journal of Family Medicine and Primary Care | 2021 |
|
Predictive hematological and immunological parameters associated with postpartum progressed Covid-19 disease.
Bozkurt F, Coskun O, Yelec S |
African health sciences | 2021 |
|
COVID-19 infection in patients with connective tissue disease: A multicity study in Hubei province, China.
Ye C, Zhong J, Cai S, Dong L, Li C, Hou X, Chen X, Zhang A, Chen W, He D, Zhou T, Shang G, Chu A, Li H, Liu Q, Wu B, Yu X, Peng T, Wen C, Huang GH, Huang H, Huang Q, Su L, Chen W, Yang H, Dong L |
2021 | |
|
The spatiotemporal trend of renal involvement in COVID-19: A pooled analysis of 17 134 patients.
Feng YF, Wang KP, Mo JG, Xu YH, Wang LZ, Jin C, Chen X, Yi B |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
|
Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.
Deng F, Zhang L, Lyu L, Lu Z, Gao D, Ma X, Guo Y, Wang R, Gong S, Jiang W |
2021 | |
|
Anti-Inflammatory and Antiviral Osmotic Polymeric Film to Treat Covid-19 Early-Stage Infection.
Shrivastava R, Shrivastava R, Johansen B, Allain T |
Journal of inflammation research | 2021 |
|
IL-6 modulation for COVID-19: the right patients at the right time?
Ascierto PA, Fu B, Wei H |
Journal for ImmunoTherapy of Cancer | 2021 |
|
A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm.
Pouladzadeh M, Safdarian M, Eshghi P, Abolghasemi H, Bavani AG, Sheibani B, Moradi Choghakabodi P, Feghhi A, Ghafourian Boroujerdnia M, Forouzan A, Jalali Far MA, Kaydani GA, Rajaei E, Amin M, Torabizadeh M, Yousefi F, Hadaddezfuli R |
Internal and Emergency Medicine | 2021 |
|
The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis.
Alkhatip AAAMM, Kamel MG, Hamza MK, Farag EM, Yassin HM, Elayashy M, Naguib AA, Wagih M, Abd-Elhay FA, Algameel HZ, Yousef MA, Purcell A, Helmy M |
Expert Review of Molecular Diagnostics | 2021 |
|
Radiographic case report of a heart transplanted patient suffering from COVID-19.
Alizadeh LS, Albrecht MH, Booz C |
Heliyon | 2021 |
|
Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality.
Flook M, Jackson C, Vasileiou E, Simpson CR, Muckian MD, Agrawal U, McCowan C, Jia Y, Murray JLK, Ritchie LD, Robertson C, Stock SJ, Wang X, Woolhouse MEJ, Sheikh A, Stagg HR |
BMC Infectious Diseases | 2021 |
|
Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy.
Chedid M, Waked R, Haddad E, Chetata N, Saliba G, Choucair J |
Journal of Infection and Public Health | 2021 |
|
Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review.
Ferrari F, Martins VM, Fuchs FD, Stein R |
2021 | |
|
C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia.
Posch W, Vosper J, Noureen A, Zaderer V, Witting C, Bertacchi G, Gstir R, Filipek PA, Bonn GK, Huber LA, Bellmann-Weiler R, Lass-Flörl C, Wilflingseder D |
Journal of Allergy and Clinical Immunology | 2021 |
|
An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts.
Yang L, Han Y, Jaffré F, Nilsson-Payant BE, Bram Y, Wang P, Zhu J, Zhang T, Redmond D, Houghton S, Uhl S, Borczuk A, Huang Y, Richardson C, Chandar V, Acklin JA, Lim JK, Chen Z, Xiang J, Ho DD, tenOever BR, Schwartz RE, Evans T, Chen S |
Circulation research | 2021 |
|
COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management.
Ye C, Qi L, Wang J, Zheng S |
Frontiers in Medicine | 2021 |
|
TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2.
Kaushik D, Bhandari R, Kuhad A |
Expert Opinion on Therapeutic Targets | 2021 |
|
Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses.
Song WJ, Hui CKM, Hull JH, Birring SS, McGarvey L, Mazzone SB, Chung KF |
The lancet. Respiratory medicine | 2021 |
|
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy.
Dentone C, Vena A, Loconte M, Grillo F, Brunetti I, Barisione E, Tedone E, Mora S, Di Biagio A, Orsi A, De Maria A, Nicolini L, Ball L, Giacobbe DR, Magnasco L, Delfino E, Mastracci L, Mangerini R, Taramasso L, Sepulcri C, Pincino R, Bavastro M, Cerchiaro M, Mikulska M, Bruzzone B, Icardi G, Frisoni P, Gratarola A, Patroniti N, Pelosi P, Bassetti M |
BMC Infectious Diseases | 2021 |
|
Decreased T Cell Levels in Critically Ill Coronavirus Patients: Single-Center, Prospective and Observational Study.
Xu J, Liu Z, Liu H, Luo Y, Kang K, Li X, Yang W, Fei D, Wang C, Yu K |
Journal of inflammation research | 2021 |
|
Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms.
Johansson A, Mohamed MS, Moulin TC, Schiöth HB |
Journal of Neuroimmunology | 2021 |
|
Post Covid-19 Infection Presenting as Rhino-Orbital Mycosis.
Garg R, Bharangar S, Gupta S, Bhardwaj S |
2021 | |
|
Traditional Chinese Medicine Enema Therapy in a Patient With a Confirmed Negative SARS-CoV-2 Test in the Respiratory Tract but Positive in the Intestinal Tract: A Case Report.
Dai Y, Zhao Z, Zhou H, Huang D, Luo J, Zhang C, Chen Q, Chen X, Yao Y, Jiang X, Cheng J |
Frontiers in public health | 2021 |
|
Elevation of Serum Cytokine Profiles and Liver Metabolomic Normalization in Early Convalescence of COVID-19 Patients.
Lou Y, He X, Deng M, Hu X, Yang X, Liu L, Hu Y, He L, Wang J, Zhang L, Zhao Q, Lu X, Qiu Y |
Frontiers in Medicine | 2021 |
|
Adverse COVID-19 outcomes in immune deficiencies: Inequality exists between subclasses.
Karakoc Aydiner E, Bilgic Eltan S, Babayeva R, Aydiner O, Kepenekli E, Kolukisa B, Sefer AP, Yalcin Gungoren E, Karabiber E, Yucel EO, Ozdemir O, Kiykim A, Artac H, Yakici N, Yalcin K, Cokugras H, Celkan TT, Orhan F, Yesilipek MA, Baris S, Ozen A |
Allergy | 2021 |
|
Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future?
Owoicho O, Tapela K, Djomkam Zune AL, Nghochuzie NN, Isawumi A, Mosi L |
Future Microbiology | 2021 |
|
Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review.
Fan Y, Wang Y, Yu S, Chang J, Yan Y, Wang Y, Bian Y |
Chinese medicine | 2021 |
|
Correlation between anxiety-depression symptoms and immune characteristics in inpatients with 2019 novel coronavirus in Wuhan, China.
Wu C, Zhou Z, Ni L, Cao J, Tan M, Wu X, Xu Y, Hu J |
Journal of Psychiatric Research | 2021 |
|
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.
Cohen CA, Li APY, Hachim A, Hui DSC, Kwan MYW, Tsang OTY, Chiu SS, Chan WH, Yau YS, Kavian N, Ma FNL, Lau EHY, Cheng SMS, Poon LLM, Peiris M, Valkenburg SA |
Nature Communications | 2021 |
|
Arbidol is associated with increased in-hospital mortality among 109 patients with severe COVID-19: A multicenter, retrospective study.
Zhou X, Hou H, Yang L, Ding G, Wei T, Li C, Heng Y, Liu R, Ma M, Hu Z, Huang L, Xu X, Hu Q, Zhao Y, Xing W, Zhao Z |
Journal of Global Health | 2021 |
|
A 34-Year-Old Woman from Brazil with Pulmonary Lymphangioleiomyomatosis Diagnosed by Raised Serum Vascular Endothelial Growth Factor-D (VEGF-D) Levels and Lung Cysts on Computed Tomography Imaging Presenting with COVID-19 Pneumonia.
Carneiro AS, Mafort TT, Lopes AJ |
2021 | |
|
Epidemiological and Clinical Characteristics of Deceased COVID-19 Patients.
Badedi M, Darraj H, Alnami AQ, Makrami A, Mahfouz MS, Alhazmi K, Mahmoud N, Mosa H |
International journal of general medicine | 2021 |
|
Th2/Th1 Cytokine Imbalance Is Associated With Higher COVID-19 Risk Mortality.
Pavel AB, Glickman JW, Michels JR, Kim-Schulze S, Miller RL, Guttman-Yassky E |
Frontiers in Genetics | 2021 |
|
Predictive Significance of the Prognostic Nutritional Index (PNI) in Patients with Severe COVID-19.
Wei W, Wu X, Jin C, Mu T, Gu G, Min M, Mu S, Han Y |
Journal of Immunology Research | 2021 |
|
SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation.
Pan P, Shen M, Yu Z, Ge W, Chen K, Tian M, Xiao F, Wang Z, Wang J, Jia Y, Wang W, Wan P, Zhang J, Chen W, Lei Z, Chen X, Luo Z, Zhang Q, Xu M, Li G, Li Y, Wu J |
Nature Communications | 2021 |
|
Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature.
Ostovan VR, Rezapanah S, Behzadi Z, Hosseini L, Jahangiri R, Anbardar MH, Rostami M |
Journal of Neurovirology | 2021 |
|
Structure-based study of immune receptors as eligible binding targets of coronavirus SARS-CoV-2 spike protein.
Mobini S, Chizari M, Mafakher L, Rismani E, Rismani E |
Journal of molecular graphics & modelling | 2021 |
|
COVID-19 and the Kidney: Should Nephrologists Care about COVID-19 rather than Maintaining Their Focus on Renal Patients?
Perico N, Perico L, Ronco C, Remuzzi G |
Contributions to nephrology | 2021 |
|
Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature.
Migliorini F, Torsiello E, Spiezia F, Oliva F, Tingart M, Maffulli N |
European Journal of Medical Research | 2021 |
|
Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review.
Kifle ZD |
2021 | |
|
Mechanisms of thrombosis and cardiovascular complications in COVID-19
Page EM, Ariëns RA |
Thrombosis Research | 2021 |
|
Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19
Kaplonek P, Wang C, Bartsch Y, Fischinger S, Gorman MJ, Bowman K, Kang J, Dayal D, Martin P, Nowak R, Hsieh CL, Feldman J, Julg B, Nilles EJ, Musk ER, Menon AS, Fischer ES, McLellan JS, Schmidt A, Goldberg MB, Filbin M, Hacohen N, Lauffenburger DA, Alter G |
2021 | |
|
Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19
Tan Q, He L, Meng X, Wang W, Pan H, Yin W, Zhu T, Huang X, Shan H |
Journal of nanobiotechnology | 2021 |
|
Therapeutic potential of ginger against COVID-19: Is there enough evidence?
Jafarzadeh A, Jafarzadeh S, Nemati M |
Journal of Traditional Chinese Medical Sciences | 2021 |
|
Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2
Francis JM, Leistritz-Edwards D, Dunn A, Tarr C, Lehman J, Dempsey C, Hamel A, Rayon V, Liu G, Wang Y, Wille M, Durkin M, Hadley K, Sheena A, Roscoe B, Ng M, Rockwell G, Manto M, Gienger E, Nickerson J, Moarefi A, Noble M, Malia T, Bardwell PD, Gordon W, Swain J, Skoberne M, Sauer K, Harris T, Goldrath AW, Shalek AK, Coyle AJ, Benoist C, Pregibon DC, Jilg N, Li J, Rosenthal A, Wong C, Daley G, Golan D, Heller H, Sharpe A, Abayneh BA, Allen P, Antille D, Armstrong K, Boyce S, Braley J, Branch K, Broderick K, Carney J, Chan A, Davidson S, Dougan M, Drew D, Elliman A, Flaherty K, Flannery J, Forde P, Gettings E, Griffin A, Grimmel S, Grinke K, Hall K, Healy M, Henault D, Holland G, Kayitesi C, LaValle V, Lu Y, Luthern S, Schneider JM, Martino B, McNamara R, Nambu C, Nelson S, Noone M, Ommerborn C, Pacheco LC, Phan N, Porto FA, Ryan E, Selleck K, Slaughenhaupt S, Sheppard KS, Suschana E, Wilson V, Carrington M, Martin M, Yuki Y, Alter G, Balazs A, Bals J, Barbash M, Bartsch Y, Boucau J, Carrington M, Chevalier J, Chowdhury F, DeMers E, Einkauf K, Fallon J, Fedirko L, Finn K, Garcia-Broncano P, Ghebremichael MS, Hartana C, Jiang C, Judge K, Kaplonek P, Karpell M, Lai P, Lam EC, Lefteri K, Lian X, Lichterfeld M, Lingwood D, Liu H, Liu J, Ly N, Hill ZM, Michell A, Millstrom I, Miranda N, O'Callaghan C, Osborn M, Pillai S, Rassadkina Y, Reissis A, Ruzicka F, Seiger K, Sessa L, Sharr C, Shin S, Singh N, Sun W, Sun X, Ticheli H, Trocha-Piechocka A, Walker B, Worrall D, Yu XG, Zhu A |
Science Immunology | 2021 |
|
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
Salvarani C, Dolci G, Massari M, Merlo DF, Cavuto S, Savoldi L, Bruzzi P, Boni F, Braglia L, Turrà C, Ballerini PF, Sciascia R, Zammarchi L, Para O, Scotton PG, Inojosa WO, Ravagnani V, Salerno ND, Sainaghi PP, Brignone A, Codeluppi M, Teopompi E, Milesi M, Bertomoro P, Claudio N, Salio M, Falcone M, Cenderello G, Donghi L, Del Bono V, Colombelli PL, Angheben A, Passaro A, Secondo G, Pascale R, Piazza I, Facciolongo N, Costantini M |
JAMA internal medicine | 2021 |
|
Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019.
Tanwar V, Adelstein JM, Wold LE |
Cardiovascular Research | 2021 |
|
WGO Guidance for the Care of Patients With COVID-19 and Liver Disease.
Hamid S, Alvares da Silva MR, Burak KW, Chen T, Drenth JPH, Esmat G, Gaspar R, LaBrecque D, Lee A, Macedo G, McMahon B, Ning Q, Reau N, Sonderup M, van Leeuwen DJ, Armstrong D, Yurdaydin C |
Journal of Clinical Gastroenterology | 2021 |
|
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
Rodrigues TS, de Sá KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, Gonçalves AV, Perucello DB, Andrade WA, Castro R, Veras FP, Toller-Kawahisa JE, Nascimento DC, de Lima MHF, Silva CMS, Caetite DB, Martins RB, Castro IA, Pontelli MC, de Barros FC, do Amaral NB, Giannini MC, Bonjorno LP, Lopes MIF, Santana RC, Vilar FC, Auxiliadora-Martins M, Luppino-Assad R, de Almeida SCL, de Oliveira FR, Batah SS, Siyuan L, Benatti MN, Cunha TM, Alves-Filho JC, Cunha FQ, Cunha LD, Frantz FG, Kohlsdorf T, Fabro AT, Arruda E, de Oliveira RDR, Louzada-Junior P, Zamboni DS |
Journal of Experimental Medicine | 2021 |
|
Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality.
De Smet D, De Smet K, Herroelen P, Gryspeerdt S, Martens GA |
American Journal of Clinical Pathology | 2021 |
|
The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients.
He X, Yao F, Chen J, Wang Y, Fang X, Lin X, Long H, Wang Q, Wu Q |
Scientific Reports | 2021 |
|
A severe COVID-19 case with schizophrenia as well as other chronic diseases.
Zeng L, Zhang H, He Y, Lai B, Huang Z, Lin L, Zhong Z, Guo X |
2021 | |
|
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial.
Veiga VC, Prats JAGG, Farias DLC, Rosa RG, Dourado LK, Zampieri FG, Machado FR, Lopes RD, Berwanger O, Azevedo LCP, Avezum Á, Lisboa TC, Rojas SSO, Coelho JC, Leite RT, Carvalho JC, Andrade LEC, Sandes AF, Pintão MCT, Castro CG Jr, Santos SV, de Almeida TML, Costa AN, Gebara OCE, de Freitas FGR, Pacheco ES, Machado DJB, Martin J, Conceição FG, Siqueira SRR, Damiani LP, Ishihara LM, Schneider D, de Souza D, Cavalcanti AB, Scheinberg P |
BMJ | 2021 |
|
Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages.
Wauters E, Van Mol P, Garg AD, Jansen S, Van Herck Y, Vanderbeke L, Bassez A, Boeckx B, Malengier-Devlies B, Timmerman A, Van Brussel T, Van Buyten T, Schepers R, Heylen E, Dauwe D, Dooms C, Gunst J, Hermans G, Meersseman P, Testelmans D, Yserbyt J, Tejpar S, De Wever W, Matthys P, Neyts J, Wauters J, Qian J, Lambrechts D |
Cell Research | 2021 |
|
D-dimer levels is associated with severe COVID-19 infections: A meta-analysis.
Du WN, Zhang Y, Yu Y, Zhang RM |
International Journal of Clinical Practice | 2021 |
|
Application of Pomegranate by-Products in Muscle Foods: Oxidative Indices, Colour Stability, Shelf Life and Health Benefits.
Das AK, Nanda PK, Chowdhury NR, Dandapat P, Gagaoua M, Chauhan P, Pateiro M, Lorenzo JM |
Molecules (Basel, Switzerland) | 2021 |
|
The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury.
Zarrilli G, Angerilli V, Businello G, Sbaraglia M, Traverso G, Fortarezza F, Rizzo S, De Gaspari M, Basso C, Calabrese F, Dei Tos AP, Fassan M |
International journal of molecular sciences | 2021 |
|
The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19).
Drewett GP, Smibert OC, Holmes NE, Trubiano JA |
Infection Control and Hospital Epidemiology | 2021 |
|
Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19.
Cooper RS, Fraser AR, Smith L, Burgoyne P, Imlach SN, Jarvis LM, Turner DM, Zahra S, Turner ML, Campbell JDM |
Frontiers in immunology | 2021 |
|
Application of a prediction model with laboratory indexes in the risk stratification of patients with COVID-19.
Ye J, Zhang X, Zhu F, Tang Y |
Experimental and therapeutic medicine | 2021 |
|
Immunological alternation in COVID-19 patients with cancer and its implications on mortality.
Cai G, Gao Y, Zeng S, Yu Y, Liu X, Liu D, Wang Y, Yu R, Desai A, Li C, Gao Q |
OncoImmunology | 2021 |
|
The Strategy of Boosting the Immune System Under the COVID-19 Pandemic.
Alagawany M, Attia YA, Farag MR, Elnesr SS, Nagadi SA, Shafi ME, Khafaga AF, Ohran H, Alaqil AA, Abd El-Hack ME |
Frontiers in Veterinary Science | 2021 |
|
Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19.
Rezaei M, Marjani M, Mahmoudi S, Mortaz E, Mansouri D |
International Archives of Allergy and Immunology | 2021 |
|
Worsening of heart failure by coronavirus disease 2019 is associated with high mortality.
Bocchi EA, Lima IGCV, Biselli B, Salemi VMC, Ferreira SMA, Chizzola PR, Munhoz RT, Pessoa RS, Cardoso FAM, Bello MVO, Hajjar LA, Gomes BR |
ESC Heart Failure | 2021 |
|
The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19.
Daou F, Abou-Sleymane G, Badro DA, Khanafer N, Tobaiqy M, Al Faraj A |
International journal of environmental research and public health | 2021 |
|
Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial.
Arnardottir H, Pawelzik SC, Öhlund Wistbacka U, Artiach G, Hofmann R, Reinholdsson I, Braunschweig F, Tornvall P, Religa D, Bäck M |
Frontiers in physiology | 2021 |
|
Clinical Characteristics and Diagnostic Challenges of COVID-19: An Update From the Global Perspective.
Israfil SMH, Sarker MMR, Rashid PT, Talukder AA, Kawsar KA, Khan F, Akhter S, Poh CL, Mohamed IN, Ming LC |
Frontiers in public health | 2021 |
|
The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19.
An X, Zhang Y, Duan L, Jin, Zhao S, Zhou R, Duan Y, Lian F, Tong X |
Biomedicine & Pharmacotherapy | 2021 |
|
Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis.
Pranata R, Lim MA, Yonas E, Huang I, Nasution SA, Setiati S, Alwi I, Kuswardhani RAT |
Epidemiology and Infection | 2021 |
|
Innate immune evasion mediated by picornaviral 3C protease: Possible lessons for coronaviral 3C-like protease?
Ng CS, Stobart CC, Luo H |
Reviews in Medical Virology | 2021 |
|
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
Rosas IO, Bräu N, Waters M, Go RC, Hunter BD, Bhagani S, Skiest D, Aziz MS, Cooper N, Douglas IS, Savic S, Youngstein T, Del Sorbo L, Cubillo Gracian A, De La Zerda DJ, Ustianowski A, Bao M, Dimonaco S, Graham E, Matharu B, Spotswood H, Tsai L, Malhotra A |
The New England journal of medicine | 2021 |
|
Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra.
Mortaz E, Bassir A, Dalil Roofchayee N, Dezfuli NK, Jamaati H, Tabarsi P, Moniri A, Rezaei M, Mehrian P, Varahram M, Marjani M, Mumby S, Adcock IM |
International Immunopharmacology | 2021 |
|
Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial.
Xu X, Jiang W, Chen L, Xu Z, Zhang Q, Zhu M, Ye P, Li H, Yu L, Zhou X, Zhou C, Chen X, Zheng X, Xu K, Cai H, Zheng S, Jiang W, Wu X, Li D, Chen L, Luo Q, Wang Y, Qu J, Li Y, Zheng W, Jiang Y, Tang L, Xiang C, Li L |
Clinical and Translational Medicine | 2021 |
|
Cardiac arrhythmias in critically ill patients with coronavirus disease 2019: A retrospective population-based cohort study.
Wetterslev M, Jacobsen PK, Hassager C, Jøns C, Risum N, Pehrson S, Bastiansen A, Andreasen AS, Tjelle Kristiansen K, Bestle MH, Mohr T, Møller-Sørensen H, Perner A |
Acta Anaesthesiologica Scandinavica | 2021 |
|
Cordifolioside: potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-β and TNF-α.
Manne M, Goudar G, Varikasuvu SR, Khetagoudar MC, Kanipakam H, Natarajan P, Ummiti MD, Yenagi VA, Chinthakindi S, Dharani P, Thota DSS, Patil S, Patil V |
3 Biotech | 2021 |
|
SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages.
Shirato K, Kizaki T |
Heliyon | 2021 |
|
Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity.
Hammad R, Eldosoky MAER, Fouad SH, Elgendy A, Tawfeik AM, Alboraie M, Abdelmaksoud MF |
Innate immunity | 2021 |
|
Mutations and polymorphisms in genes involved in the infections by covid 19: a review.
Kaltoum ABO |
Gene Reports | 2021 |
|
COVID-19 and Vulnerable Populations in Sub-Saharan Africa.
George JA, Maphayi MR, Pillay T |
Advances in experimental medicine and biology | 2021 |
|
How Does COVID-19 Affect the Neurobiology of Suicide?
Conejero I, Nobile B, Olié E, Courtet P |
Current Psychiatry Reports | 2021 |
|
Early prediction model for progression and prognosis of severe patients with coronavirus disease 2019.
Liu L, Dong L, Zhang B, Chen X, Song X, Li S, Wei W |
Medicine | 2021 |
|
MR-proADM as prognostic factor of outcome in COVID-19 patients.
Sozio E, Tascini C, Fabris M, D'Aurizio F, De Carlo C, Graziano E, Bassi F, Sbrana F, Ripoli A, Pagotto A, Giacinta A, Gerussi V, Visentini D, De Stefanis P, Merelli M, Saeed K, Curcio F |
Scientific Reports | 2021 |
|
Quantitative and semi-quantitative CT assessments of lung lesion burden in COVID-19 pneumonia.
Guan X, Yao L, Tan Y, Shen Z, Zheng H, Zhou H, Gao Y, Li Y, Ji W, Zhang H, Wang J, Zhang M, Xu X |
Scientific Reports | 2021 |
|
Promoting the Resilience of the Italian Population Against SARS-CoV-2.
Bottaccioli AG, Lazzari D, Bottaccioli F |
Frontiers in Psychiatry | 2021 |
|
Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
Zhang J, Wang Z, Wang X, Hu Z, Yang C, Lei P |
Frontiers in immunology | 2021 |
|
Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India.
Majumdar S, Verma R, Saha A, Bhattacharyya P, Maji P, Surjit M, Kundu M, Basu J, Saha S |
Frontiers in Genetics | 2021 |
|
Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review.
Gordon JS, Drazner MH |
Current Heart Failure Reports | 2021 |
|
Neuropathies and neurological dysfunction induced by coronaviruses.
Gholami M, Safari S, Ulloa L, Motaghinejad M |
Journal of Neurovirology | 2021 |
|
Proteomic and metabolomic investigation of serum lactate dehydrogenase elevation in COVID-19 patients.
Yan H, Liang X, Du J, He Z, Wang Y, Lyu M, Yue L, Zhang F, Xue Z, Xu L, Ruan G, Li J, Zhu H, Xu J, Chen S, Zhang C, Lv D, Lin Z, Shen B, Zhu Y, Qian B, Chen H, Guo T |
PROTEOMICS | 2021 |
|
Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
Farid E, Sridharan K, Alsegai OA, Khawaja SA, Mansoor EJ, Teraifi NA, Qahtani MA, Salman JA |
Biomarkers in Medicine | 2021 |
|
Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective study.
Bai B, Xu Z, Hu Y, Qu M, Cheng J, Luo S, Yao Z, Gao H, Ma Y, Gao R, Hou J, Xin S, Mao P |
European Journal of Medical Research | 2021 |
|
Cellular Immune Response to COVID-19 and Potential Immune Modulators.
Zhou X, Ye Q |
Frontiers in immunology | 2021 |
|
A SCID mouse-human lung xenograft model of SARS-CoV-2 infection.
Fu W, Wang W, Yuan L, Lin Y, Huang X, Chen R, Cai M, Liu C, Chen L, Zhou M, Wu K, Zhao H, Pan D, Ma J, Hong J, Zhai B, Zhang Y, Kong Z, Wang Y, Chen Y, Yuan Q, Zhu H, Cheng T, Guan Y, Xia N |
Theranostics | 2021 |
|
Clinical features of 50 cases of 2019 novel coronavirus in Bandar Abbas, Iran.
Jarineshin H, Saljoughi F, Estabraghnia Babaki H, Hassaniazad M, Kheirandish M, Ghanbarnejad A, Sohrabipour S |
Medical journal of the Islamic Republic of Iran | 2021 |
|
β-Sitosterol Alters the Inflammatory Response in CLP Rat Model of Sepsis by Modulation of NFκB Signaling.
Kasirzadeh S, Ghahremani MH, Setayesh N, Jeivad F, Shadboorestan A, Taheri A, Beh-Pajooh A, Azadkhah Shalmani A, Ebadollahi-Natanzi A, Khan A, Sabzevari S, Sabzevari O |
BioMed Research International | 2021 |
|
Changes of coagulation function and risk of stroke in patients with COVID-19.
Qiu F, Wu Y, Zhang A, Xie G, Cao H, Du M, Jiang H, Li S, Ding M |
Brain and Behavior | 2021 |
|
Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19.
Chao Y, Rebetz J, Bläckberg A, Hovold G, Sunnerhagen T, Rasmussen M, Semple JW, Shannon O |
Platelets | 2021 |
|
Emerging role of air pollution and meteorological parameters in COVID-19.
Zhao C, Fang X, Feng Y, Fang X, He J, Pan H |
Journal of Evidence-Based Medicine | 2021 |
|
Clinical characteristics and laboratory features of COVID-19 in high altitude areas: A retrospective cohort study.
Chen H, Qin L, Wu S, Xu W, Gao R, Zhang X |
PloS one | 2021 |
|
Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment.
Chinnici CM, Russelli G, Bulati M, Miceli V, Gallo A, Busà R, Tinnirello R, Conaldi PG, Iannolo G |
World Journal of Gastroenterology | 2021 |
|
Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis.
Xiong X, Chi J, Gao Q |
Thrombosis Journal | 2021 |
|
COVID-19 and Hypertension: The What, the Why, and the How.
Muhamad SA, Ugusman A, Kumar J, Skiba D, Hamid AA, Aminuddin A |
Frontiers in physiology | 2021 |
|
TNF controls a speed-accuracy tradeoff in the cell death decision to restrict viral spread.
Oyler-Yaniv J, Oyler-Yaniv A, Maltz E, Wollman R |
Nature Communications | 2021 |
|
Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease.
Lakkireddy M, Gadiga SG, Malathi RD, Karra ML, Raju ISSVPM, Ragini, Chinapaka S, Baba KSSS, Kandakatla M |
Scientific Reports | 2021 |
|
Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia.
Liu G, Jiang X, Zeng X, Pan Y, Xu H |
Journal of Immunology Research | 2021 |
|
Cardiopulmonary Pathophysiological Aspects in the Context of COVID-19 and Obesity.
Fayssoil A, De Carnavalet MCC, Mansencal N, Lofaso F, Davido B |
2021 | |
|
Comparison of Blood Counts and Markers of Inflammation and Coagulation in Patients With and Without COVID-19 Presenting to the Emergency Department in Seattle, WA.
Chandler CM, Reid MC, Cherian S, Sabath DE, Edlefsen KL |
American Journal of Clinical Pathology | 2021 |
|
Pulmonary Thrombosis and Thromboembolism in COVID-19.
Poor HD |
Chest | 2021 |
|
Efficacy of tocilizumab in patients with severe COVID-19: Survival and clinical outcomes.
Al-Baadani A, Eltayeb N, Alsufyani E, Albahrani S, Basheri S, Albayat H, Batubara E, Ballool S, Al Assiri A, Faqihi F, Musa AB, Robert AA, Alsherbeeni N, Elzein F |
Journal of Infection and Public Health | 2021 |
|
Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.
Charan J, Dutta S, Kaur R, Bhardwaj P, Sharma P, Ambwani S, Jahan I, Abubakar AR, Islam S, Hardcastle TC, Rahman NAA, Lugova H, Haque M |
Expert Opinion on Drug Safety | 2021 |
|
Association between Hb A1c and Severity of COVID-19 Patients.
Unluguzel Ustun G, Keskin A, Aci R, Arslanbek Erdem M, Ari M |
Hemoglobin | 2021 |
|
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
Tscherne A, Schwarz JH, Rohde C, Kupke A, Kalodimou G, Limpinsel L, Okba NMA, Bošnjak B, Sandrock I, Odak I, Halwe S, Sauerhering L, Brosinski K, Liangliang N, Duell E, Jany S, Freudenstein A, Schmidt J, Werner A, Gellhorn Serra M, Klüver M, Guggemos W, Seilmaier M, Wendtner CM, Förster R, Haagmans BL, Becker S, Sutter G, Volz A |
Proceedings of the National Academy of Sciences | 2021 |
|
COVID-19-associated diarrhea.
Megyeri K, Dernovics Á, Al-Luhaibi ZII, Rosztóczy A |
World Journal of Gastroenterology | 2021 |
|
Gastrointestinal involvement in paediatric COVID-19 - from pathogenesis to clinical management: A comprehensive review.
Calitri C, Fumi I, Ignaccolo MG, Banino E, Benetti S, Lupica MM, Fantone F, Pace M, Garofalo F |
World Journal of Gastroenterology | 2021 |
|
Circulating Cytokines and Coronavirus Disease: A Bi-Directional Mendelian Randomization Study.
Li M, Yeung CHC, Schooling CM |
Frontiers in Genetics | 2021 |
|
Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury.
Zhu DD, Tan XM, Lu LQ, Yu SJ, Jian RL, Liang XF, Liao YX, Fan W, Barbier-Torres L, Yang A, Yang HP, Liu T |
World Journal of Gastroenterology | 2021 |
|
Coronavirus disease 2019 (COVID-19) pathogenesis: a concise narrative review.
Elhamzaoui H, Rebahi H, Hachimi A |
The Pan African medical journal | 2021 |
|
The impact of COVID-19 on tuberculosis: challenges and opportunities.
Kant S, Tyagi R |
Therapeutic advances in infectious disease | 2021 |
|
The COVID-19 Menace.
Walczak P, Janowski M |
2021 | |
|
The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.
Adas G, Cukurova Z, Yasar KK, Yilmaz R, Isiksacan N, Kasapoglu P, Yesilbag Z, Koyuncu ID, Karaoz E |
Cell transplantation | 2021 |
|
SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19.
Rex DAB, Dagamajalu S, Kandasamy RK, Raju R, Prasad TSK |
Journal of Cell Communication and Signaling | 2021 |
|
Benefits of Tocilizumab in patients with a severe form of SARS-CoV-2 infection: Experience of the intensive care unit of the Mohammed VI university hospital, Oujda.
El Rhalete A, Rhazi I, Bensaid A, Diass S, Kaouini A, Ounci E, Abdi M, Maarad M, Babouh C, Alami Z, Abda N, Bkiyer H, Housni B |
2021 | |
|
COVID-19 and Cardiomyopathy: A Systematic Review.
Omidi F, Hajikhani B, Kazemi SN, Tajbakhsh A, Riazi S, Mirsaeidi M, Ansari A, Ghanbari Boroujeni M, Khalili F, Hadadi S, Nasiri MJ |
Frontiers in Cardiovascular Medicine | 2021 |
|
SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.
Zhou Y, Wang M, Li Y, Wang P, Zhao P, Yang Z, Wang S, Zhang L, Li Z, Jia K, Zhong C, Li N, Yu Y, Hou J |
Immunology Letters | 2021 |
|
Humoral immune mechanisms involved in protective and pathological immunity during COVID-19.
Widjaja G, Turki Jalil A, Sulaiman Rahman H, Abdelbasset WK, Bokov DO, Suksatan W, Ghaebi M, Marofi F, Gholizadeh Navashenaq J, Jadidi-Niaragh F, Ahmadi M |
Human Immunology | 2021 |
|
SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.
Pan Y, Jiang X, Yang L, Chen L, Zeng X, Liu G, Tang Y, Qian C, Wang X, Cheng F, Lin J, Wang X, Li Y |
Signal Transduction and Targeted Therapy | 2021 |
|
SARS-CoV-2 Infection: Differences in Hematological Parameters Between Adults and Children.
Liu L, She J, Bai Y, Liu W |
International journal of general medicine | 2021 |
|
Case Report: COVID-19-associated Rhinosinusitis Mucormycosis Caused by Rhizopus arrhizus: A Rare but Potentially Fatal Infection Occurring After Treatment with Corticosteroids.
Tabarsi P, Khalili N, Pourabdollah M, Sharifynia S, Safavi Naeini A, Ghorbani J, Mohamadnia A, Abtahian Z, Askari E |
The American journal of tropical medicine and hygiene | 2021 |
|
Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19.
Luo J, Chen YL, Chen W, Duncan DA, Mentzer A, Knight JC, Ogg G, Klenerman P, Pavord ID, Xue L |
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology | 2021 |
|
Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders.
Ruscitti P, Conforti A, Cipriani P, Giacomelli R, Tasso M, Costa L, Caso F |
2021 | |
|
Role of Prealbumin in Predicting the Prognosis of Severely and Critically Ill COVID-19 Patients.
Cui N, Tong H, Li Y, Ge Y, Shi Y, Lv P, Zhao X, Zhang J, Fu G, Zhou Y, Jiang K, Lin N, Bai T, Jin R, Wei S, Yang X, Li X |
The American journal of tropical medicine and hygiene | 2021 |
|
Between immunomodulation and immunotolerance: The role of IFNγ in SARS-CoV-2 disease.
Todorović-Raković N, Whitfield JR |
Cytokine | 2021 |
|
Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.
Sfera A, Osorio C, Zapata Martín Del Campo CM, Pereida S, Maurer S, Maldonado JC, Kozlakidis Z |
Frontiers in cellular neuroscience | 2021 |
|
Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.
Soffritti I, D'Accolti M, Fabbri C, Passaro A, Manfredini R, Zuliani G, Libanore M, Franchi M, Contini C, Caselli E |
Frontiers in microbiology | 2021 |
|
The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences.
Alshammary AF, Al-Sulaiman AM |
Virulence | 2021 |
|
Post-COVID worsening of a Parkinson's disease patient.
Boika AV, Sialitski MM, Chyzhyk VA, Ponomarev VV, Fomina EG |
Clinical Case Reports | 2021 |
|
Neurological Manifestations in COVID-19 Patients: A Meta-Analysis.
D V, Sharma A, Kumar A, Flora SJS |
ACS Chemical Neuroscience | 2021 |
|
Frailty Pathogenesis, Assessment, and Management in Older Adults With COVID-19.
She Q, Chen B, Liu W, Li M, Zhao W, Wu J |
Frontiers in Medicine | 2021 |
|
EVALUATION OF THE RELATIONSHIP OF MPV, RDW AND PVI PARAMETERS WITH DISEASE SEVERITY IN COVID-19 PATIENTS.
Atik D, Kaya HB |
Acta clinica Croatica | 2021 |
|
The Many Faces of Cytokine Release Syndrome-Related Coagulopathy.
Wang J, Doran J |
2021 | |
|
Clinical value of laboratory indicators for predicting disease progression and death in patients with COVID-19: a retrospective cohort study.
Wang Q, Cheng J, Shang J, Wang Y, Wan J, Yan YQ, Liu WB, Zhang HP, Wang JP, Wang XY, Li ZA, Lin J |
BMJ Open | 2021 |
|
Cell death and pathological findings of the spleen in COVID-19 patients.
Ping H, Zhang K, Wang Y, Tong X, Chen Z, Cai C, Lu Z, Gui X, Liu L, Wang X, Ke H |
Pathology, research and practice | 2021 |
|
Clinical Treatment Experience in Severe and Critical COVID-19.
Li M, Zhu D, Yang J, Yan L, Xiong Z, Lu J, Bi X, Xi Y, Chen Z |
Mediators of Inflammation | 2021 |
|
Patterns of Comorbidity and In-Hospital Mortality in Older Patients With COVID-19 Infection.
Mahmoud M, Carmisciano L, Tagliafico L, Muzyka M, Rosa G, Signori A, Bassetti M, Nencioni A, Monacelli F |
Frontiers in Medicine | 2021 |
|
Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
Rahman MM, Bhattacharjee B, Farhana Z, Hamiduzzaman M, Chowdhury MAB, Hossain MS, Siddiqee MH, Islam MZ, Raheem E, Uddin MJ |
Journal of Preventive Medicine and Hygiene | 2021 |
|
The role of vitamin D deficiency on COVID-19: a systematic review and meta-analysis of observational studies.
Kaya MO, Pamukçu E, Yakar B |
Epidemiology and health | 2021 |
|
Increased serum catalytic iron may mediate tissue injury and death in patients with COVID-19.
Chakurkar V, Rajapurkar M, Lele S, Mukhopadhyay B, Lobo V, Injarapu R, Sheikh M, Dholu B, Ghosh A, Jha V |
Scientific Reports | 2021 |
|
Prospect of 3D bioprinting over cardiac cell therapy and conventional tissue engineering in the treatment of COVID-19 patients with myocardial injury.
Akter F, Araf Y, Naser IB, Promon SK |
Regenerative Therapy | 2021 |
|
Impact of High Serum Levels of MMP-7, MMP-9, TGF-β and PDGF Macrophage Activation Markers on Severity of COVID-19 in Obese-Diabetic Patients.
Nasr El-Din A, Ata KAE, Abdel-Gawad AR, Fahmy NF |
Infection and drug resistance | 2021 |
|
Prognostic properties of hypoalbuminemia in COVID-19 patients: A systematic review and diagnostic meta-analysis.
Soetedjo NNM, Iryaningrum MR, Damara FA, Permadhi I, Sutanto LB, Hartono H, Rasyid H |
Clinical Nutrition ESPEN | 2021 |
|
Role of tumor necrosis factor-α in the mortality of hospitalized patients with severe and critical COVID-19 pneumonia.
Jia F, Wang G, Xu J, Long J, Deng F, Jiang W |
Aging | 2021 |
|
Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for Predicting the Severity in COVID-19 Patients: A Prospective Observational Study.
Singh Y, Singh A, Rudravaram S, Soni KD, Aggarwal R, Patel N, Wig N, Trikha A |
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine | 2021 |
|
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD.
Bernstein CN, Singh H, Murthy SK, Nguyen GC, Benchimol EI, Bitton A, Kuenzig ME, Huang JG, Jones JL, Lee K, Targownik LE, Windsor JW, Mukhtar MS, Tandon P, Kaplan GG |
2021 | |
|
Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
O'Donnell KL, Pinski AN, Clancy CS, Gourdine T, Shifflett K, Fletcher P, Messaoudi I, Marzi A |
EBioMedicine | 2021 |
|
Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review.
Hu S, Jiang S, Qi X, Bai R, Ye XY, Xie T |
Drug Development Research | 2021 |
|
Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19.
Ni Y, Alu A, Lei H, Wang Y, Wu M, Wei X |
2021 | |
|
Synthesis of Novel 2-Thiouracil-5-Sulfonamide Derivatives as Potent Inducers of Cell Cycle Arrest and CDK2A Inhibition Supported by Molecular Docking.
Fatahala SS, Sayed AI, Mahgoub S, Taha H, El-Sayed MK, El-Shehry MF, Awad SM, Abd El-Hameed RH |
International journal of molecular sciences | 2021 |
|
The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients.
Rahimi P, Tarharoudi R, Rahimpour A, Mosayebi Amroabadi J, Ahmadi I, Anvari E, Siadat SD, Aghasadeghi M, Fateh A |
Virology Journal | 2021 |
|
The Gradient of Immune/Inflammatory Response and COVID-19 Prognosis with Therapeutic Implications.
Zheng M |
Frontiers in immunology | 2021 |
|
SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis.
Yoo JS, Sasaki M, Cho SX, Kasuga Y, Zhu B, Ouda R, Orba Y, de Figueiredo P, Sawa H, Kobayashi KS |
Nature Communications | 2021 |
|
Hematological changes associated with COVID-19 infection.
Al-Saadi EAKD, Abdulnabi MA |
Journal of Clinical Laboratory Analysis | 2021 |
|
Current Clinical Application of Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients: Review.
Adugna DG |
Stem cells and cloning : advances and applications | 2021 |
|
Immune Response to SARS-CoV-2 Vaccine in 2 Men.
Gupta S, Su H, Agrawal S |
International Archives of Allergy and Immunology | 2021 |
|
COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications.
Lim MS, Mcrae S |
Critical Reviews in Oncology/Hematology | 2021 |
|
Association of body composition parameters measured on CT with risk of hospitalization in patients with Covid-19.
Chandarana H, Pisuchpen N, Krieger R, Dane B, Mikheev A, Feng Y, Kambadakone A, Rusinek H |
European Journal of Radiology | 2021 |
|
Six-month follow-up of functional status in discharged patients with coronavirus disease 2019.
Du HW, Fang SF, Wu SR, Chen XL, Chen JN, Zhang YX, Huang HY, Lei HH, Chen RH, Pan XB, Li XQ, Xia PC, Zheng ZY, Ling-Luo, Lin HL, Chen LM, Liu N |
BMC Infectious Diseases | 2021 |
|
Development of plant-made monoclonal antibodies against viral infections.
Chen Q |
Current Opinion in Virology | 2021 |
|
Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review.
Tomerak S, Khan S, Almasri M, Hussein R, Abdelati A, Aly A, Salameh MA, Saed Aldien A, Naveed H, Elshazly MB, Zakaria D |
Scandinavian Journal of Immunology | 2021 |
|
Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.
Kim N, Lee JM, Oh EJ, Jekarl DW, Lee DG, Im KI, Cho SG |
Frontiers in immunology | 2021 |
|
Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial.
Kumar PN, Hernández-Sánchez J, Nagel S, Feng Y, Cai F, Rabin J, Morse CG, Nadig NR, Ashraf O, Gotur DB, McComsey GA, Gafoor K, Perin P, Thornton SC, Stubbings W, Lin CJF, Tsai L |
Open Forum Infectious Diseases | 2021 |
|
Current status of therapeutic alternatives for COVID-19: A narrative review.
Aslan AT, Akova M |
Le infezioni in medicina | 2021 |
|
A label-free graphene-based impedimetric biosensor for real-time tracing of the cytokine storm in blood serum; suitable for screening COVID-19 patients.
Khayamian MA, Parizi MS, Ghaderinia M, Abadijoo H, Vanaei S, Simaee H, Abdolhosseini S, Shalileh S, Faramarzpour M, Naeini VF, Hoseinpour P, Shojaeian F, Abbasvandi F, Abdolahad M |
RSC Advances | 2021 |
|
Covid 19-the 21st Century Pandemic: The Novel Coronavirus Outbreak and the Treatment Strategies.
Joseph S, Kutty Narayanan A |
Advanced pharmaceutical bulletin | 2021 |
|
Fast and Efficient Genome Editing of Human FOXP3+ Regulatory T Cells
Van Zeebroeck L, Arroyo Hornero R, Côrte-Real BF, Hamad I, Meissner TB, Kleinewietfeld M |
Frontiers in immunology | 2021 |
|
Association of HScore Parameters with Severe COVID-19: A Systematic Review and Meta-Analysis
Hossein Kazemi M, Kuhestani Dehaghi B, Roshandel E, Bonakchi H, Parkhideh S, Mehdizadeh M, Hajifathali A |
Iranian journal of medical sciences | 2021 |
|
Host factors: Implications in immunopathogenesis of COVID-19
Jafarpour R, Pashangzadeh S, Dowran R |
Pathology, research and practice | 2021 |
|
Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8+ T Cells in Unexposed Individuals
Jo N, Zhang R, Ueno H, Yamamoto T, Weiskopf D, Nagao M, Yamanaka S, Hamazaki Y |
2021 | |
|
Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging.
Schaefer EJ, Dulipsingh L, Comite F, Jimison J, Grajower MM, Lebowitz NE, Lang M, Geller AS, Diffenderfer MR, He L, Breton G, Dansinger ML, Saida B, Yuan C |
PloS one | 2021 |
|
Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection.
Koenecke A, Powell M, Xiong R, Shen Z, Fischer N, Huq S, Khalafallah AM, Trevisan M, Sparen P, Carrero JJ, Nishimura A, Caffo B, Stuart EA, Bai R, Staedtke V, Thomas DL, Papadopoulos N, Kinzler KW, Vogelstein B, Zhou S, Bettegowda C, Konig MF, Mensh BD, Vogelstein JT, Athey S |
eLife | 2021 |
|
DeepR2cov: deep representation learning on heterogeneous drug networks to discover anti-inflammatory agents for COVID-19.
Wang X, Xin B, Tan W, Xu Z, Li K, Li F, Zhong W, Peng S |
Briefings in Bioinformatics | 2021 |
|
Prognostic value of inflammatory markers in patients with COVID-19 in Indonesia.
Prasetya IB, Cucunawangsih, Lorens JO, Sungono V, El-Khobar KE, Wijaya RS |
Clinical Epidemiology and Global Health | 2021 |
|
Impact of age and gender on lymphocyte subset counts in patients with COVID-19.
Löhr P, Schiele S, Arndt TT, Grützner S, Claus R, Römmele C, Müller G, Schmid C, Dennehy KM, Rank A |
Cytometry Part A | 2021 |
|
The immunological response among COVID-19 patients with acute respiratory distress syndrome.
Almutairi AS, Abunurah H, Hadi Alanazi A, Alenazi F, Nagy H, Saad Almutairi N, Wells M, Alawam A, Alqahtani MM |
Journal of Infection and Public Health | 2021 |
|
Do Anxiety and Depression Levels Affect the Inflammation Response in Patients Hospitalized for COVID-19.
Kahve AC, Kaya H, Okuyucu M, Goka E, Barun S, Hacimusalar Y |
Psychiatry investigation | 2021 |
|
Position Statement on Post-COVID-19 Cardiovascular Preparticipation Screening: Guidance for Returning to Physical Exercise and Sports - 2020.
Colombo CSSS, Leitão MB, Avanza Junior AC, Borges SF, Silveira ADD, Braga F, Camarozano AC, Kopiler DA, Lazzoli JK, Freitas OGA, Grossman GB, Milani M, Nunes MB, Ritt LEF, Sellera CAC, Ghorayeb N |
Arquivos brasileiros de cardiologia | 2021 |
|
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy.
Basar R, Uprety N, Ensley E, Daher M, Klein K, Martinez F, Aung F, Shanley M, Hu B, Gokdemir E, Nunez Cortes AK, Mendt M, Reyes Silva F, Acharya S, Laskowski T, Muniz-Feliciano L, Banerjee PP, Li Y, Li S, Melo Garcia L, Lin P, Shaim H, Yates SG, Marin D, Kaur I, Rao S, Mak D, Lin A, Miao Q, Dou J, Chen K, Champlin RE, Shpall EJ, Rezvani K |
Cell Reports | 2021 |
|
COVID-19 and obesity: fighting two pandemics with intermittent fasting.
Ealey KN, Phillips J, Sung HK |
Trends in endocrinology and metabolism: TEM | 2021 |
|
Two novel nomograms based on inflammatory cytokines or lymphocyte subsets to differentially diagnose severe or critical and Non-Severe COVID-19.
Li Z, Jiang N, Li X, Yang B, Jin M, Sun Y, He Y, Liu Y, Wang Y, Si D, Ma P, Zhang J, Liu T, Yu Q |
Aging | 2021 |
|
White blood count, D-dimers, and ferritin levels as predictive factors of pulmonary embolism suspected upon admission in noncritically ill COVID-19 patients: The French multicenter CLOTVID retrospective study.
Galland J, Thoreau B, Delrue M, Neuwirth M, Stepanian A, Chauvin A, Dellal A, Nallet O, Roriz M, Devaux M, London J, Martin-Lecamp G, Froissart A, Arab N, Ferron B, Groff MH, Queyrel V, Lorut C, Regard L, Berthoux E, Bayer G, Comarmond C, Lioger B, Mekinian A, Szwebel TA, Sené T, Amador-Boreiro B, Mangin O, Sellier PO, Mouly S, Kevorkian JP, Siguret V, Vodovar D, Sene D |
European Journal of Haematology | 2021 |
|
Development of rapid and cost-effective top-loading device for the detection of anti-SARS-CoV-2 IgG/IgM antibodies.
Ibrahim EH, Ghramh HA, Kilany M |
Scientific Reports | 2021 |
|
Vitamin D in the time of the coronavirus (COVID-19) pandemic - a clinical review from a public health and public mental health perspective.
Werneke U, Gaughran F, Taylor DM |
Therapeutic Advances in Psychopharmacology | 2021 |
|
Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection.
Dvornikova KA, Bystrova EY, Churilov LP, Lerner A |
Molecular Biology Reports | 2021 |
|
SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage.
Ma J, Zhu F, Zhao M, Shao F, Yu D, Ma J, Zhang X, Li W, Qian Y, Zhang Y, Jiang D, Wang S, Xia P |
The EMBO Journal | 2021 |
|
Use of the Barthel Index to Assess Activities of Daily Living before and after SARS-COVID 19 Infection of Institutionalized Nursing Home Patients.
Trevissón-Redondo B, López-López D, Pérez-Boal E, Marqués-Sánchez P, Liébana-Presa C, Navarro-Flores E, Jiménez-Fernández R, Corral-Liria I, Losa-Iglesias M, Becerro-de-Bengoa-Vallejo R |
International journal of environmental research and public health | 2021 |
|
Immunologic resilience and COVID-19 survival advantage.
Lee GC, Restrepo MI, Harper N, Manoharan MS, Smith AM, Meunier JA, Sanchez-Reilly S, Ehsan A, Branum AP, Winter C, Winter L, Jimenez F, Pandranki L, Carrillo A, Perez GL, Anzueto A, Trinh H, Lee M, Hecht JM, Martinez-Vargas C, Sehgal RT, Cadena J, Walter EA, Oakman K, Benavides R, Pugh JA, Letendre S, Steri M, Orrù V, Fiorillo E, Cucca F, Moreira AG, Zhang N, Leadbetter E, Agan BK, Richman DD, He W, Clark RA, Okulicz JF, Ahuja SK |
Journal of Allergy and Clinical Immunology | 2021 |
|
Cascade of immune mechanism and consequences of inflammatory disorders.
Megha KB, Joseph X, Akhil V, Mohanan PV |
Phytomedicine : international journal of phytotherapy and phytopharmacology | 2021 |
|
Peripheral granular lymphocytopenia and dysmorphic leukocytosis as simple prognostic markers in COVID-19.
Horiuchi Y, Hayashi F, Iwasaki Y, Matsuzaki A, Nishibe K, Kaniyu K, Marutani S, Saito K, Matsuoka S, Uchihashi K, Miida T, Ai T, Tabe Y |
International Journal of Laboratory Hematology | 2021 |
|
Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements.
Montrucchio G, Lupia T, Lombardo D, Stroffolini G, Corcione S, De Rosa FG, Brazzi L |
Annals of Intensive Care | 2021 |
|
Applications of Brain Organoids for Infectious Diseases.
Fan W, Christian KM, Song H, Ming GL |
Journal of Molecular Biology | 2021 |
|
Chronic Diseases as a Predictor for Severity and Mortality of COVID-19: A Systematic Review With Cumulative Meta-Analysis.
Geng J, Yu X, Bao H, Feng Z, Yuan X, Zhang J, Chen X, Chen Y, Li C, Yu H |
Frontiers in Medicine | 2021 |
|
Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can.
Tamayo-Velasco Á, Peñarrubia Ponce MJ, Álvarez FJ, Gonzalo-Benito H, de la Fuente I, Pérez-González S, Rico L, Jiménez García MT, Sánchez Rodríguez A, Hijas Villaizan M, Martín-Fernández M, Dueñas C, Gómez-Sánchez E, Heredia-Rodríguez M, Gorgojo-Galindo Ó, Fernández I, Del Río L, Carnicero-Frutos I, Muñoz-Moreno MF, Tamayo E, Bernardo D, Martínez-Paz P |
Frontiers in immunology | 2021 |
|
Cost-effectiveness of telemedicine care for patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia.
Faleh AlMutairi M, Tourkmani AM, Alrasheedy AA, ALHarbi TJ, Bin Rsheed AM, ALjehani M, AlRuthia Y |
Therapeutic Advances in Chronic Disease | 2021 |
|
SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdown.
Martínez PT, García PD, Salas MR, Sánchez RR, Avendaño-Ortíz J, Guerrero-Monjo S, García F, Llamas MÁ, López-Collazo E, Saz-Leal P, Del Fresno C |
Scientific Reports | 2021 |
|
Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia.
Bradley J, Sbaih N, Chandler TR, Furmanek S, Ramirez JA, Cavallazzi R |
Chest | 2021 |
|
Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements.
García-González P, Tempio F, Fuentes C, Merino C, Vargas L, Simon V, Ramirez-Pereira M, Rojas V, Tobar E, Landskron G, Araya JP, Navarrete M, Bastias C, Tordecilla R, Varas MA, Maturana P, Marcoleta AE, Allende ML, Naves R, Hermoso MA, Salazar-Onfray F, Lopez M, Bono MR, Osorio F |
Frontiers in immunology | 2021 |
|
Outcomes of treatment of severe COVID-19 pneumonia with tocilizumab: a report of two cases from Tunisia.
Azaiz MB, Chatbri B, Sellami W, Romdhani C, Lamine K, Ghazouani E, Oueslati R, Gharsallah H, Ferjani M |
The Pan African medical journal | 2021 |
|
COVID-19 vaccination strategies depend on the underlying network of social interactions.
Saunders HA, Schwartz JM |
Scientific Reports | 2021 |
|
Predictors of COVID-19 severity: a systematic review and meta-analysis
Mudatsir M, Fajar JK, Wulandari L, Soegiarto G, Ilmawan M, Purnamasari Y, Mahdi BA, Jayanto GD, Suhendra S, Setianingsih YA, Hamdani R, Suseno DA, Agustina K, Naim HY, Muchlas M, Alluza HH, Rosida NA, Mayasari M, Mustofa M, Hartono A, Aditya R, Prastiwi F, Meku FX, Sitio M, Azmy A, Santoso AS, Nugroho RA, Gersom C, Rabaan AA, Masyeni S, Nainu F, Wagner AL, Dhama K, Harapan H |
F1000Research | 2021 |
|
MAIT cells in respiratory viral infections in mouse and human
Long Y, Hinks TS |
Critical reviews in immunology | 2021 |
|
Antiplatelet therapy in patients with Covid-19: A retrospective observational study
Banik J, Mezera V, Köhler C, Schmidtmann M |
2021 | |
|
Coronaviruses in children: A review of potential mechanisms of childhood protection
Rabi FA, Al Zoubi MS, Al\u2010Iede MM, Kasasbeh G, Badran EF |
Acta paediatrica (Oslo, Norway : 1992) | 2021 |
|
COVID‐19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities
Chavarot N, Gueguen J, Bonnet G, Jdidou M, Trimaille A, Burger C, Amrouche L, Weizman O, Pommier T, Aubert O, Celier J, Sberro\u2010Soussan R, Geneste L, Panagides V, Delahousse M, Marsou W, Aguilar C, Deney A, Zuber J, Fauvel C, Legendre C, Mika D, Pezel T, Anglicheau D, Sutter W, Zaidan M, Snanoudj R, Cohen A, Scemla A |
American Journal of Transplantation | 2021 |
|
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia
Quartuccio L, Fabris M, Sonaglia A, Peghin M, Domenis R, Cifù A, Curcio F, Tascini C |
Cytokine | 2021 |
|
Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)
Díaz E, Amézaga Menéndez R, Vidal Cortés P, Escapa MG, Suberviola B, Serrano Lázaro A, Marcos Neira P, Quintana Díaz M, Catalán González M |
Medicina Intensiva | 2021 |
|
Chest CT manifestations with emphasis on the role of CT scoring and serum ferritin/lactate dehydrogenase in prognosis of coronavirus disease 2019 (COVID-19)
El Bakry RA, Sayed AI |
The Egyptian Journal of Radiology and Nuclear Medicine | 2021 |
|
Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis
Mutiawati E, Syahrul S, Fahriani M, Fajar JK, Mamada SS, Maliga HA, Samsu N, Ilmawan M, Purnamasari Y, Asmiragani AA, Ichsan I, Emran TB, Rabaan AA, Masyeni S, Nainu F, Harapan H |
F1000Research | 2021 |
|
Promising gas therapies for severe COVID-19
Wang T, Xiang Q, Bian J |
2021 | |
|
Potential biomarkers for the early prediction of SARS-COV-2 disease outcome
Mariappan V, Manoharan PS, R P, Shanmugam L, Rao SR, Pillai AB |
Microbial Pathogenesis | 2021 |
|
Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial
Fakharian A, Barati S, Mirenayat M, Rezaei M, Haseli S, Torkaman P, Yousefian S, Dastan A, jamaati H, Dastan F |
International Immunopharmacology | 2021 |
|
Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India
Dravid A, Kashiva R, Khan Z, Memon D, Kodre A, Potdar P, Mane M, Borse R, Pawar V, Patil D, Banerjee D, Bhoite K, Pharande R, Kalyani S, Raut P, Bapte M, Mehta A, Reddy MS, Bhayani K, Laxmi SS, Vishnu PD, Srivastava S, Khandelwal S, More S, Shinde R, Pawar M, Harshe A, Kadam S, Mahajan U, Joshi G, Mane D |
Medicine | 2021 |
|
Lines of Treatment of COVID-19 Infection
El-Goly AM |
2021 | |
|
Evaluation of Mortality and Morbidity According to Initial Symptoms in COVID-19 Patients Using Clinical Epidemiologic Data from the Korea Centers for Disease Control & Prevention
Kim SY, Yoo DM, Min C, Kim JH, Choi HG |
Medicina | 2021 |
|
SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial Cells
Caccuri F, Bugatti A, Zani A, De Palma A, Di Silvestre D, Manocha E, Filippini F, Messali S, Chiodelli P, Campisi G, Fiorentini S, Facchetti F, Mauri P, Caruso A |
Microorganisms | 2021 |
|
Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity
Volpatti LR, Wallace RP, Cao S, Raczy MM, Wang R, Gray LT, Alpar AT, Briquez PS, Mitrousis N, Marchell TM, Sasso MS, Nguyen M, Mansurov A, Budina E, Solanki A, Watkins EA, Schnorenberg MR, Tremain AC, Reda JW, Nicolaescu V, Furlong K, Dvorkin S, Yu SS, Manicassamy B, LaBelle JL, Tirrell MV, Randall G, Kwissa M, Swartz MA, Hubbell JA |
ACS Central Science | 2021 |
|
Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives
Huang YK, Li YJ, Li B, Wang P, Wang QH |
World Journal of Gastroenterology | 2021 |
|
Gut Microbiota Diversity and C-Reactive Protein Are Predictors of Disease Severity in COVID-19 Patients
Moreira-Rosário A, Marques C, Pinheiro H, Araújo JR, Ribeiro P, Rocha R, Mota I, Pestana D, Ribeiro R, Pereira A, de Sousa MJ, Pereira-Leal J, de Sousa J, Morais J, Teixeira D, Rocha JC, Silvestre M, Príncipe N, Gatta N, Amado J, Santos L, Maltez F, Boquinhas A, de Sousa G, Germano N, Sarmento G, Granja C, Póvoa P, Faria A, Calhau C |
Frontiers in microbiology | 2021 |
|
Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
Park JG, Oladunni FS, Rohaim MA, Whittingham-Dowd J, Tollitt J, Hodges MD, Fathallah N, Assas MB, Alhazmi W, Almilaibary A, Iqbal M, Chang P, Escalona R, Shivanna V, Torrelles JB, Worthington JJ, Jackson-Jones LH, Martinez-Sobrido L, Munir M |
iScience | 2021 |
|
CAR Macrophages for SARS-CoV-2 Immunotherapy
Fu W, Lei C, Ma Z, Qian K, Li T, Zhao J, Hu S |
Frontiers in immunology | 2021 |
|
The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19
Emanuele S, Celesia A, D\u2019Anneo A, Lauricella M, Carlisi D, De Blasio A, Giuliano M |
International journal of molecular sciences | 2021 |
|
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
Kyriazopoulou E, Huet T, Cavalli G, Gori A, Kyprianou M, Pickkers P, Eugen-Olsen J, Clerici M, Veas F, Chatellier G, Kaplanski G, Netea MG, Pontali E, Gattorno M, Cauchois R, Kooistra E, Kox M, Bandera A, Beaussier H, Mangioni D, Dagna L, van der Meer JW, Giamarellos-Bourboulis EJ, Hayem G |
2021 | |
|
Effects of Covid-19 on the audio-vestibular system
Tan M, Cengiz DU, Demir İ, Demirel S, Çolak SC, Karakaş O, Bayındır T |
American Journal of Otolaryngology | 2021 |
|
IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial
Moll-Bernardes R, de Sousa AS, Macedo AV, Lopes RD, Vera N, Maia LC, Feldman A, Arruda GD, Castro MJ, Pimentel-Coelho PM, de Albuquerque DC, de Paula TC, Furquim TA, Loures VA, Giusti KG, de Oliveira NM, De Luca FA, Kotsugai MD, Domiciano RA, Santos MF, de Souza OF, Bozza FA, Luiz RR, Medei E |
Frontiers in Cardiovascular Medicine | 2021 |
|
SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects
Constant O, Barthelemy J, Bolloré K, Tuaillon E, Gosselet F, Chable-Bessia C, Merida P, Muriaux D, Van de Perre P, Salinas S, Simonin Y |
Frontiers in immunology | 2021 |
|
Chronic kidney disease linked to SARS-CoV-2 infection: a case report
Tarris G, de Rougemont A, Estienney MA, Journet J, Lariotte AC, Aubignat D, Rebibou JM, De La Vega MF, Legendre M, Belliot G, Martin L |
BMC Nephrology | 2021 |
|
Predictive value of HbA1c for in-hospital adverse prognosis in COVID-19: A systematic review and meta-analysis
Zhu Z, Mao Y, Chen G |
Primary Care Diabetes | 2021 |
|
Insights into Pathology and Pathogenesis of Coronavirus Disease 2019 from a Histopathological and Immunological Perspective
Iida S, Arashiro T, Suzuki T |
2021 | |
|
Impact of vitamin D on the course of COVID-19 during pregnancy: A case control study
Sinaci S, Ocal DF, Yucel Yetiskin DF, Uyan Hendem D, Buyuk GN, Goncu Ayhan S, Tanacan A, Ozgu-Erdinc AS, Moraloglu Tekin O, Sahin D |
The Journal of Steroid Biochemistry and Molecular Biology | 2021 |
|
COVID-19 et marqueurs immunologiques pertinents
Admou B |
The Pan African medical journal | 2021 |
|
The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
Neubauer A, Johow J, Mack E, Burchert A, Meyn D, Kadlubiec A, Torje I, Wulf H, Vogelmeier CF, Hoyer J, Skevaki C, Muellenbach RM, Keller C, Schade-Brittinger C, Rolfes C, Wiesmann T |
Leukemia | 2021 |
|
COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence?
Maleki A, Look-Why S, Manhapra A, Foster CS |
Journal of Ophthalmic & Vision Research | 2021 |
|
Lower Serum Angiotensin-Converting Enzyme Level in Relation to Hyperinflammation and Impaired Antiviral Immune Response Contributes to Progression of COVID-19 Infection
Chen Y, Huang D, Yuan W, Chang J, Yuan Z, Wu D, Han M, Luo X, Ning Q, Yan W |
Infectious Diseases and Therapy | 2021 |
|
Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B: a multi-center retrospective cohort study
Wang J, Lu Z, Jin M, Wang Y, Tian K, Xiao J, Cai Y, Wang Y, Zhang X, Chen T, Yao Z, Yang C, Deng R, Zhong Q, Deng X, Chen X, Yang XP, Wei G, Wang Z, Tian J, Chen XP |
Frontiers of Medicine | 2021 |
|
Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide
Alon D, Paitan Y, Robinson E, Ganor N, Lipovetsky J, Yerushalmi R, Cohen CJ, Raiter A |
Frontiers in Medicine | 2021 |
|
Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients
Sui J, Noubouossie DF, Gandotra S, Cao L |
Frontiers in Cellular and Infection Microbiology | 2021 |
|
COVID-19 Associated Coagulopathy in an Indian Scenario: A Correlation with Disease Severity and Survival Status
Raychaudhuri S, Pujani M, Menia R, Verma N, Singh M, Chauhan V, Jain M, Chandoke RK, Kaur H, Agrawal S, Singh A |
Indian Journal of Hematology and Blood Transfusion | 2021 |
|
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients
Trougakos IP, Terpos E, Zirou C, Sklirou AD, Apostolakou F, Gumeni S, Charitaki I, Papanagnou ED, Bagratuni T, Liacos CI, Scorilas A, Korompoki E, Papassotiriou I, Kastritis E, Dimopoulos MA |
BMC Medicine | 2021 |
|
Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease
Tomchaney M, Contoli M, Mayo J, Baraldo S, Li S, Cabel CR, Bull DA, Lick S, Malo J, Knoper S, Kim SS, Tram J, Rojas-Quintero J, Kraft M, Ledford JG, Tesfaigzi Y, Martinez FD, Thorne CA, Kheradmand F, Campos SK, Papi A, Polverino F |
BMC Pulmonary Medicine | 2021 |
|
Meta-analysis of single-cell RNA-seq data reveals phenotypic switching of immune cells in severe COVID-19 patients
Hasan MZ, Islam S, Matsumoto K, Kawai T |
Computers in Biology and Medicine | 2021 |
|
Immunomodulation and immunotherapeutics of COVID-19
Garg SS, Sharma A, Gupta J |
Clinical Immunology | 2021 |
|
Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients
Abdelhafiz AS, Fouad MA, Sayed-Ahmed MM, Kamel MM, Ali A, Fouda M, Khalil MA, Abdel-Moneim AS, Kamal LM |
Virology | 2021 |
|
Deep immune profiling of the maternal-fetal interface with mild SARS-CoV-2 infection
Sureshchandra S, Zulu MZ, Doratt B, Jankeel A, Tifrea D, Edwards R, Rincon M, Marshall NE, Messaoudi I |
2021 | |
|
Cryptococcus neoformans blood stream infection in severe COVID-19 pneumonia
Thyagarajan RV, Mondy KE, Rose DT |
IDCases | 2021 |
|
Novel coronavirus disease (COVID-19): origin, transmission through the environment, health effects, and mitigation strategies—a review
Singh A, Haq I |
2021 | |
|
Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2
Zheng HY, He XY, Li W, Song TZ, Han JB, Yang X, Liu FL, Luo RH, Tian RR, Feng XL, Ma YH, Liu C, Li MH, Zheng YT |
Signal Transduction and Targeted Therapy | 2021 |
|
SARS-CoV-2 Accessory Protein ORF7b Mediates Tumor Necrosis Factor-α-Induced Apoptosis in Cells
Yang R, Zhao Q, Rao J, Zeng F, Yuan S, Ji M, Sun X, Li J, Yang J, Cui J, Jin Z, Liu L, Liu Z |
Frontiers in microbiology | 2021 |
|
Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients
Chauvin M, Larsen M, Quirant B, Quentric P, Dorgham K, Royer L, Vallet H, Guihot A, Combadière B, Combadière C, Barallat J, Mayaux J, Luyt CE, Mathian A, Amoura Z, Boddaert J, Armestar F, Gorochov G, Martinez-Caceres E, Sauce D |
Frontiers in Cellular and Infection Microbiology | 2021 |
|
SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐19
Maiese A, Manetti AC, Bosetti C, Del Duca F, La Russa R, Frati P, Di Paolo M, Turillazzi E, Fineschi V |
Brain Pathology | 2021 |
|
Association of COVID‐19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection
Lambadiari V, Mitrakou A, Kountouri A, Thymis J, Katogiannis K, Korakas E, Varlamos C, Andreadou I, Tsoumani M, Triantafyllidi H, Bamias A, Thomas K, Kazakou P, Grigoropoulou S, Kavatha D, Antoniadou A, Dimopoulos M, Ikonomidis I |
European Journal of Heart Failure | 2021 |
|
Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
Zhu Z, Wang M, Lin W, Cai Q, Zhang L, Chen D, Liu F, Xiong X, Chu J, Peng J, Chen K |
Immunity, Inflammation and Disease | 2021 |
|
Nerve Growth Factor: A Potential Therapeutic Target for Lung Diseases
Liu P, Li S, Tang L |
International journal of molecular sciences | 2021 |
|
TNF-α and IFN-γ Participate in Improving the Immunoregulatory Capacity of Mesenchymal Stem/Stromal Cells: Importance of Cell–Cell Contact and Extracellular Vesicles
López-García L, Castro-Manrreza ME |
International journal of molecular sciences | 2021 |
|
Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19
García-García JA, Pérez-Quintana M, Ramos-Giráldez C, Cebrián-González I, Martín-Ponce ML, del Valle-Villagrán J, Navarro-Puerto MA, Sánchez-Villegas J, Gómez-Herreros R, Manoja-Bustos I, León-Martí D, Serrano-Rodríguez L, de Miguel-Albarreal A, Velasco-Romero MJ, Mula-Falcón F, Fernández-Pérez P, Melguizo-Moya I, Pérez-Quintana MJ, Romero-Molina G, Vergara-López S, Marenco-de la Fuente JL, Marín-Martín J, Mira-Escarti JA |
Journal of Clinical Medicine | 2021 |
|
Predisposing factors of important invasive fungal coinfections in COVID-19 patients: a review article
Zia M, Goli M |
2021 | |
|
Immune normalization strategy against suboptimal health status: safe and efficacious therapy using mixed-natural killer cells
Li Y, Harunori O, Fu S, Xing F, Wu H, Wang J, Chen A, Ren X, Peng D, Ling X, Shi M, Wu H |
Aging | 2021 |
|
The relationship between Dietary Inflammatory Index and disease severity and inflammatory status: a case–control study of COVID-19 patients
Moludi J, Qaisar SA, Alizadeh M, Jafari Vayghan H, Naemi M, Rahimi A, Mousavi R |
The British journal of nutrition | 2021 |
|
Higher Levels of C-Reactive Protein and Ferritin in Patients with Overweight and Obesity and SARS-CoV-2-Related Pneumonia
Bettini S, Bucca G, Sensi C, Dal Prà C, Fabris R, Vettor R, Busetto L |
Obesity facts | 2021 |
|
Janus Kinase inhibitors for the treatment of hospitalized patients with COVID-19
Florescu DF, Kalil AC |
Current Opinion in Critical Care | 2021 |
|
Evaluation of anorexia and analysis of related factors in patients with COVID-19
Shahbazi S, Hajimohammadebrahim-Ketabforoush M, Vahdat Shariatpanahi M, Shahbazi E, Vahdat Shariatpanahi Z |
2021 | |
|
Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
Chavda VP, Gajjar N, Shah N, Dave DJ |
2021 | |
|
Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2
Rowland R, Brandariz-Nuñez A |
Microbiology spectrum | 2021 |
|
Hematologic and coagulopathy parameter as a survival predictor among moderate to severe COVID-19 patients in non- ICU ward: a single-center study at the main referral hospital in Surabaya, East Java, Indonesia
Bintoro SU, Dwijayanti NM, Pramudya D, Amrita PN, Romadhon PZ, Asmarawati TP, Bachtiar A, Hadi U |
F1000Research | 2021 |
|
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage
Costa TJ, Potje SR, Fraga-Silva TF, da Silva-Neto JA, Barros PR, Rodrigues D, Machado MR, Martins RB, Santos-Eichler RA, Benatti MN, de Sá KS, Almado CE, Castro ÍA, Pontelli MC, Serra LL, Carneiro FS, Becari C, Louzada-Junior P, Oliveira RD, Zamboni DS, Arruda E, Auxiliadora-Martins M, Giachini FR, Bonato VL, Zachara NE, Bomfim GF, Tostes RC |
Vascular Pharmacology | 2021 |
|
Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm
Feret W, Nalewajska M, Wojczyński Ł, Witkiewicz W, Kłos P, Dziedziejko V, Pawlik A |
Journal of Clinical Medicine | 2021 |
|
Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course
Beran J, Špajdel M, Slíva J |
Viruses | 2021 |
|
Robust and Persistent B- and T-Cell Responses after COVID-19 in Immunocompetent and Solid Organ Transplant Recipient Patients
Zavaglio F, Frangipane V, Morosini M, Gabanti E, Zelini P, Sammartino JC, Ferrari A, Gregorini M, Rampino T, Asti A, Seminari E, Di Matteo A, Cattadori B, Pellegrini C, Tonello S, Mallela VR, Minisini R, Rizzi M, Sainaghi PP, Meloni F, Lilleri D, Baldanti F |
Viruses | 2021 |
|
Predictive Modeling of Poor Outcome in Severe COVID-19: A Single-Center Observational Study Based on Clinical, Cytokine and Laboratory Profiles
Gorgojo-Galindo Ó, Martín-Fernández M, Peñarrubia-Ponce MJ, Álvarez FJ, Ortega-Loubon C, Gonzalo-Benito H, Martínez-Paz P, Miramontes-González JP, Gómez-Sánchez E, Poves-Álvarez R, Jorge-Monjas P, Tamayo E, Heredia-Rodríguez M, Tamayo-Velasco Á |
Journal of Clinical Medicine | 2021 |
|
SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
Jugler C, Sun H, Chen Q |
Human vaccines | 2021 |
|
Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19
Codina H, Vieitez I, Gutierrez-Valencia A, Skouridou V, Martínez C, Patiño L, Botero-Gallego M, Trujillo-Rodríguez M, Serna-Gallego A, Muñoz-Muela E, Bobillo MM, Pérez A, Cabrera-Alvar JJ, Crespo M, O\u2019Sullivan CK, Ruiz-Mateos E, Poveda E |
Microorganisms | 2021 |
|
Dynamics of Inflammatory Markers in Predicting Mortality in COVID-19
Parimoo A, Biswas A, Baitha U, Gupta G, Pandey S, Ranjan P, Gupta V, Barman Roy D, Prakash B, Wig N |
Cureus | 2021 |
|
Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction
Rouhani SJ, Trujillo JA, Pyzer AR, Yu J, Fessler J, Cabanov A, Higgs EF, Cron KR, Zha Y, Lu Y, Bloodworth JC, Abasiyanik MF, Okrah S, Flood BA, Hatogai K, Leung MY, Pezeshk A, Kozloff L, Reschke R, Strohbehn GW, Chervin CS, Kumar M, Schrantz S, Madariaga ML, Beavis KG, Yeo KT, Sweis RF, Segal J, Tay S, Izumchenko E, Mueller J, Chen LS, Gajewski TF |
Research square | 2021 |
|
A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection
Counoupas C, Johansen MD, Stella AO, Nguyen DH, Ferguson AL, Aggarwal A, Bhattacharyya ND, Grey A, Hutchings O, Patel K, Siddiquee R, Stewart EL, Feng CG, Hansbro NG, Palendira U, Steain MC, Saunders BM, Low JK, Mackay JP, Kelleher AD, Britton WJ, Turville SG, Hansbro PM, Triccas JA |
npj Vaccines | 2021 |
|
Acute estradiol and progesterone therapy in hospitalised adults to reduce COVID-19 severity: a randomised control trial
Lovre D, Bateman K, Sherman M, Fonseca VA, Lefante J, Mauvais-Jarvis F |
BMJ Open | 2021 |
|
Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in Japan
Oba S, Hosoya T, Amamiya M, Mitsumura T, Kawata D, Sasaki H, Kamiya M, Yamamoto A, Ando T, Shimada S, Shirai T, Okamoto T, Tateishi T, Endo A, Aiboshi J, Nosaka N, Yamanouchi H, Ugawa T, Nagaoka E, Oi K, Tao S, Maejima Y, Tanaka Y, Tanimoto K, Takeuchi H, Tohda S, Hirakawa A, Sasano T, Arai H, Otomo Y, Miyazaki Y, Yasuda S |
Frontiers in Cardiovascular Medicine | 2021 |
|
Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention
Danilenko V, Devyatkin A, Marsova M, Shibilova M, Ilyasov R, Shmyrev V |
Journal of inflammation research | 2021 |
|
An association between immune status and chest CT scores in COVID‐19 patients
Çölkesen F, Poyraz N, Arslan Ş, Yılmaz PD, Kepenek Kurt E, Korkmaz C, Yıldız E, Çölkesen F, Aytekin G, Keleş S, Reisli İ |
International Journal of Clinical Practice | 2021 |
|
HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients
Meyer A, Buetti N, Houhou-Fidouh N, Patrier J, Abdel-Nabey M, Jaquet P, Presente S, Girard T, Sayagh F, Ruckly S, Wicky PH, de Montmollin E, Bouadma L, Sonneville R, Descamps D, Timsit JF |
Critical Care | 2021 |
|
Virus infection induced pulmonary fibrosis
Huang WJ, Tang XX |
Journal of Translational Medicine | 2021 |
|
Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2
Narayanaswamy V, Pentecost B, Alfandari D, Chin E, Minor K, Kastrinakis A, Lieberman T, Arcaro KF, Leftwich H |
Breastfeeding Medicine | 2021 |
|
Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease
Balcom EF, Nath A, Power C |
Brain : a journal of neurology | 2021 |
|
Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID‐19 patients
Duarte\u2010Millán MA, Mesa\u2010Plaza N, Guerrero\u2010Santillán M, Morales\u2010Ortega A, Bernal\u2010Bello D, Farfán\u2010Sedano AI, García de Viedma\u2010García V, Velázquez\u2010Ríos L, Frutos\u2010Pérez B, De Ancos\u2010Aracil CL, Soria Fernández\u2010Llamazares G, Toledano\u2010Macías M, Cristóbal\u2010Bilbao R, Luquín\u2010Ciuro N, Marrero\u2010Francés J, Piedrabuena\u2010García SI, Satué\u2010Bartolomé JA, Gonzalo\u2010Pascua S, Rivilla\u2010Jiménez M, Carpintero\u2010García L, Ayala\u2010Larrañaga I, García\u2010Bermúdez V, Lara\u2010Montes C, Llerena\u2010Riofrío ÁR, RIvas\u2010Prado L, Walter S, Escriba\u2010Barcena A, San Martín López JV, Ruíz\u2010Giardín JM |
Journal of Medical Virology | 2021 |
|
The systemic immunosuppressive effects of peripheral corticosteroid injections: A narrative review of the evidence in the context of COVID‐19
Regan P, Elkhalifa S, Barratt P |
Musculoskeletal Care | 2021 |
|
Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, China
Liu T, Wu D, Yan W, Wang X, Zhang X, Ma K, Chen H, Zeng Z, Qin Y, Wang H, Xing M, Xu D, Li W, Ni M, Zhu L, Chen L, Chen G, Qi W, Wu T, Yu H, Huang J, Han M, Zhu W, Guo W, Luo X, Chen T, Ning Q |
Clinical Infectious Diseases | 2021 |
|
Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact
Zhang S, Asquith B, Szydlo R, Tregoning JS, Pollock KM |
2021 | |
|
Viral respiratory infections and psychosis: A review of the literature and the implications of COVID-19.
Kulaga SS, Miller CWT |
Neuroscience and biobehavioral reviews | 2021 |
|
Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients.
Teixeira PC, Dorneles GP, Santana Filho PC, da Silva IM, Schipper LL, Postiga IAL, Neves CAM, Rodrigues Junior LC, Peres A, Souto JT, Fonseca SG, Eller S, Oliveira TF, Rotta LN, Thompson CE, Romão PRT |
International Immunopharmacology | 2021 |
|
Immunomodulatory activity of β-glucan polysaccharides isolated from different species of mushroom - A potential treatment for inflammatory lung conditions.
Murphy EJ, Rezoagli E, Pogue R, Simonassi-Paiva B, Abidin IIZ, Fehrenbach GW, O'Neil E, Major I, Laffey JG, Rowan N |
The Science of The Total Environment | 2021 |
|
NMDA receptor modulation and severe acute respiratory syndrome treatment
Costa BM |
F1000Research | 2021 |
|
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role
Bertoletti A, Tan AT, Le Bert N |
2021 | |
|
What do we know about IL-6 in COVID-19 so far?
Jiang J, Wang J, Yao L, Lai S, Zhang X |
Biophysics Reports | 2021 |
|
Prognostic factors for the severity of SARS-CoV-2 infection
Rubio-Sánchez R, Lepe-Balsalobre E, Viloria-Peñas MD |
2021 | |
|
Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus-2 infection: a systematic review
Cho J, Lee J, Sia CH, Koo CS, Tan BY, Hong W, Choi E, Goh X, Chai L, Chandran NS, Chua HR, Chan BP, Muthiah M, Low TT, Yap ES, Lahiri M |
Singapore Medical Journal | 2021 |
|
Circulating furin, IL-6, and presepsin levels and disease severity in SARS-CoV-2–infected patients
Kocyigit A, Sogut O, Durmus E, Kanimdan E, Guler EM, Kaplan O, Yenigun VB, Eren C, Ozman Z, Yasar O |
Science Progress | 2021 |
|
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.
Cohen CA, Li AP, Hachim A, Hui DS, Kwan MY, Tsang OT, Chiu SS, Chan WH, Yau YS, Kavian N, Ma FN, Lau EH, Cheng SM, Poon LL, Peiris JM, Valkenburg SA |
medRxiv : the preprint server for health sciences | 2021 |
|
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.
Feyaerts D, Hédou J, Gillard J, Chen H, Tsai ES, Peterson LS, Ando K, Manohar M, Do E, Dhondalay GKR, Fitzpatrick J, Artandi M, Chang I, Snow TT, Chinthrajah RS, Warren CM, Wittman R, Meyerowitz JG, Ganio EA, Stelzer IA, Han X, Verdonk F, Gaudillière DK, Mukherjee N, Tsai AS, Rumer KK, Jiang S, Valdés Ferrer SI, Kelly JD, Furman D, Aghaeepour N, Angst MS, Boyd SD, Pinsky BA, Nolan GP, Nadeau KC, Gaudillière B, McIlwain DR |
bioRxiv : the preprint server for biology | 2021 |
|
In depth analysis of patients with severe SARS-CoV-2 in sub-Saharan Africa demonstrates distinct clinical and immunological profiles.
Morton B, Barnes KG, Anscombe C, Jere K, Kamng'ona R, Brown C, Nyirenda J, Phiri T, Banda N, Van Der Veer C, Mndolo KS, Mponda K, Rylance J, Phiri C, Mallewa J, Nyirenda M, Katha G, Kambiya P, Jafali J, Mwandumba HC, Gordon SB, Cornick J, Jambo KC |
medRxiv : the preprint server for health sciences | 2021 |
|
A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2.
Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe A, Abbondanza D, Fleming SJ, Subramanian A, Montoro DT, Jagadeesh KA, Dey KK, Sen P, Slyper M, Pita-Juárez YH, Phillips D, Bloom-Ackerman Z, Barkas N, Ganna A, Gomez J, Normandin E, Naderi P, Popov YV, Raju SS, Niezen S, Tsai LT, Siddle KJ, Sud M, Tran VM, Vellarikkal SK, Amir-Zilberstein L, Atri DS, Beechem J, Brook OR, Chen J, Divakar P, Dorceus P, Engreitz JM, Essene A, Fitzgerald DM, Fropf R, Gazal S, Gould J, Grzyb J, Harvey T, Hecht J, Hether T, Jane-Valbuena J, Leney-Greene M, Ma H, McCabe C, McLoughlin DE, Miller EM, Muus C, Niemi M, Padera R, Pan L, Pant D, Pe'er C, Pfiffner-Borges J, Pinto CJ, Plaisted J, Reeves J, Ross M, Rudy M, Rueckert EH, Siciliano M, Sturm A, Todres E, Waghray A, Warren S, Zhang S, Zollinger DR, Cosimi L, Gupta RM, Hacohen N, Hide W, Price AL, Rajagopal J, Tata PR, Riedel S, Szabo G, Tickle TL, Hung D, Sabeti PC, Novak R, Rogers R, Ingber DE, Jiang ZG, Juric D, Babadi M, Farhi SL, Stone JR, Vlachos IS, Solomon IH, Ashenberg O, Porter CBM, Li B, Shalek AK, Villani AC, Rozenblatt-Rosen O, Regev A |
bioRxiv : the preprint server for biology | 2021 |
|
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.
Puray-Chavez M, LaPak KM, Schrank TP, Elliott JL, Bhatt DP, Agajanian MJ, Jasuja R, Lawson DQ, Davis K, Rothlauf PW, Jo H, Lee N, Tenneti K, Eschbach JE, Mugisha CS, Vuong HR, Bailey AL, Hayes DN, Whelan SPJ, Horani A, Brody SL, Goldfarb D, Major MB, Kutluay SB |
bioRxiv : the preprint server for biology | 2021 |
|
A differential regulatory T cell signature distinguishes the immune landscape of COVID-19 hospitalized patients from those hospitalized with other respiratory viral infections.
Vick SC, Frutoso M, Mair F, Konecny AJ, Greene E, Wolf CR, Logue JK, Boonyaratanakornkit J, Gottardo R, Schiffer JT, Chu HY, Prlic M, Lund JM |
medRxiv : the preprint server for health sciences | 2021 |
|
Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity.
Volpatti LR, Wallace RP, Cao S, Raczy MM, Wang R, Gray LT, Alpar AT, Briquez PS, Mitrousis N, Marchell TM, Sasso MS, Nguyen M, Mansurov A, Budina E, Solanki A, Watkins EA, Schnorenberg MR, Tremain AC, Reda JW, Nicolaescu V, Furlong K, Dvorkin S, Yu SS, Manicassamy B, LaBelle JL, Tirrell MV, Randall G, Kwissa M, Swartz MA, Hubbell JA |
bioRxiv : the preprint server for biology | 2021 |
|
ORAI1 establishes resistance to SARS-CoV-2 infection by regulating tonic type I interferon signaling.
Wu B, Ramaiah A, Garcia G Jr, Gwack Y, Arumugaswami V, Srikanth S |
bioRxiv : the preprint server for biology | 2021 |
|
Western diet increases COVID-19 disease severity in the Syrian hamster.
Port JR, Adney DR, Schwarz B, Schulz JE, Sturdevant DE, Smith BJ, Avanzato VA, Holbrook MG, Purushotham JN, Stromberg KA, Leighton I, Bosio CM, Shaia C, Munster VJ |
bioRxiv : the preprint server for biology | 2021 |
|
Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
O'Donnell KL, Pinski AN, Clancy CS, Gourdine T, Shifflett K, Fletcher P, Messaoudi I, Marzi A |
bioRxiv : the preprint server for biology | 2021 |
|
Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19
Neidleman J, Luo X, George AF, McGregor M, Yang J, Yun C, Murray V, Gill G, Greene WC, Vasquez J, Lee S, Ghosn E, Lynch K, Roan NR |
2021 | |
|
Innate lymphoid cells and disease tolerance in SARS-CoV-2 infection
Silverstein NJ, Wang Y, Manickas-Hill Z, Carbone C, Dauphin A, Boribong BP, Loiselle M, Davis J, Leonard MM, Kuri-Cervantes L, Meyer NJ, Betts MR, Li JZ, Walker B, Yu XG, Yonker LM, Luban J |
2021 | |
|
Systematic temporal analysis of peripheral blood transcriptomes using TrendCatcher identifies early and persistent neutrophil activation as a hallmark of severe COVID-19
Wang X, Sanborn M, Dai Y, Rehman J |
2021 | |
|
Clinicopathologic features of a feline SARS-CoV-2 infection model parallel acute COVID-19 in humans
Rudd JM, Selvan MT, Cowan S, Kao YF, Midkiff CC, Ritchey JW, Miller CA |
2021 | |
|
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status
Neidleman J, Luo X, McGregor M, Xie G, Murray V, Greene WC, Lee SA, Roan NR |
2021 | |
|
Hydroxychloroquine and COVID-19: a Rheumatologist’s Take on the Lessons Learned
Udupa A, Leverenz D, Balevic SJ, Sadun RE, Tarrant TK, Rogers JL |
Current Allergy and Asthma Reports | 2021 |
|
Is liver involvement overestimated in COVID-19 patients? A meta-analysis
Li G, Yang Y, Gao D, Xu Y, Gu J, Liu P |
International journal of medical sciences | 2021 |
|
Coalescence of co-infection and antimicrobial resistance with SARS-CoV-2 infection: The blues of post-COVID-19 world
Mazumder P, Kalamdhad A, Chaminda GT, Kumar M |
2021 | |
|
Infectious events in patients with severe COVID-19: results of a cohort of patients with high prevalence of underlying immune defect
Saade A, Moratelli G, Dumas G, Mabrouki A, Tudesq JJ, Zafrani L, Azoulay E, Darmon M |
Annals of Intensive Care | 2021 |
|
Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection
Yang B, Fan J, Huang J, Guo E, Fu Y, Liu S, Xiao R, Liu C, Lu F, Qin T, He C, Wang Z, Qin X, Hu D, You L, Li X, Wang T, Wu P, Chen G, Zhou J, Li K, Sun C |
Nature Communications | 2021 |
|
Clinical Features and Laboratory Examination to Identify Severe Patients with COVID-19: A Systematic Review and Meta-Analysis
Meng Y, Wang J, Wen K, Da W, Yang K, Zhou S, Tao Z, Liu H, Tao L |
BioMed Research International | 2021 |
|
The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
Copaescu A, James F, Mouhtouris E, Vogrin S, Smibert OC, Gordon CL, Drewett G, Holmes NE, Trubiano JA |
Frontiers in immunology | 2021 |
|
High Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients.
Sivakorn C, Dechsanga J, Jamjumrus L, Boonnak K, Schultz MJ, Dondorp AM, Phumratanaprapin W, Ratanarat R, Naorungroj T, Wattanawinitchai P, Siripoon T, Duangdee C, Techarang T |
The American journal of tropical medicine and hygiene | 2021 |
|
T-cell immunophenotyping in COVID-19 pneumonia.
Nematollahi P, Ashrafi F, Darakhshandeh A, Salmasi M |
Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences | 2021 |
|
SARS-CoV-2: A Storm is Raging
Savannah F. Pedersen, Ya-Chi Ho |
Journal of Clinical Investigation | 2020 |
|
Are T cells helpful for COVID-19: the relationship between response and risk
Diane E. Griffin |
Journal of Clinical Investigation | 2020 |
|
COVID-19 and myeloid cells: complex interplay correlates with lung severity
Franco R. D'Alessio, Nicola M. Heller |
Journal of Clinical Investigation | 2020 |
|
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, Manuela Capone, Anna Vanni, Michele Spinicci, Jessica Mencarini, Roberto Caporale, Benedetta Peruzzi, Alberto Antonelli, Michele Trotta, Lorenzo Zammarchi, Luca Ciani, Leonardo Gori, Chiara Lazzeri, Andrea Matucci, Alessandra Vultaggio, Oliviero Rossi, Fabio Almerigogna, Paola Parronchi, Paolo Fontanari, Federico Lavorini, Adriano Peris, Gian Maria Rossolini, Alessandro Bartoloni, Sergio Romagnani, Francesco Liotta, Francesco Annunziato, Lorenzo Cosmi |
Journal of Clinical Investigation | 2020 |
|
Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children
Pui Y. Lee, Megan Day-Lewis, Lauren A. Henderson, Kevin Friedman, Jeffrey Lo, Jordan E. Roberts, Mindy S. Lo, Craig D. Platt, Janet Chou, Kacie J. Hoyt, Annette L. Baker, Tina Banzon, Margaret H. Chang, Ezra Cohen, Sarah de Ferranti, Audrey Dionne, Saddiq Habiballah, Olha Halyabar, Jonathan S. Hausmann, Melissa Hazen, Erin Janssen, Esra Meidan, Ryan W. Nelson, Alan A. Nguyen, Robert P. Sundel, Fatma Dedeoglu, Peter A. Nigrovic, Jane W. Newburger, Mary Beth F. Son |
Journal of Clinical Investigation | 2020 |
|
Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals
Fang Gong, Yaping Dai, Ting Zheng, Liang Cheng, Dan Zhao, Hao Wang, Min Liu, Hao Pei, Tengchuan Jin, Di Yu, Pengcheng Zhou |
Journal of Clinical Investigation | 2020 |
|
SARS-CoV-2 specific T-cell responses and correlations with COVID-19 patient predisposition
Arne Sattler, Stefan Angermair, Helena Stockmann, Katrin Moira Heim, Dmytro Khadzhynov, Sascha Treskatsch, Fabian Halleck, Martin E. Kreis, Katja Kotsch |
Journal of Clinical Investigation | 2020 |
|
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
Gunjan L. Shah, Susan DeWolf, Yeon Joo Lee, Roni Tamari, Parastoo B. Dahi, Jessica A. Lavery, Josel D. Ruiz, Sean M. Devlin, Christina Cho, Jonathan U. Peled, Ioannis Politikos, Michael Scordo, N. Esther Babady, Tania Jain, Santosha Vardhana, Anthony F. Daniyan, Craig S. Sauter, Juliet N. Barker, Sergio A. Giralt, Cheryl Goss, Peter Maslak, Tobias M. Hohl, Mini Kamboj, Lakshmi Ramanathan, Marcel R.M. van den Brink, Esperanza B. Papadopoulos, Genovefa A. Papanicolaou, Miguel-Angel Perales |
Journal of Clinical Investigation | 2020 |
|
Clinical and pathological investigation of severe COVID-19 patients
Shaohua Li, Lina Jiang, Xi Li, Fang Lin, Yijin Wang, Boan Li, Tianjun Jiang, Weimin An, Shuhong Liu, Hongyang Liu, Pengfei Xu, Lihua Zhao, Lixin Zhang, Jinsong Mu, Hongwei Wang, Jiarui Kang, Yan Li, Lei Huang, Caizhong Zhu, Shousong Zhao, Jiangyang Lu, Junsheng Ji, Jingmin Zhao |
JCI Insight | 2020 |
|
IL-6 combined with CD8+T cell count early predict in-hospital mortality for patients with COVID-19
Miao Luo, Jing Liu, Weiling Jiang, Shuang Yue, Huiguo Liu, Shuang Wei |
JCI Insight | 2020 |
|
Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis
Jennifer G. Wilson, Laura J. Simpson, Anne-Maud Ferreira, Arjun Rustagi, Jonasel A. Roque, Adijat Asuni, Thanmayi Ranganath, Philip M. Grant, Aruna K. Subramanian, Yael Rosenberg-Hasson, Holden Maecker, Susan Holmes, Joseph E. Levitt, Catherine Blish, Angela J. Rogers |
JCI Insight | 2020 |
|
High levels of SARS-CoV-2 specific T-cells with restricted functionality in severe course of COVID-19
David Schub, Verena Klemis, Sophie Schneitler, Janine Mihm, Philipp M. Lepper, Heinrike Wilkens, Robert Bals, Hermann Eichler, Barbara C. Gärtner, Sören L. Becker, Urban Sester, Martina Sester, Tina Schmidt |
JCI Insight | 2020 |
|
Unique immunological profile in patients with COVID-19
S Varchetta, D Mele, B Oliviero, S Mantovani, S Ludovisi, A Cerino, R Bruno, A Castelli, M Mosconi, M Vecchia, S Roda, M Sachs, C Klersy, MU Mondelli |
Cellular and Molecular Immunology | 2020 |
|
Clinical Characteristics and Short-Term Outcomes of Severe Patients With COVID-19 in Wuhan, China
X Feng, P Li, L Ma, H Liang, J Lei, W Li, K Wang, Y Song, S Li, W Yang, C Yang |
Frontiers in Medicine | 2020 |
|
Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients
Y Jouan, A Guillon, L Gonzalez, Y Perez, C Boisseau, S Ehrmann, M Ferreira, T Daix, R Jeannet, B François, PF Dequin, M Si-Tahar, T Baranek, C Paget |
Journal of Experimental Medicine | 2020 |
|
Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study
M Rivera-Izquierdo, M del Carmen Valero-Ubierna, JL R-delAmo, MÁ Fernández-García, S Martínez-Diz, A Tahery-Mahmoud, M Rodríguez-Camacho, AB Gámiz-Molina, N Barba-Gyengo, P Gámez-Baeza, C Cabrero-Rodríguez, PA Guirado-Ruiz, DT Martín-Romero, AJ Láinez-Ramos-Bossini, MR Sánchez-Pérez, J Mancera-Romero, M García-Martín, LM Martín-delosReyes, V Martínez-Ruiz, P Lardelli-Claret, E Jiménez-Mejías, M Adrish |
PloS one | 2020 |
|
Scoring systems for predicting mortality for severe patients with COVID-19
Y Shang, T Liu, Y Wei, J Li, L Shao, M Liu, Y Zhang, Z Zhao, H Xu, Z Peng, X Wang, F Zhou |
eClinicalMedicine | 2020 |
|
Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study
J Zhang, Y Hao, W Ou, F Ming, G Liang, Y Qian, Q Cai, S Dong, S Hu, W Wang, S Wei |
Journal of Translational Medicine | 2020 |
|
Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients
Y Duan, M Xia, L Ren, Y Zhang, Q Ao, S Xu, D Kuang, Q Liu, B Yan, Y Zhou, Q Chu, L Liu, XP Yang, G Wang |
Current Medical Science | 2020 |
|
Gastrointestinal symptoms associated with unfavorable prognosis of COVID-19 patients: A retrospective study
Rong Chen, Yan-li Yu, Wei Li, Shan Tang, Jing-xiao Lu, Fangyue Chen, Qin Zhou, Zhong-yuan Xia, Qing-tao Meng, Daqing Ma |
Frontiers in Medicine | 2020 |
|
Severe SARS‐CoV‐2 patients develop a higher specific T‐cell response
J Demaret, G Lefèvre, F Vuotto, J Trauet, A Duhamel, J Labreuche, P Varlet, A Dendooven, S Stabler, B Gachet, J Bauer, B Prevost, L Bocket, EK Alidjinou, M Lambert, C Yelnik, B Meresse, L Dubuquoy, D Launay, S Dubucquoi, D Montaigne, E Woitrain, F Maggiotto, MB Saleh, I Top, V Elsermans, E Jeanpierre, A Dupont, S Susen, T Brousseau, J Poissy, K Faure, M Labalette |
IBMS BoneKEy | 2020 |
|
Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options?
U Hellman, MG Karlsson, A Engström-Laurent, S Cajander, L Dorofte, C Ahlm, C Laurent, A Blomberg |
The Journal of biological chemistry | 2020 |
|
Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients
R Angioni, R Sánchez-Rodríguez, F Munari, N Bertoldi, D Arcidiacono, S Cavinato, D Marturano, A Zaramella, S Realdon, A Cattelan, A Viola, B Molon |
Cell Death and Disease | 2020 |
|
Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis
X Dong, C Wang, X Liu, W Gao, X Bai, Z Li |
Frontiers in immunology | 2020 |
|
Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients
ZJ Hu, J Xu, JM Yin, L Li, W Hou, LL Zhang, Z Zhou, YZ Yu, HJ Li, YM Feng, RH Jin |
Frontiers in immunology | 2020 |
|
Alteration of serum markers in COVID‐19 and implications on mortality
D Liu, R Li, R Yu, Y Wang, X Feng, Y Yuan, S Wang, S Zeng, Y Gao, S Xu, H Li, X Jiao, J Chi, Y Yu, C Song, N Jin, P Cui, J Liu, X Zheng, W Gong, X Liu, G Cai, J Song, SY Kwan, A Desai, C Li, Q Gao |
Clinical and Translational Medicine | 2020 |
|
Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease
M Li, W Guo, Y Dong, X Wang, D Dai, X Liu, Y Wu, M Li, W Zhang, H Zhou, Z Zhang, L Lin, Z Kang, T Yu, C Tian, R Qin, Y Gui, F Jiang, H Fan, V Heissmeyer, A Sarapultsev, L Wang, S Luo, D Hu |
Frontiers in immunology | 2020 |
|
Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study
M Wu, J Ji, L Zhong, Z Shao, Q Xie, Z Liu, C Wang, L Su, Y Feng, Z Liu, Y Yao |
International Immunopharmacology | 2020 |
|
T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis
B Kalfaoglu, J Almeida-Santos, CA Tye, Y Satou, M Ono |
Frontiers in immunology | 2020 |
|
Taming the Autophagy as a Strategy for Treating COVID-19
BE García-Pérez, JA González-Rojas, MI Salazar, C Torres-Torres, NS Castrejón-Jiménez |
Cells | 2020 |
|
Innate immunity during SARS‐CoV‐2: evasion strategies and activation trigger hypoxia and vascular damage
S Amor, LF Blanco, D Baker |
Clinical & Experimental Immunology | 2020 |
|
COVID-19 disease—Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study
S Lanini, C Montaldo, E Nicastri, F Vairo, C Agrati, N Petrosillo, P Scognamiglio, A Antinori, V Puro, AD Caro, GD Carli, A Navarra, A Agresta, C Cimaglia, F Palmieri, G DOffizi, L Marchioni, GP Kobinger, M Maeurer, E Girardi, MR Capobianchi, A Zumla, F Locatelli, G Ippolito, S Ricci |
PloS one | 2020 |
|
COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches
AV Sorokin, SK Karathanasis, ZH Yang, L Freeman, K Kotani, AT Remaley |
The FASEB Journal | 2020 |
|
I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People
AJ Pietrobon, FM Teixeira, MN Sato |
Frontiers in immunology | 2020 |
|
Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
J Hazeldine, J M. |
Frontiers in immunology | 2020 |
|
Targeting the NLRP3 Inflammasome in Severe COVID-19
TL Freeman, TH Swartz |
Frontiers in immunology | 2020 |
|
Non‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19
CT Robb, M Goepp, AG Rossi, C Yao |
British Journal of Pharmacology | 2020 |
|
COVID-19 and diabetes mellitus: how one pandemic worsens the other
WS Azar, R Njeim, AH Fares, NS Azar, ST Azar, ME Sayed, AA Eid |
Reviews in Endocrine and Metabolic Disorders | 2020 |
|
Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines
Y Xiao, H Xu, W Guo, Y Zhao, Y Luo, M Wang, Z He, Z Ding, J Liu, L Deng, F Sha, X Ma |
2020 | |
|
Telomeres and COVID‐19
A Aviv |
The FASEB Journal | 2020 |
|
The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2
JA Collora, R Liu, K Albrecht, YC Ho |
Current Opinion in HIV and AIDS | 2020 |
|
Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era SM Hamdy, M Abdel-Naseer, HS Shehata, NM Shalaby, A Hassan, A Elmazny, E Shaker, MA Nada, SM Ahmed, MI Hegazy, HS Mourad, A Abdelalim, R Magdy, AS Othman, DA Mekkawy, NA Kishk |
Therapeutics and Clinical Risk Management | 2020 |
|
A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization
BS Johnson, M Laloraya |
Cytokine & Growth Factor Reviews | 2020 |
|
Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities
L Falasca, R Nardacci, D Colombo, E Lalle, AD Caro, E Nicastri, A Antinori, N Petrosillo, L Marchioni, G Biava, G DOffizi, F Palmieri, D Goletti, A Zumla, G Ippolito, M Piacentini, FD Nonno |
The Journal of Infectious Diseases | 2020 |
|
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices
MA Sparks, AM South, AD Badley, CM Baker-Smith, D Batlle, B Bozkurt, R Cattaneo, SD Crowley, LJ DellItalia, AL Ford, K Griendling, SB Gurley, SE Kasner, JA Murray, KA Nath, MA Pfeffer, J Rangaswami, WR Taylor, VD Garovic |
Hypertension | 2020 |
|
Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications
N Banu, SS Panikar, LR Leal, AR Leal |
Life Sciences | 2020 |
|
Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link?
CJ Rebello, JP Kirwan, FL Greenway |
International Journal of Obesity | 2020 |
|
Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics
A Ritter, NN Kreis, F Louwen, J Yuan |
International journal of molecular sciences | 2020 |
|
Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19
FD Virgiliis, SD Giovanni |
Nature Reviews Neurology | 2020 |
|
Infections of the lung: a predictive, preventive and personalized perspective through the lens of evolution, the emergence of SARS-CoV-2 and its pathogenesis
P Ahluwalia, M Ahluwalia, K Vaibhav, A Mondal, N Sahajpal, S Islam, S Fulzele, V Kota, K Dhandapani, B Baban, AM Rojiani, R Kolhe |
The EPMA Journal | 2020 |
|
NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19
A López-Reyes, C Martinez-Armenta, R Espinosa-Velázquez, P Vázquez-Cárdenas, M Cruz-Ramos, B Palacios-Gonzalez, LE Gomez-Quiroz, GA Martínez-Nava |
Frontiers in immunology | 2020 |
|
Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis
C Quan, C Li, H Ma, Y Li, H Zhang |
Clinical microbiology reviews | 2020 |
|
New insights into the cell- and tissue-specificity of glucocorticoid actions
L Quatrini, S Ugolini |
Cellular and Molecular Immunology | 2020 |
|
Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection
R Gopal, MA Marinelli, JF Alcorn |
Frontiers in immunology | 2020 |
|
The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System
GM Ellison-Hughes, L Colley, KA O'Brien, KA Roberts, TA Agbaedeng, MD Ross |
Frontiers in Cardiovascular Medicine | 2020 |
|
Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19
F Mauvais-Jarvis |
Diabetes | 2020 |
|
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
N Labò, H Ohnuki, G Tosato |
Cells | 2020 |
|
The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19)
N Batra, CD Souza, J Batra, AG Raetz, AM Yu |
International journal of molecular sciences | 2020 |
|
COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?
SD Turco, A Vianello, R Ragusa, C Caselli, G Basta |
Thrombosis Research | 2020 |
|
Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11
RD Metcalfe, TL Putoczki, MD Griffin |
Frontiers in immunology | 2020 |
|
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, B Zhang, B Krämer, T Krammer, S Brumhard, L Bonaguro, ED Domenico, D Wendisch, M Grasshoff, TS Kapellos, M Beckstette, T Pecht, A Saglam, O Dietrich, HE Mei, AR Schulz, C Conrad, D Kunkel, E Vafadarnejad, CJ Xu, A Horne, M Herbert, A Drews, C Thibeault, M Pfeiffer, S Hippenstiel, A Hocke, H Müller-Redetzky, KM Heim, F Machleidt, A Uhrig, LB de Jarcy, L Jürgens, M Stegemann, CR Glösenkamp, HD Volk, C Goffinet, M Landthaler, E Wyler, P Georg, M Schneider, C Dang-Heine, N Neuwinger, K Kappert, R Tauber, V Corman, J Raabe, KM Kaiser, MT Vinh, G Rieke, C Meisel, T Ulas, M Becker, R Geffers, M Witzenrath, C Drosten, N Suttorp, C von Kalle, F Kurth, K Händler, JL Schultze, AC Aschenbrenner, Y Li, J Nattermann, B Sawitzki, AE Saliba, LE Sander, A Angelov, R Bals, A Bartholomäus, A Becker, D Bezdan, E Bonifacio, P Bork, T Clavel, M Colome-Tatche, A Diefenbach, A Dilthey, N Fischer, K Förstner, JS Frick, J Gagneur, A Goesmann, T Hain, M Hummel, S Janssen, J Kalinowski, R Kallies, B Kehr, A Keller, S Kim-Hellmuth, C Klein, O Kohlbacher, JO Korbel, I Kurth, M Landthaler, Y Li, K Ludwig, O Makarewicz, M Marz, A McHardy, C Mertes, M Nöthen, P Nürnberg, U Ohler, S Ossowski, J Overmann, S Peter, K Pfeffer, AR Poetsch, A Pühler, N Rajewsky, M Ralser, O Rieß, S Ripke, UN da Rocha, P Rosenstiel, AE Saliba, LE Sander, B Sawitzki, P Schiffer, EC Schulte, JL Schultze, A Sczyrba, O Stegle, J Stoye, F Theis, J Vehreschild, J Vogel, M von Kleist, A Walker, J Walter, D Wieczorek, J Ziebuhr |
Cell | 2020 |
|
Pathogenesis of COVID-19-induced ARDS: implications for an aging population
MA Acosta, BD Singer |
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology | 2020 |
|
Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression
G Schönrich, MJ Raftery, Y Samstag |
Advances in Biological Regulation | 2020 |
|
Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
N Taefehshokr, S Taefehshokr, B Heit |
Pathogens | 2020 |
|
A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction
PR Ray, A Wangzhou, N Ghneim, MS Yousuf, C Paige, D Tavares-Ferreira, JM Mwirigi, S Shiers, I Sankaranarayanan, AJ McFarland, SV Neerukonda, S Davidson, G Dussor, MD Burton, TJ Price |
Brain, Behavior, and Immunity | 2020 |
|
A Pharmacological Interactome between COVID-19 Patient Samples and Human Sensory Neurons Reveals Potential Drivers of Neurogenic Pulmonary Dysfunction
P Ray, A Wangzhou, N Ghneim, M Yousuf, C Paige, D Tavares-Ferreira, J Mwirigi, S Shiers, I Sankaranarayanan, A Balmain, S Neerukonda, S Davidson, G Dussor, M Burton, T Price |
SSRN Electronic Journal | 2020 |
|
Association between cytokine profiles and lung injury in COVID-19 pneumonia
LD Chen, ZY Zhang, XJ Wei, YQ Cai, WZ Yao, MH Wang, QF Huang, XB Zhang |
Respiratory Research | 2020 |
|
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
M Merad, JC Martin |
Nature Reviews Immunology | 2020 |
|
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
SX Gu, T Tyagi, K Jain, VW Gu, SH Lee, JM Hwa, JM Kwan, DS Krause, AI Lee, S Halene, KA Martin, HJ Chun, J Hwa |
Nature Reviews Cardiology | 2020 |
|
Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma
J Cai, H Deng, L Luo, L You, H Liao, Y Zheng |
Aging | 2020 |
|
The trinity of COVID-19: immunity, inflammation and intervention
MZ Tay, CM Poh, L Rénia, PA MacAry, LF Ng |
Nature Reviews Immunology | 2020 |
|
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
F Coperchini, L Chiovato, L Croce, F Magri, M Rotondi |
Cytokine & Growth Factor Reviews | 2020 |
|
Lessons for COVID-19 Immunity from Other Coronavirus Infections
A Sariol, S Perlman |
Immunity | 2020 |
|
The Virological, Immunological, and Imaging Approaches for COVID-19 Diagnosis and Research
AS Tan, SN Nerurkar, WC Tan, D Goh, CP Lai, JP Yeong |
SLAS Technology | 2020 |
|
Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness
C Tincati, ES Cannizzo, M Giacomelli, R Badolato, A dArminio Monforte, G Marchetti |
Frontiers in immunology | 2020 |
|
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
CR Moderbacher, SI Ramirez, JM Dan, A Grifoni, KM Hastie, D Weiskopf, S Belanger, RK Abbott, C Kim, J Choi, Y Kato, EG Crotty, C Kim, SA Rawlings, J Mateus, LP Tse, A Frazier, R Baric, B Peters, J Greenbaum, EO Saphire, DM Smith, A Sette, S Crotty |
Cell | 2020 |
|
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study
J Tian, X Yuan, J Xiao, Q Zhong, C Yang, B Liu, Y Cai, Z Lu, J Wang, Y Wang, S Liu, B Cheng, J Wang, M Zhang, L Wang, S Niu, Z Yao, X Deng, F Zhou, W Wei, Q Li, X Chen, W Chen, Q Yang, S Wu, J Fan, B Shu, Z Hu, S Wang, XP Yang, W Liu, X Miao, Z Wang |
The Lancet Oncology | 2020 |
|
Implication of Aging Related Chronic Neuroinflammation on COVID-19 Pandemic
P Bossù, E Toppi, V Sterbini, G Spalletta |
Journal of Personalized Medicine | 2020 |
|
Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome
EA Middleton, XY He, F Denorme, RA Campbell, D Ng, SP Salvatore, M Mostyka, A Baxter-Stoltzfus, AC Borczuk, M Loda, MJ Cody, BK Manne, I Portier, ES Harris, AC Petrey, EJ Beswick, AF Caulin, A Iovino, LM Abegglen, AS Weyrich, MT Rondina, M Egeblad, JD Schiffman, CC Yost |
Blood | 2020 |
|
Neurological consequences of COVID-19: what have we learned and where do we go from here?
A Jarrahi, M Ahluwalia, H Khodadadi, E da Silva Lopes Salles, R Kolhe, DC Hess, F Vale, M Kumar, B Baban, K Vaibhav, KM Dhandapani |
Journal of Neuroinflammation | 2020 |
|
Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression
J Beltrán-García, R Osca-Verdegal, FV Pallardó, J Ferreres, M Rodríguez, S Mulet, F Sanchis-Gomar, N Carbonell, JL García-Giménez |
Antioxidants | 2020 |
|
Association between markers of immune response at hospital admission and COVID‐19 disease severity and mortality: A meta‐analysis and meta‐regression
J Khinda, NZ Janjua, S Cheng, ER Heuvel, P Bhatti, M Darvishian |
Journal of Medical Virology | 2020 |
|
Antiviral anticoagulation
EL Pryzdial, MR Sutherland, BH Lin, M Horwitz |
Research and Practice in Thrombosis and Haemostasis | 2020 |
|
The many faces of the anti-COVID immune response
SA Vardhana, JD Wolchok |
Journal of Experimental Medicine | 2020 |
|
Coronavirus Disease 2019 (COVID-19) and Nutritional Status: The Missing Link?
R Silverio, DC Gonçalves, MF Andrade, M Seelaender |
Advances in Nutrition | 2020 |
|
COVID-19, Virology and Geroscience: A Perspective
C Vellas, P Delobel, PD Barreto, J Izopet |
The journal of nutrition, health & aging | 2020 |
|
Is pregnancy a risk factor of COVID-19?
W Phoswa, O Khaliq |
European journal of obstetrics, gynecology, and reproductive biology | 2020 |
|
Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality
N Moradian, M Gouravani, MA Salehi, A Heidari, M Shafeghat, MR Hamblin, N Rezaei |
European cytokine network | 2020 |
|
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
X Peng, J Ouyang, S Isnard, J Lin, B Fombuena, B Zhu, JP Routy |
Frontiers in immunology | 2020 |
|
Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia
F Taus, G Salvagno, S Canè, C Fava, F Mazzaferri, E Carrara, V Petrova, RM Barouni, F Dima, A Dalbeni, S Romano, G Poli, M Benati, SD Nitto, G Mansueto, M Iezzi, E Tacconelli, G Lippi, V Bronte, P Minuz |
Arteriosclerosis, thrombosis, and vascular biology | 2020 |
|
A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy
N Kusadasi, M Sikma, A Huisman, J Westerink, C Maas, R Schutgens |
HemaSphere | 2020 |
|
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
A Silvin, N Chapuis, G Dunsmore, AG Goubet, A Dubuisson, L Derosa, C Almire, C Hénon, O Kosmider, N Droin, P Rameau, C Catelain, A Alfaro, C Dussiau, C Friedrich, E Sourdeau, N Marin, TA Szwebel, D Cantin, L Mouthon, D Borderie, M Deloger, D Bredel, S Mouraud, D Drubay, M Andrieu, AS Lhonneur, V Saada, A Stoclin, C Willekens, F Pommeret, F Griscelli, LG Ng, Z Zhang, P Bost, I Amit, F Barlesi, A Marabelle, F Pène, B Gachot, F André, L Zitvogel, F Ginhoux, M Fontenay, E Solary |
Cell | 2020 |
|
The immunology of SARS-CoV-2 infections and vaccines
L Grigoryan, B Pulendran |
Seminars in Immunology | 2020 |
|
Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
V Kumar |
International Immunopharmacology | 2020 |
|
Immunology of COVID‐19 and disease‐modifying therapies: the good, the bad and the unknown
T Zrzavy, I Wimmer, PS Rommer, T Berger |
European journal of neurology : the official journal of the European Federation of Neurological Societies | 2020 |
|
Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses
N Mackman, S Antoniak, AS Wolberg, R Kasthuri, NS Key |
Arteriosclerosis, thrombosis, and vascular biology | 2020 |
|
MAIT cell activation and dynamics associated with COVID-19 disease severity
T Parrot, JB Gorin, A Ponzetta, KT Maleki, T Kammann, J Emgård, A Perez-Potti, T Sekine, O Rivera-Ballesteros, S Gredmark-Russ, O Rooyackers, E Folkesson, LI Eriksson, A Norrby-Teglund, HG Ljunggren, NK Björkström, S Aleman, M Buggert, J Klingström, K Strålin, JK Sandberg, JT Sandberg, H Bergsten, NK Björkström, S Brighenti, M Buggert, M Butrym, BJ Chambers, P Chen, M Cornillet, A Cuapio, ID Lozano, M Dzidic, J Emgård, M Flodström-Tullberg, JB Gorin, S Gredmark-Russ, A Haroun-Izquierdo, L Hertwig, S Kalsum, J Klingström, E Kokkinou, E Kvedaraite, HG Ljunggren, M Lourda, KT Maleki, KJ Malmberg, J Michaëlsson, J Mjösberg, K Moll, JR Muvva, A Norrby-Teglund, LM Medina, T Parrot, L Radler, E Ringqvist, JK Sandberg, T Sekine, T Soini, M Svensson, J Tynell, AV Kries, D Wullimann, A Perez-Potti, O Rivera-Ballesteros, C Maucourant, R Varnaite, M Akber, L Berglin, D Brownlie, MG Loreti, E Sohlberg, T Kammann, E Henriksson, N Marquardt, K Strålin, S Aleman, A Sönnerborg, L Dillner, A Färnert, H Glans, P Nauclér, O Rooyackers, J Mårtensson, LI Eriksson, BP Persson, J Grip, C Unge |
Science Immunology | 2020 |
|
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
J Hadjadj, N Yatim, L Barnabei, A Corneau, J Boussier, N Smith, H Péré, B Charbit, V Bondet, C Chenevier-Gobeaux, P Breillat, N Carlier, R Gauzit, C Morbieu, F Pène, N Marin, N Roche, TA Szwebel, SH Merkling, JM Treluyer, D Veyer, L Mouthon, C Blanc, PL Tharaux, F Rozenberg, A Fischer, D Duffy, F Rieux-Laucat, S Kernéis, B Terrier |
Science | 2020 |
|
COVID-19 and Oxidative Stress
BV Chernyak, EN Popova, AS Prikhodko, OA Grebenchikov, LA Zinovkina, RA Zinovkin |
Biochemistry (Moscow) | 2020 |
|
A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19
OJ McElvaney, BD Hobbs, D Qiao, OF McElvaney, M Moll, NL McEvoy, J Clarke, E O'Connor, S Walsh, MH Cho, GF Curley, NG McElvaney |
EBioMedicine | 2020 |
|
Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS
L Lupu, A Palmer, M Huber-Lang |
Frontiers in immunology | 2020 |
|
Considerations for cancer immunotherapy biomarker research during COVID-19
JW Carlisle, CS Jansen, MA Bilen, H Kissick |
Endocrine Related Cancer | 2020 |
|
Nutrition, immunity and COVID-19
PC Calder |
2020 | |
|
The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis
I Wessels, B Rolles, L Rink |
Frontiers in immunology | 2020 |
|
A Longitudinal Study of Immune Cells in Severe COVID-19 Patients
D Payen, M Cravat, H Maadadi, C Didelot, L Prosic, C Dupuis, MR Losser, MD Bittencourt |
Frontiers in immunology | 2020 |
|
Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships
BM Popkin, S Du, WD Green, MA Beck, T Algaith, CH Herbst, RF Alsukait, M Alluhidan, N Alazemi, M Shekar |
Obesity reviews : an official journal of the International Association for the Study of Obesity | 2020 |
|
Obesity and COVID-19: A Perspective from the European Association for the Study of Obesity on Immunological Perturbations, Therapeutic Challenges, and Opportunities in Obesity
GH Goossens, D Dicker, NJ Farpour-Lambert, G Frühbeck, D Mullerova, E Woodward, JC Holm |
Obesity facts | 2020 |
|
The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19
LA Callender, M Curran, SM Bates, M Mairesse, J Weigandt, CJ Betts |
Frontiers in immunology | 2020 |
|
How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic
D Rossi, M Shadman, A Condoluci, JR Brown, JC Byrd, G Gaidano, M Hallek, P Hillmen, A Mato, E Montserrat, P Ghia |
2020 | |
|
COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis
KM Sohn, SG Lee, HJ Kim, S Cheon, H Jeong, J Lee, IS Kim, P Silwal, YJ Kim, S Paik, C Chung, C Park, YS Kim, EK Jo |
Journal of Korean Medical Science | 2020 |
|
Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity
G Pasquarelli-do-Nascimento, HA Braz-de-Melo, SS Faria, I de Oliveira Santos, GP Kobinger, KG Magalhães |
Frontiers in Endocrinology | 2020 |
|
Underlying Vulnerabilities to the Cytokine Storm and Adverse COVID-19 Outcomes in the Aging Immune System
LS Nidadavolu, JD Walston, AB Newman |
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences | 2020 |
|
A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
CD Funk, A Ardakani |
Frontiers in pharmacology | 2020 |
|
Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19
ME Carter-Timofte, SE Jørgensen, MR Freytag, MM Thomsen, NS Andersen, A Al-Mousawi, AS Hait, TH Mogensen |
Frontiers in immunology | 2020 |
|
Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents
L Su, Y Tu, D Kong, D Chen, C Zhang, W Zhang, C Zhuang, Z Wang |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2020 |
|
Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine
V Gies, N Bekaddour, Y Dieudonné, A Guffroy, Q Frenger, F Gros, MP Rodero, JP Herbeuval, AS Korganow |
Frontiers in immunology | 2020 |
|
Comprehensive mapping of immune perturbations associated with severe COVID-19
L Kuri-Cervantes, MB Pampena, W Meng, AM Rosenfeld, CA Ittner, AR Weisman, RS Agyekum, D Mathew, AE Baxter, LA Vella, O Kuthuru, SA Apostolidis, L Bershaw, J Dougherty, AR Greenplate, A Pattekar, J Kim, N Han, S Gouma, ME Weirick, CP Arevalo, MJ Bolton, EC Goodwin, EM Anderson, SE Hensley, TK Jones, NS Mangalmurti, ET Prak, EJ Wherry, NJ Meyer, MR Betts |
Science Immunology | 2020 |
|
Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals
F Zhang, R Gan, Z Zhen, X Hu, X Li, F Zhou, Y Liu, C Chen, S Xie, B Zhang, X Wu, Z Huang |
Signal Transduction and Targeted Therapy | 2020 |
|
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
RB Polidoro, RS Hagan, R de Santis Santiago, NW Schmidt |
Frontiers in immunology | 2020 |
|
Revisiting the Immune Balance Theory: A Neurological Insight Into the Epidemic of COVID-19 and Its Alike
J Wu, Y Tang |
Frontiers in neurology | 2020 |
|
HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP
M Ogier, G Andéol, E Sagui, GD Bo |
2020 | |
|
Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID‐19): autopsy reveals a ferroptosis signature
W Jacobs, M Lammens, A Kerckhofs, E Voets, EV San, SV Coillie, C Peleman, M Mergeay, S Sirimsi, V Matheeussen, H Jansens, I Baar, TV Berghe, PG Jorens |
ESC Heart Failure | 2020 |
|
NK cells: A double edge sword against SARS-CoV-2
E Masselli, M Vaccarezza, C Carubbi, G Pozzi, V Presta, P Mirandola, M Vitale |
Advances in Biological Regulation | 2020 |
|
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Y Jamilloux, T Henry, A Belot, S Viel, M Fauter, TE Jammal, T Walzer, B François, P Sève |
Autoimmunity Reviews | 2020 |
|
A 21st Century Evil: Immunopathology and New Therapies of COVID-19
TF Silva, F Tomiotto-Pellissier, RA Sanfelice, MD Gonçalves, BT da Silva Bortoleti, MB Detoni, AC Rodrigues, AC Carloto, VM Concato, E da Silva Siqueira, IN Costa, WR Pavanelli, I Conchon-Costa, MM Miranda-Sapla |
Frontiers in immunology | 2020 |
|
Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression
R Jeannet, T Daix, R Formento, J Feuillard, B François |
Intensive Care Medicine | 2020 |
|
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
C Agrati, A Sacchi, V Bordoni, E Cimini, S Notari, G Grassi, R Casetti, E Tartaglia, E Lalle, A DAbramo, C Castilletti, L Marchioni, Y Shi, A Mariano, JW Song, JY Zhang, FS Wang, C Zhang, GM Fimia, MR Capobianchi, M Piacentini, A Antinori, E Nicastri, M Maeurer, A Zumla, G Ippolito |
Cell Death and Differentiation | 2020 |
|
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
T Torres, L Puig |
American Journal of Clinical Dermatology | 2020 |
|
Gaucher disease and SARS-CoV-2 infection: Emerging management challenges
P Mistry, M Balwani, D Barbouth, TA Burrow, EI Ginns, O Goker-Alpan, GA Grabowski, RV Kartha, PS Kishnani, H Lau, CU Lee, G Lopez, G Maegawa, S Packman, C Prada, B Rosenbloom, TR Lal, R Schiffmann, N Weinreb, E Sidransky |
Molecular Genetics and Metabolism | 2020 |
|
Consideration of Pannexin 1 channels in COVID-19 pathology and treatment
LA Swayne, SR Johnstone, CS Ng, JC Sanchez-Arias, ME Good, S Penuela, AW Lohman, AG Wolpe, VE Laubach, M Koval, BE Isakson |
American journal of physiology. Lung cellular and molecular physiology | 2020 |
|
Microbiota Modulating Nutritional Approaches to Countering the Effects of Viral Respiratory Infections Including SARS-CoV-2 through Promoting Metabolic and Immune Fitness with Probiotics and Plant Bioactives
T Shinde, PM Hansbro, SS Sohal, P Dingle, R Eri, R Stanley |
Microorganisms | 2020 |
|
SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
MD Keller, KM Harris, MA Jensen-Wachspress, VV Kankate, H Lang, CA Lazarski, J Durkee-Shock, PH Lee, K Chaudhry, K Webber, A Datar, M Terpilowski, EK Reynolds, EM Stevenson, S Val, Z Shancer, N Zhang, R Ulrey, U Ekanem, M Stanojevic, A Geiger, H Liang, F Hoq, AA Abraham, PJ Hanley, CR Cruz, K Ferrer, L Dropulic, K Gangler, PD Burbelo, RB Jones, JI Cohen, CM Bollard |
Blood | 2020 |
|
Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19
LD Vecchio, F Locatelli |
Clinical Kidney Journal | 2020 |
|
Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19)
I Parra-Izquierdo, JE Aslan |
Seminars in thrombosis and hemostasis | 2020 |
|
Immunology of COVID-19: Current State of the Science
N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, L Malle, A Moreira, MD Park, L Pia, E Risson, M Saffern, B Salomé, ME Selvan, MP Spindler, J Tan, V van der Heide, JK Gregory, K Alexandropoulos, N Bhardwaj, BD Brown, B Greenbaum, ZH Gümüş, D Homann, A Horowitz, AO Kamphorst, MA de Lafaille, S Mehandru, M Merad, RM Samstein, M Agrawal, M Aleynick, M Belabed, M Brown, M Casanova-Acebes, J Catalan, M Centa, A Charap, A Chan, ST Chen, J Chung, CC Bozkus, E Cody, F Cossarini, E Dalla, N Fernandez, J Grout, DF Ruan, P Hamon, E Humblin, D Jha, J Kodysh, A Leader, M Lin, K Lindblad, D Lozano-Ojalvo, G Lubitz, A Magen, Z Mahmood, G Martinez-Delgado, J Mateus-Tique, E Meritt, C Moon, J Noel, T ODonnell, M Ota, T Plitt, V Pothula, J Redes, IR Torres, M Roberto, AR Sanchez-Paulete, J Shang, AS Schanoski, M Suprun, M Tran, N Vaninov, CM Wilk, J Aguirre-Ghiso, D Bogunovic, J Cho, J Faith, E Grasset, P Heeger, E Kenigsberg, F Krammer, U Laserson |
Immunity | 2020 |
|
COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
T Ahmad, R Chaudhuri, MC Joshi, A Almatroudi, AH Rahmani, SM Ali |
Frontiers in microbiology | 2020 |
|
Does SARS-CoV-2 Trigger Stress-Induced Autoimmunity by Molecular Mimicry? A Hypothesis
F Cappello, AM Gammazza, F Dieli, EC de Macario, AJ Macario |
Journal of Clinical Medicine | 2020 |
|
The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity
IG Ovsyannikova, IH Haralambieva, SN Crooke, GA Poland, RB Kennedy |
Immunological Reviews | 2020 |
|
COVID-19: Immunology and treatment options
S Felsenstein, JA Herbert, PS McNamara, CM Hedrich |
Clinical Immunology | 2020 |
|
Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns
RM Zellweger, TA Wartel, F Marks, M Song, JH Kim |
Expert Review of Vaccines | 2020 |
|
Severe COVID-19: what have we learned with the immunopathogenesis?
B Bordallo, M Bellas, AF Cortez, M Vieira, M Pinheiro |
2020 | |
|
Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?
E Sinderewicz, W Czelejewska, K Jezierska-Wozniak, J Staszkiewicz-Chodor, W Maksymowicz |
Pathogens | 2020 |
|
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
D Baker, S Amor, AS Kang, K Schmierer, G Giovannoni |
Multiple Sclerosis and Related Disorders | 2020 |
|
On the genetics and immunopathogenesis of COVID-19
CO Jacob |
Clinical Immunology | 2020 |
|
Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections
I Ramos, K Stamatakis, CL Oeste, D Pérez-Sala |
International journal of molecular sciences | 2020 |
|
T‐cell responses and therapies against SARS‐CoV‐2 infection
SM Toor, R Saleh, VS Nair, RZ Taha, E Elkord |
Immunology | 2020 |
|
Pregnancy, Viral Infection, and COVID-19
RW Alberca, NZ Pereira, LM Oliveira, SC Gozzi-Silva, MN Sato |
Frontiers in immunology | 2020 |
|
Deciphering the TCR Repertoire to Solve the COVID-19 Mystery
L Gutierrez, J Beckford, H Alachkar |
Trends in Pharmacological Sciences | 2020 |
|
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
ER Mann, M Menon, SB Knight, JE Konkel, C Jagger, TN Shaw, S Krishnan, M Rattray, A Ustianowski, ND Bakerly, P Dark, Graham, A Simpson, T Felton, LP Ho, M Feldmann, JR Grainger, T Hussell |
Science Immunology | 2020 |
|
Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease
M Herrmann, S Schulte, NH Wildner, M Wittner, TT Brehm, M Ramharter, R Woost, AW Lohse, T Jacobs, JS zur Wiesch |
Frontiers in immunology | 2020 |
|
Harnessing Memory NK Cell to Protect Against COVID-19
S Soleimanian, R Yaghobi |
Frontiers in pharmacology | 2020 |
|
Targeting the interleukin‐17 pathway to prevent acute respiratory distress syndrome associated with SARS‐CoV ‐2 infection
TR Salinas, B Zheng, JP Routy, P Ancuta |
Respirology (Carlton, Vic.) | 2020 |
|
Understanding immunopathological fallout of human coronavirus infections including COVID‐19: Will they cross the path of rheumatologists?
J Kabeerdoss, D Danda |
International Journal of Rheumatic Diseases | 2020 |
|
Covid-19: Perspectives on Innate Immune Evasion
N Taefehshokr, S Taefehshokr, N Hemmat, B Heit |
Frontiers in immunology | 2020 |
|
Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review
M Lingeswaran, T Goyal, R Ghosh, S Suri, P Mitra, S Misra, P Sharma |
Indian Journal of Clinical Biochemistry | 2020 |
|
Current status of potential therapeutic candidates for the COVID-19 crisis
J Zhang, B Xie, K Hashimoto |
Brain, Behavior, and Immunity | 2020 |
|
Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course
R Bansal, S Gubbi, R Muniyappa |
Endocrinology | 2020 |
|
SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities
MF Osuchowski, F Aletti, JM Cavaillon, SB Flohé, EJ Giamarellos-Bourboulis, M Huber-Lang, B Relja, T Skirecki, A Szabó, M Maegele |
Shock | 2020 |
|
Immunological aspects of COVID-19: What do we know?
TV Velikova, SV Kotsev, DS Georgiev, HM Batselova |
World journal of biological chemistry | 2020 |
|
ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis
M Cloutier, M Nandi, AU Ihsan, HA Chamard, S Ilangumaran, S Ramanathan |
Cytokine | 2020 |
|
When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality?
S Lockhart, S ORahilly |
The American Journal of Medicine | 2020 |
|
ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential therapeutic agents to suppress COVID-19
V Börger, DJ Weiss, JD Anderson, FE Borràs, B Bussolati, DR Carter, M Dominici, JM Falcón-Pérez, M Gimona, AF Hill, AM Hoffman, D de Kleijn, BL Levine, R Lim, J Lötvall, SA Mitsialis, M Monguió-Tortajada, M Muraca, R Nieuwland, A Nowocin, L O'Driscoll, LA Ortiz, DG Phinney, I Reischl, E Rohde, R Sanzenbacher, C Théry, WS Toh, KW Witwer, SK Lim, B Giebel |
Cytotherapy | 2020 |
|
Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia
A Akbari, J Rezaie |
Stem Cell Research & Therapy | 2020 |
|
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
C Atyeo, S Fischinger, T Zohar, MD Slein, J Burke, C Loos, DJ McCulloch, KL Newman, C Wolf, J Yu, K Shuey, J Feldman, BM Hauser, T Caradonna, AG Schmidt, TJ Suscovich, C Linde, Y Cai, D Barouch, ET Ryan, RC Charles, D Lauffenburger, H Chu, G Alter |
Immunity | 2020 |
|
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
JT England, A Abdulla, CM Biggs, AY Lee, KA Hay, RL Hoiland, CL Wellington, M Sekhon, S Jamal, K Shojania, LY Chen |
Blood Reviews | 2020 |
|
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous n-acetylcysteine
H Ibrahim, A Perl, D Smith, T Lewis, Z Kon, R Goldenberg, K Yarta, C Staniloae, M Williams |
Clinical Immunology | 2020 |
|
Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?
A Guillon, PS Hiemstra, M Si-Tahar |
Intensive Care Medicine | 2020 |
|
COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?
J Boeckmans, RM Rodrigues, T Demuyser, D Piérard, T Vanhaecke, V Rogiers |
Archives of Toxicology | 2020 |
|
Diabetes, infection risk and COVID-19
S Erener |
Molecular Metabolism | 2020 |
|
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
S Lim, JH Bae, HS Kwon, MA Nauck |
Nature Reviews Endocrinology | 2020 |
|
IL-6: Relevance for immunopathology of SARS-CoV-2
EO Gubernatorova, EA Gorshkova, AI Polinova, MS Drutskaya |
Cytokine & Growth Factor Reviews | 2020 |
|
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
R Rathnasinghe, S Strohmeier, F Amanat, VL Gillespie, F Krammer, A García-Sastre, L Coughlan, M Schotsaert, MB Uccellini |
Emerging Microbes & Infections | 2020 |
|
Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature
P Katulanda, HA Dissanayake, I Ranathunga, V Ratnasamy, PS Wijewickrama, N Yogendranathan, KK Gamage, NL de Silva, M Sumanatilleke, NP Somasundaram, DR Matthews |
Diabetologia | 2020 |
|
Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract
JC Smith, EL Sausville, V Girish, ML Yuan, A Vasudevan, KM John, JM Sheltzer |
Developmental Cell | 2020 |
|
COVID-19 Pandemic in India: What Lies Ahead
P Mitra, S Misra, P Sharma |
Indian Journal of Clinical Biochemistry | 2020 |
|
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
W Wen, W Su, H Tang, W Le, X Zhang, Y Zheng, X Liu, L Xie, J Li, J Ye, L Dong, X Cui, Y Miao, D Wang, J Dong, C Xiao, W Chen, H Wang |
Cell Discovery | 2020 |
|
SARS-CoV-2 infection in infants under 1 year of age in Wuhan City, China
D Sun, X Chen, H Li, XX Lu, H Xiao, FR Zhang, ZS Liu |
World Journal of Pediatrics | 2020 |
|
Clonal haematopoiesis and COVID‐19: A possible deadly liaison
V Shivarov, M Ivanova |
International Journal of Immunogenetics | 2020 |
|
Mild Cytokine Elevation, Moderate CD4+ T Cell Response and Abundant Antibody Production in Children with COVID-19
R Jia, X Wang, P Liu, X Liang, Y Ge, H Tian, H Chang, H Zhou, M Zeng, J Xu |
Virologica Sinica | 2020 |
|
Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
MJ Frigault, S Nikiforow, MK Mansour, ZH Hu, MM Horowitz, ML Riches, P Hematti, CJ Turtle, MJ Zhang, MA Perales, MC Pasquini |
Blood | 2020 |
|
Effects of COVID-19 on the Nervous System
C Iadecola, J Anrather, H Kamel |
Cell | 2020 |
|
SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?
E Meacci, M Garcia-Gil, F Pierucci |
International journal of molecular sciences | 2020 |
|
Overview of the COVID-19 and JAK/STAT Pathway Inhibition: Ruxolitinib Perspective
BG Bagca, CB Avci |
Cytokine & Growth Factor Reviews | 2020 |
|
COVID-19 Usurps Host Regulatory Networks
CS Curran, DR Rivera, JB Kopp |
Frontiers in pharmacology | 2020 |
|
Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection
M Aslam, Y Ladilov |
Cells | 2020 |
|
A systematic meta‐analysis of immune signatures in patients with COVID‐19
K Liu, T Yang, XF Peng, SM Lv, X Ye, TS Zhao, JC Li, ZJ Shao, QB Lu, JY Li, W Liu |
Reviews in Medical Virology | 2020 |
|
IL‐10 served as an indicator in severe COVID‐19 patients
F Huang, X Liu, X Sun, Z Li |
Journal of Medical Virology | 2020 |
|
Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases
A Barek, A Aziz, MS Islam |
Heliyon | 2020 |
|
Deciphering SARS-CoV-2 Virologic and Immunologic Features
G Lebeau, D Vagner, É Frumence, F Ah-Pine, X Guillot, E Nobécourt, L Raffray, P Gasque |
International journal of molecular sciences | 2020 |
|
Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020)
DS Kim, S Rowland-Jones, E Gea-Mallorquí |
Frontiers in immunology | 2020 |
|
Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
L Pirofski, A Casadevall, TE Morrison, DA Garsin |
mBio | 2020 |
|
Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy
Y Shimizu |
World journal of clinical cases | 2020 |
|
Acute Ischemic Stroke in COVID-19: Putative Mechanisms, Clinical Characteristics, and Management
AS Ojo, SA Balogun, AO Idowu, H Brok |
Neurology Research International | 2020 |
|
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
A Copaescu, O Smibert, A Gibson, EJ Phillips, JA Trubiano |
Journal of Allergy and Clinical Immunology | 2020 |
|
The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19)
SK Das |
Indian Journal of Clinical Biochemistry | 2020 |
|
Natural history of COVID-19 and current knowledge on treatment therapeutic options
WG dos Santos |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2020 |
|
Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation during Acute Respiratory Distress: A Case Report and Literature Review
F Farooqi, N Dhawan, R Morgan, J Dinh, K Nedd, G Yatzkan |
Tropical Medicine and Infectious Disease | 2020 |
|
The role of passive immunization in the age of SARS-CoV-2: an update
JC Fischer, K Zänker, M van Griensven, M Schneider, D Kindgen-Milles, WT Knoefel, A Lichtenberg, B Tamaskovics, FJ Djiepmo-Njanang, W Budach, S Corradini, U Ganswindt, D Häussinger, T Feldt, H Schelzig, H Bojar, M Peiper, E Bölke, J Haussmann, C Matuschek |
European Journal of Medical Research | 2020 |
|
Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – The 2020 COVID‐19 pandemic: A statement from the EAACI‐section on pediatrics
HA Brough, O Kalayci, A Sediva, E Untersmayr, D Munblit, PR del Rio, M VazquezOrtiz, S Arasi, M AlvaroLozano, S Tsabouri, E Galli, B Beken, PA Eigenmann, J Genuneit |
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology | 2020 |
|
General Approach to the Clinical Care of Solid Organ Transplant Recipients with COVID-19 Infection: Management for Transplant Recipients
MY Kim, DC Brennan, P Shah |
Current Transplantation Reports | 2020 |
|
Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms
E Ahmadian, SM Khatibi, SR Soofiyani, S Abediazar, MM Shoja, M Ardalan, SZ Vahed |
Reviews in Medical Virology | 2020 |
|
Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection
J Yang, E Zhang, M Zhong, Q Yang, K Hong, T Shu, D Zhou, J Xiang, J Xia, , D Zhang, C Huang, Y Shang, H Yan |
Virologica Sinica | 2020 |
|
T cell responses in patients with COVID-19
Z Chen, EJ Wherry |
Nature Reviews Immunology | 2020 |
|
Natural killer cell immunotypes related to COVID-19 disease severity
C Maucourant, I Filipovic, A Ponzetta, S Aleman, M Cornillet, L Hertwig, B Strunz, A Lentini, B Reinius, D Brownlie, A Cuapio, EH Ask, RM Hull, A Haroun-Izquierdo, M Schaffer, J Klingström, E Folkesson, M Buggert, JK Sandberg, LI Eriksson, O Rooyackers, HG Ljunggren, KJ Malmberg, J Michaëlsson, N Marquardt, Q Hammer, K Strålin, NK Björkström |
Science Immunology | 2020 |
|
Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset
JF Gutiérrez-Bautista, A Rodriguez-Nicolas, A Rosales-Castillo, P Jiménez, F Garrido, P Anderson, F Ruiz-Cabello, MÁ López-Ruz |
Frontiers in immunology | 2020 |
|
Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility
X Wang, K Huang, H Jiang, L Hua, W Yu, D Ding, K Wang, X Li, Z Zou, M Jin, S Xu |
Virologica Sinica | 2020 |
|
Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study
BJ Webb, ID Peltan, P Jensen, D Hoda, B Hunter, A Silver, N Starr, W Buckel, N Grisel, E Hummel, G Snow, D Morris, E Stenehjem, R Srivastava, SM Brown |
2020 | |
|
Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation
I Amigues, AH Pearlman, A Patel, P Reid, PC Robinson, R Sinha, AH Kim, T Youngstein, A Jayatilleke, M Konig |
Expert Review of Clinical Immunology | 2020 |
|
Lymphocyte subsets early predict mortality in a large series of hospitalized COVID‐19 patients in Spain
S CantenysMolina, E FernándezCruz, P Francos, JC de Quirós, P Muñoz, J GilHerrera |
Clinical & Experimental Immunology | 2020 |
|
Potential Effect of COVID-19 on Maternal and Infant Outcome: Lesson From SARS
Y Wang, Y Wang, X Han, J Ye, R Li |
Frontiers in Pediatrics | 2020 |
|
Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
L Lu, H Zhang, M Zhan, J Jiang, H Yin, DJ Dauphars, SY Li, Y Li, YW He |
Frontiers in Cell and Developmental Biology | 2020 |
|
SARS‐CoV‐2 infection, COVID‐19 pathogenesis, and exposure to air pollution: What is the connection?
B Woodby, MM Arnold, G Valacchi |
Annals of the New York Academy of Sciences | 2020 |
|
A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer
C Nagant, F Ponthieux, J Smet, N Dauby, V Doyen, T Besse-Hammer, DD Bels, E Maillart, F Corazza |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020 |
|
A Review on Currently Available Potential Therapeutic Options for COVID-19 SO Moghadam |
International journal of general medicine | 2020 |
|
Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial
D Ibrahim, L Dulipsingh, L Zapatka, R Eadie, R Crowell, K Williams, DB Wakefield, L Cook, J Puff, SA Hussain |
Infectious Diseases and Therapy | 2020 |
|
Therapeutic plasma exchange in adults with severe COVID-19 infection
F Khamis, I Al-Zakwani, SA Hashmi, SA Dowaiki, MA Bahrani, N Pandak, HA Khalili, Z Memish |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020 |
|
The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism
H Blasco, C Bessy, L Plantier, A Lefevre, E Piver, L Bernard, J Marlet, K Stefic, IB Bretagne, P Cannet, H Lumbu, T Morel, P Boulard, CR Andres, P Vourch, O Hérault, A Guillon, P Emond |
Scientific Reports | 2020 |
|
How SARS-CoV-2 (COVID-19) spreads within infected hosts — what we know so far
J Low, S Sanyal |
Emerging Topics in Life Sciences | 2020 |
|
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
DE Leisman, L Ronner, R Pinotti, MD Taylor, P Sinha, CS Calfee, AV Hirayama, F Mastroiani, CJ Turtle, MO Harhay, M Legrand, CS Deutschman |
The lancet. Respiratory medicine | 2020 |
|
Factors leading to high morbidity and mortality of COVID ‐19 in patients with type 2 diabetes
A Rajpal, L Rahimi, F IsmailBeigi |
Journal of Diabetes | 2020 |
|
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
L Perico, A Benigni, F Casiraghi, LF Ng, L Renia, G Remuzzi |
Nature Reviews Nephrology | 2020 |
|
A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes
SS Cabler, AR French, A Orvedahl |
Trends in Molecular Medicine | 2020 |
|
Coronavirus global pandemic: An overview of current findings among pediatric patients
E Perikleous, A Tsalkidis, A Bush, E Paraskakis |
Pediatric Pulmonology | 2020 |
|
Coagulopathy in COVID-19: Focus on vascular thrombotic events
W Shi, J Lv, L Lin |
Journal of Molecular and Cellular Cardiology | 2020 |
|
Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile
JC Law, WH Koh, P Budylowski, J Lin, FY Yue, KT Abe, B Rathod, M Girard, Z Li, JM Rini, S Mubareka, A McGeer, AK Chan, AC Gingras, TH Watts, MA Ostrowski |
Journal of immunology (Baltimore, Md. : 1950) | 2020 |
|
Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge.
Carnero Contentti E, Correa J |
Multiple Sclerosis and Related Disorders | 2020 |
|
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.
Nguyen A, David JK, Maden SK, Wood MA, Weeder BR, Nellore A, Thompson RF |
Journal of virology | 2020 |
|
COVID-19 and immunomodulation in IBD.
Neurath MF |
Gut | 2020 |
|
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science.
Holmes EA, O'Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, Ballard C, Christensen H, Cohen Silver R, Everall I, Ford T, John A, Kabir T, King K, Madan I, Michie S, Przybylski AK, Shafran R, Sweeney A, Worthman CM, Yardley L, Cowan K, Cope C, Hotopf M, Bullmore E |
The Lancet Psychiatry | 2020 |
|
Invasive fungal diseases during COVID-19: We should be prepared.
Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR |
Journal de mycologie medicale | 2020 |
|
Thrombosis and COVID-19 pneumonia: the clot thickens!
Price LC, McCabe C, Garfield B, Wort SJ |
European Respiratory Journal | 2020 |
|
Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS).
Neubauer A, Wiesmann T, Vogelmeier CF, Mack E, Skevaki C, Gaik C, Keller C, Figiel J, Sohlbach K, Rolfes C, Renz H, Wulf H, Burchert A |
Leukemia | 2020 |
|
Severe COVID-19 and aging: are monocytes the key?
Pence BD |
GeroScience | 2020 |
|
Positive results for patients with COVID-19 discharged form hospital in Chongqing, China.
Deng W, Guang TW, Yang M, Li JR, Jiang DP, Li CY, Wang DX |
BMC Infectious Diseases | 2020 |
|
2019 novel coronavirus (COVID-19) pneumonia complications: the importance of lung ultrasound.
Consoli L, Bendotti V, Cicchinelli S, Gaioni F, Prandolini P, Bettonagli M, Terragnoli P |
Journal of Ultrasound | 2020 |
|
Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies.
Parohan M, Yaghoubi S, Seraji A |
European heart journal. Acute cardiovascular care | 2020 |
|
Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration.
Azoulay D, Shehadeh M, Chepa S, Shaoul E, Baroum M, Horowitz NA, Kaykov E |
Journal of Infection | 2020 |
|
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care.
Quartuccio L, Sonaglia A, McGonagle D, Fabris M, Peghin M, Pecori D, De Monte A, Bove T, Curcio F, Bassi F, De Vita S, Tascini C |
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2020 |
|
Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies.
Mantovani A, Byrne CD, Zheng MH, Targher G |
Nutrition, Metabolism, and Cardiovascular Diseases | 2020 |
|
Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?
Berthelot JM, Drouet L, Lioté F |
Emerging Microbes & Infections | 2020 |
|
Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation.
Cardone M, Yano M, Rosenberg AS, Puig M |
Frontiers in immunology | 2020 |
|
Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health.
Raony Í, de Figueiredo CS, Pandolfo P, Giestal-de-Araujo E, Oliveira-Silva Bomfim P, Savino W |
Frontiers in immunology | 2020 |
|
Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
Sallenave JM, Guillot L |
Frontiers in immunology | 2020 |
|
HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa.
Cainelli F, Dzudzor B, Lanzafame M, Goushchi A, Chhem S, Vento S |
Frontiers in Medicine | 2020 |
|
Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19.
Reiter RJ, Abreu-Gonzalez P, Marik PE, Dominguez-Rodriguez A |
Frontiers in Medicine | 2020 |
|
Coronavirus Disease 2019 (COVID-19): A Short Review on Hematological Manifestations.
Słomka A, Kowalewski M, Żekanowska E |
2020 | |
|
Prediction of the Rehabilitation Duration and Risk Management for Mild-Moderate COVID-19.
Zheng QN, Xu MY, Zheng YL, Wang XY, Zhao H |
Disaster Medicine and Public Health Preparedness | 2020 |
|
Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?
Bodei L, Bergsland E, de Herder WW, Ferone D, Hicks RJ, Hope TA, Kunikowska J, Pavel M, Reidy-Lagunes D, Siveke J, Strosberg J, Dittmer U, Herrmann K |
Journal of Nuclear Medicine | 2020 |
|
A Rapid Advice Guideline for the Prevention of Novel Coronavirus Through Nutritional Intervention.
Budhwar S, Sethi K, Chakraborty M |
Current Nutrition Reports | 2020 |
|
Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?
Gómez-Pastora J, Weigand M, Kim J, Wu X, Strayer J, Palmer AF, Zborowski M, Yazer M, Chalmers JJ |
Clinica chimica acta; international journal of clinical chemistry | 2020 |
|
Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus.
Skevaki C, Fragkou PC, Cheng C, Xie M, Renz H |
Journal of Infection | 2020 |
|
Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?
Giammaria D, Pajewski A |
Journal of Global Health | 2020 |
|
COVID-19 in recent heart transplant recipients: Clinicopathologic features and early outcomes.
Lima B, Gibson GT, Vullaganti S, Malhame K, Maybaum S, Hussain ST, Shah S, Majure DT, Wallach F, Jang K, Bijol V, Esposito MJ, Williamson AK, Thomas RM, Bhuiya TA, Fernandez HA, Stevens GR |
Transplant Infectious Disease | 2020 |
|
A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19).
Danwang C, Endomba FT, Nkeck JR, Wouna DLA, Robert A, Noubiap JJ |
Biomarker Research | 2020 |
|
Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review.
Chen EC, Zon RL, Battinelli EM, Connors JM |
The oncologist | 2020 |
|
Laboratory diagnosis of COVID-19.
Goudouris ES |
Jornal de Pediatria | 2020 |
|
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies.
Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND |
Seminars in thrombosis and hemostasis | 2020 |
|
A protein interaction map identifies existing drugs targeting SARS-CoV-2.
Cava C, Bertoli G, Castiglioni I |
2020 | |
|
Coronavirus 2019, Microthromboses, and Platelet Activating Factor.
Theoharides TC, Antonopoulou S, Demopoulos CA |
Clinical Therapeutics | 2020 |
|
The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach.
Najafi S, Rajaei E, Moallemian R, Nokhostin F |
Clinical Rheumatology | 2020 |
|
Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury.
Lei P, Zhang L, Han P, Zheng C, Tong Q, Shang H, Yang F, Hu Y, Li X, Song Y |
Hepatology International | 2020 |
|
COVID-19: more than a cytokine storm.
Riva G, Nasillo V, Tagliafico E, Trenti T, Comoli P, Luppi M |
Critical Care | 2020 |
|
Diabetes and COVID-19: A pooled analysis related to disease severity and mortality.
Varikasuvu SR, Dutt N, Thangappazham B, Varshney S |
Primary Care Diabetes | 2020 |
|
Storm of soluble immune checkpoints associated with disease severity of COVID-19.
Kong Y, Wang Y, Wu X, Han J, Li G, Hua M, Han K, Zhang H, Li A, Zeng H |
Signal Transduction and Targeted Therapy | 2020 |
|
Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis.
Fu EL, Janse RJ, de Jong Y, van der Endt VHW, Milders J, van der Willik EM, de Rooij ENM, Dekkers OM, Rotmans JI, van Diepen M |
Clinical Kidney Journal | 2020 |
|
In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
Lieberman NAP, Peddu V, Xie H, Shrestha L, Huang ML, Mears MC, Cajimat MN, Bente DA, Shi PY, Bovier F, Roychoudhury P, Jerome KR, Moscona A, Porotto M, Greninger AL |
PLoS Biology | 2020 |
|
SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization.
Bernal-Monterde V, Casas-Deza D, Letona-Giménez L, de la Llama-Celis N, Calmarza P, Sierra-Gabarda O, Betoré-Glaria E, Martínez-de Lagos M, Martínez-Barredo L, Espinosa-Pérez M, M Arbones-Mainar J |
Biomedicines | 2020 |
|
Assessment of extra-parenchymal lung involvement in asymptomatic cancer patients with COVID-19 pneumonia detected on 18F-FDG PET-CT studies.
Wakfie-Corieh CG, Blanes García AM, Ferrando-Castagnetto F, Valhondo-Rama R, Ortega Candil A, Rodríguez Rey C, Cabrera Martín MN, García-Esquinas MG, Couto Caro RM, Pedrera Canal M, Carreras Delgado JL |
European Journal of Nuclear Medicine and Molecular Imaging | 2020 |
|
D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis.
Paliogiannis P, Mangoni AA, Dettori P, Nasrallah GK, Pintus G, Zinellu A |
Frontiers in public health | 2020 |
|
Preliminary Exploration of the Cause of Liver Disorders During Early Stages in COVID-19 Patients.
Gao Y, Li Q, Shi H, Feng Y, Zhang T, Chen Y, Liang L, Chen D, Wu H, Jin R, Huang X |
Frontiers in Medicine | 2020 |
|
Bone Metabolism in SARS-CoV-2 Disease: Possible Osteoimmunology and Gender Implications.
Salvio G, Gianfelice C, Firmani F, Lunetti S, Balercia G, Giacchetti G |
Clinical Reviews in Bone and Mineral Metabolism | 2020 |
|
The impact of obesity on severe disease and mortality in people with SARS-CoV-2: A systematic review and meta-analysis.
Seidu S, Gillies C, Zaccardi F, Kunutsor SK, Hartmann-Boyce J, Yates T, Singh AK, Davies MJ, Khunti K |
2020 | |
|
Immuno-Inflammatory Characteristics in Low Severity COVID-19 Patients with Digestive Symptoms.
Duan C, Zhang S, Wang J, Qian W, Han C, Hou X |
Gastroenterology Research and Practice | 2020 |
|
Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, China.
Chen J, Xu X, Hu J, Chen Q, Xu F, Liang H, Liu N, Zhu H, Lan J, Zhou L, Xing J, Pu N, Cai Z |
Aging | 2020 |
|
Clinical and Neuroimaging Correlation in Patients with COVID-19.
Yoon BC, Buch K, Lang M, Applewhite BP, Li MD, Mehan WA Jr, Leslie-Mazwi TM, Rincon SP |
American Journal of Neuroradiology | 2020 |
|
Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.
Asghar MS, Haider Kazmi SJ, Khan NA, Akram M, Hassan M, Rasheed U, Ahmed Khan S |
Cureus | 2020 |
|
Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children.
Rekhtman S, Tannenbaum R, Strunk A, Birabaharan M, Wright S, Garg A |
Journal of the American Academy of Dermatology | 2020 |
|
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
Borie R, Savale L, Dossier A, Ghosn J, Taillé C, Visseaux B, Jebreen K, Diallo A, Tesmoingt C, Morer L, Goletto T, Faucher N, Hajouji L, Neukirch C, Phillips M, Stelianides S, Bouadma L, Brosseau S, Ottaviani S, Pluvy J, Le Pluart D, Debray MP, Raynaud-Simon A, Descamps D, Khalil A, Timsit JF, Lescure FX, Descamps V, Papo T, Humbert M, Crestani B, Dieude P, Vicaut E, Zalcman G |
PloS one | 2020 |
|
The Need for Ongoing Antimicrobial Stewardship during the COVID-19 Pandemic and Actionable Recommendations.
Khor WP, Olaoye O, D'Arcy N, Krockow EM, Elshenawy RA, Rutter V, Ashiru-Oredope D |
2020 | |
|
Clinical Profile, Treatment and Predictors during the First COVID-19 Wave: A Population-Based Registry Analysis from Castile and Leon Hospitals.
Gutiérrez-Abejón E, Tamayo E, Martín-García D, Álvarez FJ, Herrera-Gómez F |
International journal of environmental research and public health | 2020 |
|
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology.
Ribeiro DE, Oliveira-Giacomelli Á, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H |
Molecular Psychiatry | 2020 |
|
Controlling Cytokine Storm Is Vital in COVID-19.
Tang L, Yin Z, Hu Y, Mei H |
Frontiers in immunology | 2020 |
|
Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth.
Kamposioras K, Mauri D, Papadimitriou K, Anthoney A, Hindi N, Petricevic B, Dambrosio M, Valachis A, Kountourakis P, Kopecky J, Kuhar CG, Popovic L, Chilingirova NP, Zarkavelis G, de Mello RA, Plavetić ND, Christopoulos C, Mostert B, Goffin JR, Tzachanis D, Saraireh HH, Ma F, Pavese I, Tolia M |
Frontiers in Oncology | 2020 |
|
Role of serum albumin and proteinuria in patients with SARS-CoV-2 pneumonia.
Bassoli C, Oreni L, Ballone E, Foschi A, Perotti A, Mainini A, Casalini G, Galimberti L, Meroni L, Antinori S, Milazzo L |
International Journal of Clinical Practice | 2020 |
|
Tocilizumab in the treatment of critical COVID-19 pneumonia: A retrospective cohort study of mechanically ventilated patients.
Fisher MJ, Marcos Raymundo LA, Monteforte M, Taub EM, Go R |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020 |
|
Acute Limb Ischemia: A Rare Complication of COVID-19.
Hasan SA, Haque A, Nazir F |
Cureus | 2020 |
|
Human Bone Marrow Mesenchymal Stem/Stromal Cells Exposed to an Inflammatory Environment Increase the Expression of ICAM-1 and Release Microvesicles Enriched in This Adhesive Molecule: Analysis of the Participation of TNF-α and IFN-γ.
Montesinos JJ, López-García L, Cortés-Morales VA, Arriaga-Pizano L, Valle-Ríos R, Fajardo-Orduña GR, Castro-Manrreza ME |
Journal of Immunology Research | 2020 |
|
Wildland firefighter exposure to smoke and COVID-19: A new risk on the fire line.
Navarro KM, Clark KA, Hardt DJ, Reid CE, Lahm PW, Domitrovich JW, Butler CR, Balmes JR |
The Science of The Total Environment | 2020 |
|
B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients.
Sosa-Hernández VA, Torres-Ruíz J, Cervantes-Díaz R, Romero-Ramírez S, Páez-Franco JC, Meza-Sánchez DE, Juárez-Vega G, Pérez-Fragoso A, Ortiz-Navarrete V, Ponce-de-León A, Llorente L, Berrón-Ruiz L, Mejía-Domínguez NR, Gómez-Martín D, Maravillas-Montero JL |
Frontiers in immunology | 2020 |
|
Innate lymphoid cell composition associates with COVID-19 disease severity.
García M, Kokkinou E, Carrasco García A, Parrot T, Palma Medina LM, Maleki KT, Christ W, Varnaitė R, Filipovic I, Ljunggren HG, Björkström NK, Folkesson E, Rooyackers O, Eriksson LI, Sönnerborg A, Aleman S, Strålin K, Gredmark-Russ S, Klingström J, Mjösberg J |
IBMS BoneKEy | 2020 |
|
Outcomes Associated with the Use of Renin-Angiotensin-Aldosterone System Blockade in Hospitalized Patients with SARS-CoV-2 Infection.
Chaudhri I, Koraishy FM, Bolotova O, Yoo J, Marcos LA, Taub E, Sahib H, Bloom M, Ahmad S, Skopicki H, Mallipattu SK |
2020 | |
|
Association of liver abnormalities with in-hospital mortality in patients with COVID-19.
Ding ZY, Li GX, Chen L, Shu C, Song J, Wang W, Wang YW, Chen Q, Jin GN, Liu TT, Liang JN, Zhu P, Zhu W, Li Y, Zhang BH, Feng H, Zhang WG, Yin ZY, Yu WK, Yang Y, Zhang HQ, Tang ZP, Wang H, Hu JB, Liu JH, Yin P, Chen XP, Zhang B |
Journal of Hepatology | 2020 |
|
Epidemiological, Clinical and Serological Characteristics of Children with Coronavirus Disease 2019 in Wuhan: A Single-centered, Retrospective Study.
Luo D, Xia Z, Li H, Tu D, Wang T, Zhang W, Peng L, Yi W, Zhang S, Shu J, Xu H, Li Y, Shi B, Huang C, Tang W, Xiao S, Shu X, Liu Y, Zhang Y, Guo S, Yu Z, Wang B, Gao Y, Hu Q, Wang H, Song X, Mei H, Zhou X, Zheng Z |
Virologica Sinica | 2020 |
|
Risk factors associated with 28-day all-cause mortality in older severe COVID-19 patients in Wuhan, China: a retrospective observational study.
Jiang Y, Abudurexiti S, An MM, Cao D, Wei J, Gong P |
Scientific Reports | 2020 |
|
Tocilizumab in the Management of COVID-19: A Preliminary Report.
Li M, Yoo EJ, Baram M, McArthur M, Skeehan C, Awsare B, George G, Summer R, Zurlo J, Jallo J, Roman J |
The American Journal of the Medical Sciences | 2020 |
|
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count.
Paolucci S, Cassaniti I, Novazzi F, Fiorina L, Piralla A, Comolli G, Bruno R, Maserati R, Gulminetti R, Novati S, Mojoli F, Baldanti F |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020 |
|
Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.
Thepmankorn P, Bach J, Lasfar A, Zhao X, Souayah S, Chong ZZ, Souayah N |
Cytokine | 2020 |
|
Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19.
Omarjee L, Perrot F, Meilhac O, Mahe G, Bousquet G, Janin A |
Aging | 2020 |
|
Neutrophil:lymphocyte ratio predicts short-term outcome of COVID-19 in haemodialysis patients.
Mutinelli-Szymanski P, Hude I, Merle E, Lombardi Y, Seris P, Abtahi M, Azeroual L, Bourgain C, Ensergueix G, Katerinis I, Kolko A, Kolta A, Maheas C, Mehrbanian S, Morel P, Ossman R, de Préneuf H, Roux A, Saltiel C, Vendé F, Verhoeven AS, Viron B, Laplanche S, Le Monnier A, Ridel C, Ureña-Torres P, Touzot M |
Clinical Kidney Journal | 2020 |
|
Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure.
Durand N, Mallea J, Zubair AC |
npj Regenerative Medicine | 2020 |
|
Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.
Frager SZ, Szymanski J, Schwartz JM, Massoumi HS, Kinkhabwala M, Wolkoff AW |
Hepatology Communications | 2020 |
|
Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia.
Ridge CA, Desai SR, Jeyin N, Mahon C, Lother DL, Mirsadraee S, Semple T, Price S, Bleakley C, Arachchillage DJ, Shaw E, Patel BV, Padley SP, Devaraj A |
2020 | |
|
The genetic sequence, origin, and diagnosis of SARS-CoV-2.
Wang H, Li X, Li T, Zhang S, Wang L, Wu X, Liu J |
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2020 |
|
Elevated interleukin-6 and severe COVID-19: A meta-analysis.
Aziz M, Fatima R, Assaly R |
Journal of Medical Virology | 2020 |
|
Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.
Radbel J, Narayanan N, Bhatt PJ |
Chest | 2020 |
|
COVID-19: Key Concepts for the Surgeon.
Rubio-Pérez I, Badia JM, Mora-Rillo M, Martín Quirós A, García Rodríguez J, Balibrea JM |
2020 | |
|
Diabetes and covid-19: a global health challenge.
Shenoy A, Ismaily M, Bajaj M |
BMJ Open Diabetes Research & Care | 2020 |
|
The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection.
Landi F, Barillaro C, Bellieni A, Brandi V, Carfì A, D'Angelo M, Fusco D, Landi G, Lo Monaco R, Martone AM, Marzetti E, Pagano F, Pais C, Russo A, Salini S, Tosato M, Tummolo A, Benvenuto F, Bramato G, Catalano L, Ciciarello F, Martis I, Rocchi S, Rota E, Salerno A, Tritto M, Sgadari A, Zuccalà G, Bernabei R |
The journal of nutrition, health & aging | 2020 |
|
Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis.
Zhou YJ, Zheng KI, Wang XB, Yan HD, Sun QF, Pan KH, Wang TY, Ma HL, Chen YP, George J, Zheng MH |
Journal of Hepatology | 2020 |
|
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists.
Konig MF, Powell M, Staedtke V, Bai RY, Thomas DL, Fischer N, Huq S, Khalafallah AM, Koenecke A, Xiong R, Mensh B, Papadopoulos N, Kinzler KW, Vogelstein B, Vogelstein JT, Athey S, Zhou S, Bettegowda C |
Journal of Clinical Investigation | 2020 |
|
Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic.
Patnaik MM, Lasho T, Padron E, McCullough K, Al-Kali A, Tefferi A, Zeidan AM, Gangat N, Savona M, Steensma DP, Solary E |
American Journal of Hematology | 2020 |
|
A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2.
Wei XS, Wang XR, Zhang JC, Yang WB, Ma WL, Yang BH, Jiang NC, Gao ZC, Shi HZ, Zhou Q |
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2020 |
|
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
Liu J, Li S, Liu J, Liang B, Wang X, Wang H, Li W, Tong Q, Yi J, Zhao L, Xiong L, Guo C, Tian J, Luo J, Yao J, Pang R, Shen H, Peng C, Liu T, Zhang Q, Wu J, Xu L, Lu S, Wang B, Weng Z, Han C, Zhu H, Zhou R, Zhou H, Chen X, Ye P, Zhu B, Wang L, Zhou W, He S, He Y, Jie S, Wei P, Zhang J, Lu Y, Wang W, Zhang L, Li L, Zhou F, Wang J, Dittmer U, Lu M, Hu Y, Yang D, Zheng X |
EBioMedicine | 2020 |
|
Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
Serrano-Castro PJ, Estivill-Torrús G, Cabezudo-García P, Reyes-Bueno JA, Ciano Petersen N, Aguilar-Castillo MJ, Suárez-Pérez J, Jiménez-Hernández MD, Moya-Molina MÁ, Oliver-Martos B, Arrabal-Gómez C, Rodríguez de Fonseca F |
Neurologia (Barcelona, Spain) | 2020 |
|
Fatal Guillain-Barre syndrome after infection with SARS-CoV-2.
Marta-Enguita J, Rubio-Baines I, Gastón-Zubimendi I |
Neurologia (Barcelona, Spain) | 2020 |
|
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology.
Batlle D, Soler MJ, Sparks MA, Hiremath S, South AM, Welling PA, Swaminathan S |
Journal of the American Society of Nephrology : JASN | 2020 |
|
Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR.
Tam LS, Tanaka Y, Handa R, Chang CC, Cheng YK, Isalm N, Li M, Lorenzo JP, Song YW, Yamamoto K, Zeng X, Haq SA |
International Journal of Rheumatic Diseases | 2020 |
|
Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19.
Menendez JA |
Aging | 2020 |
|
COVID-19 and SCA: an old friend comes to the rescue.
Novelli EM |
Blood | 2020 |
|
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
Costiniuk CT, Jenabian MA |
Cytokine & Growth Factor Reviews | 2020 |
|
COVID-19 and Asthma: Reflection During the Pandemic.
Liu S, Zhi Y, Ying S |
Clinical Reviews in Allergy & Immunology | 2020 |
|
COVID-19 and the immune system.
Paces J, Strizova Z, Smrz D, Cerny J |
2020 | |
|
Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
Ni M, Tian FB, Xiang DD, Yu B |
Journal of Medical Virology | 2020 |
|
Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure".
Fedson DS, Opal SM, Rordam OM |
mBio | 2020 |
|
Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019.
Shalev N, Scherer M, LaSota ED, Antoniou P, Yin MT, Zucker J, Sobieszczyk ME |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020 |
|
Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
Qu W, Wang Z, Hare JM, Bu G, Mallea JM, Pascual JM, Caplan AI, Kurtzberg J, Zubair AC, Kubrova E, Engelberg-Cook E, Nayfeh T, Shah VP, Hill JC, Wolf ME, Prokop LJ, Murad MH, Sanfilippo FP |
Stem Cells Translational Medicine | 2020 |
|
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH |
Thrombosis and haemostasis | 2020 |
|
Biosensors for Managing the COVID-19 Cytokine Storm: Challenges Ahead.
Russell SM, Alba-Patiño A, Barón E, Borges M, Gonzalez-Freire M, de la Rica R |
ACS Sensors | 2020 |
|
Interrelationship Between Coronavirus Infection and Liver Disease.
Schaefer EAK, Arvind A, Bloom PP, Chung RT |
Clinical Liver Disease | 2020 |
|
Whole-lung Low Dose Irradiation for SARS-Cov2 Induced Pneumonia in the Geriatric Population: An Old Effective Treatment for a New Disease? Recommendation of the International Geriatric Radiotherapy Group.
Lara PC, Nguyen NP, Macias-Verde D, Burgos-Burgos J, Arenas M, Zamagni A, Vinh-Hung V, Baumert BG, Motta M, Myint AS, Bonet M, Popescu T, Vuong T, Appalanaido GK, Trigo L, Karlsson U, Thariat J |
Aging and disease | 2020 |
|
17β-Estradiol, a potential ally to alleviate SARS-CoV-2 infection.
Breithaupt-Faloppa AC, Correia CJ, Prado CM, Stilhano RS, Ureshino RP, Moreira LFP |
2020 | |
|
COVID-19 and Hypercoagulable State: A New Therapeutic Perspective.
Nascimento JHP, Gomes BFO, Carmo Júnior PRD, Petriz JLF, Rizk SI, Costa IBSDS, Lacerda MVG, Bacal F, Hajjar LA, Oliveira GMM |
Arquivos brasileiros de cardiologia | 2020 |
|
Understanding the age divide in COVID-19: why are children overwhelmingly spared?
Lingappan K, Karmouty-Quintana H, Davies J, Akkanti B, Harting MT |
American journal of physiology. Lung cellular and molecular physiology | 2020 |
|
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H, Zhu H, Yuan C, Yao C, Luo W, Shen X, Wang J, Shao J, Xiang Y |
2020 | |
|
Utility of lateral flow tests in SARS-CoV-2 infection monitorization.
Candel FJ, Viñuela-Prieto JM, González Del Castillo J, Barreiro García P, Fragiel Saavedra M, Hernández Píriz A, Jiménez Virumbrales D, Canora Lebrato J, García de Casasola G, Gil Prieto R, San-Román Montero J, Ortega Anselmi J, Barba Martín R, Prados Roa F, Marco Martínez J, Zapatero Gaviria A |
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia | 2020 |
|
Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.
Yap JKY, Moriyama M, Iwasaki A |
Journal of immunology (Baltimore, Md. : 1950) | 2020 |
|
COVID-19 and kidney transplantation: an Italian Survey and Consensus.
Vistoli F, Furian L, Maggiore U, Caldara R, Cantaluppi V, Ferraresso M, Zaza G, Cardillo M, Biancofiore G, Menichetti F, Russo A, Turillazzi E, Di Paolo M, Grandaliano G, Boggi U |
Journal of Nephrology | 2020 |
|
In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction.
Silva-Arrieta S, Goulder PJR, Brander C |
PLoS pathogens | 2020 |
|
Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19.
Dalamaga M, Karampela I, Mantzoros CS |
Metabolism: clinical and experimental | 2020 |
|
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease.
Heneka MT, Golenbock D, Latz E, Morgan D, Brown R |
Alzheimer's research & therapy | 2020 |
|
Inpatient Management of COVID-19 Pneumonia: a Practical Approach from the Hospitalist Perspective.
Cutler TS, Eisenberg N, Evans AT |
Journal of General Internal Medicine | 2020 |
|
Bloodstream Infection by Saccharomyces cerevisiae in Two COVID-19 Patients after Receiving Supplementation of Saccharomyces in the ICU.
Ventoulis I, Sarmourli T, Amoiridou P, Mantzana P, Exindari M, Gioula G, Vyzantiadis TA |
2020 | |
|
[Possible protective factors of SARS-CoV-2 infection in a vulnerable patient: Report of a case].
Alcántara Montero A, Pacheco de Vasconcelos SR, Cadenas Holguín A, Matsuki Martín de Prado MT |
SEMERGEN - Medicina de Familia | 2020 |
|
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.
De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, Gozzi L, Iannone A, Lo Tartaro D, Mattioli M, Paolini A, Menozzi M, Milić J, Franceschi G, Fantini R, Tonelli R, Sita M, Sarti M, Trenti T, Brugioni L, Cicchetti L, Facchinetti F, Pietrangelo A, Clini E, Girardis M, Guaraldi G, Mussini C, Cossarizza A |
Nature Communications | 2020 |
|
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic.
Funk CD, Laferrière C, Ardakani A |
Frontiers in pharmacology | 2020 |
|
Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role?
Mantero V, Rigamonti A, Basilico P, Crespi M, Balgera R, Salmaggi A |
Journal of Neurology | 2020 |
|
Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19.
Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R, Talukdar R, Sharma M, Qi X, Rao PN, Reddy DN |
Alimentary Pharmacology & Therapeutics | 2020 |
|
Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp WT, Mas-Peiro S, Cremer S, John D, Dimmeler S, Zeiher AM |
JAMA Cardiology | 2020 |
|
Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19.
Kong M, Zhang H, Cao X, Mao X, Lu Z |
Epidemiology and Infection | 2020 |
|
Prevalence of acute liver injury and hypertransaminemia in patients with COVID-19: a protocol for a systematic review.
Li G, Xu Y, Yang YT, Liu PF |
BMJ Open | 2020 |
|
Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update.
Pal A, Pawar A, Goswami K, Sharma P, Prasad R |
Indian journal of clinical biochemistry : IJCB | 2020 |
|
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
Sun J, Zhuang Z, Zheng J, Li K, Wong RL, Liu D, Huang J, He J, Zhu A, Zhao J, Li X, Xi Y, Chen R, Alshukairi AN, Chen Z, Zhang Z, Chen C, Huang X, Li F, Lai X, Chen D, Wen L, Zhuo J, Zhang Y, Wang Y, Huang S, Dai J, Shi Y, Zheng K, Leidinger MR, Chen J, Li Y, Zhong N, Meyerholz DK, McCray PB Jr, Perlman S, Zhao J |
Cell | 2020 |
|
Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19.
Kroemer A, Khan K, Plassmeyer M, Alpan O, Haseeb MA, Gupta R, Fishbein TM |
Journal of Hepatology | 2020 |
|
Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU.
Zhang D, Zhou X, Yan S, Tian R, Su L, Ding X, Xiao M, Chen Y, Zhao H, Chen H, Zhang H, Li Z, Li Q, Xu Y, Yan X, Li Y, Zhang S |
Clinica chimica acta; international journal of clinical chemistry | 2020 |
|
Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019.
Xiao LS, Zhang WF, Gong MC, Zhang YP, Chen LY, Zhu HB, Hu CY, Kang P, Liu L, Zhu H |
EBioMedicine | 2020 |
|
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Scarfò L, Chatzikonstantinou T, Rigolin GM, Quaresmini G, Motta M, Vitale C, Garcia-Marco JA, Hernández-Rivas JÁ, Mirás F, Baile M, Marquet J, Niemann CU, Reda G, Munir T, Gimeno E, Marchetti M, Quaglia FM, Varettoni M, Delgado J, Iyengar S, Janssens A, Marasca R, Ferrari A, Cuéllar-García C, Itchaki G, Špaček M, De Paoli L, Laurenti L, Levin MD, Lista E, Mauro FR, Šimkovič M, Van Der Spek E, Vandenberghe E, Trentin L, Wasik-Szczepanek E, Ruchlemer R, Bron D, De Paolis MR, Del Poeta G, Farina L, Foglietta M, Gentile M, Herishanu Y, Herold T, Jaksic O, Kater AP, Kersting S, Malerba L, Orsucci L, Popov VM, Sportoletti P, Yassin M, Pocali B, Barna G, Chiarenza A, Dos Santos G, Nikitin E, Andres M, Dimou M, Doubek M, Enrico A, Hakobyan Y, Kalashnikova O, Ortiz Pareja M, Papaioannou M, Rossi D, Shah N, Shrestha A, Stanca O, Stavroyianni N, Strugov V, Tam C, Zdrenghea M, Coscia M, Stamatopoulos K, Rossi G, Rambaldi A, Montserrat E, Foà R, Cuneo A, Ghia P |
Leukemia | 2020 |
|
Extrapulmonary complications of COVID-19: A multisystem disease?
Zheng KI, Feng G, Liu WY, Targher G, Byrne CD, Zheng MH |
Journal of Medical Virology | 2020 |
|
Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection.
Trottein F, Sokol H |
Cell Reports | 2020 |
|
High prevalence for obesity in severe COVID-19: Possible links and perspectives towards patient stratification.
Dugail I, Amri EZ, Vitale N |
Biochimie | 2020 |
|
Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.
Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, Choi B, Nam SK, Sa M, Kwon JS, Jeong SJ, Lee HK, Park SH, Park SH, Choi JY, Kim SH, Jung I, Shin EC |
Science Immunology | 2020 |
|
Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report.
Zhou X, Zhou J, Zhao J |
BMC Infectious Diseases | 2020 |
|
Immunosenescence exacerbates the COVID-19.
Napoli C, Tritto I, Mansueto G, Coscioni E, Ambrosio G |
Archives of Gerontology and Geriatrics | 2020 |
|
Management of Idiopathic CNS inflammatory diseases during the COVID-19 pandemic: Perspectives and strategies for continuity of care from a South East Asian Center with limited resources.
Viswanathan S |
Multiple Sclerosis and Related Disorders | 2020 |
|
COVID-19, coagulopathy and venous thromboembolism: more questions than answers.
Marietta M, Coluccio V, Luppi M |
Internal and Emergency Medicine | 2020 |
|
Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes.
Kastritis E, Kitas GD, Vassilopoulos D, Giannopoulos G, Dimopoulos MA, Sfikakis PP |
Rheumatology International | 2020 |
|
Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.
Zeng X, Song X, Ma T, Pan X, Zhou Y, Hou Y, Zhang Z, Li K, Karypis G, Cheng F |
Journal of Proteome Research | 2020 |
|
Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19.
Chan AS, Rout A |
Journal of clinical medicine research | 2020 |
|
Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases.
Sheianov MV, Udalov YD, Ochkin SS, Bashkov AN, Samoilov AS |
Cureus | 2020 |
|
COVID-19: collaboration will keep us ahead of the curve.
Shamdasani P, Trubiano JA, Smibert OC, Owen CE, Liew DFL |
Internal Medicine Journal | 2020 |
|
Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
Liao D, Zhou F, Luo L, Xu M, Wang H, Xia J, Gao Y, Cai L, Wang Z, Yin P, Wang Y, Tang L, Deng J, Mei H, Hu Y |
The Lancet Haematology | 2020 |
|
Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study.
Luan YY, Liu Y, Liu XY, Yu BJ, Chen RL, Peng M, Ren D, Li HL, Huang L, Liu Y, Li JX, Feng YW, Wu M |
Thrombosis Research | 2020 |
|
Obesity and COVID-19: The Two Sides of the Coin.
Dicker D, Bettini S, Farpour-Lambert N, Frühbeck G, Golan R, Goossens G, Halford J, O'Malley G, Mullerova D, Ramos Salas X, Hassapiou MN, Sagen J, Woodward E, Yumuk V, Busetto L |
Obesity facts | 2020 |
|
Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.
Biscetti F, Rando MM, Nardella E, Cecchini AL, Bruno P, Landolfi R, Flex A |
International journal of molecular sciences | 2020 |
|
Chest Computed Tomography Scoring in Patients With Novel Coronavirus-infected Pneumonia: Correlation With Clinical and Laboratory Features and Disease Outcome.
Pugliese L, Sbordone FP, Grimaldi F, Ricci F, DI Tosto F, Spiritigliozzi L, DI Donna C, Presicce M, DE Stasio V, Benelli L, D'Errico F, Pasqualetto M, Legramante JM, Materazzo M, Pellicciaro M, Buonomo OC, Vanni G, Rizza S, Bellia A, Floris R, Garaci F, Chiocchi M |
In vivo (Athens, Greece) | 2020 |
|
Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
Yan L, Cai B, Li Y, Wang MJ, An YF, Deng R, Li DD, Wang LC, Xu H, Gao XD, Wang LL |
Journal of Cellular and Molecular Medicine | 2020 |
|
High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.
Shi W, Liu X, Cao Q, Ma P, Le W, Xie L, Ye J, Wen W, Tang H, Su W, Zheng Y, Liu Y |
American journal of physiology. Lung cellular and molecular physiology | 2020 |
|
A meta-analysis of the impact of COVID-19 on liver dysfunction.
Wu ZH, Yang DL |
European Journal of Medical Research | 2020 |
|
Burn Unit admission and management protocol during COVID-19 pandemic.
Azzena B, Perozzo FAG, De Lazzari A, Valotto G, Pontini A |
Burns : journal of the International Society for Burn Injuries | 2020 |
|
Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins.
Stervbo U, Rahmann S, Roch T, Westhoff TH, Babel N |
Scientific Reports | 2020 |
|
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis.
Tleyjeh IM, Kashour Z, Damlaj M, Riaz M, Tlayjeh H, Altannir M, Altannir Y, Al-Tannir M, Tleyjeh R, Hassett L, Kashour T |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2020 |
|
Hydroxychloroquine and the risk of respiratory infections among RA patients.
Kremer JM, Reed G, Pappas DA, Harold LR, Kane K, Greenberg J, Winthrop K |
RMD Open | 2020 |
|
COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Asakura H, Ogawa H |
International Journal of Hematology | 2020 |
|
Gastrointestinal predictors of severe COVID-19: systematic review and meta-analysis.
Aziz M, Haghbin H, Lee-Smith W, Goyal H, Nawras A, Adler DG |
Annals of Gastroenterology | 2020 |
|
Predictors of COVID-19 severity: a systematic review and meta-analysis.
Mudatsir M, Fajar JK, Wulandari L, Soegiarto G, Ilmawan M, Purnamasari Y, Mahdi BA, Jayanto GD, Suhendra S, Setianingsih YA, Hamdani R, Suseno DA, Agustina K, Naim HY, Muchlas M, Alluza HHD, Rosida NA, Mayasari M, Mustofa M, Hartono A, Aditya R, Prastiwi F, Meku FX, Sitio M, Azmy A, Santoso AS, Nugroho RA, Gersom C, Rabaan AA, Masyeni S, Nainu F, Wagner AL, Dhama K, Harapan H |
F1000Research | 2020 |
|
Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review.
Ahmed MH, Hassan A |
2020 | |
|
Inflammatory Biomarker Trends Predict Respiratory Decline in COVID-19 Patients.
Mueller AA, Tamura T, Crowley CP, DeGrado JR, Haider H, Jezmir JL, Keras G, Penn EH, Massaro AF, Kim EY |
Cell reports. Medicine | 2020 |
|
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection.
Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, O'Connor L, Leavy D, O'Brien K, Dowds J, Sugrue JA, Hopkins D, Martin-Loeches I, Ni Cheallaigh C, Nadarajan P, McLaughlin AM, Bourke NM, Bergin C, O'Farrelly C, Bannan C, Conlon N |
PloS one | 2020 |
|
Antibody-Based Immunotherapeutic Strategies for COVID-19.
Hussen J, Kandeel M, Hemida MG, Al-Mubarak AIA |
2020 | |
|
Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis.
Mutiawati E, Syahrul S, Fahriani M, Fajar JK, Mamada SS, Maliga HA, Samsu N, Ilmawan M, Purnamasari Y, Asmiragani AA, Ichsan I, Emran TB, Rabaan AA, Masyeni S, Nainu F, Harapan H |
F1000Research | 2020 |
|
Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study.
Zheng X, Luo S, Sun Y, Han M, Liu J, Sun L, Zhang L, Ling P, Ding Y, Jin T, Liu Z, Weng J |
National Science Review | 2020 |
|
A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host
Minakshi R, Jan AT, Rahman S, Kim J |
Frontiers in Cellular and Infection Microbiology | 2020 |
|
Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities
Wang L, Sun Y, Yuan Y, Mei Q, Yuan X |
Aging | 2020 |
|
COVID-19, SARS and MERS: A neurological perspective.
Ng Kee Kwong KC, Mehta PR, Shukla G, Mehta AR |
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia | 2020 |
|
Complement activation in patients with COVID-19: A novel therapeutic target.
Cugno M, Meroni PL, Gualtierotti R, Griffini S, Grovetti E, Torri A, Panigada M, Aliberti S, Blasi F, Tedesco F, Peyvandi F |
Journal of Allergy and Clinical Immunology | 2020 |
|
Is the HScore useful in COVID-19?
Leverenz DL, Tarrant TK |
2020 | |
|
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.
Ielapi N, Licastro N, Provenzano M, Andreucci M, Franciscis S, Serra R |
Biomarkers in Medicine | 2020 |
|
Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
Burbelo PD, Riedo FX, Morishima C, Rawlings S, Smith D, Das S, Strich JR, Chertow DS, Davey RT, Cohen JI |
The Journal of Infectious Diseases | 2020 |
|
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
Quiros Roldan E, Biasiotto G, Magro P, Zanella I |
Pharmacological Research | 2020 |
|
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?
Sardu C, D'Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, Maggi P, Coppola N, Paolisso G, Marfella R |
Diabetes care | 2020 |
|
SARS-CoV-2 and Stroke in a New York Healthcare System.
Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, Henninger N, Trivedi T, Lillemoe K, Alam S, Sanger M, Kim S, Scher E, Dehkharghani S, Wachs M, Tanweer O, Volpicelli F, Bosworth B, Lord A, Frontera J |
Stroke; a journal of cerebral circulation | 2020 |
|
The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities.
Buja LM, Wolf DA, Zhao B, Akkanti B, McDonald M, Lelenwa L, Reilly N, Ottaviani G, Elghetany MT, Trujillo DO, Aisenberg GM, Madjid M, Kar B |
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology | 2020 |
|
COVID-19 and lung cancer: risks, mechanisms and treatment interactions.
Addeo A, Obeid M, Friedlaender A |
Journal for ImmunoTherapy of Cancer | 2020 |
|
Virus-induced genetics revealed by multidimensional precision medicine transcriptional workflow applicable to COVID-19.
Prokop JW, Shankar R, Gupta R, Leimanis ML, Nedveck D, Uhl K, Chen B, Hartog NL, Van Veen J, Sisco JS, Sirpilla O, Lydic T, Boville B, Hernandez A, Braunreiter C, Kuk CC, Singh V, Mills J, Wegener M, Adams M, Rhodes M, Bachmann AS, Pan W, Byrne-Steele ML, Smith DC, Depinet M, Brown BE, Eisenhower M, Han J, Haw M, Madura C, Sanfilippo DJ, Seaver LH, Bupp C, Rajasekaran S |
Physiological genomics | 2020 |
|
Delayed diagnosis of COVID-19 in a 34-year-old man with atypical presentation.
Harkin TJ, Rurak KM, Martins J, Eber C, Szporn AH, Beasley MB |
The lancet. Respiratory medicine | 2020 |
|
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS |
The Lancet Psychiatry | 2020 |
|
The current understanding and potential therapeutic options to combat COVID-19.
Pooladanda V, Thatikonda S, Godugu C |
Life Sciences | 2020 |
|
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, Li X, Xu P, Zhang L, Zhao L, Cao Y, Kang J, Yang J, Li L, Liu X, Li Y, Nie R, Mu J, Lu F, Zhao S, Lu J, Zhao J |
Journal of Hepatology | 2020 |
|
[Emergency Surgery and Trauma Care During COVID-19 Pandemic. Recommendations of the Spanish Association of Surgeons].
Aranda-Narváez JM, Tallón-Aguilar L, Pareja-Ciuró F, Martín-Martín G, González-Sánchez AJ, Rey-Simó I, Tamayo-Medel G, Yánez-Benítez C, Costa-Navarro D, Montón-Condón S, Navarro-Soto S, Turégano-Fuentes F, Pérez-Díaz MD, Ceballos-Esparragón J, Jover-Navalón JM, Balibrea JM, Morales-Conde S |
2020 | |
|
A simple algorithm helps early identification of SARS-CoV-2 infection patients with severe progression tendency.
Li Q, Zhang J, Ling Y, Li W, Zhang X, Lu H, Chen L |
Infection | 2020 |
|
Intensive Care Risk Estimation in COVID-19 Pneumonia Based on Clinical and Imaging Parameters: Experiences from the Munich Cohort.
Burian E, Jungmann F, Kaissis GA, Lohöfer FK, Spinner CD, Lahmer T, Treiber M, Dommasch M, Schneider G, Geisler F, Huber W, Protzer U, Schmid RM, Schwaiger M, Makowski MR, Braren RF |
Journal of Clinical Medicine | 2020 |
|
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy.
Morena V, Milazzo L, Oreni L, Bestetti G, Fossali T, Bassoli C, Torre A, Cossu MV, Minari C, Ballone E, Perotti A, Mileto D, Niero F, Merli S, Foschi A, Vimercati S, Rizzardini G, Sollima S, Bradanini L, Galimberti L, Colombo R, Micheli V, Negri C, Ridolfo AL, Meroni L, Galli M, Antinori S, Corbellino M |
European Journal of Internal Medicine | 2020 |
|
Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.
An PJ, Zhu YZ, Yang LP |
Pharmacological Research | 2020 |
|
Pediatric Crohn Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated With Infliximab.
Dolinger MT, Person H, Smith R, Jarchin L, Pittman N, Dubinsky MC, Lai J |
Journal of Pediatric Gastroenterology and Nutrition | 2020 |
|
The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis.
Aziz M, Fatima R, Lee-Smith W, Assaly R |
Critical Care | 2020 |
|
Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.
Maatman TK, Jalali F, Feizpour C, Douglas A 2nd, McGuire SP, Kinnaman G, Hartwell JL, Maatman BT, Kreutz RP, Kapoor R, Rahman O, Zyromski NJ, Meagher AD |
Critical Care Medicine | 2020 |
|
The case of complement activation in COVID-19 multiorgan impact.
Noris M, Benigni A, Remuzzi G |
Kidney International | 2020 |
|
Efficacy of acupuncture and moxibustion in adjuvant treatment of patients with novel coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
Zhang Q, Xu X, Sun S, Cao F, Li J, Qi X, Ji G, Wang Y, Song B |
Medicine | 2020 |
|
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations.
Patel BV, Arachchillage DJ, Ridge CA, Bianchi P, Doyle JF, Garfield B, Ledot S, Morgan C, Passariello M, Price S, Singh S, Thakuria L, Trenfield S, Trimlett R, Weaver C, Wort SJ, Xu T, Padley SPG, Devaraj A, Desai SR |
American journal of respiratory and critical care medicine | 2020 |
|
Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
Schultheiß C, Paschold L, Simnica D, Mohme M, Willscher E, von Wenserski L, Scholz R, Wieters I, Dahlke C, Tolosa E, Sedding DG, Ciesek S, Addo M, Binder M |
Immunity | 2020 |
|
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, Alanio C, Kuri-Cervantes L, Pampena MB, D'Andrea K, Manne S, Chen Z, Huang YJ, Reilly JP, Weisman AR, Ittner CAG, Kuthuru O, Dougherty J, Nzingha K, Han N, Kim J, Pattekar A, Goodwin EC, Anderson EM, Weirick ME, Gouma S, Arevalo CP, Bolton MJ, Chen F, Lacey SF, Ramage H, Cherry S, Hensley SE, Apostolidis SA, Huang AC, Vella LA, Betts MR, Meyer NJ, Wherry EJ |
Science (New York, N.Y.) | 2020 |
|
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure.
Jaiswal SR, Malhotra P, Mitra DK, Chakrabarti S |
Mediterranean journal of hematology and infectious diseases | 2020 |
|
Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.
Kadambari S, Klenerman P, Pollard AJ |
Reviews in Medical Virology | 2020 |
|
Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, Georgia.
Collins LF, Moran CA, Oliver NT, Moanna A, Lahiri CD, Colasanti JA, Kelley CF, Nguyen ML, Marconi VC, Armstrong WS, Ofotokun I, Sheth AN |
AIDS | 2020 |
|
COVID-19 Sepsis and Microcirculation Dysfunction.
Colantuoni A, Martini R, Caprari P, Ballestri M, Capecchi PL, Gnasso A, Lo Presti R, Marcoccia A, Rossi M, Caimi G |
Frontiers in physiology | 2020 |
|
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19.
Hottz ED, Azevedo-Quintanilha IG, Palhinha L, Teixeira L, Barreto EA, Pão CRR, Righy C, Franco S, Souza TML, Kurtz P, Bozza FA, Bozza PT |
Blood | 2020 |
|
Hemostatic Changes in Patients with COVID-19: A Meta-Analysis with Meta-Regressions.
Di Minno MND, Calcaterra I, Lupoli R, Storino A, Spedicato GA, Maniscalco M, Di Minno A, Ambrosino P |
Journal of Clinical Medicine | 2020 |
|
Gastrointestinal and hepatic abnormalities in patients with confirmed COVID-19: A systematic review and meta-analysis.
Zarifian A, Zamiri Bidary M, Arekhi S, Rafiee M, Gholamalizadeh H, Amiriani A, Ghaderi MS, Khadem-Rezaiyan M, Amini M, Ganji A |
Journal of Medical Virology | 2020 |
|
Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body.
Saha A, Saha B |
Reviews in Medical Virology | 2020 |
|
COVID-19 in people with diabetes: understanding the reasons for worse outcomes.
Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S |
The lancet. Diabetes & endocrinology | 2020 |
|
COVID-19 and Myocarditis: What Do We Know So Far?
Pirzada A, Mokhtar AT, Moeller AD |
2020 | |
|
Blood Targets of Adjuvant Drugs Against COVID19.
Di Micco P, Di Micco G, Russo V, Poggiano MR, Salzano C, Bosevski M, Imparato M, Fontanella L, Fontanella A |
Journal of blood medicine | 2020 |
|
Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis.
Jesenak M, Brndiarova M, Urbancikova I, Rennerova Z, Vojtkova J, Bobcakova A, Ostro R, Banovcin P |
Frontiers in Cellular and Infection Microbiology | 2020 |
|
Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019.
Betts BC, Young JW |
2020 | |
|
Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors.
Odabasi Z, Cinel I |
2020 | |
|
Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barré syndrome.
Galassi G, Marchioni A |
Acta Neurologica Belgica | 2020 |
|
A comparative study of the laboratory features of COVID-19 and other viral pneumonias in the recovery stage.
Zhao G, Su Y, Sun X, Cui X, Dang L, Zhao L, Tan X, Wang H, Yang M |
Journal of Clinical Laboratory Analysis | 2020 |
|
Are superantigens the cause of cytokine storm and viral sepsis in severe COVID-19? Observations and hypothesis.
Scaglioni V, Soriano ER |
Scandinavian Journal of Immunology | 2020 |
|
The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan.
Huang H, Chen S, Li H, Zhou XL, Dai Y, Wu J, Zhang J, Shao L, Yan R, Wang M, Wang J, Tu Y, Ge M |
Alimentary Pharmacology & Therapeutics | 2020 |
|
COVID-19: Pain Management in Patients with SARS-CoV-2 Infection-Molecular Mechanisms, Challenges, and Perspectives.
Drożdżal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Majewski P, Rotter I, Kotfis K |
Brain Sciences | 2020 |
|
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A, Ralfs P, Chirkova T, Upadhyay AA, Zimmerman MG, Bedoya S, Aoued H, Tharp GM, Pellegrini KL, Manfredi C, Sorscher E, Mainou B, Lobby JL, Kohlmeier JE, Lowen AC, Shi PY, Menachery VD, Anderson LJ, Grakoui A, Bosinger SE, Suthar MS |
Journal of virology | 2020 |
|
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.
Cauchois R, Koubi M, Delarbre D, Manet C, Carvelli J, Blasco VB, Jean R, Fouche L, Bornet C, Pauly V, Mazodier K, Pestre V, Jarrot PA, Dinarello CA, Kaplanski G |
Proceedings of the National Academy of Sciences | 2020 |
|
Cobrotoxin could be an effective therapeutic for COVID-19.
Lin F, Reid PF, Qin ZH |
Acta Pharmacologica Sinica | 2020 |
|
Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
Cunha LL, Perazzio SF, Azzi J, Cravedi P, Riella LV |
Frontiers in immunology | 2020 |
|
Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
Li C, Cheng G |
Frontiers in immunology | 2020 |
|
The Enigma of Low COVID-19 Fatality Rate in India.
Samaddar A, Gadepalli R, Nag VL, Misra S |
Frontiers in Genetics | 2020 |
|
A Controllable Inflammatory Response and Temporary Abnormal Coagulation in Moderate Disease of COVID-19 in Wuhan, China.
Liu Y, Zhang X, Qiao J, Gong R, You Q, Sun J, Liu W, Sun B |
Journal of clinical medicine research | 2020 |
|
Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions.
Bunders MJ, Altfeld M |
Immunity | 2020 |
|
Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
Zeng Z, Yu H, Chen H, Qi W, Chen L, Chen G, Yan W, Chen T, Ning Q, Han M, Wu D |
Critical Care | 2020 |
|
[Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)].
Díaz E, Amézaga Menéndez R, Vidal Cortés P, Escapa MG, Suberviola B, Serrano Lázaro A, Marcos Neira P, Quintana Díaz M, Catalán González M |
Medicina Intensiva | 2020 |
|
Characteristics of Large-Vessel Occlusion Associated with COVID-19 and Ischemic Stroke.
John S, Kesav P, Mifsud VA, Piechowski-Jozwiak B, Dibu J, Bayrlee A, Elkambergy H, Roser F, Elhammady MS, Zahra K, Hussain SI |
American Journal of Neuroradiology | 2020 |
|
Thrombosis in COVID-19.
Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA |
American Journal of Hematology | 2020 |
|
SARS-CoV-2 another kind of liver aggressor, how does it do that?
Lozano-Sepulveda SA, Galan-Huerta K, Martínez-Acuña N, Arellanos-Soto D, Rivas-Estilla AM |
2020 | |
|
Early coagulation tests predict risk stratification and prognosis of COVID-19.
Luo L, Xu M, Du M, Kou H, Liao D, Cheng Z, Mei H, Hu Y |
Aging | 2020 |
|
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19).
Rodríguez-Baño J, Pachón J, Carratalà J, Ryan P, Jarrín I, Yllescas M, Arribas JR, Berenguer J |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2020 |
|
Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019.
Awano N, Inomata M, Kuse N, Tone M, Takada K, Muto Y, Fujimoto K, Akagi Y, Mawatari M, Ueda A, Izumo T |
Respiratory Investigation | 2020 |
|
Nanomedicine therapies modulating Macrophage Dysfunction: a potential strategy to attenuate Cytokine Storms in severe infections.
Liu J, Wan M, Lyon CJ, Hu TY |
Theranostics | 2020 |
|
Systematic analysis of disease-specific immunological signatures in patients with febrile illness from Saudi Arabia.
Kam YW, Ahmed MY, Amrun SN, Lee B, Refaie T, Elgizouli K, Fong SW, Renia L, Ng LF |
IBMS BoneKEy | 2020 |
|
COVID-19 and Liver Injury: A Systematic Review and Meta-Analysis.
Ahmed J, Rizwan T, Malik F, Akhter R, Malik M, Ahmad J, Khan AW, Chaudhary MA, Usman MS |
Cureus | 2020 |
|
Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
Pugliese G, Vitale M, Resi V, Orsi E |
Acta Diabetologica | 2020 |
|
Cardiovascular System in COVID-19: Simply a Viewer or a Leading Actor?
Mottola FF, Verde N, Ricciolino R, Di Mauro MD, Migliaccio MG, Carfora V, Spiniello G, Coppola N, Vanvitelli Covid-Group |
2020 | |
|
Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports.
Okamori S, Lee H, Kondo Y, Akiyama Y, Kabata H, Kaneko Y, Ishii M, Hasegawa N, Fukunaga K |
Medicine | 2020 |
|
Laboratory diagnosis for Covid-19: A mini-review.
Pizzol JLD, Hora VPD, Reis AJ, Vianna J, Ramis I, Groll AV, Silva PAD |
Revista da Sociedade Brasileira de Medicina Tropical | 2020 |
|
Visual and software-based quantitative chest CT assessment of COVID-19: correlation with clinical findings.
Durhan G, Ardalı Düzgün S, Başaran Demirkazık F, Irmak İ, İdilman İ, Gülsün Akpınar M, Akpınar E, Öcal S, Telli G, Topeli A, Arıyürek OM |
2020 | |
|
Immune-Mediated Coagulopathy in COVID-19 Infection.
Vadasz Z, Brenner B, Toubi E |
Seminars in thrombosis and hemostasis | 2020 |
|
Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.
O'Connell P, Aldhamen YA |
Human Vaccines & Immunotherapeutics | 2020 |
|
Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review.
Váncsa S, Hegyi PJ, Zádori N, Szakó L, Vörhendi N, Ocskay K, Földi M, Dembrovszky F, Dömötör ZR, Jánosi K, Rakonczay Z Jr, Hartmann P, Horváth T, Erőss B, Kiss S, Szakács Z, Németh D, Hegyi P, Pár G |
Frontiers in Medicine | 2020 |
|
Multi-dimensional COVID-19 short- and long-term outcome prediction algorithm.
Deng MC |
Expert Review of Precision Medicine and Drug Development | 2020 |
|
Similarity and Specificity of Traditional Chinese Medicine Formulas for Management of Coronavirus Disease 2019 and Rheumatoid Arthritis.
Li Z, Chen H, Zhang H, Li Y, Wang C, Bai L, Zhang W, Jiang Z |
ACS Omega | 2020 |
|
Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19 : A Retrospective Study.
Fu Y, Li Y, Guo E, He L, Liu J, Yang B, Li F, Wang Z, Li Y, Xiao R, Liu C, Huang Y, Wu X, Lu F, You L, Qin T, Wang C, Li K, Wu P, Ma D, Sun C, Chen G |
Annals of internal medicine | 2020 |
|
Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
Dorjee K, Kim H, Bonomo E, Dolma R |
PloS one | 2020 |
|
Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles.
Gamage AM, Tan KS, Chan WOY, Liu J, Tan CW, Ong YK, Thong M, Andiappan AK, Anderson DE, Wang Y, Wang LF |
PLoS pathogens | 2020 |
|
Hidden in plain sight: The effects of BCG vaccination in the COVID-19 pandemic.
Toraih EA, Sedhom JA, Dokunmu TM, Hussein MH, Ruiz EML, Muthusamy K, Zerfaoui M, Kandil E |
Journal of Medical Virology | 2020 |
|
Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63.
Saletti G, Gerlach T, Jansen JM, Molle A, Elbahesh H, Ludlow M, Li W, Bosch BJ, Osterhaus ADME, Rimmelzwaan GF |
Scientific Reports | 2020 |
|
The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19.
Robinson PC, Liew DFL, Liew JW, Monaco C, Richards D, Shivakumar S, Tanner HL, Feldmann M |
2020 | |
|
Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.
Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, Bordoni D, Franzenburg J, Geisen U, Josephs-Spaulding J, Köhler P, Künstner A, Rosati E, Aschenbrenner AC, Bacher P, Baran N, Boysen T, Brandt B, Bruse N, Dörr J, Dräger A, Elke G, Ellinghaus D, Fischer J, Forster M, Franke A, Franzenburg S, Frey N, Friedrichs A, Fuß J, Glück A, Hamm J, Hinrichsen F, Hoeppner MP, Imm S, Junker R, Kaiser S, Kan YH, Knoll R, Lange C, Laue G, Lier C, Lindner M, Marinos G, Markewitz R, Nattermann J, Noth R, Pickkers P, Rabe KF, Renz A, Röcken C, Rupp J, Schaffarzyk A, Scheffold A, Schulte-Schrepping J, Schunk D, Skowasch D, Ulas T, Wandinger KP, Wittig M, Zimmermann J, Busch H, Hoyer BF, Kaleta C, Heyckendorf J, Kox M, Rybniker J, Schreiber S, Schultze JL, Rosenstiel P |
Immunity | 2020 |
|
Clinical characteristics and laboratory biomarkers changes in COVID-19 patients requiring or not intensive or sub-intensive care: a comparative study.
Cattelan AM, Di Meco E, Trevenzoli M, Frater A, Ferrari A, Villano M, Gomiero F, Carretta G, Sasset L |
BMC Infectious Diseases | 2020 |
|
Biomarkers of acute respiratory distress syndrome in adults hospitalised for severe SARS-CoV-2 infection in Tenerife Island, Spain.
Figueira Gonçalves JM, Hernández Pérez JM, Acosta Sorensen M, Wangüemert Pérez AL, Martín Ruiz de la Rosa E, Trujillo Castilla JL, Díaz Pérez D, Ramallo-Fariña Y |
BMC Research Notes | 2020 |
|
A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.
Vanassche T, Engelen MM, Van Thillo Q, Wauters J, Gunst J, Wouters C, Vandenbriele C, Rex S, Liesenborghs L, Wilmer A, Meersseman P, Van den Berghe G, Dauwe D, Verbeke G, Thomeer M, Fivez T, Mesotten D, Ruttens D, Heytens L, Dapper I, Tuyls S, De Tavernier B, Verhamme P |
Trials | 2020 |
|
Repurposed Tocilizumab in Patients with Severe COVID-19.
Tian J, Zhang M, Jin M, Zhang F, Chu Q, Wang X, Chen C, Yue H, Zhang L, Du R, Zhao D, Zeng Z, Zhao Y, Liu K, Wang M, Hu K, Miao X, Zhang H |
Journal of immunology (Baltimore, Md. : 1950) | 2020 |
|
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection.
Desai N, Neyaz A, Szabolcs A, Shih AR, Chen JH, Thapar V, Nieman LT, Solovyov A, Mehta A, Lieb DJ, Kulkarni AS, Jaicks C, Xu KH, Raabe MJ, Pinto CJ, Juric D, Chebib I, Colvin RB, Kim AY, Monroe R, Warren SE, Danaher P, Reeves JW, Gong J, Rueckert EH, Greenbaum BD, Hacohen N, Lagana SM, Rivera MN, Sholl LM, Stone JR, Ting DT, Deshpande V |
Nature Communications | 2020 |
|
How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity.
Smorenberg A, Peters EJ, van Daele P, Nossent EJ, Muller M |
European Journal of Internal Medicine | 2020 |
|
Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients.
Dupont T, Caillat-Zucman S, Fremeaux-Bacchi V, Morin F, Lengliné E, Darmon M, Peffault de Latour R, Zafrani L, Azoulay E, Dumas G |
Chest | 2020 |
|
Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment.
Gomez-Cadena A, Spehner L, Kroemer M, Khelil MB, Bouiller K, Verdeil G, Trabanelli S, Borg C, Loyon R, Jandus C |
Cellular & molecular immunology | 2020 |
|
The Prevalence of Acute Kidney Injury in Patients Hospitalized With COVID-19 Infection: A Systematic Review and Meta-analysis.
Silver SA, Beaubien-Souligny W, Shah PS, Harel S, Blum D, Kishibe T, Meraz-Munoz A, Wald R, Harel Z |
2020 | |
|
T cell response in patients with COVID-19.
Liu L, Xu L, Lin C |
2020 | |
|
Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis.
Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, Wang F |
2020 | |
|
A Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes.
Qiu L, Jiao R, Zhang A, Chen X, Ning Q, Fang F, Zeng F, Tian N, Zhang Y, Huang Y, Sun Z, Dhuromsingh M, Li H, Li Y, Xu R, Chen Y, Luo X |
The Pediatric Infectious Disease Journal | 2020 |
|
Immunomodulation in COVID-19.
Ingraham NE, Lotfi-Emran S, Thielen BK, Techar K, Morris RS, Holtan SG, Dudley RA, Tignanelli CJ |
The lancet. Respiratory medicine | 2020 |
|
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response.
Arnaldez FI, O'Day SJ, Drake CG, Fox BA, Fu B, Urba WJ, Montesarchio V, Weber JS, Wei H, Wigginton JM, Ascierto PA |
Journal for ImmunoTherapy of Cancer | 2020 |
|
Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis.
Pothuri B, Alvarez Secord A, Armstrong DK, Chan J, Fader AN, Huh W, Kesterson J, Liu JF, Moore K, Westin SN, Naumann RW |
Gynecologic Oncology | 2020 |
|
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Colafrancesco S, Alessandri C, Conti F, Priori R |
Autoimmunity Reviews | 2020 |
|
A glimpse into the eye of the COVID-19 cytokine storm.
Kuppalli K, Rasmussen AL |
EBioMedicine | 2020 |
|
Pain: A potential new label of COVID-19.
Su S, Cui H, Wang T, Shen X, Ma C |
Brain, Behavior, and Immunity | 2020 |
|
COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.
Härter G, Spinner CD, Roider J, Bickel M, Krznaric I, Grunwald S, Schabaz F, Gillor D, Postel N, Mueller MC, Müller M, Römer K, Schewe K, Hoffmann C |
Infection | 2020 |
|
Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity.
Picchianti Diamanti A, Rosado MM, Pioli C, Sesti G, Laganà B |
International journal of molecular sciences | 2020 |
|
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.
Encinar JA, Menendez JA |
Viruses | 2020 |
|
Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019.
Latif F, Farr MA, Clerkin KJ, Habal MV, Takeda K, Naka Y, Restaino S, Sayer G, Uriel N |
JAMA Cardiology | 2020 |
|
Letter to the Editor: Kim, S.-W., Su, K.-P. (2020) Using psychoneuroimmunity against COVID-19, Brain, Behavior, and Immunity (2020), doi: https://doi.org/10.1016/j.bbi.2020.03.025.
Lazzari D, Bottaccioli AG, Bottaccioli F |
Brain, Behavior, and Immunity | 2020 |
|
The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection.
Rajaram S, Canaday LM, Ochayon DE, Rangel KM, Ali A, Gyurova IE, Krishnamurthy D, Fletcher JS, Reighard SD, Cox A, Weirauch MT, Kottyan LC, Deshmukh H, Zacharias WJ, Borchers MT, Waggoner SN |
Immunity | 2020 |
|
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China.
Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, Xie J, Guan W, Liang W, Ni Z, Hu Y, Liu L, Shan H, Lei C, Peng Y, Wei L, Liu Y, Hu Y, Peng P, Wang J, Liu J, Chen Z, Li G, Zheng Z, Qiu S, Luo J, Ye C, Zhu S, Zheng J, Zhang N, Li Y, He J, Li J, Li S, Zhong N |
Journal of Allergy and Clinical Immunology | 2020 |
|
COVID-19: implications for immunosuppression in kidney disease and transplantation.
Kronbichler A, Gauckler P, Windpessl M, Il Shin J, Jha V, Rovin BH, Oberbauer R |
Nature reviews. Nephrology | 2020 |
|
Cardiac valves: Another "Disaster-hit area" of COVID-19 patients?
Li X, Yu S |
Heart & lung : the journal of critical care | 2020 |
|
Headaches During COVID-19: My Clinical Case and Review of the Literature.
Belvis R |
Headache: The Journal of Head and Face Pain | 2020 |
|
Procalcitonin for patient stratification and identification of bacterial co-infection in COVID-19.
Han J, Gatheral T, Williams C |
2020 | |
|
Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?
Pahan P, Pahan K |
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology | 2020 |
|
Does vitamin D deficiency increase the severity of COVID-19?
Weir EK, Thenappan T, Bhargava M, Chen Y |
2020 | |
|
Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools.
Kong Q, Wu Y, Gu Y, Lv Q, Qi F, Gong S, Chen X |
Biomedicine & Pharmacotherapy | 2020 |
|
Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China.
Chen F, Sun W, Sun S, Li Z, Wang Z, Yu L |
Clinical and Translational Medicine | 2020 |
|
Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City.
Cheung EW, Zachariah P, Gorelik M, Boneparth A, Kernie SG, Orange JS, Milner JD |
Journal of the American Medical Association | 2020 |
|
Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19.
Bao J, Li C, Zhang K, Kang H, Chen W, Gu B |
Clinica chimica acta; international journal of clinical chemistry | 2020 |
|
The effects of allium sativum on immunity within the scope of COVID-19 infection.
Donma MM, Donma O |
Medical Hypotheses | 2020 |
|
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L |
Cytokine & Growth Factor Reviews | 2020 |
|
Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic.
Ling KL, Hilmi I, Raja Ali RA, Leong RWL, Leung WK, Ng SC, Wu KC, Chen MH, Ran ZH, Hisamatsu T, Ahuja V, Makharia GK, Banerjee R, Wei SC, Wu DC, Pisespongsa P, Ye BD, Sollano J, Simadibrata M, Chuah SW, Ooi CJ |
2020 | |
|
Cancer and COVID-19: Unmasking their ties.
Addeo A, Friedlaender A |
Cancer Treatment Reviews | 2020 |
|
COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge.
Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz R, Forma A, Karakuła K, Flieger W, Portincasa P, Maciejewski R |
Journal of Clinical Medicine | 2020 |
|
Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients.
Bosch-Barrera J, Martin-Castillo B, Buxó M, Brunet J, Encinar JA, Menendez JA |
Journal of Clinical Medicine | 2020 |
|
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation.
La Rosée F, Bremer HC, Gehrke I, Kehr A, Hochhaus A, Birndt S, Fellhauer M, Henkes M, Kumle B, Russo SG, La Rosée P |
Leukemia | 2020 |
|
Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.
Meng Y, Lu W, Guo E, Liu J, Yang B, Wu P, Lin S, Peng T, Fu Y, Li F, Wang Z, Li Y, Xiao R, Liu C, Huang Y, Lu F, Wu X, You L, Ma D, Sun C, Wu P, Chen G |
Journal of Hematology & Oncology | 2020 |
|
Hemoptysis in COVID-19: Pulmonary Emboli Should be Ruled Out.
Ozaras R, Uraz S |
Korean Journal of Radiology | 2020 |
|
Azithromycin for COVID-19: More Than Just an Antimicrobial?
Bleyzac N, Goutelle S, Bourguignon L, Tod M |
Clinical Drug Investigation | 2020 |
|
Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis.
Yamada T, Wakabayashi M, Yamaji T, Chopra N, Mikami T, Miyashita H, Miyashita S |
Clinica chimica acta; international journal of clinical chemistry | 2020 |
|
Elevated nucleoprotein-induced interferon-γ release in COVID-19 patients detected in a SARS-CoV-2 enzyme-linked immunosorbent spot assay.
Thijsen S, Heron M, Gremmels H, van der Kieft R, Reusken C, Kremer K, Limonard G, Bossink A |
Journal of Infection | 2020 |
|
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.
Pons S, Fodil S, Azoulay E, Zafrani L |
Critical Care | 2020 |
|
Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?
Abdullah A, Neurath MF, Atreya R |
Viszeralmedizin | 2020 |
|
Zoonotic evolution and implications of microbiome in viral transmission and infection.
Rajeev R, Prathiviraj R, Kiran GS, Selvin J |
Virus Research | 2020 |
|
Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis.
Tlayjeh H, Mhish OH, Enani MA, Alruwaili A, Tleyjeh R, Thalib L, Hassett L, Arabi YM, Kashour T, Tleyjeh IM |
Journal of Infection and Public Health | 2020 |
|
Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline.
Sieswerda E, de Boer MGJ, Bonten MMJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, Schouten JA, van de Garde EMW, Verheij TJ, van der Eerden MM, Prins JM, Wiersinga WJ |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2020 |
|
SARS-CoV-2 Vaccine Development: Current Status.
Poland GA, Ovsyannikova IG, Crooke SN, Kennedy RB |
Mayo Clinic Proceedings | 2020 |
|
COVID-19 and Sex Differences: Mechanisms and Biomarkers.
Haitao T, Vermunt JV, Abeykoon J, Ghamrawi R, Gunaratne M, Jayachandran M, Narang K, Parashuram S, Suvakov S, Garovic VD |
Mayo Clinic Proceedings | 2020 |
|
Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations.
Guadarrama-Ortiz P, Choreño-Parra JA, Sánchez-Martínez CM, Pacheco-Sánchez FJ, Rodríguez-Nava AI, García-Quintero G |
Frontiers in neurology | 2020 |
|
How COVID-19 induces cytokine storm with high mortality.
Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, Hirano T |
Ensho Saisei | 2020 |
|
Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective Study.
Ramtohul T, Cabel L, Paoletti X, Chiche L, Moreau P, Noret A, Vuagnat P, Cherel P, Tardivon A, Cottu P, Bidard FC, Servois V |
Frontiers in Oncology | 2020 |
|
Elevated D-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, Turagam MK, Lakkireddy D, Garg J |
Cardiology in Review | 2020 |
|
Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
Quintana-Ortega C, Remesal A, Ruiz de Valbuena M, de la Serna O, Laplaza-González M, Álvarez-Rojas E, Udaondo C, Alcobendas R, Murias S |
Modern Rheumatology Case Reports | 2020 |
|
Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?
Costa LHA, Santos BM, Branco LGS |
European Journal of Pharmacology | 2020 |
|
Evidence of a wide gap between COVID-19 in humans and animal models: a systematic review.
Ehaideb SN, Abdullah ML, Abuyassin B, Bouchama A |
Critical Care | 2020 |
|
Risk factors and severity predictors in COVID-19 hospitalized patients: Analysis of 52 patients: Factores de riesgo y predictores de gravedad en pacientes hospitalizados por COVID-19: análisis de 52 casos.
Marta-Enguita J, Corroza-Laviñeta J, Ostolaza A |
2020 | |
|
A higher D-dimer threshold for predicting pulmonary embolism in patients with COVID-19: a retrospective study.
Ventura-Díaz S, Quintana-Pérez JV, Gil-Boronat A, Herrero-Huertas M, Gorospe-Sarasúa L, Montilla J, Acosta-Batlle J, Blázquez-Sánchez J, Vicente-Bártulos A |
Emergency Radiology | 2020 |
|
Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China.
Wang M, Yan W, Qi W, Wu D, Zhu L, Li W, Wang X, Ma K, Ni M, Xu D, Wang H, Chen G, Yu H, Ding H, Xing M, Han M, Luo X, Chen T, Guo W, Xi D, Ning Q |
Hepatology International | 2020 |
|
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey.
Fantini MC, Biancone L, Dragoni G, Bezzio C, Miranda A, Ribaldone DG, Bertani A, Bossa F, Allocca M, Buda A, Mocci G, Soriano A, Guglielmi FW, Bertani L, Baccini F, Loddo E, Privitera AC, Sartini A, Viscido A, Grossi L, Casini V, Gerardi V, Ascolani M, Di Ruscio M, Casella G, Savarino E, Stradella D, Pumpo R, Cortelezzi CC, Daperno M, Ciardo V, Nardone OM, Caprioli F, Vitale G, Cappello M, Comberlato M, Alvisi P, Festa S, Campigotto M, Bodini G, Balestrieri P, Viola A, Pugliese D, Armuzzi A, Saibeni S, Fiorino G |
Inflammatory Bowel Diseases | 2020 |
|
Two distinct immunopathological profiles in autopsy lungs of COVID-19.
Nienhold R, Ciani Y, Koelzer VH, Tzankov A, Haslbauer JD, Menter T, Schwab N, Henkel M, Frank A, Zsikla V, Willi N, Kempf W, Hoyler T, Barbareschi M, Moch H, Tolnay M, Cathomas G, Demichelis F, Junt T, Mertz KD |
Nature Communications | 2020 |
|
Comparative ACE2 variation and primate COVID-19 risk.
Melin AD, Janiak MC, Marrone F 3rd, Arora PS, Higham JP |
2020 | |
|
Paediatric COVID-19 Infection in Iraq: Is it not prevalent or underestimated?
Al-Mendalawi MD |
Sultan Qaboos University medical journal | 2020 |
|
Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19.
Talukdar J, Bhadra B, Dattaroy T, Nagle V, Dasgupta S |
Biomedicine & Pharmacotherapy | 2020 |
|
Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt.
Ramadan HK, Mahmoud MA, Aburahma MZ, Elkhawaga AA, El-Mokhtar MA, Sayed IM, Hosni A, Hassany SM, Medhat MA |
Infection and drug resistance | 2020 |
|
The mNCP-SPI Score Predicting Risk of Severe COVID-19 among Mild-Pneumonia Patients on Admission.
Guo L, Xiong W, Liu D, Feng Y, Wang P, Dong X, Chen R, Wang Y, Zhang L, Huang J, Summah HD, Lu F, Xie Y, Lin H, Yan J, Lu H, Zhou M, Qu J |
Infection and drug resistance | 2020 |
|
Triglyceride to High-Density Lipoprotein Cholesterol Ratio is an Important Determinant of Cardiovascular Risk and Poor Prognosis in Coronavirus Disease-19: A Retrospective Case Series Study.
Zhang B, Dong C, Li S, Song X, Wei W, Liu L |
Diabetes, metabolic syndrome and obesity : targets and therapy | 2020 |
|
Stroke and Novel Coronavirus Infection in Humans: A Systematic Review and Meta-Analysis.
Lee KW, Yusof Khan AHK, Ching SM, Chia PK, Loh WC, Abdul Rashid AM, Baharin J, Inche Mat LN, Wan Sulaiman WA, Devaraj NK, Sivaratnam D, Basri H, Hoo FK |
Frontiers in neurology | 2020 |
|
A "Window of Therapeutic Opportunity" for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019.
De Stefano L, Bobbio-Pallavicini F, Manzo A, Montecucco C, Bugatti S |
Frontiers in immunology | 2020 |
|
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.
Flanagan KL, Best E, Crawford NW, Giles M, Koirala A, Macartney K, Russell F, Teh BW, Wen SC |
Frontiers in immunology | 2020 |
|
COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia.
Rahman AK, Purdy AG, Ender PT |
Case Reports in Infectious Diseases | 2020 |
|
Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis.
Boregowda U, Perisetti A, Nanjappa A, Gajendran M, Kutti Sridharan G, Goyal H |
Frontiers in Medicine | 2020 |
|
The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection.
Mok DZL, Chan CYY, Ooi EE, Chan KR |
The FEBS journal | 2020 |
|
Effect of blood analysis and immune function on the prognosis of patients with COVID-19.
Fu YQ, Sun YL, Lu SW, Yang Y, Wang Y, Xu F |
PloS one | 2020 |
|
Catecholamine physiology and its implications in patients with COVID-19.
Gubbi S, Nazari MA, Taieb D, Klubo-Gwiezdzinska J, Pacak K |
The lancet. Diabetes & endocrinology | 2020 |
|
The effect of environmental pollution on immune evasion checkpoints of SARS-CoV-2.
Engin AB, Engin ED, Engin A |
Environmental Toxicology and Pharmacology | 2020 |
|
Immune Correlates of COVID-19 Control.
Poonia B, Kottilil S |
Frontiers in immunology | 2020 |
|
Health Disparities in COVID-19: Addressing the Role of Social Determinants of Health in Immune System Dysfunction to Turn the Tide.
Baumer Y, Farmer N, Premeaux TA, Wallen GR, Powell-Wiley TM |
Frontiers in public health | 2020 |
|
Evaluation of mechanisms of action of re-purposed drugs for treatment of COVID-19.
Rajaiah R, Abhilasha KV, Shekar MA, Vogel SN, Vishwanath BS |
Cellular Immunology | 2020 |
|
COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients.
Genet B, Vidal JS, Cohen A, Boully C, Beunardeau M, Marine Harlé L, Gonçalves A, Boudali Y, Hernandorena I, Bailly H, Lenoir H, Piccoli M, Chahwakilian A, Kermanach L, de Jong L, Duron E, Girerd X, Hanon O |
Journal of the American Medical Directors Association | 2020 |
|
Complement activation and endothelial perturbation parallel COVID-19 severity and activity.
Cugno M, Meroni PL, Gualtierotti R, Griffini S, Grovetti E, Torri A, Lonati P, Grossi C, Borghi MO, Novembrino C, Boscolo M, Uceda Renteria SC, Valenti L, Lamorte G, Manunta M, Prati D, Pesenti A, Blasi F, Costantino G, Gori A, Bandera A, Tedesco F, Peyvandi F |
Journal of Autoimmunity | 2020 |
|
COVID-19 gender susceptibility and outcomes: A systematic review.
Lakbar I, Luque-Paz D, Mege JL, Einav S, Leone M |
PloS one | 2020 |
|
Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19.
Husain-Syed F, Vadász I, Wilhelm J, Walmrath HD, Seeger W, Birk HW, Jennert B, Dietrich H, Herold S, Trauth J, Tello K, Sander M, Morty RE, Slanina H, Schüttler CG, Ziebuhr J, Kassoumeh S, Ronco C, Ferrari F, Warnatz K, Stahl K, Seeliger B, Hoeper MM, Welte T, David S |
American journal of physiology. Lung cellular and molecular physiology | 2020 |
|
Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.
Zhang Y, Chen Y, Meng Z |
Frontiers in immunology | 2020 |
|
A Shift Towards an Immature Myeloid Profile in Peripheral Blood of Critically Ill COVID-19 Patients.
Vadillo E, Taniguchi-Ponciano K, Lopez-Macias C, Carvente-Garcia R, Mayani H, Ferat-Osorio E, Flores-Padilla G, Torres J, Gonzalez-Bonilla CR, Majluf A, Albarran-Sanchez A, Galan JC, Peña-Martínez E, Silva-Román G, Vela-Patiño S, Ferreira-Hermosillo A, Ramirez-Renteria C, Espinoza-Sanchez NA, Pelayo-Camacho R, Bonifaz L, Arriaga-Pizano L, Mata-Lozano C, Andonegui-Elguera S, Wacher N, Blanco-Favela F, De-Lira-Barraza R, Villanueva-Compean H, Esquivel-Pineda A, Ramírez-Montes-de-Oca R, Anda-Garay C, Noyola-García M, Guizar-García L, Cerbulo-Vazquez A, Zamudio-Meza H, Marrero-Rodríguez D, Mercado M |
Archives of Medical Research | 2020 |
|
Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia?
Laganà AS, Unfer V, Garzon S, Bizzarri M |
Medical Hypotheses | 2020 |
|
Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study.
Liu QQ, Cheng A, Wang Y, Li H, Hu L, Zhao X, Wang T, He F |
BMJ Open | 2020 |
|
Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.
Dolan ME, Hill DP, Mukherjee G, McAndrews MS, Chesler EJ, Blake JA |
Scientific Reports | 2020 |
|
Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19.
S SLJ, V R |
Pulmonary Pharmacology & Therapeutics | 2020 |
|
Immunological Evaluation on Potential Treatment Window for Hospitalized COVID-19 Patients.
Yuan J, Kou S, Liang Y, Lan J, Li X, Zeng L, Zou R, Liu Y, Liu L, Pan Y |
Journal of inflammation research | 2020 |
|
Right Atrial Thrombus in a COVID-19 Child Treated Through Cardiac Surgery.
Bigdelian H, Sedighi M, Sabri MR, Dehghan B, Pourmoghaddas Z, Saleh R, Sherafat A, Massoumi G, Rezaei MK, Shahbazi M |
Frontiers in Cardiovascular Medicine | 2020 |
|
Antimicrobial Management of Respiratory Infections in Severe Acute Respiratory Syndrome Coronavirus 2 Patients: Clinical and Antimicrobial Stewardship Programs Conundrums.
Goldstein EJC, Tillotson G, Redell M |
Open Forum Infectious Diseases | 2020 |
|
Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency.
Delavari S, Abolhassani H, Abolnezhadian F, Babaha F, Iranparast S, Ahanchian H, Moazzen N, Nabavi M, Arshi S, Fallahpour M, Bemanian MH, Shokri S, Momen T, Sadeghi-Shabestari M, Molatefi R, Shirkani A, Vosughimotlagh A, Safarirad M, Sharifzadeh M, Pashangzadeh S, Salami F, Shirmast P, Rezaei A, Moeini Shad T, Mohraz M, Rezaei N, Hammarström L, Yazdani R, Aghamohamamdi A |
Journal of Clinical Immunology | 2020 |
|
COVID-19 gastrointestinal manifestations: a systematic review.
Silva FAFD, Brito BB, Santos MLC, Marques HS, Silva Júnior RTD, Carvalho LS, Vieira ES, Oliveira MV, Melo FF |
Revista da Sociedade Brasileira de Medicina Tropical | 2020 |
|
Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis.
Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Shojaie L, Sedighi S, Shamshirian D, Rezaei N |
The American Journal of Emergency Medicine | 2020 |
|
Large-vessel thrombotic stroke despite concurrent therapeutic anticoagulation in COVID-19-positive patient.
Shoukry A, Kite TA |
Oxford Medical Case Reports | 2020 |
|
Systemic microvascular endothelial dysfunction and disease severity in COVID-19 patients: Evaluation by laser Doppler perfusion monitoring and cytokine/chemokine analysis.
Sabioni L, De Lorenzo A, Lamas C, Muccillo F, Castro-Faria-Neto HC, Estato V, Tibirica E |
Microvascular Research | 2020 |
|
Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective.
Malik YS, Kumar N, Sircar S, Kaushik R, Bhat S, Dhama K, Gupta P, Goyal K, Singh MP, Ghoshal U, El Zowalaty ME, O R V, Yatoo MI, Tiwari R, Pathak M, Patel SK, Sah R, Rodriguez-Morales AJ, Ganesh B, Kumar P, Singh RK |
2020 | |
|
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19.
García LF |
Frontiers in immunology | 2020 |
|
Glycemic control before admission is an important determinant of prognosis in patients with coronavirus disease 2019.
Liu L, Wei W, Yang K, Li S, Yu X, Dong C, Zhang B |
Journal of Diabetes Investigation | 2020 |
|
SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
Li S, Zhang Y, Guan Z, Li H, Ye M, Chen X, Shen J, Zhou Y, Shi ZL, Zhou P, Peng K |
Signal Transduction and Targeted Therapy | 2020 |
|
COVID-19: Discovery, diagnostics and drug development.
Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF |
Journal of Hepatology | 2020 |
|
Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression: A Case Report.
Mathiasen VD, Oversoe SK, Ott P, Jensen-Fangel S, Leth S |
Transplantation Proceedings | 2020 |
|
Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes.
Zhang D, Guo R, Lei L, Liu H, Wang Y, Wang Y, Qian H, Dai T, Zhang T, Lai Y, Wang J, Liu Z, Chen T, He A, O'Dwyer M, Hu J |
Journal of leukocyte biology | 2020 |
|
Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.
Zinovkin RA, Grebenchikov OA |
Biochemistry (Moscow) | 2020 |
|
Fungal co-infection in COVID-19 patients: Should we be concerned?
Pemán J, Ruiz-Gaitán A, García-Vidal C, Salavert M, Ramírez P, Puchades F, García-Hita M, Alastruey-Izquierdo A, Quindós G |
2020 | |
|
Commentary: APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort.
Kasparian K, Graykowski D, Cudaback E |
Frontiers in immunology | 2020 |
|
Demographics, laboratory parameters and outcomes of 1061 patients with coronavirus disease 2019: a report from Tehran, Iran.
Pourabdollah Toutkaboni M, Askari E, Khalili N, Tabarsi P, Jamaati H, Velayati AA, Dorudinia A, Rezaei M, Nadji SA, Mohamadnia A, Khalili N |
New Microbes and New Infections | 2020 |
|
Retrospective Analysis of Inflammatory Markers and Patient Characteristics in Hospitalized Covid-19 Patients: An Early Experience in Louisiana.
Miatech JL, Yaslik CP, Tarleton HE, West D, Kellum W, McKnight M, Stagg MP |
Cureus | 2020 |
|
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid.
Calles A, Aparicio MI, Alva M, Bringas M, Gutierrez N, Soto J, Arregui M, Tirado VC, Álvarez EL, Del Monte-Millán M, Massarrah T, Galera M, Álvarez R, Martín M |
Frontiers in Oncology | 2020 |
|
Puzzling out the COVID-19: Therapy targeting HLA-G and HLA-E.
Zidi I |
Human Immunology | 2020 |
|
Poxvirus-encoded TNF receptor homolog dampens inflammation and protects from uncontrolled lung pathology during respiratory infection.
Al Rumaih Z, Tuazon Kels MJ, Ng E, Pandey P, Pontejo SM, Alejo A, Alcamí A, Chaudhri G, Karupiah G |
Proceedings of the National Academy of Sciences | 2020 |
|
Clinical characteristics and prognostic factors of COVID-19 patients progression to severe: a retrospective, observational study.
Liao Y, Feng Y, Wang B, Wang H, Huang J, Wu Y, Wu Z, Chen X, Yang C, Fu X, Sun H |
Aging | 2020 |
|
Emergency Department Management of COVID-19: An Evidence-Based Approach.
McManus NM, Offman R, Oetman JD |
The western journal of emergency medicine | 2020 |
|
Genetic Risk of Severe Covid-19.
Kaser A |
The New England journal of medicine | 2020 |
|
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, Bullock TA, McGary HM, Khan JA, Razmpour R, Hale JF, Galie PA, Potula R, Andrews AM, Ramirez SH |
Neurobiology of Disease | 2020 |
|
The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19.
Hoiland RL, Fergusson NA, Mitra AR, Griesdale DEG, Devine DV, Stukas S, Cooper J, Thiara S, Foster D, Chen LYC, Lee AYY, Conway EM, Wellington CL, Sekhon MS |
Blood Advances | 2020 |
|
Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.
Mulchandani R, Lyngdoh T, Kakkar AK |
European Journal of Clinical Investigation | 2020 |
|
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.
Gordon DE, Hiatt J, Bouhaddou M, Rezelj VV, Ulferts S, Braberg H, Jureka AS, Obernier K, Guo JZ, Batra J, Kaake RM, Weckstein AR, Owens TW, Gupta M, Pourmal S, Titus EW, Cakir M, Soucheray M, McGregor M, Cakir Z, Jang G, O'Meara MJ, Tummino TA, Zhang Z, Foussard H, Rojc A, Zhou Y, Kuchenov D, Hüttenhain R, Xu J, Eckhardt M, Swaney DL, Fabius JM, Ummadi M, Tutuncuoglu B, Rathore U, Modak M, Haas P, Haas KM, Naing ZZC, Pulido EH, Shi Y, Barrio-Hernandez I, Memon D, Petsalaki E, Dunham A, Marrero MC, Burke D, Koh C, Vallet T, Silvas JA, Azumaya CM, Billesbølle C, Brilot AF, Campbell MG, Diallo A, Dickinson MS, Diwanji D, Herrera N, Hoppe N, Kratochvil HT, Liu Y, Merz GE, Moritz M, Nguyen HC, Nowotny C, Puchades C, Rizo AN, Schulze-Gahmen U, Smith AM, Sun M, Young ID, Zhao J, Asarnow D, Biel J, Bowen A, Braxton JR, Chen J, Chio CM, Chio US, Deshpande I, Doan L, Faust B, Flores S, Jin M, Kim K, Lam VL, Li F, Li J, Li YL, Li Y, Liu X, Lo M, Lopez KE, Melo AA, Moss FR 3rd, Nguyen P, Paulino J, Pawar KI, Peters JK, Pospiech TH Jr, Safari M, Sangwan S, Schaefer K, Thomas PV, Thwin AC, Trenker R, Tse E, Tsui TKM, Wang F, Whitis N, Yu Z, Zhang K, Zhang Y, Zhou F, Saltzberg D, Hodder AJ, Shun-Shion AS, Williams DM, White KM, Rosales R, Kehrer T, Miorin L, Moreno E, Patel AH, Rihn S, Khalid MM, Vallejo-Gracia A, Fozouni P, Simoneau CR, Roth TL, Wu D, Karim MA, Ghoussaini M, Dunham I, Berardi F, Weigang S, Chazal M, Park J, Logue J, McGrath M, Weston S, Haupt R, Hastie CJ, Elliott M, Brown F, Burness KA, Reid E, Dorward M, Johnson C, Wilkinson SG, Geyer A, Giesel DM, Baillie C, Raggett S, Leech H, Toth R, Goodman N, Keough KC, Lind AL, Klesh RJ, Hemphill KR, Carlson-Stevermer J, Oki J, Holden K, Maures T, Pollard KS, Sali A, Agard DA, Cheng Y, Fraser JS, Frost A, Jura N, Kortemme T, Manglik A, Southworth DR, Stroud RM, Alessi DR, Davies P, Frieman MB, Ideker T, Abate C, Jouvenet N, Kochs G, Shoichet B, Ott M, Palmarini M, Shokat KM, García-Sastre A, Rassen JA, Grosse R, Rosenberg OS, Verba KA, Basler CF, Vignuzzi M, Peden AA, Beltrao P, Krogan NJ |
Science (New York, N.Y.) | 2020 |
|
Herpes Zoster and Postherpetic Neuralgia in an Elderly Patient with Critical COVID-19: A Case Report.
Cao X, Zhang X, Meng W, Zheng H |
Journal of pain research | 2020 |
|
Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.
Zhao R, Sun Y, Zhang Y, Wang W, Wang S, Wang C, Liu J, Gao L, Hu Z, Fei J, Hou X, Zheng H, Chen L |
Mediators of Inflammation | 2020 |
|
The Association of Inflammatory Cytokines in the Pulmonary Pathophysiology of Respiratory Failure in Critically Ill Patients With Coronavirus Disease 2019.
Stukas S, Hoiland RL, Cooper J, Thiara S, Griesdale DE, Thomas AD, Orde MM, English JC, Chen LYC, Foster D, Mitra AR, Romano K, Sweet DD, Ronco JJ, Kanji HD, Chen YR, Wong SL, Wellington CL, Sekhon MS |
2020 | |
|
Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy.
Shabalin IG, Czub MP, Majorek KA, Brzezinski D, Grabowski M, Cooper DR, Panasiuk M, Chruszcz M, Minor W |
IUCrJ | 2020 |
|
Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques.
Aid M, Busman-Sahay K, Vidal SJ, Maliga Z, Bondoc S, Starke C, Terry M, Jacobson CA, Wrijil L, Ducat S, Brook OR, Miller AD, Porto M, Pellegrini KL, Pino M, Hoang TN, Chandrashekar A, Patel S, Stephenson K, Bosinger SE, Andersen H, Lewis MG, Hecht JL, Sorger PK, Martinot AJ, Estes JD, Barouch DH |
Cell | 2020 |
|
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.
Poland GA, Ovsyannikova IG, Kennedy RB |
2020 | |
|
Silent hypoxia: higher NO in red blood cells of COVID-19 patients.
Mortaz E, Malkmohammad M, Jamaati H, Naghan PA, Hashemian SM, Tabarsi P, Varahram M, Zaheri H, Chousein EGU, Folkerts G, Adcock IM |
BMC Pulmonary Medicine | 2020 |
|
Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
Vetter P, Eberhardt CS, Meyer B, Martinez Murillo PA, Torriani G, Pigny F, Lemeille S, Cordey S, Laubscher F, Vu DL, Calame A, Schibler M, Jacquerioz F, Blanchard-Rohner G, Siegrist CA, Kaiser L, Didierlaurent AM, Eckerle I |
mSphere | 2020 |
|
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.
Borghi MO, Beltagy A, Garrafa E, Curreli D, Cecchini G, Bodio C, Grossi C, Blengino S, Tincani A, Franceschini F, Andreoli L, Lazzaroni MG, Piantoni S, Masneri S, Crisafulli F, Brugnoni D, Muiesan ML, Salvetti M, Parati G, Torresani E, Mahler M, Heilbron F, Pregnolato F, Pengo M, Tedesco F, Pozzi N, Meroni PL |
Frontiers in immunology | 2020 |
|
Coronavirus Disease 2019 (COVID-19) in a Patient with Disseminated Histoplasmosis and HIV-A Case Report from Argentina and Literature Review.
Messina FA, Marin E, Caceres DH, Romero M, Depardo R, Priarone MM, Rey L, Vázquez M, Verweij PE, Chiller TM, Santiso G |
2020 | |
|
COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a+.
Anft M, Paniskaki K, Blazquez-Navarro A, Doevelaar A, Seibert FS, Hölzer B, Skrzypczyk S, Kohut E, Kurek J, Zapka J, Wehler P, Kaliszczyk S, Bajda S, Thieme CJ, Roch T, Konik MJ, Berger MM, Brenner T, Kölsch U, Meister TL, Pfaender S, Steinmann E, Tempfer C, Watzl C, Dolff S, Dittmer U, Abou-El-Enein M, Westhoff TH, Witzke O, Stervbo U, Babel N |
Molecular Therapy | 2020 |
|
Severe liver injury of coronavirus disease 2019 (COVID-19) in recovery.
Zhou WQ, Chen Y, Liu D, Yang DL, Zheng X |
Journal of Digestive Diseases | 2020 |
|
Clinical and laboratory characteristics of patients with novel coronavirus disease-2019 infection and deep venous thrombosis.
Motaganahalli RL, Kapoor R, Timsina LR, Gutwein AR, Ingram MD, Raman S, Roberts SD, Rahman O, Rollins D, Dalsing MC |
Journal of vascular surgery. Venous and lymphatic disorders | 2020 |
|
Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia.
Alonso-Lana S, Marquié M, Ruiz A, Boada M |
Frontiers in aging neuroscience | 2020 |
|
Heparin Therapy Improving Hypoxia in COVID-19 Patients - A Case Series.
Negri EM, Piloto BM, Morinaga LK, Jardim CVP, Lamy SAE, Ferreira MA, D'Amico EA, Deheinzelin D |
Frontiers in physiology | 2020 |
|
COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management.
Wang Z, Yang Y, Liang X, Gao B, Liu M, Li W, Chen Z, Wang Z |
Frontiers in neurology | 2020 |
|
[SARS-CoV-2 infection in a patient treated by hydroxychloroquine and anti TNF α for Inflammatory Rheumatic Disease].
Malek SA, Bouchti IE |
The Pan African medical journal | 2020 |
|
Hematological characteristics of patients in coronavirus 19 infection: a systematic review and meta-analysis.
Asghar M, Hussain N, Shoaib H, Kim M, Lynch TJ |
Journal of Community Hospital Internal Medicine Perspectives | 2020 |
|
SARS-CoV-2 Infected Patient: from a Hematologist's Perspective.
Kreidieh F, Temraz S |
Mediterranean journal of hematology and infectious diseases | 2020 |
|
COVID-19-Induced Hepatic Injury: A Systematic Review and Meta-Analysis.
Abdulla S, Hussain A, Azim D, Abduallah EH, Elawamy H, Nasim S, Kumar S, Naveed H |
Cureus | 2020 |
|
Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?
Liu D, Zhang T, Wang Y, Xia L |
Frontiers in Medicine | 2020 |
|
Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients.
Guo H, Sheng Y, Li W, Li F, Xie Z, Li J, Zhu Y, Geng J, Liu G, Wang L, Li J, Wang F |
Frontiers in Medicine | 2020 |
|
Covid-19 Quarantine: Impact of Lifestyle Behaviors Changes on Endothelial Function and Possible Protective Effect of Beetroot Juice.
Volino-Souza M, de Oliveira GV, Conte-Junior CA, Alvares TS |
Frontiers in Nutrition | 2020 |
|
Vascular Manifestations of COVID-19 - Thromboembolism and Microvascular Dysfunction.
Roberts KA, Colley L, Agbaedeng TA, Ellison-Hughes GM, Ross MD |
Frontiers in Cardiovascular Medicine | 2020 |
|
Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients.
Yang Q, Yang X |
PloS one | 2020 |
|
SARS-CoV-2 Proteins Induce IFNG in Th1 Lymphocytes Generated from CD4+ Cells from Healthy, Unexposed Polish Donors.
Sałkowska A, Karwaciak I, Karaś K, Dastych J, Ratajewski M |
Human vaccines | 2020 |
|
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
Arnold F, Westermann L, Rieg S, Neumann-Haefelin E, Biever PM, Walz G, Kalbhenn J, Tanriver Y |
BMC Nephrology | 2020 |
|
Similarities and differences between the 'cytokine storms' in acute dengue and COVID-19.
Dayarathna S, Jeewandara C, Gomes L, Somathilaka G, Jayathilaka D, Vimalachandran V, Wijewickrama A, Narangoda E, Idampitiya D, Ogg GS, Malavige GN |
Scientific Reports | 2020 |
|
Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.
Zhang J, Wu Q, Liu Z, Wang Q, Wu J, Hu Y, Bai T, Xie T, Huang M, Wu T, Peng D, Huang W, Jin K, Niu L, Guo W, Luo D, Lei D, Wu Z, Li G, Huang R, Lin Y, Xie X, He S, Deng Y, Liu J, Li W, Lu Z, Chen H, Zeng T, Luo Q, Li YP, Wang Y, Liu W, Qu X |
Nature Microbiology | 2020 |
|
Anticoagulation in COVID - 19: An Update.
Tiwari NR, Khatib KI, Dixit SB, Rathore PK, Melinkeri S, Ganapule A, Borawake KS, Mhatre U |
2020 | |
|
Dynamic monitoring of immune function indexes in COVID-19 patients.
Song Y, Zhong H, Li L, Yin M, Yin Y, Guo X, Zhang B, Liu W |
Aging | 2020 |
|
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes.
Lombardi A, Trombetta E, Cattaneo A, Castelli V, Palomba E, Tirone M, Mangioni D, Lamorte G, Manunta M, Prati D, Ceriotti F, Gualtierotti R, Costantino G, Aliberti S, Scaravilli V, Grasselli G, Gori A, Porretti L, Bandera A |
Frontiers in immunology | 2020 |
|
Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
Zeng Q, Li YZ, Dong SY, Chen ZT, Gao XY, Zhang H, Huang G, Xu Y |
Frontiers in immunology | 2020 |
|
Gastrointestinal and hepatic manifestations of COVID-19: A systematic review and meta-analysis.
Dorrell RD, Dougherty MK, Barash EL, Lichtig AE, Clayton SB, Jensen ET |
2020 | |
|
COVID-19 pneumonia with back pain: Presentation of an acute pulmonary embolism associated with novel coronavirus infection in an outpatient setting.
Davis K |
Clinical Case Reports | 2020 |
|
Cell-mediated immunity to SARS-CoV-2.
Wang X, Gui J |
2020 | |
|
Technical considerations to development of serological tests for SARS-CoV-2.
Ernst E, Wolfe P, Stahura C, Edwards KA |
Talanta | 2020 |
|
Coronavirus Receptors as Immune Modulators.
Devarakonda CKV, Meredith E, Ghosh M, Shapiro LH |
Journal of immunology (Baltimore, Md. : 1950) | 2020 |
|
SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It?
Fernandes IG, de Brito CA, Dos Reis VMS, Sato MN, Pereira NZ |
Oxidative medicine and cellular longevity | 2020 |
|
Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment.
Mello MT, Silva A, Guerreiro RC, da-Silva FR, Esteves AM, Poyares D, Piovezan R, Treptow E, Starling M, Rosa DS, Pires GN, Andersen ML, Tufik S |
2020 | |
|
Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.
Gorham J, Moreau A, Corazza F, Peluso L, Ponthieux F, Talamonti M, Izzi A, Nagant C, Ndieugnou Djangang N, Garufi A, Creteur J, Taccone FS |
PloS one | 2020 |
|
Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis.
Han Q, Guo M, Zheng Y, Zhang Y, De Y, Xu C, Zhang L, Sun R, Lv Y, Liang Y, Xu F, Pang J, Chen Y |
Frontiers in pharmacology | 2020 |
|
The plausible mechanisms of tramadol for treatment of COVID-19.
El-Ashmawy NE, Lashin AA, Okasha KM, Abo Kamer AM, Mostafa TM, El-Aasr M, Goda AE, Haggag YA, Tawfik HO, Abo-Saif MA |
Medical Hypotheses | 2020 |
|
Immediate Amelioration of Severe Respiratory Distress in Sjögren's Syndrome with COVID-19 Treated with a Single Dose of Off-label Tocilizumab.
Kataoka H, Kodama F, Tomita T, Kondo M, Nagasaka A, Nishikawa S, Mukai M |
Internal Medicine | 2020 |
|
Pain as clinical manifestations of COVID-19 infection and its management in the pandemic era: a literature review.
Widyadharma IPE, Sari NNSP, Pradnyaswari KE, Yuwana KT, Adikarya IPGD, Tertia C, Wijayanti IAS, Indrayani IAS, Utami DKI |
2020 | |
|
SARS-CoV-2 reinfection and implications for vaccine development.
Nainu F, Abidin RS, Bahar MA, Frediansyah A, Emran TB, Rabaan AA, Dhama K, Harapan H |
Human Vaccines & Immunotherapeutics | 2020 |
|
Elevated interleukin levels are associated with higher severity and mortality in COVID 19 - A systematic review, meta-analysis, and meta-regression.
Yonas E, Alwi I, Pranata R, Huang I, Lim MA, Yamin M, Nasution SA, Setiati S, Virani SS |
Diabetes & metabolic syndrome | 2020 |
|
From quarantine room: Physician perspective.
Bawaskar HS, Bawaskar PH |
Journal of Family Medicine and Primary Care | 2020 |
|
Clinical Characteristics, Treatment, and Outcomes of Critically Ill Patients With COVID-19: A Scoping Review.
Huang C, Soleimani J, Herasevich S, Pinevich Y, Pennington KM, Dong Y, Pickering BW, Barwise AK |
Mayo Clinic Proceedings | 2020 |
|
Impairment in selenocysteine synthesis as a candidate mechanism of inducible coagulopathy in COVID-19 patients.
Vavougios GD, Ntoskas KT, Doskas TK |
Medical Hypotheses | 2020 |
|
Prognostic value of lung ultrasound and its link with inflammatory biomarkers in patients with SARS-CoV-2 infection.
Wangüemert Pérez AL, Figueira Gonçalves JM, Hernández Pérez JM, Ramallo Fariña Y, Del Castillo Rodriguez JC |
2020 | |
|
[Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19].
Deng F, Zhang L, Lyu L, Lu Z, Gao D, Ma X, Guo Y, Wang R, Gong S, Jiang W |
2020 | |
|
Tackling the COVID-19 "cytokine storm" with microRNA mimics directly targeting the 3'UTR of pro-inflammatory mRNAs.
Gasparello J, Finotti A, Gambari R |
Medical Hypotheses | 2020 |
|
Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection.
Vomero M, Barbati C, Colasanti T, Celia AI, Speziali M, Ucci FM, Ciancarella C, Conti F, Alessandri C |
Frontiers in pharmacology | 2020 |
|
Risk factors and predictors associated with the severity of COVID-19 in China: a systematic review, meta-analysis, and meta-regression.
Zhang T, Huang WS, Guan W, Hong Z, Gao J, Gao G, Wu G, Qin YY |
Journal of Thoracic Disease | 2020 |
|
[Update on COVID-19 and mental health].
Rodríguez-Quiroga A, Buiza C, Mon MAÁ, Quintero J |
Medicine | 2020 |
|
Paper biosensors for detecting elevated IL-6 levels in blood and respiratory samples from COVID-19 patients.
Adrover-Jaume C, Alba-Patiño A, Clemente A, Santopolo G, Vaquer A, Russell SM, Barón E, González Del Campo MDM, Ferrer JM, Berman-Riu M, García-Gasalla M, Aranda M, Borges M, de la Rica R |
Sensors and actuators. B, Chemical | 2020 |
|
Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis.
Ignatius EH, Wang K, Karaba A, Robinson M, Avery RK, Blair P, Chida N, Jain T, Petty BG, Siddiqui Z, Melia MT, Auwaerter PG, Xu Y, Garibaldi BT |
Open Forum Infectious Diseases | 2020 |
|
[Can SARS-CoV-2 be a Risk Factor for Pulmonary Aspergillosis?]
García Clemente M, Hermida Valverde T, Leizaola-Irigoyen O, Enríquez Rodríguez AI, Arias Guillén M, Telenti Asensio M, García Carus E, Peláez García T |
2020 | |
|
Delivering Safe and Effective Hemodialysis in Patients with Suspected or Confirmed COVID-19 Infection: A Single-Center Perspective from Italy.
Gallieni M, Sabiu G, Scorza D |
2020 | |
|
Decrease of Non‐Classical and Intermediate Monocyte Subsets in Severe Acute SARS‐CoV‐2 Infection
Gatti A, Radrizzani D, Viganò P, Mazzone A, Brando B |
Cytometry Part A | 2020 |
|
IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19
Leija-Martínez JJ, Huang F, Del-Río-Navarro BE, Sanchéz-Muñoz F, Muñoz-Hernández O, Giacoman-Martínez A, Hall-Mondragon MS, Espinosa-Velazquez D |
Medical Hypotheses | 2020 |
|
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.
Scaldaferri F, Ianiro G, Privitera G, Lopetuso LR, Vetrone LM, Petito V, Pugliese D, Neri M, Cammarota G, Ringel Y, Costamagna G, Gasbarrini A, Boskoski I, Armuzzi A |
Inflammatory Bowel Diseases | 2020 |
|
Low Albumin Levels Are Associated with Poorer Outcomes in a Case Series of COVID-19 Patients in Spain: A Retrospective Cohort Study.
de la Rica R, Borges M, Aranda M, Del Castillo A, Socias A, Payeras A, Rialp G, Socias L, Masmiquel L, Gonzalez-Freire M |
Microorganisms | 2020 |
|
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.
Zheng C, Kar I, Chen CK, Sau C, Woodson S, Serra A, Abboud H |
CNS Drugs | 2020 |
|
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy.
Montesarchio V, Parrela R, Iommelli C, Bianco A, Manzillo E, Fraganza F, Palumbo C, Rea G, Murino P, De Rosa R, Atripaldi L, D'Abbraccio M, Curvietto M, Mallardo D, Celentano E, Grimaldi AM, Palla M, Trojaniello C, Vitale MG, Million-Weaver SL, Ascierto PA |
Journal for ImmunoTherapy of Cancer | 2020 |
|
Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
Huang L, Zhao X, Qi Y, Li H, Ye G, Liu Y, Zhang Y, Gou J |
Cellular & molecular immunology | 2020 |
|
When two for the price of one isn't a bargain: estimating prevalence and microbiology of bacterial co-infections in patients with COVID-19.
Thaden JT, Maskarinec SA |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2020 |
|
The role of Interleukin 6 inhibitors in therapy of severe COVID-19.
Nasonov E, Samsonov M |
Biomedicine & Pharmacotherapy | 2020 |
|
Congenital Bleeding Disorders amid the COVID-19 pandemic: Open questions and recommendations.
Naderi M, Malek F, Miri Aliabad G, Behnampoor M, Karimi M, De Sanctis V |
Acta bio-medica : Atenei Parmensis | 2020 |
|
Pathways in the Pathophysiology of Coronavirus 19 Lung Disease Accessible to Prevention and Treatment.
Eisenhut M, Shin JI |
Frontiers in physiology | 2020 |
|
Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
Gujar S, Pol JG, Kim Y, Kroemer G |
OncoImmunology | 2020 |
|
COVID-19, Companion Animals, Comparative Medicine, and One Health.
Mobasheri A |
Frontiers in Veterinary Science | 2020 |
|
COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications.
Yamamoto V, Bolanos JF, Fiallos J, Strand SE, Morris K, Shahrokhinia S, Cushing TR, Hopp L, Tiwari A, Hariri R, Sokolov R, Wheeler C, Kaushik A, Elsayegh A, Eliashiv D, Hedrick R, Jafari B, Johnson JP, Khorsandi M, Gonzalez N, Balakhani G, Lahiri S, Ghavidel K, Amaya M, Kloor H, Hussain N, Huang E, Cormier J, Wesson Ashford J, Wang JC, Yaghobian S, Khorrami P, Shamloo B, Moon C, Shadi P, Kateb B |
Journal of Alzheimer's disease : JAD | 2020 |
|
The Effect of the COVID-19 Pandemic on People with Parkinson's Disease.
Brown EG, Chahine LM, Goldman SM, Korell M, Mann E, Kinel DR, Arnedo V, Marek KL, Tanner CM |
Journal of Parkinson's disease | 2020 |
|
A Telemedicine Approach to Covid-19 Assessment and Triage.
Reiss AB, De Leon J, Dapkins IP, Shahin G, Peltier MR, Goldberg ER |
2020 | |
|
Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients.
Wang Z, Pan H, Jiang B |
Signal Transduction and Targeted Therapy | 2020 |
|
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2.
Mudgal R, Nehul S, Tomar S |
Human Vaccines & Immunotherapeutics | 2020 |
|
Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany.
Shoumariyeh K, Biavasco F, Ihorst G, Rieg S, Nieters A, Kern WV, Miething C, Duyster J, Engelhardt M, Bertz H |
Cancer Medicine | 2020 |
|
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis.
Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M, Gabrilove JL, Sacks H |
2020 | |
|
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19.
Sugiyama M, Kinoshita N, Ide S, Nomoto H, Nakamoto T, Saito S, Ishikane M, Kutsuna S, Hayakawa K, Hashimoto M, Suzuki M, Izumi S, Hojo M, Tsuchiya K, Gatanaga H, Takasaki J, Usami M, Kano T, Yanai H, Nishida N, Kanto T, Sugiyama H, Ohmagari N, Mizokami M |
Gene | 2020 |
|
Candesartan could ameliorate the COVID-19 cytokine storm.
Elkahloun AG, Saavedra JM |
Biomedicine & Pharmacotherapy | 2020 |
|
Autopsy Findings in 32 Patients with COVID-19: A Single-Institution Experience.
Elsoukkary SS, Mostyka M, Dillard A, Berman DR, Ma LX, Chadburn A, Yantiss RK, Jessurun J, Seshan SV, Borczuk AC, Salvatore SP |
Pathobiology | 2020 |
|
SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients.
Parrill A, Tsao T, Dong V, Huy NT |
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2020 |
|
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L |
Thrombosis Research | 2020 |
|
Lymphocyte Subset Counts in COVID‐19 Patients: A Meta‐Analysis
Huang W, Berube J, McNamara M, Saksena S, Hartman M, Arshad T, Bornheimer SJ, O'Gorman M |
Cytometry Part A | 2020 |
|
How to Build the Plane While Flying: VTE/PE Thromboprophylaxis Clinical Guidelines for COVID-19 Patients
Costa A, Weinstein ES, Sahoo DR, Thompson SC, Faccincani R, Ragazzoni L |
Disaster Medicine and Public Health Preparedness | 2020 |
|
Cardiac inflammation in COVID-19: Lessons from heart failure
Unudurthi SD, Luthra P, Bose RJ, McCarthy JR, Kontaridis MI |
Life Sciences | 2020 |
|
COVID-19 and Liver Damage: Narrative Review and Proposed Clinical Protocol for Critically ill Pediatric Patients
Luglio M, Tannuri U, de Carvalho WB, de Medeiros Bastos KL, Rodriguez IS, Johnston C, Delgado AF |
Clinics | 2020 |
|
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.
Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, Perricone R, Gerli R |
Journal of Autoimmunity | 2020 |
|
COVID-19 and the Kidney: From Epidemiology to Clinical Practice.
Gagliardi I, Patella G, Michael A, Serra R, Provenzano M, Andreucci M |
Journal of Clinical Medicine | 2020 |
|
Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19.
Keller MJ, Kitsis EA, Arora S, Chen JT, Agarwal S, Ross MJ, Tomer Y, Southern W |
Journal of Hospital Medicine | 2020 |
|
Vitamin D Supplementation in COVID-19 Patients: A Clinical Case Series.
Ohaegbulam KC, Swalih M, Patel P, Smith MA, Perrin R |
American Journal of Therapeutics | 2020 |
|
Driving Force of Covid-19 Among People Living With HIV/AIDS in Wuhan, China.
Guo W, Ming F, Dong Y, Zhang Q, Liu L, Gao M, Zhang X, Mo P, Feng Y, Tang W, Liang K |
Research square | 2020 |
|
Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study.
Shahjouei S, Naderi S, Li J, Khan A, Chaudhary D, Farahmand G, Male S, Griessenauer C, Sabra M, Mondello S, Cernigliaro A, Khodadadi F, Dev A, Goyal N, Ranji-Burachaloo S, Olulana O, Avula V, Ebrahimzadeh SA, Alizada O, Hancı MM, Ghorbani A, Vaghefi Far A, Ranta A, Punter M, Ramezani M, Ostadrahimi N, Tsivgoulis G, Fragkou PC, Nowrouzi-Sohrabi P, Karofylakis E, Tsiodras S, Neshin Aghayari Sheikh S, Saberi A, Niemelä M, Rezai Jahromi B, Mowla A, Mashayekhi M, Bavarsad Shahripour R, Sajedi SA, Ghorbani M, Kia A, Rahimian N, Abedi V, Zand R |
EBioMedicine | 2020 |
|
Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
Elshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin MN, Hussein MH, Killackey MT, Fawzy MS, Kandil E |
PloS one | 2020 |
|
Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches.
Beltrán-García J, Osca-Verdegal R, Pallardó FV, Ferreres J, Rodríguez M, Mulet S, Ferrando-Sánchez C, Carbonell N, García-Giménez JL |
Critical Care Medicine | 2020 |
|
Triage tool for suspected COVID-19 patients in the emergency room: AIFELL score.
Levenfus I, Ullmann E, Battegay E, Schuurmans MM |
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases | 2020 |
|
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
Bouadma L, Wiedemann A, Patrier J, Surénaud M, Wicky PH, Foucat E, Diehl JL, Hejblum BP, Sinnah F, de Montmollin E, Lacabaratz C, Thiébaut R, Timsit JF, Lévy Y |
Journal of Clinical Immunology | 2020 |
|
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2.
Renn A, Fu Y, Hu X, Hall MD, Simeonov A |
Trends in Pharmacological Sciences | 2020 |
|
Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19.
Douedi S, Chaudhri M, Miskoff J |
Annals of thoracic medicine | 2020 |
|
Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019.
Buckley LF, Wohlford GF, Ting C, Alahmed A, Van Tassell BW, Abbate A, Devlin JW, Libby P |
2020 | |
|
Posterior reversible encephalopathy syndrome (PRES): Another imaging manifestation of COVID-19.
Rogg J, Baker A, Tung G |
2020 | |
|
Can tocilizumab calm the cytokine storm of COVID-19?
Schulert GS |
2020 | |
|
Diagnosing COVID-19-associated pulmonary aspergillosis.
Verweij PE, Gangneux JP, Bassetti M, Brüggemann RJM, Cornely OA, Koehler P, Lass-Flörl C, van de Veerdonk FL, Chakrabarti A, Hoenigl M |
2020 | |
|
COVID-19-associated pulmonary aspergillosis: adding insult to injury.
Bruno G, Fabrizio C, Buccoliero GB |
2020 | |
|
COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report.
Sharma A, Hofmeyr A, Bansal A, Thakkar D, Lam L, Harrington Z, Bhonagiri D |
Medical Mycology Case Reports | 2020 |
|
Initial Real-Life Experience from a Designated COVID-19 Centre in Athens, Greece: a Proposed Therapeutic Algorithm.
Baraboutis IG, Gargalianos P, Aggelonidou E, Adraktas A |
2020 | |
|
Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cells.
Lüke F, Orsó E, Kirsten J, Poeck H, Grube M, Wolff D, Burkhardt R, Lunz D, Lubnow M, Schmidt B, Hitzenbichler F, Hanses F, Salzberger B, Evert M, Herr W, Brochhausen C, Pukrop T, Reichle A, Heudobler D |
2020 | |
|
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus.
Katneni UK, Alexaki A, Hunt RC, Schiller T, DiCuccio M, Buehler PW, Ibla JC, Kimchi-Sarfaty C |
Thrombosis and haemostasis | 2020 |
|
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
Winkler ES, Bailey AL, Kafai NM, Nair S, McCune BT, Yu J, Fox JM, Chen RE, Earnest JT, Keeler SP, Ritter JH, Kang LI, Dort S, Robichaud A, Head R, Holtzman MJ, Diamond MS |
Nature Immunology | 2020 |
|
Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study.
Liu D, Cui P, Zeng S, Wang S, Feng X, Xu S, Li R, Gao Y, Yu R, Wang Y, Yuan Y, Li H, Jiao X, Chi J, Liu J, Yu Y, Zheng X, Song C, Jin N, Gong W, Liu X, Cai G, Li C, Gao Q |
2020 | |
|
Metabolic Syndrome and COVID-19 Mortality Among Adult Black Patients in New Orleans.
Xie J, Zu Y, Alkhatib A, Pham TT, Gill F, Jang A, Radosta S, Chaaya G, Myers L, Zifodya JS, Bojanowski CM, Marrouche NF, Mauvais-Jarvis F, Denson JL |
Diabetes care | 2020 |
|
SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
Nchioua R, Kmiec D, Müller JA, Conzelmann C, Groß R, Swanson CM, Neil SJD, Stenger S, Sauter D, Münch J, Sparrer KMJ, Kirchhoff F |
mBio | 2020 |
|
Development of a prognostic model for mortality in COVID-19 infection using machine learning.
Booth AL, Abels E, McCaffrey P |
Modern Pathology | 2020 |
|
The role of Chinese medicine in COVID-19 pneumonia: A systematic review and meta-analysis.
Sun CY, Sun YL, Li XM |
The American Journal of Emergency Medicine | 2020 |
|
COVID-19: In the Eye of the Cytokine Storm.
de la Rica R, Borges M, Gonzalez-Freire M |
Frontiers in immunology | 2020 |
|
Obesity and COVID-19: A jigsaw puzzle with still missing pieces.
Michalakis K, Panagiotou G, Ilias I, Pazaitou-Panayiotou K |
Clinical Obesity | 2020 |
|
Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment.
Gąsecka A, Borovac JA, Guerreiro RA, Giustozzi M, Parker W, Caldeira D, Chiva-Blanch G |
Cardiovascular Drugs and Therapy | 2020 |
|
Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients.
Allenbach Y, Saadoun D, Maalouf G, Vieira M, Hellio A, Boddaert J, Gros H, Salem JE, Resche Rigon M, Menyssa C, Biard L, Benveniste O, Cacoub P |
PloS one | 2020 |
|
Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19.
Osman M, Faridi RM, Sligl W, Shabani-Rad MT, Dharmani-Khan P, Parker A, Kalra A, Tripathi MB, Storek J, Cohen Tervaert JW, Khan FM |
Blood Advances | 2020 |
|
High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19.
Guirao JJ, Cabrera CM, Jiménez N, Rincón L, Urra JM |
Molecular Immunology | 2020 |
|
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial.
Malekzadeh R, Abedini A, Mohsenpour B, Sharifipour E, Ghasemian R, Javad-Mousavi SA, Khodashahi R, Darban M, Kalantari S, Abdollahi N, Salehi MR, Rezaei Hosseinabadi A, Khorvash F, Valizadeh M, Dastan F, Yousefian S, Hosseini H, Anjidani N, Tabarsi P |
International Immunopharmacology | 2020 |
|
SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study.
Amodio E, Pipitone RM, Grimaudo S, Immordino P, Maida CM, Prestileo T, Restivo V, Tramuto F, Vitale F, Craxì A, Casuccio A |
Journal of Clinical Medicine | 2020 |
|
New HIV diagnoses in patients with COVID-19: two case reports and a brief literature review.
Zhang JC, Yu XH, Ding XH, Ma HY, Cai XQ, Kang SC, Xiang DW |
BMC Infectious Diseases | 2020 |
|
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).
Guisado-Vasco P, Valderas-Ortega S, Carralón-González MM, Roda-Santacruz A, González-Cortijo L, Sotres-Fernández G, Martí-Ballesteros EM, Luque-Pinilla JM, Almagro-Casado E, La Coma-Lanuza FJ, Barrena-Puertas R, Malo-Benages EJ, Monforte-Gómez MJ, Diez-Munar R, Merino-Lanza E, Comeche-Casanova L, Remirez-de-Esparza-Otero M, Correyero-Plaza M, Recio-Rodríguez M, Rodríguez-López M, Sánchez-Manzano MD, Andreu-Vázquez C, Thuissard-Vasallo IJ, María-Tomé JME, Carnevali-Ruiz D |
2020 | |
|
Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y |
Journal of Clinical Laboratory Analysis | 2020 |
|
Characteristics of coagulation alteration in patients with COVID-19.
Luo HC, You CY, Lu SW, Fu YQ |
Annals of Hematology | 2020 |
|
Combination of serum lactate dehydrogenase and sex is predictive of severe disease in patients with COVID-19.
Hu J, Zhou J, Dong F, Tan J, Wang S, Li Z, Zhang X, Zhang H, Ming J, Huang T |
Medicine | 2020 |
|
Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study.
Fu L, Fei J, Xu S, Xiang HX, Xiang Y, Hu B, Li MD, Liu FF, Li Y, Li XY, Zhao H, Xu DX |
Journal of Clinical and Translational Hepatology | 2020 |
|
Anisocytosis is Associated With Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults.
Hornick A, Tashtish N, Osnard M, Shah B, Bradigan A, Albar Z, Tomalka J, Dalton J, Sharma A, Sekaly RP, Hejal R, Simon DI, Zidar DA, Al-Kindi SG |
Pathogens & immunity | 2020 |
|
COVID-19 fulminant myocarditis: a case report.
Bernal-Torres W, Herrera-Escandón Á, Hurtado-Rivera M, Plata-Mosquera CA |
2020 | |
|
Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions.
Favas TT, Dev P, Chaurasia RN, Chakravarty K, Mishra R, Joshi D, Mishra VN, Kumar A, Singh VK, Pandey M, Pathak A |
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2020 |
|
Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis.
Li Z, Niu S, Guo B, Gao T, Wang L, Wang Y, Wang L, Tan Y, Wu J, Hao J |
Cell Proliferation | 2020 |
|
Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19).
Zhou W, Song L, Wang X, Xu Z, Wang S, Wang J, Xu H, Zheng Y, Wang Y |
International Journal of Cardiology | 2020 |
|
COVID-19-Associated Coagulopathy: A Case Report of Thrombosis despite Therapeutic Anticoagulation.
Hussain H, Sehring M, Aulakh BS |
Case Reports in Critical Care | 2020 |
|
Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis.
Kassem DH, Kamal MM |
Frontiers in Cell and Developmental Biology | 2020 |
|
Understanding Gender-Bias in Critically Ill Patients With COVID-19.
Chamekh M, Casimir G |
Frontiers in Medicine | 2020 |
|
Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
Yang Q, Hughes TA, Kelkar A, Yu X, Cheng K, Park S, Huang WC, Lovell JF, Neelamegham S |
eLife | 2020 |
|
Prevalence of readily detected amyloid blood clots in 'unclotted' Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report.
Pretorius E, Venter C, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB |
Cardiovascular Diabetology | 2020 |
|
Immune suppression in the early stage of COVID-19 disease.
Tian W, Zhang N, Jin R, Feng Y, Wang S, Gao S, Gao R, Wu G, Tian D, Tan W, Chen Y, Gao GF, Wong CCL |
Nature Communications | 2020 |
|
Risk Assessment and Prediction of Severe or Critical COVID-19 Illness in Older Adults.
Zhang XY, Zhang L, Zhao Y, Chen L |
Clinical Interventions in Aging | 2020 |
|
Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety.
Takla M, Jeevaratnam K |
2020 | |
|
Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study.
Kalicińska E, Szymczak D, Andrasiak I, Bogucka-Fedorczuk A, Zińczuk A, Szymański W, Biernat M, Rymko M, Semeńczuk G, Jabłonowska P, Rybka J, Simon K, Wróbel T |
Translational oncology | 2020 |
|
Clinical Cutaneous Features of Patients Infected With SARS-CoV-2 Hospitalized for Pneumonia: A Cross-sectional Study.
Mascitti H, Bonsang B, Dinh A, Assan F, Perronne V, Leblanc T, Duran C, Bouchand F, Matt M, Le Gal A, N'guyen Van Thanh J, Lanore A, Jacob L, Kiavue N, Siméon S, Bessis S, de Truchis P, Landowski S, Davido B, Moreau F, Rameix-Welti MA, Gault E, Gaillard JL, Roux AL, Sivadon-Tardy V, Salomon E, El Sayed F, Carlier R, Emile JF, Perronne C, Bourgault-Villada I |
Open Forum Infectious Diseases | 2020 |
|
Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis.
Chidambaram V, Tun NL, Haque WZ, Majella MG, Sivakumar RK, Kumar A, Hsu AT, Ishak IA, Nur AA, Ayeh SK, Salia EL, Zil-E-Ali A, Saeed MA, Sarena APB, Seth B, Ahmadzada M, Haque EF, Neupane P, Wang KH, Pu TM, Ali SMH, Arshad MA, Wang L, Baksh S, Karakousis PC, Galiatsatos P |
PloS one | 2020 |
|
Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report.
Monte Junior ESD, Santos MELD, Ribeiro IB, Luz GO, Baba ER, Hirsch BS, Funari MP, de Moura EGH |
Clinical Endoscopy | 2020 |
|
Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19.
Neumann J, Prezzemolo T, Vanderbeke L, Roca CP, Gerbaux M, Janssens S, Willemsen M, Burton O, Van Mol P, Van Herck Y, Wauters J, Wauters E, Liston A, Humblet-Baron S |
IBMS BoneKEy | 2020 |
|
nSARS-Cov-2, pulmonary edema and thrombosis: possible molecular insights using miRNA-gene circuits in regulatory networks.
Khurana P, Gupta A, Sugadev R, Sharma YK, Varshney R, Ganju L, Kumar B |
2020 | |
|
Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry.
Cremer S, Jakob C, Berkowitsch A, Borgmann S, Pilgram L, Tometten L, Classen A, Wille K, Weidlich S, Gruener B, Dimmeler S, Massberg S, Rieg S, Zeiher AM |
Clinical research in cardiology : official journal of the German Cardiac Society | 2020 |
|
COVID-19: A review of therapeutic strategies and vaccine candidates.
Izda V, Jeffries MA, Sawalha AH |
Clinical Immunology | 2020 |
|
Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky VN, Elrashdy F, Aljadawi A, Ali SM, Khan RH, Redwan EM |
Journal of Neuroscience Research | 2020 |
|
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.
Bozzi G, Mangioni D, Minoia F, Aliberti S, Grasselli G, Barbetta L, Castelli V, Palomba E, Alagna L, Lombardi A, Ungaro R, Agostoni C, Baldini M, Blasi F, Cesari M, Costantino G, Fracanzani AL, Montano N, Monzani V, Pesenti A, Peyvandi F, Sottocorno M, Muscatello A, Filocamo G, Gori A, Bandera A |
Journal of Allergy and Clinical Immunology | 2020 |
|
T-cell dysregulation in COVID-19.
Kalfaoglu B, Almeida-Santos J, Tye CA, Satou Y, Ono M |
Biochemical and Biophysical Research Communications | 2020 |
|
Correlations of disease severity and age with hematology parameter variations in patients with COVID-19 pre- and post-treatment.
Liang J, Nong S, Jiang L, Chi X, Bi D, Cao J, Mo L, Luo X, Huang H |
Journal of Clinical Laboratory Analysis | 2020 |
|
Acute Seizures Occurring in Association With SARS-CoV-2.
Hwang ST, Ballout AA, Mirza U, Sonti AN, Husain A, Kirsch C, Kuzniecky R, Najjar S |
Frontiers in neurology | 2020 |
|
Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19.
Zhu Y, Geng S, Li Q, Jiang H |
Frontiers in Bioengineering and Biotechnology | 2020 |
|
Chronic Kidney Diseases and Acute Kidney Injury in Patients With COVID-19: Evidence From a Meta-Analysis.
Zhou Y, Ren Q, Chen G, Jin Q, Cui Q, Luo H, Zheng K, Qin Y, Li X |
Frontiers in Medicine | 2020 |
|
Cardiovascular Manifestations of COVID-19 Infection.
Magadum A, Kishore R |
Cells | 2020 |
|
Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis.
Huang Z, Huang P, Du B, Kong L, Zhang W, Zhang Y, Dong J |
Nutrition, Metabolism, and Cardiovascular Diseases | 2020 |
|
Coagulopathy in patients with COVID-19: a systematic review and meta-analysis.
Zhang X, Yang X, Jiao H, Liu X |
Aging | 2020 |
|
Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin-6.
Da BL, Kushner T, El Halabi M, Paka P, Khalid M, Uberoi A, Lee BT, Perumalswami PV, Rutledge SM, Schiano TD, Friedman SL, Saberi B |
Hepatology Communications | 2020 |
|
Estimating the release of inflammatory factors and use of glucocorticoid therapy for COVID-19 patients with comorbidities.
Han D, Peng C, Meng R, Yao J, Zhou Q, Xiao Y, Ma H |
Aging | 2020 |
|
Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A |
Virus Research | 2020 |
|
Characteristics of mortal COVID-19 cases compared to the survivors.
Zhou X, Cheng Z, Shu D, Lin W, Ming Z, Chen W, Hu Y |
Aging | 2020 |
|
How can clinical immunology laboratories contribute to the management of severe COVID-19 cases in limited resource contexts?
Admou B, Hachimi A, Samkaoui MA |
African Journal of Laboratory Medicine | 2020 |
|
The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India.
Banerjee A, Sarkar R, Mitra S, Lo M, Dutta S, Chawla-Sarkar M |
2020 | |
|
Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome
Schrijver B, Assmann JLJC, van Gammeren AJ, Vermeulen RCH, Portengen L, Heukels P, Langerak AW, Dik WA, van der Velden VHJ, Ermens TAAM |
European cytokine network | 2020 |
|
A Case of COVID-19 Complicated by Venous Thromboembolism Despite Being on Prophylactic Anticoagulation.
Rout A, Chan A |
Journal of Medical Cases | 2020 |
|
Sequi Ad Maius Bonum; Targeting Ion Channels in the Lung.
Bakowski D, Wood AJ, Parekh AB |
2020 | |
|
Haematological manifestations of COVID‐19: From cytopenia to coagulopathy
Agbuduwe C, Basu S |
European Journal of Haematology | 2020 |
|
The dynamic changes of serum IgM and IgG against SARS‐CoV‐2 in patients with COVID‐19
Zhou W, Xu X, Chang Z, Wang H, Zhong X, Tong X, Liu T, Li Y |
Journal of Medical Virology | 2020 |
|
COVID‐19 and coagulation dysfunction in adults: A systematic review and meta‐analysis
Lin J, Yan H, Chen H, He C, Lin C, He H, Zhang S, Shi S, Lin K |
Journal of Medical Virology | 2020 |
|
T cell immunobiology and cytokine storm of COVID‐19
Luo X, Zhu Y, Mao J, Du R |
Scandinavian Journal of Immunology | 2020 |
|
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Pierce CA, Preston-Hurlburt P, Dai Y, Aschner CB, Cheshenko N, Galen B, Garforth SJ, Herrera NG, Jangra RK, Morano NC, Orner E, Sy S, Chandran K, Dziura J, Almo SC, Ring A, Keller MJ, Herold KC, Herold BC |
Science Translational Medicine | 2020 |
|
Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
Schijns V, Lavelle EC |
European Journal of Immunology | 2020 |
|
A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.
Ren YR, Golding A, Sorbello A, Ji P, Chen J, Saluja B, Witzmann K, Arya V, Reynolds KS, Choi SY, Nikolov NP, Sahajwalla C |
Journal of clinical pharmacology | 2020 |
|
Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients.
Zhang Y, Wang X, Li X, Xi D, Mao R, Wu X, Cheng S, Sun X, Yi C, Ling Z, Ma L, Ning Q, Fang Y, Sun B, Wu D |
Cellular & molecular immunology | 2020 |
|
Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.
Weiskopf D, Schmitz KS, Raadsen MP, Grifoni A, Okba NMA, Endeman H, van den Akker JPC, Molenkamp R, Koopmans MPG, van Gorp ECM, Haagmans BL, de Swart RL, Sette A, de Vries RD |
Science Immunology | 2020 |
|
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
Delpino MV, Quarleri J |
Frontiers in Cellular and Infection Microbiology | 2020 |
|
AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectives.
Turski WA, Wnorowski A, Turski GN, Turski CA, Turski L |
Restorative neurology and neuroscience | 2020 |
|
Less expression of CD4+ and CD8+ T cells might reflect the severity of infection and predict worse prognosis in patients with COVID-19: Evidence from a pooled analysis.
Hu D, Li L, Shi W, Zhang L |
Clinica chimica acta; international journal of clinical chemistry | 2020 |
|
Matrix metalloproteinase 3 as a valuable marker for patients with COVID-19.
Shi S, Su M, Shen G, Hu Y, Yi F, Zeng Z, Zhu P, Yang G, Zhou H, Li Q, Xie X |
Journal of Medical Virology | 2020 |
|
COVID-19 and immunomodulation treatment for women with reproductive failures.
Kwak-Kim J, Ota K, Sung N, Huang C, Alsubki L, Lee S, Han JW, Han A, Yang X, Saab W, Derbala Y, Wang WJ, He Q, Liao A, Takahashi T, Cavalcante MB, Barini R, Bao S, Fukui A, Lédée N, Coulam C |
Journal of Reproductive Immunology | 2020 |
|
A Novel Viral Epidemic Collides with an Ancient Scourge: COVID-19 Associated with Tuberculosis.
Cutler T, Scales D, Levine W, Schluger N, O'Donnell M |
American journal of respiratory and critical care medicine | 2020 |
|
Clinical management of COVID-19.
Varghese GM, John R, Manesh A, Karthik R, Abraham OC |
The Indian journal of medical research | 2020 |
|
Neuromechanisms of SARS-CoV-2: A Review.
DosSantos MF, Devalle S, Aran V, Capra D, Roque NR, Coelho-Aguiar JM, Spohr TCLSE, Subilhaga JG, Pereira CM, D'Andrea Meira I, Niemeyer Soares Filho P, Moura-Neto V |
Frontiers in neuroanatomy | 2020 |
|
The COVID-19 Cytokine Storm; What We Know So Far.
Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R |
Frontiers in immunology | 2020 |
|
Strategy for Disease Diagnosis, Progression Prediction, Risk Group Stratification and Treatment-Case of COVID-19.
Vihinen M |
Frontiers in Medicine | 2020 |
|
Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries.
Li T, Wang L, Wang H, Gao Y, Hu X, Li X, Zhang S, Xu Y, Wei W |
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2020 |
|
C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.
Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B |
Therapeutic advances in respiratory disease | 2020 |
|
Potential of regulatory T-cell-based therapies in the management of severe COVID-19.
Stephen-Victor E, Das M, Karnam A, Pitard B, Gautier JF, Bayry J |
European Respiratory Journal | 2020 |
|
Clinical characteristics of hematological patients concomitant with COVID-19.
Zhou X, Wang G, Chen L, Meng F, Huang L, Huang L, Wang N, Li T, Cao Y, Zhou J |
Cancer Science | 2020 |
|
COVID-19 and venous thromboembolism: current insights and prophylactic strategies.
Ambrosino P, Di Minno A, Maniscalco M, Di Minno MND |
Annals of Medicine | 2020 |
|
Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?
Reznik SE, Tiwari AK, Ashby CR Jr |
Pharmacological Research | 2020 |
|
Rapidly fatal outcome of Covid-19 after successful emergency surgery during pandemic outbreak in Northern Italy.
Montali F, Palmieri G, Casali L, Pagliai L, Costi R |
International Journal of Surgery Case Reports | 2020 |
|
A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease 2019 in the Hospital Setting.
Razonable RR, Pennington KM, Meehan AM, Wilson JW, Froemming AT, Bennett CE, Marshall AL, Virk A, Carmona EM |
Mayo Clinic Proceedings | 2020 |
|
Fatal Guillain-Barre syndrome after infection with SARS-CoV-2
Marta-Enguita J, Rubio-Baines I, Gastón-Zubimendi I |
Neurología (English Edition) | 2020 |
|
Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic?
Serrano-Castro PJ, Estivill-Torrús G, Cabezudo-García P, Reyes-Bueno JA, Ciano Petersen N, Aguilar-Castillo MJ, Suárez-Pérez J, Jiménez-Hernández MD, Moya-Molina MÁ, Oliver-Martos B, Arrabal-Gómez C, Rodríguez de Fonseca F |
Neurología (English Edition) | 2020 |
|
El ambiente, los desplazamientos y el riesgo cardiovascular en la pandemia por COVID-19
Lizcano F, Arroyave F |
2020 | |
|
High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients
Lagunas\u2010Rangel FA, Chávez\u2010Valencia V |
Journal of Medical Virology | 2020 |
|
Could HIV infection alter the clinical course of SARS‐CoV‐2 infection? When less is better
Mascolo S, Romanelli A, Carleo MA, Esposito V |
Journal of Medical Virology | 2020 |
|
On the Alert for Cytokine Storm: Immunopathology in COVID‐19
Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, Caricchio R, Mahmud S, Hazen MM, Halyabar O, Hoyt KJ, Han J, Grom AA, Gattorno M, Ravelli A, De Benedetti F, Behrens EM, Cron RQ, Nigrovic PA |
Arthritis & Rheumatism | 2020 |
|
Does High Cardiorespiratory Fitness Confer Some Protection Against Proinflammatory Responses After Infection by SARS‐CoV‐2?
Zbinden\u2010Foncea H, Francaux M, Deldicque L, Hawley JA |
Obesity (Silver Spring, Md.) | 2020 |
|
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
Lei F, Liu Y, Zhou F, Qin J, Zhang P, Zhu L, Zhang X, Cai J, Lin L, Ouyang S, Wang X, Yang C, Cheng X, Liu W, Li H, Xie J, Wu B, Luo H, Xiao F, Chen J, Tao L, Cheng G, She Z, Zhou J, Wang H, Lin J, Luo P, Fu S, Zhou J, Ye P, Xiao B, Mao W, Liu L, Yan Y, Liu L, Chen G, Li H, Huang X, Zhang B, Yuan Y |
Hepatology | 2020 |
|
Clinical course of COVID‐19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report
Hammami MB, Garibaldi B, Shah P, Liu G, Jain T, Chen P, Kim AK, Avdic E, Petty B, Strout S, Fine DM, Niranjan\u2010Azadi A, Garneau WM, Cameron AM, Monroy Trujillo JM, Gurakar A, Avery R |
American Journal of Transplantation | 2020 |
|
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen M, O\u2019Mahony L, Gao Y, Nadeau K, Akdis CA |
Allergy | 2020 |
|
Liver injury is associated with severe coronavirus disease 2019 (COVID‐19) infection: A systematic review and meta‐analysis of retrospective studies
Parohan M, Yaghoubi S, Seraji A |
Hepatology Research | 2020 |
|
COVID-19 and its implications for thrombosis and anticoagulation
Connors JM, Levy JH |
Blood | 2020 |
|
Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)
Bourgonje AR, Abdulle AE, Timens W, Hillebrands J, Navis GJ, Gordijn SJ, Bolling MC, Dijkstra G, Voors AA, Osterhaus AD, van der Voort PH, Mulder DJ, van Goor H |
The Journal of Pathology | 2020 |
|
High‐fluorescent lymphocytes are increased in patients with COVID‐19
Wang Z, He Y, Shu H, Wang P, Xing H, Zeng X, Tang Z |
British Journal of Haematology | 2020 |
|
COVID‐19 and liver dysfunction: A systematic review and meta‐analysis of retrospective studies
Youssef M, H Hussein M, Attia AS, M Elshazli R, Omar M, Zora G, S Farhoud A, Elnahla A, Shihabi A, Toraih EA, S Fawzy M, Kandil E |
Journal of Medical Virology | 2020 |
|
COVID‐19 in pancreas transplant recipients
Dube GK, Husain SA, McCune KR, Sandoval PR, Ratner LE, Cohen DJ |
Transplant Infectious Disease | 2020 |
|
Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19)
Baig AM, Sanders EC |
Journal of Medical Virology | 2020 |
|
Selective C‐reactive protein apheresis for Covid‐19 patients suffering from organ damage
Kayser S, Kunze R, Sheriff A |
Therapeutic Apheresis and Dialysis | 2020 |
|
Hypoalbuminaemia in COVID‐19 infection: A predictor of severity or a potential therapeutic target?
Herlekar R, Sur Roy A, Matson M |
Journal of Medical Virology | 2020 |
|
Can steroids reverse the severe COVID‐19 induced “cytokine storm”?
Kolilekas L, Loverdos K, Giannakaki S, Vlassi L, Levounets A, Zervas E, Gaga M |
Journal of Medical Virology | 2020 |
|
Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID‐19 patients: A meta‐regression and decision tree analysis
Toraih EA, Elshazli RM, Hussein MH, Elgaml A, Amin M, El\u2010Mowafy M, El\u2010Mesery M, Ellythy A, Duchesne J, Killackey MT, Ferdinand KC, Kandil E, Fawzy MS |
Journal of Medical Virology | 2020 |
|
Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis
Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, Mohan S |
Kidney International Reports | 2020 |
|
Factores de riesgo y predictores de gravedad en pacientes hospitalizados por COVID-19: análisis de 52 casos
Marta-Enguita J, Corroza-Laviñeta J, Ostolaza A |
2020 | |
|
A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID‐19 infection: A novel management for a new disease?
Giannattasio A, Maglione M, Zenzeri L, Mauro A, Di Mita O, Iodice RM, Tipo V |
Journal of Medical Virology | 2020 |
|
Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID‐19
Jorgensen SC, Tse CL, Burry L, Dresser LD |
Pharmacotherapy | 2020 |
|
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
Thompson III GR, Cornely OA, Pappas PG, Patterson TF, Hoenigl M, Jenks JD, Clancy CJ, Nguyen MH |
Open Forum Infectious Diseases | 2020 |
|
Coronavirus infection and immune system: An insight of COVID-19 in cancer patients
Indini A, Rijavec E, Ghidini M, Bareggi C, Cattaneo M, Galassi B, Gambini D, Grossi F |
Critical Reviews in Oncology/Hematology | 2020 |
|
Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy
Wu J, Yuan X, Wang B, Gu R, Li W, Xiang X, Tang L, Sun H |
Frontiers in microbiology | 2020 |
|
Physical Exercise Potentials Against Viral Diseases Like COVID-19 in the Elderly
Amatriain-Fernández S, Gronwald T, Murillo-Rodríguez E, Imperatori C, Solano AF, Latini A, Budde H |
Frontiers in Medicine | 2020 |
|
The cytokine storm and COVID‐19
Hu B, Huang S, Yin L |
Journal of Medical Virology | 2020 |
|
Amelioration of COVID‐19‐related cytokine storm syndrome: parallels to chimeric antigen receptor‐T cell cytokine release syndrome
Hoiland RL, Stukas S, Cooper J, Thiara S, Chen LY, Biggs CM, Hay K, Lee AY, Shojania K, Abdulla A, Wellington CL, Sekhon MS |
British Journal of Haematology | 2020 |
|
Pregnancy and postpartum outcomes in a universally tested population for SARS‐CoV‐2 in New York City: a prospective cohort study
Prabhu M, Cagino K, Matthews K, Friedlander R, Glynn S, Kubiak J, Yang Y, Zhao Z, Baergen R, DiPace J, Razavi A, Skupski D, Snyder J, Singh H, Kalish R, Oxford C, Riley L |
BJOG : an international journal of obstetrics and gynaecology | 2020 |
|
Antibody responses against SARS‐CoV‐2 in COVID‐19 patients
Liu A, Li Y, peng J, Huang Y, Xu D |
Journal of Medical Virology | 2020 |
|
Incidental and simultaneous finding of pulmonary thrombus and COVID-19 pneumonia in a cancer patient derived to 18F-FDG PET/CT. New pathophysiological insights from hybrid imaging
Ferrando-Castagnetto F, Wakfie-Corieh CG, García AM, García-Esquinas MG, Caro RM, Delgado JL |
Radiology Case Reports | 2020 |
|
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C |
Frontiers in immunology | 2020 |
|
Coronavirus disease 2019 in chronic kidney disease
D\u2019Marco L, Puchades MJ, Romero-Parra M, Gimenez-Civera E, Soler MJ, Ortiz A, Gorriz JL |
Clinical Kidney Journal | 2020 |
|
Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19?
Geller A, Yan J |
Frontiers in immunology | 2020 |
|
Coronavirus disease 2019 (COVID-19) in pregnancy: 2 case reports on maternal and neonatal outcomes in Yichang city, Hubei Province, China
Zheng T, Guo J, He W, Wang H, Yu H, Ye H |
Medicine | 2020 |
|
IL-6–based mortality risk model for hospitalized patients with COVID-19
Laguna-Goya R, Utrero-Rico A, Talayero P, Lasa-Lazaro M, Ramirez-Fernandez A, Naranjo L, Segura-Tudela A, Cabrera-Marante O, Rodriguez de Frias E, Garcia-Garcia R, Fernández-Ruiz M, Aguado JM, Martinez-Lopez J, Lopez EA, Catalan M, Serrano A, Paz-Artal E |
Journal of Allergy and Clinical Immunology | 2020 |
|
Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel
Rudski L, Januzzi JL, Rigolin VH, Bohula EA, Blankstein R, Patel AR, Bucciarelli-Ducci C, Vorovich E, Mukherjee M, Rao SV, Beanlands R, Villines TC, Di Carli MF |
Journal of the American College of Cardiology | 2020 |
|
Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19
Liu Z, Li J, Chen D, Gao R, Zeng W, Chen S, Huang Y, Huang J, Long W, Li M, Guo L, Wang X, Wu X |
Frontiers in pharmacology | 2020 |
|
Immunological co-ordination between gut and lungs in SARS-CoV-2 infection
Ahlawat S, Asha, Sharma KK |
Virus Research | 2020 |
|
Reply
Chambers ES, Akbar AN |
Journal of Allergy and Clinical Immunology | 2020 |
|
Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019
Ong SW, Tan WY, Chan Y, Fong S, Renia L, Ng LF, Leo Y, Lye DC, Young BE |
IBMS BoneKEy | 2020 |
|
SARS-CoV-2: A Piece of Bad News
Abdullah SF, Sharquie IK |
2020 | |
|
The SARS-CoV-2 and mental health: From biological mechanisms to social consequences
Szcześniak D, Gładka A, Misiak B, Cyran A, Rymaszewska J |
Progress in neuro-psychopharmacology & biological psychiatry | 2020 |
|
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19
Graham SP, McLean RK, Spencer AJ, Belij-Rammerstorfer S, Wright D, Ulaszewska M, Edwards JC, Hayes JW, Martini V, Thakur N, Conceicao C, Dietrich I, Shelton H, Waters R, Ludi A, Wilsden G, Browning C, Bialy D, Bhat S, Stevenson-Leggett P, Hollinghurst P, Gilbride C, Pulido D, Moffat K, Sharpe H, Allen E, Mioulet V, Chiu C, Newman J, Asfor AS, Burman A, Crossley S, Huo J, Owens RJ, Carroll M, Hammond JA, Tchilian E, Bailey D, Charleston B, Gilbert SC, Tuthill TJ, Lambe T |
npj Vaccines | 2020 |
|
Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy
Shabalin IG, Czub MP, Majorek KA, Brzezinski D, Grabowski M, Cooper DR, Panasiuk M, Chruszcz M, Minor W |
2020 | |
|
Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19
Tanner T, Wahezi DM |
Paediatric Respiratory Reviews | 2020 |
|
The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
Akbari H, Tabrizi R, Lankarani KB, Aria H, Vakili S, Asadian F, Noroozi S, Keshavarz P, Faramarz S |
Life Sciences | 2020 |
|
Clinical characteristics of 276 hospitalized patients with coronavirus disease 2019 in Zengdu District, Hubei Province: a single-center descriptive study
Wei Y, Zeng W, Huang X, Li J, Qiu X, Li H, Liu D, He Z, Yao W, Huang P, Li C, Zhu M, Zhong C, Zhu X, Liu J |
BMC Infectious Diseases | 2020 |
|
IL-17A moonlighting in lung type 2 immunity
Ruscher R, Giacomin PR |
Mucosal Immunology | 2020 |
|
Implementation of Antibody Rapid Diagnostic Testing versus Real-Time Reverse Transcription-PCR Sample Pooling in the Screening of COVID-19: a Case of Different Testing Strategies in Africa
Nyazika TK, Kaela R, Mugoni M, Musomekwa K, Kyei-Baafour E, Chiwanda S, Mapondera PT, Makawa TS, Sithole EM, Mavunganidze G, Manasa J, Jambo KC, Musarurwa C |
mSphere | 2020 |
|
The importance of cell-mediated immunity in COVID-19 – An opinion
Iqbal H |
Medical Hypotheses | 2020 |
|
Covid-19-induced coagulopathy and observed benefits with anticoagulation
Karimzadeh S, Dong V, Hassan OG, Raut A, Fouda A, Parrill A, Eaton K, Huy NT |
Transfusion and Apheresis Science | 2020 |
|
The characteristics and predictive role of lymphocyte subsets in COVID-19 patients
Zhang W, Li L, Liu J, Chen L, Zhou F, Jin T, Jiang L, Li X, Yang M, Wang H |
International Journal of Infectious Diseases | 2020 |
|
Visceral adipose tissue in patients with COVID-19: risk stratification for severity
Chandarana H, Dane B, Mikheev A, Taffel MT, Feng Y, Rusinek H |
2020 | |
|
COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response
Jayarangaiah A, Kariyanna PT, Chen X, Jayarangaiah A, Kumar A |
Clinical and Applied Thrombosis/Hemostasis | 2020 |
|
Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary Infection
Desai N, Neyaz A, Szabolcs A, Shih AR, Chen JH, Thapar V, Nieman LT, Solovyov A, Mehta A, Lieb DJ, Kulkarni AS, Jaicks C, Pinto CJ, Juric D, Chebib I, Colvin RB, Kim AY, Monroe R, Warren SE, Danaher P, Reeves JW, Gong J, Rueckert EH, Greenbaum BD, Hacohen N, Lagana SM, Rivera MN, Sholl LM, Stone JR, Ting DT, Deshpande V |
2020 | |
|
Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review
Napoli C, Tritto I, Benincasa G, Mansueto G, Ambrosio G |
Annals of Medicine and Surgery | 2020 |
|
The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity?
Holuka C, Merz MP, Fernandes SB, Charalambous EG, Seal SV, Grova N, Turner JD |
International journal of molecular sciences | 2020 |
|
Management of immunosuppression in kidney transplant recipients with COVID‐19 pneumonia: A summary of 41 confirmed cases reported worldwide
Hu Q, Zhong Z, Xiong Y, Ye S, Wang Y, Ye Q |
Transplant Infectious Disease | 2020 |
|
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1
Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, Behrens EM, Ferris A, Kernan KF, Schulert GS, Seo P, F. Son MB, Tremoulet AH, Yeung RS, Mudano AS, Turner AS, Karp DR, Mehta JJ |
Arthritis & Rheumatism | 2020 |
|
Characteristics and roles of severe acute respiratory syndrome coronavirus 2‐specific antibodies in patients with different severities of coronavirus 19
Huang Z, Chen H, Xue M, Huang H, Zheng P, Luo W, Liang X, Sun B, Zhong N |
Clinical & Experimental Immunology | 2020 |
|
Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system
Alam SB, Willows S, Kulka M, Sandhu JK |
European Journal of Neurology | 2020 |
|
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19
Tang L, Jiang Y, Zhu M, Chen L, Zhou X, Zhou C, Ye P, Chen X, Wang B, Xu Z, Zhang Q, Xu X, Gao H, Wu X, Li D, Jiang W, Qu J, Xiang C, Li L |
Frontiers of Medicine | 2020 |
|
Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study
Liu S, Luo H, Wang Y, Cuevas LE, Wang D, Ju S, Yang Y |
BMC Infectious Diseases | 2020 |
|
Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation?
O\u2019Brien ER, Sandhu JK |
Cell Stress & Chaperones | 2020 |
|
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19
Duployez N, Demonchy J, Berthon C, Goutay J, Caplan M, Moreau AS, Bignon A, Marceau-Renaut A, Garrigue D, Raczkiewicz I, Geffroy S, Bucci M, Alidjinou K, Demaret J, Labalette M, Brousseau T, Dupont A, Rauch A, Poissy J, Susen S, Preudhomme C, Quesnel B |
Cancers | 2020 |
|
Multiple Lacunar Cerebral Infarcts as the Initial Presentation of COVID-19
Elshereye A, Erdinc B |
Cureus | 2020 |
|
High neutrophil-to-lymphocyte ratio associated with progression to critical illness in older patients with COVID-19: a multicenter retrospective study
Lian J, jin C, Hao S, Zhang X, Yang M, Jin X, Lu Y, Hu J, Zhang S, Zheng L, Jia H, Cai H, Zhang Y, Yu G, Wang X, Gu J, Ye C, Yu X, Gao J, Yang Y, Sheng J |
Aging | 2020 |
|
Management of gastrointestinal endoscopy unit during post covid-19 endemic outbreak: A report from Wuhan epicenter
Cao L, Guo Q, Chen Y, Chen N, Liu M, Tian D |
American journal of infection control | 2020 |
|
COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study
Jurado A, Martín MC, Abad-Molina C, Orduña A, Martínez A, Ocaña E, Yarce O, Navas AM, Trujillo A, Fernández L, Vergara E, Rodríguez B, Quirant B, Martínez-Cáceres E, Hernández M, Perurena-Prieto J, Gil J, Cantenys S, González-Martínez G, Martínez-Saavedra MT, Rojo R, Marco FM, Mora S, Ontañón J, López-Hoyos M, Ocejo-Vinyals G, Melero J, Aguilar M, Almeida D, Medina S, Vegas MC, Jiménez Y, Prada Á, Monzón D, Boix F, Cunill V, Molina J |
Immunity & ageing : I & A | 2020 |
|
The challenges of COVID-19 in the Brazilian Amazonian communities and the importance of seroepidemiological surveillance studies
Vallinoto AC, da Silva Torres MK, Vallinoto MC, Cayres Vallinoto IM |
International Journal for Equity in Health | 2020 |
|
Is pregnancy an immunological contributor to severe or controlled COVID‐19 disease?
Hanna N, Hanna M, Sharma S |
American Journal of Reproductive Immunology | 2020 |
|
The “Infodemic” of COVID‐19
Solomon DH, Bucala R, Kaplan MJ, Nigrovic PA |
Arthritis & Rheumatism | 2020 |
|
COVID‐19 in lung transplant recipients: A single center case series from New York City
Aversa M, Benvenuto L, Anderson M, Shah L, Robbins H, Pereira M, Scheffert J, Carroll M, Hum J, Nolan M, Reilly G, Lemaitre P, Stanifer BP, D\u2019Ovidio F, Sonett J, Arcasoy S |
American Journal of Transplantation | 2020 |
|
Immunomodulatory Therapeutic Proteins in COVID‐19: Current Clinical Development and Clinical Pharmacology Considerations
Ji P, Chen J, Golding A, Nikolov NP, Saluja B, Ren YR, Sahajwalla CG |
Journal of clinical pharmacology | 2020 |
|
Ferritin levels in patients with COVID‐19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis
Feld J, Tremblay D, Thibaud S, Kessler A, Naymagon L |
International Journal of Laboratory Hematology | 2020 |
|
Co‐reactivation of the human herpesvirus alpha subfamily (herpes simplex virus‐1 and varicella zoster virus) in a critically ill patient with COVID‐19
Xu R, Zhou Y, Cai L, Wang L, Han J, Yang X, Chen J, Chen J, Ma C, Shen L |
The British journal of dermatology | 2020 |
|
Potential effects of SARS‐CoV‐2 infection during pregnancy on fetuses and newborns are worthy of attention
Dang D, Wang L, Zhang C, Li Z, Wu H |
The journal of obstetrics and gynaecology research | 2020 |
|
Characteristics of peripheral blood differential counts in hospitalized patients with COVID‐19
Pakos IS, Lo KB, Salacup G, Pelayo J, Bhargav R, Peterson E, Gul F, DeJoy R III, Albano J, Patarroyo\u2010Aponte G, Rangaswami J, Azmaiparashvili Z |
European Journal of Haematology | 2020 |
|
COVID‐19 and Vitamin D: A lesson from the skin
Slominski RM, Stefan J, Athar M, Holick MF, Jetten AM, Raman C, Slominski AT |
Experimental Dermatology | 2020 |
|
Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes
Mauvais-Jarvis F, Klein SL, Levin ER |
Endocrinology | 2020 |
|
A Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Prediction Model From Standard Laboratory Tests
Bayat V, Phelps S, Ryono R, Lee C, Parekh H, Mewton J, Sedghi F, Etminani P, Holodniy M |
Clinical Infectious Diseases | 2020 |
|
Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside
Sahu KK, Siddiqui AD, Cerny J |
Laboratory Medicine | 2020 |
|
Studying smoking benefit in farmer’s lung to understand Covid-19
Bellanger AP, Reboux G |
Occupational Medicine | 2020 |
|
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic
Alivernini S, Petricca L, Perniola S, Fedele AL, Gigante MR, Capacci A, Paglionico A, Varriano V, De Lorenzis E, Lanzo L, Melpignano F, Rubortone P, Tanti G, Tur C, Bruno D, Gigante L, Natalello G, Verardi L, Di Mario C, Tolusso B, Mirone L, Lizzio MM, Zoli A, Peluso G, Bosello SL, Gremese E |
Rheumatology (Oxford, England) | 2020 |
|
Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series
Clark KE, Collas O, Lachmann H, Singh A, Buckley J, Bhagani S |
2020 | |
|
Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury
Chen X, Guo H, Qiu L, Zhang C, Deng Q, Leng Q |
Frontiers in immunology | 2020 |
|
Probiotics at War Against Viruses: What Is Missing From the Picture?
Tiwari SK, Dicks LM, Popov IV, Karaseva A, Ermakov AM, Suvorov A, Tagg JR, Weeks R, Chikindas ML |
Frontiers in microbiology | 2020 |
|
Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW
Zheng S, Baak JP, Li S, Xiao W, Ren H, Yang H, Gan Y, Wen C |
Phytomedicine | 2020 |
|
Immunological features of coronavirus disease 2019 in patients with cancer
Thibaudin M, Fumet JD, Bon M, Hampe L, Limagne E, Ghiringhelli F |
European Journal of Cancer | 2020 |
|
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Lucas C, Wong P, Klein J, Castro TB, Silva J, Sundaram M, Ellingson MK, Mao T, Oh JE, Israelow B, Takahashi T, Tokuyama M, Lu P, Venkataraman A, Park A, Mohanty S, Wang H, Wyllie AL, Vogels CB, Earnest R, Lapidus S, Ott IM, Moore AJ, Muenker MC, Fournier JB, Campbell M, Odio CD, Casanovas-Massana A, Herbst R, Shaw AC, Medzhitov R, Schulz WL, Grubaugh ND, Cruz CD, Farhadian S, Ko AI, Omer SB, Iwasaki A |
Nature | 2020 |
|
Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view
Simon Junior H, Sakano TM, Rodrigues RM, Eisencraft AP, Carvalho VE, Schvartsman C, Reis AG |
Jornal de Pediatria | 2020 |
|
Incidence of myocardial injury in coronavirus disease 2019 (COVID-19): a pooled analysis of 7,679 patients from 53 studies
Gu ZC, Zhang C, Kong LC, Shen L, Li Z, Ge H, Lin HW, Pu J |
Cardiovascular diagnosis and therapy | 2020 |
|
Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses
Dutta S, Das N, Mukherjee P |
Frontiers in microbiology | 2020 |
|
Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic
Terracciano D, Buonerba C, Scafuri L, De Berardinis P, Calin GA, Ferrajoli A, Fabbri M, Cimmino A |
Frontiers in Oncology | 2020 |
|
Coronavirus Disease 2019 (COVID-19): A Haematologist's Perspective
Cheung CK, Law MF, Lui GC, Wong SH, Wong RS |
Acta Haematologica | 2020 |
|
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
Strollo R, Maddaloni E, Dauriz M, Pedone C, Buzzetti R, Pozzilli P |
Diabetes Research and Clinical Practice | 2020 |
|
Cytokine Storm in COVID-19: “When You Come Out of the Storm, You Won’t Be the Same Person Who Walked in”
Castelli V, Cimini A, Ferri C |
Frontiers in immunology | 2020 |
|
Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China
Chen X, Huang J, Huang Y, Chen J, Huang Y, Jiang X, Shi Y |
Human Immunology | 2020 |
|
Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on “Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome” by Quartuccio et al. Joint Bone Spine. 2020;87:191–93
Vieira M, Maalouf G, Hasan M, Le Joncour A, Karkeni E, Idir M, Amelin D, Salem JE, Gougis P, Lacorte JM, Biard L, Benveniste O, Cacoub P, Saadoun D, Allenbach Y |
Joint, bone, spine : revue du rhumatisme | 2020 |
|
Thromboelastography to Detect Hypercoagulability and Reduced Fibrinolysis in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients
Sadd C, Rowe T, Nazeef M, Kory P, Sultan S, Faust H |
2020 | |
|
COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate
Bhattacharjee S, Banerjee M, Pal R |
Indian Pediatrics | 2020 |
|
The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study
Oussalah A, Gleye S, Urmes IC, Laugel E, Barbé F, Orlowski S, Malaplate C, Aimone-Gastin I, Caillierez BM, Merten M, Jeannesson E, Kormann R, Olivier JL, Rodriguez-Guéant RM, Namour F, Bevilacqua S, Thilly N, Losser MR, Kimmoun A, Frimat L, Levy B, Gibot S, Schvoerer E, Guéant JL |
2020 | |
|
Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 Patients
Westmeier J, Paniskaki K, Karaköse Z, Werner T, Sutter K, Dolff S, Overbeck M, Limmer A, Liu J, Zheng X, Brenner T, Berger MM, Witzke O, Trilling M, Lu M, Yang D, Babel N, Westhoff T, Dittmer U, Zelinskyy G |
mBio | 2020 |
|
SARS-CoV-2 Pandemic Impacts on NASA Ground Operations to Protect ISS Astronauts
Makedonas G, Mehta SK, Scheuring RA, Haddon R, Crucian BE |
The journal of allergy and clinical immunology. In practice | 2020 |
|
IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection
Gadotti AC, de Castro Deus M, Telles JP, Wind R, Goes M, Garcia Charello Ossoski R, de Padua AM, de Noronha L, Moreno-Amaral A, Baena CP, Tuon FF |
Virus Research | 2020 |
|
Emergency surgery and trauma care during COVID-19 pandemic. Recommendations of the Spanish Association of Surgeons
Aranda-Narváez JM, Tallón-Aguilar L, Pareja-Ciuró F, Martín-Martín G, González-Sánchez AJ, Rey-Simó I, Tamayo-Medel G, Yánez-Benítez C, Costa-Navarro D, Montón-Condón S, Navarro-Soto S, Turégano-Fuentes F, Pérez-Díaz MD, Ceballos-Esparragón J, Jover-Navalón JM, Balibrea JM, Morales-Conde S |
2020 | |
|
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Fara A, Mitrev Z, Rosalia RA, Assas BM |
Open Biology | 2020 |
|
Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study
Basso C, Leone O, Rizzo S, De Gaspari M, van der Wal AC, Aubry MC, Bois MC, Lin PT, Maleszewski JJ, Stone JR |
European Heart Journal | 2020 |
|
Postulated Adjuvant Therapeutic Strategies for COVID-19
Ferreira AO, Polonini HC, Dijkers EC |
Journal of Personalized Medicine | 2020 |
|
SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime
Domingues R, Lippi A, Setz C, Outeiro TF, Krisko A |
Aging | 2020 |
|
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge
Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M |
International Journal of Infectious Diseases | 2020 |
|
Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection
Hou X, Zhang X, Wu X, Lu M, Wang D, Xu M, Wang H, Liang T, Dai J, Duan H, Xu Y, Yu X, Li Y |
Molecular & cellular proteomics : MCP | 2020 |
|
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Arunachalam PS, Wimmers F, Mok CK, Perera RA, Scott M, Hagan T, Sigal N, Feng Y, Bristow L, Tak-Yin Tsang O, Wagh D, Coller J, Pellegrini KL, Kazmin D, Alaaeddine G, Leung WS, Chan JM, Chik TS, Choi CY, Huerta C, Paine McCullough M, Lv H, Anderson E, Edupuganti S, Upadhyay AA, Bosinger SE, Maecker HT, Khatri P, Rouphael N, Peiris M, Pulendran B |
Science (New York, N.Y.) | 2020 |
|
Impact of disease‐modifying drugs on the severity of COVID‐19 infection in multiple sclerosis patients
Rostami Mansoor S, Ghasemi\u2010Kasman M |
Journal of Medical Virology | 2020 |
|
The clinical characteristics and prognosis of COVID‐19 patients with cerebral stroke: A retrospective study of 113 cases from one single‐centre
Yao X, Liu S, Wang J, Zhao K, Long X, He X, Kang H, Yang Y, Ma X, Yue P, Shu K, Tang Z, Lei T, Liu J, Wang W, Zhang H |
The European journal of neuroscience | 2020 |
|
Inhibition of the NLRP3 inflammasome by HSP90 inhibitors
Nizami S, Arunasalam K, Green J, Cook J, Lawrence CB, Zarganes\u2010Tzitzikas T, Davis JB, Di Daniel E, Brough D |
Immunology | 2020 |
|
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
Ramlall V, Thangaraj PM, Meydan C, Foox J, Butler D, Kim J, May B, De Freitas JK, Glicksberg BS, Mason CE, Tatonetti NP, Shapira SD |
Nature Medicine | 2020 |
|
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study
Meyts I, Bucciol G, Quinti I, Neven B, Fischer A, Seoane E, Lopez-Granados E, Gianelli C, Robles-Marhuenda A, Jeandel PY, Paillard C, Sankaran VG, Demirdag YY, Lougaris V, Aiuti A, Plebani A, Milito C, Dalm VA, Guevara-Hoyer K, Sánchez-Ramón S, Bezrodnik L, Barzaghi F, Gonzalez-Granado LI, Hayman GR, Uzel G, Mendonça LO, Agostini C, Spadaro G, Badolato R, Soresina A, Vermeulen F, Bosteels C, Lambrecht BN, Keller M, Mustillo PJ, Abraham RS, Gupta S, Ozen A, Karakoc-Aydiner E, Baris S, Freeman AF, Yamazaki-Nakashimada M, Scheffler-Mendoza S, Espinosa-Padilla S, Gennery AR, Jolles S, Espinosa Y, Poli MC, Fieschi C, Hauck F, Cunningham-Rundles C, Mahlaoui N, Warnatz K, Sullivan KE, Tangye SG |
Journal of Allergy and Clinical Immunology | 2020 |
|
The Impact of SARS-CoV-2 on the Human Immune System and Microbiome
Wang C, Zhou X, Wang M, Chen X |
2020 | |
|
COVID-19 Outcomes of Gynecologic Cancer Patients in New York City
Lara OD, O\u2019Cearbhaill R, Smith M, Sutter ME, Knisely A, McEachron J, Gabor L, Jee J, Fehniger J, Lee YC, Isani S, Wright JD, Pothuri B |
Cancer | 2020 |
|
The potential public health consequences of COVID-19 on malaria in Africa.
Sherrard-Smith E, Hogan AB, Hamlet A, Watson OJ, Whittaker C, Winskill P, Ali F, Mohammad AB, Uhomoibhi P, Maikore I, Ogbulafor N, Nikau J, Kont MD, Challenger JD, Verity R, Lambert B, Cairns M, Rao B, Baguelin M, Whittles LK, Lees JA, Bhatia S, Knock ES, Okell L, Slater HC, Ghani AC, Walker PGT, Okoko OO, Churcher TS |
Nature Medicine | 2020 |
|
Single-cell landscape of immunological responses in patients with COVID-19.
Zhang JY, Wang XM, Xing X, Xu Z, Zhang C, Song JW, Fan X, Xia P, Fu JL, Wang SY, Xu RN, Dai XP, Shi L, Huang L, Jiang TJ, Shi M, Zhang Y, Zumla A, Maeurer M, Bai F, Wang FS |
Nature Immunology | 2020 |
|
A systematic review and meta-analysis of the COVID-19 associated liver injury
Wong YJ, Tan M, Zheng Q, Li JW, Kumar R, Fock KM, Teo EK, Ang TL |
2020 | |
|
The Novel Coronavirus Disease (COVID-19): A PRISMA Systematic Review and Meta-Analysis of Clinical and Paraclinical Characteristics.
Hasani H, Mardi S, Shakerian S, Taherzadeh-Ghahfarokhi N, Mardi P |
BioMed Research International | 2020 |
|
Factores pronósticos de gravedad de la infección por SARS-CoV-2
Rubio Sánchez R, Lepe Balsalobre E, Viloria Peñas MD |
2020 | |
|
SARS-CoV-2: una nueva amenaza
López Rodríguez CA, Boigues Pons M, Quirant Sánchez B, Teniente Serra A, Climent Martí J, Martínez Cáceres EM |
2020 | |
|
SARS-CoV-2: a new threat
López Rodríguez CA, Pons MB, Sánchez BQ, Serra AT, Martí JC, Martínez Cáceres EM |
2020 | |
|
Metabolic programs define dysfunctional immune responses in severe COVID-19 patients
Thompson EA, Cascino K, Ordonez AA, Zhou W, Vaghasia A, Hamacher-Brady A, Brady NR, Sun IH, Wang R, Rosenberg AZ, Delannoy M, Rothman R, Fenstermacher K, Sauer L, Shaw-Saliba K, Bloch EM, Redd AD, Tobian AA, Horton M, Smith K, Pekosz A, D\u2019Alessio FR, Yegnasubramanian S, Ji H, Cox AL, Powell JD |
2020 | |
|
Characteristic and quantifiable COVID-19-like abnormalities in CT- and PET/CT-imaged lungs of SARS-CoV-2-infected crab-eating macaques (Macaca fascicularis).
Finch CL, Crozier I, Lee JH, Byrum R, Cooper TK, Liang J, Sharer K, Solomon J, Sayre PJ, Kocher G, Bartos C, Aiosa NM, Castro M, Larson PA, Adams R, Beitzel B, Di Paola N, Kugelman JR, Kurtz JR, Burdette T, Nason MC, Feuerstein IM, Palacios G, St Claire MC, Lackemeyer MG, Johnson RF, Braun KM, Ramuta MD, Wada J, Schmaljohn CS, Friedrich TC, O'Connor DH, Kuhn JH |
bioRxiv : the preprint server for biology | 2020 |
|
Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions.
Mathew D, Giles JR, Baxter AE, Greenplate AR, Wu JE, Alanio C, Oldridge DA, Kuri-Cervantes L, Pampena MB, D'Andrea K, Manne S, Chen Z, Huang YJ, Reilly JP, Weisman AR, Ittner CAG, Kuthuru O, Dougherty J, Nzingha K, Han N, Kim J, Pattekar A, Goodwin EC, Anderson EM, Weirick ME, Gouma S, Arevalo CP, Bolton MJ, Chen F, Lacey SF, Hensley SE, Apostolidis S, Huang AC, Vella LA, Betts MR, Meyer NJ, Wherry EJ |
bioRxiv : the preprint server for biology | 2020 |
|
Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients.
Burbelo PD, Riedo FX, Morishima C, Rawlings S, Smith D, Das S, Strich JR, Chertow DS, Davey RT Jr, Cohen JI |
medRxiv : the preprint server for health sciences | 2020 |
|
Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.
Dolan ME, Hill DP, Mukherjee G, McAndrews MS, Chesler EJ, Blake JA |
bioRxiv : the preprint server for biology | 2020 |
|
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis.
Tan EH, Sena AG, Prats-Uribe A, You SC, Ahmed WU, Kostka K, Reich C, Duvall SL, Lynch KE, Matheny ME, Duarte-Salles T, Bertolin SF, Hripcsak G, Natarajan K, Falconer T, Spotnitz M, Ostropolets A, Blacketer C, Alshammari TM, Alghoul H, Alser O, Lane JCE, Dawoud DM, Shah K, Yang Y, Zhang L, Areia C, Golozar A, Relcade M, Casajust P, Jonnagaddala J, Subbian V, Vizcaya D, Lai LY, Nyberg F, Morales DR, Posada JD, Shah NH, Gong M, Vivekanantham A, Abend A, Minty EP, Suchard M, Rijnbeek P, Ryan PB, Prieto-Alhambra D |
medRxiv : the preprint server for health sciences | 2020 |
|
T cell and antibody functional correlates of severe COVID-19.
Yu KKQ, Fischinger S, Smith MT, Atyeo C, Cizmeci D, Wolf CR, Layton ED, Logue JK, Aguilar MS, Shuey K, Loos C, Yu J, Franko N, Choi RY, Wald A, Barouch DH, Koelle DM, Lauffenburger D, Chu HY, Alter G, Seshadri C |
medRxiv : the preprint server for health sciences | 2020 |
|
Kinetics of antibody responses dictate COVID-19 outcome.
Lucas C, Klein J, Sundaram M, Liu F, Wong P, Silva J, Mao T, Oh JE, Tokuyama M, Lu P, Venkataraman A, Park A, Israelow B, Wyllie AL, Vogels CBF, Muenker MC, Casanovas-Massana A, Schulz WL, Zell J, Campbell M, Fournier JB, Grubaugh ND, Farhadian S, Wisnewski AV, Cruz CD, Omer S, Ko AI, Ring A, Iwasaki A |
medRxiv : the preprint server for health sciences | 2020 |
|
Comparative ACE2 variation and primate COVID-19 risk
Melin AD, Janiak MC, Marrone F III, Arora PS, Higham JP |
2020 | |
|
Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection
Singh K, Chen YC, Judy JT, Seifuddin F, Tunc I, Pirooznia M |
2020 | |
|
Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium
Ravindra NG, Alfajaro MM, Gasque V, Habet V, Wei J, Filler RB, Huston NC, Wan H, Szigeti-Buck K, Wang B, Wang G, Montgomery RR, Eisenbarth SC, Williams A, Pyle AM, Iwasaki A, Horvath TL, Foxman EF, Pierce RW, van Dijk D, Wilen CB |
2020 | |
|
Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcome
Ramlall V, Thangaraj PM, Meydan C, Foox J, Butler D, May B, De Freitas JK, Glicksberg BS, Mason CE, Tatonetti NP, Shapira SD |
2020 | |
|
K18-hACE2 mice develop respiratory disease resembling severe COVID-19
Yinda CK, Port JR, Bushmaker T, Owusu IO, Avanzato VA, Fischer RJ, Schulz JE, Holbrook MG, Hebner MJ, Rosenke R, Thomas T, Marzi A, Best SM, de Wit E, Shaia C, van Doremalen N, Munster VJ |
2020 | |
|
COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative review
Kowalewski M, Fina D, Słomka A, Raffa GM, Martucci G, Lo Coco V, De Piero ME, Ranucci M, Suwalski P, Lorusso R |
Critical Care | 2020 |
|
Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands
Oudkerk M, Büller HR, Kuijpers D, van Es N, Oudkerk SF, McLoud TC, Gommers D, van Dissel J, ten Cate H, van Beek EJ |
Radiology | 2020 |
|
Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages
Zhao M, Wang M, Zhang J, Gu J, Zhang P, Xu Y, Ye J, Wang Z, Ye D, Pan W, Shen B, He H, Liu M, Liu M, Luo Z, Li D, Liu J, Wan J |
Aging | 2020 |
|
Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
Moutchia J, Pokharel P, Kerri A, McGaw K, Uchai S, Nji M, Goodman M |
PloS one | 2020 |
|
Plausible mechanisms explaining the role of cucurbitacins as potential therapeutic drugs against coronavirus 2019
Kapoor N, Ghorai SM, Kushwaha PK, Shukla R, Aggarwal C, Bandichhor R |
Informatics in medicine unlocked | 2020 |
|
Acute kidney injury is associated with worse prognosis in COVID-19 patients: a systematic review and meta-analysis
Cheruiyot I, Kipkorir V, Ngure B, Misiani M, Munguti J, Henry B, Lippi G |
2020 | |
|
Pre-test probability for SARS-Cov-2-related infection score: The PARIS score
Tordjman M, Mekki A, Mali RD, Saab I, Chassagnon G, Guillo E, Burns R, Eshagh D, Beaune S, Madelin G, Bessis S, Feydy A, Mihoubi F, Doumenc B, Mouthon L, Carlier RY, Drapé JL, Revel MP |
PloS one | 2020 |
|
COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection
Casey K, Iteen A, Nicolini R, Auten J |
The American Journal of Emergency Medicine | 2020 |
|
Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19)
Lippi G, Wong J, Henry BM |
World Journal of Emergency Medicine | 2020 |
|
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
McGonagle D, Sharif K, O'Regan A, Bridgewood C |
Autoimmunity Reviews | 2020 |
|
Current Options in the Treatment of COVID-19: A Review.
Teimury A, Mahmoodi Khaledi E |
Risk Management and Healthcare Policy | 2020 |
|
Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation.
Antony SJ, Singh J, de Jesus M, Lance J |
IDCases | 2020 |
|
A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
Wilk AJ, Rustagi A, Zhao NQ, Roque J, Martínez-Colón GJ, McKechnie JL, Ivison GT, Ranganath T, Vergara R, Hollis T, Simpson LJ, Grant P, Subramanian A, Rogers AJ, Blish CA |
Nature Medicine | 2020 |
|
COVID-19: Key Concepts for the Surgeon
Rubio-Pérez I, Badía JM, Mora-Rillo M, Martín Quirós A, García Rodríguez J, Balibrea JM |
Cirugía Española (English Edition) | 2020 |
|
Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: a systematic review and meta-analysis
Xu L, Mao Y, Chen G |
Aging | 2020 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)